{
    "5e2900368b3851296d000001_001": [
        {
            "text": "",
            "probability": 0.9871574996016803,
            "start_logit": 2.4673120975494385,
            "end_logit": 2.8538057804107666
        },
        {
            "text": "Compound 12c showed potent and prolonged LH suppression",
            "probability": 0.002353020530762621,
            "start_logit": -0.7342110276222229,
            "end_logit": 0.0161991398781538
        },
        {
            "text": "Compound 12c showed potent and prolonged LH suppression after a single dose was orally administered in castrated monkeys",
            "probability": 0.00199092124786682,
            "start_logit": -0.7342110276222229,
            "end_logit": -0.15090322494506836
        },
        {
            "text": "LH suppression",
            "probability": 0.0011410771313892414,
            "start_logit": -1.4579381942749023,
            "end_logit": 0.0161991398781538
        },
        {
            "text": "Compound 12c showed potent and prolonged LH suppression after a single dose was orally administered in castrated monkeys compared to a known antagonist",
            "probability": 0.0010148161627221211,
            "start_logit": -0.7342110276222229,
            "end_logit": -0.8247932195663452
        },
        {
            "text": "LH suppression after a single dose was orally administered in castrated monkeys",
            "probability": 0.0009654801888198848,
            "start_logit": -1.4579381942749023,
            "end_logit": -0.15090322494506836
        },
        {
            "text": "prolonged LH suppression",
            "probability": 0.000768551205234057,
            "start_logit": -1.853158950805664,
            "end_logit": 0.0161991398781538
        },
        {
            "text": "prolonged LH suppression after a single dose was orally administered in castrated monkeys",
            "probability": 0.0006502811618384899,
            "start_logit": -1.853158950805664,
            "end_logit": -0.15090322494506836
        },
        {
            "text": "showed potent and prolonged LH suppression",
            "probability": 0.0005053660047402965,
            "start_logit": -2.272383213043213,
            "end_logit": 0.0161991398781538
        },
        {
            "text": "castrated monkeys",
            "probability": 0.0004978322861265323,
            "start_logit": -2.120300531387329,
            "end_logit": -0.15090322494506836
        },
        {
            "text": "LH suppression after a single dose was orally administered in castrated monkeys compared to a known antagonist",
            "probability": 0.0004921263969894431,
            "start_logit": -1.4579381942749023,
            "end_logit": -0.8247932195663452
        },
        {
            "text": "showed potent and prolonged LH suppression after a single dose was orally administered in castrated monkeys",
            "probability": 0.00042759674368881363,
            "start_logit": -2.272383213043213,
            "end_logit": -0.15090322494506836
        },
        {
            "text": "We identified compound 12c as a highly potent GnRH antagonist with moderate CYP inhibition. Compound 12c showed potent and prolonged LH suppression",
            "probability": 0.0003407677286850291,
            "start_logit": -2.6664650440216064,
            "end_logit": 0.0161991398781538
        },
        {
            "text": "prolonged LH suppression after a single dose was orally administered in castrated monkeys compared to a known antagonist",
            "probability": 0.00033146254983942137,
            "start_logit": -1.853158950805664,
            "end_logit": -0.8247932195663452
        },
        {
            "text": "potent and prolonged LH suppression",
            "probability": 0.0002917643614691674,
            "start_logit": -2.8217196464538574,
            "end_logit": 0.0161991398781538
        },
        {
            "text": "castrated monkeys compared to a known antagonist",
            "probability": 0.0002537560191431056,
            "start_logit": -2.120300531387329,
            "end_logit": -0.8247932195663452
        },
        {
            "text": "potent and prolonged LH suppression after a single dose was orally administered in castrated monkeys",
            "probability": 0.00024686561762850235,
            "start_logit": -2.8217196464538574,
            "end_logit": -0.15090322494506836
        },
        {
            "text": "showed potent and prolonged LH suppression after a single dose was orally administered in castrated monkeys compared to a known antagonist",
            "probability": 0.000217955424950984,
            "start_logit": -2.272383213043213,
            "end_logit": -0.8247932195663452
        },
        {
            "text": "Compound 12c",
            "probability": 0.00020840910176975102,
            "start_logit": -0.7342110276222229,
            "end_logit": -2.4077529907226562
        },
        {
            "text": "moderate CYP inhibition. Compound 12c showed potent and prolonged LH suppression",
            "probability": 0.00014445053465554574,
            "start_logit": -3.524729013442993,
            "end_logit": 0.0161991398781538
        }
    ],
    "5e2900368b3851296d000001_002": [
        {
            "text": "orally active, non-peptide, competitive gonadotropin-releasing hormone",
            "probability": 0.15653236280028124,
            "start_logit": -1.3376057147979736,
            "end_logit": -0.3777150511741638
        },
        {
            "text": "a robust model was developed to describe elagolix population pharmacokinetics",
            "probability": 0.11363547056025228,
            "start_logit": -1.2515407800674438,
            "end_logit": -0.7840470671653748
        },
        {
            "text": "a robust model",
            "probability": 0.10091220766923568,
            "start_logit": -1.2515407800674438,
            "end_logit": -0.9027918577194214
        },
        {
            "text": "a novel, orally active, non-peptide, competitive gonadotropin-releasing hormone",
            "probability": 0.09089962892346244,
            "start_logit": -1.8811125755310059,
            "end_logit": -0.3777150511741638
        },
        {
            "text": "gonadotropin-releasing hormone",
            "probability": 0.08878780216329682,
            "start_logit": -1.9046192169189453,
            "end_logit": -0.3777150511741638
        },
        {
            "text": "novel, orally active, non-peptide, competitive gonadotropin-releasing hormone",
            "probability": 0.0778321792472933,
            "start_logit": -2.036313533782959,
            "end_logit": -0.3777150511741638
        },
        {
            "text": "orally active, non-peptide, competitive gonadotropin-releasing hormone (GnRH)",
            "probability": 0.04276412901417107,
            "start_logit": -1.3376057147979736,
            "end_logit": -1.6752781867980957
        },
        {
            "text": "robust model was developed to describe elagolix population pharmacokinetics",
            "probability": 0.04175844535311193,
            "start_logit": -2.2526347637176514,
            "end_logit": -0.7840470671653748
        },
        {
            "text": "robust model",
            "probability": 0.037082936240258976,
            "start_logit": -2.2526347637176514,
            "end_logit": -0.9027918577194214
        },
        {
            "text": "organic anion transporting polypeptide (OATP) 1B1 genotype status",
            "probability": 0.03164403174948673,
            "start_logit": -0.8957405090332031,
            "end_logit": -2.4182934761047363
        },
        {
            "text": "Elagolix is a novel, orally active, non-peptide, competitive gonadotropin-releasing hormone",
            "probability": 0.02914562299713457,
            "start_logit": -3.018563747406006,
            "end_logit": -0.3777150511741638
        },
        {
            "text": "a novel, orally active, non-peptide, competitive gonadotropin-releasing hormone (GnRH)",
            "probability": 0.024833481007265804,
            "start_logit": -1.8811125755310059,
            "end_logit": -1.6752781867980957
        },
        {
            "text": "gonadotropin-releasing hormone (GnRH)",
            "probability": 0.02425653685072401,
            "start_logit": -1.9046192169189453,
            "end_logit": -1.6752781867980957
        },
        {
            "text": "organic anion transporting polypeptide",
            "probability": 0.023875549691802448,
            "start_logit": -0.8957405090332031,
            "end_logit": -2.6999881267547607
        },
        {
            "text": "population pharmacokinetics",
            "probability": 0.02213563559504216,
            "start_logit": -2.88734769821167,
            "end_logit": -0.7840470671653748
        },
        {
            "text": "novel, orally active, non-peptide, competitive gonadotropin-releasing hormone (GnRH)",
            "probability": 0.02126349653989481,
            "start_logit": -2.036313533782959,
            "end_logit": -1.6752781867980957
        },
        {
            "text": "orally active",
            "probability": 0.01916189258874553,
            "start_logit": -1.3376057147979736,
            "end_logit": -2.4780542850494385
        },
        {
            "text": "",
            "probability": 0.018428835733135706,
            "start_logit": -2.324409246444702,
            "end_logit": -1.5302577018737793
        },
        {
            "text": "orally active, non-peptide, competitive gonadotropin-releasing hormone (GnRH) receptor antagonist",
            "probability": 0.018266127343212785,
            "start_logit": -1.3376057147979736,
            "end_logit": -2.5259294509887695
        },
        {
            "text": "non-peptide, competitive gonadotropin-releasing hormone",
            "probability": 0.0167836279321919,
            "start_logit": -3.570464611053467,
            "end_logit": -0.3777150511741638
        }
    ],
    "5e2900368b3851296d000001_003": [
        {
            "text": "an oral, nonpeptide gonadotropin-releasing hormone antagonist",
            "probability": 0.28819398985878975,
            "start_logit": 0.8871380090713501,
            "end_logit": 3.431760787963867
        },
        {
            "text": "oral, nonpeptide gonadotropin-releasing hormone antagonist",
            "probability": 0.20387494599540998,
            "start_logit": 0.5410109758377075,
            "end_logit": 3.431760787963867
        },
        {
            "text": "gonadotropin-releasing hormone antagonist",
            "probability": 0.18921764319854867,
            "start_logit": 0.4664020836353302,
            "end_logit": 3.431760787963867
        },
        {
            "text": "an oral, nonpeptide gonadotropin-releasing hormone",
            "probability": 0.06013537516431077,
            "start_logit": 0.8871380090713501,
            "end_logit": 1.8647252321243286
        },
        {
            "text": "nonpeptide gonadotropin-releasing hormone antagonist",
            "probability": 0.04768455631287997,
            "start_logit": -0.9118882417678833,
            "end_logit": 3.431760787963867
        },
        {
            "text": "oral, nonpeptide gonadotropin-releasing hormone",
            "probability": 0.04254112436572609,
            "start_logit": 0.5410109758377075,
            "end_logit": 1.8647252321243286
        },
        {
            "text": "gonadotropin-releasing hormone",
            "probability": 0.03948268999997808,
            "start_logit": 0.4664020836353302,
            "end_logit": 1.8647252321243286
        },
        {
            "text": "CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT01760954 and NCT02143713",
            "probability": 0.022534835624492853,
            "start_logit": 2.8718972206115723,
            "end_logit": -1.1015698909759521
        },
        {
            "text": "CLINICAL TRIAL",
            "probability": 0.021723997943025708,
            "start_logit": 2.8718972206115723,
            "end_logit": -1.1382147073745728
        },
        {
            "text": "CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT01760954 and NCT02143713.",
            "probability": 0.017282917338722902,
            "start_logit": 2.8718972206115723,
            "end_logit": -1.3669136762619019
        },
        {
            "text": "To evaluate the efficacy and safety of elagolix, an oral, nonpeptide gonadotropin-releasing hormone antagonist",
            "probability": 0.015524273394290754,
            "start_logit": -2.034090995788574,
            "end_logit": 3.431760787963867
        },
        {
            "text": "nonpeptide gonadotropin-releasing hormone",
            "probability": 0.00994999474077784,
            "start_logit": -0.9118882417678833,
            "end_logit": 1.8647252321243286
        },
        {
            "text": "an oral, nonpeptide gonadotropin-releasing hormone antagonist,",
            "probability": 0.006653516894316086,
            "start_logit": 0.8871380090713501,
            "end_logit": -0.33672747015953064
        },
        {
            "text": "hormone antagonist",
            "probability": 0.006275101749288551,
            "start_logit": -2.939906120300293,
            "end_logit": 3.431760787963867
        },
        {
            "text": "an oral, nonpeptide gonadotropin-releasing",
            "probability": 0.005390198327581459,
            "start_logit": 0.8871380090713501,
            "end_logit": -0.5472908616065979
        },
        {
            "text": "antagonist",
            "probability": 0.004887475963952862,
            "start_logit": -3.189819812774658,
            "end_logit": 3.431760787963867
        },
        {
            "text": "oral, nonpeptide gonadotropin-releasing hormone antagonist,",
            "probability": 0.0047068483217602665,
            "start_logit": 0.5410109758377075,
            "end_logit": -0.33672747015953064
        },
        {
            "text": "gonadotropin-releasing hormone antagonist,",
            "probability": 0.0043684560748164375,
            "start_logit": 0.4664020836353302,
            "end_logit": -0.33672747015953064
        },
        {
            "text": "oral, nonpeptide gonadotropin-releasing",
            "probability": 0.0038131481974300534,
            "start_logit": 0.5410109758377075,
            "end_logit": -0.5472908616065979
        },
        {
            "text": "gonadotropin-releasing",
            "probability": 0.0035390072652710988,
            "start_logit": 0.4664020836353302,
            "end_logit": -0.5472908616065979
        },
        {
            "text": "",
            "probability": 0.002219903268629754,
            "start_logit": -0.526441216468811,
            "end_logit": -0.020830193534493446
        }
    ],
    "5e2900368b3851296d000001_004": [
        {
            "text": "a new oral GnRH antagonist",
            "probability": 0.6028269369638843,
            "start_logit": 1.5698034763336182,
            "end_logit": 1.5342738628387451
        },
        {
            "text": "oral GnRH antagonist",
            "probability": 0.08094880654496144,
            "start_logit": -0.43800973892211914,
            "end_logit": 1.5342738628387451
        },
        {
            "text": "Promising preliminary data have emerged from multicenter Phase III trials",
            "probability": 0.07033676923583211,
            "start_logit": -1.2196722030639648,
            "end_logit": 2.1754140853881836
        },
        {
            "text": "Promising preliminary data have emerged from multicenter Phase III trials on elagolix, a new oral GnRH antagonist",
            "probability": 0.037045781023929754,
            "start_logit": -1.2196722030639648,
            "end_logit": 1.5342738628387451
        },
        {
            "text": "Phase III trials",
            "probability": 0.023326454365942,
            "start_logit": -2.323378801345825,
            "end_logit": 2.1754140853881836
        },
        {
            "text": "multicenter Phase III trials",
            "probability": 0.023259928679776568,
            "start_logit": -2.326234817504883,
            "end_logit": 2.1754140853881836
        },
        {
            "text": "elagolix, a new oral GnRH antagonist",
            "probability": 0.02023616422689691,
            "start_logit": -1.8243553638458252,
            "end_logit": 1.5342738628387451
        },
        {
            "text": "",
            "probability": 0.019457041436067916,
            "start_logit": -0.3716840147972107,
            "end_logit": 0.0423402339220047
        },
        {
            "text": "new oral GnRH antagonist",
            "probability": 0.017689022063587818,
            "start_logit": -1.958882451057434,
            "end_logit": 1.5342738628387451
        },
        {
            "text": "a new oral GnRH antagonist but non-inferiority RCT data",
            "probability": 0.015865875940298032,
            "start_logit": 1.5698034763336182,
            "end_logit": -2.1031856536865234
        },
        {
            "text": "preliminary data have emerged from multicenter Phase III trials",
            "probability": 0.015519086660994741,
            "start_logit": -2.730896234512329,
            "end_logit": 2.1754140853881836
        },
        {
            "text": "Phase III trials on elagolix, a new oral GnRH antagonist",
            "probability": 0.012285846078712834,
            "start_logit": -2.323378801345825,
            "end_logit": 1.5342738628387451
        },
        {
            "text": "multicenter Phase III trials on elagolix, a new oral GnRH antagonist",
            "probability": 0.01225080756288496,
            "start_logit": -2.326234817504883,
            "end_logit": 1.5342738628387451
        },
        {
            "text": "a new oral GnRH antagonist but non-inferiority RCT data are required to compare elagolix",
            "probability": 0.010573879310541672,
            "start_logit": 1.5698034763336182,
            "end_logit": -2.50896954536438
        },
        {
            "text": "non-inferiority RCT data are required to compare elagolix with first-line therapies for endometriosis.",
            "probability": 0.00963622105944584,
            "start_logit": -0.46669673919677734,
            "end_logit": -0.5653270483016968
        },
        {
            "text": "preliminary data have emerged from multicenter Phase III trials on elagolix, a new oral GnRH antagonist",
            "probability": 0.008173771590318039,
            "start_logit": -2.730896234512329,
            "end_logit": 1.5342738628387451
        },
        {
            "text": "a new oral GnRH",
            "probability": 0.006226601684428954,
            "start_logit": 1.5698034763336182,
            "end_logit": -3.0385255813598633
        },
        {
            "text": "a new oral GnRH antagonist but non-inferiority RCT",
            "probability": 0.005757059024102594,
            "start_logit": 1.5698034763336182,
            "end_logit": -3.116929531097412
        },
        {
            "text": "a new oral GnRH antagonist but non-inferiority RCT data are required",
            "probability": 0.0044995076936321715,
            "start_logit": 1.5698034763336182,
            "end_logit": -3.3633882999420166
        },
        {
            "text": "elagolix with first-line therapies for endometriosis.",
            "probability": 0.004084438853761497,
            "start_logit": -1.32504141330719,
            "end_logit": -0.5653270483016968
        }
    ],
    "5e2900368b3851296d000001_005": [
        {
            "text": "gonadotropin-releasing hormone (GnRH) receptor antagonist",
            "probability": 0.449983140411873,
            "start_logit": 1.9452826976776123,
            "end_logit": 3.0005717277526855
        },
        {
            "text": "an orally bioavailable, second-generation, non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist",
            "probability": 0.15522124164809933,
            "start_logit": 0.8809240460395813,
            "end_logit": 3.0005717277526855
        },
        {
            "text": "gonadotropin-releasing hormone",
            "probability": 0.10589415360457817,
            "start_logit": 1.9452826976776123,
            "end_logit": 1.5538016557693481
        },
        {
            "text": "orally bioavailable, second-generation, non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist",
            "probability": 0.09125139165687819,
            "start_logit": 0.34969082474708557,
            "end_logit": 3.0005717277526855
        },
        {
            "text": "non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist",
            "probability": 0.04846075979046312,
            "start_logit": -0.2831730246543884,
            "end_logit": 3.0005717277526855
        },
        {
            "text": "an orally bioavailable, second-generation, non-peptide gonadotropin-releasing hormone",
            "probability": 0.03652808412051226,
            "start_logit": 0.8809240460395813,
            "end_logit": 1.5538016557693481
        },
        {
            "text": "gonadotropin-releasing hormone (GnRH)",
            "probability": 0.025986536558510256,
            "start_logit": 1.9452826976776123,
            "end_logit": 0.14894019067287445
        },
        {
            "text": "orally bioavailable, second-generation, non-peptide gonadotropin-releasing hormone",
            "probability": 0.02147411317655229,
            "start_logit": 0.34969082474708557,
            "end_logit": 1.5538016557693481
        },
        {
            "text": "non-peptide gonadotropin-releasing hormone",
            "probability": 0.01140422980369614,
            "start_logit": -0.2831730246543884,
            "end_logit": 1.5538016557693481
        },
        {
            "text": "receptor antagonist",
            "probability": 0.00997727134693898,
            "start_logit": -1.8636177778244019,
            "end_logit": 3.0005717277526855
        },
        {
            "text": "gonadotropin-releasing hormone (GnRH) receptor",
            "probability": 0.009629658260289525,
            "start_logit": 1.9452826976776123,
            "end_logit": -0.8437906503677368
        },
        {
            "text": "an orally bioavailable, second-generation, non-peptide gonadotropin-releasing hormone (GnRH)",
            "probability": 0.008964030223562703,
            "start_logit": 0.8809240460395813,
            "end_logit": 0.14894019067287445
        },
        {
            "text": "orally bioavailable, second-generation, non-peptide gonadotropin-releasing hormone (GnRH)",
            "probability": 0.005269769936571239,
            "start_logit": 0.34969082474708557,
            "end_logit": 0.14894019067287445
        },
        {
            "text": "gonadotropin-releasing hormone (GnRH) receptor antagonist,",
            "probability": 0.004264837800827576,
            "start_logit": 1.9452826976776123,
            "end_logit": -1.6582342386245728
        },
        {
            "text": "antagonist",
            "probability": 0.0038367240835972365,
            "start_logit": -2.8193085193634033,
            "end_logit": 3.0005717277526855
        },
        {
            "text": "an orally bioavailable, second-generation, non-peptide gonadotropin-releasing hormone (GnRH) receptor",
            "probability": 0.0033217411444368358,
            "start_logit": 0.8809240460395813,
            "end_logit": -0.8437906503677368
        },
        {
            "text": "non-peptide gonadotropin-releasing hormone (GnRH)",
            "probability": 0.002798609976354629,
            "start_logit": -0.2831730246543884,
            "end_logit": 0.14894019067287445
        },
        {
            "text": "second-generation, non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist",
            "probability": 0.0019693616269801334,
            "start_logit": -3.486217975616455,
            "end_logit": 3.0005717277526855
        },
        {
            "text": "orally bioavailable, second-generation, non-peptide gonadotropin-releasing hormone (GnRH) receptor",
            "probability": 0.0019527836456878648,
            "start_logit": 0.34969082474708557,
            "end_logit": -0.8437906503677368
        },
        {
            "text": "an orally bioavailable",
            "probability": 0.0018109416516325406,
            "start_logit": 0.8809240460395813,
            "end_logit": -1.4504327774047852
        },
        {
            "text": "",
            "probability": 6.195319580388145e-07,
            "start_logit": -4.670635223388672,
            "end_logit": -3.8792667388916016
        }
    ],
    "5e2900368b3851296d000001_006": [
        {
            "text": "elagolix with 1.0 mg estradiol/0.5 mg norethindrone acetate",
            "probability": 0.28479963845564304,
            "start_logit": -1.0721428394317627,
            "end_logit": 1.178700566291809
        },
        {
            "text": "1.0 mg estradiol/0.5 mg norethindrone acetate",
            "probability": 0.13436296366654338,
            "start_logit": -1.8233839273452759,
            "end_logit": 1.178700566291809
        },
        {
            "text": "oral gonadotropin-releasing hormone receptor antagonist",
            "probability": 0.1293997015893431,
            "start_logit": -0.7873685359954834,
            "end_logit": 0.10504642874002457
        },
        {
            "text": "",
            "probability": 0.07692416818898523,
            "start_logit": -0.8342428803443909,
            "end_logit": -0.36816519498825073
        },
        {
            "text": "an oral gonadotropin-releasing hormone receptor antagonist",
            "probability": 0.07235633976029401,
            "start_logit": -1.3686715364456177,
            "end_logit": 0.10504642874002457
        },
        {
            "text": "gonadotropin-releasing hormone receptor antagonist",
            "probability": 0.06873883693842414,
            "start_logit": -1.4199602603912354,
            "end_logit": 0.10504642874002457
        },
        {
            "text": "estradiol/0.5 mg norethindrone acetate",
            "probability": 0.027624076707542914,
            "start_logit": -3.405241012573242,
            "end_logit": 1.178700566291809
        },
        {
            "text": "oral gonadotropin-releasing hormone",
            "probability": 0.026866823108393882,
            "start_logit": -0.7873685359954834,
            "end_logit": -1.4669674634933472
        },
        {
            "text": "oral gonadotropin-releasing hormone receptor antagonist, alone or with add-back therapy",
            "probability": 0.024797391843286425,
            "start_logit": -0.7873685359954834,
            "end_logit": -1.5471211671829224
        },
        {
            "text": "norethindrone acetate",
            "probability": 0.023269720364372123,
            "start_logit": -3.5767757892608643,
            "end_logit": 1.178700566291809
        },
        {
            "text": "oral gonadotropin-releasing hormone receptor",
            "probability": 0.022409176635257322,
            "start_logit": -0.7873685359954834,
            "end_logit": -1.6483891010284424
        },
        {
            "text": "an oral gonadotropin-releasing hormone",
            "probability": 0.015023102505135654,
            "start_logit": -1.3686715364456177,
            "end_logit": -1.4669674634933472
        },
        {
            "text": "gonadotropin-releasing hormone",
            "probability": 0.014272012609134702,
            "start_logit": -1.4199602603912354,
            "end_logit": -1.4669674634933472
        },
        {
            "text": "an oral gonadotropin-releasing hormone receptor antagonist, alone or with add-back therapy",
            "probability": 0.013865940085983505,
            "start_logit": -1.3686715364456177,
            "end_logit": -1.5471211671829224
        },
        {
            "text": "gonadotropin-releasing hormone receptor antagonist, alone or with add-back therapy",
            "probability": 0.013172703286622218,
            "start_logit": -1.4199602603912354,
            "end_logit": -1.5471211671829224
        },
        {
            "text": "an oral gonadotropin-releasing hormone receptor",
            "probability": 0.012530523474581626,
            "start_logit": -1.3686715364456177,
            "end_logit": -1.6483891010284424
        },
        {
            "text": "gonadotropin-releasing hormone receptor",
            "probability": 0.011904051707505308,
            "start_logit": -1.4199602603912354,
            "end_logit": -1.6483891010284424
        },
        {
            "text": "hormone receptor antagonist",
            "probability": 0.011121438127982008,
            "start_logit": -3.2414000034332275,
            "end_logit": 0.10504642874002457
        },
        {
            "text": "oral gonadotropin-releasing",
            "probability": 0.009225076083166752,
            "start_logit": -0.7873685359954834,
            "end_logit": -2.5359342098236084
        },
        {
            "text": "0.5 mg estradiol/0.1 mg norethindrone acetate",
            "probability": 0.007336314861802602,
            "start_logit": -2.5539581775665283,
            "end_logit": -0.9984333515167236
        }
    ],
    "5c7006037c78d6947100005d_001": [
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.5009494385223676,
            "start_logit": 5.240076541900635,
            "end_logit": 4.591526985168457
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.22297003324609646,
            "start_logit": 4.430608749389648,
            "end_logit": 4.591526985168457
        },
        {
            "text": "8 for central nervous system and vascular",
            "probability": 0.113947458064691,
            "start_logit": 5.240076541900635,
            "end_logit": 3.1107592582702637
        },
        {
            "text": "central nervous system and vascular",
            "probability": 0.050717430860755246,
            "start_logit": 4.430608749389648,
            "end_logit": 3.1107592582702637
        },
        {
            "text": "4 for renal and musculoskeletal",
            "probability": 0.04067361668249477,
            "start_logit": 2.7291510105133057,
            "end_logit": 4.591526985168457
        },
        {
            "text": "renal and musculoskeletal",
            "probability": 0.03961617482105144,
            "start_logit": 2.7028088569641113,
            "end_logit": 4.591526985168457
        },
        {
            "text": "2 for serosal, dermal, immunologic, and 1 for constitutional and hematologic",
            "probability": 0.009374904631171957,
            "start_logit": 1.6294957399368286,
            "end_logit": 4.223639011383057
        },
        {
            "text": "8 for central nervous system and vascular,",
            "probability": 0.004837625783678878,
            "start_logit": 5.240076541900635,
            "end_logit": -0.048554129898548126
        },
        {
            "text": "serosal, dermal, immunologic, and 1 for constitutional and hematologic",
            "probability": 0.003271648081143724,
            "start_logit": 0.5767531991004944,
            "end_logit": 4.223639011383057
        },
        {
            "text": "central nervous system and vascular,",
            "probability": 0.002153202496844182,
            "start_logit": 4.430608749389648,
            "end_logit": -0.048554129898548126
        },
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal,",
            "probability": 0.0019807878945416464,
            "start_logit": 5.240076541900635,
            "end_logit": -0.9414834976196289
        },
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal, 2",
            "probability": 0.00169302669865371,
            "start_logit": 5.240076541900635,
            "end_logit": -1.09846031665802
        },
        {
            "text": "2 for serosal, dermal, immunologic, and 1 for constitutional and hematologic.",
            "probability": 0.001599255894691968,
            "start_logit": 1.6294957399368286,
            "end_logit": 2.455141067504883
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal, 2 for serosal, dermal, immunologic",
            "probability": 0.0014569820631863237,
            "start_logit": 4.430608749389648,
            "end_logit": -0.43914318084716797
        },
        {
            "text": "",
            "probability": 0.0014325636537835648,
            "start_logit": 2.017364263534546,
            "end_logit": 1.9571996927261353
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal,",
            "probability": 0.0008816385621713721,
            "start_logit": 4.430608749389648,
            "end_logit": -0.9414834976196289
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal, 2",
            "probability": 0.0007535575254836649,
            "start_logit": 4.430608749389648,
            "end_logit": -1.09846031665802
        },
        {
            "text": "1 for constitutional and hematologic",
            "probability": 0.0006611435706593065,
            "start_logit": -1.0223249197006226,
            "end_logit": 4.223639011383057
        },
        {
            "text": "serosal, dermal, immunologic, and 1 for constitutional and hematologic.",
            "probability": 0.0005581072752174428,
            "start_logit": 0.5767531991004944,
            "end_logit": 2.455141067504883
        },
        {
            "text": "for central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.0004714036713158419,
            "start_logit": -1.7284691333770752,
            "end_logit": 4.591526985168457
        }
    ],
    "5c7006037c78d6947100005d_002": [
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.5009494385223676,
            "start_logit": 5.240076541900635,
            "end_logit": 4.591526985168457
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.22297003324609646,
            "start_logit": 4.430608749389648,
            "end_logit": 4.591526985168457
        },
        {
            "text": "8 for central nervous system and vascular",
            "probability": 0.113947458064691,
            "start_logit": 5.240076541900635,
            "end_logit": 3.1107592582702637
        },
        {
            "text": "central nervous system and vascular",
            "probability": 0.050717430860755246,
            "start_logit": 4.430608749389648,
            "end_logit": 3.1107592582702637
        },
        {
            "text": "4 for renal and musculoskeletal",
            "probability": 0.04067361668249477,
            "start_logit": 2.7291510105133057,
            "end_logit": 4.591526985168457
        },
        {
            "text": "renal and musculoskeletal",
            "probability": 0.03961617482105144,
            "start_logit": 2.7028088569641113,
            "end_logit": 4.591526985168457
        },
        {
            "text": "2 for serosal, dermal, immunologic, and 1 for constitutional and hematologic",
            "probability": 0.009374904631171957,
            "start_logit": 1.6294957399368286,
            "end_logit": 4.223639011383057
        },
        {
            "text": "8 for central nervous system and vascular,",
            "probability": 0.004837625783678878,
            "start_logit": 5.240076541900635,
            "end_logit": -0.048554129898548126
        },
        {
            "text": "serosal, dermal, immunologic, and 1 for constitutional and hematologic",
            "probability": 0.003271648081143724,
            "start_logit": 0.5767531991004944,
            "end_logit": 4.223639011383057
        },
        {
            "text": "central nervous system and vascular,",
            "probability": 0.002153202496844182,
            "start_logit": 4.430608749389648,
            "end_logit": -0.048554129898548126
        },
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal,",
            "probability": 0.0019807878945416464,
            "start_logit": 5.240076541900635,
            "end_logit": -0.9414834976196289
        },
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal, 2",
            "probability": 0.00169302669865371,
            "start_logit": 5.240076541900635,
            "end_logit": -1.09846031665802
        },
        {
            "text": "2 for serosal, dermal, immunologic, and 1 for constitutional and hematologic.",
            "probability": 0.001599255894691968,
            "start_logit": 1.6294957399368286,
            "end_logit": 2.455141067504883
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal, 2 for serosal, dermal, immunologic",
            "probability": 0.0014569820631863237,
            "start_logit": 4.430608749389648,
            "end_logit": -0.43914318084716797
        },
        {
            "text": "",
            "probability": 0.0014325636537835648,
            "start_logit": 2.017364263534546,
            "end_logit": 1.9571996927261353
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal,",
            "probability": 0.0008816385621713721,
            "start_logit": 4.430608749389648,
            "end_logit": -0.9414834976196289
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal, 2",
            "probability": 0.0007535575254836649,
            "start_logit": 4.430608749389648,
            "end_logit": -1.09846031665802
        },
        {
            "text": "1 for constitutional and hematologic",
            "probability": 0.0006611435706593065,
            "start_logit": -1.0223249197006226,
            "end_logit": 4.223639011383057
        },
        {
            "text": "serosal, dermal, immunologic, and 1 for constitutional and hematologic.",
            "probability": 0.0005581072752174428,
            "start_logit": 0.5767531991004944,
            "end_logit": 2.455141067504883
        },
        {
            "text": "for central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.0004714036713158419,
            "start_logit": -1.7284691333770752,
            "end_logit": 4.591526985168457
        }
    ],
    "5c7006037c78d6947100005d_003": [
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.5009494385223676,
            "start_logit": 5.240076541900635,
            "end_logit": 4.591526985168457
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.22297003324609646,
            "start_logit": 4.430608749389648,
            "end_logit": 4.591526985168457
        },
        {
            "text": "8 for central nervous system and vascular",
            "probability": 0.113947458064691,
            "start_logit": 5.240076541900635,
            "end_logit": 3.1107592582702637
        },
        {
            "text": "central nervous system and vascular",
            "probability": 0.050717430860755246,
            "start_logit": 4.430608749389648,
            "end_logit": 3.1107592582702637
        },
        {
            "text": "4 for renal and musculoskeletal",
            "probability": 0.04067361668249477,
            "start_logit": 2.7291510105133057,
            "end_logit": 4.591526985168457
        },
        {
            "text": "renal and musculoskeletal",
            "probability": 0.03961617482105144,
            "start_logit": 2.7028088569641113,
            "end_logit": 4.591526985168457
        },
        {
            "text": "2 for serosal, dermal, immunologic, and 1 for constitutional and hematologic",
            "probability": 0.009374904631171957,
            "start_logit": 1.6294957399368286,
            "end_logit": 4.223639011383057
        },
        {
            "text": "8 for central nervous system and vascular,",
            "probability": 0.004837625783678878,
            "start_logit": 5.240076541900635,
            "end_logit": -0.048554129898548126
        },
        {
            "text": "serosal, dermal, immunologic, and 1 for constitutional and hematologic",
            "probability": 0.003271648081143724,
            "start_logit": 0.5767531991004944,
            "end_logit": 4.223639011383057
        },
        {
            "text": "central nervous system and vascular,",
            "probability": 0.002153202496844182,
            "start_logit": 4.430608749389648,
            "end_logit": -0.048554129898548126
        },
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal,",
            "probability": 0.0019807878945416464,
            "start_logit": 5.240076541900635,
            "end_logit": -0.9414834976196289
        },
        {
            "text": "8 for central nervous system and vascular, 4 for renal and musculoskeletal, 2",
            "probability": 0.00169302669865371,
            "start_logit": 5.240076541900635,
            "end_logit": -1.09846031665802
        },
        {
            "text": "2 for serosal, dermal, immunologic, and 1 for constitutional and hematologic.",
            "probability": 0.001599255894691968,
            "start_logit": 1.6294957399368286,
            "end_logit": 2.455141067504883
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal, 2 for serosal, dermal, immunologic",
            "probability": 0.0014569820631863237,
            "start_logit": 4.430608749389648,
            "end_logit": -0.43914318084716797
        },
        {
            "text": "",
            "probability": 0.0014325636537835648,
            "start_logit": 2.017364263534546,
            "end_logit": 1.9571996927261353
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal,",
            "probability": 0.0008816385621713721,
            "start_logit": 4.430608749389648,
            "end_logit": -0.9414834976196289
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal, 2",
            "probability": 0.0007535575254836649,
            "start_logit": 4.430608749389648,
            "end_logit": -1.09846031665802
        },
        {
            "text": "1 for constitutional and hematologic",
            "probability": 0.0006611435706593065,
            "start_logit": -1.0223249197006226,
            "end_logit": 4.223639011383057
        },
        {
            "text": "serosal, dermal, immunologic, and 1 for constitutional and hematologic.",
            "probability": 0.0005581072752174428,
            "start_logit": 0.5767531991004944,
            "end_logit": 2.455141067504883
        },
        {
            "text": "for central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.0004714036713158419,
            "start_logit": -1.7284691333770752,
            "end_logit": 4.591526985168457
        }
    ],
    "5c7006037c78d6947100005d_004": [
        {
            "text": "renal, immunological and hematologic active descriptors",
            "probability": 0.6691437085842634,
            "start_logit": 5.21848201751709,
            "end_logit": 4.986583709716797
        },
        {
            "text": "renal, immunological and hematologic",
            "probability": 0.08505514140595244,
            "start_logit": 5.21848201751709,
            "end_logit": 2.923884630203247
        },
        {
            "text": "Patients with SLEDAI-2K renal, immunological and hematologic active descriptors",
            "probability": 0.0847399465520983,
            "start_logit": 3.1520702838897705,
            "end_logit": 4.986583709716797
        },
        {
            "text": "renal, immunological and hematologic active descriptors were identified",
            "probability": 0.040223094339996567,
            "start_logit": 5.21848201751709,
            "end_logit": 2.1750261783599854
        },
        {
            "text": "",
            "probability": 0.037257087517274065,
            "start_logit": 3.979451894760132,
            "end_logit": 3.3374571800231934
        },
        {
            "text": "renal, immunological and hematologic active descriptors were identified. The percentage of descriptors with partial and complete recovery",
            "probability": 0.022315299729434322,
            "start_logit": 5.21848201751709,
            "end_logit": 1.5858573913574219
        },
        {
            "text": "renal, immunological and hematologic active descriptors were identified.",
            "probability": 0.015861337473007896,
            "start_logit": 5.21848201751709,
            "end_logit": 1.244469404220581
        },
        {
            "text": "active descriptors",
            "probability": 0.012683696320055607,
            "start_logit": 1.2528005838394165,
            "end_logit": 4.986583709716797
        },
        {
            "text": "Patients with SLEDAI-2K renal, immunological and hematologic",
            "probability": 0.010771330648794323,
            "start_logit": 3.1520702838897705,
            "end_logit": 2.923884630203247
        },
        {
            "text": "SLEDAI-2K renal, immunological and hematologic active descriptors",
            "probability": 0.009256269861174712,
            "start_logit": 0.9377843141555786,
            "end_logit": 4.986583709716797
        },
        {
            "text": "Patients with SLEDAI-2K renal, immunological and hematologic active descriptors were identified",
            "probability": 0.005093827859104937,
            "start_logit": 3.1520702838897705,
            "end_logit": 2.1750261783599854
        },
        {
            "text": "Patients with SLEDAI-2K renal, immunological and hematologic active descriptors were identified.",
            "probability": 0.0020086699948972555,
            "start_logit": 3.1520702838897705,
            "end_logit": 1.244469404220581
        },
        {
            "text": "renal",
            "probability": 0.0013119832514240943,
            "start_logit": 5.21848201751709,
            "end_logit": -1.2478752136230469
        },
        {
            "text": "SLEDAI-2K renal, immunological and hematologic",
            "probability": 0.0011765683990358096,
            "start_logit": 0.9377843141555786,
            "end_logit": 2.923884630203247
        },
        {
            "text": "active descriptors were identified",
            "probability": 0.0007624334012507848,
            "start_logit": 1.2528005838394165,
            "end_logit": 2.1750261783599854
        },
        {
            "text": "SLEDAI-2K renal, immunological and hematologic active descriptors were identified",
            "probability": 0.0005564063609747183,
            "start_logit": 0.9377843141555786,
            "end_logit": 2.1750261783599854
        },
        {
            "text": "hematologic active descriptors",
            "probability": 0.0005434092234690966,
            "start_logit": -1.897409439086914,
            "end_logit": 4.986583709716797
        },
        {
            "text": "renal, immunological and hematologic active descriptors were identified. The percentage of descriptors",
            "probability": 0.0004581561397639785,
            "start_logit": 5.21848201751709,
            "end_logit": -2.2999603748321533
        },
        {
            "text": "active descriptors were identified. The percentage of descriptors with partial and complete recovery",
            "probability": 0.00042298908504722417,
            "start_logit": 1.2528005838394165,
            "end_logit": 1.5858573913574219
        },
        {
            "text": "renal, immunological",
            "probability": 0.00035864385298024743,
            "start_logit": 5.21848201751709,
            "end_logit": -2.5448405742645264
        }
    ],
    "5c7006037c78d6947100005d_005": [
        {
            "text": "Patients followed for a minimum of 3 visits, and without absence for a period > 18 consecutive months",
            "probability": 0.679717630352594,
            "start_logit": 2.422187328338623,
            "end_logit": 1.9518568515777588
        },
        {
            "text": "Patients followed for a minimum of 3 visits",
            "probability": 0.15510251349409596,
            "start_logit": 2.422187328338623,
            "end_logit": 0.4742656648159027
        },
        {
            "text": "",
            "probability": 0.06622518103785349,
            "start_logit": 0.1365821808576584,
            "end_logit": 1.90884530544281
        },
        {
            "text": "Patients followed for a minimum of 3 visits, and without absence for a period > 18 consecutive months, were included in the study",
            "probability": 0.02055961326451357,
            "start_logit": 2.422187328338623,
            "end_logit": -1.5464919805526733
        },
        {
            "text": "without absence for a period > 18 consecutive months",
            "probability": 0.019293086243660863,
            "start_logit": -1.1397433280944824,
            "end_logit": 1.9518568515777588
        },
        {
            "text": "Patients followed for a minimum of 3 visits, and without absence",
            "probability": 0.013787739319052158,
            "start_logit": 2.422187328338623,
            "end_logit": -1.9460408687591553
        },
        {
            "text": "sex, age at diagnosis, SLEDAI-2K at presentation, and disease duration",
            "probability": 0.009688010611890494,
            "start_logit": -0.2525864839553833,
            "end_logit": 0.37584230303764343
        },
        {
            "text": "absence for a period > 18 consecutive months",
            "probability": 0.008939983339646218,
            "start_logit": -1.9089564085006714,
            "end_logit": 1.9518568515777588
        },
        {
            "text": "major risk factors such as sex, age at diagnosis, SLEDAI-2K at presentation, and disease duration",
            "probability": 0.007332979173113801,
            "start_logit": -0.5310937166213989,
            "end_logit": 0.37584230303764343
        },
        {
            "text": "Patients followed for a minimum of 3 visits, and without absence for a period > 18 consecutive months, were included in the study.",
            "probability": 0.005268635993413173,
            "start_logit": 2.422187328338623,
            "end_logit": -2.9080491065979004
        },
        {
            "text": "Patients followed for a minimum of 3 visits, and without absence for a period > 18 consecutive months,",
            "probability": 0.0036509604484141153,
            "start_logit": 2.422187328338623,
            "end_logit": -3.2748303413391113
        },
        {
            "text": "followed for a minimum of 3 visits, and without absence for a period > 18 consecutive months",
            "probability": 0.001978606490035776,
            "start_logit": -3.417097330093384,
            "end_logit": 1.9518568515777588
        },
        {
            "text": "Patients followed for a minimum of 3 visits,",
            "probability": 0.001909141871204856,
            "start_logit": 2.422187328338623,
            "end_logit": -3.9231667518615723
        },
        {
            "text": "death, presence of damage, coronary artery disease (CAD), and osteonecrosis",
            "probability": 0.0017285566896986474,
            "start_logit": -1.0039786100387573,
            "end_logit": -0.5963678956031799
        },
        {
            "text": "3 visits, and without absence for a period > 18 consecutive months",
            "probability": 0.0012442097414611475,
            "start_logit": -3.8809895515441895,
            "end_logit": 1.9518568515777588
        },
        {
            "text": "age at diagnosis, SLEDAI-2K at presentation, and disease duration",
            "probability": 0.0012213689620786132,
            "start_logit": -2.323503255844116,
            "end_logit": 0.37584230303764343
        },
        {
            "text": "minimum of 3 visits, and without absence for a period > 18 consecutive months",
            "probability": 0.0006358605588314529,
            "start_logit": -4.5522661209106445,
            "end_logit": 1.9518568515777588
        },
        {
            "text": "major risk factors",
            "probability": 0.0006219993478490455,
            "start_logit": -0.5310937166213989,
            "end_logit": -2.091355800628662
        },
        {
            "text": "without absence for a period > 18 consecutive months, were included in the study",
            "probability": 0.0005835634889193815,
            "start_logit": -1.1397433280944824,
            "end_logit": -1.5464919805526733
        },
        {
            "text": "death, presence of damage, coronary artery disease (CAD), and osteonecrosis (ON)",
            "probability": 0.0005103595716732956,
            "start_logit": -1.0039786100387573,
            "end_logit": -1.8162944316864014
        }
    ],
    "5e2894109499698331000002_002": [
        {
            "text": "CNEFinder",
            "probability": 0.8910039256427684,
            "start_logit": 5.773565769195557,
            "end_logit": 6.440690994262695
        },
        {
            "text": "presenting CNEFinder",
            "probability": 0.09076621755706078,
            "start_logit": 3.489504098892212,
            "end_logit": 6.440690994262695
        },
        {
            "text": "CNEFinder;",
            "probability": 0.01358479054971993,
            "start_logit": 5.773565769195557,
            "end_logit": 2.2572929859161377
        },
        {
            "text": "presenting CNEFinder;",
            "probability": 0.0013838772411843977,
            "start_logit": 3.489504098892212,
            "end_logit": 2.2572929859161377
        },
        {
            "text": "by presenting CNEFinder",
            "probability": 0.0009021815404146241,
            "start_logit": -1.1217225790023804,
            "end_logit": 6.440690994262695
        },
        {
            "text": "CNEFind",
            "probability": 0.000711990370361181,
            "start_logit": 5.773565769195557,
            "end_logit": -0.6913487315177917
        },
        {
            "text": "",
            "probability": 0.0006677309903082829,
            "start_logit": 2.3890743255615234,
            "end_logit": 2.6289637088775635
        },
        {
            "text": "CN",
            "probability": 0.00024952807114560476,
            "start_logit": 5.773565769195557,
            "end_logit": -1.7398416996002197
        },
        {
            "text": "CNEFinder; a tool for identifying CNEs between two given DNA sequences with user-defined criteria",
            "probability": 0.00017264243079795252,
            "start_logit": 5.773565769195557,
            "end_logit": -2.1081905364990234
        },
        {
            "text": "CNEF",
            "probability": 0.00012296614511093514,
            "start_logit": 5.773565769195557,
            "end_logit": -2.4475040435791016
        },
        {
            "text": "CNEFinder; a tool for identifying CNEs between two given DNA sequences with user-defined criteria.",
            "probability": 0.00012072999017213958,
            "start_logit": 5.773565769195557,
            "end_logit": -2.4658565521240234
        },
        {
            "text": "CNEFinder; a tool",
            "probability": 9.389315864868668e-05,
            "start_logit": 5.773565769195557,
            "end_logit": -2.7172555923461914
        },
        {
            "text": "presenting CNEFind",
            "probability": 7.253017747156965e-05,
            "start_logit": 3.489504098892212,
            "end_logit": -0.6913487315177917
        },
        {
            "text": "CNEFinder; a tool for identifying CNEs between two given DNA sequences with user-defined criteria. The results presented here show the tool",
            "probability": 4.2781347403090984e-05,
            "start_logit": 5.773565769195557,
            "end_logit": -3.5033109188079834
        },
        {
            "text": "presenting CN",
            "probability": 2.541932593154061e-05,
            "start_logit": 3.489504098892212,
            "end_logit": -1.7398416996002197
        },
        {
            "text": "presenting",
            "probability": 2.2628005117748128e-05,
            "start_logit": 3.489504098892212,
            "end_logit": -1.8561631441116333
        },
        {
            "text": "presenting CNEFinder; a tool for identifying CNEs between two given DNA sequences with user-defined criteria",
            "probability": 1.758701615380919e-05,
            "start_logit": 3.489504098892212,
            "end_logit": -2.1081905364990234
        },
        {
            "text": "by presenting CNEFinder;",
            "probability": 1.3755211297767221e-05,
            "start_logit": -1.1217225790023804,
            "end_logit": 2.2572929859161377
        },
        {
            "text": "presenting CNEF",
            "probability": 1.2526512575397013e-05,
            "start_logit": 3.489504098892212,
            "end_logit": -2.4475040435791016
        },
        {
            "text": "presenting CNEFinder; a tool for identifying CNEs between two given DNA sequences with user-defined criteria.",
            "probability": 1.2298716356071053e-05,
            "start_logit": 3.489504098892212,
            "end_logit": -2.4658565521240234
        }
    ],
    "5e29f666aa19d74431000001_001": [
        {
            "text": "Protein phosphatase 2A",
            "probability": 0.8235553088611463,
            "start_logit": 4.2856974601745605,
            "end_logit": 4.749851703643799
        },
        {
            "text": "Protein",
            "probability": 0.07811962876678016,
            "start_logit": 4.2856974601745605,
            "end_logit": 2.3944623470306396
        },
        {
            "text": "Protein phosphatase 2A (PP2A)",
            "probability": 0.041375432162871,
            "start_logit": 4.2856974601745605,
            "end_logit": 1.7589082717895508
        },
        {
            "text": "Protein phosphatase 2A (PP2A) is a ubiquitously expressed serine/threonine",
            "probability": 0.023859210223018363,
            "start_logit": 4.2856974601745605,
            "end_logit": 1.2083913087844849
        },
        {
            "text": "Protein phosphatase",
            "probability": 0.011046843867803285,
            "start_logit": 4.2856974601745605,
            "end_logit": 0.43836575746536255
        },
        {
            "text": "phosphatase 2A",
            "probability": 0.008532545487758472,
            "start_logit": -0.2840455174446106,
            "end_logit": 4.749851703643799
        },
        {
            "text": "",
            "probability": 0.00750620981791917,
            "start_logit": 2.0549449920654297,
            "end_logit": 2.2827041149139404
        },
        {
            "text": "Protein phosphatase 2A (PP2A) is a ubiquitously expressed serine/threonine phosphatase",
            "probability": 0.002404655741773743,
            "start_logit": 4.2856974601745605,
            "end_logit": -1.0863722562789917
        },
        {
            "text": "Protein phosphatase 2A (PP2A",
            "probability": 0.0013313183374074966,
            "start_logit": 4.2856974601745605,
            "end_logit": -1.6776093244552612
        },
        {
            "text": "2A",
            "probability": 0.0009911573170447322,
            "start_logit": -2.4368152618408203,
            "end_logit": 4.749851703643799
        },
        {
            "text": "phosphatase 2A (PP2A)",
            "probability": 0.0004286752246106701,
            "start_logit": -0.2840455174446106,
            "end_logit": 1.7589082717895508
        },
        {
            "text": "phosphatase 2A (PP2A) is a ubiquitously expressed serine/threonine",
            "probability": 0.00024719626519245744,
            "start_logit": -0.2840455174446106,
            "end_logit": 1.2083913087844849
        },
        {
            "text": "serine/threonine",
            "probability": 0.00021192999461899407,
            "start_logit": -0.43797212839126587,
            "end_logit": 1.2083913087844849
        },
        {
            "text": "phosphatase",
            "probability": 0.00011445217678038109,
            "start_logit": -0.2840455174446106,
            "end_logit": 0.43836575746536255
        },
        {
            "text": "Protein phosphatase 2A (PP2A) is a ubiquitously expressed",
            "probability": 6.406014465618912e-05,
            "start_logit": 4.2856974601745605,
            "end_logit": -4.711711883544922
        },
        {
            "text": "2A (PP2A)",
            "probability": 4.979575979035048e-05,
            "start_logit": -2.4368152618408203,
            "end_logit": 1.7589082717895508
        },
        {
            "text": "(PP2A)",
            "probability": 4.905162061496868e-05,
            "start_logit": -2.451871871948242,
            "end_logit": 1.7589082717895508
        },
        {
            "text": "PP2A",
            "probability": 4.3157507182517535e-05,
            "start_logit": -0.6059898138046265,
            "end_logit": -0.21499063074588776
        },
        {
            "text": "Protein phosphatase 2A (PP2A) is a ubiquitously expressed serine/threonine ph",
            "probability": 4.0579953493642534e-05,
            "start_logit": 4.2856974601745605,
            "end_logit": -5.168260097503662
        },
        {
            "text": "DNA",
            "probability": 2.8790769537701096e-05,
            "start_logit": 0.20194809138774872,
            "end_logit": -1.4277300834655762
        }
    ],
    "5e29f666aa19d74431000001_003": [
        {
            "text": "Protein phosphatase 2A",
            "probability": 0.8235553088611463,
            "start_logit": 4.2856974601745605,
            "end_logit": 4.749851703643799
        },
        {
            "text": "Protein",
            "probability": 0.07811962876678016,
            "start_logit": 4.2856974601745605,
            "end_logit": 2.3944623470306396
        },
        {
            "text": "Protein phosphatase 2A (PP2A)",
            "probability": 0.041375432162871,
            "start_logit": 4.2856974601745605,
            "end_logit": 1.7589082717895508
        },
        {
            "text": "Protein phosphatase 2A (PP2A) is a ubiquitously expressed serine/threonine",
            "probability": 0.023859210223018363,
            "start_logit": 4.2856974601745605,
            "end_logit": 1.2083913087844849
        },
        {
            "text": "Protein phosphatase",
            "probability": 0.011046843867803285,
            "start_logit": 4.2856974601745605,
            "end_logit": 0.43836575746536255
        },
        {
            "text": "phosphatase 2A",
            "probability": 0.008532545487758472,
            "start_logit": -0.2840455174446106,
            "end_logit": 4.749851703643799
        },
        {
            "text": "",
            "probability": 0.00750620981791917,
            "start_logit": 2.0549449920654297,
            "end_logit": 2.2827041149139404
        },
        {
            "text": "Protein phosphatase 2A (PP2A) is a ubiquitously expressed serine/threonine phosphatase",
            "probability": 0.002404655741773743,
            "start_logit": 4.2856974601745605,
            "end_logit": -1.0863722562789917
        },
        {
            "text": "Protein phosphatase 2A (PP2A",
            "probability": 0.0013313183374074966,
            "start_logit": 4.2856974601745605,
            "end_logit": -1.6776093244552612
        },
        {
            "text": "2A",
            "probability": 0.0009911573170447322,
            "start_logit": -2.4368152618408203,
            "end_logit": 4.749851703643799
        },
        {
            "text": "phosphatase 2A (PP2A)",
            "probability": 0.0004286752246106701,
            "start_logit": -0.2840455174446106,
            "end_logit": 1.7589082717895508
        },
        {
            "text": "phosphatase 2A (PP2A) is a ubiquitously expressed serine/threonine",
            "probability": 0.00024719626519245744,
            "start_logit": -0.2840455174446106,
            "end_logit": 1.2083913087844849
        },
        {
            "text": "serine/threonine",
            "probability": 0.00021192999461899407,
            "start_logit": -0.43797212839126587,
            "end_logit": 1.2083913087844849
        },
        {
            "text": "phosphatase",
            "probability": 0.00011445217678038109,
            "start_logit": -0.2840455174446106,
            "end_logit": 0.43836575746536255
        },
        {
            "text": "Protein phosphatase 2A (PP2A) is a ubiquitously expressed",
            "probability": 6.406014465618912e-05,
            "start_logit": 4.2856974601745605,
            "end_logit": -4.711711883544922
        },
        {
            "text": "2A (PP2A)",
            "probability": 4.979575979035048e-05,
            "start_logit": -2.4368152618408203,
            "end_logit": 1.7589082717895508
        },
        {
            "text": "(PP2A)",
            "probability": 4.905162061496868e-05,
            "start_logit": -2.451871871948242,
            "end_logit": 1.7589082717895508
        },
        {
            "text": "PP2A",
            "probability": 4.3157507182517535e-05,
            "start_logit": -0.6059898138046265,
            "end_logit": -0.21499063074588776
        },
        {
            "text": "Protein phosphatase 2A (PP2A) is a ubiquitously expressed serine/threonine ph",
            "probability": 4.0579953493642534e-05,
            "start_logit": 4.2856974601745605,
            "end_logit": -5.168260097503662
        },
        {
            "text": "DNA",
            "probability": 2.8790769537701096e-05,
            "start_logit": 0.20194809138774872,
            "end_logit": -1.4277300834655762
        }
    ],
    "5e46da9c3f5415952900000a_001": [
        {
            "text": "decreased global genome repair",
            "probability": 0.5931286385805558,
            "start_logit": 4.204150676727295,
            "end_logit": 3.692397117614746
        },
        {
            "text": "decreased global genome repair in XP-E cells",
            "probability": 0.27689521465551714,
            "start_logit": 4.204150676727295,
            "end_logit": 2.9306249618530273
        },
        {
            "text": "global genome repair",
            "probability": 0.06420658914891413,
            "start_logit": 1.9808452129364014,
            "end_logit": 3.692397117614746
        },
        {
            "text": "global genome repair in XP-E cells",
            "probability": 0.02997410026808642,
            "start_logit": 1.9808452129364014,
            "end_logit": 2.9306249618530273
        },
        {
            "text": "loss of monoubiquitinated histone H2A at the sites of UV-damaged DNA is associated with decreased global genome repair",
            "probability": 0.008651137137055696,
            "start_logit": -0.023569853976368904,
            "end_logit": 3.692397117614746
        },
        {
            "text": "decreased global genome repair in XP-E cells,",
            "probability": 0.006723588714526563,
            "start_logit": 4.204150676727295,
            "end_logit": -0.7873921394348145
        },
        {
            "text": "global genome repair in XP-E cells, this study suggests that histone modification, mediated by the XPE factor, facilitates the initiation of NER",
            "probability": 0.006013674461489094,
            "start_logit": 1.9808452129364014,
            "end_logit": 1.3243272304534912
        },
        {
            "text": "decreased",
            "probability": 0.0026099774134792832,
            "start_logit": 4.204150676727295,
            "end_logit": -1.7336726188659668
        },
        {
            "text": "monoubiquitinated histone H2A at the sites of UV-damaged DNA is associated with decreased global genome repair",
            "probability": 0.0018570800040913044,
            "start_logit": -1.5622552633285522,
            "end_logit": 3.692397117614746
        },
        {
            "text": "the loss of monoubiquitinated histone H2A at the sites of UV-damaged DNA is associated with decreased global genome repair",
            "probability": 0.0017273452986279062,
            "start_logit": -1.6346749067306519,
            "end_logit": 3.692397117614746
        },
        {
            "text": "histone modification, mediated by the XPE factor, facilitates the initiation of NER",
            "probability": 0.0012608988714982196,
            "start_logit": 0.4186341166496277,
            "end_logit": 1.3243272304534912
        },
        {
            "text": "genome repair",
            "probability": 0.0011670960391829226,
            "start_logit": -2.0267419815063477,
            "end_logit": 3.692397117614746
        },
        {
            "text": "monoubiquitinated histone H2A at the sites of UV-damaged DNA is associated with decreased global genome repair in XP-E cells",
            "probability": 0.0008669562265547089,
            "start_logit": -1.5622552633285522,
            "end_logit": 2.9306249618530273
        },
        {
            "text": "decreased global genome repair in XP-E cells, this study suggests that histone modification, mediated by the XPE factor",
            "probability": 0.0008317454323868281,
            "start_logit": 4.204150676727295,
            "end_logit": -2.8772430419921875
        },
        {
            "text": "XP-E cells",
            "probability": 0.0007477757731600306,
            "start_logit": -1.710140585899353,
            "end_logit": 2.9306249618530273
        },
        {
            "text": "global genome repair in XP-E cells,",
            "probability": 0.0007278331716253007,
            "start_logit": 1.9808452129364014,
            "end_logit": -0.7873921394348145
        },
        {
            "text": "decreased global genome repair in XP-E",
            "probability": 0.0006960419025472283,
            "start_logit": 4.204150676727295,
            "end_logit": -3.0553596019744873
        },
        {
            "text": "associated with decreased global genome repair",
            "probability": 0.0006682218700238665,
            "start_logit": -2.58439564704895,
            "end_logit": 3.692397117614746
        },
        {
            "text": "genome repair in XP-E cells",
            "probability": 0.0005448452279534783,
            "start_logit": -2.0267419815063477,
            "end_logit": 2.9306249618530273
        },
        {
            "text": "decreased global genome",
            "probability": 0.0004346733893599633,
            "start_logit": 4.204150676727295,
            "end_logit": -3.526174545288086
        },
        {
            "text": "",
            "probability": 0.00026656641336428153,
            "start_logit": 0.44010165333747864,
            "end_logit": -0.25109702348709106
        }
    ],
    "5e46da9c3f5415952900000a_002": [
        {
            "text": "global genomic nucleotide excision repair (NER)",
            "probability": 0.3406131007866438,
            "start_logit": 4.694442272186279,
            "end_logit": 2.0993566513061523
        },
        {
            "text": "global genomic nucleotide excision repair (NER) in mammalian cells",
            "probability": 0.31019838564096486,
            "start_logit": 4.694442272186279,
            "end_logit": 2.005821466445923
        },
        {
            "text": "global genomic nucleotide excision repair",
            "probability": 0.2363106472687511,
            "start_logit": 4.694442272186279,
            "end_logit": 1.7337566614151
        },
        {
            "text": "genomic nucleotide excision repair (NER)",
            "probability": 0.029205160011522208,
            "start_logit": 2.2380404472351074,
            "end_logit": 2.0993566513061523
        },
        {
            "text": "genomic nucleotide excision repair (NER) in mammalian cells",
            "probability": 0.026597313688280454,
            "start_logit": 2.2380404472351074,
            "end_logit": 2.005821466445923
        },
        {
            "text": "genomic nucleotide excision repair",
            "probability": 0.020261963647232917,
            "start_logit": 2.2380404472351074,
            "end_logit": 1.7337566614151
        },
        {
            "text": "global genomic nucleotide excision repair (NER",
            "probability": 0.011985127711648178,
            "start_logit": 4.694442272186279,
            "end_logit": -1.2477240562438965
        },
        {
            "text": "global genomic nucleotide excision repair (NER) in mammalian cells.",
            "probability": 0.010353865102318246,
            "start_logit": 4.694442272186279,
            "end_logit": -1.3940306901931763
        },
        {
            "text": "global",
            "probability": 0.0029439369395674124,
            "start_logit": 4.694442272186279,
            "end_logit": -2.6516427993774414
        },
        {
            "text": "global gen",
            "probability": 0.0021648212161488123,
            "start_logit": 4.694442272186279,
            "end_logit": -2.959052801132202
        },
        {
            "text": "global genomic nucleotide excision",
            "probability": 0.0015014965283830263,
            "start_logit": 4.694442272186279,
            "end_logit": -3.3249282836914062
        },
        {
            "text": "implicated in global genomic nucleotide excision repair (NER)",
            "probability": 0.0013241015659282052,
            "start_logit": -0.8555707931518555,
            "end_logit": 2.0993566513061523
        },
        {
            "text": "implicated in global genomic nucleotide excision repair (NER) in mammalian cells",
            "probability": 0.0012058672060088554,
            "start_logit": -0.8555707931518555,
            "end_logit": 2.005821466445923
        },
        {
            "text": "genomic nucleotide excision repair (NER",
            "probability": 0.0010276397818193945,
            "start_logit": 2.2380404472351074,
            "end_logit": -1.2477240562438965
        },
        {
            "text": "implicated in global genomic nucleotide excision repair",
            "probability": 0.0009186355350731435,
            "start_logit": -0.8555707931518555,
            "end_logit": 1.7337566614151
        },
        {
            "text": "genomic nucleotide excision repair (NER) in mammalian cells.",
            "probability": 0.0008877705712216029,
            "start_logit": 2.2380404472351074,
            "end_logit": -1.3940306901931763
        },
        {
            "text": "nucleotide excision repair (NER)",
            "probability": 0.000781732415221622,
            "start_logit": -1.3825477361679077,
            "end_logit": 2.0993566513061523
        },
        {
            "text": "nucleotide excision repair (NER) in mammalian cells",
            "probability": 0.0007119283804554949,
            "start_logit": -1.3825477361679077,
            "end_logit": 2.005821466445923
        },
        {
            "text": "nucleotide excision repair",
            "probability": 0.0005423505220596298,
            "start_logit": -1.3825477361679077,
            "end_logit": 1.7337566614151
        },
        {
            "text": "global genomic nucleotide ex",
            "probability": 0.0004627464975135098,
            "start_logit": 4.694442272186279,
            "end_logit": -4.50196647644043
        },
        {
            "text": "",
            "probability": 1.4089832373050348e-06,
            "start_logit": -2.1538119316101074,
            "end_logit": -3.4480233192443848
        }
    ],
    "5e46da9c3f5415952900000a_003": [
        {
            "text": "global genomic nucleotide excision repair (NER)",
            "probability": 0.3406131007866438,
            "start_logit": 4.694442272186279,
            "end_logit": 2.0993566513061523
        },
        {
            "text": "global genomic nucleotide excision repair (NER) in mammalian cells",
            "probability": 0.31019838564096486,
            "start_logit": 4.694442272186279,
            "end_logit": 2.005821466445923
        },
        {
            "text": "global genomic nucleotide excision repair",
            "probability": 0.2363106472687511,
            "start_logit": 4.694442272186279,
            "end_logit": 1.7337566614151
        },
        {
            "text": "genomic nucleotide excision repair (NER)",
            "probability": 0.029205160011522208,
            "start_logit": 2.2380404472351074,
            "end_logit": 2.0993566513061523
        },
        {
            "text": "genomic nucleotide excision repair (NER) in mammalian cells",
            "probability": 0.026597313688280454,
            "start_logit": 2.2380404472351074,
            "end_logit": 2.005821466445923
        },
        {
            "text": "genomic nucleotide excision repair",
            "probability": 0.020261963647232917,
            "start_logit": 2.2380404472351074,
            "end_logit": 1.7337566614151
        },
        {
            "text": "global genomic nucleotide excision repair (NER",
            "probability": 0.011985127711648178,
            "start_logit": 4.694442272186279,
            "end_logit": -1.2477240562438965
        },
        {
            "text": "global genomic nucleotide excision repair (NER) in mammalian cells.",
            "probability": 0.010353865102318246,
            "start_logit": 4.694442272186279,
            "end_logit": -1.3940306901931763
        },
        {
            "text": "global",
            "probability": 0.0029439369395674124,
            "start_logit": 4.694442272186279,
            "end_logit": -2.6516427993774414
        },
        {
            "text": "global gen",
            "probability": 0.0021648212161488123,
            "start_logit": 4.694442272186279,
            "end_logit": -2.959052801132202
        },
        {
            "text": "global genomic nucleotide excision",
            "probability": 0.0015014965283830263,
            "start_logit": 4.694442272186279,
            "end_logit": -3.3249282836914062
        },
        {
            "text": "implicated in global genomic nucleotide excision repair (NER)",
            "probability": 0.0013241015659282052,
            "start_logit": -0.8555707931518555,
            "end_logit": 2.0993566513061523
        },
        {
            "text": "implicated in global genomic nucleotide excision repair (NER) in mammalian cells",
            "probability": 0.0012058672060088554,
            "start_logit": -0.8555707931518555,
            "end_logit": 2.005821466445923
        },
        {
            "text": "genomic nucleotide excision repair (NER",
            "probability": 0.0010276397818193945,
            "start_logit": 2.2380404472351074,
            "end_logit": -1.2477240562438965
        },
        {
            "text": "implicated in global genomic nucleotide excision repair",
            "probability": 0.0009186355350731435,
            "start_logit": -0.8555707931518555,
            "end_logit": 1.7337566614151
        },
        {
            "text": "genomic nucleotide excision repair (NER) in mammalian cells.",
            "probability": 0.0008877705712216029,
            "start_logit": 2.2380404472351074,
            "end_logit": -1.3940306901931763
        },
        {
            "text": "nucleotide excision repair (NER)",
            "probability": 0.000781732415221622,
            "start_logit": -1.3825477361679077,
            "end_logit": 2.0993566513061523
        },
        {
            "text": "nucleotide excision repair (NER) in mammalian cells",
            "probability": 0.0007119283804554949,
            "start_logit": -1.3825477361679077,
            "end_logit": 2.005821466445923
        },
        {
            "text": "nucleotide excision repair",
            "probability": 0.0005423505220596298,
            "start_logit": -1.3825477361679077,
            "end_logit": 1.7337566614151
        },
        {
            "text": "global genomic nucleotide ex",
            "probability": 0.0004627464975135098,
            "start_logit": 4.694442272186279,
            "end_logit": -4.50196647644043
        },
        {
            "text": "",
            "probability": 1.4089832373050348e-06,
            "start_logit": -2.1538119316101074,
            "end_logit": -3.4480233192443848
        }
    ],
    "5e46da9c3f5415952900000a_004": [
        {
            "text": "",
            "probability": 0.9998998134211566,
            "start_logit": 3.471475601196289,
            "end_logit": 3.6865737438201904
        },
        {
            "text": "deficiency",
            "probability": 7.166509153566471e-05,
            "start_logit": -1.4891066551208496,
            "end_logit": -0.8962506055831909
        },
        {
            "text": "removal of photoproducts from the non-transcribed regions of the genome",
            "probability": 5.761803972982339e-06,
            "start_logit": -3.015455961227417,
            "end_logit": -1.890654444694519
        },
        {
            "text": "removal of photoproducts",
            "probability": 2.651656846717458e-06,
            "start_logit": -3.015455961227417,
            "end_logit": -2.666720390319824
        },
        {
            "text": "a deficiency",
            "probability": 2.422143094638419e-06,
            "start_logit": -4.876457691192627,
            "end_logit": -0.8962506055831909
        },
        {
            "text": "photoproducts from the non-transcribed regions of the genome",
            "probability": 1.794796968536876e-06,
            "start_logit": -4.181814670562744,
            "end_logit": -1.890654444694519
        },
        {
            "text": "p48 protein",
            "probability": 1.7081519650268286e-06,
            "start_logit": -3.2196404933929443,
            "end_logit": -2.902308464050293
        },
        {
            "text": "deficient",
            "probability": 1.594955349147456e-06,
            "start_logit": -1.8927195072174072,
            "end_logit": -4.29779577255249
        },
        {
            "text": "deficiency in UV-DDB binding activity (DDB(-)). The role of p48 in the repair defect",
            "probability": 1.5507649889712646e-06,
            "start_logit": -1.4891066551208496,
            "end_logit": -4.729506015777588
        },
        {
            "text": "produce a deficiency",
            "probability": 1.4082102875062395e-06,
            "start_logit": -5.418790817260742,
            "end_logit": -0.8962506055831909
        },
        {
            "text": "deficiency in UV-DDB binding activity",
            "probability": 1.241565343815701e-06,
            "start_logit": -1.4891066551208496,
            "end_logit": -4.951881408691406
        },
        {
            "text": "decrease of detectable p48 protein",
            "probability": 1.1984434484294214e-06,
            "start_logit": -3.574028968811035,
            "end_logit": -2.902308464050293
        },
        {
            "text": "deficiency in UV-DDB binding activity (DDB(-))",
            "probability": 1.0662445354375284e-06,
            "start_logit": -1.4891066551208496,
            "end_logit": -5.104111671447754
        },
        {
            "text": "p127 subunit, and produce a deficiency",
            "probability": 9.823975523040924e-07,
            "start_logit": -5.77886962890625,
            "end_logit": -0.8962506055831909
        },
        {
            "text": "UV-damaged DNA",
            "probability": 9.159376820604732e-07,
            "start_logit": -4.15226411819458,
            "end_logit": -2.5929038524627686
        },
        {
            "text": "p48 protein, abolish interaction with the p127 subunit, and produce a deficiency in UV-DDB binding activity",
            "probability": 8.838179547756762e-07,
            "start_logit": -3.2196404933929443,
            "end_logit": -3.5612246990203857
        },
        {
            "text": "deficiency in UV-DDB binding activity (DDB(-)).",
            "probability": 8.781786492674225e-07,
            "start_logit": -1.4891066551208496,
            "end_logit": -5.298159599304199
        },
        {
            "text": "UV-damaged DNA (UV-DDB) and is specifically involved in the removal of photoproducts",
            "probability": 8.507614668572646e-07,
            "start_logit": -4.15226411819458,
            "end_logit": -2.666720390319824
        },
        {
            "text": "photoproducts",
            "probability": 8.259888209326162e-07,
            "start_logit": -4.181814670562744,
            "end_logit": -2.666720390319824
        },
        {
            "text": "deficiency in UV-DDB binding activity (DDB(-)). The role of p48",
            "probability": 7.856683803978862e-07,
            "start_logit": -1.4891066551208496,
            "end_logit": -5.409474849700928
        }
    ],
    "5e2902688b3851296d000005_001": [
        {
            "text": "IGF1R",
            "probability": 0.8927171644534558,
            "start_logit": 2.8852686882019043,
            "end_logit": 3.483518123626709
        },
        {
            "text": "IGF1R in active TAO. A recently completed therapeutic trial of teprotumumab, a human IGF1R",
            "probability": 0.06332830733009476,
            "start_logit": 0.23933130502700806,
            "end_logit": 3.483518123626709
        },
        {
            "text": "IGF1R inhibiting antibody",
            "probability": 0.009332469387270712,
            "start_logit": 2.8852686882019043,
            "end_logit": -1.0772520303726196
        },
        {
            "text": "",
            "probability": 0.008888370771232838,
            "start_logit": 0.6966536045074463,
            "end_logit": 1.0626071691513062
        },
        {
            "text": "active TAO. A recently completed therapeutic trial of teprotumumab, a human IGF1R",
            "probability": 0.004583793749486345,
            "start_logit": -2.386474132537842,
            "end_logit": 3.483518123626709
        },
        {
            "text": "IGF1R inhibiting antibody, in patients with moderate to severe, active TAO",
            "probability": 0.004515382070816674,
            "start_logit": 2.8852686882019043,
            "end_logit": -1.8032618761062622
        },
        {
            "text": "IGF1R inhibiting",
            "probability": 0.002812806648958061,
            "start_logit": 2.8852686882019043,
            "end_logit": -2.27656888961792
        },
        {
            "text": "thyrotropin",
            "probability": 0.0027613343243266387,
            "start_logit": 0.596296489238739,
            "end_logit": -0.0060654692351818085
        },
        {
            "text": "IGF1R. Importantly, it appears that signaling initiated from either receptor can be attenuated by inhibiting the activity of IGF1R",
            "probability": 0.0024950775693442367,
            "start_logit": -0.4078372120857239,
            "end_logit": 0.8966740369796753
        },
        {
            "text": "a human IGF1R",
            "probability": 0.0015384107431189683,
            "start_logit": -3.4782512187957764,
            "end_logit": 3.483518123626709
        },
        {
            "text": "IGF1R inhibiting antibody,",
            "probability": 0.0014179523784800302,
            "start_logit": 2.8852686882019043,
            "end_logit": -2.9615378379821777
        },
        {
            "text": "human IGF1R",
            "probability": 0.001399229892067406,
            "start_logit": -3.5730791091918945,
            "end_logit": 3.483518123626709
        },
        {
            "text": "teprotumumab, a human IGF1R",
            "probability": 0.0012033879296479498,
            "start_logit": -3.723860263824463,
            "end_logit": 3.483518123626709
        },
        {
            "text": "IGF1R. These findings underpin the rationale for therapeutically targeting IGF1R in active TAO",
            "probability": 0.0009109090171610896,
            "start_logit": 1.8597118854522705,
            "end_logit": -2.378507137298584
        },
        {
            "text": "IGF1R. These findings underpin the rationale for therapeutically targeting IGF1R",
            "probability": 0.0007007126897189015,
            "start_logit": 1.8597118854522705,
            "end_logit": -2.640852212905884
        },
        {
            "text": "IGF1R in active TAO. A recently completed therapeutic trial of teprotumumab, a human IGF1R inhibiting antibody",
            "probability": 0.000662034419230207,
            "start_logit": 0.23933130502700806,
            "end_logit": -1.0772520303726196
        },
        {
            "text": "IGF1R in active TAO. A recently completed therapeutic trial of teprotumumab, a human IGF1R inhibiting",
            "probability": 0.00019953720060306667,
            "start_logit": 0.23933130502700806,
            "end_logit": -2.27656888961792
        },
        {
            "text": "thyrotropin receptor",
            "probability": 0.00019125568085317203,
            "start_logit": 0.596296489238739,
            "end_logit": -2.6759235858917236
        },
        {
            "text": "IGF1R in active TAO",
            "probability": 0.00018019911617164194,
            "start_logit": 0.23933130502700806,
            "end_logit": -2.378507137298584
        },
        {
            "text": "IGF1R. These findings underpin the rationale for therapeutically targeting IGF1R in active",
            "probability": 0.00016166462796171426,
            "start_logit": 1.8597118854522705,
            "end_logit": -4.107426166534424
        }
    ],
    "5e2902688b3851296d000005_002": [
        {
            "text": "IGF-IR",
            "probability": 0.9445744006797733,
            "start_logit": 1.9616858959197998,
            "end_logit": 5.113672733306885
        },
        {
            "text": "",
            "probability": 0.04126558999237088,
            "start_logit": 1.3308266401290894,
            "end_logit": 2.6138265132904053
        },
        {
            "text": "IR",
            "probability": 0.005591748354925262,
            "start_logit": -3.1677565574645996,
            "end_logit": 5.113672733306885
        },
        {
            "text": "human anti-IGF-IR",
            "probability": 0.00231018356697659,
            "start_logit": -4.051721572875977,
            "end_logit": 5.113672733306885
        },
        {
            "text": "anti-IGF-IR",
            "probability": 0.002112974034668049,
            "start_logit": -4.140952110290527,
            "end_logit": 5.113672733306885
        },
        {
            "text": "inhibitory human anti-IGF-IR",
            "probability": 0.0008766891643872454,
            "start_logit": -5.020651340484619,
            "end_logit": 5.113672733306885
        },
        {
            "text": "teprotumumab, an inhibitory human anti-IGF-IR",
            "probability": 0.0008388834359726116,
            "start_logit": -5.064732074737549,
            "end_logit": 5.113672733306885
        },
        {
            "text": "IGF-IR monoclonal antibody",
            "probability": 0.0006968174436801929,
            "start_logit": 1.9616858959197998,
            "end_logit": -2.0982935428619385
        },
        {
            "text": "IGF-IR monoclonal",
            "probability": 0.0005667401212176557,
            "start_logit": 1.9616858959197998,
            "end_logit": -2.3049161434173584
        },
        {
            "text": "an inhibitory human anti-IGF-IR",
            "probability": 0.0005127196951615115,
            "start_logit": -5.557074546813965,
            "end_logit": 5.113672733306885
        },
        {
            "text": "IGF",
            "probability": 0.0004711783144125069,
            "start_logit": 1.9616858959197998,
            "end_logit": -2.4895803928375244
        },
        {
            "text": "IGF-IR monoclonal antibody,",
            "probability": 6.277895801571548e-05,
            "start_logit": 1.9616858959197998,
            "end_logit": -4.505197048187256
        },
        {
            "text": "i",
            "probability": 5.758630457836475e-05,
            "start_logit": 1.9616858959197998,
            "end_logit": -4.591532230377197
        },
        {
            "text": "IGF-IR could become the basis for paradigm-shifting treatment of this vexing disease.",
            "probability": 3.340178368487152e-05,
            "start_logit": 1.203410267829895,
            "end_logit": -4.377932071685791
        },
        {
            "text": "thyrotropin",
            "probability": 1.0098184396390981e-05,
            "start_logit": -1.804661750793457,
            "end_logit": -2.5661137104034424
        },
        {
            "text": "thyrotropin receptor, the proposed role for which is supported by substantial evidence. Considerations of any involvement of the insulin-like growth factor-I",
            "probability": 4.818755088384504e-06,
            "start_logit": -1.804661750793457,
            "end_logit": -3.3059537410736084
        },
        {
            "text": "IR monoclonal antibody",
            "probability": 4.125061817870396e-06,
            "start_logit": -3.1677565574645996,
            "end_logit": -2.0982935428619385
        },
        {
            "text": "IR monoclonal",
            "probability": 3.3550222599811255e-06,
            "start_logit": -3.1677565574645996,
            "end_logit": -2.3049161434173584
        },
        {
            "text": "monoclonal antibody",
            "probability": 3.259824680545372e-06,
            "start_logit": -3.4031641483306885,
            "end_logit": -2.0982935428619385
        },
        {
            "text": "monoclonal",
            "probability": 2.651301931885183e-06,
            "start_logit": -3.4031641483306885,
            "end_logit": -2.3049161434173584
        }
    ],
    "5e2902688b3851296d000005_003": [
        {
            "text": "IGF-1",
            "probability": 0.9959175361863817,
            "start_logit": 4.606871604919434,
            "end_logit": 5.137547016143799
        },
        {
            "text": "dexamethasone and the IGF-1",
            "probability": 0.0008786399156685411,
            "start_logit": -2.426172971725464,
            "end_logit": 5.137547016143799
        },
        {
            "text": "IGF-1 receptor",
            "probability": 0.0007619007885109036,
            "start_logit": 4.606871604919434,
            "end_logit": -2.0380563735961914
        },
        {
            "text": "",
            "probability": 0.0005252037429099805,
            "start_logit": 0.9022571444511414,
            "end_logit": 1.2945280075073242
        },
        {
            "text": "IGF-1 receptor inhibiting antibody, teprotumumab",
            "probability": 0.00037153642122592215,
            "start_logit": 4.606871604919434,
            "end_logit": -2.756225824356079
        },
        {
            "text": "1",
            "probability": 0.00032964814527873304,
            "start_logit": -3.406522274017334,
            "end_logit": 5.137547016143799
        },
        {
            "text": "the IGF-1",
            "probability": 0.00030379690109571275,
            "start_logit": -3.4881887435913086,
            "end_logit": 5.137547016143799
        },
        {
            "text": "IGF-1 receptor inhibiting antibody",
            "probability": 0.000211219906687082,
            "start_logit": 4.606871604919434,
            "end_logit": -3.3209729194641113
        },
        {
            "text": "I",
            "probability": 0.00018790605642057473,
            "start_logit": 4.606871604919434,
            "end_logit": -3.4379305839538574
        },
        {
            "text": "IGF",
            "probability": 0.0001431514899569377,
            "start_logit": 4.606871604919434,
            "end_logit": -3.7099692821502686
        },
        {
            "text": "It could be attenuated by dexamethasone and the IGF-1",
            "probability": 0.00012161794078166428,
            "start_logit": -4.403663635253906,
            "end_logit": 5.137547016143799
        },
        {
            "text": "IGF-1 receptor inhibiting antibody, teprotumumab.",
            "probability": 0.00011589146288912207,
            "start_logit": 4.606871604919434,
            "end_logit": -3.9212186336517334
        },
        {
            "text": "attenuated by dexamethasone and the IGF-1",
            "probability": 4.424748399118093e-05,
            "start_logit": -5.414749622344971,
            "end_logit": 5.137547016143799
        },
        {
            "text": "IGF-1 receptor inhibiting antibody,",
            "probability": 4.398639954605397e-05,
            "start_logit": 4.606871604919434,
            "end_logit": -4.8899922370910645
        },
        {
            "text": "IGF-1 receptor inhibiting antibody, teprotumuma",
            "probability": 4.176647825545217e-05,
            "start_logit": 4.606871604919434,
            "end_logit": -4.941778659820557
        },
        {
            "text": "dexamethasone and the IGF-1 receptor",
            "probability": 6.721805975306505e-07,
            "start_logit": -2.426172971725464,
            "end_logit": -2.0380563735961914
        },
        {
            "text": "fibrocytes is a consequence of increased TNF-\u03b1",
            "probability": 4.661142578444432e-07,
            "start_logit": -2.2904622554779053,
            "end_logit": -2.539863348007202
        },
        {
            "text": "dexamethasone and the IGF-1 receptor inhibiting antibody, teprotumumab",
            "probability": 3.277848998058436e-07,
            "start_logit": -2.426172971725464,
            "end_logit": -2.756225824356079
        },
        {
            "text": "1 receptor",
            "probability": 2.5218873319650057e-07,
            "start_logit": -3.406522274017334,
            "end_logit": -2.0380563735961914
        },
        {
            "text": "the IGF-1 receptor",
            "probability": 2.3241191171140823e-07,
            "start_logit": -3.4881887435913086,
            "end_logit": -2.0380563735961914
        }
    ],
    "5e2902688b3851296d000005_005": [
        {
            "text": "IGF-1",
            "probability": 0.8999931185096078,
            "start_logit": 4.66412878036499,
            "end_logit": 4.655329704284668
        },
        {
            "text": "IGF-1 receptor",
            "probability": 0.08443706176594462,
            "start_logit": 4.66412878036499,
            "end_logit": 2.2889490127563477
        },
        {
            "text": "IGF-1 receptor antibody teprotumumab and the interleukin-6",
            "probability": 0.0060074990768095565,
            "start_logit": 4.66412878036499,
            "end_logit": -0.35404887795448303
        },
        {
            "text": "IGF-1 receptor antibody teprotumumab and the interleukin-6 receptor antibody tocilizumab",
            "probability": 0.004695474387509819,
            "start_logit": 4.66412878036499,
            "end_logit": -0.6004582643508911
        },
        {
            "text": "",
            "probability": 0.001339021998799288,
            "start_logit": 0.9218639135360718,
            "end_logit": 1.8871469497680664
        },
        {
            "text": "6 receptor antibodies were effective. Results of randomised controlled trials investigating the efficacy of the IGF-1",
            "probability": 0.0007678175094694217,
            "start_logit": -2.402461528778076,
            "end_logit": 4.655329704284668
        },
        {
            "text": "IGF-1 receptor antibody teprotumumab and the interleukin-6 receptor",
            "probability": 0.0007397242546906218,
            "start_logit": 4.66412878036499,
            "end_logit": -2.448535203933716
        },
        {
            "text": "1",
            "probability": 0.0004981957507900784,
            "start_logit": -2.8350205421447754,
            "end_logit": 4.655329704284668
        },
        {
            "text": "I",
            "probability": 0.0002880353162871769,
            "start_logit": 4.66412878036499,
            "end_logit": -3.3917295932769775
        },
        {
            "text": "interleukin-6 receptor antibodies were effective. Results of randomised controlled trials investigating the efficacy of the IGF-1",
            "probability": 0.0002563177725483676,
            "start_logit": -3.4995956420898438,
            "end_logit": 4.655329704284668
        },
        {
            "text": "receptor antibodies were effective. Results of randomised controlled trials investigating the efficacy of the IGF-1",
            "probability": 0.0002533273521555914,
            "start_logit": -3.511331081390381,
            "end_logit": 4.655329704284668
        },
        {
            "text": "thyroid-stimulating-hormone",
            "probability": 0.00019062224489032942,
            "start_logit": 0.26493924856185913,
            "end_logit": 0.5946705341339111
        },
        {
            "text": "IGF",
            "probability": 0.0001278429049760164,
            "start_logit": 4.66412878036499,
            "end_logit": -4.204010486602783
        },
        {
            "text": "IGF-1 receptor antibody",
            "probability": 0.00011445510617565506,
            "start_logit": 4.66412878036499,
            "end_logit": -4.314630031585693
        },
        {
            "text": "receptor",
            "probability": 7.632409002613177e-05,
            "start_logit": -2.34464430809021,
            "end_logit": 2.2889490127563477
        },
        {
            "text": "6 receptor antibodies were effective. Results of randomised controlled trials investigating the efficacy of the IGF-1 receptor",
            "probability": 7.203638909973647e-05,
            "start_logit": -2.402461528778076,
            "end_logit": 2.2889490127563477
        },
        {
            "text": "1 receptor",
            "probability": 4.674056336192301e-05,
            "start_logit": -2.8350205421447754,
            "end_logit": 2.2889490127563477
        },
        {
            "text": "interleukin-6",
            "probability": 3.643332766950029e-05,
            "start_logit": -0.44115108251571655,
            "end_logit": -0.35404887795448303
        },
        {
            "text": "thyroid-stimulating-hormone receptors",
            "probability": 3.1475310779828866e-05,
            "start_logit": 0.26493924856185913,
            "end_logit": -1.2064197063446045
        },
        {
            "text": "interleukin-6 receptor antibody tocilizumab",
            "probability": 2.8476368408323372e-05,
            "start_logit": -0.44115108251571655,
            "end_logit": -0.6004582643508911
        }
    ],
    "5e2902688b3851296d000005_007": [
        {
            "text": "insulin-like growth factor I",
            "probability": 0.7102283166694479,
            "start_logit": 3.4277918338775635,
            "end_logit": 3.1443700790405273
        },
        {
            "text": "insulin-like growth factor I receptor",
            "probability": 0.23212162873430167,
            "start_logit": 3.4277918338775635,
            "end_logit": 2.026045083999634
        },
        {
            "text": "insulin-like growth factor I receptor (IGF-IR",
            "probability": 0.02218788162924174,
            "start_logit": 3.4277918338775635,
            "end_logit": -0.32167014479637146
        },
        {
            "text": "insulin-like growth factor",
            "probability": 0.012624063804993625,
            "start_logit": 3.4277918338775635,
            "end_logit": -0.8856115937232971
        },
        {
            "text": "IGF-IR",
            "probability": 0.006853721141327553,
            "start_logit": 0.9687308073043823,
            "end_logit": 0.9626363515853882
        },
        {
            "text": "the insulin-like growth factor I",
            "probability": 0.0029734071708363377,
            "start_logit": -2.048086166381836,
            "end_logit": 3.1443700790405273
        },
        {
            "text": "I",
            "probability": 0.0029485823676862625,
            "start_logit": -2.0564701557159424,
            "end_logit": 3.1443700790405273
        },
        {
            "text": "insulin-like growth factor I receptor (IGF-IR)",
            "probability": 0.0023606920808738703,
            "start_logit": 3.4277918338775635,
            "end_logit": -2.5622615814208984
        },
        {
            "text": "",
            "probability": 0.0013018963254801737,
            "start_logit": 0.07824286818504333,
            "end_logit": 0.19215446710586548
        },
        {
            "text": "insulin",
            "probability": 0.001191430977743414,
            "start_logit": 3.4277918338775635,
            "end_logit": -3.246061325073242
        },
        {
            "text": "growth factor I",
            "probability": 0.0010749479318421925,
            "start_logit": -3.0655224323272705,
            "end_logit": 3.1443700790405273
        },
        {
            "text": "the insulin-like growth factor I receptor",
            "probability": 0.0009717890700576073,
            "start_logit": -2.048086166381836,
            "end_logit": 2.026045083999634
        },
        {
            "text": "I receptor",
            "probability": 0.0009636756597570634,
            "start_logit": -2.0564701557159424,
            "end_logit": 2.026045083999634
        },
        {
            "text": "insulin-like growth",
            "probability": 0.0005554368413224984,
            "start_logit": 3.4277918338775635,
            "end_logit": -4.009216785430908
        },
        {
            "text": "growth factor I receptor",
            "probability": 0.00035132176356171525,
            "start_logit": -3.0655224323272705,
            "end_logit": 2.026045083999634
        },
        {
            "text": "like growth factor I",
            "probability": 0.0003040043577423686,
            "start_logit": -4.328507900238037,
            "end_logit": 3.1443700790405273
        },
        {
            "text": "insulin-like growth factor I receptor (I",
            "probability": 0.0002668798337342822,
            "start_logit": 3.4277918338775635,
            "end_logit": -4.742173194885254
        },
        {
            "text": "factor I",
            "probability": 0.00025928582199029175,
            "start_logit": -4.487618923187256,
            "end_logit": 3.1443700790405273
        },
        {
            "text": "proptosis",
            "probability": 0.0002490568957430056,
            "start_logit": -0.8287219405174255,
            "end_logit": -0.5547765493392944
        },
        {
            "text": "IGF-IR, in patients with active, moderate-to-severe ophthalmopathy",
            "probability": 0.00021198092231650156,
            "start_logit": 0.9687308073043823,
            "end_logit": -2.5134143829345703
        }
    ],
    "5c700c607c78d6947100005e_001": [
        {
            "text": "",
            "probability": 0.6637142913515272,
            "start_logit": 0.519688606262207,
            "end_logit": 1.2658753395080566
        },
        {
            "text": "systemic lupus erythematosus",
            "probability": 0.1431292689229927,
            "start_logit": -0.7421271800994873,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "a simple systemic lupus erythematosus",
            "probability": 0.04413160688643919,
            "start_logit": -1.9186991453170776,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "simple systemic lupus erythematosus",
            "probability": 0.03418802223588513,
            "start_logit": -2.1740000247955322,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "erythematosus",
            "probability": 0.02469514363367207,
            "start_logit": -2.4992687702178955,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "lupus erythematosus",
            "probability": 0.02464770430333275,
            "start_logit": -2.5011916160583496,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "systemic lupus erythematosus (SLE",
            "probability": 0.013478688203842282,
            "start_logit": -0.7421271800994873,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "SLE",
            "probability": 0.009794808761626554,
            "start_logit": -1.0613844394683838,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "SLE) severity index that requires knowledge of only American College of Rheumatology (ACR) criteria and subcriteria",
            "probability": 0.008466732673740169,
            "start_logit": -1.0613844394683838,
            "end_logit": -1.5147587060928345
        },
        {
            "text": "systemic lupus erythematosus (SLE)",
            "probability": 0.004609920280472286,
            "start_logit": -0.7421271800994873,
            "end_logit": -2.4419500827789307
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE",
            "probability": 0.004155936613334413,
            "start_logit": -1.9186991453170776,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "To develop a simple systemic lupus erythematosus",
            "probability": 0.00397928655512513,
            "start_logit": -4.324772834777832,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "SLE) severity index that requires knowledge of only American College of Rheumatology (ACR) criteria and subcriteria.",
            "probability": 0.0034147744011182013,
            "start_logit": -1.0613844394683838,
            "end_logit": -2.4227919578552246
        },
        {
            "text": "SLE)",
            "probability": 0.0033499764124448202,
            "start_logit": -1.0613844394683838,
            "end_logit": -2.4419500827789307
        },
        {
            "text": "simple systemic lupus erythematosus (SLE",
            "probability": 0.0032195350083947553,
            "start_logit": -2.1740000247955322,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "systemic lupus erythematosus (SLE) severity index that requires knowledge of only American College of Rheumatology",
            "probability": 0.0026068527094559673,
            "start_logit": -0.7421271800994873,
            "end_logit": -3.012017011642456
        },
        {
            "text": "erythematosus (SLE",
            "probability": 0.002325577037401434,
            "start_logit": -2.4992687702178955,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "lupus erythematosus (SLE",
            "probability": 0.0023211096077341534,
            "start_logit": -2.5011916160583496,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "SLE) severity index that requires knowledge of only American College of Rheumatology",
            "probability": 0.001894370088000888,
            "start_logit": -1.0613844394683838,
            "end_logit": -3.012017011642456
        },
        {
            "text": "systemic lupus erythematosus (SLE) severity index",
            "probability": 0.001876394313460159,
            "start_logit": -0.7421271800994873,
            "end_logit": -3.340808629989624
        }
    ],
    "5c700c607c78d6947100005e_002": [
        {
            "text": "",
            "probability": 0.6637142913515272,
            "start_logit": 0.519688606262207,
            "end_logit": 1.2658753395080566
        },
        {
            "text": "systemic lupus erythematosus",
            "probability": 0.1431292689229927,
            "start_logit": -0.7421271800994873,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "a simple systemic lupus erythematosus",
            "probability": 0.04413160688643919,
            "start_logit": -1.9186991453170776,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "simple systemic lupus erythematosus",
            "probability": 0.03418802223588513,
            "start_logit": -2.1740000247955322,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "erythematosus",
            "probability": 0.02469514363367207,
            "start_logit": -2.4992687702178955,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "lupus erythematosus",
            "probability": 0.02464770430333275,
            "start_logit": -2.5011916160583496,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "systemic lupus erythematosus (SLE",
            "probability": 0.013478688203842282,
            "start_logit": -0.7421271800994873,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "SLE",
            "probability": 0.009794808761626554,
            "start_logit": -1.0613844394683838,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "SLE) severity index that requires knowledge of only American College of Rheumatology (ACR) criteria and subcriteria",
            "probability": 0.008466732673740169,
            "start_logit": -1.0613844394683838,
            "end_logit": -1.5147587060928345
        },
        {
            "text": "systemic lupus erythematosus (SLE)",
            "probability": 0.004609920280472286,
            "start_logit": -0.7421271800994873,
            "end_logit": -2.4419500827789307
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE",
            "probability": 0.004155936613334413,
            "start_logit": -1.9186991453170776,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "To develop a simple systemic lupus erythematosus",
            "probability": 0.00397928655512513,
            "start_logit": -4.324772834777832,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "SLE) severity index that requires knowledge of only American College of Rheumatology (ACR) criteria and subcriteria.",
            "probability": 0.0034147744011182013,
            "start_logit": -1.0613844394683838,
            "end_logit": -2.4227919578552246
        },
        {
            "text": "SLE)",
            "probability": 0.0033499764124448202,
            "start_logit": -1.0613844394683838,
            "end_logit": -2.4419500827789307
        },
        {
            "text": "simple systemic lupus erythematosus (SLE",
            "probability": 0.0032195350083947553,
            "start_logit": -2.1740000247955322,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "systemic lupus erythematosus (SLE) severity index that requires knowledge of only American College of Rheumatology",
            "probability": 0.0026068527094559673,
            "start_logit": -0.7421271800994873,
            "end_logit": -3.012017011642456
        },
        {
            "text": "erythematosus (SLE",
            "probability": 0.002325577037401434,
            "start_logit": -2.4992687702178955,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "lupus erythematosus (SLE",
            "probability": 0.0023211096077341534,
            "start_logit": -2.5011916160583496,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "SLE) severity index that requires knowledge of only American College of Rheumatology",
            "probability": 0.001894370088000888,
            "start_logit": -1.0613844394683838,
            "end_logit": -3.012017011642456
        },
        {
            "text": "systemic lupus erythematosus (SLE) severity index",
            "probability": 0.001876394313460159,
            "start_logit": -0.7421271800994873,
            "end_logit": -3.340808629989624
        }
    ],
    "5c700c607c78d6947100005e_003": [
        {
            "text": "",
            "probability": 0.6637142913515272,
            "start_logit": 0.519688606262207,
            "end_logit": 1.2658753395080566
        },
        {
            "text": "systemic lupus erythematosus",
            "probability": 0.1431292689229927,
            "start_logit": -0.7421271800994873,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "a simple systemic lupus erythematosus",
            "probability": 0.04413160688643919,
            "start_logit": -1.9186991453170776,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "simple systemic lupus erythematosus",
            "probability": 0.03418802223588513,
            "start_logit": -2.1740000247955322,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "erythematosus",
            "probability": 0.02469514363367207,
            "start_logit": -2.4992687702178955,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "lupus erythematosus",
            "probability": 0.02464770430333275,
            "start_logit": -2.5011916160583496,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "systemic lupus erythematosus (SLE",
            "probability": 0.013478688203842282,
            "start_logit": -0.7421271800994873,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "SLE",
            "probability": 0.009794808761626554,
            "start_logit": -1.0613844394683838,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "SLE) severity index that requires knowledge of only American College of Rheumatology (ACR) criteria and subcriteria",
            "probability": 0.008466732673740169,
            "start_logit": -1.0613844394683838,
            "end_logit": -1.5147587060928345
        },
        {
            "text": "systemic lupus erythematosus (SLE)",
            "probability": 0.004609920280472286,
            "start_logit": -0.7421271800994873,
            "end_logit": -2.4419500827789307
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE",
            "probability": 0.004155936613334413,
            "start_logit": -1.9186991453170776,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "To develop a simple systemic lupus erythematosus",
            "probability": 0.00397928655512513,
            "start_logit": -4.324772834777832,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "SLE) severity index that requires knowledge of only American College of Rheumatology (ACR) criteria and subcriteria.",
            "probability": 0.0034147744011182013,
            "start_logit": -1.0613844394683838,
            "end_logit": -2.4227919578552246
        },
        {
            "text": "SLE)",
            "probability": 0.0033499764124448202,
            "start_logit": -1.0613844394683838,
            "end_logit": -2.4419500827789307
        },
        {
            "text": "simple systemic lupus erythematosus (SLE",
            "probability": 0.0032195350083947553,
            "start_logit": -2.1740000247955322,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "systemic lupus erythematosus (SLE) severity index that requires knowledge of only American College of Rheumatology",
            "probability": 0.0026068527094559673,
            "start_logit": -0.7421271800994873,
            "end_logit": -3.012017011642456
        },
        {
            "text": "erythematosus (SLE",
            "probability": 0.002325577037401434,
            "start_logit": -2.4992687702178955,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "lupus erythematosus (SLE",
            "probability": 0.0023211096077341534,
            "start_logit": -2.5011916160583496,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "SLE) severity index that requires knowledge of only American College of Rheumatology",
            "probability": 0.001894370088000888,
            "start_logit": -1.0613844394683838,
            "end_logit": -3.012017011642456
        },
        {
            "text": "systemic lupus erythematosus (SLE) severity index",
            "probability": 0.001876394313460159,
            "start_logit": -0.7421271800994873,
            "end_logit": -3.340808629989624
        }
    ],
    "5c700c607c78d6947100005e_004": [
        {
            "text": "",
            "probability": 0.6637142913515272,
            "start_logit": 0.519688606262207,
            "end_logit": 1.2658753395080566
        },
        {
            "text": "systemic lupus erythematosus",
            "probability": 0.1431292689229927,
            "start_logit": -0.7421271800994873,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "a simple systemic lupus erythematosus",
            "probability": 0.04413160688643919,
            "start_logit": -1.9186991453170776,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "simple systemic lupus erythematosus",
            "probability": 0.03418802223588513,
            "start_logit": -2.1740000247955322,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "erythematosus",
            "probability": 0.02469514363367207,
            "start_logit": -2.4992687702178955,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "lupus erythematosus",
            "probability": 0.02464770430333275,
            "start_logit": -2.5011916160583496,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "systemic lupus erythematosus (SLE",
            "probability": 0.013478688203842282,
            "start_logit": -0.7421271800994873,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "SLE",
            "probability": 0.009794808761626554,
            "start_logit": -1.0613844394683838,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "SLE) severity index that requires knowledge of only American College of Rheumatology (ACR) criteria and subcriteria",
            "probability": 0.008466732673740169,
            "start_logit": -1.0613844394683838,
            "end_logit": -1.5147587060928345
        },
        {
            "text": "systemic lupus erythematosus (SLE)",
            "probability": 0.004609920280472286,
            "start_logit": -0.7421271800994873,
            "end_logit": -2.4419500827789307
        },
        {
            "text": "a simple systemic lupus erythematosus (SLE",
            "probability": 0.004155936613334413,
            "start_logit": -1.9186991453170776,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "To develop a simple systemic lupus erythematosus",
            "probability": 0.00397928655512513,
            "start_logit": -4.324772834777832,
            "end_logit": 0.9935875535011292
        },
        {
            "text": "SLE) severity index that requires knowledge of only American College of Rheumatology (ACR) criteria and subcriteria.",
            "probability": 0.0034147744011182013,
            "start_logit": -1.0613844394683838,
            "end_logit": -2.4227919578552246
        },
        {
            "text": "SLE)",
            "probability": 0.0033499764124448202,
            "start_logit": -1.0613844394683838,
            "end_logit": -2.4419500827789307
        },
        {
            "text": "simple systemic lupus erythematosus (SLE",
            "probability": 0.0032195350083947553,
            "start_logit": -2.1740000247955322,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "systemic lupus erythematosus (SLE) severity index that requires knowledge of only American College of Rheumatology",
            "probability": 0.0026068527094559673,
            "start_logit": -0.7421271800994873,
            "end_logit": -3.012017011642456
        },
        {
            "text": "erythematosus (SLE",
            "probability": 0.002325577037401434,
            "start_logit": -2.4992687702178955,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "lupus erythematosus (SLE",
            "probability": 0.0023211096077341534,
            "start_logit": -2.5011916160583496,
            "end_logit": -1.3690508604049683
        },
        {
            "text": "SLE) severity index that requires knowledge of only American College of Rheumatology",
            "probability": 0.001894370088000888,
            "start_logit": -1.0613844394683838,
            "end_logit": -3.012017011642456
        },
        {
            "text": "systemic lupus erythematosus (SLE) severity index",
            "probability": 0.001876394313460159,
            "start_logit": -0.7421271800994873,
            "end_logit": -3.340808629989624
        }
    ],
    "5e2b0d167d50947c2f000002_002": [
        {
            "text": "acromelic frontonasal dysostosis",
            "probability": 0.8524157802688944,
            "start_logit": 6.607633590698242,
            "end_logit": 5.575877666473389
        },
        {
            "text": "acromelic frontonasal dysostosis (AFND)",
            "probability": 0.1376006468680876,
            "start_logit": 6.607633590698242,
            "end_logit": 3.7521588802337646
        },
        {
            "text": "acromelic frontonasal dysostosis (AFND",
            "probability": 0.006605223894023918,
            "start_logit": 6.607633590698242,
            "end_logit": 0.7156640887260437
        },
        {
            "text": "",
            "probability": 0.0015391663161786581,
            "start_logit": 3.225231647491455,
            "end_logit": 2.641446113586426
        },
        {
            "text": "acromelic frontonasal dysostosis (AFND),",
            "probability": 0.0008920660205101561,
            "start_logit": 6.607633590698242,
            "end_logit": -1.2864118814468384
        },
        {
            "text": "AFND)",
            "probability": 0.0003870764355136238,
            "start_logit": 0.7341448664665222,
            "end_logit": 3.7521588802337646
        },
        {
            "text": "frontonasal dysostosis",
            "probability": 0.00013661157768942537,
            "start_logit": -2.131054401397705,
            "end_logit": 5.575877666473389
        },
        {
            "text": "cause acromelic frontonasal dysostosis",
            "probability": 0.00013451666875790682,
            "start_logit": -2.146507978439331,
            "end_logit": 5.575877666473389
        },
        {
            "text": "ac",
            "probability": 6.236714065152856e-05,
            "start_logit": 6.607633590698242,
            "end_logit": -3.946913480758667
        },
        {
            "text": "acromelic frontonasal",
            "probability": 4.383654246429801e-05,
            "start_logit": 6.607633590698242,
            "end_logit": -4.2994842529296875
        },
        {
            "text": "acromelic",
            "probability": 3.7634471022342406e-05,
            "start_logit": 6.607633590698242,
            "end_logit": -4.45203161239624
        },
        {
            "text": "frontonasal dysostosis (AFND)",
            "probability": 2.2052432504012485e-05,
            "start_logit": -2.131054401397705,
            "end_logit": 3.7521588802337646
        },
        {
            "text": "cause acromelic frontonasal dysostosis (AFND)",
            "probability": 2.1714263231717042e-05,
            "start_logit": -2.146507978439331,
            "end_logit": 3.7521588802337646
        },
        {
            "text": "AFND), an autosomal-dominant severe frontonasal and limb malformation syndrome",
            "probability": 2.1279568516451226e-05,
            "start_logit": 0.7341448664665222,
            "end_logit": 0.8512840867042542
        },
        {
            "text": "acromelic frontonasal dysostosis (AFND), an autosomal-dominant severe frontonasal and limb",
            "probability": 1.956980547707339e-05,
            "start_logit": 6.607633590698242,
            "end_logit": -5.105964183807373
        },
        {
            "text": "AFND",
            "probability": 1.8580773992430655e-05,
            "start_logit": 0.7341448664665222,
            "end_logit": 0.7156640887260437
        },
        {
            "text": "to cause acromelic frontonasal dysostosis",
            "probability": 1.541809905555278e-05,
            "start_logit": -4.3126540184021,
            "end_logit": 5.575877666473389
        },
        {
            "text": "severe frontonasal and limb malformation syndrome",
            "probability": 1.005487317652808e-05,
            "start_logit": -0.015545111149549484,
            "end_logit": 0.8512840867042542
        },
        {
            "text": "acromelic frontonasal d",
            "probability": 8.944700929787786e-06,
            "start_logit": 6.607633590698242,
            "end_logit": -5.888890743255615
        },
        {
            "text": "acromelic frontonasal dysostosis (",
            "probability": 7.4592793228265365e-06,
            "start_logit": 6.607633590698242,
            "end_logit": -6.070493221282959
        }
    ],
    "5e2b0d167d50947c2f000002_003": [
        {
            "text": "acromelic frontonasal dysostosis",
            "probability": 0.8524157802688944,
            "start_logit": 6.607633590698242,
            "end_logit": 5.575877666473389
        },
        {
            "text": "acromelic frontonasal dysostosis (AFND)",
            "probability": 0.1376006468680876,
            "start_logit": 6.607633590698242,
            "end_logit": 3.7521588802337646
        },
        {
            "text": "acromelic frontonasal dysostosis (AFND",
            "probability": 0.006605223894023918,
            "start_logit": 6.607633590698242,
            "end_logit": 0.7156640887260437
        },
        {
            "text": "",
            "probability": 0.0015391663161786581,
            "start_logit": 3.225231647491455,
            "end_logit": 2.641446113586426
        },
        {
            "text": "acromelic frontonasal dysostosis (AFND),",
            "probability": 0.0008920660205101561,
            "start_logit": 6.607633590698242,
            "end_logit": -1.2864118814468384
        },
        {
            "text": "AFND)",
            "probability": 0.0003870764355136238,
            "start_logit": 0.7341448664665222,
            "end_logit": 3.7521588802337646
        },
        {
            "text": "frontonasal dysostosis",
            "probability": 0.00013661157768942537,
            "start_logit": -2.131054401397705,
            "end_logit": 5.575877666473389
        },
        {
            "text": "cause acromelic frontonasal dysostosis",
            "probability": 0.00013451666875790682,
            "start_logit": -2.146507978439331,
            "end_logit": 5.575877666473389
        },
        {
            "text": "ac",
            "probability": 6.236714065152856e-05,
            "start_logit": 6.607633590698242,
            "end_logit": -3.946913480758667
        },
        {
            "text": "acromelic frontonasal",
            "probability": 4.383654246429801e-05,
            "start_logit": 6.607633590698242,
            "end_logit": -4.2994842529296875
        },
        {
            "text": "acromelic",
            "probability": 3.7634471022342406e-05,
            "start_logit": 6.607633590698242,
            "end_logit": -4.45203161239624
        },
        {
            "text": "frontonasal dysostosis (AFND)",
            "probability": 2.2052432504012485e-05,
            "start_logit": -2.131054401397705,
            "end_logit": 3.7521588802337646
        },
        {
            "text": "cause acromelic frontonasal dysostosis (AFND)",
            "probability": 2.1714263231717042e-05,
            "start_logit": -2.146507978439331,
            "end_logit": 3.7521588802337646
        },
        {
            "text": "AFND), an autosomal-dominant severe frontonasal and limb malformation syndrome",
            "probability": 2.1279568516451226e-05,
            "start_logit": 0.7341448664665222,
            "end_logit": 0.8512840867042542
        },
        {
            "text": "acromelic frontonasal dysostosis (AFND), an autosomal-dominant severe frontonasal and limb",
            "probability": 1.956980547707339e-05,
            "start_logit": 6.607633590698242,
            "end_logit": -5.105964183807373
        },
        {
            "text": "AFND",
            "probability": 1.8580773992430655e-05,
            "start_logit": 0.7341448664665222,
            "end_logit": 0.7156640887260437
        },
        {
            "text": "to cause acromelic frontonasal dysostosis",
            "probability": 1.541809905555278e-05,
            "start_logit": -4.3126540184021,
            "end_logit": 5.575877666473389
        },
        {
            "text": "severe frontonasal and limb malformation syndrome",
            "probability": 1.005487317652808e-05,
            "start_logit": -0.015545111149549484,
            "end_logit": 0.8512840867042542
        },
        {
            "text": "acromelic frontonasal d",
            "probability": 8.944700929787786e-06,
            "start_logit": 6.607633590698242,
            "end_logit": -5.888890743255615
        },
        {
            "text": "acromelic frontonasal dysostosis (",
            "probability": 7.4592793228265365e-06,
            "start_logit": 6.607633590698242,
            "end_logit": -6.070493221282959
        }
    ],
    "5e2b0d167d50947c2f000002_005": [
        {
            "text": "",
            "probability": 0.9976422369916107,
            "start_logit": 5.316473484039307,
            "end_logit": 5.20572566986084
        },
        {
            "text": "craniofacial, brain and limb malformations",
            "probability": 0.002107211102341432,
            "start_logit": 2.5888478755950928,
            "end_logit": 1.7733218669891357
        },
        {
            "text": "the craniofacial, brain and limb malformations",
            "probability": 0.0002326222965919093,
            "start_logit": 0.38514336943626404,
            "end_logit": 1.7733218669891357
        },
        {
            "text": "craniofacial, brain and limb",
            "probability": 3.3810158392231507e-06,
            "start_logit": 2.5888478755950928,
            "end_logit": -4.661622524261475
        },
        {
            "text": "craniofacial,",
            "probability": 2.8398712389911575e-06,
            "start_logit": 2.5888478755950928,
            "end_logit": -4.836040019989014
        },
        {
            "text": "craniofacial, brain and limb malformations through the disruption of Hedgehog signaling.",
            "probability": 2.5906761992250577e-06,
            "start_logit": 2.5888478755950928,
            "end_logit": -4.927879810333252
        },
        {
            "text": "cr",
            "probability": 2.1514585911409995e-06,
            "start_logit": 2.5888478755950928,
            "end_logit": -5.11365270614624
        },
        {
            "text": "craniofacial",
            "probability": 2.0756285644759867e-06,
            "start_logit": 2.5888478755950928,
            "end_logit": -5.149534702301025
        },
        {
            "text": "ZSWIM6 mutation associated with AFND may lead to the craniofacial, brain and limb malformations",
            "probability": 1.4711358788480821e-06,
            "start_logit": -4.6782379150390625,
            "end_logit": 1.7733218669891357
        },
        {
            "text": "Acromelic frontonasal dysostosis",
            "probability": 4.721281767592762e-07,
            "start_logit": -2.310267925262451,
            "end_logit": -1.7311877012252808
        },
        {
            "text": "malformations",
            "probability": 4.105834936332944e-07,
            "start_logit": -5.954448699951172,
            "end_logit": 1.7733218669891357
        },
        {
            "text": "the craniofacial, brain and limb",
            "probability": 3.732419919673877e-07,
            "start_logit": 0.38514336943626404,
            "end_logit": -4.661622524261475
        },
        {
            "text": "lead to the craniofacial, brain and limb malformations",
            "probability": 3.189005986301283e-07,
            "start_logit": -6.207148551940918,
            "end_logit": 1.7733218669891357
        },
        {
            "text": "the craniofacial,",
            "probability": 3.135031743641572e-07,
            "start_logit": 0.38514336943626404,
            "end_logit": -4.836040019989014
        },
        {
            "text": "brain and limb malformations",
            "probability": 3.000121090267321e-07,
            "start_logit": -6.268205165863037,
            "end_logit": 1.7733218669891357
        },
        {
            "text": "the craniofacial, brain and limb malformations through the disruption of Hedgehog signaling.",
            "probability": 2.859936750143813e-07,
            "start_logit": 0.38514336943626404,
            "end_logit": -4.927879810333252
        },
        {
            "text": "limb malformations",
            "probability": 2.5506378917298445e-07,
            "start_logit": -6.430514335632324,
            "end_logit": 1.7733218669891357
        },
        {
            "text": "the cr",
            "probability": 2.375069293899916e-07,
            "start_logit": 0.38514336943626404,
            "end_logit": -5.11365270614624
        },
        {
            "text": "the craniofacial",
            "probability": 2.291357913802115e-07,
            "start_logit": 0.38514336943626404,
            "end_logit": -5.149534702301025
        },
        {
            "text": "the ZSWIM6 mutation associated with AFND may lead to the craniofacial, brain and limb malformations",
            "probability": 2.2375341507608987e-07,
            "start_logit": -6.561483383178711,
            "end_logit": 1.7733218669891357
        }
    ],
    "5e29f6e0aa19d74431000002_002": [
        {
            "text": "",
            "probability": 0.5439034281761089,
            "start_logit": 4.150155544281006,
            "end_logit": 3.76818585395813
        },
        {
            "text": "chordoma",
            "probability": 0.44403398486240914,
            "start_logit": 3.7425320148468018,
            "end_logit": 3.9729387760162354
        },
        {
            "text": "radiation-induced DNA damage",
            "probability": 0.005516775625261658,
            "start_logit": 1.285461187362671,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "DNA damage",
            "probability": 0.0030698940105803683,
            "start_logit": 0.6993106603622437,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "chord",
            "probability": 0.0022001620909244644,
            "start_logit": 3.7425320148468018,
            "end_logit": -1.3344312906265259
        },
        {
            "text": "Standard therapy for chordoma",
            "probability": 0.000354719435839528,
            "start_logit": -3.3897972106933594,
            "end_logit": 3.9729387760162354
        },
        {
            "text": "radiation",
            "probability": 0.0002260100139651172,
            "start_logit": 1.285461187362671,
            "end_logit": -1.1530674695968628
        },
        {
            "text": "radiation-induced DNA",
            "probability": 0.000205447992069657,
            "start_logit": 1.285461187362671,
            "end_logit": -1.2484538555145264
        },
        {
            "text": "DNA",
            "probability": 0.00011432467136281057,
            "start_logit": 0.6993106603622437,
            "end_logit": -1.2484538555145264
        },
        {
            "text": "radiation-induced DNA damage.",
            "probability": 0.00010580006264544403,
            "start_logit": 1.285461187362671,
            "end_logit": -1.9120956659317017
        },
        {
            "text": "damage",
            "probability": 9.606289664308407e-05,
            "start_logit": -2.7650845050811768,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "DNA damage.",
            "probability": 5.8874059903219543e-05,
            "start_logit": 0.6993106603622437,
            "end_logit": -1.9120956659317017
        },
        {
            "text": "induced DNA damage",
            "probability": 2.61940552778599e-05,
            "start_logit": -4.0645551681518555,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "radiation-induced",
            "probability": 1.976593784309029e-05,
            "start_logit": 1.285461187362671,
            "end_logit": -3.589686632156372
        },
        {
            "text": "radiation-induced DNA damage. Ultrastructural evidence for nuclear damage",
            "probability": 1.7734448965789696e-05,
            "start_logit": 1.285461187362671,
            "end_logit": -3.6981377601623535
        },
        {
            "text": "Quantitative \u03b3-H2AX immunofluorescence and immunoblot evaluated the effect of LB100 on radiation-induced DNA damage",
            "probability": 1.4714195768503234e-05,
            "start_logit": -4.641274929046631,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "LB100 on radiation-induced DNA damage",
            "probability": 1.3211410753370308e-05,
            "start_logit": -4.749006748199463,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "\u03b3-H2AX immunofluorescence and immunoblot evaluated the effect of LB100 on radiation-induced DNA damage",
            "probability": 1.1185166099404291e-05,
            "start_logit": -4.915499210357666,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "DNA damage. Ultrastructural evidence for nuclear damage",
            "probability": 9.868604844417394e-06,
            "start_logit": 0.6993106603622437,
            "end_logit": -3.6981377601623535
        },
        {
            "text": "damage.",
            "probability": 1.842282734175737e-06,
            "start_logit": -2.7650845050811768,
            "end_logit": -1.9120956659317017
        }
    ],
    "5e29f6e0aa19d74431000002_003": [
        {
            "text": "",
            "probability": 0.5439034281761089,
            "start_logit": 4.150155544281006,
            "end_logit": 3.76818585395813
        },
        {
            "text": "chordoma",
            "probability": 0.44403398486240914,
            "start_logit": 3.7425320148468018,
            "end_logit": 3.9729387760162354
        },
        {
            "text": "radiation-induced DNA damage",
            "probability": 0.005516775625261658,
            "start_logit": 1.285461187362671,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "DNA damage",
            "probability": 0.0030698940105803683,
            "start_logit": 0.6993106603622437,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "chord",
            "probability": 0.0022001620909244644,
            "start_logit": 3.7425320148468018,
            "end_logit": -1.3344312906265259
        },
        {
            "text": "Standard therapy for chordoma",
            "probability": 0.000354719435839528,
            "start_logit": -3.3897972106933594,
            "end_logit": 3.9729387760162354
        },
        {
            "text": "radiation",
            "probability": 0.0002260100139651172,
            "start_logit": 1.285461187362671,
            "end_logit": -1.1530674695968628
        },
        {
            "text": "radiation-induced DNA",
            "probability": 0.000205447992069657,
            "start_logit": 1.285461187362671,
            "end_logit": -1.2484538555145264
        },
        {
            "text": "DNA",
            "probability": 0.00011432467136281057,
            "start_logit": 0.6993106603622437,
            "end_logit": -1.2484538555145264
        },
        {
            "text": "radiation-induced DNA damage.",
            "probability": 0.00010580006264544403,
            "start_logit": 1.285461187362671,
            "end_logit": -1.9120956659317017
        },
        {
            "text": "damage",
            "probability": 9.606289664308407e-05,
            "start_logit": -2.7650845050811768,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "DNA damage.",
            "probability": 5.8874059903219543e-05,
            "start_logit": 0.6993106603622437,
            "end_logit": -1.9120956659317017
        },
        {
            "text": "induced DNA damage",
            "probability": 2.61940552778599e-05,
            "start_logit": -4.0645551681518555,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "radiation-induced",
            "probability": 1.976593784309029e-05,
            "start_logit": 1.285461187362671,
            "end_logit": -3.589686632156372
        },
        {
            "text": "radiation-induced DNA damage. Ultrastructural evidence for nuclear damage",
            "probability": 1.7734448965789696e-05,
            "start_logit": 1.285461187362671,
            "end_logit": -3.6981377601623535
        },
        {
            "text": "Quantitative \u03b3-H2AX immunofluorescence and immunoblot evaluated the effect of LB100 on radiation-induced DNA damage",
            "probability": 1.4714195768503234e-05,
            "start_logit": -4.641274929046631,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "LB100 on radiation-induced DNA damage",
            "probability": 1.3211410753370308e-05,
            "start_logit": -4.749006748199463,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "\u03b3-H2AX immunofluorescence and immunoblot evaluated the effect of LB100 on radiation-induced DNA damage",
            "probability": 1.1185166099404291e-05,
            "start_logit": -4.915499210357666,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "DNA damage. Ultrastructural evidence for nuclear damage",
            "probability": 9.868604844417394e-06,
            "start_logit": 0.6993106603622437,
            "end_logit": -3.6981377601623535
        },
        {
            "text": "damage.",
            "probability": 1.842282734175737e-06,
            "start_logit": -2.7650845050811768,
            "end_logit": -1.9120956659317017
        }
    ],
    "5e29f6e0aa19d74431000002_004": [
        {
            "text": "",
            "probability": 0.5439034281761089,
            "start_logit": 4.150155544281006,
            "end_logit": 3.76818585395813
        },
        {
            "text": "chordoma",
            "probability": 0.44403398486240914,
            "start_logit": 3.7425320148468018,
            "end_logit": 3.9729387760162354
        },
        {
            "text": "radiation-induced DNA damage",
            "probability": 0.005516775625261658,
            "start_logit": 1.285461187362671,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "DNA damage",
            "probability": 0.0030698940105803683,
            "start_logit": 0.6993106603622437,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "chord",
            "probability": 0.0022001620909244644,
            "start_logit": 3.7425320148468018,
            "end_logit": -1.3344312906265259
        },
        {
            "text": "Standard therapy for chordoma",
            "probability": 0.000354719435839528,
            "start_logit": -3.3897972106933594,
            "end_logit": 3.9729387760162354
        },
        {
            "text": "radiation",
            "probability": 0.0002260100139651172,
            "start_logit": 1.285461187362671,
            "end_logit": -1.1530674695968628
        },
        {
            "text": "radiation-induced DNA",
            "probability": 0.000205447992069657,
            "start_logit": 1.285461187362671,
            "end_logit": -1.2484538555145264
        },
        {
            "text": "DNA",
            "probability": 0.00011432467136281057,
            "start_logit": 0.6993106603622437,
            "end_logit": -1.2484538555145264
        },
        {
            "text": "radiation-induced DNA damage.",
            "probability": 0.00010580006264544403,
            "start_logit": 1.285461187362671,
            "end_logit": -1.9120956659317017
        },
        {
            "text": "damage",
            "probability": 9.606289664308407e-05,
            "start_logit": -2.7650845050811768,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "DNA damage.",
            "probability": 5.8874059903219543e-05,
            "start_logit": 0.6993106603622437,
            "end_logit": -1.9120956659317017
        },
        {
            "text": "induced DNA damage",
            "probability": 2.61940552778599e-05,
            "start_logit": -4.0645551681518555,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "radiation-induced",
            "probability": 1.976593784309029e-05,
            "start_logit": 1.285461187362671,
            "end_logit": -3.589686632156372
        },
        {
            "text": "radiation-induced DNA damage. Ultrastructural evidence for nuclear damage",
            "probability": 1.7734448965789696e-05,
            "start_logit": 1.285461187362671,
            "end_logit": -3.6981377601623535
        },
        {
            "text": "Quantitative \u03b3-H2AX immunofluorescence and immunoblot evaluated the effect of LB100 on radiation-induced DNA damage",
            "probability": 1.4714195768503234e-05,
            "start_logit": -4.641274929046631,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "LB100 on radiation-induced DNA damage",
            "probability": 1.3211410753370308e-05,
            "start_logit": -4.749006748199463,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "\u03b3-H2AX immunofluorescence and immunoblot evaluated the effect of LB100 on radiation-induced DNA damage",
            "probability": 1.1185166099404291e-05,
            "start_logit": -4.915499210357666,
            "end_logit": 2.0419020652770996
        },
        {
            "text": "DNA damage. Ultrastructural evidence for nuclear damage",
            "probability": 9.868604844417394e-06,
            "start_logit": 0.6993106603622437,
            "end_logit": -3.6981377601623535
        },
        {
            "text": "damage.",
            "probability": 1.842282734175737e-06,
            "start_logit": -2.7650845050811768,
            "end_logit": -1.9120956659317017
        }
    ],
    "5e29f6e0aa19d74431000002_006": [
        {
            "text": "cancers",
            "probability": 0.6608551516082537,
            "start_logit": 1.141003966331482,
            "end_logit": 2.624258518218994
        },
        {
            "text": "various cancers",
            "probability": 0.2883930595106613,
            "start_logit": 0.31179362535476685,
            "end_logit": 2.624258518218994
        },
        {
            "text": "treatment of various cancers",
            "probability": 0.019354910752733448,
            "start_logit": -2.389584541320801,
            "end_logit": 2.624258518218994
        },
        {
            "text": "",
            "probability": 0.013039034576659135,
            "start_logit": -0.37775081396102905,
            "end_logit": 0.217426136136055
        },
        {
            "text": "cancers.",
            "probability": 0.004601940985044175,
            "start_logit": 1.141003966331482,
            "end_logit": -2.3427979946136475
        },
        {
            "text": "effective chemo- and radio-sensitizer for treatment of various cancers",
            "probability": 0.0032327538416360904,
            "start_logit": -4.179196357727051,
            "end_logit": 2.624258518218994
        },
        {
            "text": "various cancers.",
            "probability": 0.002008258295535122,
            "start_logit": 0.31179362535476685,
            "end_logit": -2.3427979946136475
        },
        {
            "text": "an effective chemo- and radio-sensitizer for treatment of various cancers",
            "probability": 0.0017060803031699657,
            "start_logit": -4.818332195281982,
            "end_logit": 2.624258518218994
        },
        {
            "text": "for treatment of various cancers",
            "probability": 0.0016228510340080455,
            "start_logit": -4.868346214294434,
            "end_logit": 2.624258518218994
        },
        {
            "text": "chemo- and radio-sensitizer for treatment of various cancers",
            "probability": 0.0010593136909215317,
            "start_logit": -5.294909477233887,
            "end_logit": 2.624258518218994
        },
        {
            "text": "cancers. We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma",
            "probability": 0.0009908171692227631,
            "start_logit": 1.141003966331482,
            "end_logit": -3.8785014152526855
        },
        {
            "text": "to be an effective chemo- and radio-sensitizer for treatment of various cancers",
            "probability": 0.0008273450205286162,
            "start_logit": -5.542064189910889,
            "end_logit": 2.624258518218994
        },
        {
            "text": "cancers. We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma (MB)",
            "probability": 0.0007449353843232443,
            "start_logit": 1.141003966331482,
            "end_logit": -4.163733959197998
        },
        {
            "text": "various cancers. We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma",
            "probability": 0.0004323864225805885,
            "start_logit": 0.31179362535476685,
            "end_logit": -3.8785014152526855
        },
        {
            "text": "LB100, has been shown in pre-clinical studies to be an effective chemo- and radio-sensitizer for treatment of various cancers",
            "probability": 0.00041520742518438934,
            "start_logit": -6.231507778167725,
            "end_logit": 2.624258518218994
        },
        {
            "text": "various cancers. We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma (MB)",
            "probability": 0.00032508514778149393,
            "start_logit": 0.31179362535476685,
            "end_logit": -4.163733959197998
        },
        {
            "text": "various",
            "probability": 0.00018894707684452138,
            "start_logit": 0.31179362535476685,
            "end_logit": -4.706354141235352
        },
        {
            "text": "treatment of various cancers.",
            "probability": 0.00013478015089708477,
            "start_logit": -2.389584541320801,
            "end_logit": -2.3427979946136475
        },
        {
            "text": "cisplatin-mediated cytotoxic",
            "probability": 3.812287300215268e-05,
            "start_logit": -2.8607094287872314,
            "end_logit": -3.1345036029815674
        },
        {
            "text": "treatment of various cancers. We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma",
            "probability": 2.901873101225449e-05,
            "start_logit": -2.389584541320801,
            "end_logit": -3.8785014152526855
        }
    ],
    "5e29f6e0aa19d74431000002_007": [
        {
            "text": "cancers",
            "probability": 0.6608551516082537,
            "start_logit": 1.141003966331482,
            "end_logit": 2.624258518218994
        },
        {
            "text": "various cancers",
            "probability": 0.2883930595106613,
            "start_logit": 0.31179362535476685,
            "end_logit": 2.624258518218994
        },
        {
            "text": "treatment of various cancers",
            "probability": 0.019354910752733448,
            "start_logit": -2.389584541320801,
            "end_logit": 2.624258518218994
        },
        {
            "text": "",
            "probability": 0.013039034576659135,
            "start_logit": -0.37775081396102905,
            "end_logit": 0.217426136136055
        },
        {
            "text": "cancers.",
            "probability": 0.004601940985044175,
            "start_logit": 1.141003966331482,
            "end_logit": -2.3427979946136475
        },
        {
            "text": "effective chemo- and radio-sensitizer for treatment of various cancers",
            "probability": 0.0032327538416360904,
            "start_logit": -4.179196357727051,
            "end_logit": 2.624258518218994
        },
        {
            "text": "various cancers.",
            "probability": 0.002008258295535122,
            "start_logit": 0.31179362535476685,
            "end_logit": -2.3427979946136475
        },
        {
            "text": "an effective chemo- and radio-sensitizer for treatment of various cancers",
            "probability": 0.0017060803031699657,
            "start_logit": -4.818332195281982,
            "end_logit": 2.624258518218994
        },
        {
            "text": "for treatment of various cancers",
            "probability": 0.0016228510340080455,
            "start_logit": -4.868346214294434,
            "end_logit": 2.624258518218994
        },
        {
            "text": "chemo- and radio-sensitizer for treatment of various cancers",
            "probability": 0.0010593136909215317,
            "start_logit": -5.294909477233887,
            "end_logit": 2.624258518218994
        },
        {
            "text": "cancers. We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma",
            "probability": 0.0009908171692227631,
            "start_logit": 1.141003966331482,
            "end_logit": -3.8785014152526855
        },
        {
            "text": "to be an effective chemo- and radio-sensitizer for treatment of various cancers",
            "probability": 0.0008273450205286162,
            "start_logit": -5.542064189910889,
            "end_logit": 2.624258518218994
        },
        {
            "text": "cancers. We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma (MB)",
            "probability": 0.0007449353843232443,
            "start_logit": 1.141003966331482,
            "end_logit": -4.163733959197998
        },
        {
            "text": "various cancers. We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma",
            "probability": 0.0004323864225805885,
            "start_logit": 0.31179362535476685,
            "end_logit": -3.8785014152526855
        },
        {
            "text": "LB100, has been shown in pre-clinical studies to be an effective chemo- and radio-sensitizer for treatment of various cancers",
            "probability": 0.00041520742518438934,
            "start_logit": -6.231507778167725,
            "end_logit": 2.624258518218994
        },
        {
            "text": "various cancers. We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma (MB)",
            "probability": 0.00032508514778149393,
            "start_logit": 0.31179362535476685,
            "end_logit": -4.163733959197998
        },
        {
            "text": "various",
            "probability": 0.00018894707684452138,
            "start_logit": 0.31179362535476685,
            "end_logit": -4.706354141235352
        },
        {
            "text": "treatment of various cancers.",
            "probability": 0.00013478015089708477,
            "start_logit": -2.389584541320801,
            "end_logit": -2.3427979946136475
        },
        {
            "text": "cisplatin-mediated cytotoxic",
            "probability": 3.812287300215268e-05,
            "start_logit": -2.8607094287872314,
            "end_logit": -3.1345036029815674
        },
        {
            "text": "treatment of various cancers. We investigated effects associated with LB100 treatment alone and in combination with cisplatin for medulloblastoma",
            "probability": 2.901873101225449e-05,
            "start_logit": -2.389584541320801,
            "end_logit": -3.8785014152526855
        }
    ],
    "5e29f6e0aa19d74431000002_009": [
        {
            "text": "",
            "probability": 0.5820883657370588,
            "start_logit": 2.3531081676483154,
            "end_logit": 2.0082340240478516
        },
        {
            "text": "progressive solid tumors",
            "probability": 0.24384163257608743,
            "start_logit": 2.9794180393218994,
            "end_logit": 0.5118208527565002
        },
        {
            "text": "toxicity",
            "probability": 0.07806759990164713,
            "start_logit": 0.5403134822845459,
            "end_logit": 1.8119815587997437
        },
        {
            "text": "dose-limiting toxicity",
            "probability": 0.05454698617274246,
            "start_logit": 0.18180082738399506,
            "end_logit": 1.8119815587997437
        },
        {
            "text": "acute infection and was reenrolled after recovery; each course was analyzed as a separate patient entry. Two patients had dose-limiting toxicity",
            "probability": 0.016761850558763072,
            "start_logit": -0.9981561303138733,
            "end_logit": 1.8119815587997437
        },
        {
            "text": "progressive",
            "probability": 0.004715654140449572,
            "start_logit": 2.9794180393218994,
            "end_logit": -3.4338104724884033
        },
        {
            "text": "lymphopenia",
            "probability": 0.003580259760223118,
            "start_logit": -0.36581605672836304,
            "end_logit": -0.364028662443161
        },
        {
            "text": "stable disease",
            "probability": 0.003437428065508883,
            "start_logit": -0.4742808938026428,
            "end_logit": -0.29627564549446106
        },
        {
            "text": "an acute infection and was reenrolled after recovery; each course was analyzed as a separate patient entry. Two patients had dose-limiting toxicity",
            "probability": 0.002330599524968969,
            "start_logit": -2.9711360931396484,
            "end_logit": 1.8119815587997437
        },
        {
            "text": "pancreatic adenocarcinoma",
            "probability": 0.0021612689061077236,
            "start_logit": -1.0140936374664307,
            "end_logit": -0.2204909324645996
        },
        {
            "text": "stable",
            "probability": 0.002097547215030987,
            "start_logit": -0.4742808938026428,
            "end_logit": -0.7902305126190186
        },
        {
            "text": "progressive solid tumors.",
            "probability": 0.0017698444768684677,
            "start_logit": 2.9794180393218994,
            "end_logit": -4.413806438446045
        },
        {
            "text": "pancreatic adenocarcinoma had a partial response noted after 10 cycles, which was maintained for five additional cycles. The other patients achieving stable",
            "probability": 0.0012225708865428635,
            "start_logit": -1.0140936374664307,
            "end_logit": -0.7902305126190186
        },
        {
            "text": "prostate cancer",
            "probability": 0.0009390005365095539,
            "start_logit": -0.879534125328064,
            "end_logit": -1.1886851787567139
        },
        {
            "text": "adult patients with progressive solid tumors",
            "probability": 0.0007010810717100642,
            "start_logit": -2.872232675552368,
            "end_logit": 0.5118208527565002
        },
        {
            "text": "solid tumors",
            "probability": 0.0005356277477412379,
            "start_logit": -3.1414167881011963,
            "end_logit": 0.5118208527565002
        },
        {
            "text": "acute",
            "probability": 0.00044857415015899936,
            "start_logit": -0.9981561303138733,
            "end_logit": -1.808805227279663
        },
        {
            "text": "limiting toxicity",
            "probability": 0.0002914943250245567,
            "start_logit": -5.049996376037598,
            "end_logit": 1.8119815587997437
        },
        {
            "text": "tumors",
            "probability": 0.0002829284602779009,
            "start_logit": -3.7796621322631836,
            "end_logit": 0.5118208527565002
        },
        {
            "text": "acute infection",
            "probability": 0.0001796857865780372,
            "start_logit": -0.9981561303138733,
            "end_logit": -2.7236695289611816
        }
    ],
    "5e29f6e0aa19d74431000002_010": [
        {
            "text": "",
            "probability": 0.5820883657370588,
            "start_logit": 2.3531081676483154,
            "end_logit": 2.0082340240478516
        },
        {
            "text": "progressive solid tumors",
            "probability": 0.24384163257608743,
            "start_logit": 2.9794180393218994,
            "end_logit": 0.5118208527565002
        },
        {
            "text": "toxicity",
            "probability": 0.07806759990164713,
            "start_logit": 0.5403134822845459,
            "end_logit": 1.8119815587997437
        },
        {
            "text": "dose-limiting toxicity",
            "probability": 0.05454698617274246,
            "start_logit": 0.18180082738399506,
            "end_logit": 1.8119815587997437
        },
        {
            "text": "acute infection and was reenrolled after recovery; each course was analyzed as a separate patient entry. Two patients had dose-limiting toxicity",
            "probability": 0.016761850558763072,
            "start_logit": -0.9981561303138733,
            "end_logit": 1.8119815587997437
        },
        {
            "text": "progressive",
            "probability": 0.004715654140449572,
            "start_logit": 2.9794180393218994,
            "end_logit": -3.4338104724884033
        },
        {
            "text": "lymphopenia",
            "probability": 0.003580259760223118,
            "start_logit": -0.36581605672836304,
            "end_logit": -0.364028662443161
        },
        {
            "text": "stable disease",
            "probability": 0.003437428065508883,
            "start_logit": -0.4742808938026428,
            "end_logit": -0.29627564549446106
        },
        {
            "text": "an acute infection and was reenrolled after recovery; each course was analyzed as a separate patient entry. Two patients had dose-limiting toxicity",
            "probability": 0.002330599524968969,
            "start_logit": -2.9711360931396484,
            "end_logit": 1.8119815587997437
        },
        {
            "text": "pancreatic adenocarcinoma",
            "probability": 0.0021612689061077236,
            "start_logit": -1.0140936374664307,
            "end_logit": -0.2204909324645996
        },
        {
            "text": "stable",
            "probability": 0.002097547215030987,
            "start_logit": -0.4742808938026428,
            "end_logit": -0.7902305126190186
        },
        {
            "text": "progressive solid tumors.",
            "probability": 0.0017698444768684677,
            "start_logit": 2.9794180393218994,
            "end_logit": -4.413806438446045
        },
        {
            "text": "pancreatic adenocarcinoma had a partial response noted after 10 cycles, which was maintained for five additional cycles. The other patients achieving stable",
            "probability": 0.0012225708865428635,
            "start_logit": -1.0140936374664307,
            "end_logit": -0.7902305126190186
        },
        {
            "text": "prostate cancer",
            "probability": 0.0009390005365095539,
            "start_logit": -0.879534125328064,
            "end_logit": -1.1886851787567139
        },
        {
            "text": "adult patients with progressive solid tumors",
            "probability": 0.0007010810717100642,
            "start_logit": -2.872232675552368,
            "end_logit": 0.5118208527565002
        },
        {
            "text": "solid tumors",
            "probability": 0.0005356277477412379,
            "start_logit": -3.1414167881011963,
            "end_logit": 0.5118208527565002
        },
        {
            "text": "acute",
            "probability": 0.00044857415015899936,
            "start_logit": -0.9981561303138733,
            "end_logit": -1.808805227279663
        },
        {
            "text": "limiting toxicity",
            "probability": 0.0002914943250245567,
            "start_logit": -5.049996376037598,
            "end_logit": 1.8119815587997437
        },
        {
            "text": "tumors",
            "probability": 0.0002829284602779009,
            "start_logit": -3.7796621322631836,
            "end_logit": 0.5118208527565002
        },
        {
            "text": "acute infection",
            "probability": 0.0001796857865780372,
            "start_logit": -0.9981561303138733,
            "end_logit": -2.7236695289611816
        }
    ],
    "5e46e74e3f5415952900000b_001": [
        {
            "text": "Pathogenic variants",
            "probability": 0.9802360060698926,
            "start_logit": 6.580742835998535,
            "end_logit": 6.891688823699951
        },
        {
            "text": "Pathogenic variants in this gene",
            "probability": 0.01813279302800114,
            "start_logit": 6.580742835998535,
            "end_logit": 2.9016175270080566
        },
        {
            "text": "Pathogenic",
            "probability": 0.001142765732357603,
            "start_logit": 6.580742835998535,
            "end_logit": 0.13734686374664307
        },
        {
            "text": "Pathogen",
            "probability": 0.00012516319185954412,
            "start_logit": 6.580742835998535,
            "end_logit": -2.0742413997650146
        },
        {
            "text": "variants",
            "probability": 6.559830437743014e-05,
            "start_logit": -3.0312559604644775,
            "end_logit": 6.891688823699951
        },
        {
            "text": "",
            "probability": 6.40296303979905e-05,
            "start_logit": 1.7604941129684448,
            "end_logit": 2.075734853744507
        },
        {
            "text": "Pathogenic variants in this gene cause xeroderma pigmentosum",
            "probability": 6.105814610437698e-05,
            "start_logit": 6.580742835998535,
            "end_logit": -2.7920331954956055
        },
        {
            "text": "Pathogenic variants in this gene cause",
            "probability": 5.5924150645664836e-05,
            "start_logit": 6.580742835998535,
            "end_logit": -2.8798635005950928
        },
        {
            "text": "Pathogenic variants in this gene cause xeroderma pigmentosum, XFE progeroid syndrome, Cockayne syndrome (CS),",
            "probability": 3.580701420743213e-05,
            "start_logit": 6.580742835998535,
            "end_logit": -3.325716018676758
        },
        {
            "text": "Pathogenic variants in this gene cause xeroderma pigmentosum, XFE progeroid syndrome, Cockayne syndrome",
            "probability": 2.632143961469788e-05,
            "start_logit": 6.580742835998535,
            "end_logit": -3.6334760189056396
        },
        {
            "text": "Pathogenic variants in this gene cause xeroderma pigmentosum, XFE progeroid syndrome, Cockayne syndrome (CS)",
            "probability": 1.7412601217076593e-05,
            "start_logit": 6.580742835998535,
            "end_logit": -4.046665668487549
        },
        {
            "text": "Pathogenic variants in",
            "probability": 1.3997056806192857e-05,
            "start_logit": 6.580742835998535,
            "end_logit": -4.265012741088867
        },
        {
            "text": "Pathogenic variants in this",
            "probability": 9.234556336989044e-06,
            "start_logit": 6.580742835998535,
            "end_logit": -4.680907249450684
        },
        {
            "text": "interstrand crosslink repair. Pathogenic variants",
            "probability": 5.944348091525473e-06,
            "start_logit": -5.4323649406433105,
            "end_logit": 6.891688823699951
        },
        {
            "text": ". Pathogenic variants",
            "probability": 4.915538119863518e-06,
            "start_logit": -5.6224045753479,
            "end_logit": 6.891688823699951
        },
        {
            "text": "variants in this gene",
            "probability": 1.21346335871991e-06,
            "start_logit": -3.0312559604644775,
            "end_logit": 2.9016175270080566
        },
        {
            "text": "in this gene",
            "probability": 7.161038727757916e-07,
            "start_logit": -3.558664560317993,
            "end_logit": 2.9016175270080566
        },
        {
            "text": "gene",
            "probability": 5.066745603133492e-07,
            "start_logit": -3.904620885848999,
            "end_logit": 2.9016175270080566
        },
        {
            "text": "this gene",
            "probability": 4.829892776545017e-07,
            "start_logit": -3.9524953365325928,
            "end_logit": 2.9016175270080566
        },
        {
            "text": "interstrand crosslink repair. Pathogenic variants in this gene",
            "probability": 1.0996090019400854e-07,
            "start_logit": -5.4323649406433105,
            "end_logit": 2.9016175270080566
        }
    ],
    "5e46e74e3f5415952900000b_002": [
        {
            "text": "biallelic mutations in ERCC4. ERCC4 mutations",
            "probability": 0.41670965837302515,
            "start_logit": 6.421841621398926,
            "end_logit": 6.245952606201172
        },
        {
            "text": "ERCC4 mutations",
            "probability": 0.279912544724711,
            "start_logit": 6.023929119110107,
            "end_logit": 6.245952606201172
        },
        {
            "text": "biallelic mutations",
            "probability": 0.27960252597279617,
            "start_logit": 6.421841621398926,
            "end_logit": 5.8469319343566895
        },
        {
            "text": "biallelic mutations in ERCC4. ERCC4",
            "probability": 0.011703732941546236,
            "start_logit": 6.421841621398926,
            "end_logit": 2.6734707355499268
        },
        {
            "text": "ERCC4",
            "probability": 0.007861640844220714,
            "start_logit": 6.023929119110107,
            "end_logit": 2.6734707355499268
        },
        {
            "text": "biallelic mutations in ERCC4",
            "probability": 0.001687787805990439,
            "start_logit": 6.421841621398926,
            "end_logit": 0.7369815707206726
        },
        {
            "text": "ERCC4. ERCC4 mutations",
            "probability": 0.0006175688438739055,
            "start_logit": -0.0925128236413002,
            "end_logit": 6.245952606201172
        },
        {
            "text": "biallelic mutations in ERCC4.",
            "probability": 0.0003960345675930498,
            "start_logit": 6.421841621398926,
            "end_logit": -0.7126908898353577
        },
        {
            "text": "biallelic mutations in ERCC4. ERCC4 mutations have been known",
            "probability": 0.0002923769636810066,
            "start_logit": 6.421841621398926,
            "end_logit": -1.0161484479904175
        },
        {
            "text": "mutations",
            "probability": 0.00028666415723258075,
            "start_logit": -0.8599920272827148,
            "end_logit": 6.245952606201172
        },
        {
            "text": "mutations in ERCC4. ERCC4 mutations",
            "probability": 0.0002536571474816417,
            "start_logit": -0.9823198318481445,
            "end_logit": 6.245952606201172
        },
        {
            "text": "ERCC4 mutations have been known",
            "probability": 0.00019639568768903943,
            "start_logit": 6.023929119110107,
            "end_logit": -1.0161484479904175
        },
        {
            "text": "biallelic",
            "probability": 0.0001054033035278058,
            "start_logit": 6.421841621398926,
            "end_logit": -2.036398410797119
        },
        {
            "text": "biallelic mutations in ERCC4. ERCC4 mutations have been known to cause xeroderma pigmentosum",
            "probability": 9.635328758354905e-05,
            "start_logit": 6.421841621398926,
            "end_logit": -2.1261708736419678
        },
        {
            "text": "ERCC4 mutations have been known to cause xeroderma pigmentosum",
            "probability": 6.472250733377529e-05,
            "start_logit": 6.023929119110107,
            "end_logit": -2.1261708736419678
        },
        {
            "text": "bi",
            "probability": 6.216752294684391e-05,
            "start_logit": 6.421841621398926,
            "end_logit": -2.564359664916992
        },
        {
            "text": "Japanese ARCA patients, we identified three index patients from unrelated families who had biallelic mutations in ERCC4. ERCC4 mutations",
            "probability": 4.848800283332536e-05,
            "start_logit": -2.6369869709014893,
            "end_logit": 6.245952606201172
        },
        {
            "text": "biallelic mutations in ERCC4. ER",
            "probability": 3.383292785576847e-05,
            "start_logit": 6.421841621398926,
            "end_logit": -3.172757863998413
        },
        {
            "text": "Japanese ARCA patients, we identified three index patients from unrelated families who had biallelic mutations",
            "probability": 3.253432647687217e-05,
            "start_logit": -2.6369869709014893,
            "end_logit": 5.8469319343566895
        },
        {
            "text": "three index patients from unrelated families who had biallelic mutations in ERCC4. ERCC4 mutations",
            "probability": 3.09654638305181e-05,
            "start_logit": -3.085430860519409,
            "end_logit": 6.245952606201172
        },
        {
            "text": "",
            "probability": 4.944627770679222e-06,
            "start_logit": 0.5586503744125366,
            "end_logit": 0.767300546169281
        }
    ],
    "5e46e74e3f5415952900000b_003": [
        {
            "text": "Any mutations in XPA",
            "probability": 0.6389903928485168,
            "start_logit": 6.113933563232422,
            "end_logit": 5.36630916595459
        },
        {
            "text": "Any mutations",
            "probability": 0.2246778534988482,
            "start_logit": 6.113933563232422,
            "end_logit": 4.32108736038208
        },
        {
            "text": "mutations in XPA",
            "probability": 0.08853782983335493,
            "start_logit": 4.137474060058594,
            "end_logit": 5.36630916595459
        },
        {
            "text": "mutations",
            "probability": 0.031131124635109045,
            "start_logit": 4.137474060058594,
            "end_logit": 4.32108736038208
        },
        {
            "text": "XPA",
            "probability": 0.0068006312651514925,
            "start_logit": 1.5710595846176147,
            "end_logit": 5.36630916595459
        },
        {
            "text": "Any mutations in XPA cause classical Xeroderma pigmentosum disease.",
            "probability": 0.004797978412978345,
            "start_logit": 6.113933563232422,
            "end_logit": 0.4746144115924835
        },
        {
            "text": "Any mutations in XPA cause classical Xeroderma pigmentosum disease",
            "probability": 0.0014667857715108185,
            "start_logit": 6.113933563232422,
            "end_logit": -0.710506796836853
        },
        {
            "text": "Any mutations in XPA cause classical Xeroderma pigmentosum disease. The extent to which XPA is required in the NER",
            "probability": 0.0007195465198345358,
            "start_logit": 6.113933563232422,
            "end_logit": -1.422714352607727
        },
        {
            "text": "mutations in XPA cause classical Xeroderma pigmentosum disease.",
            "probability": 0.0006648027905062628,
            "start_logit": 4.137474060058594,
            "end_logit": 0.4746144115924835
        },
        {
            "text": "Any mutations in XPA cause classical Xeroderma pigmentosum disease. The extent to which XPA",
            "probability": 0.0005767077265678425,
            "start_logit": 6.113933563232422,
            "end_logit": -1.6439999341964722
        },
        {
            "text": "Xeroderma pigmentosum group A (XPA) protein is known to be involved in damage recognition step. Any mutations in XPA",
            "probability": 0.0003745203339035769,
            "start_logit": -1.328065037727356,
            "end_logit": 5.36630916595459
        },
        {
            "text": "Any mutations in XPA cause classical Xeroderma pigmentosum disease. The extent to which XPA is required",
            "probability": 0.00027755593738414944,
            "start_logit": 6.113933563232422,
            "end_logit": -2.3753130435943604
        },
        {
            "text": "mutations in XPA cause classical Xeroderma pigmentosum disease",
            "probability": 0.00020323627787436542,
            "start_logit": 4.137474060058594,
            "end_logit": -0.710506796836853
        },
        {
            "text": "Any mutations in XPA cause",
            "probability": 0.00015580918051085791,
            "start_logit": 6.113933563232422,
            "end_logit": -2.9527034759521484
        },
        {
            "text": "Xeroderma pigmentosum group A (XPA) protein is known to be involved in damage recognition step. Any mutations",
            "probability": 0.00013168652557985462,
            "start_logit": -1.328065037727356,
            "end_logit": 4.32108736038208
        },
        {
            "text": "damage recognition step. Any mutations in XPA",
            "probability": 0.00011638390607737906,
            "start_logit": -2.496816873550415,
            "end_logit": 5.36630916595459
        },
        {
            "text": "Any mutations in XPA cause classical Xeroderma pigmentosum",
            "probability": 0.00010260593374011463,
            "start_logit": 6.113933563232422,
            "end_logit": -3.3704397678375244
        },
        {
            "text": "mutations in XPA cause classical Xeroderma pigmentosum disease. The extent to which XPA is required in the NER",
            "probability": 9.969960118852005e-05,
            "start_logit": 4.137474060058594,
            "end_logit": -1.422714352607727
        },
        {
            "text": "Any mutations in XP",
            "probability": 8.114440709118935e-05,
            "start_logit": 6.113933563232422,
            "end_logit": -3.60510516166687
        },
        {
            "text": "mutations in XPA cause classical Xeroderma pigmentosum disease. The extent to which XPA",
            "probability": 7.99080097758987e-05,
            "start_logit": 4.137474060058594,
            "end_logit": -1.6439999341964722
        },
        {
            "text": "",
            "probability": 1.3796584495976362e-05,
            "start_logit": 0.27912357449531555,
            "end_logit": 0.45789551734924316
        }
    ],
    "5e46e74e3f5415952900000b_004": [
        {
            "text": "NER-defective",
            "probability": 0.4725277984009758,
            "start_logit": 4.2863969802856445,
            "end_logit": 2.919278144836426
        },
        {
            "text": "NER-defective xeroderma pigmentosum (XP), in which bulky DNA lesions are not efficiently removed",
            "probability": 0.20647497949362723,
            "start_logit": 4.2863969802856445,
            "end_logit": 2.0913608074188232
        },
        {
            "text": "bulky DNA lesions are not efficiently removed, are cancer-prone and suffer neurodegeneration",
            "probability": 0.15596830924821614,
            "start_logit": 2.7365241050720215,
            "end_logit": 3.3607072830200195
        },
        {
            "text": "bulky DNA lesions are not efficiently removed",
            "probability": 0.04382946750099111,
            "start_logit": 2.7365241050720215,
            "end_logit": 2.0913608074188232
        },
        {
            "text": "NER-defective xeroderma pigmentosum (XP), in which bulky DNA lesions are not efficiently removed, are cancer-prone",
            "probability": 0.027568641377401934,
            "start_logit": 4.2863969802856445,
            "end_logit": 0.0778605118393898
        },
        {
            "text": "NER-defective xeroderma pigmentosum (XP), in which bulky DNA lesions are not efficiently removed,",
            "probability": 0.022481789236821974,
            "start_logit": 4.2863969802856445,
            "end_logit": -0.12611281871795654
        },
        {
            "text": "bulky DNA lesions are not efficiently removed, are cancer-prone and suffer neurodegeneration.",
            "probability": 0.011232122236928228,
            "start_logit": 2.7365241050720215,
            "end_logit": 0.7298321723937988
        },
        {
            "text": "cancer-prone and suffer neurodegeneration",
            "probability": 0.009035037041648722,
            "start_logit": -0.11201871186494827,
            "end_logit": 3.3607072830200195
        },
        {
            "text": "neurodegeneration",
            "probability": 0.009031400810036045,
            "start_logit": -0.11242125183343887,
            "end_logit": 3.3607072830200195
        },
        {
            "text": "NER-defective xeroderma pigmentosum (XP), in which bulky DNA lesions",
            "probability": 0.008598028341127946,
            "start_logit": 4.2863969802856445,
            "end_logit": -1.0872855186462402
        },
        {
            "text": "",
            "probability": 0.006257558479345187,
            "start_logit": 1.6800527572631836,
            "end_logit": 1.2013158798217773
        },
        {
            "text": "bulky DNA lesions are not efficiently removed, are cancer-prone",
            "probability": 0.005852132177277251,
            "start_logit": 2.7365241050720215,
            "end_logit": 0.0778605118393898
        },
        {
            "text": "bulky DNA lesions are not efficiently removed,",
            "probability": 0.004772320855224171,
            "start_logit": 2.7365241050720215,
            "end_logit": -0.12611281871795654
        },
        {
            "text": "NER-defective xeroderma pigmentosum (XP), in which bulky DNA lesions are not efficiently removed, are cancer",
            "probability": 0.004698917083108927,
            "start_logit": 4.2863969802856445,
            "end_logit": -1.6914863586425781
        },
        {
            "text": "DNA lesions are not efficiently removed, are cancer-prone and suffer neurodegeneration",
            "probability": 0.0030577304143925973,
            "start_logit": -1.19545578956604,
            "end_logit": 3.3607072830200195
        },
        {
            "text": "suffer neurodegeneration",
            "probability": 0.0029030168971303054,
            "start_logit": -1.2473782300949097,
            "end_logit": 3.3607072830200195
        },
        {
            "text": "bulky DNA lesions",
            "probability": 0.0018251461008702947,
            "start_logit": 2.7365241050720215,
            "end_logit": -1.0872855186462402
        },
        {
            "text": "are cancer-prone and suffer neurodegeneration",
            "probability": 0.001410641873836558,
            "start_logit": -1.9690839052200317,
            "end_logit": 3.3607072830200195
        },
        {
            "text": "NER-defective xeroderma pigmentosum (XP)",
            "probability": 0.0013212847164936962,
            "start_logit": 4.2863969802856445,
            "end_logit": -2.9602138996124268
        },
        {
            "text": "NER-defective xeroderma pigmentosum",
            "probability": 0.0011536777145460862,
            "start_logit": 4.2863969802856445,
            "end_logit": -3.0958635807037354
        }
    ],
    "5e46e74e3f5415952900000b_005": [
        {
            "text": "mutations in the ERCC1 or ERCC4 genes",
            "probability": 0.8726747876881621,
            "start_logit": 5.534872531890869,
            "end_logit": 4.609685897827148
        },
        {
            "text": "mutations",
            "probability": 0.09401607359544573,
            "start_logit": 5.534872531890869,
            "end_logit": 2.3815886974334717
        },
        {
            "text": "mutations in the ERCC1 or ERCC4",
            "probability": 0.029851693607451952,
            "start_logit": 5.534872531890869,
            "end_logit": 1.2343645095825195
        },
        {
            "text": "ERCC1 or ERCC4 genes",
            "probability": 0.0019130545792623171,
            "start_logit": -0.5879892110824585,
            "end_logit": 4.609685897827148
        },
        {
            "text": "",
            "probability": 0.0007981794152221696,
            "start_logit": 2.0136003494262695,
            "end_logit": 1.133973240852356
        },
        {
            "text": "mutations in the ERCC1 or ERCC4 genes cause a remarkable array of rare inherited human disorders",
            "probability": 0.0003383221352023327,
            "start_logit": 5.534872531890869,
            "end_logit": -3.245633840560913
        },
        {
            "text": "mutations in the ERCC1",
            "probability": 0.00013939703745143598,
            "start_logit": 5.534872531890869,
            "end_logit": -4.132306098937988
        },
        {
            "text": "ERCC1 or ERCC4",
            "probability": 6.544009287326666e-05,
            "start_logit": -0.5879892110824585,
            "end_logit": 1.2343645095825195
        },
        {
            "text": "ERCC4 genes",
            "probability": 4.281057739472625e-05,
            "start_logit": -4.387660503387451,
            "end_logit": 4.609685897827148
        },
        {
            "text": "genes",
            "probability": 3.5024914532191684e-05,
            "start_logit": -4.588386058807373,
            "end_logit": 4.609685897827148
        },
        {
            "text": "mutations in the ERCC1 or ERCC4 genes cause a remarkable array of rare inherited human disorders. These include specific forms of xeroderma",
            "probability": 2.458827850038634e-05,
            "start_logit": 5.534872531890869,
            "end_logit": -5.8673624992370605
        },
        {
            "text": "mutations in the ERCC1 or ERCC4 genes cause a remarkable array of rare inherited human disorders. These include specific forms",
            "probability": 2.1495779280344132e-05,
            "start_logit": 5.534872531890869,
            "end_logit": -6.001775741577148
        },
        {
            "text": "mutations in the ER",
            "probability": 2.056911442613019e-05,
            "start_logit": 5.534872531890869,
            "end_logit": -6.045841693878174
        },
        {
            "text": "mutations in the ERCC1 or ERCC4 genes cause a remarkable array of rare",
            "probability": 2.05532412108197e-05,
            "start_logit": 5.534872531890869,
            "end_logit": -6.046613693237305
        },
        {
            "text": "the ERCC1 or ERCC4 genes",
            "probability": 2.017276264841885e-05,
            "start_logit": -5.140112400054932,
            "end_logit": 4.609685897827148
        },
        {
            "text": "in the ERCC1 or ERCC4 genes",
            "probability": 7.867941044273965e-06,
            "start_logit": -6.081649303436279,
            "end_logit": 4.609685897827148
        },
        {
            "text": "mice or humans. However, mutations in the ERCC1 or ERCC4 genes",
            "probability": 5.970167158949143e-06,
            "start_logit": -6.357670783996582,
            "end_logit": 4.609685897827148
        },
        {
            "text": "ERCC4",
            "probability": 1.4644266771256146e-06,
            "start_logit": -4.387660503387451,
            "end_logit": 1.2343645095825195
        },
        {
            "text": "ERCC1-XPF",
            "probability": 1.4034982265715873e-06,
            "start_logit": -2.181973457336426,
            "end_logit": -1.0138185024261475
        },
        {
            "text": "ERCC1 or ERCC4 is not compatible with viability in mice or humans. However, mutations",
            "probability": 1.1311478284882399e-06,
            "start_logit": -5.793115615844727,
            "end_logit": 2.3815886974334717
        }
    ],
    "5e2902e48b3851296d000006_001": [
        {
            "text": "",
            "probability": 0.506866931293204,
            "start_logit": 1.2814141511917114,
            "end_logit": 1.714752197265625
        },
        {
            "text": "placebo",
            "probability": 0.4865422963344018,
            "start_logit": 1.3457286357879639,
            "end_logit": 1.6095130443572998
        },
        {
            "text": "anifrolumab and placebo",
            "probability": 0.004858272986376541,
            "start_logit": -3.2609121799468994,
            "end_logit": 1.6095130443572998
        },
        {
            "text": "placebo.METHODS: Patients received intravenous placebo",
            "probability": 0.0006508030387970076,
            "start_logit": 1.3457286357879639,
            "end_logit": -5.007359027862549
        },
        {
            "text": "placebo.METHODS:",
            "probability": 0.0005434345048787405,
            "start_logit": -5.451441287994385,
            "end_logit": 1.6095130443572998
        },
        {
            "text": "place",
            "probability": 0.000166139564977862,
            "start_logit": 1.3457286357879639,
            "end_logit": -6.372737884521484
        },
        {
            "text": "anifrolumab is associated with more patients who met LLDAS criteria versus placebo",
            "probability": 7.44591351939986e-05,
            "start_logit": -3.546225070953369,
            "end_logit": -2.2833619117736816
        },
        {
            "text": "placebo-treated patients",
            "probability": 5.676261357600134e-05,
            "start_logit": -0.9321081638336182,
            "end_logit": -5.168851375579834
        },
        {
            "text": "placebo-treated",
            "probability": 5.5633121496772415e-05,
            "start_logit": -0.9321081638336182,
            "end_logit": -5.188950538635254
        },
        {
            "text": "Lupus Low Disease",
            "probability": 5.503488005042793e-05,
            "start_logit": -2.424025297164917,
            "end_logit": -3.7078449726104736
        },
        {
            "text": "Lupus Low",
            "probability": 4.881297360302678e-05,
            "start_logit": -2.424025297164917,
            "end_logit": -3.8278160095214844
        },
        {
            "text": "patients who met LLDAS criteria versus placebo",
            "probability": 2.096748147606507e-05,
            "start_logit": -4.813502788543701,
            "end_logit": -2.2833619117736816
        },
        {
            "text": "Lupus",
            "probability": 1.8017869778380315e-05,
            "start_logit": -2.424025297164917,
            "end_logit": -4.824448108673096
        },
        {
            "text": "Lupus Low Disease Activity State (LLDAS) definition as an endpoint in an systemic lupus erythematosus",
            "probability": 6.6667839365090935e-06,
            "start_logit": -2.424025297164917,
            "end_logit": -5.818674564361572
        },
        {
            "text": "vs placebo",
            "probability": 6.616102117527767e-06,
            "start_logit": -7.387467384338379,
            "end_logit": -0.8628636598587036
        },
        {
            "text": "anifrolumab and placebo.METHODS: Patients received intravenous placebo",
            "probability": 6.498466519067374e-06,
            "start_logit": -3.2609121799468994,
            "end_logit": -5.007359027862549
        },
        {
            "text": "more patients who met LLDAS criteria versus placebo",
            "probability": 5.950482048774351e-06,
            "start_logit": -6.07300329208374,
            "end_logit": -2.2833619117736816
        },
        {
            "text": "LLDAS criteria versus placebo",
            "probability": 5.891112293764089e-06,
            "start_logit": -6.083030700683594,
            "end_logit": -2.2833619117736816
        },
        {
            "text": "Low Disease",
            "probability": 5.530727999471368e-06,
            "start_logit": -4.721673011779785,
            "end_logit": -3.7078449726104736
        },
        {
            "text": "associated with more patients who met LLDAS criteria versus placebo",
            "probability": 5.280527274137036e-06,
            "start_logit": -6.192449569702148,
            "end_logit": -2.2833619117736816
        }
    ],
    "5e2902e48b3851296d000006_002": [
        {
            "text": "",
            "probability": 0.506866931293204,
            "start_logit": 1.2814141511917114,
            "end_logit": 1.714752197265625
        },
        {
            "text": "placebo",
            "probability": 0.4865422963344018,
            "start_logit": 1.3457286357879639,
            "end_logit": 1.6095130443572998
        },
        {
            "text": "anifrolumab and placebo",
            "probability": 0.004858272986376541,
            "start_logit": -3.2609121799468994,
            "end_logit": 1.6095130443572998
        },
        {
            "text": "placebo.METHODS: Patients received intravenous placebo",
            "probability": 0.0006508030387970076,
            "start_logit": 1.3457286357879639,
            "end_logit": -5.007359027862549
        },
        {
            "text": "placebo.METHODS:",
            "probability": 0.0005434345048787405,
            "start_logit": -5.451441287994385,
            "end_logit": 1.6095130443572998
        },
        {
            "text": "place",
            "probability": 0.000166139564977862,
            "start_logit": 1.3457286357879639,
            "end_logit": -6.372737884521484
        },
        {
            "text": "anifrolumab is associated with more patients who met LLDAS criteria versus placebo",
            "probability": 7.44591351939986e-05,
            "start_logit": -3.546225070953369,
            "end_logit": -2.2833619117736816
        },
        {
            "text": "placebo-treated patients",
            "probability": 5.676261357600134e-05,
            "start_logit": -0.9321081638336182,
            "end_logit": -5.168851375579834
        },
        {
            "text": "placebo-treated",
            "probability": 5.5633121496772415e-05,
            "start_logit": -0.9321081638336182,
            "end_logit": -5.188950538635254
        },
        {
            "text": "Lupus Low Disease",
            "probability": 5.503488005042793e-05,
            "start_logit": -2.424025297164917,
            "end_logit": -3.7078449726104736
        },
        {
            "text": "Lupus Low",
            "probability": 4.881297360302678e-05,
            "start_logit": -2.424025297164917,
            "end_logit": -3.8278160095214844
        },
        {
            "text": "patients who met LLDAS criteria versus placebo",
            "probability": 2.096748147606507e-05,
            "start_logit": -4.813502788543701,
            "end_logit": -2.2833619117736816
        },
        {
            "text": "Lupus",
            "probability": 1.8017869778380315e-05,
            "start_logit": -2.424025297164917,
            "end_logit": -4.824448108673096
        },
        {
            "text": "Lupus Low Disease Activity State (LLDAS) definition as an endpoint in an systemic lupus erythematosus",
            "probability": 6.6667839365090935e-06,
            "start_logit": -2.424025297164917,
            "end_logit": -5.818674564361572
        },
        {
            "text": "vs placebo",
            "probability": 6.616102117527767e-06,
            "start_logit": -7.387467384338379,
            "end_logit": -0.8628636598587036
        },
        {
            "text": "anifrolumab and placebo.METHODS: Patients received intravenous placebo",
            "probability": 6.498466519067374e-06,
            "start_logit": -3.2609121799468994,
            "end_logit": -5.007359027862549
        },
        {
            "text": "more patients who met LLDAS criteria versus placebo",
            "probability": 5.950482048774351e-06,
            "start_logit": -6.07300329208374,
            "end_logit": -2.2833619117736816
        },
        {
            "text": "LLDAS criteria versus placebo",
            "probability": 5.891112293764089e-06,
            "start_logit": -6.083030700683594,
            "end_logit": -2.2833619117736816
        },
        {
            "text": "Low Disease",
            "probability": 5.530727999471368e-06,
            "start_logit": -4.721673011779785,
            "end_logit": -3.7078449726104736
        },
        {
            "text": "associated with more patients who met LLDAS criteria versus placebo",
            "probability": 5.280527274137036e-06,
            "start_logit": -6.192449569702148,
            "end_logit": -2.2833619117736816
        }
    ],
    "5e2902e48b3851296d000006_003": [
        {
            "text": "",
            "probability": 0.9999820037369352,
            "start_logit": 4.631826400756836,
            "end_logit": 4.859619617462158
        },
        {
            "text": "sifalimumab",
            "probability": 1.5410006210855862e-05,
            "start_logit": -1.1899707317352295,
            "end_logit": -0.3990587592124939
        },
        {
            "text": "SLE",
            "probability": 5.252516419953824e-07,
            "start_logit": -2.1577253341674805,
            "end_logit": -2.810199022293091
        },
        {
            "text": "SLE disease",
            "probability": 4.962768041859512e-07,
            "start_logit": -2.1577253341674805,
            "end_logit": -2.8669426441192627
        },
        {
            "text": "sifalimumab; NCT01283139",
            "probability": 3.152588983953235e-07,
            "start_logit": -1.1899707317352295,
            "end_logit": -4.2884368896484375
        },
        {
            "text": "Chronic Illness",
            "probability": 1.2999144876111638e-07,
            "start_logit": -2.3476614952087402,
            "end_logit": -4.016671657562256
        },
        {
            "text": "sifalimumab; NCT01283139, anifrolumab",
            "probability": 1.2174504598417472e-07,
            "start_logit": -1.1899707317352295,
            "end_logit": -5.239902019500732
        },
        {
            "text": "sifalimuma",
            "probability": 1.1939774166297344e-07,
            "start_logit": -1.1899707317352295,
            "end_logit": -5.259370803833008
        },
        {
            "text": "(sifalimumab;",
            "probability": 1.0980552138392535e-07,
            "start_logit": -6.134032249450684,
            "end_logit": -0.3990587592124939
        },
        {
            "text": "(sifalimumab",
            "probability": 9.955168022900841e-08,
            "start_logit": -6.2320661544799805,
            "end_logit": -0.3990587592124939
        },
        {
            "text": "Chronic Illness Therapy-Fatigue",
            "probability": 9.919694783637286e-08,
            "start_logit": -2.3476614952087402,
            "end_logit": -4.2870330810546875
        },
        {
            "text": "SLE disease activity",
            "probability": 9.544509370299689e-08,
            "start_logit": -2.1577253341674805,
            "end_logit": -4.5155253410339355
        },
        {
            "text": "two Phase IIb trials (sifalimumab",
            "probability": 7.806817351148198e-08,
            "start_logit": -6.475160598754883,
            "end_logit": -0.3990587592124939
        },
        {
            "text": "sifalimumab; NCT01283139, anifrolumab; NCT01438489",
            "probability": 6.232442352344579e-08,
            "start_logit": -1.1899707317352295,
            "end_logit": -5.909477710723877
        },
        {
            "text": "moderate to severe SLE",
            "probability": 6.207244504266312e-08,
            "start_logit": -4.293300628662109,
            "end_logit": -2.810199022293091
        },
        {
            "text": "moderate to severe SLE disease",
            "probability": 5.8648297674530163e-08,
            "start_logit": -4.293300628662109,
            "end_logit": -2.8669426441192627
        },
        {
            "text": "si",
            "probability": 5.676408317525392e-08,
            "start_logit": -1.1899707317352295,
            "end_logit": -6.002927303314209
        },
        {
            "text": "Chronic",
            "probability": 5.658665120114987e-08,
            "start_logit": -2.3476614952087402,
            "end_logit": -4.848367214202881
        },
        {
            "text": "sifalim",
            "probability": 5.1400418686296367e-08,
            "start_logit": -1.1899707317352295,
            "end_logit": -6.102184772491455
        },
        {
            "text": "sifa",
            "probability": 4.847153657717143e-08,
            "start_logit": -1.1899707317352295,
            "end_logit": -6.160854339599609
        }
    ],
    "5e2902e48b3851296d000006_004": [
        {
            "text": "",
            "probability": 0.9743578455429356,
            "start_logit": 0.10063579678535461,
            "end_logit": 0.033147361129522324
        },
        {
            "text": "placebo",
            "probability": 0.018465057893182653,
            "start_logit": -1.2462729215621948,
            "end_logit": -2.5858423709869385
        },
        {
            "text": "placebo (n=4/cohort)",
            "probability": 0.00162730589252707,
            "start_logit": -1.2462729215621948,
            "end_logit": -5.014796733856201
        },
        {
            "text": "placebo (n=4/cohort",
            "probability": 0.0012944469810329483,
            "start_logit": -1.2462729215621948,
            "end_logit": -5.24363899230957
        },
        {
            "text": "anifrolumab 600\u2009mg SC (n=6)) and placebo",
            "probability": 0.0011105357138045658,
            "start_logit": -4.057310581207275,
            "end_logit": -2.5858423709869385
        },
        {
            "text": "300\u2009mg intravenous (n=6), anifrolumab 600\u2009mg SC (n=6)) and placebo",
            "probability": 0.0007925631839554829,
            "start_logit": -4.394636154174805,
            "end_logit": -2.5858423709869385
        },
        {
            "text": "placebo (n=4/cohort).",
            "probability": 0.0007807396399267549,
            "start_logit": -1.2462729215621948,
            "end_logit": -5.749236106872559
        },
        {
            "text": "600\u2009mg SC (n=6)) and placebo",
            "probability": 0.00034151152207345295,
            "start_logit": -5.236526966094971,
            "end_logit": -2.5858423709869385
        },
        {
            "text": "anifrolumab 600\u2009mg SC (n=6))",
            "probability": 0.00017140180678627633,
            "start_logit": -4.057310581207275,
            "end_logit": -4.454429626464844
        },
        {
            "text": "anifrolumab 300\u2009mg intravenous (n=6), anifrolumab 600\u2009mg SC (n=6))",
            "probability": 0.000157335221840674,
            "start_logit": -4.142942428588867,
            "end_logit": -4.454429626464844
        },
        {
            "text": "intravenous (n=6), anifrolumab 600\u2009mg SC (n=6)) and placebo",
            "probability": 0.00012887354441013492,
            "start_logit": -6.211076736450195,
            "end_logit": -2.5858423709869385
        },
        {
            "text": "300\u2009mg intravenous (n=6), anifrolumab 600\u2009mg SC (n=6))",
            "probability": 0.00012232543270207722,
            "start_logit": -4.394636154174805,
            "end_logit": -4.454429626464844
        },
        {
            "text": "anifrolumab 300\u2009mg intravenous",
            "probability": 0.00011267083678508772,
            "start_logit": -4.142942428588867,
            "end_logit": -4.788337707519531
        },
        {
            "text": "anifrolumab 600\u2009mg SC (n=6)) and placebo (n=4/cohort).",
            "probability": 9.787033007912428e-05,
            "start_logit": -4.057310581207275,
            "end_logit": -5.014796733856201
        },
        {
            "text": "300\u2009mg intravenous",
            "probability": 8.759964044540432e-05,
            "start_logit": -4.394636154174805,
            "end_logit": -4.788337707519531
        },
        {
            "text": "anifrolumab 600\u2009mg SC",
            "probability": 8.612104501961026e-05,
            "start_logit": -4.057310581207275,
            "end_logit": -5.142686367034912
        },
        {
            "text": "anifrolumab 300\u2009mg intravenous (n=6), anifrolumab 600\u2009mg SC",
            "probability": 7.905327240923784e-05,
            "start_logit": -4.142942428588867,
            "end_logit": -5.142686367034912
        },
        {
            "text": "(anifrolumab 300\u2009mg SC (n=6), anifrolumab 300\u2009mg intravenous",
            "probability": 7.257051984828366e-05,
            "start_logit": -4.582854270935059,
            "end_logit": -4.788337707519531
        },
        {
            "text": "300\u2009mg intravenous (n=6), anifrolumab 600\u2009mg SC",
            "probability": 6.146256153480866e-05,
            "start_logit": -4.394636154174805,
            "end_logit": -5.142686367034912
        },
        {
            "text": "600\u2009mg SC (n=6))",
            "probability": 5.2709418701344313e-05,
            "start_logit": -5.236526966094971,
            "end_logit": -4.454429626464844
        }
    ],
    "5e2902e48b3851296d000006_006": [
        {
            "text": "SLE",
            "probability": 0.7203157436847175,
            "start_logit": 2.588510513305664,
            "end_logit": 3.075348377227783
        },
        {
            "text": "patients with SLE",
            "probability": 0.0882466527311835,
            "start_logit": 0.48895663022994995,
            "end_logit": 3.075348377227783
        },
        {
            "text": "SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling.",
            "probability": 0.08332641284205781,
            "start_logit": 2.588510513305664,
            "end_logit": 0.9184243083000183
        },
        {
            "text": "SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling",
            "probability": 0.0517389086409711,
            "start_logit": 2.588510513305664,
            "end_logit": 0.4418688118457794
        },
        {
            "text": "patients with SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling.",
            "probability": 0.010208408023671959,
            "start_logit": 0.48895663022994995,
            "end_logit": 0.9184243083000183
        },
        {
            "text": "",
            "probability": 0.009842153964780444,
            "start_logit": 0.5894428491592407,
            "end_logit": 0.7814009785652161
        },
        {
            "text": "promising therapeutic for patients with SLE",
            "probability": 0.008251108345538648,
            "start_logit": -1.8808315992355347,
            "end_logit": 3.075348377227783
        },
        {
            "text": "patients with SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling",
            "probability": 0.006338589075082957,
            "start_logit": 0.48895663022994995,
            "end_logit": 0.4418688118457794
        },
        {
            "text": "SLE and other diseases that exhibit chronic dysfunctional type I",
            "probability": 0.005878338280811546,
            "start_logit": 2.588510513305664,
            "end_logit": -1.7330671548843384
        },
        {
            "text": "type I IFN autoamplification loop, and is a promising therapeutic for patients with SLE",
            "probability": 0.003996338259827932,
            "start_logit": -2.6058006286621094,
            "end_logit": 3.075348377227783
        },
        {
            "text": "IFN autoamplification loop, and is a promising therapeutic for patients with SLE",
            "probability": 0.002014353812513584,
            "start_logit": -3.2908806800842285,
            "end_logit": 3.075348377227783
        },
        {
            "text": "diseases that exhibit chronic dysfunctional type I IFN signalling.",
            "probability": 0.0016588859771983272,
            "start_logit": -1.328108787536621,
            "end_logit": 0.9184243083000183
        },
        {
            "text": "type I IFN-dependent signalling, including the type I IFN autoamplification loop, and is a promising therapeutic for patients with SLE",
            "probability": 0.0014165962291934624,
            "start_logit": -3.6429221630096436,
            "end_logit": 3.075348377227783
        },
        {
            "text": "chronic dysfunctional type I IFN signalling.",
            "probability": 0.0014048131091890347,
            "start_logit": -1.494350790977478,
            "end_logit": 0.9184243083000183
        },
        {
            "text": "diseases that exhibit chronic dysfunctional type I IFN signalling",
            "probability": 0.0010300329402483455,
            "start_logit": -1.328108787536621,
            "end_logit": 0.4418688118457794
        },
        {
            "text": "promising therapeutic for patients with SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling.",
            "probability": 0.000954491507971033,
            "start_logit": -1.8808315992355347,
            "end_logit": 0.9184243083000183
        },
        {
            "text": "a promising therapeutic for patients with SLE",
            "probability": 0.000945274431402935,
            "start_logit": -4.047459125518799,
            "end_logit": 3.075348377227783
        },
        {
            "text": "chronic dysfunctional type I IFN signalling",
            "probability": 0.0008722744041764879,
            "start_logit": -1.494350790977478,
            "end_logit": 0.4418688118457794
        },
        {
            "text": "with SLE",
            "probability": 0.000813711084630447,
            "start_logit": -4.197329044342041,
            "end_logit": 3.075348377227783
        },
        {
            "text": "therapeutic for patients with SLE",
            "probability": 0.0007469126548328062,
            "start_logit": -4.282986164093018,
            "end_logit": 3.075348377227783
        }
    ],
    "5e2902e48b3851296d000006_007": [
        {
            "text": "SLE",
            "probability": 0.7203157436847175,
            "start_logit": 2.588510513305664,
            "end_logit": 3.075348377227783
        },
        {
            "text": "patients with SLE",
            "probability": 0.0882466527311835,
            "start_logit": 0.48895663022994995,
            "end_logit": 3.075348377227783
        },
        {
            "text": "SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling.",
            "probability": 0.08332641284205781,
            "start_logit": 2.588510513305664,
            "end_logit": 0.9184243083000183
        },
        {
            "text": "SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling",
            "probability": 0.0517389086409711,
            "start_logit": 2.588510513305664,
            "end_logit": 0.4418688118457794
        },
        {
            "text": "patients with SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling.",
            "probability": 0.010208408023671959,
            "start_logit": 0.48895663022994995,
            "end_logit": 0.9184243083000183
        },
        {
            "text": "",
            "probability": 0.009842153964780444,
            "start_logit": 0.5894428491592407,
            "end_logit": 0.7814009785652161
        },
        {
            "text": "promising therapeutic for patients with SLE",
            "probability": 0.008251108345538648,
            "start_logit": -1.8808315992355347,
            "end_logit": 3.075348377227783
        },
        {
            "text": "patients with SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling",
            "probability": 0.006338589075082957,
            "start_logit": 0.48895663022994995,
            "end_logit": 0.4418688118457794
        },
        {
            "text": "SLE and other diseases that exhibit chronic dysfunctional type I",
            "probability": 0.005878338280811546,
            "start_logit": 2.588510513305664,
            "end_logit": -1.7330671548843384
        },
        {
            "text": "type I IFN autoamplification loop, and is a promising therapeutic for patients with SLE",
            "probability": 0.003996338259827932,
            "start_logit": -2.6058006286621094,
            "end_logit": 3.075348377227783
        },
        {
            "text": "IFN autoamplification loop, and is a promising therapeutic for patients with SLE",
            "probability": 0.002014353812513584,
            "start_logit": -3.2908806800842285,
            "end_logit": 3.075348377227783
        },
        {
            "text": "diseases that exhibit chronic dysfunctional type I IFN signalling.",
            "probability": 0.0016588859771983272,
            "start_logit": -1.328108787536621,
            "end_logit": 0.9184243083000183
        },
        {
            "text": "type I IFN-dependent signalling, including the type I IFN autoamplification loop, and is a promising therapeutic for patients with SLE",
            "probability": 0.0014165962291934624,
            "start_logit": -3.6429221630096436,
            "end_logit": 3.075348377227783
        },
        {
            "text": "chronic dysfunctional type I IFN signalling.",
            "probability": 0.0014048131091890347,
            "start_logit": -1.494350790977478,
            "end_logit": 0.9184243083000183
        },
        {
            "text": "diseases that exhibit chronic dysfunctional type I IFN signalling",
            "probability": 0.0010300329402483455,
            "start_logit": -1.328108787536621,
            "end_logit": 0.4418688118457794
        },
        {
            "text": "promising therapeutic for patients with SLE and other diseases that exhibit chronic dysfunctional type I IFN signalling.",
            "probability": 0.000954491507971033,
            "start_logit": -1.8808315992355347,
            "end_logit": 0.9184243083000183
        },
        {
            "text": "a promising therapeutic for patients with SLE",
            "probability": 0.000945274431402935,
            "start_logit": -4.047459125518799,
            "end_logit": 3.075348377227783
        },
        {
            "text": "chronic dysfunctional type I IFN signalling",
            "probability": 0.0008722744041764879,
            "start_logit": -1.494350790977478,
            "end_logit": 0.4418688118457794
        },
        {
            "text": "with SLE",
            "probability": 0.000813711084630447,
            "start_logit": -4.197329044342041,
            "end_logit": 3.075348377227783
        },
        {
            "text": "therapeutic for patients with SLE",
            "probability": 0.0007469126548328062,
            "start_logit": -4.282986164093018,
            "end_logit": 3.075348377227783
        }
    ],
    "5e2902e48b3851296d000006_008": [
        {
            "text": "",
            "probability": 0.9999999170938603,
            "start_logit": 6.504459381103516,
            "end_logit": 7.365344524383545
        },
        {
            "text": "Systemic lupus erythematosus",
            "probability": 5.639800552194703e-08,
            "start_logit": -2.4415814876556396,
            "end_logit": -0.3794465661048889
        },
        {
            "text": "erythematosus",
            "probability": 1.5506124335780662e-08,
            "start_logit": -3.7327802181243896,
            "end_logit": -0.3794465661048889
        },
        {
            "text": "lupus erythematosus",
            "probability": 5.274766166906873e-09,
            "start_logit": -4.8110809326171875,
            "end_logit": -0.3794465661048889
        },
        {
            "text": "Systemic lupus erythematosus (SLE)",
            "probability": 2.096692454511373e-09,
            "start_logit": -2.4415814876556396,
            "end_logit": -3.6715192794799805
        },
        {
            "text": "rituximab",
            "probability": 8.372754380112544e-10,
            "start_logit": -2.9602479934692383,
            "end_logit": -4.0708160400390625
        },
        {
            "text": "erythematosus (SLE)",
            "probability": 5.764667312728773e-10,
            "start_logit": -3.7327802181243896,
            "end_logit": -3.6715192794799805
        },
        {
            "text": "Systemic lupus erythematosus (SLE) is an autoimmune disease",
            "probability": 3.6906555141361054e-10,
            "start_logit": -2.4415814876556396,
            "end_logit": -5.408661365509033
        },
        {
            "text": "Systemic lupus erythematosus (SLE",
            "probability": 3.4084321026218504e-10,
            "start_logit": -2.4415814876556396,
            "end_logit": -5.488213062286377
        },
        {
            "text": "a monoclonal antibody targeting the type 1 IFN receptor",
            "probability": 3.0159749865537154e-10,
            "start_logit": -4.598626613616943,
            "end_logit": -3.4534971714019775
        },
        {
            "text": "lupus erythematosus (SLE)",
            "probability": 1.9609846694244782e-10,
            "start_logit": -4.8110809326171875,
            "end_logit": -3.6715192794799805
        },
        {
            "text": "monoclonal antibody targeting the type 1 IFN receptor",
            "probability": 1.8720409535329812e-10,
            "start_logit": -5.0755205154418945,
            "end_logit": -3.4534971714019775
        },
        {
            "text": "Systemic lupus",
            "probability": 1.7212628407159034e-10,
            "start_logit": -2.4415814876556396,
            "end_logit": -6.171407222747803
        },
        {
            "text": "Systemic lupus er",
            "probability": 1.1519552675826567e-10,
            "start_logit": -2.4415814876556396,
            "end_logit": -6.573004722595215
        },
        {
            "text": "SLE)",
            "probability": 1.0307619718225988e-10,
            "start_logit": -5.454229354858398,
            "end_logit": -3.6715192794799805
        },
        {
            "text": "anifrolumab, a monoclonal antibody targeting the type 1 IFN receptor",
            "probability": 1.0279521845800077e-10,
            "start_logit": -5.674981117248535,
            "end_logit": -3.4534971714019775
        },
        {
            "text": "erythematosus (SLE) is an autoimmune disease",
            "probability": 1.0147125373158638e-10,
            "start_logit": -3.7327802181243896,
            "end_logit": -5.408661365509033
        },
        {
            "text": "erythematosus (SLE",
            "probability": 9.371177488316281e-11,
            "start_logit": -3.7327802181243896,
            "end_logit": -5.488213062286377
        },
        {
            "text": "glucocorticoid therapy",
            "probability": 7.543069613811946e-11,
            "start_logit": -6.454761028289795,
            "end_logit": -2.9832417964935303
        },
        {
            "text": "rituximab,",
            "probability": 5.8192999221190966e-11,
            "start_logit": -2.9602479934692383,
            "end_logit": -6.737204074859619
        }
    ],
    "5e2902e48b3851296d000006_009": [
        {
            "text": "influenza",
            "probability": 0.9991580024070075,
            "start_logit": 5.065088272094727,
            "end_logit": 4.6780781745910645
        },
        {
            "text": "cases reported as influenza",
            "probability": 0.00022532470263247225,
            "start_logit": -3.3320374488830566,
            "end_logit": 4.6780781745910645
        },
        {
            "text": "anifrolumab 300 mg and 1,000 mg, respectively), as were cases reported as influenza",
            "probability": 0.00013156357097012569,
            "start_logit": -3.8700897693634033,
            "end_logit": 4.6780781745910645
        },
        {
            "text": "lupus erythematosus",
            "probability": 0.00012299215636701614,
            "start_logit": 0.17218464612960815,
            "end_logit": 0.5684341788291931
        },
        {
            "text": "influenza (2.0% versus 6.1% and 7.6%, respectively), in the anifrolumab",
            "probability": 8.377570521715323e-05,
            "start_logit": 5.065088272094727,
            "end_logit": -4.708446979522705
        },
        {
            "text": "systemic lupus erythematosus",
            "probability": 4.914414211055321e-05,
            "start_logit": -0.7451782822608948,
            "end_logit": 0.5684341788291931
        },
        {
            "text": "300 mg and 1,000 mg, respectively), as were cases reported as influenza",
            "probability": 3.47896942874044e-05,
            "start_logit": -5.200258731842041,
            "end_logit": 4.6780781745910645
        },
        {
            "text": "influenza (2.0% versus 6.1% and 7.6%",
            "probability": 3.3758341146478773e-05,
            "start_logit": 5.065088272094727,
            "end_logit": -5.6173624992370605
        },
        {
            "text": "lupus erythematosus (SLE)",
            "probability": 3.235576215417731e-05,
            "start_logit": 0.17218464612960815,
            "end_logit": -0.7668942809104919
        },
        {
            "text": "as influenza",
            "probability": 2.9729191692661083e-05,
            "start_logit": -5.357450485229492,
            "end_logit": 4.6780781745910645
        },
        {
            "text": "influenza (2.0% versus 6.1% and 7.6%, respectively), in the anifrolumab treatment groups",
            "probability": 2.9304913324892535e-05,
            "start_logit": 5.065088272094727,
            "end_logit": -5.7588348388671875
        },
        {
            "text": "1,000 mg, respectively), as were cases reported as influenza",
            "probability": 1.817473690075805e-05,
            "start_logit": -5.849547386169434,
            "end_logit": 4.6780781745910645
        },
        {
            "text": "Herpes zoster",
            "probability": 1.610964198950954e-05,
            "start_logit": 0.22929473221302032,
            "end_logit": -1.521378517150879
        },
        {
            "text": "systemic lupus erythematosus (SLE)",
            "probability": 1.2928435604098239e-05,
            "start_logit": -0.7451782822608948,
            "end_logit": -0.7668942809104919
        },
        {
            "text": "moderate-to-severe systemic lupus erythematosus",
            "probability": 8.793250997307315e-06,
            "start_logit": -2.465951442718506,
            "end_logit": 0.5684341788291931
        },
        {
            "text": "",
            "probability": 6.205328550899659e-06,
            "start_logit": -1.1595879793167114,
            "end_logit": -1.08650541305542
        },
        {
            "text": "moderate-to-severe systemic lupus erythematosus (SLE)",
            "probability": 2.313255952532905e-06,
            "start_logit": -2.465951442718506,
            "end_logit": -0.7668942809104919
        },
        {
            "text": "placebo",
            "probability": 2.265470556964967e-06,
            "start_logit": -3.4059600830078125,
            "end_logit": 0.1522408127784729
        },
        {
            "text": "Herpes",
            "probability": 1.5393962097005008e-06,
            "start_logit": 0.22929473221302032,
            "end_logit": -3.869406223297119
        },
        {
            "text": "lupus erythematosus (SLE",
            "probability": 9.298963276178119e-07,
            "start_logit": 0.17218464612960815,
            "end_logit": -4.316368579864502
        }
    ],
    "5e2902e48b3851296d000006_010": [
        {
            "text": "influenza",
            "probability": 0.9991580024070075,
            "start_logit": 5.065088272094727,
            "end_logit": 4.6780781745910645
        },
        {
            "text": "cases reported as influenza",
            "probability": 0.00022532470263247225,
            "start_logit": -3.3320374488830566,
            "end_logit": 4.6780781745910645
        },
        {
            "text": "anifrolumab 300 mg and 1,000 mg, respectively), as were cases reported as influenza",
            "probability": 0.00013156357097012569,
            "start_logit": -3.8700897693634033,
            "end_logit": 4.6780781745910645
        },
        {
            "text": "lupus erythematosus",
            "probability": 0.00012299215636701614,
            "start_logit": 0.17218464612960815,
            "end_logit": 0.5684341788291931
        },
        {
            "text": "influenza (2.0% versus 6.1% and 7.6%, respectively), in the anifrolumab",
            "probability": 8.377570521715323e-05,
            "start_logit": 5.065088272094727,
            "end_logit": -4.708446979522705
        },
        {
            "text": "systemic lupus erythematosus",
            "probability": 4.914414211055321e-05,
            "start_logit": -0.7451782822608948,
            "end_logit": 0.5684341788291931
        },
        {
            "text": "300 mg and 1,000 mg, respectively), as were cases reported as influenza",
            "probability": 3.47896942874044e-05,
            "start_logit": -5.200258731842041,
            "end_logit": 4.6780781745910645
        },
        {
            "text": "influenza (2.0% versus 6.1% and 7.6%",
            "probability": 3.3758341146478773e-05,
            "start_logit": 5.065088272094727,
            "end_logit": -5.6173624992370605
        },
        {
            "text": "lupus erythematosus (SLE)",
            "probability": 3.235576215417731e-05,
            "start_logit": 0.17218464612960815,
            "end_logit": -0.7668942809104919
        },
        {
            "text": "as influenza",
            "probability": 2.9729191692661083e-05,
            "start_logit": -5.357450485229492,
            "end_logit": 4.6780781745910645
        },
        {
            "text": "influenza (2.0% versus 6.1% and 7.6%, respectively), in the anifrolumab treatment groups",
            "probability": 2.9304913324892535e-05,
            "start_logit": 5.065088272094727,
            "end_logit": -5.7588348388671875
        },
        {
            "text": "1,000 mg, respectively), as were cases reported as influenza",
            "probability": 1.817473690075805e-05,
            "start_logit": -5.849547386169434,
            "end_logit": 4.6780781745910645
        },
        {
            "text": "Herpes zoster",
            "probability": 1.610964198950954e-05,
            "start_logit": 0.22929473221302032,
            "end_logit": -1.521378517150879
        },
        {
            "text": "systemic lupus erythematosus (SLE)",
            "probability": 1.2928435604098239e-05,
            "start_logit": -0.7451782822608948,
            "end_logit": -0.7668942809104919
        },
        {
            "text": "moderate-to-severe systemic lupus erythematosus",
            "probability": 8.793250997307315e-06,
            "start_logit": -2.465951442718506,
            "end_logit": 0.5684341788291931
        },
        {
            "text": "",
            "probability": 6.205328550899659e-06,
            "start_logit": -1.1595879793167114,
            "end_logit": -1.08650541305542
        },
        {
            "text": "moderate-to-severe systemic lupus erythematosus (SLE)",
            "probability": 2.313255952532905e-06,
            "start_logit": -2.465951442718506,
            "end_logit": -0.7668942809104919
        },
        {
            "text": "placebo",
            "probability": 2.265470556964967e-06,
            "start_logit": -3.4059600830078125,
            "end_logit": 0.1522408127784729
        },
        {
            "text": "Herpes",
            "probability": 1.5393962097005008e-06,
            "start_logit": 0.22929473221302032,
            "end_logit": -3.869406223297119
        },
        {
            "text": "lupus erythematosus (SLE",
            "probability": 9.298963276178119e-07,
            "start_logit": 0.17218464612960815,
            "end_logit": -4.316368579864502
        }
    ],
    "5c7019557c78d6947100005f_002": [
        {
            "text": "",
            "probability": 0.995010544373555,
            "start_logit": 2.3224573135375977,
            "end_logit": 2.969984292984009
        },
        {
            "text": "genetic variants of IRF5 and IRF7 have been associated with increased serum IFN\u03b1 levels",
            "probability": 0.0014246400451869623,
            "start_logit": -1.2770054340362549,
            "end_logit": 0.020612888038158417
        },
        {
            "text": "activation of the IFN signature",
            "probability": 0.0008615762528626712,
            "start_logit": -1.810768723487854,
            "end_logit": 0.05146528035402298
        },
        {
            "text": "increased serum IFN\u03b1 levels",
            "probability": 0.0006424444482729044,
            "start_logit": -2.073399543762207,
            "end_logit": 0.020612888038158417
        },
        {
            "text": "IRF5 and IRF7 have been associated with increased serum IFN\u03b1 levels",
            "probability": 0.0002852226384832054,
            "start_logit": -2.8854098320007324,
            "end_logit": 0.020612888038158417
        },
        {
            "text": "activation",
            "probability": 0.0002520926614718027,
            "start_logit": -1.810768723487854,
            "end_logit": -1.1775015592575073
        },
        {
            "text": "unique trend in regulation of IRF warrants further mechanistic investigation and confirmation with increased numbers of SLE patients.",
            "probability": 0.00022501320694314015,
            "start_logit": -0.5827412009239197,
            "end_logit": -2.5191667079925537
        },
        {
            "text": "IFN signature",
            "probability": 0.00017824686940875683,
            "start_logit": -3.3863627910614014,
            "end_logit": 0.05146528035402298
        },
        {
            "text": "IRF7 protein expression correlated with activation of the IFN signature",
            "probability": 0.00016646440636579945,
            "start_logit": -3.4547507762908936,
            "end_logit": 0.05146528035402298
        },
        {
            "text": "unique trend in regulation of IRF warrants further mechanistic investigation and confirmation with increased numbers of SLE patients",
            "probability": 0.00013222200008655103,
            "start_logit": -0.5827412009239197,
            "end_logit": -3.0508434772491455
        },
        {
            "text": "genetic variants of IRF5 and IRF7",
            "probability": 0.00012841282173236822,
            "start_logit": -1.2770054340362549,
            "end_logit": -2.3858113288879395
        },
        {
            "text": "unique trend in regulation of IRF",
            "probability": 0.00012305363858909082,
            "start_logit": -0.5827412009239197,
            "end_logit": -3.1227054595947266
        },
        {
            "text": "increased serum IFN\u03b1 levels, suggesting a pathogenic role in the type I IFN response.",
            "probability": 9.05282187427411e-05,
            "start_logit": -2.073399543762207,
            "end_logit": -1.9390058517456055
        },
        {
            "text": ", genetic variants of IRF5 and IRF7 have been associated with increased serum IFN\u03b1 levels",
            "probability": 8.784135031667397e-05,
            "start_logit": -4.06314754486084,
            "end_logit": 0.020612888038158417
        },
        {
            "text": "induction of IRF7 protein expression correlated with activation of the IFN signature",
            "probability": 8.256969925910777e-05,
            "start_logit": -4.155889511108398,
            "end_logit": 0.05146528035402298
        },
        {
            "text": "genetic variants",
            "probability": 7.053024681385556e-05,
            "start_logit": -1.2770054340362549,
            "end_logit": -2.9850199222564697
        },
        {
            "text": "variants of IRF5 and IRF7 have been associated with increased serum IFN\u03b1 levels",
            "probability": 7.025800105879367e-05,
            "start_logit": -4.286505699157715,
            "end_logit": 0.020612888038158417
        },
        {
            "text": "activation of the IFN",
            "probability": 6.69395167902436e-05,
            "start_logit": -1.810768723487854,
            "end_logit": -2.5035088062286377
        },
        {
            "text": "In SLE patients, genetic variants of IRF5 and IRF7 have been associated with increased serum IFN\u03b1 levels",
            "probability": 5.168528312560914e-05,
            "start_logit": -4.593506813049316,
            "end_logit": 0.020612888038158417
        },
        {
            "text": "increased serum IFN\u03b1 levels, suggesting a pathogenic role in the type I IFN response",
            "probability": 4.971432093494307e-05,
            "start_logit": -2.073399543762207,
            "end_logit": -2.538374423980713
        }
    ],
    "5c7019557c78d6947100005f_004": [
        {
            "text": "decreased expression",
            "probability": 0.5431864577026322,
            "start_logit": 3.1907870769500732,
            "end_logit": 3.410193681716919
        },
        {
            "text": "",
            "probability": 0.12184466165379208,
            "start_logit": 2.7932627201080322,
            "end_logit": 2.3130123615264893
        },
        {
            "text": "We also detected decreased expression",
            "probability": 0.07711799355392276,
            "start_logit": 1.238671064376831,
            "end_logit": 3.410193681716919
        },
        {
            "text": "decreased",
            "probability": 0.06054332228077336,
            "start_logit": 3.1907870769500732,
            "end_logit": 1.2161002159118652
        },
        {
            "text": "decreased expression of several IFN-signature genes",
            "probability": 0.043199348216071604,
            "start_logit": 3.1907870769500732,
            "end_logit": 0.8785664439201355
        },
        {
            "text": "decreased expression of several IFN-signature",
            "probability": 0.03852350438591274,
            "start_logit": 3.1907870769500732,
            "end_logit": 0.7640095949172974
        },
        {
            "text": "detected decreased expression",
            "probability": 0.03007794800413073,
            "start_logit": 0.2971267104148865,
            "end_logit": 3.410193681716919
        },
        {
            "text": "decreased expression of several IFN-signature genes Ifit3 and Isg15 in CD4+ from SLE-prone mice",
            "probability": 0.013397399268220695,
            "start_logit": 3.1907870769500732,
            "end_logit": -0.2921983599662781
        },
        {
            "text": "several IFN-signature genes",
            "probability": 0.009385724642848961,
            "start_logit": 1.6641515493392944,
            "end_logit": 0.8785664439201355
        },
        {
            "text": "We also detected decreased",
            "probability": 0.008595537446071206,
            "start_logit": 1.238671064376831,
            "end_logit": 1.2161002159118652
        },
        {
            "text": "several IFN-signature",
            "probability": 0.008369825457441618,
            "start_logit": 1.6641515493392944,
            "end_logit": 0.7640095949172974
        },
        {
            "text": "decreased expression of several IFN-signature genes Ifit3",
            "probability": 0.00798548699251517,
            "start_logit": 3.1907870769500732,
            "end_logit": -0.809633195400238
        },
        {
            "text": "decreased expression of several",
            "probability": 0.007577380364300697,
            "start_logit": 3.1907870769500732,
            "end_logit": -0.8620914220809937
        },
        {
            "text": "decreased expression of several IFN-signature genes Ifit3 and Isg15 in CD4+",
            "probability": 0.0064882737215878755,
            "start_logit": 3.1907870769500732,
            "end_logit": -1.0172624588012695
        },
        {
            "text": "We also detected decreased expression of several IFN-signature genes",
            "probability": 0.006133155585930454,
            "start_logit": 1.238671064376831,
            "end_logit": 0.8785664439201355
        },
        {
            "text": "We also detected decreased expression of several IFN-signature",
            "probability": 0.005469310438025926,
            "start_logit": 1.238671064376831,
            "end_logit": 0.7640095949172974
        },
        {
            "text": "decreased expression of several IFN",
            "probability": 0.003449319682796802,
            "start_logit": 3.1907870769500732,
            "end_logit": -1.6490819454193115
        },
        {
            "text": "detected decreased",
            "probability": 0.0033524747786612694,
            "start_logit": 0.2971267104148865,
            "end_logit": 1.2161002159118652
        },
        {
            "text": "several IFN-signature genes Ifit3 and Isg15 in CD4+ from SLE-prone mice",
            "probability": 0.002910791612708743,
            "start_logit": 1.6641515493392944,
            "end_logit": -0.2921983599662781
        },
        {
            "text": "detected decreased expression of several IFN-signature genes",
            "probability": 0.0023920842116551223,
            "start_logit": 0.2971267104148865,
            "end_logit": 0.8785664439201355
        }
    ],
    "5c7019557c78d6947100005f_005": [
        {
            "text": "Type I",
            "probability": 0.3267033119585565,
            "start_logit": 2.311491012573242,
            "end_logit": 0.8438869714736938
        },
        {
            "text": "IFN-responsive genes resembling the IFN signature found in SLE patients",
            "probability": 0.13952002404963096,
            "start_logit": -0.04435306787490845,
            "end_logit": 2.348886728286743
        },
        {
            "text": "IFN signature found in SLE patients",
            "probability": 0.11628666695048322,
            "start_logit": -0.22650279104709625,
            "end_logit": 2.348886728286743
        },
        {
            "text": "Type I interferons",
            "probability": 0.08131626807253238,
            "start_logit": 2.311491012573242,
            "end_logit": -0.5468193888664246
        },
        {
            "text": "IFN-responsive genes resembling the IFN signature",
            "probability": 0.06926504243707436,
            "start_logit": -0.04435306787490845,
            "end_logit": 1.6486189365386963
        },
        {
            "text": "IFN signature",
            "probability": 0.057730787935686693,
            "start_logit": -0.22650279104709625,
            "end_logit": 1.6486189365386963
        },
        {
            "text": "Type I interferons (IFN) are pathogenic",
            "probability": 0.02923220963067993,
            "start_logit": 2.311491012573242,
            "end_logit": -1.5698943138122559
        },
        {
            "text": "IFN-responsive genes",
            "probability": 0.02296870536290017,
            "start_logit": -0.04435306787490845,
            "end_logit": 0.5448112487792969
        },
        {
            "text": "Type I interferons (IFN) are pathogenic in systemic lupus erythematosus",
            "probability": 0.021565030081420772,
            "start_logit": 2.311491012573242,
            "end_logit": -1.87409245967865
        },
        {
            "text": "IFN-responsive genes resembling the IFN signature found",
            "probability": 0.021459699662217196,
            "start_logit": -0.04435306787490845,
            "end_logit": 0.4768553376197815
        },
        {
            "text": "IFN signature found",
            "probability": 0.017886156230806995,
            "start_logit": -0.22650279104709625,
            "end_logit": 0.4768553376197815
        },
        {
            "text": "overexpress IFN-responsive genes resembling the IFN signature found in SLE patients",
            "probability": 0.017649763481593025,
            "start_logit": -2.1118388175964355,
            "end_logit": 2.348886728286743
        },
        {
            "text": "IFN-responsive genes resembling the IFN signature found in SLE patients.",
            "probability": 0.01556240942118519,
            "start_logit": -0.04435306787490845,
            "end_logit": 0.155536949634552
        },
        {
            "text": "IFN signature found in SLE patients.",
            "probability": 0.012970903163438866,
            "start_logit": -0.22650279104709625,
            "end_logit": 0.155536949634552
        },
        {
            "text": "Type I interferons (IFN) are pathogenic in systemic lupus erythematosus (SLE)",
            "probability": 0.009928314196225337,
            "start_logit": 2.311491012573242,
            "end_logit": -2.6497747898101807
        },
        {
            "text": "overexpress IFN-responsive genes resembling the IFN signature",
            "probability": 0.008762266383511992,
            "start_logit": -2.1118388175964355,
            "end_logit": 1.6486189365386963
        },
        {
            "text": "DCs from female lupus-prone mice constitutively overexpress IFN-responsive genes resembling the IFN signature",
            "probability": 0.008349080923612971,
            "start_logit": -2.160141944885254,
            "end_logit": 1.6486189365386963
        },
        {
            "text": "SLE patients",
            "probability": 0.007648683867940655,
            "start_logit": -2.9480276107788086,
            "end_logit": 2.348886728286743
        },
        {
            "text": "female lupus-prone mice constitutively overexpress IFN-responsive genes resembling the IFN signature found in SLE patients",
            "probability": 0.007560046230351123,
            "start_logit": -2.959683895111084,
            "end_logit": 2.348886728286743
        },
        {
            "text": "Type I interferons (IFN)",
            "probability": 0.00404889122724932,
            "start_logit": 2.311491012573242,
            "end_logit": -3.546722412109375
        },
        {
            "text": "",
            "probability": 0.003585738732902404,
            "start_logit": -1.0789180994033813,
            "end_logit": -0.2777918577194214
        }
    ],
    "5c7019557c78d6947100005f_008": [
        {
            "text": "The IFN-I signature was positive in 57% of cSLE patients",
            "probability": 0.21392066428537665,
            "start_logit": 2.5355708599090576,
            "end_logit": 1.5326120853424072
        },
        {
            "text": "The IFN-I signature was positive in 57% of cSLE patients and 15% of the HCs",
            "probability": 0.10052567597926895,
            "start_logit": 2.5355708599090576,
            "end_logit": 0.7774200439453125
        },
        {
            "text": "The IFN-I signature was positive in 57%",
            "probability": 0.09893411200017763,
            "start_logit": 2.5355708599090576,
            "end_logit": 0.7614609599113464
        },
        {
            "text": "The IFN-I signature was positive",
            "probability": 0.09615785334947098,
            "start_logit": 2.5355708599090576,
            "end_logit": 0.7329980134963989
        },
        {
            "text": "57% of cSLE patients",
            "probability": 0.058234947828951486,
            "start_logit": 1.2344512939453125,
            "end_logit": 1.5326120853424072
        },
        {
            "text": "IFN-I signature was positive in 57% of cSLE patients",
            "probability": 0.05574046691752701,
            "start_logit": 1.1906720399856567,
            "end_logit": 1.5326120853424072
        },
        {
            "text": "The IFN-I signature was positive in 57% of cSLE patients and 15% of the HCs.",
            "probability": 0.0427638570810005,
            "start_logit": 2.5355708599090576,
            "end_logit": -0.07729984819889069
        },
        {
            "text": "The IFN-I signature was positive in 57% of cSLE",
            "probability": 0.03921041577793963,
            "start_logit": 2.5355708599090576,
            "end_logit": -0.16405071318149567
        },
        {
            "text": "positive in 57% of cSLE patients",
            "probability": 0.03297080390205446,
            "start_logit": 0.6655880808830261,
            "end_logit": 1.5326120853424072
        },
        {
            "text": "The IFN-I signature",
            "probability": 0.03056502686569387,
            "start_logit": 2.5355708599090576,
            "end_logit": -0.41313669085502625
        },
        {
            "text": "was positive in 57% of cSLE patients",
            "probability": 0.02876674439572792,
            "start_logit": 0.5291856527328491,
            "end_logit": 1.5326120853424072
        },
        {
            "text": "57% of cSLE patients and 15% of the HCs",
            "probability": 0.0273657877591164,
            "start_logit": 1.2344512939453125,
            "end_logit": 0.7774200439453125
        },
        {
            "text": "57%",
            "probability": 0.026932521316164547,
            "start_logit": 1.2344512939453125,
            "end_logit": 0.7614609599113464
        },
        {
            "text": "IFN-I signature was positive in 57% of cSLE patients and 15% of the HCs",
            "probability": 0.026193580386462544,
            "start_logit": 1.1906720399856567,
            "end_logit": 0.7774200439453125
        },
        {
            "text": "IFN-I signature was positive in 57%",
            "probability": 0.025778872814288405,
            "start_logit": 1.1906720399856567,
            "end_logit": 0.7614609599113464
        },
        {
            "text": "IFN-I signature was positive",
            "probability": 0.025055474006645536,
            "start_logit": 1.1906720399856567,
            "end_logit": 0.7329980134963989
        },
        {
            "text": "positive in 57% of cSLE patients and 15% of the HCs",
            "probability": 0.01549365210184845,
            "start_logit": 0.6655880808830261,
            "end_logit": 0.7774200439453125
        },
        {
            "text": "positive in 57%",
            "probability": 0.015248350209076696,
            "start_logit": 0.6655880808830261,
            "end_logit": 0.7614609599113464
        },
        {
            "text": "positive",
            "probability": 0.014820455690986944,
            "start_logit": 0.6655880808830261,
            "end_logit": 0.7329980134963989
        },
        {
            "text": "was positive in 57% of cSLE patients and 15% of the HCs",
            "probability": 0.01351807893717856,
            "start_logit": 0.5291856527328491,
            "end_logit": 0.7774200439453125
        },
        {
            "text": "",
            "probability": 0.011802658395042836,
            "start_logit": 0.37186160683631897,
            "end_logit": 0.7990409135818481
        }
    ],
    "5c7019557c78d6947100005f_009": [
        {
            "text": "The IFN-I signature was positive in 57% of cSLE patients",
            "probability": 0.21392066428537665,
            "start_logit": 2.5355708599090576,
            "end_logit": 1.5326120853424072
        },
        {
            "text": "The IFN-I signature was positive in 57% of cSLE patients and 15% of the HCs",
            "probability": 0.10052567597926895,
            "start_logit": 2.5355708599090576,
            "end_logit": 0.7774200439453125
        },
        {
            "text": "The IFN-I signature was positive in 57%",
            "probability": 0.09893411200017763,
            "start_logit": 2.5355708599090576,
            "end_logit": 0.7614609599113464
        },
        {
            "text": "The IFN-I signature was positive",
            "probability": 0.09615785334947098,
            "start_logit": 2.5355708599090576,
            "end_logit": 0.7329980134963989
        },
        {
            "text": "57% of cSLE patients",
            "probability": 0.058234947828951486,
            "start_logit": 1.2344512939453125,
            "end_logit": 1.5326120853424072
        },
        {
            "text": "IFN-I signature was positive in 57% of cSLE patients",
            "probability": 0.05574046691752701,
            "start_logit": 1.1906720399856567,
            "end_logit": 1.5326120853424072
        },
        {
            "text": "The IFN-I signature was positive in 57% of cSLE patients and 15% of the HCs.",
            "probability": 0.0427638570810005,
            "start_logit": 2.5355708599090576,
            "end_logit": -0.07729984819889069
        },
        {
            "text": "The IFN-I signature was positive in 57% of cSLE",
            "probability": 0.03921041577793963,
            "start_logit": 2.5355708599090576,
            "end_logit": -0.16405071318149567
        },
        {
            "text": "positive in 57% of cSLE patients",
            "probability": 0.03297080390205446,
            "start_logit": 0.6655880808830261,
            "end_logit": 1.5326120853424072
        },
        {
            "text": "The IFN-I signature",
            "probability": 0.03056502686569387,
            "start_logit": 2.5355708599090576,
            "end_logit": -0.41313669085502625
        },
        {
            "text": "was positive in 57% of cSLE patients",
            "probability": 0.02876674439572792,
            "start_logit": 0.5291856527328491,
            "end_logit": 1.5326120853424072
        },
        {
            "text": "57% of cSLE patients and 15% of the HCs",
            "probability": 0.0273657877591164,
            "start_logit": 1.2344512939453125,
            "end_logit": 0.7774200439453125
        },
        {
            "text": "57%",
            "probability": 0.026932521316164547,
            "start_logit": 1.2344512939453125,
            "end_logit": 0.7614609599113464
        },
        {
            "text": "IFN-I signature was positive in 57% of cSLE patients and 15% of the HCs",
            "probability": 0.026193580386462544,
            "start_logit": 1.1906720399856567,
            "end_logit": 0.7774200439453125
        },
        {
            "text": "IFN-I signature was positive in 57%",
            "probability": 0.025778872814288405,
            "start_logit": 1.1906720399856567,
            "end_logit": 0.7614609599113464
        },
        {
            "text": "IFN-I signature was positive",
            "probability": 0.025055474006645536,
            "start_logit": 1.1906720399856567,
            "end_logit": 0.7329980134963989
        },
        {
            "text": "positive in 57% of cSLE patients and 15% of the HCs",
            "probability": 0.01549365210184845,
            "start_logit": 0.6655880808830261,
            "end_logit": 0.7774200439453125
        },
        {
            "text": "positive in 57%",
            "probability": 0.015248350209076696,
            "start_logit": 0.6655880808830261,
            "end_logit": 0.7614609599113464
        },
        {
            "text": "positive",
            "probability": 0.014820455690986944,
            "start_logit": 0.6655880808830261,
            "end_logit": 0.7329980134963989
        },
        {
            "text": "was positive in 57% of cSLE patients and 15% of the HCs",
            "probability": 0.01351807893717856,
            "start_logit": 0.5291856527328491,
            "end_logit": 0.7774200439453125
        },
        {
            "text": "",
            "probability": 0.011802658395042836,
            "start_logit": 0.37186160683631897,
            "end_logit": 0.7990409135818481
        }
    ],
    "5e2b253ffbd6abf43b000006_002": [
        {
            "text": "AZD5153 was non-cytotoxic to the prostate epithelial cells",
            "probability": 0.2409142792901332,
            "start_logit": 0.6043919324874878,
            "end_logit": -0.40923872590065
        },
        {
            "text": "AZD5153 induced apoptosis activation and cell cycle arrest",
            "probability": 0.12847395946657583,
            "start_logit": 0.370772123336792,
            "end_logit": -0.8043338656425476
        },
        {
            "text": "AZD5153 induced apoptosis activation and cell cycle arrest in prostate cancer cells.",
            "probability": 0.09762130385161501,
            "start_logit": 0.370772123336792,
            "end_logit": -1.078964352607727
        },
        {
            "text": "AZD5153 induced apoptosis activation and cell cycle arrest in prostate cancer cells",
            "probability": 0.09286829813646197,
            "start_logit": 0.370772123336792,
            "end_logit": -1.1288777589797974
        },
        {
            "text": "AZD5153 inhibited proliferation and survival of established and primary prostate cancer cells. AZD5153 induced apoptosis activation and cell cycle arrest",
            "probability": 0.07719274425711398,
            "start_logit": -0.1386486440896988,
            "end_logit": -0.8043338656425476
        },
        {
            "text": "AZD5153 inhibited proliferation and survival of established and primary prostate cancer cells",
            "probability": 0.05781540741723461,
            "start_logit": -0.1386486440896988,
            "end_logit": -1.093384027481079
        },
        {
            "text": "AZD5153 was non-cytotoxic to the prostate epithelial cells.",
            "probability": 0.04554362065966393,
            "start_logit": 0.6043919324874878,
            "end_logit": -2.075009346008301
        },
        {
            "text": "AZD5153 inhibited proliferation and survival of established and primary prostate cancer cells.",
            "probability": 0.035269320231391066,
            "start_logit": -0.1386486440896988,
            "end_logit": -1.5876258611679077
        },
        {
            "text": "AZD5153 was non-cytotoxic",
            "probability": 0.029413445403187178,
            "start_logit": 0.6043919324874878,
            "end_logit": -2.512228012084961
        },
        {
            "text": "inhibited proliferation and survival of established and primary prostate cancer cells. AZD5153 induced apoptosis activation and cell cycle arrest",
            "probability": 0.02598277667570693,
            "start_logit": -1.227520227432251,
            "end_logit": -0.8043338656425476
        },
        {
            "text": "AZD5153 induced apoptosis activation and cell cycle arrest in prostate cancer cells. AZD5153 was non-cytotoxic",
            "probability": 0.023285528828302468,
            "start_logit": 0.370772123336792,
            "end_logit": -2.512228012084961
        },
        {
            "text": "non-cytotoxic to the prostate epithelial cells",
            "probability": 0.020040415689962777,
            "start_logit": -1.882298231124878,
            "end_logit": -0.40923872590065
        },
        {
            "text": "AZD5153 inhibited proliferation and survival",
            "probability": 0.01970238372863343,
            "start_logit": -0.1386486440896988,
            "end_logit": -2.1698997020721436
        },
        {
            "text": "inhibited proliferation and survival of established and primary prostate cancer cells",
            "probability": 0.01946044066439024,
            "start_logit": -1.227520227432251,
            "end_logit": -1.093384027481079
        },
        {
            "text": "inhibited proliferation and survival of established and primary prostate cancer cells. AZD5153 induced apoptosis activation and cell cycle arrest in prostate cancer cells",
            "probability": 0.018781831436902423,
            "start_logit": -1.227520227432251,
            "end_logit": -1.1288777589797974
        },
        {
            "text": "AZD5153 is a novel BRD4 inhibitor.",
            "probability": 0.01604033298870248,
            "start_logit": -0.8386490345001221,
            "end_logit": -1.675532579421997
        },
        {
            "text": "AZD5153 is a novel BRD4 inhibitor",
            "probability": 0.015572617547145569,
            "start_logit": -0.8386490345001221,
            "end_logit": -1.705124855041504
        },
        {
            "text": "inhibited proliferation and survival of established and primary prostate cancer cells.",
            "probability": 0.011871515644318768,
            "start_logit": -1.227520227432251,
            "end_logit": -1.5876258611679077
        },
        {
            "text": "AZD5153",
            "probability": 0.010493782327885772,
            "start_logit": 0.6043919324874878,
            "end_logit": -3.5428969860076904
        },
        {
            "text": "induced apoptosis activation and cell cycle arrest",
            "probability": 0.010175525552818858,
            "start_logit": -2.164968729019165,
            "end_logit": -0.8043338656425476
        },
        {
            "text": "",
            "probability": 0.0034804702018537584,
            "start_logit": -2.1182689666748047,
            "end_logit": -1.9238516092300415
        }
    ],
    "5e29f959aa19d74431000004_002": [
        {
            "text": "",
            "probability": 0.7583526838852047,
            "start_logit": 0.4390793740749359,
            "end_logit": 0.7527908086776733
        },
        {
            "text": "LB100 could sensitize ovarian cancer cells to cisplatin treatment",
            "probability": 0.13879271919115058,
            "start_logit": -0.4755500555038452,
            "end_logit": -0.03074673004448414
        },
        {
            "text": "could sensitize ovarian cancer cells to cisplatin treatment",
            "probability": 0.024318124425011016,
            "start_logit": -2.2173097133636475,
            "end_logit": -0.03074673004448414
        },
        {
            "text": "LB100",
            "probability": 0.017097665682467168,
            "start_logit": -0.4755500555038452,
            "end_logit": -2.124786376953125
        },
        {
            "text": "We hypothesized that LB100 could sensitize ovarian cancer cells to cisplatin treatment",
            "probability": 0.014929801953605016,
            "start_logit": -2.705172300338745,
            "end_logit": -0.03074673004448414
        },
        {
            "text": "LB100 could sensitize ovarian cancer cells to cisplatin treatment.",
            "probability": 0.011775338237509602,
            "start_logit": -0.4755500555038452,
            "end_logit": -2.497720956802368
        },
        {
            "text": "ovarian cancer cells to cisplatin treatment",
            "probability": 0.008499545760204927,
            "start_logit": -3.2685189247131348,
            "end_logit": -0.03074673004448414
        },
        {
            "text": "LB100 sensitized ovarian carcinoma lines to cisplatin-mediated cell death",
            "probability": 0.004131743676669946,
            "start_logit": -2.1476638317108154,
            "end_logit": -1.8729150295257568
        },
        {
            "text": "cisplatin treatment",
            "probability": 0.003308839610718973,
            "start_logit": -4.2119340896606445,
            "end_logit": -0.03074673004448414
        },
        {
            "text": "LB100 could sensitize ovarian cancer cells",
            "probability": 0.002869484379749378,
            "start_logit": -0.4755500555038452,
            "end_logit": -3.9095959663391113
        },
        {
            "text": "cisplatin",
            "probability": 0.0024022780405485167,
            "start_logit": -3.7514851093292236,
            "end_logit": -0.8113757967948914
        },
        {
            "text": "that LB100 could sensitize ovarian cancer cells to cisplatin treatment",
            "probability": 0.0021081674706437356,
            "start_logit": -4.662712574005127,
            "end_logit": -0.03074673004448414
        },
        {
            "text": "could sensitize ovarian cancer cells to cisplatin treatment.",
            "probability": 0.0020631784006765563,
            "start_logit": -2.2173097133636475,
            "end_logit": -2.497720956802368
        },
        {
            "text": "treatment",
            "probability": 0.002050627468115021,
            "start_logit": -4.690385818481445,
            "end_logit": -0.03074673004448414
        },
        {
            "text": "We hypothesized that LB100",
            "probability": 0.001839179778275138,
            "start_logit": -2.705172300338745,
            "end_logit": -2.124786376953125
        },
        {
            "text": "Sensitization via LB100 was mediated by abrogation of cell-cycle arrest induced by cisplatin",
            "probability": 0.0016110836506409813,
            "start_logit": -2.5855984687805176,
            "end_logit": -2.376772880554199
        },
        {
            "text": "We hypothesized that LB100 could sensitize ovarian cancer cells to cisplatin treatment.",
            "probability": 0.0012666620327584151,
            "start_logit": -2.705172300338745,
            "end_logit": -2.497720956802368
        },
        {
            "text": "LB100 could",
            "probability": 0.0010190771133331046,
            "start_logit": -0.4755500555038452,
            "end_logit": -4.944830894470215
        },
        {
            "text": "LB100 sensitized ovarian carcinoma lines to cisplatin-mediated cell death. Sensitization",
            "probability": 0.0008310405398556062,
            "start_logit": -2.1476638317108154,
            "end_logit": -3.476691246032715
        },
        {
            "text": "LB100 sensitized ovarian carcinoma lines to cisplatin-mediated cell death. Sensitization via LB100",
            "probability": 0.0007327587028615919,
            "start_logit": -2.1476638317108154,
            "end_logit": -3.602553367614746
        }
    ],
    "5e29f959aa19d74431000004_003": [
        {
            "text": "",
            "probability": 0.7583526838852047,
            "start_logit": 0.4390793740749359,
            "end_logit": 0.7527908086776733
        },
        {
            "text": "LB100 could sensitize ovarian cancer cells to cisplatin treatment",
            "probability": 0.13879271919115058,
            "start_logit": -0.4755500555038452,
            "end_logit": -0.03074673004448414
        },
        {
            "text": "could sensitize ovarian cancer cells to cisplatin treatment",
            "probability": 0.024318124425011016,
            "start_logit": -2.2173097133636475,
            "end_logit": -0.03074673004448414
        },
        {
            "text": "LB100",
            "probability": 0.017097665682467168,
            "start_logit": -0.4755500555038452,
            "end_logit": -2.124786376953125
        },
        {
            "text": "We hypothesized that LB100 could sensitize ovarian cancer cells to cisplatin treatment",
            "probability": 0.014929801953605016,
            "start_logit": -2.705172300338745,
            "end_logit": -0.03074673004448414
        },
        {
            "text": "LB100 could sensitize ovarian cancer cells to cisplatin treatment.",
            "probability": 0.011775338237509602,
            "start_logit": -0.4755500555038452,
            "end_logit": -2.497720956802368
        },
        {
            "text": "ovarian cancer cells to cisplatin treatment",
            "probability": 0.008499545760204927,
            "start_logit": -3.2685189247131348,
            "end_logit": -0.03074673004448414
        },
        {
            "text": "LB100 sensitized ovarian carcinoma lines to cisplatin-mediated cell death",
            "probability": 0.004131743676669946,
            "start_logit": -2.1476638317108154,
            "end_logit": -1.8729150295257568
        },
        {
            "text": "cisplatin treatment",
            "probability": 0.003308839610718973,
            "start_logit": -4.2119340896606445,
            "end_logit": -0.03074673004448414
        },
        {
            "text": "LB100 could sensitize ovarian cancer cells",
            "probability": 0.002869484379749378,
            "start_logit": -0.4755500555038452,
            "end_logit": -3.9095959663391113
        },
        {
            "text": "cisplatin",
            "probability": 0.0024022780405485167,
            "start_logit": -3.7514851093292236,
            "end_logit": -0.8113757967948914
        },
        {
            "text": "that LB100 could sensitize ovarian cancer cells to cisplatin treatment",
            "probability": 0.0021081674706437356,
            "start_logit": -4.662712574005127,
            "end_logit": -0.03074673004448414
        },
        {
            "text": "could sensitize ovarian cancer cells to cisplatin treatment.",
            "probability": 0.0020631784006765563,
            "start_logit": -2.2173097133636475,
            "end_logit": -2.497720956802368
        },
        {
            "text": "treatment",
            "probability": 0.002050627468115021,
            "start_logit": -4.690385818481445,
            "end_logit": -0.03074673004448414
        },
        {
            "text": "We hypothesized that LB100",
            "probability": 0.001839179778275138,
            "start_logit": -2.705172300338745,
            "end_logit": -2.124786376953125
        },
        {
            "text": "Sensitization via LB100 was mediated by abrogation of cell-cycle arrest induced by cisplatin",
            "probability": 0.0016110836506409813,
            "start_logit": -2.5855984687805176,
            "end_logit": -2.376772880554199
        },
        {
            "text": "We hypothesized that LB100 could sensitize ovarian cancer cells to cisplatin treatment.",
            "probability": 0.0012666620327584151,
            "start_logit": -2.705172300338745,
            "end_logit": -2.497720956802368
        },
        {
            "text": "LB100 could",
            "probability": 0.0010190771133331046,
            "start_logit": -0.4755500555038452,
            "end_logit": -4.944830894470215
        },
        {
            "text": "LB100 sensitized ovarian carcinoma lines to cisplatin-mediated cell death. Sensitization",
            "probability": 0.0008310405398556062,
            "start_logit": -2.1476638317108154,
            "end_logit": -3.476691246032715
        },
        {
            "text": "LB100 sensitized ovarian carcinoma lines to cisplatin-mediated cell death. Sensitization via LB100",
            "probability": 0.0007327587028615919,
            "start_logit": -2.1476638317108154,
            "end_logit": -3.602553367614746
        }
    ],
    "5e46e8c13f5415952900000c_001": [
        {
            "text": "",
            "probability": 0.9989073521706766,
            "start_logit": 2.2462165355682373,
            "end_logit": 2.492504119873047
        },
        {
            "text": "pyrimidine dimers",
            "probability": 0.00047802978188996433,
            "start_logit": -1.7741618156433105,
            "end_logit": -1.1318618059158325
        },
        {
            "text": "single strand breaks and oxidized bases",
            "probability": 0.00016759045102224368,
            "start_logit": -2.089684247970581,
            "end_logit": -1.864489197731018
        },
        {
            "text": "pyrimidine dimers, which explains the mutational signature found in skin tumors",
            "probability": 0.00012580909302233035,
            "start_logit": -1.7741618156433105,
            "end_logit": -2.466769218444824
        },
        {
            "text": "wide variety of oxidatively generated lesions such as single strand breaks and oxidized bases",
            "probability": 6.149041415971657e-05,
            "start_logit": -3.0923261642456055,
            "end_logit": -1.864489197731018
        },
        {
            "text": "exposure to sunlight mostly induces pyrimidine dimers",
            "probability": 5.24415128898751e-05,
            "start_logit": -3.9841363430023193,
            "end_logit": -1.1318618059158325
        },
        {
            "text": "pyrimidine dimers,",
            "probability": 3.2290286046120795e-05,
            "start_logit": -1.7741618156433105,
            "end_logit": -3.826768398284912
        },
        {
            "text": "mostly induces pyrimidine dimers",
            "probability": 3.13671084720211e-05,
            "start_logit": -4.498075008392334,
            "end_logit": -1.1318618059158325
        },
        {
            "text": "DNA photoproducts in cells and skin show that exposure to sunlight mostly induces pyrimidine dimers",
            "probability": 2.440014824236067e-05,
            "start_logit": -4.749245643615723,
            "end_logit": -1.1318618059158325
        },
        {
            "text": "Data available on the respective yield of DNA photoproducts in cells and skin show that exposure to sunlight mostly induces pyrimidine dimers",
            "probability": 1.5135197105835153e-05,
            "start_logit": -5.22681188583374,
            "end_logit": -1.1318618059158325
        },
        {
            "text": "pyrimidine dimers, which explains the mutational signature found in skin tumors, with lower amounts of 8-oxoGua and strand breaks",
            "probability": 1.3942680029491905e-05,
            "start_logit": -1.7741618156433105,
            "end_logit": -4.6665802001953125
        },
        {
            "text": "exposure to sunlight mostly induces pyrimidine dimers, which explains the mutational signature found in skin tumors",
            "probability": 1.3801690654731447e-05,
            "start_logit": -3.9841363430023193,
            "end_logit": -2.466769218444824
        },
        {
            "text": "induces pyrimidine dimers",
            "probability": 1.2119282465356445e-05,
            "start_logit": -5.449037075042725,
            "end_logit": -1.1318618059158325
        },
        {
            "text": "single strand breaks and oxidized bases.",
            "probability": 1.1585183636139533e-05,
            "start_logit": -2.089684247970581,
            "end_logit": -4.536285400390625
        },
        {
            "text": "pyrimidine dimers, which explains the mutational signature",
            "probability": 1.0837506702620347e-05,
            "start_logit": -1.7741618156433105,
            "end_logit": -4.918521881103516
        },
        {
            "text": "oxidatively generated lesions such as single strand breaks and oxidized bases",
            "probability": 9.217872560457432e-06,
            "start_logit": -4.990063190460205,
            "end_logit": -1.864489197731018
        },
        {
            "text": "single strand breaks and oxidized bases. Among those, 8-oxo-7,8-dihydroguanine",
            "probability": 9.185104813882484e-06,
            "start_logit": -2.089684247970581,
            "end_logit": -4.768429279327393
        },
        {
            "text": "a wide variety of oxidatively generated lesions such as single strand breaks and oxidized bases",
            "probability": 9.057873068483349e-06,
            "start_logit": -5.007573127746582,
            "end_logit": -1.864489197731018
        },
        {
            "text": "mostly induces pyrimidine dimers, which explains the mutational signature found in skin tumors",
            "probability": 8.25527533451128e-06,
            "start_logit": -4.498075008392334,
            "end_logit": -2.466769218444824
        },
        {
            "text": "mutational signature found in skin tumors",
            "probability": 6.091367206821344e-06,
            "start_logit": -4.8020548820495605,
            "end_logit": -2.466769218444824
        }
    ],
    "5e46e8c13f5415952900000c_002": [
        {
            "text": "",
            "probability": 0.9989073521706766,
            "start_logit": 2.2462165355682373,
            "end_logit": 2.492504119873047
        },
        {
            "text": "pyrimidine dimers",
            "probability": 0.00047802978188996433,
            "start_logit": -1.7741618156433105,
            "end_logit": -1.1318618059158325
        },
        {
            "text": "single strand breaks and oxidized bases",
            "probability": 0.00016759045102224368,
            "start_logit": -2.089684247970581,
            "end_logit": -1.864489197731018
        },
        {
            "text": "pyrimidine dimers, which explains the mutational signature found in skin tumors",
            "probability": 0.00012580909302233035,
            "start_logit": -1.7741618156433105,
            "end_logit": -2.466769218444824
        },
        {
            "text": "wide variety of oxidatively generated lesions such as single strand breaks and oxidized bases",
            "probability": 6.149041415971657e-05,
            "start_logit": -3.0923261642456055,
            "end_logit": -1.864489197731018
        },
        {
            "text": "exposure to sunlight mostly induces pyrimidine dimers",
            "probability": 5.24415128898751e-05,
            "start_logit": -3.9841363430023193,
            "end_logit": -1.1318618059158325
        },
        {
            "text": "pyrimidine dimers,",
            "probability": 3.2290286046120795e-05,
            "start_logit": -1.7741618156433105,
            "end_logit": -3.826768398284912
        },
        {
            "text": "mostly induces pyrimidine dimers",
            "probability": 3.13671084720211e-05,
            "start_logit": -4.498075008392334,
            "end_logit": -1.1318618059158325
        },
        {
            "text": "DNA photoproducts in cells and skin show that exposure to sunlight mostly induces pyrimidine dimers",
            "probability": 2.440014824236067e-05,
            "start_logit": -4.749245643615723,
            "end_logit": -1.1318618059158325
        },
        {
            "text": "Data available on the respective yield of DNA photoproducts in cells and skin show that exposure to sunlight mostly induces pyrimidine dimers",
            "probability": 1.5135197105835153e-05,
            "start_logit": -5.22681188583374,
            "end_logit": -1.1318618059158325
        },
        {
            "text": "pyrimidine dimers, which explains the mutational signature found in skin tumors, with lower amounts of 8-oxoGua and strand breaks",
            "probability": 1.3942680029491905e-05,
            "start_logit": -1.7741618156433105,
            "end_logit": -4.6665802001953125
        },
        {
            "text": "exposure to sunlight mostly induces pyrimidine dimers, which explains the mutational signature found in skin tumors",
            "probability": 1.3801690654731447e-05,
            "start_logit": -3.9841363430023193,
            "end_logit": -2.466769218444824
        },
        {
            "text": "induces pyrimidine dimers",
            "probability": 1.2119282465356445e-05,
            "start_logit": -5.449037075042725,
            "end_logit": -1.1318618059158325
        },
        {
            "text": "single strand breaks and oxidized bases.",
            "probability": 1.1585183636139533e-05,
            "start_logit": -2.089684247970581,
            "end_logit": -4.536285400390625
        },
        {
            "text": "pyrimidine dimers, which explains the mutational signature",
            "probability": 1.0837506702620347e-05,
            "start_logit": -1.7741618156433105,
            "end_logit": -4.918521881103516
        },
        {
            "text": "oxidatively generated lesions such as single strand breaks and oxidized bases",
            "probability": 9.217872560457432e-06,
            "start_logit": -4.990063190460205,
            "end_logit": -1.864489197731018
        },
        {
            "text": "single strand breaks and oxidized bases. Among those, 8-oxo-7,8-dihydroguanine",
            "probability": 9.185104813882484e-06,
            "start_logit": -2.089684247970581,
            "end_logit": -4.768429279327393
        },
        {
            "text": "a wide variety of oxidatively generated lesions such as single strand breaks and oxidized bases",
            "probability": 9.057873068483349e-06,
            "start_logit": -5.007573127746582,
            "end_logit": -1.864489197731018
        },
        {
            "text": "mostly induces pyrimidine dimers, which explains the mutational signature found in skin tumors",
            "probability": 8.25527533451128e-06,
            "start_logit": -4.498075008392334,
            "end_logit": -2.466769218444824
        },
        {
            "text": "mutational signature found in skin tumors",
            "probability": 6.091367206821344e-06,
            "start_logit": -4.8020548820495605,
            "end_logit": -2.466769218444824
        }
    ],
    "5e46e8c13f5415952900000c_003": [
        {
            "text": "",
            "probability": 0.9976836246221243,
            "start_logit": 1.9255197048187256,
            "end_logit": 2.1809768676757812
        },
        {
            "text": "deoxyribonucleic acid",
            "probability": 0.0016629466420637299,
            "start_logit": -1.097819209098816,
            "end_logit": -1.192529320716858
        },
        {
            "text": "deoxyribonucleic acid (DNA) lesions such as a cyclobutane pyrimidine dimer",
            "probability": 0.00014640880052049332,
            "start_logit": -1.097819209098816,
            "end_logit": -3.6224730014801025
        },
        {
            "text": "deoxyribonucleic acid (DNA) lesions",
            "probability": 0.00012369871401824963,
            "start_logit": -1.097819209098816,
            "end_logit": -3.7910268306732178
        },
        {
            "text": "deoxyribonucleic acid (DNA)",
            "probability": 0.00011051352709486084,
            "start_logit": -1.097819209098816,
            "end_logit": -3.903737783432007
        },
        {
            "text": "UV-induced deoxyribonucleic acid",
            "probability": 9.475469823334619e-05,
            "start_logit": -3.962874174118042,
            "end_logit": -1.192529320716858
        },
        {
            "text": "deoxyribonucleic acid (DNA",
            "probability": 4.229431630270949e-05,
            "start_logit": -1.097819209098816,
            "end_logit": -4.864223003387451
        },
        {
            "text": "deoxyribonucleic",
            "probability": 2.3227891040918695e-05,
            "start_logit": -1.097819209098816,
            "end_logit": -5.463521957397461
        },
        {
            "text": "cyclobutane pyrimidine dimer (CPD)",
            "probability": 2.1734428236068465e-05,
            "start_logit": -3.3429954051971436,
            "end_logit": -3.284801959991455
        },
        {
            "text": "cyclobutane pyrimidine dimer",
            "probability": 1.550599179221602e-05,
            "start_logit": -3.3429954051971436,
            "end_logit": -3.6224730014801025
        },
        {
            "text": "deoxyribonucleic acid (DNA) lesions such as a cyclobutane pyrimidine dimer (CPD",
            "probability": 1.2806470643541554e-05,
            "start_logit": -1.097819209098816,
            "end_logit": -6.058925151824951
        },
        {
            "text": "PHRs function as an enzyme to repair UV-induced deoxyribonucleic acid",
            "probability": 1.2528401307098471e-05,
            "start_logit": -5.9861674308776855,
            "end_logit": -1.192529320716858
        },
        {
            "text": "cyclobutane pyrimidine dimer (CPD) and a (6-4) photoproduct",
            "probability": 9.37195764922089e-06,
            "start_logit": -3.3429954051971436,
            "end_logit": -4.125977516174316
        },
        {
            "text": "UV-induced deoxyribonucleic acid (DNA) lesions such as a cyclobutane pyrimidine dimer",
            "probability": 8.342373327630714e-06,
            "start_logit": -3.962874174118042,
            "end_logit": -3.6224730014801025
        },
        {
            "text": "UV-induced deoxyribonucleic acid (DNA) lesions",
            "probability": 7.0483526182814496e-06,
            "start_logit": -3.962874174118042,
            "end_logit": -3.7910268306732178
        },
        {
            "text": "a cyclobutane pyrimidine dimer (CPD)",
            "probability": 6.848794050839564e-06,
            "start_logit": -4.4978203773498535,
            "end_logit": -3.284801959991455
        },
        {
            "text": "UV-induced deoxyribonucleic acid (DNA)",
            "probability": 6.297060678736411e-06,
            "start_logit": -3.962874174118042,
            "end_logit": -3.903737783432007
        },
        {
            "text": "a cyclobutane pyrimidine dimer",
            "probability": 4.886134716102666e-06,
            "start_logit": -4.4978203773498535,
            "end_logit": -3.6224730014801025
        },
        {
            "text": "DNA) lesions such as a cyclobutane pyrimidine dimer (CPD)",
            "probability": 3.7974016277562614e-06,
            "start_logit": -5.087575912475586,
            "end_logit": -3.284801959991455
        },
        {
            "text": "UV-induced",
            "probability": 3.363421954216297e-06,
            "start_logit": -3.962874174118042,
            "end_logit": -4.530861854553223
        }
    ],
    "5e46e8c13f5415952900000c_004": [
        {
            "text": "cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone photoproducts",
            "probability": 0.9124485162081183,
            "start_logit": 5.715156555175781,
            "end_logit": 3.631042957305908
        },
        {
            "text": "cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone",
            "probability": 0.028673538701316843,
            "start_logit": 5.715156555175781,
            "end_logit": 0.17088599503040314
        },
        {
            "text": "cyclobutane pyrimidine dimers (CPDs)",
            "probability": 0.02639611756566582,
            "start_logit": 5.715156555175781,
            "end_logit": 0.0881282314658165
        },
        {
            "text": "cyclobutane pyrimidine dimers",
            "probability": 0.023877897212723695,
            "start_logit": 5.715156555175781,
            "end_logit": -0.012135477736592293
        },
        {
            "text": "cy",
            "probability": 0.00227388079945499,
            "start_logit": 5.715156555175781,
            "end_logit": -2.363600730895996
        },
        {
            "text": "cyclobutane pyrimidine dimers (CPDs",
            "probability": 0.001679305768529808,
            "start_logit": 5.715156555175781,
            "end_logit": -2.66670823097229
        },
        {
            "text": "pyrimidine-pyrimidone photoproducts",
            "probability": 0.0009962509512672598,
            "start_logit": -1.1047312021255493,
            "end_logit": 3.631042957305908
        },
        {
            "text": "cyclobutane pyrimidine",
            "probability": 0.0006732425587503167,
            "start_logit": 5.715156555175781,
            "end_logit": -3.5807383060455322
        },
        {
            "text": "pyrimidine-pyrimidone photoproducts (6-4 PPs)",
            "probability": 0.0005360684178934424,
            "start_logit": -1.1047312021255493,
            "end_logit": 3.011305570602417
        },
        {
            "text": "cyclobutane",
            "probability": 0.0003724902317052819,
            "start_logit": 5.715156555175781,
            "end_logit": -4.172633171081543
        },
        {
            "text": "(6-4 PPs)",
            "probability": 0.00036246415825495385,
            "start_logit": -1.4960674047470093,
            "end_logit": 3.011305570602417
        },
        {
            "text": "CPDs) and pyrimidine-pyrimidone photoproducts",
            "probability": 0.0003373763774730304,
            "start_logit": -2.1875312328338623,
            "end_logit": 3.631042957305908
        },
        {
            "text": "cyclobutane pyrimidine dimers (CPDs) and",
            "probability": 0.0002737792996320684,
            "start_logit": 5.715156555175781,
            "end_logit": -4.4805216789245605
        },
        {
            "text": "(CPDs) and pyrimidine-pyrimidone photoproducts",
            "probability": 0.00022585527824635007,
            "start_logit": -2.5888359546661377,
            "end_logit": 3.631042957305908
        },
        {
            "text": "",
            "probability": 0.00020296395173745638,
            "start_logit": 1.1113386154174805,
            "end_logit": -0.17599765956401825
        },
        {
            "text": "CPDs) and pyrimidine-pyrimidone photoproducts (6-4 PPs)",
            "probability": 0.00018153741351667783,
            "start_logit": -2.1875312328338623,
            "end_logit": 3.011305570602417
        },
        {
            "text": "cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone photo",
            "probability": 0.00013576945529671658,
            "start_logit": 5.715156555175781,
            "end_logit": -5.181885719299316
        },
        {
            "text": "photoproducts",
            "probability": 0.0001263649321577044,
            "start_logit": -3.1695563793182373,
            "end_logit": 3.631042957305908
        },
        {
            "text": "(CPDs) and pyrimidine-pyrimidone photoproducts (6-4 PPs)",
            "probability": 0.00012152950170676838,
            "start_logit": -2.5888359546661377,
            "end_logit": 3.011305570602417
        },
        {
            "text": "cyclobutane pyrimidine dimers (",
            "probability": 0.00010505121655286209,
            "start_logit": 5.715156555175781,
            "end_logit": -5.438395977020264
        }
    ],
    "5e2903978b3851296d000007_001": [
        {
            "text": "erythropoiesis stimulating fusion protein",
            "probability": 0.4931830777039515,
            "start_logit": 2.1847991943359375,
            "end_logit": 5.48486852645874
        },
        {
            "text": "stimulating fusion protein",
            "probability": 0.2885462234269938,
            "start_logit": 1.6487740278244019,
            "end_logit": 5.48486852645874
        },
        {
            "text": "another erythropoiesis stimulating fusion protein",
            "probability": 0.1458219130863663,
            "start_logit": 0.9663048386573792,
            "end_logit": 5.48486852645874
        },
        {
            "text": "fusion protein",
            "probability": 0.039764812235555606,
            "start_logit": -0.3330988585948944,
            "end_logit": 5.48486852645874
        },
        {
            "text": "erythropoiesis stimulating fusion protein.",
            "probability": 0.011577158091582608,
            "start_logit": 2.1847991943359375,
            "end_logit": 1.7330220937728882
        },
        {
            "text": "stimulating fusion protein.",
            "probability": 0.006773438498529932,
            "start_logit": 1.6487740278244019,
            "end_logit": 1.7330220937728882
        },
        {
            "text": "Luspatercept (ACE-536, ACVR2B-Fc), another erythropoiesis stimulating fusion protein",
            "probability": 0.004189953343748529,
            "start_logit": -2.5833916664123535,
            "end_logit": 5.48486852645874
        },
        {
            "text": "another erythropoiesis stimulating fusion protein.",
            "probability": 0.003423076373336714,
            "start_logit": 0.9663048386573792,
            "end_logit": 1.7330220937728882
        },
        {
            "text": "(ACE-536, ACVR2B-Fc), another erythropoiesis stimulating fusion protein",
            "probability": 0.003343555488341346,
            "start_logit": -2.809046506881714,
            "end_logit": 5.48486852645874
        },
        {
            "text": "fusion protein.",
            "probability": 0.0009334535967381126,
            "start_logit": -0.3330988585948944,
            "end_logit": 1.7330220937728882
        },
        {
            "text": "protein",
            "probability": 0.0007219013619369049,
            "start_logit": -4.34194803237915,
            "end_logit": 5.48486852645874
        },
        {
            "text": "erythropoiesis",
            "probability": 0.0004888262646308802,
            "start_logit": 2.1847991943359375,
            "end_logit": -1.4317600727081299
        },
        {
            "text": "ACE-536, ACVR2B-Fc), another erythropoiesis stimulating fusion protein",
            "probability": 0.0003118026456027999,
            "start_logit": -5.181466102600098,
            "end_logit": 5.48486852645874
        },
        {
            "text": "erythropoiesis stimulating",
            "probability": 0.0001900926265156265,
            "start_logit": 2.1847991943359375,
            "end_logit": -2.376255750656128
        },
        {
            "text": "erythropoiesis stimulating fusion",
            "probability": 0.0001571590644797396,
            "start_logit": 2.1847991943359375,
            "end_logit": -2.5665087699890137
        },
        {
            "text": "another erythropoiesis",
            "probability": 0.00014453371232280254,
            "start_logit": 0.9663048386573792,
            "end_logit": -1.4317600727081299
        },
        {
            "text": "",
            "probability": 0.0001274997325511871,
            "start_logit": -1.4441615343093872,
            "end_logit": 0.8533077836036682
        },
        {
            "text": "stimulating",
            "probability": 0.00011121733887902735,
            "start_logit": 1.6487740278244019,
            "end_logit": -2.376255750656128
        },
        {
            "text": "Luspatercept (ACE-536, ACVR2B-Fc), another erythropoiesis stimulating fusion protein.",
            "probability": 9.835648149722236e-05,
            "start_logit": -2.5833916664123535,
            "end_logit": 1.7330220937728882
        },
        {
            "text": "stimulating fusion",
            "probability": 9.194892643938123e-05,
            "start_logit": 1.6487740278244019,
            "end_logit": -2.5665087699890137
        }
    ],
    "5e2903978b3851296d000007_002": [
        {
            "text": "a modified ActRIIB-Fc",
            "probability": 0.5703998122555383,
            "start_logit": 1.7223517894744873,
            "end_logit": 4.077364444732666
        },
        {
            "text": "ActRIIB-Fc",
            "probability": 0.2530358484278362,
            "start_logit": 0.9095454216003418,
            "end_logit": 4.077364444732666
        },
        {
            "text": "modified ActRIIB-Fc",
            "probability": 0.13680632505165524,
            "start_logit": 0.29458048939704895,
            "end_logit": 4.077364444732666
        },
        {
            "text": "(a modified ActRIIB-Fc",
            "probability": 0.020029301969809933,
            "start_logit": -1.6267894506454468,
            "end_logit": 4.077364444732666
        },
        {
            "text": "a modified ActRIIB-Fc) in particular are now in phase 2/3 of clinical trials",
            "probability": 0.006941917101587519,
            "start_logit": 1.7223517894744873,
            "end_logit": -0.33139511942863464
        },
        {
            "text": "ActRIIB-Fc) in particular are now in phase 2/3 of clinical trials",
            "probability": 0.0030795134321134217,
            "start_logit": 0.9095454216003418,
            "end_logit": -0.33139511942863464
        },
        {
            "text": "Sotatercept (ActRIIA-Fc) and Luspatercept (a modified ActRIIB-Fc",
            "probability": 0.0018641978454300742,
            "start_logit": -4.001154899597168,
            "end_logit": 4.077364444732666
        },
        {
            "text": "modified ActRIIB-Fc) in particular are now in phase 2/3 of clinical trials",
            "probability": 0.0016649692848355341,
            "start_logit": 0.29458048939704895,
            "end_logit": -0.33139511942863464
        },
        {
            "text": "Luspatercept (a modified ActRIIB-Fc",
            "probability": 0.0014746667160285875,
            "start_logit": -4.235553741455078,
            "end_logit": 4.077364444732666
        },
        {
            "text": "a modified ActRIIB-Fc) in particular are now in phase 2/3 of clinical trials against anemia",
            "probability": 0.001245377002777266,
            "start_logit": 1.7223517894744873,
            "end_logit": -2.049534797668457
        },
        {
            "text": "Fc",
            "probability": 0.0007664677793765455,
            "start_logit": -4.88994836807251,
            "end_logit": 4.077364444732666
        },
        {
            "text": "ActRIIB-Fc) in particular are now in phase 2/3 of clinical trials against anemia",
            "probability": 0.000552463412048049,
            "start_logit": 0.9095454216003418,
            "end_logit": -2.049534797668457
        },
        {
            "text": "ActRIIA-Fc) and Luspatercept (a modified ActRIIB-Fc",
            "probability": 0.00039725333679673257,
            "start_logit": -5.54716682434082,
            "end_logit": 4.077364444732666
        },
        {
            "text": "a modified ActRIIB-Fc)",
            "probability": 0.00032365688377547665,
            "start_logit": 1.7223517894744873,
            "end_logit": -3.3970444202423096
        },
        {
            "text": "modified ActRIIB-Fc) in particular are now in phase 2/3 of clinical trials against anemia",
            "probability": 0.0002986947880997458,
            "start_logit": 0.29458048939704895,
            "end_logit": -2.049534797668457
        },
        {
            "text": "(ActRIIA-Fc) and Luspatercept (a modified ActRIIB-Fc",
            "probability": 0.00026221471380404596,
            "start_logit": -5.9625773429870605,
            "end_logit": 4.077364444732666
        },
        {
            "text": "(a modified ActRIIB-Fc) in particular are now in phase 2/3 of clinical trials",
            "probability": 0.00024376192083105678,
            "start_logit": -1.6267894506454468,
            "end_logit": -0.33139511942863464
        },
        {
            "text": "a modified",
            "probability": 0.00020434817884542553,
            "start_logit": 1.7223517894744873,
            "end_logit": -3.856903076171875
        },
        {
            "text": "a modified ActRIIB",
            "probability": 0.00017840800620185814,
            "start_logit": 1.7223517894744873,
            "end_logit": -3.9926552772521973
        },
        {
            "text": "ActRIIB-Fc)",
            "probability": 0.00014357787717669807,
            "start_logit": 0.9095454216003418,
            "end_logit": -3.3970444202423096
        },
        {
            "text": "",
            "probability": 8.722401543259737e-05,
            "start_logit": -2.17314076423645,
            "end_logit": -0.8127561211585999
        }
    ],
    "5e2903978b3851296d000007_003": [
        {
            "text": "",
            "probability": 0.5721655146666984,
            "start_logit": 0.20903101563453674,
            "end_logit": 0.0031178146600723267
        },
        {
            "text": "The mechanism of the action of the novel drugs is incompletely understood",
            "probability": 0.15009627185752225,
            "start_logit": -0.3688337504863739,
            "end_logit": -0.7571688294410706
        },
        {
            "text": "The mechanism of the action of the novel drugs is incompletely understood, but it seems to be based on the inactivation of soluble proteins",
            "probability": 0.11455416178260919,
            "start_logit": -0.3688337504863739,
            "end_logit": -1.0273979902267456
        },
        {
            "text": "incompletely understood",
            "probability": 0.030469920086008854,
            "start_logit": -1.963370680809021,
            "end_logit": -0.7571688294410706
        },
        {
            "text": "it seems to be based on the inactivation of soluble proteins",
            "probability": 0.02340863823929652,
            "start_logit": -1.9567763805389404,
            "end_logit": -1.0273979902267456
        },
        {
            "text": "incompletely understood, but it seems to be based on the inactivation of soluble proteins",
            "probability": 0.02325478249285979,
            "start_logit": -1.963370680809021,
            "end_logit": -1.0273979902267456
        },
        {
            "text": "it seems to be based on the inactivation of soluble proteins of the transforming growth factor-\u00df (TGF\u00df) family",
            "probability": 0.014354507720703642,
            "start_logit": -1.9567763805389404,
            "end_logit": -1.5164390802383423
        },
        {
            "text": "based on the inactivation of soluble proteins",
            "probability": 0.013239244985074507,
            "start_logit": -2.526695966720581,
            "end_logit": -1.0273979902267456
        },
        {
            "text": "The mechanism of the action of the novel drugs",
            "probability": 0.012172010203963654,
            "start_logit": -0.3688337504863739,
            "end_logit": -3.2693066596984863
        },
        {
            "text": "based on the inactivation of soluble proteins of the transforming growth factor-\u00df (TGF\u00df) family",
            "probability": 0.008118492088767065,
            "start_logit": -2.526695966720581,
            "end_logit": -1.5164390802383423
        },
        {
            "text": "inactivation of soluble proteins",
            "probability": 0.006494906540433471,
            "start_logit": -3.238863229751587,
            "end_logit": -1.0273979902267456
        },
        {
            "text": "it seems to be based on the inactivation of soluble proteins of the transforming growth factor-\u00df (TGF\u00df) family.",
            "probability": 0.0059824632394836355,
            "start_logit": -1.9567763805389404,
            "end_logit": -2.3916707038879395
        },
        {
            "text": "The mechanism of the action of the novel drugs is incompletely understood,",
            "probability": 0.0040680961574165045,
            "start_logit": -0.3688337504863739,
            "end_logit": -4.365270614624023
        },
        {
            "text": "inactivation of soluble proteins of the transforming growth factor-\u00df (TGF\u00df) family",
            "probability": 0.003982768460379379,
            "start_logit": -3.238863229751587,
            "end_logit": -1.5164390802383423
        },
        {
            "text": "based on the inactivation of soluble proteins of the transforming growth factor-\u00df (TGF\u00df) family.",
            "probability": 0.003383507217808435,
            "start_logit": -2.526695966720581,
            "end_logit": -2.3916707038879395
        },
        {
            "text": "The mechanism of the action of the novel drugs is incompletely understood, but it seems to be based on the inactivation",
            "probability": 0.0033475678645097113,
            "start_logit": -0.3688337504863739,
            "end_logit": -4.560211658477783
        },
        {
            "text": "mechanism of the action of the novel drugs is incompletely understood",
            "probability": 0.0032882803826192013,
            "start_logit": -4.189745903015137,
            "end_logit": -0.7571688294410706
        },
        {
            "text": "Sotatercept and luspatercept are recombinant soluble activin type-II receptor-IgG-Fc fusion proteins",
            "probability": 0.00306211442748065,
            "start_logit": -3.351642370223999,
            "end_logit": -1.6665314435958862
        },
        {
            "text": "mechanism of the action of the novel drugs is incompletely understood, but it seems to be based on the inactivation of soluble proteins",
            "probability": 0.0025096306408909784,
            "start_logit": -4.189745903015137,
            "end_logit": -1.0273979902267456
        },
        {
            "text": "novel drugs is incompletely understood",
            "probability": 0.00204712094547413,
            "start_logit": -4.6636762619018555,
            "end_logit": -0.7571688294410706
        }
    ],
    "5e2903978b3851296d000007_004": [
        {
            "text": "activin receptor type II-Fc fusion proteins",
            "probability": 0.5380792474800962,
            "start_logit": 3.6812996864318848,
            "end_logit": 2.943315267562866
        },
        {
            "text": "",
            "probability": 0.3103329168863879,
            "start_logit": 3.4142279624938965,
            "end_logit": 2.660026788711548
        },
        {
            "text": "activin receptor type II-Fc",
            "probability": 0.05340119758622247,
            "start_logit": 3.6812996864318848,
            "end_logit": 0.6331425905227661
        },
        {
            "text": "activin receptor type II-Fc fusion proteins (ActRII-Fc",
            "probability": 0.04378529359330576,
            "start_logit": 3.6812996864318848,
            "end_logit": 0.4346074163913727
        },
        {
            "text": "activin receptor type II-Fc fusion proteins (ActRII-Fc)",
            "probability": 0.03444072738602027,
            "start_logit": 3.6812996864318848,
            "end_logit": 0.19454921782016754
        },
        {
            "text": "activin receptor",
            "probability": 0.0048918010819101795,
            "start_logit": 3.6812996864318848,
            "end_logit": -1.7571300268173218
        },
        {
            "text": "both activin receptor type II-Fc fusion proteins",
            "probability": 0.004066642122213443,
            "start_logit": -1.2038885354995728,
            "end_logit": 2.943315267562866
        },
        {
            "text": "activin receptor type II-Fc fusion proteins (ActRII-Fc) - are also now prohibited",
            "probability": 0.003485680210893132,
            "start_logit": 3.6812996864318848,
            "end_logit": -2.096027374267578
        },
        {
            "text": "activin",
            "probability": 0.0023267882420759645,
            "start_logit": 3.6812996864318848,
            "end_logit": -2.50020170211792
        },
        {
            "text": "fusion proteins",
            "probability": 0.0020546397791811866,
            "start_logit": -1.8866056203842163,
            "end_logit": 2.943315267562866
        },
        {
            "text": "both activin receptor type II-Fc",
            "probability": 0.00040359028990206156,
            "start_logit": -1.2038885354995728,
            "end_logit": 0.6331425905227661
        },
        {
            "text": "activin receptor type II",
            "probability": 0.00036476490662875737,
            "start_logit": 3.6812996864318848,
            "end_logit": -4.3531928062438965
        },
        {
            "text": "sotatercept, both activin receptor type II-Fc fusion proteins",
            "probability": 0.00033717589097073463,
            "start_logit": -3.693856716156006,
            "end_logit": 2.943315267562866
        },
        {
            "text": "ESAs - luspatercept and sotatercept, both activin receptor type II-Fc fusion proteins",
            "probability": 0.0003309693323791802,
            "start_logit": -3.712435722351074,
            "end_logit": 2.943315267562866
        },
        {
            "text": "both activin receptor type II-Fc fusion proteins (ActRII-Fc",
            "probability": 0.00033091616168788617,
            "start_logit": -1.2038885354995728,
            "end_logit": 0.4346074163913727
        },
        {
            "text": "Fc fusion proteins",
            "probability": 0.00031118700699379057,
            "start_logit": -3.7740674018859863,
            "end_logit": 2.943315267562866
        },
        {
            "text": "receptor type II-Fc fusion proteins",
            "probability": 0.000306886662327995,
            "start_logit": -3.787982940673828,
            "end_logit": 2.943315267562866
        },
        {
            "text": "activin receptor type II-Fc fusion proteins (ActRII-Fc) -",
            "probability": 0.0002670026282610459,
            "start_logit": 3.6812996864318848,
            "end_logit": -4.665187358856201
        },
        {
            "text": "both activin receptor type II-Fc fusion proteins (ActRII-Fc)",
            "probability": 0.00026029272335547737,
            "start_logit": -1.2038885354995728,
            "end_logit": 0.19454921782016754
        },
        {
            "text": "act",
            "probability": 0.00022228002918671294,
            "start_logit": 3.6812996864318848,
            "end_logit": -4.848507881164551
        }
    ],
    "5e2903978b3851296d000007_005": [
        {
            "text": "activin inhibitors",
            "probability": 0.7168845110872619,
            "start_logit": 3.4037299156188965,
            "end_logit": 3.554532766342163
        },
        {
            "text": "activin inhibitors such as Luspatercept have shown to be effective in patients' refractory to ESAs",
            "probability": 0.24338062683731984,
            "start_logit": 3.4037299156188965,
            "end_logit": 2.4742445945739746
        },
        {
            "text": "effective in patients' refractory to ESAs",
            "probability": 0.008788366821879973,
            "start_logit": 0.08253222703933716,
            "end_logit": 2.4742445945739746
        },
        {
            "text": "activin",
            "probability": 0.007050415539007976,
            "start_logit": 3.4037299156188965,
            "end_logit": -1.0672954320907593
        },
        {
            "text": "Luspatercept have shown to be effective in patients' refractory to ESAs",
            "probability": 0.006286580570666921,
            "start_logit": -0.2524793744087219,
            "end_logit": 2.4742445945739746
        },
        {
            "text": "activin inhibitors such as Luspatercept have shown to be effective in patients' refractory to ESAs and further clinical trials",
            "probability": 0.004773329230725731,
            "start_logit": 3.4037299156188965,
            "end_logit": -1.4573379755020142
        },
        {
            "text": "patients' refractory to ESAs",
            "probability": 0.0025817105327808755,
            "start_logit": -1.1424444913864136,
            "end_logit": 2.4742445945739746
        },
        {
            "text": "inhibitors",
            "probability": 0.0017625385323158812,
            "start_logit": -2.6044297218322754,
            "end_logit": 3.554532766342163
        },
        {
            "text": "activin inhibitors such as Luspatercept",
            "probability": 0.0013782892313996212,
            "start_logit": 3.4037299156188965,
            "end_logit": -2.6995389461517334
        },
        {
            "text": "activin inhibitors such as Luspatercept have shown to be effective in patients'",
            "probability": 0.0012257001762537678,
            "start_logit": 3.4037299156188965,
            "end_logit": -2.8168697357177734
        },
        {
            "text": "Recently, activin inhibitors",
            "probability": 0.0011653404671015434,
            "start_logit": -3.018171548843384,
            "end_logit": 3.554532766342163
        },
        {
            "text": "Managing anaemia effectively has shown to improve the patient outcome, yet treatment option remain limited. Recently, activin inhibitors",
            "probability": 0.0010346926319184323,
            "start_logit": -3.137080430984497,
            "end_logit": 3.554532766342163
        },
        {
            "text": "inhibitors such as Luspatercept have shown to be effective in patients' refractory to ESAs",
            "probability": 0.0005983777389322801,
            "start_logit": -2.6044297218322754,
            "end_logit": 2.4742445945739746
        },
        {
            "text": "ESAs",
            "probability": 0.0005238159132428447,
            "start_logit": -2.73751163482666,
            "end_logit": 2.4742445945739746
        },
        {
            "text": "activin inhibitors such as Luspatercept have shown to be effective in patients' refractory",
            "probability": 0.0005124582038148241,
            "start_logit": 3.4037299156188965,
            "end_logit": -3.688918113708496
        },
        {
            "text": "shown to be effective in patients' refractory to ESAs",
            "probability": 0.0005094768099248778,
            "start_logit": -2.7652676105499268,
            "end_logit": 2.4742445945739746
        },
        {
            "text": "have shown to be effective in patients' refractory to ESAs",
            "probability": 0.00040333616411822364,
            "start_logit": -2.9988815784454346,
            "end_logit": 2.4742445945739746
        },
        {
            "text": "Recently, activin inhibitors such as Luspatercept have shown to be effective in patients' refractory to ESAs",
            "probability": 0.00039563038254504176,
            "start_logit": -3.018171548843384,
            "end_logit": 2.4742445945739746
        },
        {
            "text": "treatment option remain limited. Recently, activin inhibitors",
            "probability": 0.00036690569054131683,
            "start_logit": -4.173835277557373,
            "end_logit": 3.554532766342163
        },
        {
            "text": "refractory to ESAs",
            "probability": 0.00028375713101902255,
            "start_logit": -3.3505332469940186,
            "end_logit": 2.4742445945739746
        },
        {
            "text": "",
            "probability": 9.414030722916296e-05,
            "start_logit": -1.2744011878967285,
            "end_logit": -0.7052198648452759
        }
    ],
    "5e2903978b3851296d000007_007": [
        {
            "text": "modified ActRIIB-Fc",
            "probability": 0.3778592891889279,
            "start_logit": -0.4957355558872223,
            "end_logit": 1.1496913433074951
        },
        {
            "text": "inhibit negative regulators of late-stage erythropoiesis",
            "probability": 0.3086721819781934,
            "start_logit": 0.24089378118515015,
            "end_logit": 0.21081994473934174
        },
        {
            "text": "ActRIIB-Fc",
            "probability": 0.08306126140875578,
            "start_logit": -2.010679006576538,
            "end_logit": 1.1496913433074951
        },
        {
            "text": "(modified ActRIIB-Fc",
            "probability": 0.04821409812627393,
            "start_logit": -2.5546059608459473,
            "end_logit": 1.1496913433074951
        },
        {
            "text": "inhibit negative regulators",
            "probability": 0.045033631454635195,
            "start_logit": 0.24089378118515015,
            "end_logit": -1.71405029296875
        },
        {
            "text": "Luspatercept (modified ActRIIB-Fc",
            "probability": 0.03166688048369598,
            "start_logit": -2.9749860763549805,
            "end_logit": 1.1496913433074951
        },
        {
            "text": "modified ActRIIB-Fc), have the potential for being misused as doping agents in sports as they were found to inhibit negative regulators",
            "probability": 0.021558717071069464,
            "start_logit": -0.4957355558872223,
            "end_logit": -1.71405029296875
        },
        {
            "text": "",
            "probability": 0.02090273038057865,
            "start_logit": -1.62338387966156,
            "end_logit": -0.617302417755127
        },
        {
            "text": "modified ActRIIB-Fc), have the potential for being misused as doping agents",
            "probability": 0.01681243582627486,
            "start_logit": -0.4957355558872223,
            "end_logit": -1.9627116918563843
        },
        {
            "text": "inhibit negative regulators of late-stage erythropoiesis.",
            "probability": 0.009566208456750113,
            "start_logit": 0.24089378118515015,
            "end_logit": -3.2632229328155518
        },
        {
            "text": "inhibit",
            "probability": 0.00575583928026066,
            "start_logit": 0.24089378118515015,
            "end_logit": -3.771245002746582
        },
        {
            "text": "ActRIIB-Fc), have the potential for being misused as doping agents in sports as they were found to inhibit negative regulators",
            "probability": 0.0047390504494972665,
            "start_logit": -2.010679006576538,
            "end_logit": -1.71405029296875
        },
        {
            "text": "modified ActRIIB-Fc), have the potential for being misused as doping agents in sports",
            "probability": 0.004439625519024463,
            "start_logit": -0.4957355558872223,
            "end_logit": -3.2942605018615723
        },
        {
            "text": "erythropoiesis",
            "probability": 0.003970676117275488,
            "start_logit": -4.112449645996094,
            "end_logit": 0.21081994473934174
        },
        {
            "text": "ActRIIB-Fc), have the potential for being misused as doping agents",
            "probability": 0.003695719986351646,
            "start_logit": -2.010679006576538,
            "end_logit": -1.9627116918563843
        },
        {
            "text": "late-stage erythropoiesis",
            "probability": 0.0036211785057219327,
            "start_logit": -4.204586505889893,
            "end_logit": 0.21081994473934174
        },
        {
            "text": "Sotatercept (ActRIIA-Fc) and Luspatercept (modified ActRIIB-Fc",
            "probability": 0.002778929413498227,
            "start_logit": -5.408191680908203,
            "end_logit": 1.1496913433074951
        },
        {
            "text": "modified ActRIIB-Fc), have the potential for being misused as doping agents in sports as they were found to inhibit",
            "probability": 0.002755463118151791,
            "start_logit": -0.4957355558872223,
            "end_logit": -3.771245002746582
        },
        {
            "text": "(modified ActRIIB-Fc), have the potential for being misused as doping agents in sports as they were found to inhibit negative regulators",
            "probability": 0.0027508496683309215,
            "start_logit": -2.5546059608459473,
            "end_logit": -1.71405029296875
        },
        {
            "text": "(modified ActRIIB-Fc), have the potential for being misused as doping agents",
            "probability": 0.002145233566732311,
            "start_logit": -2.5546059608459473,
            "end_logit": -1.9627116918563843
        }
    ],
    "5e2903978b3851296d000007_008": [
        {
            "text": "an activin-receptor trap that modifies transforming growth factor-\u03b2 signaling",
            "probability": 0.5834688114279412,
            "start_logit": 6.149726867675781,
            "end_logit": 6.322262763977051
        },
        {
            "text": "activin-receptor trap that modifies transforming growth factor-\u03b2 signaling",
            "probability": 0.13766154677344375,
            "start_logit": 4.705533981323242,
            "end_logit": 6.322262763977051
        },
        {
            "text": "an activin-receptor trap",
            "probability": 0.09838424114372943,
            "start_logit": 6.149726867675781,
            "end_logit": 4.542152404785156
        },
        {
            "text": "an activin-receptor trap that modifies transforming growth factor-\u03b2",
            "probability": 0.0499181427026905,
            "start_logit": 6.149726867675781,
            "end_logit": 3.8636562824249268
        },
        {
            "text": "an activin-receptor trap that modifies transforming growth factor-\u03b2 signaling, thereby increasing the efficiency of erythropoiesis",
            "probability": 0.04619517489280835,
            "start_logit": 6.149726867675781,
            "end_logit": 3.786147117614746
        },
        {
            "text": "activin-receptor trap",
            "probability": 0.023212426352029508,
            "start_logit": 4.705533981323242,
            "end_logit": 4.542152404785156
        },
        {
            "text": "an activin-receptor trap that modifies transforming growth factor-\u03b2 signaling, thereby increasing the efficiency of erythropoiesis.",
            "probability": 0.01776494139992936,
            "start_logit": 6.149726867675781,
            "end_logit": 2.830498695373535
        },
        {
            "text": "activin-receptor trap that modifies transforming growth factor-\u03b2",
            "probability": 0.011777508243657923,
            "start_logit": 4.705533981323242,
            "end_logit": 3.8636562824249268
        },
        {
            "text": "activin-receptor trap that modifies transforming growth factor-\u03b2 signaling, thereby increasing the efficiency of erythropoiesis",
            "probability": 0.010899124519870124,
            "start_logit": 4.705533981323242,
            "end_logit": 3.786147117614746
        },
        {
            "text": "modifies transforming growth factor-\u03b2 signaling",
            "probability": 0.0060613117516828355,
            "start_logit": 1.5826621055603027,
            "end_logit": 6.322262763977051
        },
        {
            "text": "an activin-receptor trap that modifies transforming growth factor-\u03b2 signaling,",
            "probability": 0.004399810203618557,
            "start_logit": 6.149726867675781,
            "end_logit": 1.4348331689834595
        },
        {
            "text": "activin-receptor trap that modifies transforming growth factor-\u03b2 signaling, thereby increasing the efficiency of erythropoiesis.",
            "probability": 0.004191396804001905,
            "start_logit": 4.705533981323242,
            "end_logit": 2.830498695373535
        },
        {
            "text": "luspatercept, an activin-receptor trap that modifies transforming growth factor-\u03b2 signaling",
            "probability": 0.0013737351891433603,
            "start_logit": 0.09826931357383728,
            "end_logit": 6.322262763977051
        },
        {
            "text": "activin-receptor trap that modifies transforming growth factor-\u03b2 signaling,",
            "probability": 0.0010380754999695704,
            "start_logit": 4.705533981323242,
            "end_logit": 1.4348331689834595
        },
        {
            "text": "transforming growth factor-\u03b2 signaling",
            "probability": 0.0009372546887212408,
            "start_logit": -0.2840643525123596,
            "end_logit": 6.322262763977051
        },
        {
            "text": "an activin-receptor trap that modifies transforming growth factor",
            "probability": 0.000737925271884255,
            "start_logit": 6.149726867675781,
            "end_logit": -0.3506409525871277
        },
        {
            "text": "trap that modifies transforming growth factor-\u03b2 signaling",
            "probability": 0.0006521512221219194,
            "start_logit": -0.6467429399490356,
            "end_logit": 6.322262763977051
        },
        {
            "text": "modifies transforming growth factor-\u03b2",
            "probability": 0.0005185700059023057,
            "start_logit": 1.5826621055603027,
            "end_logit": 3.8636562824249268
        },
        {
            "text": "modifies transforming growth factor-\u03b2 signaling, thereby increasing the efficiency of erythropoiesis",
            "probability": 0.00047989429934320276,
            "start_logit": 1.5826621055603027,
            "end_logit": 3.786147117614746
        },
        {
            "text": "an activin-receptor",
            "probability": 0.00032794740390765383,
            "start_logit": 6.149726867675781,
            "end_logit": -1.1616302728652954
        },
        {
            "text": "",
            "probability": 1.0203603488717342e-08,
            "start_logit": -2.6169612407684326,
            "end_logit": -2.7728097438812256
        }
    ],
    "5e2903978b3851296d000007_009": [
        {
            "text": "a novel fusion protein that blocks transforming growth factor beta",
            "probability": 0.1466181948623304,
            "start_logit": 3.6340620517730713,
            "end_logit": 5.662211894989014
        },
        {
            "text": "a novel fusion protein that blocks transforming growth factor beta (TGF \u03b2) superfamily inhibitors of erythropoiesis",
            "probability": 0.1391432893983541,
            "start_logit": 3.6340620517730713,
            "end_logit": 5.609884262084961
        },
        {
            "text": "Luspatercept (ACE-536) is a novel fusion protein that blocks transforming growth factor beta",
            "probability": 0.08573184899861117,
            "start_logit": 3.09745454788208,
            "end_logit": 5.662211894989014
        },
        {
            "text": "blocks transforming growth factor beta",
            "probability": 0.07415029108983588,
            "start_logit": 2.952324151992798,
            "end_logit": 5.662211894989014
        },
        {
            "text": "a novel fusion protein that blocks transforming growth factor beta (TGF \u03b2)",
            "probability": 0.07251899932329789,
            "start_logit": 3.6340620517730713,
            "end_logit": 4.958228588104248
        },
        {
            "text": "blocks transforming growth factor beta (TGF \u03b2) superfamily inhibitors of erythropoiesis",
            "probability": 0.07036995252719509,
            "start_logit": 2.952324151992798,
            "end_logit": 5.609884262084961
        },
        {
            "text": "novel fusion protein that blocks transforming growth factor beta",
            "probability": 0.06655041126095211,
            "start_logit": 2.8441898822784424,
            "end_logit": 5.662211894989014
        },
        {
            "text": "novel fusion protein that blocks transforming growth factor beta (TGF \u03b2) superfamily inhibitors of erythropoiesis",
            "probability": 0.06315753063497348,
            "start_logit": 2.8441898822784424,
            "end_logit": 5.609884262084961
        },
        {
            "text": "Luspatercept (ACE-536) is a novel fusion protein that blocks transforming growth factor beta (TGF \u03b2)",
            "probability": 0.04240393155401409,
            "start_logit": 3.09745454788208,
            "end_logit": 4.958228588104248
        },
        {
            "text": "blocks transforming growth factor beta (TGF \u03b2)",
            "probability": 0.03667556345524005,
            "start_logit": 2.952324151992798,
            "end_logit": 4.958228588104248
        },
        {
            "text": "novel fusion protein that blocks transforming growth factor beta (TGF \u03b2)",
            "probability": 0.0329165778758209,
            "start_logit": 2.8441898822784424,
            "end_logit": 4.958228588104248
        },
        {
            "text": "is a novel fusion protein that blocks transforming growth factor beta",
            "probability": 0.02940231868145869,
            "start_logit": 2.027303695678711,
            "end_logit": 5.662211894989014
        },
        {
            "text": "is a novel fusion protein that blocks transforming growth factor beta (TGF \u03b2) superfamily inhibitors of erythropoiesis",
            "probability": 0.027903326330802797,
            "start_logit": 2.027303695678711,
            "end_logit": 5.609884262084961
        },
        {
            "text": "a novel fusion protein",
            "probability": 0.01998383892393761,
            "start_logit": 3.6340620517730713,
            "end_logit": 3.6693038940429688
        },
        {
            "text": "a novel fusion protein that blocks transforming growth factor beta (TGF \u03b2) superfamily inhibitors",
            "probability": 0.018955464296106575,
            "start_logit": 3.6340620517730713,
            "end_logit": 3.6164722442626953
        },
        {
            "text": "fusion protein that blocks transforming growth factor beta",
            "probability": 0.01857415083624364,
            "start_logit": 1.5680010318756104,
            "end_logit": 5.662211894989014
        },
        {
            "text": "fusion protein that blocks transforming growth factor beta (TGF \u03b2) superfamily inhibitors of erythropoiesis",
            "probability": 0.017627201368580887,
            "start_logit": 1.5680010318756104,
            "end_logit": 5.609884262084961
        },
        {
            "text": "is a novel fusion protein that blocks transforming growth factor beta (TGF \u03b2)",
            "probability": 0.01454271572887786,
            "start_logit": 2.027303695678711,
            "end_logit": 4.958228588104248
        },
        {
            "text": "Luspatercept (ACE-536) is a novel fusion protein",
            "probability": 0.01168512177256222,
            "start_logit": 3.09745454788208,
            "end_logit": 3.6693038940429688
        },
        {
            "text": "Luspatercept (ACE-536) is a novel fusion protein that blocks transforming growth factor beta (TGF \u03b2) superfamily inhibitors",
            "probability": 0.011083801735918766,
            "start_logit": 3.09745454788208,
            "end_logit": 3.6164722442626953
        },
        {
            "text": "",
            "probability": 5.469344885524339e-06,
            "start_logit": -0.5429832339286804,
            "end_logit": -0.3571711480617523
        }
    ],
    "5c701f4f7c78d69471000060_001": [
        {
            "text": "chronic myeloid leukemia",
            "probability": 0.5857478887583304,
            "start_logit": 4.512967109680176,
            "end_logit": 4.557562351226807
        },
        {
            "text": "",
            "probability": 0.3829988002302623,
            "start_logit": 4.265458106994629,
            "end_logit": 4.380213737487793
        },
        {
            "text": "myeloid leukemia",
            "probability": 0.015471706527062366,
            "start_logit": 0.8790906071662903,
            "end_logit": 4.557562351226807
        },
        {
            "text": "leukemia",
            "probability": 0.011625735471127722,
            "start_logit": 0.5932988524436951,
            "end_logit": 4.557562351226807
        },
        {
            "text": "Patients with chronic myeloid leukemia",
            "probability": 0.0029907965678619866,
            "start_logit": -0.7643826007843018,
            "end_logit": 4.557562351226807
        },
        {
            "text": "chronic myeloid leukemia,",
            "probability": 0.0003157509341111634,
            "start_logit": 4.512967109680176,
            "end_logit": -2.9681286811828613
        },
        {
            "text": "chronic myeloid",
            "probability": 0.0002880910369597608,
            "start_logit": 4.512967109680176,
            "end_logit": -3.0598058700561523
        },
        {
            "text": "chronic",
            "probability": 0.00018286439388389827,
            "start_logit": 4.512967109680176,
            "end_logit": -3.5143375396728516
        },
        {
            "text": "imatinib failure",
            "probability": 0.00012393161255203438,
            "start_logit": 3.0489652156829834,
            "end_logit": -2.4393506050109863
        },
        {
            "text": "chronic myeloid leukemia, treated with imatinib",
            "probability": 6.0777464924980186e-05,
            "start_logit": 4.512967109680176,
            "end_logit": -4.61586332321167
        },
        {
            "text": "chronic my",
            "probability": 3.85534681904094e-05,
            "start_logit": 4.512967109680176,
            "end_logit": -5.071036338806152
        },
        {
            "text": "myeloid leukemia,",
            "probability": 2.7416961461431876e-05,
            "start_logit": -5.456515789031982,
            "end_logit": 4.557562351226807
        },
        {
            "text": "im",
            "probability": 2.2595854880904334e-05,
            "start_logit": 3.0489652156829834,
            "end_logit": -4.1413140296936035
        },
        {
            "text": "chronic myeloid leukemia, treated with imatinib, who have a durable complete molecular response, might remain in complete molecular response after stopping treatment.",
            "probability": 1.796655533985478e-05,
            "start_logit": 4.512967109680176,
            "end_logit": -5.834570407867432
        },
        {
            "text": "chronic myeloid leukemia, treated with imatinib,",
            "probability": 1.667442336537596e-05,
            "start_logit": 4.512967109680176,
            "end_logit": -5.909206390380859
        },
        {
            "text": "chronic myeloid leukemia, treated with imatinib, who have a durable complete molecular response, might remain in complete molecular response after stopping treatment",
            "probability": 1.4852548608316146e-05,
            "start_logit": 4.512967109680176,
            "end_logit": -6.024910926818848
        },
        {
            "text": "chronic myelo",
            "probability": 1.4783621720734586e-05,
            "start_logit": 4.512967109680176,
            "end_logit": -6.029562473297119
        },
        {
            "text": "with chronic myeloid leukemia",
            "probability": 1.4150886478620856e-05,
            "start_logit": -6.117900371551514,
            "end_logit": 4.557562351226807
        },
        {
            "text": "imatinib",
            "probability": 1.41010652581258e-05,
            "start_logit": 3.0489652156829834,
            "end_logit": -4.61283016204834
        },
        {
            "text": "imatinib failure. Two of the 3 patients remain in complete molecular response more than 12 months after stopping dasatinib",
            "probability": 1.256161761960864e-05,
            "start_logit": 3.0489652156829834,
            "end_logit": -4.7284345626831055
        }
    ],
    "5c701f4f7c78d69471000060_002": [
        {
            "text": "chronic myeloid leukemia",
            "probability": 0.5857478887583304,
            "start_logit": 4.512967109680176,
            "end_logit": 4.557562351226807
        },
        {
            "text": "",
            "probability": 0.3829988002302623,
            "start_logit": 4.265458106994629,
            "end_logit": 4.380213737487793
        },
        {
            "text": "myeloid leukemia",
            "probability": 0.015471706527062366,
            "start_logit": 0.8790906071662903,
            "end_logit": 4.557562351226807
        },
        {
            "text": "leukemia",
            "probability": 0.011625735471127722,
            "start_logit": 0.5932988524436951,
            "end_logit": 4.557562351226807
        },
        {
            "text": "Patients with chronic myeloid leukemia",
            "probability": 0.0029907965678619866,
            "start_logit": -0.7643826007843018,
            "end_logit": 4.557562351226807
        },
        {
            "text": "chronic myeloid leukemia,",
            "probability": 0.0003157509341111634,
            "start_logit": 4.512967109680176,
            "end_logit": -2.9681286811828613
        },
        {
            "text": "chronic myeloid",
            "probability": 0.0002880910369597608,
            "start_logit": 4.512967109680176,
            "end_logit": -3.0598058700561523
        },
        {
            "text": "chronic",
            "probability": 0.00018286439388389827,
            "start_logit": 4.512967109680176,
            "end_logit": -3.5143375396728516
        },
        {
            "text": "imatinib failure",
            "probability": 0.00012393161255203438,
            "start_logit": 3.0489652156829834,
            "end_logit": -2.4393506050109863
        },
        {
            "text": "chronic myeloid leukemia, treated with imatinib",
            "probability": 6.0777464924980186e-05,
            "start_logit": 4.512967109680176,
            "end_logit": -4.61586332321167
        },
        {
            "text": "chronic my",
            "probability": 3.85534681904094e-05,
            "start_logit": 4.512967109680176,
            "end_logit": -5.071036338806152
        },
        {
            "text": "myeloid leukemia,",
            "probability": 2.7416961461431876e-05,
            "start_logit": -5.456515789031982,
            "end_logit": 4.557562351226807
        },
        {
            "text": "im",
            "probability": 2.2595854880904334e-05,
            "start_logit": 3.0489652156829834,
            "end_logit": -4.1413140296936035
        },
        {
            "text": "chronic myeloid leukemia, treated with imatinib, who have a durable complete molecular response, might remain in complete molecular response after stopping treatment.",
            "probability": 1.796655533985478e-05,
            "start_logit": 4.512967109680176,
            "end_logit": -5.834570407867432
        },
        {
            "text": "chronic myeloid leukemia, treated with imatinib,",
            "probability": 1.667442336537596e-05,
            "start_logit": 4.512967109680176,
            "end_logit": -5.909206390380859
        },
        {
            "text": "chronic myeloid leukemia, treated with imatinib, who have a durable complete molecular response, might remain in complete molecular response after stopping treatment",
            "probability": 1.4852548608316146e-05,
            "start_logit": 4.512967109680176,
            "end_logit": -6.024910926818848
        },
        {
            "text": "chronic myelo",
            "probability": 1.4783621720734586e-05,
            "start_logit": 4.512967109680176,
            "end_logit": -6.029562473297119
        },
        {
            "text": "with chronic myeloid leukemia",
            "probability": 1.4150886478620856e-05,
            "start_logit": -6.117900371551514,
            "end_logit": 4.557562351226807
        },
        {
            "text": "imatinib",
            "probability": 1.41010652581258e-05,
            "start_logit": 3.0489652156829834,
            "end_logit": -4.61283016204834
        },
        {
            "text": "imatinib failure. Two of the 3 patients remain in complete molecular response more than 12 months after stopping dasatinib",
            "probability": 1.256161761960864e-05,
            "start_logit": 3.0489652156829834,
            "end_logit": -4.7284345626831055
        }
    ],
    "5c701f4f7c78d69471000060_004": [
        {
            "text": "chronic myeloid leukemia",
            "probability": 0.2582556112369205,
            "start_logit": 2.332606077194214,
            "end_logit": 4.708809852600098
        },
        {
            "text": "myeloid leukemia",
            "probability": 0.1980945520643191,
            "start_logit": 2.0674006938934326,
            "end_logit": 4.708809852600098
        },
        {
            "text": "leukemia",
            "probability": 0.18589483405928472,
            "start_logit": 2.0038373470306396,
            "end_logit": 4.708809852600098
        },
        {
            "text": "",
            "probability": 0.1528774506428028,
            "start_logit": 3.138136386871338,
            "end_logit": 3.3789663314819336
        },
        {
            "text": "Sclerotic chronic graft-versus-host disease",
            "probability": 0.12334620214015243,
            "start_logit": 4.0518951416015625,
            "end_logit": 2.250566005706787
        },
        {
            "text": "Sclerotic chronic graft-versus-host disease (scGVHD)",
            "probability": 0.03897303716344202,
            "start_logit": 4.0518951416015625,
            "end_logit": 1.0984410047531128
        },
        {
            "text": "Sclerotic chronic graft-versus-host disease (scGVHD",
            "probability": 0.024164558970031707,
            "start_logit": 4.0518951416015625,
            "end_logit": 0.6204580068588257
        },
        {
            "text": "Sclerotic chronic graft-versus-host",
            "probability": 0.006359201829972419,
            "start_logit": 4.0518951416015625,
            "end_logit": -0.7145261764526367
        },
        {
            "text": "scGVHD. Dasatinib, a second-generation TKI with a well-established safety and efficacy profile in chronic myeloid leukemia",
            "probability": 0.004176117923525365,
            "start_logit": -1.791961669921875,
            "end_logit": 4.708809852600098
        },
        {
            "text": "scGVHD)",
            "probability": 0.0018355880543113028,
            "start_logit": 0.9963899850845337,
            "end_logit": 1.0984410047531128
        },
        {
            "text": "chronic graft-versus-host disease",
            "probability": 0.0014652526550960685,
            "start_logit": -0.3810722231864929,
            "end_logit": 2.250566005706787
        },
        {
            "text": "scGVHD",
            "probability": 0.0011381246885397676,
            "start_logit": 0.9963899850845337,
            "end_logit": 0.6204580068588257
        },
        {
            "text": "Sclerotic chronic",
            "probability": 0.0010199432837541848,
            "start_logit": 4.0518951416015625,
            "end_logit": -2.544682025909424
        },
        {
            "text": "Sclerotic chronic graft-versus-host disease (scGVHD) is a severe form of this disease that resembles systemic sclerosis",
            "probability": 0.0005047426824776909,
            "start_logit": 4.0518951416015625,
            "end_logit": -3.248135566711426
        },
        {
            "text": "chronic graft-versus-host disease (scGVHD)",
            "probability": 0.00046296801352671617,
            "start_logit": -0.3810722231864929,
            "end_logit": 1.0984410047531128
        },
        {
            "text": "Dasatinib, a second-generation TKI with a well-established safety and efficacy profile in chronic myeloid leukemia",
            "probability": 0.00038566424803609657,
            "start_logit": -4.174131870269775,
            "end_logit": 4.708809852600098
        },
        {
            "text": "Sclerotic",
            "probability": 0.00029290004622997456,
            "start_logit": 4.0518951416015625,
            "end_logit": -3.7923529148101807
        },
        {
            "text": "chronic graft-versus-host disease (scGVHD",
            "probability": 0.00028705532538272216,
            "start_logit": -0.3810722231864929,
            "end_logit": 0.6204580068588257
        },
        {
            "text": "chronic myeloid leukemia patients, who are refractory or intolerant to imatinib",
            "probability": 0.0002345125691175555,
            "start_logit": 2.332606077194214,
            "end_logit": -2.2953860759735107
        },
        {
            "text": "Sc",
            "probability": 0.00023168240307658105,
            "start_logit": 4.0518951416015625,
            "end_logit": -4.0268168449401855
        }
    ],
    "5c701f4f7c78d69471000060_005": [
        {
            "text": "myeloproliferative diseases",
            "probability": 0.5374587620839787,
            "start_logit": 6.45118522644043,
            "end_logit": 3.6807377338409424
        },
        {
            "text": "myeloproliferative diseases (MPDs) involving c-Cbl mutations",
            "probability": 0.34666694473933807,
            "start_logit": 6.45118522644043,
            "end_logit": 3.2422502040863037
        },
        {
            "text": "myeloproliferative",
            "probability": 0.04592650376258113,
            "start_logit": 6.45118522644043,
            "end_logit": 1.2209280729293823
        },
        {
            "text": "myeloproliferative diseases (MPDs) involving c-Cbl mutations.",
            "probability": 0.030013951492401568,
            "start_logit": 6.45118522644043,
            "end_logit": 0.7955480217933655
        },
        {
            "text": "myeloproliferative diseases (MPDs)",
            "probability": 0.024257349980793198,
            "start_logit": 6.45118522644043,
            "end_logit": 0.5826053619384766
        },
        {
            "text": "myeloproliferative diseases (MPDs) involving c-Cbl",
            "probability": 0.007851352788067924,
            "start_logit": 6.45118522644043,
            "end_logit": -0.545428454875946
        },
        {
            "text": "c-Cbl mutations",
            "probability": 0.003053942611140423,
            "start_logit": 1.7192541360855103,
            "end_logit": 3.2422502040863037
        },
        {
            "text": "myeloproliferative diseases (MPDs",
            "probability": 0.0023205175263180814,
            "start_logit": 6.45118522644043,
            "end_logit": -1.7643240690231323
        },
        {
            "text": "my",
            "probability": 0.001258801891436901,
            "start_logit": 6.45118522644043,
            "end_logit": -2.3759539127349854
        },
        {
            "text": "c-Cbl mutations.",
            "probability": 0.0002644061880784955,
            "start_logit": 1.7192541360855103,
            "end_logit": 0.7955480217933655
        },
        {
            "text": "myeloproliferative diseases (MPDs) involving c",
            "probability": 0.00015542264036960752,
            "start_logit": 6.45118522644043,
            "end_logit": -4.467721462249756
        },
        {
            "text": "leukemia",
            "probability": 0.00015042598708357938,
            "start_logit": 1.0064278841018677,
            "end_logit": 0.9443589448928833
        },
        {
            "text": "myeloproliferative diseases (MPDs) involving c-Cbl mutations. These mutations",
            "probability": 0.00014568837548414472,
            "start_logit": 6.45118522644043,
            "end_logit": -4.532399654388428
        },
        {
            "text": "MPDs) involving c-Cbl mutations",
            "probability": 0.0001300413382830612,
            "start_logit": -1.4370821714401245,
            "end_logit": 3.2422502040863037
        },
        {
            "text": "myelo",
            "probability": 0.00010585316800128941,
            "start_logit": 6.45118522644043,
            "end_logit": -4.851816654205322
        },
        {
            "text": "c-Cbl",
            "probability": 6.916604308093392e-05,
            "start_logit": 1.7192541360855103,
            "end_logit": -0.545428454875946
        },
        {
            "text": "mutations",
            "probability": 5.654623119894281e-05,
            "start_logit": -2.269876003265381,
            "end_logit": 3.2422502040863037
        },
        {
            "text": "",
            "probability": 5.408664947244664e-05,
            "start_logit": 1.2164174318313599,
            "end_logit": -0.2885144054889679
        },
        {
            "text": "involving c-Cbl mutations",
            "probability": 4.379144821688044e-05,
            "start_logit": -2.525496006011963,
            "end_logit": 3.2422502040863037
        },
        {
            "text": "diseases",
            "probability": 1.644505467479787e-05,
            "start_logit": -3.943397283554077,
            "end_logit": 3.6807377338409424
        }
    ],
    "5c701f4f7c78d69471000060_006": [
        {
            "text": "myeloproliferative diseases",
            "probability": 0.5374587620839787,
            "start_logit": 6.45118522644043,
            "end_logit": 3.6807377338409424
        },
        {
            "text": "myeloproliferative diseases (MPDs) involving c-Cbl mutations",
            "probability": 0.34666694473933807,
            "start_logit": 6.45118522644043,
            "end_logit": 3.2422502040863037
        },
        {
            "text": "myeloproliferative",
            "probability": 0.04592650376258113,
            "start_logit": 6.45118522644043,
            "end_logit": 1.2209280729293823
        },
        {
            "text": "myeloproliferative diseases (MPDs) involving c-Cbl mutations.",
            "probability": 0.030013951492401568,
            "start_logit": 6.45118522644043,
            "end_logit": 0.7955480217933655
        },
        {
            "text": "myeloproliferative diseases (MPDs)",
            "probability": 0.024257349980793198,
            "start_logit": 6.45118522644043,
            "end_logit": 0.5826053619384766
        },
        {
            "text": "myeloproliferative diseases (MPDs) involving c-Cbl",
            "probability": 0.007851352788067924,
            "start_logit": 6.45118522644043,
            "end_logit": -0.545428454875946
        },
        {
            "text": "c-Cbl mutations",
            "probability": 0.003053942611140423,
            "start_logit": 1.7192541360855103,
            "end_logit": 3.2422502040863037
        },
        {
            "text": "myeloproliferative diseases (MPDs",
            "probability": 0.0023205175263180814,
            "start_logit": 6.45118522644043,
            "end_logit": -1.7643240690231323
        },
        {
            "text": "my",
            "probability": 0.001258801891436901,
            "start_logit": 6.45118522644043,
            "end_logit": -2.3759539127349854
        },
        {
            "text": "c-Cbl mutations.",
            "probability": 0.0002644061880784955,
            "start_logit": 1.7192541360855103,
            "end_logit": 0.7955480217933655
        },
        {
            "text": "myeloproliferative diseases (MPDs) involving c",
            "probability": 0.00015542264036960752,
            "start_logit": 6.45118522644043,
            "end_logit": -4.467721462249756
        },
        {
            "text": "leukemia",
            "probability": 0.00015042598708357938,
            "start_logit": 1.0064278841018677,
            "end_logit": 0.9443589448928833
        },
        {
            "text": "myeloproliferative diseases (MPDs) involving c-Cbl mutations. These mutations",
            "probability": 0.00014568837548414472,
            "start_logit": 6.45118522644043,
            "end_logit": -4.532399654388428
        },
        {
            "text": "MPDs) involving c-Cbl mutations",
            "probability": 0.0001300413382830612,
            "start_logit": -1.4370821714401245,
            "end_logit": 3.2422502040863037
        },
        {
            "text": "myelo",
            "probability": 0.00010585316800128941,
            "start_logit": 6.45118522644043,
            "end_logit": -4.851816654205322
        },
        {
            "text": "c-Cbl",
            "probability": 6.916604308093392e-05,
            "start_logit": 1.7192541360855103,
            "end_logit": -0.545428454875946
        },
        {
            "text": "mutations",
            "probability": 5.654623119894281e-05,
            "start_logit": -2.269876003265381,
            "end_logit": 3.2422502040863037
        },
        {
            "text": "",
            "probability": 5.408664947244664e-05,
            "start_logit": 1.2164174318313599,
            "end_logit": -0.2885144054889679
        },
        {
            "text": "involving c-Cbl mutations",
            "probability": 4.379144821688044e-05,
            "start_logit": -2.525496006011963,
            "end_logit": 3.2422502040863037
        },
        {
            "text": "diseases",
            "probability": 1.644505467479787e-05,
            "start_logit": -3.943397283554077,
            "end_logit": 3.6807377338409424
        }
    ],
    "5c701f4f7c78d69471000060_007": [
        {
            "text": "",
            "probability": 0.8014550539943696,
            "start_logit": 4.558825969696045,
            "end_logit": 3.319749116897583
        },
        {
            "text": "Minimal residual disease",
            "probability": 0.1354141607113366,
            "start_logit": 4.017634391784668,
            "end_logit": 2.0828497409820557
        },
        {
            "text": "Minimal residual disease (mrd",
            "probability": 0.018621582409014806,
            "start_logit": 4.017634391784668,
            "end_logit": 0.09883305430412292
        },
        {
            "text": "Minimal residual disease (mrd)",
            "probability": 0.013873958221416714,
            "start_logit": 4.017634391784668,
            "end_logit": -0.19547462463378906
        },
        {
            "text": "Minimal residual disease (mrd) is a useful tool for predicting leukemia",
            "probability": 0.01282878406717285,
            "start_logit": 4.017634391784668,
            "end_logit": -0.27379679679870605
        },
        {
            "text": "Minimal residual disease (mrd) is a useful tool for predicting leukemia relapse",
            "probability": 0.010597983954035304,
            "start_logit": 4.017634391784668,
            "end_logit": -0.4648244082927704
        },
        {
            "text": "Minimal residual",
            "probability": 0.0024407686059038664,
            "start_logit": 4.017634391784668,
            "end_logit": -1.9331752061843872
        },
        {
            "text": "Minimal",
            "probability": 0.0015167495317946896,
            "start_logit": 4.017634391784668,
            "end_logit": -2.408918619155884
        },
        {
            "text": "Minimal residual disease (mrd) is a useful tool for predicting leukemia relapse.",
            "probability": 0.0012318412851437645,
            "start_logit": 4.017634391784668,
            "end_logit": -2.616978168487549
        },
        {
            "text": "leukemia",
            "probability": 0.0005624096284217141,
            "start_logit": 0.8904181718826294,
            "end_logit": -0.27379679679870605
        },
        {
            "text": "leukemia relapse",
            "probability": 0.00046461209311802,
            "start_logit": 0.8904181718826294,
            "end_logit": -0.4648244082927704
        },
        {
            "text": "mrd",
            "probability": 0.00015272912719868412,
            "start_logit": -0.7857761979103088,
            "end_logit": 0.09883305430412292
        },
        {
            "text": "lymphoblastic leukemia (all). Minimal residual disease",
            "probability": 0.00014170781707064636,
            "start_logit": -2.844691514968872,
            "end_logit": 2.0828497409820557
        },
        {
            "text": "acute lymphoblastic leukemia (all). Minimal residual disease",
            "probability": 0.00013265905586861142,
            "start_logit": -2.9106764793395996,
            "end_logit": 2.0828497409820557
        },
        {
            "text": "mrd)",
            "probability": 0.0001137904117601834,
            "start_logit": -0.7857761979103088,
            "end_logit": -0.19547462463378906
        },
        {
            "text": "mrd) is a useful tool for predicting leukemia",
            "probability": 0.00010521817913021039,
            "start_logit": -0.7857761979103088,
            "end_logit": -0.27379679679870605
        },
        {
            "text": "leukemia (all). Minimal residual disease",
            "probability": 9.704710861715583e-05,
            "start_logit": -3.223262310028076,
            "end_logit": 2.0828497409820557
        },
        {
            "text": "mrd) is a useful tool for predicting leukemia relapse",
            "probability": 8.692176657242021e-05,
            "start_logit": -0.7857761979103088,
            "end_logit": -0.4648244082927704
        },
        {
            "text": "Minimal residual disease (mr",
            "probability": 8.393988850891284e-05,
            "start_logit": 4.017634391784668,
            "end_logit": -5.303142547607422
        },
        {
            "text": "residual disease",
            "probability": 7.80821435453452e-05,
            "start_logit": -3.440697431564331,
            "end_logit": 2.0828497409820557
        }
    ],
    "5c701f4f7c78d69471000060_009": [
        {
            "text": "minimal residual disease",
            "probability": 0.9528715318541848,
            "start_logit": 6.806519031524658,
            "end_logit": 4.815798282623291
        },
        {
            "text": "minimal residual disease (MRD)",
            "probability": 0.03050672408632642,
            "start_logit": 6.806519031524658,
            "end_logit": 1.3742653131484985
        },
        {
            "text": "minimal residual disease (MRD",
            "probability": 0.011873211712516138,
            "start_logit": 6.806519031524658,
            "end_logit": 0.43060293793678284
        },
        {
            "text": "minimal residual",
            "probability": 0.003136056625373382,
            "start_logit": 6.806519031524658,
            "end_logit": -0.9007156491279602
        },
        {
            "text": "minimal",
            "probability": 0.0012034895745440671,
            "start_logit": 6.806519031524658,
            "end_logit": -1.8584564924240112
        },
        {
            "text": "residual disease",
            "probability": 7.8475212240535e-05,
            "start_logit": -2.597933530807495,
            "end_logit": 4.815798282623291
        },
        {
            "text": "minimal residual disease (MRD)-based effect",
            "probability": 6.78387208378818e-05,
            "start_logit": 6.806519031524658,
            "end_logit": -4.734303951263428
        },
        {
            "text": "minimal residual disease (MRD)-based effect and long-term outcome of first-line incorporation of dasatinib",
            "probability": 6.630200622952885e-05,
            "start_logit": 6.806519031524658,
            "end_logit": -4.757216930389404
        },
        {
            "text": "minimal residual disease (MRD)-based effect and long-term outcome of first-line incorporation of dasatinib (100 mg once daily",
            "probability": 6.482872088442321e-05,
            "start_logit": 6.806519031524658,
            "end_logit": -4.779688358306885
        },
        {
            "text": "",
            "probability": 5.8542508646446695e-05,
            "start_logit": 1.8249709606170654,
            "end_logit": 0.09986411780118942
        },
        {
            "text": "disease",
            "probability": 3.081253612204969e-05,
            "start_logit": -3.532794713973999,
            "end_logit": 4.815798282623291
        },
        {
            "text": "lymphoblastic leukemia",
            "probability": 1.2824636262474336e-05,
            "start_logit": -0.30698174238204956,
            "end_logit": 0.713431715965271
        },
        {
            "text": "leukemia",
            "probability": 7.63980633708643e-06,
            "start_logit": -0.8249775171279907,
            "end_logit": 0.713431715965271
        },
        {
            "text": "disease progression.PATIENTS AND METHODS: We assessed the minimal residual disease",
            "probability": 5.81521427182428e-06,
            "start_logit": -5.2002387046813965,
            "end_logit": 4.815798282623291
        },
        {
            "text": "acute lymphoblastic leukemia",
            "probability": 4.54068637280954e-06,
            "start_logit": -1.3452715873718262,
            "end_logit": 0.713431715965271
        },
        {
            "text": "Philadelphia chromosome-positive acute lymphoblastic leukemia",
            "probability": 2.8311355240045155e-06,
            "start_logit": -1.8176718950271606,
            "end_logit": 0.713431715965271
        },
        {
            "text": "residual disease (MRD)",
            "probability": 2.5124285566380603e-06,
            "start_logit": -2.597933530807495,
            "end_logit": 1.3742653131484985
        },
        {
            "text": "adults with Ph-positive ALL",
            "probability": 2.0549998822069666e-06,
            "start_logit": -2.1095476150512695,
            "end_logit": 0.6849053502082825
        },
        {
            "text": "lymphoblastic leukemia (Ph-positive ALL)",
            "probability": 1.989510074677508e-06,
            "start_logit": -0.30698174238204956,
            "end_logit": -1.1500478982925415
        },
        {
            "text": "DFS in adults with Ph-positive ALL",
            "probability": 1.9780248122474532e-06,
            "start_logit": -2.1477246284484863,
            "end_logit": 0.6849053502082825
        }
    ],
    "5c701f4f7c78d69471000060_010": [
        {
            "text": "minimal residual disease",
            "probability": 0.9528715318541848,
            "start_logit": 6.806519031524658,
            "end_logit": 4.815798282623291
        },
        {
            "text": "minimal residual disease (MRD)",
            "probability": 0.03050672408632642,
            "start_logit": 6.806519031524658,
            "end_logit": 1.3742653131484985
        },
        {
            "text": "minimal residual disease (MRD",
            "probability": 0.011873211712516138,
            "start_logit": 6.806519031524658,
            "end_logit": 0.43060293793678284
        },
        {
            "text": "minimal residual",
            "probability": 0.003136056625373382,
            "start_logit": 6.806519031524658,
            "end_logit": -0.9007156491279602
        },
        {
            "text": "minimal",
            "probability": 0.0012034895745440671,
            "start_logit": 6.806519031524658,
            "end_logit": -1.8584564924240112
        },
        {
            "text": "residual disease",
            "probability": 7.8475212240535e-05,
            "start_logit": -2.597933530807495,
            "end_logit": 4.815798282623291
        },
        {
            "text": "minimal residual disease (MRD)-based effect",
            "probability": 6.78387208378818e-05,
            "start_logit": 6.806519031524658,
            "end_logit": -4.734303951263428
        },
        {
            "text": "minimal residual disease (MRD)-based effect and long-term outcome of first-line incorporation of dasatinib",
            "probability": 6.630200622952885e-05,
            "start_logit": 6.806519031524658,
            "end_logit": -4.757216930389404
        },
        {
            "text": "minimal residual disease (MRD)-based effect and long-term outcome of first-line incorporation of dasatinib (100 mg once daily",
            "probability": 6.482872088442321e-05,
            "start_logit": 6.806519031524658,
            "end_logit": -4.779688358306885
        },
        {
            "text": "",
            "probability": 5.8542508646446695e-05,
            "start_logit": 1.8249709606170654,
            "end_logit": 0.09986411780118942
        },
        {
            "text": "disease",
            "probability": 3.081253612204969e-05,
            "start_logit": -3.532794713973999,
            "end_logit": 4.815798282623291
        },
        {
            "text": "lymphoblastic leukemia",
            "probability": 1.2824636262474336e-05,
            "start_logit": -0.30698174238204956,
            "end_logit": 0.713431715965271
        },
        {
            "text": "leukemia",
            "probability": 7.63980633708643e-06,
            "start_logit": -0.8249775171279907,
            "end_logit": 0.713431715965271
        },
        {
            "text": "disease progression.PATIENTS AND METHODS: We assessed the minimal residual disease",
            "probability": 5.81521427182428e-06,
            "start_logit": -5.2002387046813965,
            "end_logit": 4.815798282623291
        },
        {
            "text": "acute lymphoblastic leukemia",
            "probability": 4.54068637280954e-06,
            "start_logit": -1.3452715873718262,
            "end_logit": 0.713431715965271
        },
        {
            "text": "Philadelphia chromosome-positive acute lymphoblastic leukemia",
            "probability": 2.8311355240045155e-06,
            "start_logit": -1.8176718950271606,
            "end_logit": 0.713431715965271
        },
        {
            "text": "residual disease (MRD)",
            "probability": 2.5124285566380603e-06,
            "start_logit": -2.597933530807495,
            "end_logit": 1.3742653131484985
        },
        {
            "text": "adults with Ph-positive ALL",
            "probability": 2.0549998822069666e-06,
            "start_logit": -2.1095476150512695,
            "end_logit": 0.6849053502082825
        },
        {
            "text": "lymphoblastic leukemia (Ph-positive ALL)",
            "probability": 1.989510074677508e-06,
            "start_logit": -0.30698174238204956,
            "end_logit": -1.1500478982925415
        },
        {
            "text": "DFS in adults with Ph-positive ALL",
            "probability": 1.9780248122474532e-06,
            "start_logit": -2.1477246284484863,
            "end_logit": 0.6849053502082825
        }
    ],
    "5c701f4f7c78d69471000060_012": [
        {
            "text": "chronic myeloid leukemia",
            "probability": 0.9724128572282872,
            "start_logit": 8.586502075195312,
            "end_logit": 8.265279769897461
        },
        {
            "text": "myeloid leukemia",
            "probability": 0.015881842384075202,
            "start_logit": 4.471898078918457,
            "end_logit": 8.265279769897461
        },
        {
            "text": "leukemia",
            "probability": 0.010075742155174356,
            "start_logit": 4.016852378845215,
            "end_logit": 8.265279769897461
        },
        {
            "text": "chronic myeloid leukemia (CML",
            "probability": 0.000871889228075673,
            "start_logit": 8.586502075195312,
            "end_logit": 1.2484064102172852
        },
        {
            "text": "chronic myeloid leukemia (CML)",
            "probability": 0.0004096400074068876,
            "start_logit": 8.586502075195312,
            "end_logit": 0.49302276968955994
        },
        {
            "text": "chronic",
            "probability": 0.00013507540007340338,
            "start_logit": 8.586502075195312,
            "end_logit": -0.6164228320121765
        },
        {
            "text": "chronic myeloid leukemia (CML) after dasatinib (Das) treatment was significantly associated with natural killer (NK",
            "probability": 6.660503237591158e-05,
            "start_logit": 8.586502075195312,
            "end_logit": -1.3234758377075195
        },
        {
            "text": "chronic myeloid",
            "probability": 5.4415925084829825e-05,
            "start_logit": 8.586502075195312,
            "end_logit": -1.5255991220474243
        },
        {
            "text": "chronic myeloid leukemia (CML) after dasatinib (Das) treatment was significantly associated with natural killer (NK)",
            "probability": 1.7508800458344596e-05,
            "start_logit": 8.586502075195312,
            "end_logit": -2.6595523357391357
        },
        {
            "text": "chronic my",
            "probability": 1.510272660412328e-05,
            "start_logit": 8.586502075195312,
            "end_logit": -2.8073806762695312
        },
        {
            "text": "myeloid leukemia (CML",
            "probability": 1.424004957743994e-05,
            "start_logit": 4.471898078918457,
            "end_logit": 1.2484064102172852
        },
        {
            "text": "leukemia (CML",
            "probability": 9.034157646788607e-06,
            "start_logit": 4.016852378845215,
            "end_logit": 1.2484064102172852
        },
        {
            "text": "chronic myeloid leukemia (CML) after dasatinib (Das) treatment was significantly associated with natural killer",
            "probability": 8.24423815543359e-06,
            "start_logit": 8.586502075195312,
            "end_logit": -3.4127414226531982
        },
        {
            "text": "myeloid leukemia (CML)",
            "probability": 6.690407251906845e-06,
            "start_logit": 4.471898078918457,
            "end_logit": 0.49302276968955994
        },
        {
            "text": "leukemia (CML)",
            "probability": 4.2445213063514075e-06,
            "start_logit": 4.016852378845215,
            "end_logit": 0.49302276968955994
        },
        {
            "text": "of chronic myeloid leukemia",
            "probability": 3.950647575954353e-06,
            "start_logit": -3.8271541595458984,
            "end_logit": 8.265279769897461
        },
        {
            "text": "chronic myeloid leukemia (CML) after dasatinib (Das) treatment was significantly associated with natural killer (NK) cell proliferation",
            "probability": 3.5321380308400086e-06,
            "start_logit": 8.586502075195312,
            "end_logit": -4.260352611541748
        },
        {
            "text": "treatment-free remission (TFR) of chronic myeloid leukemia",
            "probability": 2.842791606229284e-06,
            "start_logit": -4.156247138977051,
            "end_logit": 8.265279769897461
        },
        {
            "text": "chronic myeloid leukemia (CML) after dasatinib (Das",
            "probability": 2.776186395708035e-06,
            "start_logit": 8.586502075195312,
            "end_logit": -4.501177787780762
        },
        {
            "text": "chronic myelo",
            "probability": 2.1183118780561e-06,
            "start_logit": 8.586502075195312,
            "end_logit": -4.771636486053467
        },
        {
            "text": "",
            "probability": 1.6476629593839915e-06,
            "start_logit": 1.8982511758804321,
            "end_logit": 1.6653528213500977
        }
    ],
    "5c701f4f7c78d69471000060_014": [
        {
            "text": "",
            "probability": 0.9999959122108876,
            "start_logit": 6.869682312011719,
            "end_logit": 7.274585247039795
        },
        {
            "text": "chronic myeloid leukemia",
            "probability": 1.8310362682092584e-06,
            "start_logit": 0.298176646232605,
            "end_logit": 0.6354665160179138
        },
        {
            "text": "chronic phase chronic myeloid leukemia",
            "probability": 8.215556494056965e-07,
            "start_logit": -0.5032610297203064,
            "end_logit": 0.6354665160179138
        },
        {
            "text": "leukemia",
            "probability": 3.5068693191788425e-07,
            "start_logit": -1.3545668125152588,
            "end_logit": 0.6354665160179138
        },
        {
            "text": "mixed connective tissue disease",
            "probability": 3.4896937568649034e-07,
            "start_logit": -0.4133964776992798,
            "end_logit": -0.3106135427951813
        },
        {
            "text": "myeloid leukemia",
            "probability": 3.476956036498367e-07,
            "start_logit": -1.3631333112716675,
            "end_logit": 0.6354665160179138
        },
        {
            "text": "connective tissue disease",
            "probability": 1.3980621934161358e-07,
            "start_logit": -1.3281233310699463,
            "end_logit": -0.3106135427951813
        },
        {
            "text": "autoimmune diseases",
            "probability": 1.089046271355189e-07,
            "start_logit": -0.8822550773620605,
            "end_logit": -1.0062665939331055
        },
        {
            "text": "mixed connective tissue disease (MCTD",
            "probability": 3.881806583463649e-08,
            "start_logit": -0.4133964776992798,
            "end_logit": -2.506711959838867
        },
        {
            "text": "chronic myeloid leukemia. Nilotinib",
            "probability": 1.9403827670158837e-08,
            "start_logit": 0.298176646232605,
            "end_logit": -3.911700487136841
        },
        {
            "text": "mixed connective tissue disease (MCTD)",
            "probability": 1.7438905324993993e-08,
            "start_logit": -0.4133964776992798,
            "end_logit": -3.306894063949585
        },
        {
            "text": "connective tissue disease (MCTD",
            "probability": 1.5551528026831616e-08,
            "start_logit": -1.3281233310699463,
            "end_logit": -2.506711959838867
        },
        {
            "text": "chronic phase chronic myeloid leukemia. Nilotinib",
            "probability": 8.706176125120711e-09,
            "start_logit": -0.5032610297203064,
            "end_logit": -3.911700487136841
        },
        {
            "text": "connective tissue disease (MCTD)",
            "probability": 6.9864795962327436e-09,
            "start_logit": -1.3281233310699463,
            "end_logit": -3.306894063949585
        },
        {
            "text": "mixed connective tissue",
            "probability": 6.637059358156563e-09,
            "start_logit": -0.4133964776992798,
            "end_logit": -4.272928714752197
        },
        {
            "text": "chronic myeloid",
            "probability": 6.2200571188827165e-09,
            "start_logit": 0.298176646232605,
            "end_logit": -5.049391746520996
        },
        {
            "text": "chronic myeloid leukemia.",
            "probability": 5.577559009903305e-09,
            "start_logit": 0.298176646232605,
            "end_logit": -5.158419609069824
        },
        {
            "text": "autoimmune",
            "probability": 5.37226973221423e-09,
            "start_logit": -0.8822550773620605,
            "end_logit": -4.015488624572754
        },
        {
            "text": "MCTD",
            "probability": 4.240682559590827e-09,
            "start_logit": -2.6275579929351807,
            "end_logit": -2.506711959838867
        },
        {
            "text": "chronic",
            "probability": 4.181827113083231e-09,
            "start_logit": 0.298176646232605,
            "end_logit": -5.446422576904297
        }
    ],
    "5e2b3784fbd6abf43b000009_001": [
        {
            "text": "implicated in late embryonic and postnatal mouse development",
            "probability": 0.16067070413722356,
            "start_logit": 0.656754195690155,
            "end_logit": 1.9261349439620972
        },
        {
            "text": "has been implicated in late embryonic and postnatal mouse development",
            "probability": 0.15034459542067946,
            "start_logit": 0.5903272032737732,
            "end_logit": 1.9261349439620972
        },
        {
            "text": "unknown role of GRG5 in early developmental stages",
            "probability": 0.08496481116680807,
            "start_logit": 0.9881101846694946,
            "end_logit": 0.9576591849327087
        },
        {
            "text": "implicated",
            "probability": 0.064267299196057,
            "start_logit": 0.656754195690155,
            "end_logit": 1.0098289251327515
        },
        {
            "text": "implicated in late embryonic and postnatal mouse development. Here, we describe a previously unknown role of GRG5 in early developmental stages",
            "probability": 0.061000447213918854,
            "start_logit": 0.656754195690155,
            "end_logit": 0.9576591849327087
        },
        {
            "text": "has been implicated",
            "probability": 0.06013691885086125,
            "start_logit": 0.5903272032737732,
            "end_logit": 1.0098289251327515
        },
        {
            "text": "has been implicated in late embryonic and postnatal mouse development. Here, we describe a previously unknown role of GRG5 in early developmental stages",
            "probability": 0.05708002343118147,
            "start_logit": 0.5903272032737732,
            "end_logit": 0.9576591849327087
        },
        {
            "text": "unknown role",
            "probability": 0.05129617333841297,
            "start_logit": 0.9881101846694946,
            "end_logit": 0.45303815603256226
        },
        {
            "text": "implicated in late embryonic and postnatal mouse development. Here, we describe a previously unknown role",
            "probability": 0.03682806412483722,
            "start_logit": 0.656754195690155,
            "end_logit": 0.45303815603256226
        },
        {
            "text": "has been implicated in late embryonic and postnatal mouse development. Here, we describe a previously unknown role",
            "probability": 0.034461169699278885,
            "start_logit": 0.5903272032737732,
            "end_logit": 0.45303815603256226
        },
        {
            "text": "implicated in late embryonic and postnatal mouse development.",
            "probability": 0.0305841729546893,
            "start_logit": 0.656754195690155,
            "end_logit": 0.2672606408596039
        },
        {
            "text": "GRG5) is a multifunctional protein that has been implicated in late embryonic and postnatal mouse development",
            "probability": 0.029384551290658197,
            "start_logit": -1.0421336889266968,
            "end_logit": 1.9261349439620972
        },
        {
            "text": "has been implicated in late embryonic and postnatal mouse development.",
            "probability": 0.028618565741902198,
            "start_logit": 0.5903272032737732,
            "end_logit": 0.2672606408596039
        },
        {
            "text": "unknown",
            "probability": 0.025886615684823727,
            "start_logit": 0.9881101846694946,
            "end_logit": -0.2308519333600998
        },
        {
            "text": "previously unknown role of GRG5 in early developmental stages",
            "probability": 0.02526894274268471,
            "start_logit": -0.22455091774463654,
            "end_logit": 0.9576591849327087
        },
        {
            "text": "unknown role of GRG5 in early developmental stages by analyzing its function in stem cell fate decisions",
            "probability": 0.023961029774049052,
            "start_logit": 0.9881101846694946,
            "end_logit": -0.3081492483615875
        },
        {
            "text": "a previously unknown role of GRG5 in early developmental stages",
            "probability": 0.01953348020932514,
            "start_logit": -0.4819970726966858,
            "end_logit": 0.9576591849327087
        },
        {
            "text": "been implicated in late embryonic and postnatal mouse development",
            "probability": 0.0188925633858941,
            "start_logit": -1.4838343858718872,
            "end_logit": 1.9261349439620972
        },
        {
            "text": "implicated in late embryonic and postnatal mouse development. Here, we describe a previously unknown",
            "probability": 0.01858528385979601,
            "start_logit": 0.656754195690155,
            "end_logit": -0.2308519333600998
        },
        {
            "text": "has been implicated in late embryonic and postnatal mouse development. Here, we describe a previously unknown",
            "probability": 0.01739083050444021,
            "start_logit": 0.5903272032737732,
            "end_logit": -0.2308519333600998
        },
        {
            "text": "",
            "probability": 0.0008437572724784057,
            "start_logit": -1.3976308107376099,
            "end_logit": -1.268727421760559
        }
    ],
    "5e29fb27aa19d74431000005_001": [
        {
            "text": "hyperphosphorylation",
            "probability": 0.36727995003622993,
            "start_logit": 6.39572286605835,
            "end_logit": 9.259429931640625
        },
        {
            "text": "constitutive hyperphosphorylation",
            "probability": 0.3265833155255679,
            "start_logit": 6.278283596038818,
            "end_logit": 9.259429931640625
        },
        {
            "text": "induced constitutive hyperphosphorylation",
            "probability": 0.30260284080953537,
            "start_logit": 6.202019691467285,
            "end_logit": 9.259429931640625
        },
        {
            "text": "hyperphosphorylation of DDR proteins",
            "probability": 0.0010598788333947712,
            "start_logit": 6.39572286605835,
            "end_logit": 3.4114601612091064
        },
        {
            "text": "constitutive hyperphosphorylation of DDR proteins",
            "probability": 0.0009424384408440779,
            "start_logit": 6.278283596038818,
            "end_logit": 3.4114601612091064
        },
        {
            "text": "induced constitutive hyperphosphorylation of DDR proteins",
            "probability": 0.0008732367390801396,
            "start_logit": 6.202019691467285,
            "end_logit": 3.4114601612091064
        },
        {
            "text": "mitotic entry (p-histone H3). LB100 also induced constitutive hyperphosphorylation",
            "probability": 0.00016993448241727667,
            "start_logit": -1.2827438116073608,
            "end_logit": 9.259429931640625
        },
        {
            "text": "LB100 also induced constitutive hyperphosphorylation",
            "probability": 0.000138397904155475,
            "start_logit": -1.4880238771438599,
            "end_logit": 9.259429931640625
        },
        {
            "text": "hyperphosphorylation of DDR",
            "probability": 6.518710183430368e-05,
            "start_logit": 6.39572286605835,
            "end_logit": 0.6228119134902954
        },
        {
            "text": "constitutive hyperphosphorylation of DDR",
            "probability": 5.796401313071866e-05,
            "start_logit": 6.278283596038818,
            "end_logit": 0.6228119134902954
        },
        {
            "text": "increased mitotic entry (p-histone H3). LB100 also induced constitutive hyperphosphorylation",
            "probability": 5.7909816899476026e-05,
            "start_logit": -2.359269857406616,
            "end_logit": 9.259429931640625
        },
        {
            "text": "induced constitutive hyperphosphorylation of DDR",
            "probability": 5.370781115945735e-05,
            "start_logit": 6.202019691467285,
            "end_logit": 0.6228119134902954
        },
        {
            "text": "hyperphosphorylation of",
            "probability": 1.7623091137617788e-05,
            "start_logit": 6.39572286605835,
            "end_logit": -0.6852396726608276
        },
        {
            "text": "constitutive hyperphosphorylation of",
            "probability": 1.56703559041672e-05,
            "start_logit": 6.278283596038818,
            "end_logit": -0.6852396726608276
        },
        {
            "text": "constitutive",
            "probability": 1.5511611379402844e-05,
            "start_logit": 6.278283596038818,
            "end_logit": -0.695421576499939
        },
        {
            "text": "induced constitutive hyperphosphorylation of",
            "probability": 1.4519707491689761e-05,
            "start_logit": 6.202019691467285,
            "end_logit": -0.6852396726608276
        },
        {
            "text": "induced constitutive",
            "probability": 1.4372619315800102e-05,
            "start_logit": 6.202019691467285,
            "end_logit": -0.695421576499939
        },
        {
            "text": "hyperphosphorylation of DDR proteins (BRCA1, Chk2, and \u03b3H2AX",
            "probability": 1.2133466023662472e-05,
            "start_logit": 6.39572286605835,
            "end_logit": -1.05848228931427
        },
        {
            "text": "constitutive hyperphosphorylation of DDR proteins (BRCA1, Chk2, and \u03b3H2AX",
            "probability": 1.0789011386092904e-05,
            "start_logit": 6.278283596038818,
            "end_logit": -1.05848228931427
        },
        {
            "text": "induced constitutive hyperphosphorylation of DDR proteins (BRCA1, Chk2, and \u03b3H2AX",
            "probability": 9.996792058112776e-06,
            "start_logit": 6.202019691467285,
            "end_logit": -1.05848228931427
        },
        {
            "text": "",
            "probability": 4.6218310548980435e-06,
            "start_logit": 1.5869789123535156,
            "end_logit": 2.7850852012634277
        }
    ],
    "5e480909d14c9f295d000003_001": [
        {
            "text": "evidence for excess cardiovascular disease or cancer mortality",
            "probability": 0.18966905604042306,
            "start_logit": 1.3971927165985107,
            "end_logit": 1.661086916923523
        },
        {
            "text": "evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.1507215937223438,
            "start_logit": 1.3971927165985107,
            "end_logit": 1.4312405586242676
        },
        {
            "text": "excess cardiovascular disease or cancer mortality",
            "probability": 0.08105659079453305,
            "start_logit": 0.5470595359802246,
            "end_logit": 1.661086916923523
        },
        {
            "text": "whether there is evidence for excess cardiovascular disease or cancer mortality",
            "probability": 0.07841071978623115,
            "start_logit": 0.5138726234436035,
            "end_logit": 1.661086916923523
        },
        {
            "text": "excess cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.0644120807120385,
            "start_logit": 0.5470595359802246,
            "end_logit": 1.4312405586242676
        },
        {
            "text": "whether there is evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.06230952427252095,
            "start_logit": 0.5138726234436035,
            "end_logit": 1.4312405586242676
        },
        {
            "text": "there is evidence for excess cardiovascular disease or cancer mortality",
            "probability": 0.05790630125372862,
            "start_logit": 0.2107381820678711,
            "end_logit": 1.661086916923523
        },
        {
            "text": "evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts and if a correlation exists between space radiation exposure and mortality.",
            "probability": 0.0545173762274213,
            "start_logit": 1.3971927165985107,
            "end_logit": 0.41432565450668335
        },
        {
            "text": "early NASA astronauts",
            "probability": 0.05247735362314137,
            "start_logit": 0.3421400487422943,
            "end_logit": 1.4312405586242676
        },
        {
            "text": "there is evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.04601557151034718,
            "start_logit": 0.2107381820678711,
            "end_logit": 1.4312405586242676
        },
        {
            "text": "excess cardiovascular disease or cancer mortality in early NASA astronauts and if a correlation exists between space radiation exposure and mortality.",
            "probability": 0.023298437543317025,
            "start_logit": 0.5470595359802246,
            "end_logit": 0.41432565450668335
        },
        {
            "text": "whether there is evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts and if a correlation exists between space radiation exposure and mortality.",
            "probability": 0.022537923687129126,
            "start_logit": 0.5138726234436035,
            "end_logit": 0.41432565450668335
        },
        {
            "text": "early NASA astronauts and if a correlation exists between space radiation exposure and mortality.",
            "probability": 0.018981537815759633,
            "start_logit": 0.3421400487422943,
            "end_logit": 0.41432565450668335
        },
        {
            "text": "We evaluated whether there is evidence for excess cardiovascular disease or cancer mortality",
            "probability": 0.018753934638983873,
            "start_logit": -0.9166844487190247,
            "end_logit": 1.661086916923523
        },
        {
            "text": "there is evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts and if a correlation exists between space radiation exposure and mortality.",
            "probability": 0.016644252242786036,
            "start_logit": 0.2107381820678711,
            "end_logit": 0.41432565450668335
        },
        {
            "text": "NASA astronauts",
            "probability": 0.016458154462436373,
            "start_logit": -0.8174206018447876,
            "end_logit": 1.4312405586242676
        },
        {
            "text": "We evaluated whether there is evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.014902920784030773,
            "start_logit": -0.9166844487190247,
            "end_logit": 1.4312405586242676
        },
        {
            "text": "evidence for excess cardiovascular disease",
            "probability": 0.014635983565370886,
            "start_logit": 1.3971927165985107,
            "end_logit": -0.9007107019424438
        },
        {
            "text": "cancer mortality",
            "probability": 0.007882692161215699,
            "start_logit": -1.7834185361862183,
            "end_logit": 1.661086916923523
        },
        {
            "text": "cardiovascular disease or cancer mortality",
            "probability": 0.00736841773303104,
            "start_logit": -1.850885033607483,
            "end_logit": 1.661086916923523
        },
        {
            "text": "",
            "probability": 0.00103957742321061,
            "start_logit": -1.0665919780731201,
            "end_logit": -1.0815948247909546
        }
    ],
    "5e480909d14c9f295d000003_002": [
        {
            "text": "evidence for excess cardiovascular disease or cancer mortality",
            "probability": 0.18966905604042306,
            "start_logit": 1.3971927165985107,
            "end_logit": 1.661086916923523
        },
        {
            "text": "evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.1507215937223438,
            "start_logit": 1.3971927165985107,
            "end_logit": 1.4312405586242676
        },
        {
            "text": "excess cardiovascular disease or cancer mortality",
            "probability": 0.08105659079453305,
            "start_logit": 0.5470595359802246,
            "end_logit": 1.661086916923523
        },
        {
            "text": "whether there is evidence for excess cardiovascular disease or cancer mortality",
            "probability": 0.07841071978623115,
            "start_logit": 0.5138726234436035,
            "end_logit": 1.661086916923523
        },
        {
            "text": "excess cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.0644120807120385,
            "start_logit": 0.5470595359802246,
            "end_logit": 1.4312405586242676
        },
        {
            "text": "whether there is evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.06230952427252095,
            "start_logit": 0.5138726234436035,
            "end_logit": 1.4312405586242676
        },
        {
            "text": "there is evidence for excess cardiovascular disease or cancer mortality",
            "probability": 0.05790630125372862,
            "start_logit": 0.2107381820678711,
            "end_logit": 1.661086916923523
        },
        {
            "text": "evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts and if a correlation exists between space radiation exposure and mortality.",
            "probability": 0.0545173762274213,
            "start_logit": 1.3971927165985107,
            "end_logit": 0.41432565450668335
        },
        {
            "text": "early NASA astronauts",
            "probability": 0.05247735362314137,
            "start_logit": 0.3421400487422943,
            "end_logit": 1.4312405586242676
        },
        {
            "text": "there is evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.04601557151034718,
            "start_logit": 0.2107381820678711,
            "end_logit": 1.4312405586242676
        },
        {
            "text": "excess cardiovascular disease or cancer mortality in early NASA astronauts and if a correlation exists between space radiation exposure and mortality.",
            "probability": 0.023298437543317025,
            "start_logit": 0.5470595359802246,
            "end_logit": 0.41432565450668335
        },
        {
            "text": "whether there is evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts and if a correlation exists between space radiation exposure and mortality.",
            "probability": 0.022537923687129126,
            "start_logit": 0.5138726234436035,
            "end_logit": 0.41432565450668335
        },
        {
            "text": "early NASA astronauts and if a correlation exists between space radiation exposure and mortality.",
            "probability": 0.018981537815759633,
            "start_logit": 0.3421400487422943,
            "end_logit": 0.41432565450668335
        },
        {
            "text": "We evaluated whether there is evidence for excess cardiovascular disease or cancer mortality",
            "probability": 0.018753934638983873,
            "start_logit": -0.9166844487190247,
            "end_logit": 1.661086916923523
        },
        {
            "text": "there is evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts and if a correlation exists between space radiation exposure and mortality.",
            "probability": 0.016644252242786036,
            "start_logit": 0.2107381820678711,
            "end_logit": 0.41432565450668335
        },
        {
            "text": "NASA astronauts",
            "probability": 0.016458154462436373,
            "start_logit": -0.8174206018447876,
            "end_logit": 1.4312405586242676
        },
        {
            "text": "We evaluated whether there is evidence for excess cardiovascular disease or cancer mortality in early NASA astronauts",
            "probability": 0.014902920784030773,
            "start_logit": -0.9166844487190247,
            "end_logit": 1.4312405586242676
        },
        {
            "text": "evidence for excess cardiovascular disease",
            "probability": 0.014635983565370886,
            "start_logit": 1.3971927165985107,
            "end_logit": -0.9007107019424438
        },
        {
            "text": "cancer mortality",
            "probability": 0.007882692161215699,
            "start_logit": -1.7834185361862183,
            "end_logit": 1.661086916923523
        },
        {
            "text": "cardiovascular disease or cancer mortality",
            "probability": 0.00736841773303104,
            "start_logit": -1.850885033607483,
            "end_logit": 1.661086916923523
        },
        {
            "text": "",
            "probability": 0.00103957742321061,
            "start_logit": -1.0665919780731201,
            "end_logit": -1.0815948247909546
        }
    ],
    "5e480909d14c9f295d000003_003": [
        {
            "text": "",
            "probability": 0.44164086821855775,
            "start_logit": 1.166947364807129,
            "end_logit": 1.4250986576080322
        },
        {
            "text": "There is a disparity",
            "probability": 0.09949751243972167,
            "start_logit": 1.1275582313537598,
            "end_logit": -0.0258766021579504
        },
        {
            "text": "There is a disparity between research results and observed empirical effects seen in human astronaut crews",
            "probability": 0.0680832863365355,
            "start_logit": 1.1275582313537598,
            "end_logit": -0.4052774906158447
        },
        {
            "text": "There is a disparity between research results and observed empirical effects",
            "probability": 0.05653359145572651,
            "start_logit": 1.1275582313537598,
            "end_logit": -0.5911742448806763
        },
        {
            "text": "remains limited.",
            "probability": 0.053445796673406556,
            "start_logit": -0.8840621709823608,
            "end_logit": 1.3642791509628296
        },
        {
            "text": "There is a disparity between research results and observed empirical effects seen in human astronaut crews,",
            "probability": 0.046254518448826214,
            "start_logit": 1.1275582313537598,
            "end_logit": -0.7918500900268555
        },
        {
            "text": "disparity",
            "probability": 0.03504536215601518,
            "start_logit": 0.08406887203454971,
            "end_logit": -0.0258766021579504
        },
        {
            "text": "disparity between research results and observed empirical effects seen in human astronaut crews",
            "probability": 0.02398053346189005,
            "start_logit": 0.08406887203454971,
            "end_logit": -0.4052774906158447
        },
        {
            "text": "research results and observed empirical effects seen in human astronaut crews",
            "probability": 0.02245174736409303,
            "start_logit": 0.01819492131471634,
            "end_logit": -0.4052774906158447
        },
        {
            "text": "disparity between research results and observed empirical effects",
            "probability": 0.019912459497381213,
            "start_logit": 0.08406887203454971,
            "end_logit": -0.5911742448806763
        },
        {
            "text": "research results and observed empirical effects",
            "probability": 0.018643017710320016,
            "start_logit": 0.01819492131471634,
            "end_logit": -0.5911742448806763
        },
        {
            "text": "There is a disparity between research results",
            "probability": 0.016519521445469275,
            "start_logit": 1.1275582313537598,
            "end_logit": -1.8214664459228516
        },
        {
            "text": "disparity between research results and observed empirical effects seen in human astronaut crews,",
            "probability": 0.01629192841753959,
            "start_logit": 0.08406887203454971,
            "end_logit": -0.7918500900268555
        },
        {
            "text": "limited.",
            "probability": 0.01571864622544425,
            "start_logit": -2.107882499694824,
            "end_logit": 1.3642791509628296
        },
        {
            "text": "research results and observed empirical effects seen in human astronaut crews,",
            "probability": 0.015253299576750009,
            "start_logit": 0.01819492131471634,
            "end_logit": -0.7918500900268555
        },
        {
            "text": "remains limited. There is a disparity",
            "probability": 0.013309954859252456,
            "start_logit": -0.8840621709823608,
            "end_logit": -0.0258766021579504
        },
        {
            "text": "There is a disparity between research results and observed empirical effects seen",
            "probability": 0.009957291075147782,
            "start_logit": 1.1275582313537598,
            "end_logit": -2.3277041912078857
        },
        {
            "text": "remains limited",
            "probability": 0.009520475930005304,
            "start_logit": -0.8840621709823608,
            "end_logit": -0.360944002866745
        },
        {
            "text": "remains limited. There is a disparity between research results and observed empirical effects seen in human astronaut crews",
            "probability": 0.009107619332270634,
            "start_logit": -0.8840621709823608,
            "end_logit": -0.4052774906158447
        },
        {
            "text": "Despite years of research, understanding of the space radiation environment and the risk it poses to long-duration astronauts remains limited.",
            "probability": 0.0088325693756471,
            "start_logit": -2.684284210205078,
            "end_logit": 1.3642791509628296
        }
    ],
    "5e2905da8b3851296d000009_001": [
        {
            "text": "an APOC3 antisense oligonucleotide",
            "probability": 0.61176576096355,
            "start_logit": 2.6652297973632812,
            "end_logit": 4.391825199127197
        },
        {
            "text": "APOC3 antisense oligonucleotide",
            "probability": 0.3447663538187554,
            "start_logit": 2.091747283935547,
            "end_logit": 4.391825199127197
        },
        {
            "text": "antisense oligonucleotide",
            "probability": 0.02468251932314586,
            "start_logit": -0.5450243949890137,
            "end_logit": 4.391825199127197
        },
        {
            "text": "Volanesorsen, an APOC3 antisense oligonucleotide",
            "probability": 0.0044938344901119046,
            "start_logit": -2.248413324356079,
            "end_logit": 4.391825199127197
        },
        {
            "text": "an APOC3 antisense oligonucleotide, report very promising lipid-lowering",
            "probability": 0.0022693990132449616,
            "start_logit": 2.6652297973632812,
            "end_logit": -1.2050092220306396
        },
        {
            "text": "an APOC3",
            "probability": 0.002093351494125778,
            "start_logit": 2.6652297973632812,
            "end_logit": -1.2857578992843628
        },
        {
            "text": "Clinical trials with Volanesorsen, an APOC3 antisense oligonucleotide",
            "probability": 0.002049431122359972,
            "start_logit": -3.033557415008545,
            "end_logit": 4.391825199127197
        },
        {
            "text": "APOC3 antisense oligonucleotide, report very promising lipid-lowering",
            "probability": 0.0012789411782771613,
            "start_logit": 2.091747283935547,
            "end_logit": -1.2050092220306396
        },
        {
            "text": "APOC3",
            "probability": 0.0011797279415475318,
            "start_logit": 2.091747283935547,
            "end_logit": -1.2857578992843628
        },
        {
            "text": "oligonucleotide",
            "probability": 0.001097668451270494,
            "start_logit": -3.657931327819824,
            "end_logit": 4.391825199127197
        },
        {
            "text": "an APOC3 antisense oligonucleotide, report very promising lipid-lowering outcomes",
            "probability": 0.000994677033860615,
            "start_logit": 2.6652297973632812,
            "end_logit": -2.0298614501953125
        },
        {
            "text": "an APOC3 antisense oligonucleotide, report very promising lipid-lowering outcomes.",
            "probability": 0.0006549650700945439,
            "start_logit": 2.6652297973632812,
            "end_logit": -2.447697639465332
        },
        {
            "text": "APOC3 antisense oligonucleotide, report very promising lipid-lowering outcomes",
            "probability": 0.0005605596064272243,
            "start_logit": 2.091747283935547,
            "end_logit": -2.0298614501953125
        },
        {
            "text": "APOC3 antisense oligonucleotide,",
            "probability": 0.0004829384249279929,
            "start_logit": -4.478985786437988,
            "end_logit": 4.391825199127197
        },
        {
            "text": "oligonucleotide,",
            "probability": 0.0004495389236490587,
            "start_logit": -4.550652503967285,
            "end_logit": 4.391825199127197
        },
        {
            "text": "APOC3 antisense oligonucleotide, report very promising lipid-lowering outcomes.",
            "probability": 0.0003691117311624041,
            "start_logit": 2.091747283935547,
            "end_logit": -2.447697639465332
        },
        {
            "text": "Volanesorsen, an APOC3 antisense oligonucleotide,",
            "probability": 0.0003391688243685083,
            "start_logit": -4.832376956939697,
            "end_logit": 4.391825199127197
        },
        {
            "text": "an APOC3 antisense",
            "probability": 0.00019707400307075097,
            "start_logit": 2.6652297973632812,
            "end_logit": -3.64870023727417
        },
        {
            "text": "an",
            "probability": 0.0001517579188806113,
            "start_logit": 2.6652297973632812,
            "end_logit": -3.9099929332733154
        },
        {
            "text": "APOC3 antisense",
            "probability": 0.00011106290970608481,
            "start_logit": 2.091747283935547,
            "end_logit": -3.64870023727417
        },
        {
            "text": "",
            "probability": 1.2157757463368283e-05,
            "start_logit": -2.415499448776245,
            "end_logit": -1.3535828590393066
        }
    ],
    "5e2905da8b3851296d000009_003": [
        {
            "text": "an investigational inhibitor of apoC-III synthesis",
            "probability": 0.48447950689220537,
            "start_logit": 2.5291433334350586,
            "end_logit": 5.01122522354126
        },
        {
            "text": "inhibitor of apoC-III synthesis",
            "probability": 0.28294300892498925,
            "start_logit": 1.9913136959075928,
            "end_logit": 5.01122522354126
        },
        {
            "text": "investigational inhibitor of apoC-III synthesis",
            "probability": 0.15680314869527817,
            "start_logit": 1.4010593891143799,
            "end_logit": 5.01122522354126
        },
        {
            "text": "apoC-III synthesis",
            "probability": 0.043850718621268006,
            "start_logit": 0.12685930728912354,
            "end_logit": 5.01122522354126
        },
        {
            "text": "Volanesorsen, an investigational inhibitor of apoC-III synthesis",
            "probability": 0.010458563460057788,
            "start_logit": -1.3065106868743896,
            "end_logit": 5.01122522354126
        },
        {
            "text": "an investigational inhibitor of apoC-III synthesis,",
            "probability": 0.00484368758835045,
            "start_logit": 2.5291433334350586,
            "end_logit": 0.4058264195919037
        },
        {
            "text": "inhibitor of apoC-III synthesis,",
            "probability": 0.002828783304647453,
            "start_logit": 1.9913136959075928,
            "end_logit": 0.4058264195919037
        },
        {
            "text": "BACKGROUND: Volanesorsen, an investigational inhibitor of apoC-III synthesis",
            "probability": 0.002231663324833009,
            "start_logit": -2.851184606552124,
            "end_logit": 5.01122522354126
        },
        {
            "text": "an investigational inhibitor of apoC-III",
            "probability": 0.002103124802175509,
            "start_logit": 2.5291433334350586,
            "end_logit": -0.428425669670105
        },
        {
            "text": "investigational inhibitor of apoC-III synthesis,",
            "probability": 0.001567673047765415,
            "start_logit": 1.4010593891143799,
            "end_logit": 0.4058264195919037
        },
        {
            "text": "an investigational inhibitor",
            "probability": 0.0012419028588434601,
            "start_logit": 2.5291433334350586,
            "end_logit": -0.9552051424980164
        },
        {
            "text": "inhibitor of apoC-III",
            "probability": 0.0012282551711825253,
            "start_logit": 1.9913136959075928,
            "end_logit": -0.428425669670105
        },
        {
            "text": "an investigational inhibitor of apoC-III synthesis, significantly reduced triglyceride levels",
            "probability": 0.0011944264723218957,
            "start_logit": 2.5291433334350586,
            "end_logit": -0.9941837787628174
        },
        {
            "text": "synthesis",
            "probability": 0.0008835631908292777,
            "start_logit": -3.777724266052246,
            "end_logit": 5.01122522354126
        },
        {
            "text": "inhibitor",
            "probability": 0.0007252891539783892,
            "start_logit": 1.9913136959075928,
            "end_logit": -0.9552051424980164
        },
        {
            "text": "inhibitor of apoC-III synthesis, significantly reduced triglyceride levels",
            "probability": 0.0006975622605511177,
            "start_logit": 1.9913136959075928,
            "end_logit": -0.9941837787628174
        },
        {
            "text": "investigational inhibitor of apoC-III",
            "probability": 0.0006806822298752621,
            "start_logit": 1.4010593891143799,
            "end_logit": -0.428425669670105
        },
        {
            "text": "apoC-III synthesis,",
            "probability": 0.00043840694705244104,
            "start_logit": 0.12685930728912354,
            "end_logit": 0.4058264195919037
        },
        {
            "text": "investigational inhibitor",
            "probability": 0.00040194533694414795,
            "start_logit": 1.4010593891143799,
            "end_logit": -0.9552051424980164
        },
        {
            "text": "investigational inhibitor of apoC-III synthesis, significantly reduced triglyceride levels",
            "probability": 0.0003865794715373543,
            "start_logit": 1.4010593891143799,
            "end_logit": -0.9941837787628174
        },
        {
            "text": "",
            "probability": 1.1508245313701404e-05,
            "start_logit": -2.406543731689453,
            "end_logit": -0.7008543610572815
        }
    ],
    "5e2905da8b3851296d000009_004": [
        {
            "text": "New apo C-III antisense oligonucleotide drug",
            "probability": 0.6957388460495678,
            "start_logit": 0.8675701022148132,
            "end_logit": 3.8183131217956543
        },
        {
            "text": "reducing levels of apo C-III mRNA",
            "probability": 0.1145695441701712,
            "start_logit": 0.9704363942146301,
            "end_logit": 1.9116544723510742
        },
        {
            "text": "antisense oligonucleotide drug",
            "probability": 0.047115458474398006,
            "start_logit": -1.824803113937378,
            "end_logit": 3.8183131217956543
        },
        {
            "text": "New apo C-III",
            "probability": 0.0303342573827698,
            "start_logit": 0.8675701022148132,
            "end_logit": 0.6856164336204529
        },
        {
            "text": "apo C-III antisense oligonucleotide drug",
            "probability": 0.0256737838257875,
            "start_logit": -2.431933879852295,
            "end_logit": 3.8183131217956543
        },
        {
            "text": "decreasing elevated TGs by reducing levels of apo C-III mRNA",
            "probability": 0.020400953693919734,
            "start_logit": -0.7551639676094055,
            "end_logit": 1.9116544723510742
        },
        {
            "text": "oligonucleotide drug",
            "probability": 0.019747894367137173,
            "start_logit": -2.694357395172119,
            "end_logit": 3.8183131217956543
        },
        {
            "text": "New apo C-III antisense oligonucleotide",
            "probability": 0.01032050459159315,
            "start_logit": 0.8675701022148132,
            "end_logit": -0.39252859354019165
        },
        {
            "text": "reducing levels of apo C-III mRNA.",
            "probability": 0.009237594759593836,
            "start_logit": 0.9704363942146301,
            "end_logit": -0.6062459945678711
        },
        {
            "text": "New apo C-III antisense oligonucleotide drug (Volanesorsen) showed to be promising in decreasing elevated TGs",
            "probability": 0.007838557099267594,
            "start_logit": 0.8675701022148132,
            "end_logit": -0.6676064729690552
        },
        {
            "text": "New apo C-III antisense",
            "probability": 0.0036598637054353427,
            "start_logit": 0.8675701022148132,
            "end_logit": -1.4292353391647339
        },
        {
            "text": "promising in decreasing elevated TGs by reducing levels of apo C-III mRNA",
            "probability": 0.0023522589138998268,
            "start_logit": -2.9153695106506348,
            "end_logit": 1.9116544723510742
        },
        {
            "text": "Volanesorsen) showed to be promising in decreasing elevated TGs by reducing levels of apo C-III mRNA",
            "probability": 0.0023079778729225946,
            "start_logit": -2.9343738555908203,
            "end_logit": 1.9116544723510742
        },
        {
            "text": "cardiovascular disease New apo C-III antisense oligonucleotide drug",
            "probability": 0.0018152266619980422,
            "start_logit": -5.081193923950195,
            "end_logit": 3.8183131217956543
        },
        {
            "text": "apo C-III could be an important target for prevention of cardiovascular disease New apo C-III antisense oligonucleotide drug",
            "probability": 0.0017625310385820465,
            "start_logit": -5.110653400421143,
            "end_logit": 3.8183131217956543
        },
        {
            "text": "decreasing elevated TGs by reducing levels of apo C-III mRNA.",
            "probability": 0.0016449026161241796,
            "start_logit": -0.7551639676094055,
            "end_logit": -0.6062459945678711
        },
        {
            "text": "decreasing elevated TGs",
            "probability": 0.0015470048460598516,
            "start_logit": -0.7551639676094055,
            "end_logit": -0.6676064729690552
        },
        {
            "text": "III antisense oligonucleotide drug",
            "probability": 0.0014767106798036392,
            "start_logit": -5.2875871658325195,
            "end_logit": 3.8183131217956543
        },
        {
            "text": "drug",
            "probability": 0.001253613539578185,
            "start_logit": -5.451374053955078,
            "end_logit": 3.8183131217956543
        },
        {
            "text": "apo C-III",
            "probability": 0.0011193785872142391,
            "start_logit": -2.431933879852295,
            "end_logit": 0.6856164336204529
        },
        {
            "text": "",
            "probability": 8.313712417651374e-05,
            "start_logit": -3.0662882328033447,
            "end_logit": -1.2800668478012085
        }
    ],
    "5e2905da8b3851296d000009_005": [
        {
            "text": "inhibits the production of the Apo C-III",
            "probability": 0.6993541817391505,
            "start_logit": 4.533718109130859,
            "end_logit": 6.039501667022705
        },
        {
            "text": "an antisense oligonucleotid that inhibits the production of the Apo C-III",
            "probability": 0.07139302404827629,
            "start_logit": 2.251760959625244,
            "end_logit": 6.039501667022705
        },
        {
            "text": "inhibits the production of the Apo C-III which is crucial in regulating TGs metabolism",
            "probability": 0.06749583810198964,
            "start_logit": 4.533718109130859,
            "end_logit": 3.7014102935791016
        },
        {
            "text": "antisense oligonucleotid that inhibits the production of the Apo C-III",
            "probability": 0.04728189740955818,
            "start_logit": 1.8396883010864258,
            "end_logit": 6.039501667022705
        },
        {
            "text": "Volanesorsen, is an antisense oligonucleotid that inhibits the production of the Apo C-III",
            "probability": 0.034092190957540375,
            "start_logit": 1.5126291513442993,
            "end_logit": 6.039501667022705
        },
        {
            "text": "an antisense oligonucleotid",
            "probability": 0.02123640139347648,
            "start_logit": 2.251760959625244,
            "end_logit": 4.8270182609558105
        },
        {
            "text": "antisense oligonucleotid",
            "probability": 0.014064362245750766,
            "start_logit": 1.8396883010864258,
            "end_logit": 4.8270182609558105
        },
        {
            "text": "is an antisense oligonucleotid that inhibits the production of the Apo C-III",
            "probability": 0.01079743283738298,
            "start_logit": 0.3628692030906677,
            "end_logit": 6.039501667022705
        },
        {
            "text": "Volanesorsen, is an antisense oligonucleotid",
            "probability": 0.010140983117171331,
            "start_logit": 1.5126291513442993,
            "end_logit": 4.8270182609558105
        },
        {
            "text": "an antisense oligonucleotid that inhibits the production of the Apo C-III which is crucial in regulating TGs metabolism",
            "probability": 0.0068902597833771576,
            "start_logit": 2.251760959625244,
            "end_logit": 3.7014102935791016
        },
        {
            "text": "antisense oligonucleotid that inhibits the production of the Apo C-III which is crucial in regulating TGs metabolism",
            "probability": 0.004563254751368235,
            "start_logit": 1.8396883010864258,
            "end_logit": 3.7014102935791016
        },
        {
            "text": "is an antisense oligonucleotid",
            "probability": 0.003211779033182792,
            "start_logit": 0.3628692030906677,
            "end_logit": 4.8270182609558105
        },
        {
            "text": "inhibits the production",
            "probability": 0.0026228992254896796,
            "start_logit": 4.533718109130859,
            "end_logit": 0.4536246359348297
        },
        {
            "text": "inhibits the production of the Apo C-III which is crucial in regulating TGs metabolism because it inhibits lipoprotein lipase",
            "probability": 0.0023192727603335685,
            "start_logit": 4.533718109130859,
            "end_logit": 0.33059802651405334
        },
        {
            "text": "Apo C-III",
            "probability": 0.0021511532391480822,
            "start_logit": -1.2504351139068604,
            "end_logit": 6.039501667022705
        },
        {
            "text": "oligonucleotid that inhibits the production of the Apo C-III",
            "probability": 0.0006288337260944046,
            "start_logit": -2.480327606201172,
            "end_logit": 6.039501667022705
        },
        {
            "text": "production of the Apo C-III",
            "probability": 0.0006082350902045704,
            "start_logit": -2.5136330127716064,
            "end_logit": 6.039501667022705
        },
        {
            "text": "crucial in regulating TGs metabolism",
            "probability": 0.0005329259461560326,
            "start_logit": -0.3077206313610077,
            "end_logit": 3.7014102935791016
        },
        {
            "text": "inhibits the production of the Apo C-III which is crucial in regulating TGs",
            "probability": 0.0003473055193454016,
            "start_logit": 4.533718109130859,
            "end_logit": -1.5682060718536377
        },
        {
            "text": "an antisense oligonucleotid that inhibits the production",
            "probability": 0.000267756613703118,
            "start_logit": 2.251760959625244,
            "end_logit": 0.4536246359348297
        },
        {
            "text": "",
            "probability": 1.2461300478269948e-08,
            "start_logit": -4.26783561706543,
            "end_logit": -3.0019845962524414
        }
    ],
    "5e2905da8b3851296d000009_006": [
        {
            "text": "targets apolipoprotein C-III",
            "probability": 0.43512547751586966,
            "start_logit": 0.1103484183549881,
            "end_logit": 2.750946521759033
        },
        {
            "text": "apolipoprotein C-III",
            "probability": 0.38231042543172383,
            "start_logit": -0.01905311457812786,
            "end_logit": 2.750946521759033
        },
        {
            "text": "(which targets apolipoprotein C-III",
            "probability": 0.049369556181528336,
            "start_logit": -2.0659520626068115,
            "end_logit": 2.750946521759033
        },
        {
            "text": "volanesorsen (which targets apolipoprotein C-III",
            "probability": 0.048164448292460624,
            "start_logit": -2.090664863586426,
            "end_logit": 2.750946521759033
        },
        {
            "text": "targets apolipoprotein C-III)",
            "probability": 0.01897474379040501,
            "start_logit": 0.1103484183549881,
            "end_logit": -0.38157910108566284
        },
        {
            "text": "apolipoprotein C-III)",
            "probability": 0.016671610249949398,
            "start_logit": -0.01905311457812786,
            "end_logit": -0.38157910108566284
        },
        {
            "text": "Some new drugs are on the horizon, such as volanesorsen (which targets apolipoprotein C-III",
            "probability": 0.012674822522203632,
            "start_logit": -3.425668478012085,
            "end_logit": 2.750946521759033
        },
        {
            "text": "",
            "probability": 0.011107446562312955,
            "start_logit": -0.6995573043823242,
            "end_logit": -0.10716645419597626
        },
        {
            "text": "new drugs are on the horizon, such as volanesorsen (which targets apolipoprotein C-III",
            "probability": 0.0071770804406723655,
            "start_logit": -3.9943933486938477,
            "end_logit": 2.750946521759033
        },
        {
            "text": "which targets apolipoprotein C-III",
            "probability": 0.006155164631721483,
            "start_logit": -4.147994518280029,
            "end_logit": 2.750946521759033
        },
        {
            "text": "volanesorsen (which targets apolipoprotein C-III),",
            "probability": 0.0031071869030678653,
            "start_logit": -4.831568241119385,
            "end_logit": 2.750946521759033
        },
        {
            "text": "(which targets apolipoprotein C-III)",
            "probability": 0.00215288400242282,
            "start_logit": -2.0659520626068115,
            "end_logit": -0.38157910108566284
        },
        {
            "text": "volanesorsen (which targets apolipoprotein C-III)",
            "probability": 0.0021003322337573736,
            "start_logit": -2.090664863586426,
            "end_logit": -0.38157910108566284
        },
        {
            "text": "III",
            "probability": 0.0015804129830642238,
            "start_logit": -5.507599830627441,
            "end_logit": 2.750946521759033
        },
        {
            "text": "targets apolipoprotein C-III), pemafibrate, and others.",
            "probability": 0.0007815508865621003,
            "start_logit": 0.1103484183549881,
            "end_logit": -3.5711629390716553
        },
        {
            "text": "apolipoprotein C-III), pemafibrate, and others.",
            "probability": 0.000686687099187843,
            "start_logit": -0.01905311457812786,
            "end_logit": -3.5711629390716553
        },
        {
            "text": "Some new drugs are on the horizon, such as volanesorsen (which targets apolipoprotein C-III)",
            "probability": 0.0005527176007267869,
            "start_logit": -3.425668478012085,
            "end_logit": -0.38157910108566284
        },
        {
            "text": "targets",
            "probability": 0.0005078343623741592,
            "start_logit": 0.1103484183549881,
            "end_logit": -4.002287864685059
        },
        {
            "text": "targets apolipoprotein",
            "probability": 0.00040995380589561045,
            "start_logit": 0.1103484183549881,
            "end_logit": -4.2163987159729
        },
        {
            "text": "targets apolipoprotein C",
            "probability": 0.00038966450409402316,
            "start_logit": 0.1103484183549881,
            "end_logit": -4.267157077789307
        }
    ],
    "5c70273c7c78d69471000061_001": [
        {
            "text": "",
            "probability": 0.9999006306589602,
            "start_logit": 6.637764930725098,
            "end_logit": 5.646806716918945
        },
        {
            "text": "renal, peripheral vascular, and musculoskeletal",
            "probability": 5.095195262108909e-05,
            "start_logit": 2.555785894393921,
            "end_logit": -0.155742347240448
        },
        {
            "text": "renal, peripheral vascular",
            "probability": 2.49014396833478e-05,
            "start_logit": 2.555785894393921,
            "end_logit": -0.8716998100280762
        },
        {
            "text": "renal",
            "probability": 1.0908795335455231e-05,
            "start_logit": 2.555785894393921,
            "end_logit": -1.6970560550689697
        },
        {
            "text": "renal, peripheral vascular, and musculoskeletal damage",
            "probability": 7.776184363693594e-06,
            "start_logit": 2.555785894393921,
            "end_logit": -2.03555965423584
        },
        {
            "text": "Ocular damage",
            "probability": 1.4234561615089752e-06,
            "start_logit": -0.11605088412761688,
            "end_logit": -1.0617008209228516
        },
        {
            "text": "musculoskeletal",
            "probability": 4.778189753693781e-07,
            "start_logit": -2.1136205196380615,
            "end_logit": -0.155742347240448
        },
        {
            "text": "renal, peripheral vascular, and musculoskeletal damage (24, 19, 38% of patients",
            "probability": 4.5797434634702787e-07,
            "start_logit": 2.555785894393921,
            "end_logit": -4.867567539215088
        },
        {
            "text": "oral section (62% of patients). The patients with SLE and SS had the greatest renal, peripheral vascular",
            "probability": 4.127441790323052e-07,
            "start_logit": -1.5440670251846313,
            "end_logit": -0.8716998100280762
        },
        {
            "text": "peripheral vascular, and musculoskeletal",
            "probability": 4.039950692314951e-07,
            "start_logit": -2.281449794769287,
            "end_logit": -0.155742347240448
        },
        {
            "text": "renal,",
            "probability": 2.9185159824278594e-07,
            "start_logit": 2.555785894393921,
            "end_logit": -5.3181352615356445
        },
        {
            "text": "renal, peripheral vascular, and musculoskeletal damage (24, 19, 38% of patients, respectively)",
            "probability": 2.9100419849678676e-07,
            "start_logit": 2.555785894393921,
            "end_logit": -5.321043014526367
        },
        {
            "text": "Ocular",
            "probability": 2.17441676618356e-07,
            "start_logit": -0.11605088412761688,
            "end_logit": -2.940613269805908
        },
        {
            "text": "peripheral vascular",
            "probability": 1.9744206711077294e-07,
            "start_logit": -2.281449794769287,
            "end_logit": -0.8716998100280762
        },
        {
            "text": "musculoskeletal damage (24, 19, 38% of patients, respectively) followed by the SLE group. Ocular damage",
            "probability": 1.9311260695051882e-07,
            "start_logit": -2.1136205196380615,
            "end_logit": -1.0617008209228516
        },
        {
            "text": "oral section (62% of patients). The patients with SLE and SS had the greatest renal",
            "probability": 1.8081451643837561e-07,
            "start_logit": -1.5440670251846313,
            "end_logit": -1.6970560550689697
        },
        {
            "text": "oral",
            "probability": 7.700038609165389e-08,
            "start_logit": -1.5440670251846313,
            "end_logit": -2.550717353820801
        },
        {
            "text": "musculoskeletal damage",
            "probability": 7.292376942989927e-08,
            "start_logit": -2.1136205196380615,
            "end_logit": -2.03555965423584
        },
        {
            "text": "the oral section (62% of patients). The patients with SLE and SS had the greatest renal, peripheral vascular",
            "probability": 7.173257185251155e-08,
            "start_logit": -3.293950080871582,
            "end_logit": -0.8716998100280762
        },
        {
            "text": "peripheral vascular, and musculoskeletal damage",
            "probability": 6.165691359720285e-08,
            "start_logit": -2.281449794769287,
            "end_logit": -2.03555965423584
        }
    ],
    "5c70273c7c78d69471000061_002": [
        {
            "text": "neuropsychiatric and renal systems",
            "probability": 0.7324123395362687,
            "start_logit": 3.575279951095581,
            "end_logit": 4.516404151916504
        },
        {
            "text": "",
            "probability": 0.23447248310132882,
            "start_logit": 2.937008857727051,
            "end_logit": 4.015669822692871
        },
        {
            "text": "the neuropsychiatric and renal systems",
            "probability": 0.021162837816318007,
            "start_logit": 0.031183000653982162,
            "end_logit": 4.516404151916504
        },
        {
            "text": "renal systems",
            "probability": 0.008735695393846702,
            "start_logit": -0.8536461591720581,
            "end_logit": 4.516404151916504
        },
        {
            "text": "neuropsychiatric and renal",
            "probability": 0.0017758221125707197,
            "start_logit": 3.575279951095581,
            "end_logit": -1.505676031112671
        },
        {
            "text": "involving the neuropsychiatric and renal systems",
            "probability": 0.0004010778124387237,
            "start_logit": -3.9346635341644287,
            "end_logit": 4.516404151916504
        },
        {
            "text": "systems",
            "probability": 0.00024202433440664254,
            "start_logit": -4.4397807121276855,
            "end_logit": 4.516404151916504
        },
        {
            "text": "lupus-related organ damage involving the neuropsychiatric and renal systems",
            "probability": 0.00021821840639535525,
            "start_logit": -4.543322563171387,
            "end_logit": 4.516404151916504
        },
        {
            "text": "neuropsychiatric",
            "probability": 0.0001695925943841444,
            "start_logit": 3.575279951095581,
            "end_logit": -3.8542957305908203
        },
        {
            "text": "organ damage involving the neuropsychiatric and renal systems",
            "probability": 9.434828217519942e-05,
            "start_logit": -5.381825923919678,
            "end_logit": 4.516404151916504
        },
        {
            "text": "ne",
            "probability": 6.216758645224238e-05,
            "start_logit": 3.575279951095581,
            "end_logit": -4.857861042022705
        },
        {
            "text": "the neuropsychiatric and renal",
            "probability": 5.131185444357787e-05,
            "start_logit": 0.031183000653982162,
            "end_logit": -1.505676031112671
        },
        {
            "text": "neuropsychiatric and renal systems also remains a major factor that limits survival improvement in patients with this disease",
            "probability": 4.7262795832862666e-05,
            "start_logit": 3.575279951095581,
            "end_logit": -5.13197135925293
        },
        {
            "text": "and renal systems",
            "probability": 3.905616446399815e-05,
            "start_logit": -6.263818264007568,
            "end_logit": 4.516404151916504
        },
        {
            "text": "neuropsychiatric and",
            "probability": 3.690797203712109e-05,
            "start_logit": 3.575279951095581,
            "end_logit": -5.37926721572876
        },
        {
            "text": "renal",
            "probability": 2.1180747799657948e-05,
            "start_logit": -0.8536461591720581,
            "end_logit": -1.505676031112671
        },
        {
            "text": "damage involving the neuropsychiatric and renal systems",
            "probability": 2.0148008494830298e-05,
            "start_logit": -6.925713539123535,
            "end_logit": 4.516404151916504
        },
        {
            "text": "neuropsychiatric and renal systems also remains a major factor that limits survival improvement in patients with this disease.",
            "probability": 1.8405028766572746e-05,
            "start_logit": 3.575279951095581,
            "end_logit": -6.075070858001709
        },
        {
            "text": "related organ damage involving the neuropsychiatric and renal systems",
            "probability": 1.422012374702086e-05,
            "start_logit": -7.274160861968994,
            "end_logit": 4.516404151916504
        },
        {
            "text": "the neuropsychiatric",
            "probability": 4.900327829092403e-06,
            "start_logit": 0.031183000653982162,
            "end_logit": -3.8542957305908203
        }
    ],
    "5c70273c7c78d69471000061_003": [
        {
            "text": "neuropsychiatric and renal systems",
            "probability": 0.7324123395362687,
            "start_logit": 3.575279951095581,
            "end_logit": 4.516404151916504
        },
        {
            "text": "",
            "probability": 0.23447248310132882,
            "start_logit": 2.937008857727051,
            "end_logit": 4.015669822692871
        },
        {
            "text": "the neuropsychiatric and renal systems",
            "probability": 0.021162837816318007,
            "start_logit": 0.031183000653982162,
            "end_logit": 4.516404151916504
        },
        {
            "text": "renal systems",
            "probability": 0.008735695393846702,
            "start_logit": -0.8536461591720581,
            "end_logit": 4.516404151916504
        },
        {
            "text": "neuropsychiatric and renal",
            "probability": 0.0017758221125707197,
            "start_logit": 3.575279951095581,
            "end_logit": -1.505676031112671
        },
        {
            "text": "involving the neuropsychiatric and renal systems",
            "probability": 0.0004010778124387237,
            "start_logit": -3.9346635341644287,
            "end_logit": 4.516404151916504
        },
        {
            "text": "systems",
            "probability": 0.00024202433440664254,
            "start_logit": -4.4397807121276855,
            "end_logit": 4.516404151916504
        },
        {
            "text": "lupus-related organ damage involving the neuropsychiatric and renal systems",
            "probability": 0.00021821840639535525,
            "start_logit": -4.543322563171387,
            "end_logit": 4.516404151916504
        },
        {
            "text": "neuropsychiatric",
            "probability": 0.0001695925943841444,
            "start_logit": 3.575279951095581,
            "end_logit": -3.8542957305908203
        },
        {
            "text": "organ damage involving the neuropsychiatric and renal systems",
            "probability": 9.434828217519942e-05,
            "start_logit": -5.381825923919678,
            "end_logit": 4.516404151916504
        },
        {
            "text": "ne",
            "probability": 6.216758645224238e-05,
            "start_logit": 3.575279951095581,
            "end_logit": -4.857861042022705
        },
        {
            "text": "the neuropsychiatric and renal",
            "probability": 5.131185444357787e-05,
            "start_logit": 0.031183000653982162,
            "end_logit": -1.505676031112671
        },
        {
            "text": "neuropsychiatric and renal systems also remains a major factor that limits survival improvement in patients with this disease",
            "probability": 4.7262795832862666e-05,
            "start_logit": 3.575279951095581,
            "end_logit": -5.13197135925293
        },
        {
            "text": "and renal systems",
            "probability": 3.905616446399815e-05,
            "start_logit": -6.263818264007568,
            "end_logit": 4.516404151916504
        },
        {
            "text": "neuropsychiatric and",
            "probability": 3.690797203712109e-05,
            "start_logit": 3.575279951095581,
            "end_logit": -5.37926721572876
        },
        {
            "text": "renal",
            "probability": 2.1180747799657948e-05,
            "start_logit": -0.8536461591720581,
            "end_logit": -1.505676031112671
        },
        {
            "text": "damage involving the neuropsychiatric and renal systems",
            "probability": 2.0148008494830298e-05,
            "start_logit": -6.925713539123535,
            "end_logit": 4.516404151916504
        },
        {
            "text": "neuropsychiatric and renal systems also remains a major factor that limits survival improvement in patients with this disease.",
            "probability": 1.8405028766572746e-05,
            "start_logit": 3.575279951095581,
            "end_logit": -6.075070858001709
        },
        {
            "text": "related organ damage involving the neuropsychiatric and renal systems",
            "probability": 1.422012374702086e-05,
            "start_logit": -7.274160861968994,
            "end_logit": 4.516404151916504
        },
        {
            "text": "the neuropsychiatric",
            "probability": 4.900327829092403e-06,
            "start_logit": 0.031183000653982162,
            "end_logit": -3.8542957305908203
        }
    ],
    "5c70273c7c78d69471000061_004": [
        {
            "text": "neuropsychiatric and renal systems",
            "probability": 0.7324123395362687,
            "start_logit": 3.575279951095581,
            "end_logit": 4.516404151916504
        },
        {
            "text": "",
            "probability": 0.23447248310132882,
            "start_logit": 2.937008857727051,
            "end_logit": 4.015669822692871
        },
        {
            "text": "the neuropsychiatric and renal systems",
            "probability": 0.021162837816318007,
            "start_logit": 0.031183000653982162,
            "end_logit": 4.516404151916504
        },
        {
            "text": "renal systems",
            "probability": 0.008735695393846702,
            "start_logit": -0.8536461591720581,
            "end_logit": 4.516404151916504
        },
        {
            "text": "neuropsychiatric and renal",
            "probability": 0.0017758221125707197,
            "start_logit": 3.575279951095581,
            "end_logit": -1.505676031112671
        },
        {
            "text": "involving the neuropsychiatric and renal systems",
            "probability": 0.0004010778124387237,
            "start_logit": -3.9346635341644287,
            "end_logit": 4.516404151916504
        },
        {
            "text": "systems",
            "probability": 0.00024202433440664254,
            "start_logit": -4.4397807121276855,
            "end_logit": 4.516404151916504
        },
        {
            "text": "lupus-related organ damage involving the neuropsychiatric and renal systems",
            "probability": 0.00021821840639535525,
            "start_logit": -4.543322563171387,
            "end_logit": 4.516404151916504
        },
        {
            "text": "neuropsychiatric",
            "probability": 0.0001695925943841444,
            "start_logit": 3.575279951095581,
            "end_logit": -3.8542957305908203
        },
        {
            "text": "organ damage involving the neuropsychiatric and renal systems",
            "probability": 9.434828217519942e-05,
            "start_logit": -5.381825923919678,
            "end_logit": 4.516404151916504
        },
        {
            "text": "ne",
            "probability": 6.216758645224238e-05,
            "start_logit": 3.575279951095581,
            "end_logit": -4.857861042022705
        },
        {
            "text": "the neuropsychiatric and renal",
            "probability": 5.131185444357787e-05,
            "start_logit": 0.031183000653982162,
            "end_logit": -1.505676031112671
        },
        {
            "text": "neuropsychiatric and renal systems also remains a major factor that limits survival improvement in patients with this disease",
            "probability": 4.7262795832862666e-05,
            "start_logit": 3.575279951095581,
            "end_logit": -5.13197135925293
        },
        {
            "text": "and renal systems",
            "probability": 3.905616446399815e-05,
            "start_logit": -6.263818264007568,
            "end_logit": 4.516404151916504
        },
        {
            "text": "neuropsychiatric and",
            "probability": 3.690797203712109e-05,
            "start_logit": 3.575279951095581,
            "end_logit": -5.37926721572876
        },
        {
            "text": "renal",
            "probability": 2.1180747799657948e-05,
            "start_logit": -0.8536461591720581,
            "end_logit": -1.505676031112671
        },
        {
            "text": "damage involving the neuropsychiatric and renal systems",
            "probability": 2.0148008494830298e-05,
            "start_logit": -6.925713539123535,
            "end_logit": 4.516404151916504
        },
        {
            "text": "neuropsychiatric and renal systems also remains a major factor that limits survival improvement in patients with this disease.",
            "probability": 1.8405028766572746e-05,
            "start_logit": 3.575279951095581,
            "end_logit": -6.075070858001709
        },
        {
            "text": "related organ damage involving the neuropsychiatric and renal systems",
            "probability": 1.422012374702086e-05,
            "start_logit": -7.274160861968994,
            "end_logit": 4.516404151916504
        },
        {
            "text": "the neuropsychiatric",
            "probability": 4.900327829092403e-06,
            "start_logit": 0.031183000653982162,
            "end_logit": -3.8542957305908203
        }
    ],
    "5c70273c7c78d69471000061_005": [
        {
            "text": "",
            "probability": 0.9999888717771022,
            "start_logit": 4.924026966094971,
            "end_logit": 4.820856094360352
        },
        {
            "text": "organ damage",
            "probability": 6.933165940309053e-06,
            "start_logit": -0.8886762261390686,
            "end_logit": -1.2456235885620117
        },
        {
            "text": "organ",
            "probability": 3.449682947788969e-06,
            "start_logit": -2.136082410812378,
            "end_logit": -0.696251630783081
        },
        {
            "text": "belimumab",
            "probability": 1.5210338886687565e-07,
            "start_logit": -3.5924527645111084,
            "end_logit": -2.361358404159546
        },
        {
            "text": "damage",
            "probability": 1.0797204984371617e-07,
            "start_logit": -5.050875663757324,
            "end_logit": -1.2456235885620117
        },
        {
            "text": "long-term organ",
            "probability": 7.173098358123028e-08,
            "start_logit": -6.009197235107422,
            "end_logit": -0.696251630783081
        },
        {
            "text": "organ damage at baseline",
            "probability": 6.141539219088829e-08,
            "start_logit": -0.8886762261390686,
            "end_logit": -5.972034931182861
        },
        {
            "text": "prior to belimumab",
            "probability": 5.8817212804829946e-08,
            "start_logit": -4.54257869720459,
            "end_logit": -2.361358404159546
        },
        {
            "text": "belimumab.",
            "probability": 5.7986930385348526e-08,
            "start_logit": -3.5924527645111084,
            "end_logit": -3.3257012367248535
        },
        {
            "text": "organ damage and safety following treatment with belimumab plus standard of care (SoC) in patients with systemic lupus erythematosus",
            "probability": 4.807035522968097e-08,
            "start_logit": -2.136082410812378,
            "end_logit": -4.969623565673828
        },
        {
            "text": "organ damage at baseline, 211/241 (87.6%) had no change in SDI",
            "probability": 2.78460232772407e-08,
            "start_logit": -0.8886762261390686,
            "end_logit": -6.763005256652832
        },
        {
            "text": "infections/infestations (282, 28.3%) and gastrointestinal disorders",
            "probability": 2.3491494322127325e-08,
            "start_logit": -4.0308146476745605,
            "end_logit": -3.7909185886383057
        },
        {
            "text": "patients without organ damage",
            "probability": 2.2627293746123876e-08,
            "start_logit": -6.613591194152832,
            "end_logit": -1.2456235885620117
        },
        {
            "text": "prior to belimumab.",
            "probability": 2.2423100824919584e-08,
            "start_logit": -4.54257869720459,
            "end_logit": -3.3257012367248535
        },
        {
            "text": "baseline damage",
            "probability": 2.1681558454896245e-08,
            "start_logit": -3.8079593181610107,
            "end_logit": -4.093950271606445
        },
        {
            "text": "organ damage and safety following treatment with belimumab plus standard of care (SoC) in patients with systemic lupus",
            "probability": 1.8051594928033932e-08,
            "start_logit": -2.136082410812378,
            "end_logit": -5.949055194854736
        },
        {
            "text": "SDI\u2009\u2265\u20092: 176 (17.6%)) prior to belimumab.",
            "probability": 1.5523746315209758e-08,
            "start_logit": -5.874642372131348,
            "end_logit": -2.361358404159546
        },
        {
            "text": "baseline",
            "probability": 1.234058552085386e-08,
            "start_logit": -3.8079593181610107,
            "end_logit": -4.6575188636779785
        },
        {
            "text": "(SDI\u2009=\u20091: 235 (23.5%); SDI\u2009\u2265\u20092: 176 (17.6%)) prior to belimumab.",
            "probability": 1.2136107407687138e-08,
            "start_logit": -6.120828151702881,
            "end_logit": -2.361358404159546
        },
        {
            "text": "gastrointestinal disorders",
            "probability": 1.1156192486461913e-08,
            "start_logit": -4.775458335876465,
            "end_logit": -3.7909185886383057
        }
    ],
    "5e2d7fabfbd6abf43b00000c_002": [
        {
            "text": "rescues these effects",
            "probability": 0.724308606900653,
            "start_logit": 1.5305708646774292,
            "end_logit": 2.939650297164917
        },
        {
            "text": "",
            "probability": 0.10309285529752028,
            "start_logit": 0.8039952516555786,
            "end_logit": 1.716638445854187
        },
        {
            "text": "rescues",
            "probability": 0.0744669885455432,
            "start_logit": 1.5305708646774292,
            "end_logit": 0.6647886633872986
        },
        {
            "text": "senescence-induced CTCF clustering and for loop reshuffling, while ectopically expressing HMGB2 rescues these effects",
            "probability": 0.023246841281381436,
            "start_logit": -1.9084774255752563,
            "end_logit": 2.939650297164917
        },
        {
            "text": "rescues these effects.",
            "probability": 0.021497134144109965,
            "start_logit": 1.5305708646774292,
            "end_logit": -0.5776476263999939
        },
        {
            "text": "ectopically expressing HMGB2 rescues these effects",
            "probability": 0.017771327142835736,
            "start_logit": -2.17706036567688,
            "end_logit": 2.939650297164917
        },
        {
            "text": "Knocking down HMGB2 suffices",
            "probability": 0.005288179654092201,
            "start_logit": -0.22901509702205658,
            "end_logit": -0.22050721943378448
        },
        {
            "text": "loop reshuffling, while ectopically expressing HMGB2 rescues these effects",
            "probability": 0.0050741211357838755,
            "start_logit": -3.4304933547973633,
            "end_logit": 2.939650297164917
        },
        {
            "text": "suffices for senescence-induced CTCF clustering and for loop reshuffling, while ectopically expressing HMGB2 rescues",
            "probability": 0.0043716060445261945,
            "start_logit": -1.304654598236084,
            "end_logit": 0.6647886633872986
        },
        {
            "text": "effects",
            "probability": 0.004098905836837109,
            "start_logit": -3.6439266204833984,
            "end_logit": 2.939650297164917
        },
        {
            "text": "dramatic spatial clustering of CTCF. Knocking down HMGB2 suffices",
            "probability": 0.0029397495226127163,
            "start_logit": -0.8161647915840149,
            "end_logit": -0.22050721943378448
        },
        {
            "text": "senescence-induced CTCF clustering and for loop reshuffling, while ectopically expressing HMGB2 rescues",
            "probability": 0.002390034091722639,
            "start_logit": -1.9084774255752563,
            "end_logit": 0.6647886633872986
        },
        {
            "text": "Knocking down HMGB2 suffices for senescence-induced CTCF clustering and for loop reshuffling",
            "probability": 0.0019514864302385244,
            "start_logit": -0.22901509702205658,
            "end_logit": -1.2173899412155151
        },
        {
            "text": "ectopically expressing HMGB2 rescues",
            "probability": 0.001827090279166275,
            "start_logit": -2.17706036567688,
            "end_logit": 0.6647886633872986
        },
        {
            "text": "suffices",
            "probability": 0.0018036900147171196,
            "start_logit": -1.304654598236084,
            "end_logit": -0.22050721943378448
        },
        {
            "text": "for senescence-induced CTCF clustering and for loop reshuffling, while ectopically expressing HMGB2 rescues these effects",
            "probability": 0.001404314470197303,
            "start_logit": -4.715097427368164,
            "end_logit": 2.939650297164917
        },
        {
            "text": "spatial clustering of CTCF. Knocking down HMGB2 suffices",
            "probability": 0.0012783327833863077,
            "start_logit": -1.6489324569702148,
            "end_logit": -0.22050721943378448
        },
        {
            "text": "Knocking down HMGB2 suffices for senescence-induced",
            "probability": 0.0011895065290247972,
            "start_logit": -0.22901509702205658,
            "end_logit": -1.7124427556991577
        },
        {
            "text": "Knocking down HMGB2 suffices for senescence-induced CTCF clustering",
            "probability": 0.0010241672667009212,
            "start_logit": -0.22901509702205658,
            "end_logit": -1.862101435661316
        },
        {
            "text": "induced CTCF clustering and for loop reshuffling, while ectopically expressing HMGB2 rescues these effects",
            "probability": 0.0009750626289503999,
            "start_logit": -5.07990026473999,
            "end_logit": 2.939650297164917
        }
    ],
    "5e29fc57aa19d74431000006_001": [
        {
            "text": "sensitized ovarian carcinoma lines to cisplatin-mediated cell death",
            "probability": 0.5328286414982695,
            "start_logit": 0.7667677402496338,
            "end_logit": 1.442730188369751
        },
        {
            "text": "cisplatin-mediated cell death",
            "probability": 0.15210248600575016,
            "start_logit": -0.48687759041786194,
            "end_logit": 1.442730188369751
        },
        {
            "text": "",
            "probability": 0.062324056281128595,
            "start_logit": -0.7315990924835205,
            "end_logit": 0.7952446341514587
        },
        {
            "text": "sensitized ovarian carcinoma lines to cisplatin-mediated cell death.",
            "probability": 0.051597448801138035,
            "start_logit": 0.7667677402496338,
            "end_logit": -0.8919974565505981
        },
        {
            "text": "sensitize ovarian cancer cells to cisplatin treatment",
            "probability": 0.037198444429625895,
            "start_logit": -0.4943179190158844,
            "end_logit": 0.041882917284965515
        },
        {
            "text": "sensitizes cancer cells to radiation-mediated DNA damage",
            "probability": 0.027007648406535266,
            "start_logit": -1.2312027215957642,
            "end_logit": 0.4586208760738373
        },
        {
            "text": "radiation-mediated DNA damage",
            "probability": 0.02241104919748879,
            "start_logit": -1.4177687168121338,
            "end_logit": 0.4586208760738373
        },
        {
            "text": "decreased Wee1 expression, increased cdc2 activation, and increased mitotic entry (p-histone H3)",
            "probability": 0.014865799432412027,
            "start_logit": -0.1698862612247467,
            "end_logit": -1.1997524499893188
        },
        {
            "text": "radiation-mediated DNA damage. We hypothesized that LB100 could sensitize ovarian cancer cells to cisplatin treatment",
            "probability": 0.014773220944588883,
            "start_logit": -1.4177687168121338,
            "end_logit": 0.041882917284965515
        },
        {
            "text": "cisplatin-mediated cell death.",
            "probability": 0.014729126069761017,
            "start_logit": -0.48687759041786194,
            "end_logit": -0.8919974565505981
        },
        {
            "text": "sensitized",
            "probability": 0.013781103880709017,
            "start_logit": 0.7667677402496338,
            "end_logit": -2.2121713161468506
        },
        {
            "text": "could sensitize ovarian cancer cells to cisplatin treatment",
            "probability": 0.011400426192099264,
            "start_logit": -1.6769341230392456,
            "end_logit": 0.041882917284965515
        },
        {
            "text": "LB100 sensitized ovarian carcinoma lines to cisplatin-mediated cell death",
            "probability": 0.00957162367427328,
            "start_logit": -3.252629280090332,
            "end_logit": 1.442730188369751
        },
        {
            "text": "sensitized ovarian carcinoma lines",
            "probability": 0.006825875016982444,
            "start_logit": 0.7667677402496338,
            "end_logit": -2.9147491455078125
        },
        {
            "text": "LB100 could sensitize ovarian cancer cells to cisplatin treatment",
            "probability": 0.0062035755126657,
            "start_logit": -2.285459041595459,
            "end_logit": 0.041882917284965515
        },
        {
            "text": "prevented disease progression",
            "probability": 0.006198845565985522,
            "start_logit": -1.5317134857177734,
            "end_logit": -0.7126253843307495
        },
        {
            "text": "sensitize ovarian cancer cells",
            "probability": 0.005978959553103675,
            "start_logit": -0.4943179190158844,
            "end_logit": -1.7861374616622925
        },
        {
            "text": "decreased Wee1 expression, increased cdc2 activation, and increased mitotic entry (p-histone H3).",
            "probability": 0.003479501124905543,
            "start_logit": -0.1698862612247467,
            "end_logit": -2.6519267559051514
        },
        {
            "text": "cisplatin-mediated cell death. Sensitization via LB100 was mediated by abrogation of cell-cycle arrest induced by cisplatin",
            "probability": 0.0033718097709730358,
            "start_logit": -0.48687759041786194,
            "end_logit": -2.3663747310638428
        },
        {
            "text": "decreased Wee1 expression, increased cdc2 activation, and increased mitotic entry",
            "probability": 0.0033503586416044097,
            "start_logit": -0.1698862612247467,
            "end_logit": -2.6897482872009277
        }
    ],
    "5e29fc57aa19d74431000006_002": [
        {
            "text": "sensitized ovarian carcinoma lines to cisplatin-mediated cell death",
            "probability": 0.5328286414982695,
            "start_logit": 0.7667677402496338,
            "end_logit": 1.442730188369751
        },
        {
            "text": "cisplatin-mediated cell death",
            "probability": 0.15210248600575016,
            "start_logit": -0.48687759041786194,
            "end_logit": 1.442730188369751
        },
        {
            "text": "",
            "probability": 0.062324056281128595,
            "start_logit": -0.7315990924835205,
            "end_logit": 0.7952446341514587
        },
        {
            "text": "sensitized ovarian carcinoma lines to cisplatin-mediated cell death.",
            "probability": 0.051597448801138035,
            "start_logit": 0.7667677402496338,
            "end_logit": -0.8919974565505981
        },
        {
            "text": "sensitize ovarian cancer cells to cisplatin treatment",
            "probability": 0.037198444429625895,
            "start_logit": -0.4943179190158844,
            "end_logit": 0.041882917284965515
        },
        {
            "text": "sensitizes cancer cells to radiation-mediated DNA damage",
            "probability": 0.027007648406535266,
            "start_logit": -1.2312027215957642,
            "end_logit": 0.4586208760738373
        },
        {
            "text": "radiation-mediated DNA damage",
            "probability": 0.02241104919748879,
            "start_logit": -1.4177687168121338,
            "end_logit": 0.4586208760738373
        },
        {
            "text": "decreased Wee1 expression, increased cdc2 activation, and increased mitotic entry (p-histone H3)",
            "probability": 0.014865799432412027,
            "start_logit": -0.1698862612247467,
            "end_logit": -1.1997524499893188
        },
        {
            "text": "radiation-mediated DNA damage. We hypothesized that LB100 could sensitize ovarian cancer cells to cisplatin treatment",
            "probability": 0.014773220944588883,
            "start_logit": -1.4177687168121338,
            "end_logit": 0.041882917284965515
        },
        {
            "text": "cisplatin-mediated cell death.",
            "probability": 0.014729126069761017,
            "start_logit": -0.48687759041786194,
            "end_logit": -0.8919974565505981
        },
        {
            "text": "sensitized",
            "probability": 0.013781103880709017,
            "start_logit": 0.7667677402496338,
            "end_logit": -2.2121713161468506
        },
        {
            "text": "could sensitize ovarian cancer cells to cisplatin treatment",
            "probability": 0.011400426192099264,
            "start_logit": -1.6769341230392456,
            "end_logit": 0.041882917284965515
        },
        {
            "text": "LB100 sensitized ovarian carcinoma lines to cisplatin-mediated cell death",
            "probability": 0.00957162367427328,
            "start_logit": -3.252629280090332,
            "end_logit": 1.442730188369751
        },
        {
            "text": "sensitized ovarian carcinoma lines",
            "probability": 0.006825875016982444,
            "start_logit": 0.7667677402496338,
            "end_logit": -2.9147491455078125
        },
        {
            "text": "LB100 could sensitize ovarian cancer cells to cisplatin treatment",
            "probability": 0.0062035755126657,
            "start_logit": -2.285459041595459,
            "end_logit": 0.041882917284965515
        },
        {
            "text": "prevented disease progression",
            "probability": 0.006198845565985522,
            "start_logit": -1.5317134857177734,
            "end_logit": -0.7126253843307495
        },
        {
            "text": "sensitize ovarian cancer cells",
            "probability": 0.005978959553103675,
            "start_logit": -0.4943179190158844,
            "end_logit": -1.7861374616622925
        },
        {
            "text": "decreased Wee1 expression, increased cdc2 activation, and increased mitotic entry (p-histone H3).",
            "probability": 0.003479501124905543,
            "start_logit": -0.1698862612247467,
            "end_logit": -2.6519267559051514
        },
        {
            "text": "cisplatin-mediated cell death. Sensitization via LB100 was mediated by abrogation of cell-cycle arrest induced by cisplatin",
            "probability": 0.0033718097709730358,
            "start_logit": -0.48687759041786194,
            "end_logit": -2.3663747310638428
        },
        {
            "text": "decreased Wee1 expression, increased cdc2 activation, and increased mitotic entry",
            "probability": 0.0033503586416044097,
            "start_logit": -0.1698862612247467,
            "end_logit": -2.6897482872009277
        }
    ],
    "5e480ccfd14c9f295d000005_001": [
        {
            "text": "excellent indicator",
            "probability": 0.3139850884576532,
            "start_logit": 4.056332588195801,
            "end_logit": 3.3391242027282715
        },
        {
            "text": "excellent indicator or marker",
            "probability": 0.15458015867918748,
            "start_logit": 4.056332588195801,
            "end_logit": 2.6304914951324463
        },
        {
            "text": "an excellent indicator",
            "probability": 0.14732003216479414,
            "start_logit": 3.2995944023132324,
            "end_logit": 3.3391242027282715
        },
        {
            "text": "an excellent indicator or marker",
            "probability": 0.07252813839192308,
            "start_logit": 3.2995944023132324,
            "end_logit": 2.6304914951324463
        },
        {
            "text": "excellent",
            "probability": 0.05555411232542668,
            "start_logit": 4.056332588195801,
            "end_logit": 1.6071362495422363
        },
        {
            "text": "is an excellent indicator",
            "probability": 0.053164266104592864,
            "start_logit": 2.2803735733032227,
            "end_logit": 3.3391242027282715
        },
        {
            "text": "excellent indicator or marker of DNA double-strand breaks",
            "probability": 0.033721455966726425,
            "start_logit": 4.056332588195801,
            "end_logit": 1.1079130172729492
        },
        {
            "text": "excellent indicator or marker of DNA double-strand breaks (DSBs).",
            "probability": 0.028324367513680105,
            "start_logit": 4.056332588195801,
            "end_logit": 0.9335011839866638
        },
        {
            "text": "is an excellent indicator or marker",
            "probability": 0.02617366554214209,
            "start_logit": 2.2803735733032227,
            "end_logit": 2.6304914951324463
        },
        {
            "text": "an excellent",
            "probability": 0.026065676095864163,
            "start_logit": 3.2995944023132324,
            "end_logit": 1.6071362495422363
        },
        {
            "text": "excellent indicator or marker of DNA double-strand breaks (DSBs)",
            "probability": 0.01641306244424309,
            "start_logit": 4.056332588195801,
            "end_logit": 0.38785621523857117
        },
        {
            "text": "an excellent indicator or marker of DNA double-strand breaks",
            "probability": 0.015821916900782485,
            "start_logit": 3.2995944023132324,
            "end_logit": 1.1079130172729492
        },
        {
            "text": "an excellent indicator or marker of DNA double-strand breaks (DSBs).",
            "probability": 0.013289633446161494,
            "start_logit": 3.2995944023132324,
            "end_logit": 0.9335011839866638
        },
        {
            "text": "is an excellent",
            "probability": 0.009406477311968784,
            "start_logit": 2.2803735733032227,
            "end_logit": 1.6071362495422363
        },
        {
            "text": "indicator",
            "probability": 0.008318804673999798,
            "start_logit": 0.425505667924881,
            "end_logit": 3.3391242027282715
        },
        {
            "text": "an excellent indicator or marker of DNA double-strand breaks (DSBs)",
            "probability": 0.007700916304930755,
            "start_logit": 3.2995944023132324,
            "end_logit": 0.38785621523857117
        },
        {
            "text": "is an excellent indicator or marker of DNA double-strand breaks",
            "probability": 0.00570975031730255,
            "start_logit": 2.2803735733032227,
            "end_logit": 1.1079130172729492
        },
        {
            "text": "is an excellent indicator or marker of DNA double-strand breaks (DSBs).",
            "probability": 0.004795909955910744,
            "start_logit": 2.2803735733032227,
            "end_logit": 0.9335011839866638
        },
        {
            "text": "indicator or marker",
            "probability": 0.004095487950860081,
            "start_logit": 0.425505667924881,
            "end_logit": 2.6304914951324463
        },
        {
            "text": "is an excellent indicator or marker of DNA double-strand breaks (DSBs)",
            "probability": 0.0027790759862620805,
            "start_logit": 2.2803735733032227,
            "end_logit": 0.38785621523857117
        },
        {
            "text": "",
            "probability": 0.0002520034655882231,
            "start_logit": 0.41546428203582764,
            "end_logit": -0.14766542613506317
        }
    ],
    "5e480ccfd14c9f295d000005_002": [
        {
            "text": "",
            "probability": 0.9999651968056219,
            "start_logit": 5.0632734298706055,
            "end_logit": 5.353712558746338
        },
        {
            "text": "NUCKS1 expression and expression of the DNA double-strand break marker",
            "probability": 9.33004957596672e-06,
            "start_logit": -1.3293243646621704,
            "end_logit": 0.16407492756843567
        },
        {
            "text": "gamma-H2AX",
            "probability": 4.148428318454573e-06,
            "start_logit": -0.7932239770889282,
            "end_logit": -1.182536244392395
        },
        {
            "text": "DNA double-strand break marker",
            "probability": 3.1852895377829366e-06,
            "start_logit": -2.4040215015411377,
            "end_logit": 0.16407492756843567
        },
        {
            "text": "NUCKS1 expression and expression of the DNA double-strand break marker gamma-H2AX",
            "probability": 2.4269350294687124e-06,
            "start_logit": -1.3293243646621704,
            "end_logit": -1.182536244392395
        },
        {
            "text": "gamma",
            "probability": 1.961100577847775e-06,
            "start_logit": -0.7932239770889282,
            "end_logit": -1.9317599534988403
        },
        {
            "text": "NUCKS1",
            "probability": 1.795903574175466e-06,
            "start_logit": -1.3293243646621704,
            "end_logit": -1.4836571216583252
        },
        {
            "text": "gamma-H2AX (\u03b3H2AX",
            "probability": 1.744650501887968e-06,
            "start_logit": -0.7932239770889282,
            "end_logit": -2.0487115383148193
        },
        {
            "text": "NUCKS1 expression and expression",
            "probability": 1.5237450009049601e-06,
            "start_logit": -1.3293243646621704,
            "end_logit": -1.6479942798614502
        },
        {
            "text": "double-strand break marker",
            "probability": 1.5198379849932367e-06,
            "start_logit": -3.143960952758789,
            "end_logit": 0.16407492756843567
        },
        {
            "text": "NUCKS1 expression and expression of the DNA double-strand break marker gamma",
            "probability": 1.1472932212706417e-06,
            "start_logit": -1.3293243646621704,
            "end_logit": -1.9317599534988403
        },
        {
            "text": "NUCKS1 expression and expression of the DNA double-strand break marker gamma-H2AX (\u03b3H2AX",
            "probability": 1.0206644763213462e-06,
            "start_logit": -1.3293243646621704,
            "end_logit": -2.0487115383148193
        },
        {
            "text": "gamma-H2AX (\u03b3H2AX)",
            "probability": 8.892502088755476e-07,
            "start_logit": -0.7932239770889282,
            "end_logit": -2.722642421722412
        },
        {
            "text": "DNA double-strand break marker gamma-H2AX",
            "probability": 8.285583795994598e-07,
            "start_logit": -2.4040215015411377,
            "end_logit": -1.182536244392395
        },
        {
            "text": "expression of the DNA double-strand break marker",
            "probability": 6.909485883955667e-07,
            "start_logit": -3.9322545528411865,
            "end_logit": 0.16407492756843567
        },
        {
            "text": "Methods: NUCKS1 expression and expression of the DNA double-strand break marker",
            "probability": 5.723494831298942e-07,
            "start_logit": -4.120570182800293,
            "end_logit": 0.16407492756843567
        },
        {
            "text": "expression and expression of the DNA double-strand break marker",
            "probability": 5.398163533801497e-07,
            "start_logit": -4.179090976715088,
            "end_logit": 0.16407492756843567
        },
        {
            "text": "NUCKS1 expression and expression of the DNA double-strand break marker gamma-H2AX (\u03b3H2AX)",
            "probability": 5.202337647445284e-07,
            "start_logit": -1.3293243646621704,
            "end_logit": -2.722642421722412
        },
        {
            "text": "the DNA double-strand break marker",
            "probability": 5.07216457352461e-07,
            "start_logit": -4.241382122039795,
            "end_logit": 0.16407492756843567
        },
        {
            "text": "marker",
            "probability": 4.5092334339546763e-07,
            "start_logit": -4.359022617340088,
            "end_logit": 0.16407492756843567
        }
    ],
    "5e480ccfd14c9f295d000005_003": [
        {
            "text": "",
            "probability": 0.9997040282247799,
            "start_logit": 4.717517852783203,
            "end_logit": 5.141841411590576
        },
        {
            "text": "prolonged expression",
            "probability": 4.598641294356959e-05,
            "start_logit": -0.8400166034698486,
            "end_logit": 0.7125073075294495
        },
        {
            "text": "nonregenerating APAP600 dose showed prolonged expression",
            "probability": 2.688994822580151e-05,
            "start_logit": -1.3766100406646729,
            "end_logit": 0.7125073075294495
        },
        {
            "text": "showed prolonged expression",
            "probability": 2.6857844772547735e-05,
            "start_logit": -1.3778046369552612,
            "end_logit": 0.7125073075294495
        },
        {
            "text": "pH2AX",
            "probability": 2.581114612255007e-05,
            "start_logit": -0.8309339284896851,
            "end_logit": 0.12588506937026978
        },
        {
            "text": "prolonged expression of pH2AX",
            "probability": 2.557777330053762e-05,
            "start_logit": -0.8400166034698486,
            "end_logit": 0.12588506937026978
        },
        {
            "text": "Mice treated with nonregenerating APAP600 dose showed prolonged expression",
            "probability": 2.2182068988979967e-05,
            "start_logit": -1.5690783262252808,
            "end_logit": 0.7125073075294495
        },
        {
            "text": "pH2AX, a marker of the DNA double-strand break",
            "probability": 1.5294967629066045e-05,
            "start_logit": -0.8309339284896851,
            "end_logit": -0.3973974883556366
        },
        {
            "text": "prolonged expression of pH2AX, a marker of the DNA double-strand break",
            "probability": 1.5156677382626125e-05,
            "start_logit": -0.8400166034698486,
            "end_logit": -0.3973974883556366
        },
        {
            "text": "nonregenerating APAP600 dose showed prolonged expression of pH2AX",
            "probability": 1.495626546533936e-05,
            "start_logit": -1.3766100406646729,
            "end_logit": 0.12588506937026978
        },
        {
            "text": "showed prolonged expression of pH2AX",
            "probability": 1.4938409433591524e-05,
            "start_logit": -1.3778046369552612,
            "end_logit": 0.12588506937026978
        },
        {
            "text": "Mice treated with nonregenerating APAP600 dose showed prolonged expression of pH2AX",
            "probability": 1.2337729681878827e-05,
            "start_logit": -1.5690783262252808,
            "end_logit": 0.12588506937026978
        },
        {
            "text": "nonregenerating APAP600 dose showed prolonged expression of pH2AX, a marker of the DNA double-strand break",
            "probability": 8.862667122876429e-06,
            "start_logit": -1.3766100406646729,
            "end_logit": -0.3973974883556366
        },
        {
            "text": "showed prolonged expression of pH2AX, a marker of the DNA double-strand break",
            "probability": 8.85208613486954e-06,
            "start_logit": -1.3778046369552612,
            "end_logit": -0.3973974883556366
        },
        {
            "text": "H2AX",
            "probability": 7.900813484113625e-06,
            "start_logit": -0.8858010768890381,
            "end_logit": -1.0030884742736816
        },
        {
            "text": "Mice treated with nonregenerating APAP600 dose showed prolonged expression of pH2AX, a marker of the DNA double-strand break",
            "probability": 7.310995614241265e-06,
            "start_logit": -1.5690783262252808,
            "end_logit": -0.3973974883556366
        },
        {
            "text": "APAP600 dose showed prolonged expression",
            "probability": 6.079393305915288e-06,
            "start_logit": -2.863457679748535,
            "end_logit": 0.7125073075294495
        },
        {
            "text": "expression",
            "probability": 3.748437544829036e-06,
            "start_logit": -3.3470234870910645,
            "end_logit": 0.7125073075294495
        },
        {
            "text": "pH2AX, a marker of the DNA double-strand break (DSB)",
            "probability": 3.6304816275588734e-06,
            "start_logit": -0.8309339284896851,
            "end_logit": -1.8355560302734375
        },
        {
            "text": "prolonged expression of pH2AX, a marker of the DNA double-strand break (DSB)",
            "probability": 3.597656438833621e-06,
            "start_logit": -0.8400166034698486,
            "end_logit": -1.8355560302734375
        }
    ],
    "5e2906948b3851296d00000a_001": [
        {
            "text": "rapidly evolving",
            "probability": 0.4825762882436717,
            "start_logit": 1.4855817556381226,
            "end_logit": 1.0854583978652954
        },
        {
            "text": "rapidly evolving and PARP inhibitors have become more available as a targeted therapy option",
            "probability": 0.15094224445809382,
            "start_logit": 1.4855817556381226,
            "end_logit": -0.07678334414958954
        },
        {
            "text": "rapidly evolving and PARP inhibitors have become more available as a targeted therapy option for ovarian cancer treatment",
            "probability": 0.0815275026227291,
            "start_logit": 1.4855817556381226,
            "end_logit": -0.6927402019500732
        },
        {
            "text": "rapidly evolving and PARP inhibitors have become more available as a targeted therapy option for ovarian cancer treatment.",
            "probability": 0.0731265502994733,
            "start_logit": 1.4855817556381226,
            "end_logit": -0.8014891147613525
        },
        {
            "text": "rapidly evolving and PARP inhibitors have become more available",
            "probability": 0.05394449728881467,
            "start_logit": 1.4855817556381226,
            "end_logit": -1.1057249307632446
        },
        {
            "text": "The landscape of PARP inhibitor use for ovarian cancer is rapidly evolving",
            "probability": 0.03381897657075741,
            "start_logit": -1.1725351810455322,
            "end_logit": 1.0854583978652954
        },
        {
            "text": "Niraparib and olaparib have been approved by the US FDA for maintenance therapy",
            "probability": 0.02618373113997326,
            "start_logit": 1.0378514528274536,
            "end_logit": -1.3808120489120483
        },
        {
            "text": "",
            "probability": 0.016802612259982995,
            "start_logit": -0.3384968638420105,
            "end_logit": -0.44806763529777527
        },
        {
            "text": "evolving",
            "probability": 0.013796585310296617,
            "start_logit": -2.069136142730713,
            "end_logit": 1.0854583978652954
        },
        {
            "text": "is rapidly evolving",
            "probability": 0.011604762095681393,
            "start_logit": -2.2421417236328125,
            "end_logit": 1.0854583978652954
        },
        {
            "text": "The landscape of PARP inhibitor use for ovarian cancer is rapidly evolving and PARP inhibitors have become more available as a targeted therapy option",
            "probability": 0.01057804196605748,
            "start_logit": -1.1725351810455322,
            "end_logit": -0.07678334414958954
        },
        {
            "text": "rapidly evolving and",
            "probability": 0.009152177974736168,
            "start_logit": 1.4855817556381226,
            "end_logit": -2.8796887397766113
        },
        {
            "text": "Niraparib and olaparib have been approved by the US FDA",
            "probability": 0.006816572799894381,
            "start_logit": 1.0378514528274536,
            "end_logit": -2.726593494415283
        },
        {
            "text": "rapidly evolving and PARP inhibitors have become more available as a targeted therapy",
            "probability": 0.0066721351490050505,
            "start_logit": 1.4855817556381226,
            "end_logit": -3.1957406997680664
        },
        {
            "text": "approved by the US FDA for maintenance therapy after partial or complete remission in recurrent ovarian cancer",
            "probability": 0.005367918024566224,
            "start_logit": -2.635312557220459,
            "end_logit": 0.707653820514679
        },
        {
            "text": "evolving and PARP inhibitors have become more available as a targeted therapy option",
            "probability": 0.004315354076291059,
            "start_logit": -2.069136142730713,
            "end_logit": -0.07678334414958954
        },
        {
            "text": "The landscape of PARP inhibitor use for ovarian cancer is rapidly evolving and PARP inhibitors have become more available",
            "probability": 0.0037804337560210267,
            "start_logit": -1.1725351810455322,
            "end_logit": -1.1057249307632446
        },
        {
            "text": "is rapidly evolving and PARP inhibitors have become more available as a targeted therapy option",
            "probability": 0.003629786377402541,
            "start_logit": -2.2421417236328125,
            "end_logit": -0.07678334414958954
        },
        {
            "text": "landscape of PARP inhibitor use for ovarian cancer is rapidly evolving",
            "probability": 0.002771110791886484,
            "start_logit": -3.674309015274048,
            "end_logit": 1.0854583978652954
        },
        {
            "text": "rapidly",
            "probability": 0.0025927187946651084,
            "start_logit": 1.4855817556381226,
            "end_logit": -4.1409735679626465
        }
    ],
    "5e2906948b3851296d00000a_002": [
        {
            "text": "maintenance monotherapy",
            "probability": 0.4904815143547856,
            "start_logit": 2.213879108428955,
            "end_logit": 2.955979347229004
        },
        {
            "text": "maintenance monotherapy for platinum-sensitive, high-grade ovarian cancers independent of BRCA status",
            "probability": 0.1399662541141005,
            "start_logit": 2.213879108428955,
            "end_logit": 1.7019931077957153
        },
        {
            "text": "maintenance monotherapy for platinum-sensitive, high-grade ovarian cancers",
            "probability": 0.08742870267884195,
            "start_logit": 2.213879108428955,
            "end_logit": 1.2314153909683228
        },
        {
            "text": "independent of BRCA status",
            "probability": 0.06893920140281881,
            "start_logit": 1.5057027339935303,
            "end_logit": 1.7019931077957153
        },
        {
            "text": "niraparib and olaparib as maintenance monotherapy",
            "probability": 0.06873985690384803,
            "start_logit": 0.2488207072019577,
            "end_logit": 2.955979347229004
        },
        {
            "text": "The recent United States Food and Drug Administration approvals of niraparib and olaparib as maintenance monotherapy",
            "probability": 0.02624817368516237,
            "start_logit": -0.7139120697975159,
            "end_logit": 2.955979347229004
        },
        {
            "text": "as maintenance monotherapy",
            "probability": 0.026139460828909424,
            "start_logit": -0.7180624008178711,
            "end_logit": 2.955979347229004
        },
        {
            "text": "niraparib and olaparib as maintenance monotherapy for platinum-sensitive, high-grade ovarian cancers independent of BRCA status",
            "probability": 0.019615948812724146,
            "start_logit": 0.2488207072019577,
            "end_logit": 1.7019931077957153
        },
        {
            "text": "recent United States Food and Drug Administration approvals of niraparib and olaparib as maintenance monotherapy",
            "probability": 0.012488091299421415,
            "start_logit": -1.456732988357544,
            "end_logit": 2.955979347229004
        },
        {
            "text": "niraparib and olaparib as maintenance monotherapy for platinum-sensitive, high-grade ovarian cancers",
            "probability": 0.01225293173248015,
            "start_logit": 0.2488207072019577,
            "end_logit": 1.2314153909683228
        },
        {
            "text": "as maintenance monotherapy for platinum-sensitive, high-grade ovarian cancers independent of BRCA status",
            "probability": 0.0074592870673170055,
            "start_logit": -0.7180624008178711,
            "end_logit": 1.7019931077957153
        },
        {
            "text": "United States Food and Drug Administration approvals of niraparib and olaparib as maintenance monotherapy",
            "probability": 0.0068327854402249555,
            "start_logit": -2.0597760677337646,
            "end_logit": 2.955979347229004
        },
        {
            "text": "maintenance",
            "probability": 0.005607362309879983,
            "start_logit": 2.213879108428955,
            "end_logit": -1.51532781124115
        },
        {
            "text": "approvals of niraparib and olaparib as maintenance monotherapy",
            "probability": 0.005425572775865267,
            "start_logit": -2.2903850078582764,
            "end_logit": 2.955979347229004
        },
        {
            "text": "as maintenance monotherapy for platinum-sensitive, high-grade ovarian cancers",
            "probability": 0.004659378757632192,
            "start_logit": -0.7180624008178711,
            "end_logit": 1.2314153909683228
        },
        {
            "text": "maintenance monotherapy for platinum-sensitive, high-grade",
            "probability": 0.004458707693710724,
            "start_logit": 2.213879108428955,
            "end_logit": -1.74454927444458
        },
        {
            "text": "platinum-sensitive, high-grade ovarian cancers independent of BRCA status",
            "probability": 0.0038613610663867553,
            "start_logit": -1.376502513885498,
            "end_logit": 1.7019931077957153
        },
        {
            "text": "Food and Drug Administration approvals of niraparib and olaparib as maintenance monotherapy",
            "probability": 0.00362486306926873,
            "start_logit": -2.6936919689178467,
            "end_logit": 2.955979347229004
        },
        {
            "text": "PURPOSE OF REVIEW: The recent United States Food and Drug Administration approvals of niraparib and olaparib as maintenance monotherapy",
            "probability": 0.0032567091389224803,
            "start_logit": -2.8007912635803223,
            "end_logit": 2.955979347229004
        },
        {
            "text": "monotherapy",
            "probability": 0.0025107285882670395,
            "start_logit": -3.0609354972839355,
            "end_logit": 2.955979347229004
        },
        {
            "text": "",
            "probability": 3.1082794323591978e-06,
            "start_logit": -3.9339792728424072,
            "end_logit": -2.8652358055114746
        }
    ],
    "5e2906948b3851296d00000a_003": [
        {
            "text": "in complete or partial response to platinum-based chemotherapy",
            "probability": 0.1529211527188797,
            "start_logit": 1.2153047323226929,
            "end_logit": 1.896563172340393
        },
        {
            "text": "Niraparib is a highly selective inhibitor of PARP-1 and PARP-2 approved in the United States for maintenance treatment",
            "probability": 0.11270360272756534,
            "start_logit": 2.44319748878479,
            "end_logit": 0.3635093569755554
        },
        {
            "text": "Niraparib is a highly selective inhibitor of PARP-1 and PARP-2",
            "probability": 0.11260137948582323,
            "start_logit": 2.44319748878479,
            "end_logit": 0.3626019358634949
        },
        {
            "text": "Niraparib is a highly selective inhibitor of PARP-1 and PARP-2 approved in the United States",
            "probability": 0.09466244921516964,
            "start_logit": 2.44319748878479,
            "end_logit": 0.1890653669834137
        },
        {
            "text": "maintenance treatment of adult patients with recurrent ovarian cancer in complete or partial response to platinum-based chemotherapy",
            "probability": 0.053860157633385884,
            "start_logit": 0.171773299574852,
            "end_logit": 1.896563172340393
        },
        {
            "text": "Niraparib is a highly selective inhibitor of PARP-1 and PARP-2 approved",
            "probability": 0.04981424796042274,
            "start_logit": 2.44319748878479,
            "end_logit": -0.45295098423957825
        },
        {
            "text": "Niraparib is a highly selective inhibitor",
            "probability": 0.04610598788837153,
            "start_logit": 2.44319748878479,
            "end_logit": -0.5303092002868652
        },
        {
            "text": "maintenance treatment of adult patients with recurrent ovarian cancer",
            "probability": 0.045297427820265766,
            "start_logit": 0.171773299574852,
            "end_logit": 1.7234224081039429
        },
        {
            "text": "Niraparib is a highly selective",
            "probability": 0.03881878486762599,
            "start_logit": 2.44319748878479,
            "end_logit": -0.7023477554321289
        },
        {
            "text": "a highly selective inhibitor of PARP-1 and PARP-2 approved in the United States for maintenance treatment",
            "probability": 0.03704161797075444,
            "start_logit": 1.3304781913757324,
            "end_logit": 0.3635093569755554
        },
        {
            "text": "a highly selective inhibitor of PARP-1 and PARP-2",
            "probability": 0.03700802087024741,
            "start_logit": 1.3304781913757324,
            "end_logit": 0.3626019358634949
        },
        {
            "text": "highly selective inhibitor of PARP-1 and PARP-2 approved in the United States for maintenance treatment",
            "probability": 0.03426913295970895,
            "start_logit": 1.2526811361312866,
            "end_logit": 0.3635093569755554
        },
        {
            "text": "highly selective inhibitor of PARP-1 and PARP-2",
            "probability": 0.03423805052952879,
            "start_logit": 1.2526811361312866,
            "end_logit": 0.3626019358634949
        },
        {
            "text": "a highly selective inhibitor of PARP-1 and PARP-2 approved in the United States",
            "probability": 0.031112140119249634,
            "start_logit": 1.3304781913757324,
            "end_logit": 0.1890653669834137
        },
        {
            "text": "highly selective inhibitor of PARP-1 and PARP-2 approved in the United States",
            "probability": 0.02878346370424341,
            "start_logit": 1.2526811361312866,
            "end_logit": 0.1890653669834137
        },
        {
            "text": "in complete or partial response to platinum-based chemotherapy.",
            "probability": 0.02164894737272816,
            "start_logit": 1.2153047323226929,
            "end_logit": -0.05840244144201279
        },
        {
            "text": "for maintenance treatment of adult patients with recurrent ovarian cancer in complete or partial response to platinum-based chemotherapy",
            "probability": 0.019502011163582987,
            "start_logit": -0.8441001176834106,
            "end_logit": 1.896563172340393
        },
        {
            "text": "selective inhibitor of PARP-1 and PARP-2 approved in the United States for maintenance treatment of adult patients with recurrent ovarian cancer",
            "probability": 0.01682455757054314,
            "start_logit": -0.8186373710632324,
            "end_logit": 1.7234224081039429
        },
        {
            "text": "for maintenance treatment of adult patients with recurrent ovarian cancer",
            "probability": 0.01640156623835866,
            "start_logit": -0.8441001176834106,
            "end_logit": 1.7234224081039429
        },
        {
            "text": "a highly selective inhibitor of PARP-1 and PARP-2 approved",
            "probability": 0.01637215047074186,
            "start_logit": 1.3304781913757324,
            "end_logit": -0.45295098423957825
        },
        {
            "text": "",
            "probability": 1.3150712802666173e-05,
            "start_logit": -3.157089948654175,
            "end_logit": -3.0922439098358154
        }
    ],
    "5e2906948b3851296d00000a_004": [
        {
            "text": "approved",
            "probability": 0.4872737588137697,
            "start_logit": 0.5831602811813354,
            "end_logit": 1.8632267713546753
        },
        {
            "text": "approved by the Food and Drug Administration for the treatment of ovarian cancer",
            "probability": 0.1262673081325746,
            "start_logit": 0.5831602811813354,
            "end_logit": 0.5128018260002136
        },
        {
            "text": "Niraparib) have recently been approved",
            "probability": 0.08572657142573381,
            "start_logit": -1.1545029878616333,
            "end_logit": 1.8632267713546753
        },
        {
            "text": "have recently been approved",
            "probability": 0.08174821542021589,
            "start_logit": -1.202021837234497,
            "end_logit": 1.8632267713546753
        },
        {
            "text": "recently been approved",
            "probability": 0.0764958444555653,
            "start_logit": -1.2684293985366821,
            "end_logit": 1.8632267713546753
        },
        {
            "text": "approved by the Food and Drug Administration for the treatment",
            "probability": 0.031335257014109295,
            "start_logit": 0.5831602811813354,
            "end_logit": -0.8808554410934448
        },
        {
            "text": "Niraparib) have recently been approved by the Food and Drug Administration for the treatment of ovarian cancer",
            "probability": 0.02221433683544465,
            "start_logit": -1.1545029878616333,
            "end_logit": 0.5128018260002136
        },
        {
            "text": "have recently been approved by the Food and Drug Administration for the treatment of ovarian cancer",
            "probability": 0.021183424961937015,
            "start_logit": -1.202021837234497,
            "end_logit": 0.5128018260002136
        },
        {
            "text": "recently been approved by the Food and Drug Administration for the treatment of ovarian cancer",
            "probability": 0.01982237743778008,
            "start_logit": -1.2684293985366821,
            "end_logit": 0.5128018260002136
        },
        {
            "text": "",
            "probability": 0.010038039295766773,
            "start_logit": -1.0011470317840576,
            "end_logit": -0.43491020798683167
        },
        {
            "text": "Niraparib) have recently been approved by the Food and Drug Administration for the treatment",
            "probability": 0.005512843858251816,
            "start_logit": -1.1545029878616333,
            "end_logit": -0.8808554410934448
        },
        {
            "text": "three PARP1 inhibitors (Olaparib, Rucaparib, and Niraparib) have recently been approved",
            "probability": 0.005472167223089093,
            "start_logit": -3.9059910774230957,
            "end_logit": 1.8632267713546753
        },
        {
            "text": "have recently been approved by the Food and Drug Administration for the treatment",
            "probability": 0.005257006547763331,
            "start_logit": -1.202021837234497,
            "end_logit": -0.8808554410934448
        },
        {
            "text": "recently been approved by the Food and Drug Administration for the treatment",
            "probability": 0.004919240782351626,
            "start_logit": -1.2684293985366821,
            "end_logit": -0.8808554410934448
        },
        {
            "text": "ovarian cancer",
            "probability": 0.004546609725809057,
            "start_logit": -2.740859031677246,
            "end_logit": 0.5128018260002136
        },
        {
            "text": "approved by the Food and Drug Administration for the treatment of o",
            "probability": 0.00371366139678313,
            "start_logit": 0.5831602811813354,
            "end_logit": -3.0135810375213623
        },
        {
            "text": "approved by the Food and Drug Administration for the treatment of ovarian cancer.",
            "probability": 0.002801251789794498,
            "start_logit": 0.5831602811813354,
            "end_logit": -3.2955329418182373
        },
        {
            "text": "treatment of ovarian cancer",
            "probability": 0.0020397682940457465,
            "start_logit": -3.5424046516418457,
            "end_logit": 0.5128018260002136
        },
        {
            "text": "approved by the Food and Drug Administration",
            "probability": 0.001843441836775566,
            "start_logit": 0.5831602811813354,
            "end_logit": -3.7139649391174316
        },
        {
            "text": "Food and Drug Administration for the treatment of ovarian cancer",
            "probability": 0.0017888747524391047,
            "start_logit": -3.673654079437256,
            "end_logit": 0.5128018260002136
        }
    ],
    "5e2906948b3851296d00000a_005": [
        {
            "text": "maintenance treatment of women with recurrent ovarian cancer",
            "probability": 0.38280401656315294,
            "start_logit": -0.6522672772407532,
            "end_logit": 1.4314237833023071
        },
        {
            "text": "maintenance treatment of women with recurrent ovarian cancer who are in complete or partial response to platinum-based chemotherapy",
            "probability": 0.1246745145095514,
            "start_logit": -0.6522672772407532,
            "end_logit": 0.3096070885658264
        },
        {
            "text": "maintenance treatment of women with recurrent ovarian cancer who are in complete or partial response to platinum-based chemotherapy.",
            "probability": 0.07645480212582077,
            "start_logit": -0.6522672772407532,
            "end_logit": -0.17939962446689606
        },
        {
            "text": "women with recurrent ovarian cancer",
            "probability": 0.060967252465964454,
            "start_logit": -2.4894535541534424,
            "end_logit": 1.4314237833023071
        },
        {
            "text": "Niraparib testing is ongoing in newly diagnosed ovarian cancer patients as maintenance therapy",
            "probability": 0.04163515957127611,
            "start_logit": 0.3959691524505615,
            "end_logit": -1.8353908061981201
        },
        {
            "text": "Niraparib testing is ongoing",
            "probability": 0.04032979323310754,
            "start_logit": 0.3959691524505615,
            "end_logit": -1.8672453165054321
        },
        {
            "text": "European Medicines Agency (EMA) for the maintenance treatment of women with recurrent ovarian cancer",
            "probability": 0.03973491724822,
            "start_logit": -2.91756010055542,
            "end_logit": 1.4314237833023071
        },
        {
            "text": "ovarian cancer",
            "probability": 0.035649753982061855,
            "start_logit": -3.026048183441162,
            "end_logit": 1.4314237833023071
        },
        {
            "text": "maintenance treatment",
            "probability": 0.03015074111769294,
            "start_logit": -0.6522672772407532,
            "end_logit": -1.1098898649215698
        },
        {
            "text": "for the maintenance treatment of women with recurrent ovarian cancer",
            "probability": 0.027740838321897467,
            "start_logit": -3.2768847942352295,
            "end_logit": 1.4314237833023071
        },
        {
            "text": "the maintenance treatment of women with recurrent ovarian cancer",
            "probability": 0.02623810448809942,
            "start_logit": -3.332577705383301,
            "end_logit": 1.4314237833023071
        },
        {
            "text": "women with recurrent ovarian cancer who are in complete or partial response to platinum-based chemotherapy",
            "probability": 0.01985627703287535,
            "start_logit": -2.4894535541534424,
            "end_logit": 0.3096070885658264
        },
        {
            "text": "Niraparib testing is ongoing in newly diagnosed ovarian cancer patients as maintenance therapy following completion of platinum-based chemotherapy",
            "probability": 0.019501509280641573,
            "start_logit": 0.3959691524505615,
            "end_logit": -2.593843936920166
        },
        {
            "text": "women with recurrent ovarian cancer who are in complete or partial response to platinum-based chemotherapy.",
            "probability": 0.01217656822227017,
            "start_logit": -2.4894535541534424,
            "end_logit": -0.17939962446689606
        },
        {
            "text": "Niraparib testing is ongoing in newly diagnosed ovarian cancer patients",
            "probability": 0.012119555824328759,
            "start_logit": 0.3959691524505615,
            "end_logit": -3.0695154666900635
        },
        {
            "text": "ovarian cancer who are in complete or partial response to platinum-based chemotherapy",
            "probability": 0.011610682171003969,
            "start_logit": -3.026048183441162,
            "end_logit": 0.3096070885658264
        },
        {
            "text": "approved by the European Medicines Agency (EMA) for the maintenance treatment of women with recurrent ovarian cancer",
            "probability": 0.011282339313376648,
            "start_logit": -4.176551818847656,
            "end_logit": 1.4314237833023071
        },
        {
            "text": "for the maintenance treatment of women with recurrent ovarian cancer who are in complete or partial response to platinum-based chemotherapy",
            "probability": 0.009034846553915267,
            "start_logit": -3.2768847942352295,
            "end_logit": 0.3096070885658264
        },
        {
            "text": "the maintenance treatment of women with recurrent ovarian cancer who are in complete or partial response to platinum-based chemotherapy",
            "probability": 0.008545424805293305,
            "start_logit": -3.332577705383301,
            "end_logit": 0.3096070885658264
        },
        {
            "text": "cancer",
            "probability": 0.00836097117800895,
            "start_logit": -4.476215839385986,
            "end_logit": 1.4314237833023071
        },
        {
            "text": "",
            "probability": 0.0011319319914411747,
            "start_logit": -2.772134304046631,
            "end_logit": -2.272306442260742
        }
    ],
    "5c72768a7c78d6947100006c_002": [
        {
            "text": "moderately biased X-chromosome inactivation profile and presenting with mild intellectual delay and minor psychotic features. The low mutation rate",
            "probability": 0.3177216193108013,
            "start_logit": 3.390692710876465,
            "end_logit": 1.5012242794036865
        },
        {
            "text": "moderately biased",
            "probability": 0.2305667180178732,
            "start_logit": 3.390692710876465,
            "end_logit": 1.180588960647583
        },
        {
            "text": "moderately biased X-chromosome inactivation profile and presenting with mild intellectual delay and minor psychotic features.",
            "probability": 0.07099888055649133,
            "start_logit": 3.390692710876465,
            "end_logit": 0.0027128010988235474
        },
        {
            "text": "moderately biased X-chromosome inactivation profile",
            "probability": 0.06407216925138517,
            "start_logit": 3.390692710876465,
            "end_logit": -0.09994121640920639
        },
        {
            "text": "borderline mental impairment without any features of Rett syndrome",
            "probability": 0.06353957255776113,
            "start_logit": 0.9921551942825317,
            "end_logit": 2.2902491092681885
        },
        {
            "text": "low mutation rate",
            "probability": 0.0536356420510198,
            "start_logit": 1.611730933189392,
            "end_logit": 1.5012242794036865
        },
        {
            "text": "without any features of Rett syndrome",
            "probability": 0.03848755261798804,
            "start_logit": 0.49082717299461365,
            "end_logit": 2.2902491092681885
        },
        {
            "text": "moderately biased X-chromosome inactivation profile and presenting with mild intellectual delay and minor psychotic features",
            "probability": 0.030011496594335732,
            "start_logit": 3.390692710876465,
            "end_logit": -0.8583707809448242
        },
        {
            "text": "borderline mental impairment without any features of Rett syndrome.",
            "probability": 0.02133036967161834,
            "start_logit": 0.9921551942825317,
            "end_logit": 1.1987180709838867
        },
        {
            "text": "presenting with borderline mental impairment without any features of Rett syndrome",
            "probability": 0.01930928074862868,
            "start_logit": -0.19892185926437378,
            "end_logit": 2.2902491092681885
        },
        {
            "text": "The low mutation rate",
            "probability": 0.01614184552654965,
            "start_logit": 0.41093212366104126,
            "end_logit": 1.5012242794036865
        },
        {
            "text": "moderately biased X-chromosome inactivation profile and presenting with mild intellectual delay and minor psychotic features. The low",
            "probability": 0.013373900273592731,
            "start_logit": 3.390692710876465,
            "end_logit": -1.6666462421417236
        },
        {
            "text": "without any features of Rett syndrome.",
            "probability": 0.012920353286154906,
            "start_logit": 0.49082717299461365,
            "end_logit": 1.1987180709838867
        },
        {
            "text": "",
            "probability": 0.012232743897985435,
            "start_logit": 1.1719416379928589,
            "end_logit": 0.4629160463809967
        },
        {
            "text": "borderline mental impairment",
            "probability": 0.011256126737965867,
            "start_logit": 0.9921551942825317,
            "end_logit": 0.5594987869262695
        },
        {
            "text": "presenting with borderline mental impairment without any features of Rett syndrome.",
            "probability": 0.006482166622806533,
            "start_logit": -0.19892185926437378,
            "end_logit": 1.1987180709838867
        },
        {
            "text": "a moderately biased X-chromosome inactivation profile and presenting with mild intellectual delay and minor psychotic features. The low mutation rate",
            "probability": 0.005989662964197143,
            "start_logit": -0.5804477334022522,
            "end_logit": 1.5012242794036865
        },
        {
            "text": "a moderately biased",
            "probability": 0.004346625623663351,
            "start_logit": -0.5804477334022522,
            "end_logit": 1.180588960647583
        },
        {
            "text": "low mutation rate suggests that a large-scale routine screening for MECP2 in mentally retarded subjects is not cost-effective in clinical practice.",
            "probability": 0.004018370082613264,
            "start_logit": 1.611730933189392,
            "end_logit": -1.0901131629943848
        },
        {
            "text": "borderline",
            "probability": 0.0035649036065684946,
            "start_logit": 0.9921551942825317,
            "end_logit": -0.5902767777442932
        }
    ],
    "5c72768a7c78d6947100006c_003": [
        {
            "text": "moderately biased X-chromosome inactivation profile and presenting with mild intellectual delay and minor psychotic features. The low mutation rate",
            "probability": 0.3177216193108013,
            "start_logit": 3.390692710876465,
            "end_logit": 1.5012242794036865
        },
        {
            "text": "moderately biased",
            "probability": 0.2305667180178732,
            "start_logit": 3.390692710876465,
            "end_logit": 1.180588960647583
        },
        {
            "text": "moderately biased X-chromosome inactivation profile and presenting with mild intellectual delay and minor psychotic features.",
            "probability": 0.07099888055649133,
            "start_logit": 3.390692710876465,
            "end_logit": 0.0027128010988235474
        },
        {
            "text": "moderately biased X-chromosome inactivation profile",
            "probability": 0.06407216925138517,
            "start_logit": 3.390692710876465,
            "end_logit": -0.09994121640920639
        },
        {
            "text": "borderline mental impairment without any features of Rett syndrome",
            "probability": 0.06353957255776113,
            "start_logit": 0.9921551942825317,
            "end_logit": 2.2902491092681885
        },
        {
            "text": "low mutation rate",
            "probability": 0.0536356420510198,
            "start_logit": 1.611730933189392,
            "end_logit": 1.5012242794036865
        },
        {
            "text": "without any features of Rett syndrome",
            "probability": 0.03848755261798804,
            "start_logit": 0.49082717299461365,
            "end_logit": 2.2902491092681885
        },
        {
            "text": "moderately biased X-chromosome inactivation profile and presenting with mild intellectual delay and minor psychotic features",
            "probability": 0.030011496594335732,
            "start_logit": 3.390692710876465,
            "end_logit": -0.8583707809448242
        },
        {
            "text": "borderline mental impairment without any features of Rett syndrome.",
            "probability": 0.02133036967161834,
            "start_logit": 0.9921551942825317,
            "end_logit": 1.1987180709838867
        },
        {
            "text": "presenting with borderline mental impairment without any features of Rett syndrome",
            "probability": 0.01930928074862868,
            "start_logit": -0.19892185926437378,
            "end_logit": 2.2902491092681885
        },
        {
            "text": "The low mutation rate",
            "probability": 0.01614184552654965,
            "start_logit": 0.41093212366104126,
            "end_logit": 1.5012242794036865
        },
        {
            "text": "moderately biased X-chromosome inactivation profile and presenting with mild intellectual delay and minor psychotic features. The low",
            "probability": 0.013373900273592731,
            "start_logit": 3.390692710876465,
            "end_logit": -1.6666462421417236
        },
        {
            "text": "without any features of Rett syndrome.",
            "probability": 0.012920353286154906,
            "start_logit": 0.49082717299461365,
            "end_logit": 1.1987180709838867
        },
        {
            "text": "",
            "probability": 0.012232743897985435,
            "start_logit": 1.1719416379928589,
            "end_logit": 0.4629160463809967
        },
        {
            "text": "borderline mental impairment",
            "probability": 0.011256126737965867,
            "start_logit": 0.9921551942825317,
            "end_logit": 0.5594987869262695
        },
        {
            "text": "presenting with borderline mental impairment without any features of Rett syndrome.",
            "probability": 0.006482166622806533,
            "start_logit": -0.19892185926437378,
            "end_logit": 1.1987180709838867
        },
        {
            "text": "a moderately biased X-chromosome inactivation profile and presenting with mild intellectual delay and minor psychotic features. The low mutation rate",
            "probability": 0.005989662964197143,
            "start_logit": -0.5804477334022522,
            "end_logit": 1.5012242794036865
        },
        {
            "text": "a moderately biased",
            "probability": 0.004346625623663351,
            "start_logit": -0.5804477334022522,
            "end_logit": 1.180588960647583
        },
        {
            "text": "low mutation rate suggests that a large-scale routine screening for MECP2 in mentally retarded subjects is not cost-effective in clinical practice.",
            "probability": 0.004018370082613264,
            "start_logit": 1.611730933189392,
            "end_logit": -1.0901131629943848
        },
        {
            "text": "borderline",
            "probability": 0.0035649036065684946,
            "start_logit": 0.9921551942825317,
            "end_logit": -0.5902767777442932
        }
    ],
    "5c72768a7c78d6947100006c_005": [
        {
            "text": "There is an excess",
            "probability": 0.24125663581057905,
            "start_logit": 4.90087890625,
            "end_logit": 1.5215175151824951
        },
        {
            "text": "There is an excess of escaping genes associated with mental retardation,",
            "probability": 0.14909270337256586,
            "start_logit": 4.90087890625,
            "end_logit": 1.040224552154541
        },
        {
            "text": "There is an excess of escaping genes",
            "probability": 0.13491805042903549,
            "start_logit": 4.90087890625,
            "end_logit": 0.9403238296508789
        },
        {
            "text": "an excess",
            "probability": 0.12105916278766513,
            "start_logit": 4.211297035217285,
            "end_logit": 1.5215175151824951
        },
        {
            "text": "an excess of escaping genes associated with mental retardation,",
            "probability": 0.07481260686318944,
            "start_logit": 4.211297035217285,
            "end_logit": 1.040224552154541
        },
        {
            "text": "an excess of escaping genes",
            "probability": 0.06769996678021661,
            "start_logit": 4.211297035217285,
            "end_logit": 0.9403238296508789
        },
        {
            "text": "excess",
            "probability": 0.04154131888892168,
            "start_logit": 3.1417062282562256,
            "end_logit": 1.5215175151824951
        },
        {
            "text": "There is an excess of escaping genes associated with mental retardation",
            "probability": 0.03565826088992031,
            "start_logit": 4.90087890625,
            "end_logit": -0.3903628885746002
        },
        {
            "text": "excess of escaping genes associated with mental retardation,",
            "probability": 0.025671863963459874,
            "start_logit": 3.1417062282562256,
            "end_logit": 1.040224552154541
        },
        {
            "text": "excess of escaping genes",
            "probability": 0.02323116932271513,
            "start_logit": 3.1417062282562256,
            "end_logit": 0.9403238296508789
        },
        {
            "text": "There is an excess of escaping genes associated with mental retardation, consistent with this being a common phenotype of polyX phenotypes",
            "probability": 0.018350528522027294,
            "start_logit": 4.90087890625,
            "end_logit": -1.054685354232788
        },
        {
            "text": "an excess of escaping genes associated with mental retardation",
            "probability": 0.01789281026527771,
            "start_logit": 4.211297035217285,
            "end_logit": -0.3903628885746002
        },
        {
            "text": "an excess of escaping genes associated with mental retardation, consistent with this being a common phenotype of polyX phenotypes.",
            "probability": 0.013294195932076253,
            "start_logit": 4.211297035217285,
            "end_logit": -0.6874343156814575
        },
        {
            "text": "an excess of escaping genes associated with mental retardation, consistent with this being a common phenotype of polyX phenotypes",
            "probability": 0.009208035302838216,
            "start_logit": 4.211297035217285,
            "end_logit": -1.054685354232788
        },
        {
            "text": "excess of escaping genes associated with mental retardation",
            "probability": 0.006139898211196019,
            "start_logit": 3.1417062282562256,
            "end_logit": -0.3903628885746002
        },
        {
            "text": "There is an excess of escaping genes associated",
            "probability": 0.0050588152632088206,
            "start_logit": 4.90087890625,
            "end_logit": -2.3432114124298096
        },
        {
            "text": "There is an excess of escaping genes associated with mental retardation, consistent with this being a common phenotype",
            "probability": 0.0048457651357381466,
            "start_logit": 4.90087890625,
            "end_logit": -2.3862385749816895
        },
        {
            "text": "excess of escaping genes associated with mental retardation, consistent with this being a common phenotype of polyX phenotypes.",
            "probability": 0.004561888748188628,
            "start_logit": 3.1417062282562256,
            "end_logit": -0.6874343156814575
        },
        {
            "text": "excess of escaping genes associated with mental retardation, consistent with this being a common phenotype of polyX phenotypes",
            "probability": 0.0031597272114509095,
            "start_logit": 3.1417062282562256,
            "end_logit": -1.054685354232788
        },
        {
            "text": "an excess of escaping genes associated",
            "probability": 0.0025384418480507856,
            "start_logit": 4.211297035217285,
            "end_logit": -2.3432114124298096
        },
        {
            "text": "",
            "probability": 8.154451678837854e-06,
            "start_logit": -1.2055160999298096,
            "end_logit": -2.667140007019043
        }
    ],
    "5e2d80cafbd6abf43b00000d_001": [
        {
            "text": "analyzes two 4D spectra recorded using a single, fully protonated protein sample",
            "probability": 0.8014059471956364,
            "start_logit": 3.9158291816711426,
            "end_logit": 5.084181785583496
        },
        {
            "text": "analyzes two 4D spectra recorded using a single, fully protonated protein sample in an iterative ansatz",
            "probability": 0.16065489408340602,
            "start_logit": 3.9158291816711426,
            "end_logit": 3.4770727157592773
        },
        {
            "text": "The 4D-CHAINS algorithm analyzes two 4D spectra recorded using a single, fully protonated protein sample",
            "probability": 0.007530108887315235,
            "start_logit": -0.7516289353370667,
            "end_logit": 5.084181785583496
        },
        {
            "text": "4D-CHAINS algorithm analyzes two 4D spectra recorded using a single, fully protonated protein sample",
            "probability": 0.00623330165954782,
            "start_logit": -0.9406322836875916,
            "end_logit": 5.084181785583496
        },
        {
            "text": "two 4D spectra recorded using a single, fully protonated protein sample",
            "probability": 0.0057846570516680825,
            "start_logit": -1.015329360961914,
            "end_logit": 5.084181785583496
        },
        {
            "text": "analyzes two 4D spectra",
            "probability": 0.002804592392124186,
            "start_logit": 3.9158291816711426,
            "end_logit": -0.570927619934082
        },
        {
            "text": "analyzes two",
            "probability": 0.002740860332889386,
            "start_logit": 3.9158291816711426,
            "end_logit": -0.5939139723777771
        },
        {
            "text": "a complete pipeline for NOE-driven structure determination of medium- to larger-sized proteins",
            "probability": 0.0018691606158522064,
            "start_logit": 1.4220731258392334,
            "end_logit": 1.5170596837997437
        },
        {
            "text": "4D spectra recorded using a single, fully protonated protein sample",
            "probability": 0.001829803050539002,
            "start_logit": -2.166330099105835,
            "end_logit": 5.084181785583496
        },
        {
            "text": "a single, fully protonated protein sample",
            "probability": 0.0016850546607030308,
            "start_logit": -2.2487404346466064,
            "end_logit": 5.084181785583496
        },
        {
            "text": "The 4D-CHAINS algorithm analyzes two 4D spectra recorded using a single, fully protonated protein sample in an iterative ansatz",
            "probability": 0.0015095331522824646,
            "start_logit": -0.7516289353370667,
            "end_logit": 3.4770727157592773
        },
        {
            "text": "4D-CHAINS algorithm analyzes two 4D spectra recorded using a single, fully protonated protein sample in an iterative ansatz",
            "probability": 0.0012495669908724962,
            "start_logit": -0.9406322836875916,
            "end_logit": 3.4770727157592773
        },
        {
            "text": "two 4D spectra recorded using a single, fully protonated protein sample in an iterative ansatz",
            "probability": 0.0011596288612488897,
            "start_logit": -1.015329360961914,
            "end_logit": 3.4770727157592773
        },
        {
            "text": "analyzes two 4D spectra recorded",
            "probability": 0.0008856528959847195,
            "start_logit": 3.9158291816711426,
            "end_logit": -1.7236160039901733
        },
        {
            "text": "analyzes two 4D spectra recorded using a single, fully protonated protein sample in an iterative ansatz where",
            "probability": 0.0006723163352736317,
            "start_logit": 3.9158291816711426,
            "end_logit": -1.9992121458053589
        },
        {
            "text": "NOE-driven structure determination of medium- to larger-sized proteins",
            "probability": 0.00045756051621160095,
            "start_logit": 0.014737537130713463,
            "end_logit": 1.5170596837997437
        },
        {
            "text": "complete pipeline for NOE-driven structure determination of medium- to larger-sized proteins",
            "probability": 0.00045470584372220074,
            "start_logit": 0.008479097858071327,
            "end_logit": 1.5170596837997437
        },
        {
            "text": "4D spectra recorded using a single, fully protonated protein sample in an iterative ansatz",
            "probability": 0.00036681386793611416,
            "start_logit": -2.166330099105835,
            "end_logit": 3.4770727157592773
        },
        {
            "text": "a complete pipeline for NOE-driven structure determination",
            "probability": 0.0003621768340257846,
            "start_logit": 1.4220731258392334,
            "end_logit": -0.12405247241258621
        },
        {
            "text": "an iterative ansatz",
            "probability": 0.00034265906571250075,
            "start_logit": -2.2344486713409424,
            "end_logit": 3.4770727157592773
        },
        {
            "text": "",
            "probability": 1.005707048073874e-06,
            "start_logit": -2.3317699432373047,
            "end_logit": -2.2566511631011963
        }
    ],
    "5e29fe76aa19d74431000007_001": [
        {
            "text": "There were 29 patient entries over 7 dose escalations",
            "probability": 0.23107508049855224,
            "start_logit": 1.757069706916809,
            "end_logit": 2.4357833862304688
        },
        {
            "text": "29 patient entries over 7 dose escalations",
            "probability": 0.21143405732036682,
            "start_logit": 1.6682401895523071,
            "end_logit": 2.4357833862304688
        },
        {
            "text": "There were 29 patient entries over 7 dose escalations.",
            "probability": 0.19264426077890665,
            "start_logit": 1.757069706916809,
            "end_logit": 2.2538859844207764
        },
        {
            "text": "29 patient entries over 7 dose escalations.",
            "probability": 0.17626979762632708,
            "start_logit": 1.6682401895523071,
            "end_logit": 2.2538859844207764
        },
        {
            "text": "Results: There were 29 patient entries over 7 dose escalations",
            "probability": 0.05149404288478737,
            "start_logit": 0.25579315423965454,
            "end_logit": 2.4357833862304688
        },
        {
            "text": "Results: There were 29 patient entries over 7 dose escalations.",
            "probability": 0.042929907477060616,
            "start_logit": 0.25579315423965454,
            "end_logit": 2.2538859844207764
        },
        {
            "text": "There were 29 patient entries",
            "probability": 0.03098637870735719,
            "start_logit": 1.757069706916809,
            "end_logit": 0.42658841609954834
        },
        {
            "text": "29 patient entries",
            "probability": 0.028352584612874345,
            "start_logit": 1.6682401895523071,
            "end_logit": 0.42658841609954834
        },
        {
            "text": "Results: There were 29 patient entries",
            "probability": 0.0069051751948255215,
            "start_logit": 0.25579315423965454,
            "end_logit": 0.42658841609954834
        },
        {
            "text": "7 dose escalations",
            "probability": 0.004652810794860968,
            "start_logit": -2.1482014656066895,
            "end_logit": 2.4357833862304688
        },
        {
            "text": "There were 29",
            "probability": 0.003943726461053895,
            "start_logit": 1.757069706916809,
            "end_logit": -1.6348332166671753
        },
        {
            "text": "7 dose escalations.",
            "probability": 0.003878987271956069,
            "start_logit": -2.1482014656066895,
            "end_logit": 2.2538859844207764
        },
        {
            "text": "29",
            "probability": 0.0036085158331364987,
            "start_logit": 1.6682401895523071,
            "end_logit": -1.6348332166671753
        },
        {
            "text": "over 7 dose escalations",
            "probability": 0.002533102322698003,
            "start_logit": -2.75622820854187,
            "end_logit": 2.4357833862304688
        },
        {
            "text": "over 7 dose escalations.",
            "probability": 0.002111814148806693,
            "start_logit": -2.75622820854187,
            "end_logit": 2.2538859844207764
        },
        {
            "text": "LB-100 was administered intravenously daily for 3 days in 21-day cycles in a 3 + 3 dose escalation design.",
            "probability": 0.0017433054363558149,
            "start_logit": -0.5966925024986267,
            "end_logit": -0.09741409868001938
        },
        {
            "text": "patient entries over 7 dose escalations",
            "probability": 0.001486014753614433,
            "start_logit": -3.2895750999450684,
            "end_logit": 2.4357833862304688
        },
        {
            "text": "29 patient entries over 7 dose escalations. One patient stopped treatment after one dose because of an acute infection and was reenrolled after recovery",
            "probability": 0.0014152583146429935,
            "start_logit": 1.6682401895523071,
            "end_logit": -2.570817708969116
        },
        {
            "text": "There were 29 patient entries over 7",
            "probability": 0.0012724537251964931,
            "start_logit": 1.757069706916809,
            "end_logit": -2.766012191772461
        },
        {
            "text": "patient entries over 7 dose escalations.",
            "probability": 0.0012388709898919418,
            "start_logit": -3.2895750999450684,
            "end_logit": 2.2538859844207764
        },
        {
            "text": "",
            "probability": 2.3854846728445102e-05,
            "start_logit": -2.2208828926086426,
            "end_logit": -2.7647745609283447
        }
    ],
    "5e480da0d14c9f295d000006_001": [
        {
            "text": "treatment option for uveal melanoma.",
            "probability": 0.3251461172968367,
            "start_logit": 1.3234541416168213,
            "end_logit": 1.9490269422531128
        },
        {
            "text": "treatment option for uveal melanoma",
            "probability": 0.1934863386516579,
            "start_logit": 1.3234541416168213,
            "end_logit": 1.4299591779708862
        },
        {
            "text": "a\u00a0new treatment option for uveal melanoma.OBJECTIVE:",
            "probability": 0.15218048014715546,
            "start_logit": 0.564246654510498,
            "end_logit": 1.9490269422531128
        },
        {
            "text": "treatment option",
            "probability": 0.11963640470892972,
            "start_logit": 1.3234541416168213,
            "end_logit": 0.949209451675415
        },
        {
            "text": "a\u00a0new treatment option",
            "probability": 0.05599428854647273,
            "start_logit": 0.564246654510498,
            "end_logit": 0.949209451675415
        },
        {
            "text": "",
            "probability": 0.047273087176018365,
            "start_logit": 0.6603657603263855,
            "end_logit": 0.6837818026542664
        },
        {
            "text": "treatment",
            "probability": 0.020193847596035975,
            "start_logit": 1.3234541416168213,
            "end_logit": -0.8298697471618652
        },
        {
            "text": "is a\u00a0new treatment option for uveal melanoma.OBJECTIVE:",
            "probability": 0.019272648671409282,
            "start_logit": -1.5021336078643799,
            "end_logit": 1.9490269422531128
        },
        {
            "text": "uveal melanoma.",
            "probability": 0.0130993726422019,
            "start_logit": -1.8882561922073364,
            "end_logit": 1.9490269422531128
        },
        {
            "text": "stereotactic radiosurgery is a\u00a0new treatment option for uveal melanoma.OBJECTIVE:",
            "probability": 0.010013910738202089,
            "start_logit": -2.1568453311920166,
            "end_logit": 1.9490269422531128
        },
        {
            "text": "a\u00a0new treatment",
            "probability": 0.009451471998903475,
            "start_logit": 0.564246654510498,
            "end_logit": -0.8298697471618652
        },
        {
            "text": "uveal melanoma",
            "probability": 0.00779510969481904,
            "start_logit": -1.8882561922073364,
            "end_logit": 1.4299591779708862
        },
        {
            "text": "is a\u00a0new treatment option",
            "probability": 0.007091305335074257,
            "start_logit": -1.5021336078643799,
            "end_logit": 0.949209451675415
        },
        {
            "text": "treatment option for uveal melanoma.OBJECTIVE: This review outlines the technique of robot-assisted CyberKnife\u00ae therapy",
            "probability": 0.005186042058301878,
            "start_logit": 1.3234541416168213,
            "end_logit": -2.189276933670044
        },
        {
            "text": "CyberKnife\u00ae stereotactic radiosurgery is a\u00a0new treatment option for uveal melanoma.OBJECTIVE:",
            "probability": 0.004041828300589961,
            "start_logit": -3.0641233921051025,
            "end_logit": 1.9490269422531128
        },
        {
            "text": "stereotactic radiosurgery is a\u00a0new treatment option",
            "probability": 0.003684584296299386,
            "start_logit": -2.1568453311920166,
            "end_logit": 0.949209451675415
        },
        {
            "text": "a\u00a0new treatment option for uveal melanoma.OBJECTIVE: This review outlines the technique of robot-assisted CyberKnife\u00ae therapy,",
            "probability": 0.0024272606330255583,
            "start_logit": 0.564246654510498,
            "end_logit": -2.189276933670044
        },
        {
            "text": "CyberKnife\u00ae stereotactic radiosurgery is a\u00a0new treatment option",
            "probability": 0.0014871769355681332,
            "start_logit": -3.0641233921051025,
            "end_logit": 0.949209451675415
        },
        {
            "text": "radiosurgery is a\u00a0new treatment option for uveal melanoma.OBJECTIVE:",
            "probability": 0.0013417583184400605,
            "start_logit": -4.166839599609375,
            "end_logit": 1.9490269422531128
        },
        {
            "text": "is a\u00a0new treatment",
            "probability": 0.0011969662540582664,
            "start_logit": -1.5021336078643799,
            "end_logit": -0.8298697471618652
        }
    ],
    "5e480da0d14c9f295d000006_002": [
        {
            "text": "",
            "probability": 0.9998604077955318,
            "start_logit": 2.2125954627990723,
            "end_logit": 3.9761321544647217
        },
        {
            "text": "with a prescription dose based on the intent to cover the entire tumor with a higher dose while ensuring dose limitation to the visual pathways and brainstem",
            "probability": 3.861468404982571e-05,
            "start_logit": -3.2185699939727783,
            "end_logit": -0.7544407248497009
        },
        {
            "text": "prescription dose based on the intent to cover the entire tumor with a higher dose while ensuring dose limitation to the visual pathways and brainstem",
            "probability": 2.9139242021098952e-05,
            "start_logit": -3.5001168251037598,
            "end_logit": -0.7544407248497009
        },
        {
            "text": "a prescription dose based on the intent to cover the entire tumor with a higher dose while ensuring dose limitation to the visual pathways and brainstem",
            "probability": 1.9786924323747198e-05,
            "start_logit": -3.887181282043457,
            "end_logit": -0.7544407248497009
        },
        {
            "text": "ensuring dose limitation to the visual pathways and brainstem",
            "probability": 8.963854541994245e-06,
            "start_logit": -4.679002285003662,
            "end_logit": -0.7544407248497009
        },
        {
            "text": "used with a prescription dose based on the intent to cover the entire tumor with a higher dose while ensuring dose limitation to the visual pathways and brainstem",
            "probability": 8.409422363049737e-06,
            "start_logit": -4.742849826812744,
            "end_logit": -0.7544407248497009
        },
        {
            "text": "cover the entire tumor with a higher dose while ensuring dose limitation to the visual pathways and brainstem",
            "probability": 7.482755572949823e-06,
            "start_logit": -4.8596014976501465,
            "end_logit": -0.7544407248497009
        },
        {
            "text": "with a prescription dose based on the intent to cover the entire tumor with a higher dose",
            "probability": 6.076184796833244e-06,
            "start_logit": -3.2185699939727783,
            "end_logit": -2.603696346282959
        },
        {
            "text": "prescription dose based on the intent to cover the entire tumor with a higher dose",
            "probability": 4.585183686376557e-06,
            "start_logit": -3.5001168251037598,
            "end_logit": -2.603696346282959
        },
        {
            "text": "a prescription dose based on the intent to cover the entire tumor with a higher dose",
            "probability": 3.1135567132158195e-06,
            "start_logit": -3.887181282043457,
            "end_logit": -2.603696346282959
        },
        {
            "text": "intent to cover the entire tumor with a higher dose while ensuring dose limitation to the visual pathways and brainstem",
            "probability": 2.712647301783467e-06,
            "start_logit": -5.874277591705322,
            "end_logit": -0.7544407248497009
        },
        {
            "text": "to cover the entire tumor with a higher dose while ensuring dose limitation to the visual pathways and brainstem",
            "probability": 1.8775306259361288e-06,
            "start_logit": -6.242245197296143,
            "end_logit": -0.7544407248497009
        },
        {
            "text": "massive hemorrhage during surgery",
            "probability": 1.6139484492385946e-06,
            "start_logit": -4.0687761306762695,
            "end_logit": -3.079183578491211
        },
        {
            "text": "with a prescription dose based on the intent to cover the entire tumor with a higher dose while ensuring dose limitation to the visual pathways and brainstem.",
            "probability": 1.3570976192177383e-06,
            "start_logit": -3.2185699939727783,
            "end_logit": -4.102725028991699
        },
        {
            "text": "used with a prescription dose based on the intent to cover the entire tumor with a higher dose",
            "probability": 1.3232583813603143e-06,
            "start_logit": -4.742849826812744,
            "end_logit": -2.603696346282959
        },
        {
            "text": "cover the entire tumor with a higher dose",
            "probability": 1.1774434200241026e-06,
            "start_logit": -4.8596014976501465,
            "end_logit": -2.603696346282959
        },
        {
            "text": "prescription dose based on the intent to cover the entire tumor with a higher dose while ensuring dose limitation to the visual pathways and brainstem.",
            "probability": 1.0240870007279356e-06,
            "start_logit": -3.5001168251037598,
            "end_logit": -4.102725028991699
        },
        {
            "text": "with a prescription dose based on the intent to cover the entire tumor",
            "probability": 8.902661109579258e-07,
            "start_logit": -3.2185699939727783,
            "end_logit": -4.524308204650879
        },
        {
            "text": "with a prescription dose",
            "probability": 7.487139528077434e-07,
            "start_logit": -3.2185699939727783,
            "end_logit": -4.697471618652344
        },
        {
            "text": "a prescription dose based on the intent to cover the entire tumor with a higher dose while ensuring dose limitation to the visual pathways and brainstem.",
            "probability": 6.954035375959548e-07,
            "start_logit": -3.887181282043457,
            "end_logit": -4.102725028991699
        }
    ],
    "5e480da0d14c9f295d000006_003": [
        {
            "text": "treating head and neck paragangliomas",
            "probability": 0.34198304041992966,
            "start_logit": 1.363806128501892,
            "end_logit": 2.333800792694092
        },
        {
            "text": "stereotactic radiotherapy system",
            "probability": 0.118804019619041,
            "start_logit": 0.45662665367126465,
            "end_logit": 2.183694362640381
        },
        {
            "text": "head and neck paragangliomas",
            "probability": 0.11396445565541077,
            "start_logit": 0.2649315893650055,
            "end_logit": 2.333800792694092
        },
        {
            "text": "radiotherapy system",
            "probability": 0.1097678377562429,
            "start_logit": 0.37751898169517517,
            "end_logit": 2.183694362640381
        },
        {
            "text": "a robotic stereotactic radiotherapy system",
            "probability": 0.10646880991354901,
            "start_logit": 0.3470034897327423,
            "end_logit": 2.183694362640381
        },
        {
            "text": "stereotactic radiotherapy",
            "probability": 0.03086267031504414,
            "start_logit": 0.45662665367126465,
            "end_logit": 0.8357664942741394
        },
        {
            "text": "robotic stereotactic radiotherapy system",
            "probability": 0.03049006340802435,
            "start_logit": -0.9034477472305298,
            "end_logit": 2.183694362640381
        },
        {
            "text": "radiotherapy",
            "probability": 0.028515269085417544,
            "start_logit": 0.37751898169517517,
            "end_logit": 0.8357664942741394
        },
        {
            "text": "a robotic stereotactic radiotherapy",
            "probability": 0.02765825423864973,
            "start_logit": 0.3470034897327423,
            "end_logit": 0.8357664942741394
        },
        {
            "text": "on treating head and neck paragangliomas",
            "probability": 0.018032987844120302,
            "start_logit": -1.5787522792816162,
            "end_logit": 2.333800792694092
        },
        {
            "text": "stereotactic radiotherapy system.",
            "probability": 0.014161723217229909,
            "start_logit": 0.45662665367126465,
            "end_logit": 0.05676189810037613
        },
        {
            "text": "radiotherapy system.",
            "probability": 0.013084588732287027,
            "start_logit": 0.37751898169517517,
            "end_logit": 0.05676189810037613
        },
        {
            "text": "a robotic stereotactic radiotherapy system.",
            "probability": 0.012691336724956141,
            "start_logit": 0.3470034897327423,
            "end_logit": 0.05676189810037613
        },
        {
            "text": "to evaluate the effectiveness and the safety of CyberKnife\u00ae on treating head and neck paragangliomas",
            "probability": 0.011796770104725931,
            "start_logit": -2.003129243850708,
            "end_logit": 2.333800792694092
        },
        {
            "text": "robotic stereotactic radiotherapy",
            "probability": 0.007920647616672305,
            "start_logit": -0.9034477472305298,
            "end_logit": 0.8357664942741394
        },
        {
            "text": "robotic stereotactic radiotherapy system.",
            "probability": 0.0036344884646565133,
            "start_logit": -0.9034477472305298,
            "end_logit": 0.05676189810037613
        },
        {
            "text": "treating head and neck paragangliomas and to report our results",
            "probability": 0.0031417483597386666,
            "start_logit": 1.363806128501892,
            "end_logit": -2.3561809062957764
        },
        {
            "text": "CyberKnife\u00ae is a robotic stereotactic radiotherapy system",
            "probability": 0.0029722489104579905,
            "start_logit": -3.231529712677002,
            "end_logit": 2.183694362640381
        },
        {
            "text": "",
            "probability": 0.0020281562472536808,
            "start_logit": -0.952423632144928,
            "end_logit": -0.4776034653186798
        },
        {
            "text": "paragangliomas",
            "probability": 0.0020208833665922715,
            "start_logit": -3.7674202919006348,
            "end_logit": 2.333800792694092
        }
    ],
    "5e480da0d14c9f295d000006_004": [
        {
            "text": "treating head and neck paragangliomas",
            "probability": 0.34198304041992966,
            "start_logit": 1.363806128501892,
            "end_logit": 2.333800792694092
        },
        {
            "text": "stereotactic radiotherapy system",
            "probability": 0.118804019619041,
            "start_logit": 0.45662665367126465,
            "end_logit": 2.183694362640381
        },
        {
            "text": "head and neck paragangliomas",
            "probability": 0.11396445565541077,
            "start_logit": 0.2649315893650055,
            "end_logit": 2.333800792694092
        },
        {
            "text": "radiotherapy system",
            "probability": 0.1097678377562429,
            "start_logit": 0.37751898169517517,
            "end_logit": 2.183694362640381
        },
        {
            "text": "a robotic stereotactic radiotherapy system",
            "probability": 0.10646880991354901,
            "start_logit": 0.3470034897327423,
            "end_logit": 2.183694362640381
        },
        {
            "text": "stereotactic radiotherapy",
            "probability": 0.03086267031504414,
            "start_logit": 0.45662665367126465,
            "end_logit": 0.8357664942741394
        },
        {
            "text": "robotic stereotactic radiotherapy system",
            "probability": 0.03049006340802435,
            "start_logit": -0.9034477472305298,
            "end_logit": 2.183694362640381
        },
        {
            "text": "radiotherapy",
            "probability": 0.028515269085417544,
            "start_logit": 0.37751898169517517,
            "end_logit": 0.8357664942741394
        },
        {
            "text": "a robotic stereotactic radiotherapy",
            "probability": 0.02765825423864973,
            "start_logit": 0.3470034897327423,
            "end_logit": 0.8357664942741394
        },
        {
            "text": "on treating head and neck paragangliomas",
            "probability": 0.018032987844120302,
            "start_logit": -1.5787522792816162,
            "end_logit": 2.333800792694092
        },
        {
            "text": "stereotactic radiotherapy system.",
            "probability": 0.014161723217229909,
            "start_logit": 0.45662665367126465,
            "end_logit": 0.05676189810037613
        },
        {
            "text": "radiotherapy system.",
            "probability": 0.013084588732287027,
            "start_logit": 0.37751898169517517,
            "end_logit": 0.05676189810037613
        },
        {
            "text": "a robotic stereotactic radiotherapy system.",
            "probability": 0.012691336724956141,
            "start_logit": 0.3470034897327423,
            "end_logit": 0.05676189810037613
        },
        {
            "text": "to evaluate the effectiveness and the safety of CyberKnife\u00ae on treating head and neck paragangliomas",
            "probability": 0.011796770104725931,
            "start_logit": -2.003129243850708,
            "end_logit": 2.333800792694092
        },
        {
            "text": "robotic stereotactic radiotherapy",
            "probability": 0.007920647616672305,
            "start_logit": -0.9034477472305298,
            "end_logit": 0.8357664942741394
        },
        {
            "text": "robotic stereotactic radiotherapy system.",
            "probability": 0.0036344884646565133,
            "start_logit": -0.9034477472305298,
            "end_logit": 0.05676189810037613
        },
        {
            "text": "treating head and neck paragangliomas and to report our results",
            "probability": 0.0031417483597386666,
            "start_logit": 1.363806128501892,
            "end_logit": -2.3561809062957764
        },
        {
            "text": "CyberKnife\u00ae is a robotic stereotactic radiotherapy system",
            "probability": 0.0029722489104579905,
            "start_logit": -3.231529712677002,
            "end_logit": 2.183694362640381
        },
        {
            "text": "",
            "probability": 0.0020281562472536808,
            "start_logit": -0.952423632144928,
            "end_logit": -0.4776034653186798
        },
        {
            "text": "paragangliomas",
            "probability": 0.0020208833665922715,
            "start_logit": -3.7674202919006348,
            "end_logit": 2.333800792694092
        }
    ],
    "5e290a268b3851296d00000d_001": [
        {
            "text": "",
            "probability": 0.9893454465966425,
            "start_logit": 1.697631597518921,
            "end_logit": 2.119931936264038
        },
        {
            "text": "poor prognoses",
            "probability": 0.0024301384193887382,
            "start_logit": -0.48064616322517395,
            "end_logit": -1.7108856439590454
        },
        {
            "text": "poor",
            "probability": 0.0023795093433799336,
            "start_logit": -0.48064616322517395,
            "end_logit": -1.7319395542144775
        },
        {
            "text": "Palbociclib is also food and drug administration-approved",
            "probability": 0.0019157296448927335,
            "start_logit": -0.24339303374290466,
            "end_logit": -2.185988426208496
        },
        {
            "text": "Palbociclib and ribociclib are currently food and drug administration-approved for use in combination with aromatase inhibitors",
            "probability": 0.0006592616222384251,
            "start_logit": -1.6052155494689941,
            "end_logit": -1.8908993005752563
        },
        {
            "text": "poor prognoses as glioblastoma multiforme, mantle cell lymphoma, and metastatic melanoma.",
            "probability": 0.0004285029809387996,
            "start_logit": -0.48064616322517395,
            "end_logit": -3.446291446685791
        },
        {
            "text": "breast cancer progressing after endocrine therapy",
            "probability": 0.00041871844257181134,
            "start_logit": -4.329862594604492,
            "end_logit": 0.37982600927352905
        },
        {
            "text": "breast cancer",
            "probability": 0.00029962107089450524,
            "start_logit": -3.692246675491333,
            "end_logit": -0.5924700498580933
        },
        {
            "text": "human epidermal growth factor receptor 2-negative breast cancer",
            "probability": 0.0002801585208013751,
            "start_logit": -3.7594096660614014,
            "end_logit": -0.5924700498580933
        },
        {
            "text": "poor prognoses as glioblastoma multiforme",
            "probability": 0.00025631873622075033,
            "start_logit": -0.48064616322517395,
            "end_logit": -3.960167407989502
        },
        {
            "text": "poor prognoses as glioblastoma multiforme, mantle cell lymphoma, and metastatic melanoma",
            "probability": 0.00024377346962015488,
            "start_logit": -0.48064616322517395,
            "end_logit": -4.010349750518799
        },
        {
            "text": "food and drug administration-approved",
            "probability": 0.00024143410560769314,
            "start_logit": -2.314650297164917,
            "end_logit": -2.185988426208496
        },
        {
            "text": "metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer",
            "probability": 0.0002239781477048292,
            "start_logit": -3.9832167625427246,
            "end_logit": -0.5924700498580933
        },
        {
            "text": "intriguing developments in the treatment of various malignancies, including those with such poor prognoses",
            "probability": 0.00020985950554383912,
            "start_logit": -2.9299113750457764,
            "end_logit": -1.7108856439590454
        },
        {
            "text": "intriguing developments in the treatment of various malignancies, including those with such poor",
            "probability": 0.00020548732955066187,
            "start_logit": -2.9299113750457764,
            "end_logit": -1.7319395542144775
        },
        {
            "text": "intriguing developments",
            "probability": 0.0001161428962747056,
            "start_logit": -2.9299113750457764,
            "end_logit": -2.3025026321411133
        },
        {
            "text": "postmenopausal women with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer",
            "probability": 9.155981244781867e-05,
            "start_logit": -4.877772808074951,
            "end_logit": -0.5924700498580933
        },
        {
            "text": "use in combination with fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer",
            "probability": 9.056560857504356e-05,
            "start_logit": -3.488100051879883,
            "end_logit": -1.9930607080459595
        },
        {
            "text": "breast cancer.",
            "probability": 8.255740492157507e-05,
            "start_logit": -3.692246675491333,
            "end_logit": -1.8814947605133057
        },
        {
            "text": "intriguing developments in the treatment of various malignancies",
            "probability": 8.123634178404659e-05,
            "start_logit": -2.9299113750457764,
            "end_logit": -2.659961223602295
        }
    ],
    "5e290a268b3851296d00000d_002": [
        {
            "text": "not an effective treatment for recurrent glioblastoma",
            "probability": 0.20130398235906896,
            "start_logit": 3.755256175994873,
            "end_logit": 2.5296432971954346
        },
        {
            "text": "not",
            "probability": 0.17035987251082613,
            "start_logit": 3.755256175994873,
            "end_logit": 2.3627402782440186
        },
        {
            "text": "not an effective treatment",
            "probability": 0.10919633810631937,
            "start_logit": 3.755256175994873,
            "end_logit": 1.9179747104644775
        },
        {
            "text": "not an effective treatment for recurrent glioblastoma.",
            "probability": 0.09220488856694177,
            "start_logit": 3.755256175994873,
            "end_logit": 1.74884033203125
        },
        {
            "text": "Palbociclib is an oral inhibitor",
            "probability": 0.08653135083464478,
            "start_logit": 2.896925926208496,
            "end_logit": 2.5436642169952393
        },
        {
            "text": "an oral inhibitor of CDK4/6, which leads to phosphorylation of RB1 and cell-cycle arrest",
            "probability": 0.059470885752665965,
            "start_logit": 1.7402762174606323,
            "end_logit": 3.325294017791748
        },
        {
            "text": "not an effective",
            "probability": 0.053680707528660554,
            "start_logit": 3.755256175994873,
            "end_logit": 1.2078808546066284
        },
        {
            "text": "oral inhibitor of CDK4/6, which leads to phosphorylation of RB1 and cell-cycle arrest",
            "probability": 0.05118105686136317,
            "start_logit": 1.5901588201522827,
            "end_logit": 3.325294017791748
        },
        {
            "text": "Palbociclib is an oral inhibitor of CDK4/6",
            "probability": 0.03378133049995386,
            "start_logit": 2.896925926208496,
            "end_logit": 1.6030657291412354
        },
        {
            "text": "an oral inhibitor",
            "probability": 0.027217416391967817,
            "start_logit": 1.7402762174606323,
            "end_logit": 2.5436642169952393
        },
        {
            "text": "oral inhibitor",
            "probability": 0.02342349736928639,
            "start_logit": 1.5901588201522827,
            "end_logit": 2.5436642169952393
        },
        {
            "text": "an oral inhibitor of CDK4/6, which leads to phosphorylation of RB1 and cell-cycle arrest.",
            "probability": 0.019700301947415746,
            "start_logit": 1.7402762174606323,
            "end_logit": 2.2204411029815674
        },
        {
            "text": "leads to phosphorylation of RB1 and cell-cycle arrest",
            "probability": 0.017244320604025164,
            "start_logit": 0.5022721886634827,
            "end_logit": 3.325294017791748
        },
        {
            "text": "oral inhibitor of CDK4/6, which leads to phosphorylation of RB1 and cell-cycle arrest.",
            "probability": 0.016954216527900117,
            "start_logit": 1.5901588201522827,
            "end_logit": 2.2204411029815674
        },
        {
            "text": "an oral inhibitor of CDK4/6",
            "probability": 0.010625519301656481,
            "start_logit": 1.7402762174606323,
            "end_logit": 1.6030657291412354
        },
        {
            "text": "oral inhibitor of CDK4/6",
            "probability": 0.009144395626144067,
            "start_logit": 1.5901588201522827,
            "end_logit": 1.6030657291412354
        },
        {
            "text": "leads to phosphorylation of RB1 and cell-cycle arrest.",
            "probability": 0.005712346780745729,
            "start_logit": 0.5022721886634827,
            "end_logit": 2.2204411029815674
        },
        {
            "text": "Palbociclib is an oral inhibitor of CDK4/6,",
            "probability": 0.005070896625194481,
            "start_logit": 2.896925926208496,
            "end_logit": -0.29332491755485535
        },
        {
            "text": "not an",
            "probability": 0.003482964453168162,
            "start_logit": 3.755256175994873,
            "end_logit": -1.5272890329360962
        },
        {
            "text": "phosphorylation of RB1 and cell-cycle arrest",
            "probability": 0.00339444428940663,
            "start_logit": -1.1230705976486206,
            "end_logit": 3.325294017791748
        },
        {
            "text": "",
            "probability": 0.00031926706264455114,
            "start_logit": -0.5250813961029053,
            "end_logit": 0.3634374141693115
        }
    ],
    "5c72c9207c78d6947100007b_001": [
        {
            "text": "",
            "probability": 0.2200570523438023,
            "start_logit": 2.636500358581543,
            "end_logit": 2.7704756259918213
        },
        {
            "text": "reversible jump Markov Chain Monte Carlo",
            "probability": 0.1500511315653706,
            "start_logit": 2.39082670211792,
            "end_logit": 2.6332385540008545
        },
        {
            "text": "piecewise constant intensity models with varying number of pieces, and show how a reversible jump Markov Chain Monte Carlo",
            "probability": 0.10431089961156025,
            "start_logit": 2.027226448059082,
            "end_logit": 2.6332385540008545
        },
        {
            "text": "reversible jump Markov Chain Monte Carlo (RJMCMC) method",
            "probability": 0.09205760135963667,
            "start_logit": 2.39082670211792,
            "end_logit": 2.144676923751831
        },
        {
            "text": "RJMCMC) method",
            "probability": 0.0916524530327239,
            "start_logit": 2.386415958404541,
            "end_logit": 2.144676923751831
        },
        {
            "text": "a reversible jump Markov Chain Monte Carlo",
            "probability": 0.08635490555904753,
            "start_logit": 1.8383162021636963,
            "end_logit": 2.6332385540008545
        },
        {
            "text": "a reversible jump Markov Chain Monte Carlo (RJMCMC) method",
            "probability": 0.05297944366344596,
            "start_logit": 1.8383162021636963,
            "end_logit": 2.144676923751831
        },
        {
            "text": "reversible jump Markov Chain Monte Carlo (RJMCMC",
            "probability": 0.029960992963191192,
            "start_logit": 2.39082670211792,
            "end_logit": 1.0221587419509888
        },
        {
            "text": "RJMCMC",
            "probability": 0.029829133714281798,
            "start_logit": 2.386415958404541,
            "end_logit": 1.0221587419509888
        },
        {
            "text": "reversible jump Markov Chain Monte Carlo (RJMCMC)",
            "probability": 0.0212180358782376,
            "start_logit": 2.39082670211792,
            "end_logit": 0.6771140098571777
        },
        {
            "text": "RJMCMC)",
            "probability": 0.021124654651598213,
            "start_logit": 2.386415958404541,
            "end_logit": 0.6771140098571777
        },
        {
            "text": "piecewise constant intensity models with varying number of pieces, and show how a reversible jump Markov Chain Monte Carlo (RJMCMC",
            "probability": 0.02082795442222016,
            "start_logit": 2.027226448059082,
            "end_logit": 1.0221587419509888
        },
        {
            "text": "a reversible jump Markov Chain Monte Carlo (RJMCMC",
            "probability": 0.017242647161674354,
            "start_logit": 1.8383162021636963,
            "end_logit": 1.0221587419509888
        },
        {
            "text": "piecewise constant intensity models with varying number of pieces, and show how a reversible jump Markov Chain Monte Carlo (RJMCMC)",
            "probability": 0.014750121424343288,
            "start_logit": 2.027226448059082,
            "end_logit": 0.6771140098571777
        },
        {
            "text": "jump Markov Chain Monte Carlo",
            "probability": 0.014656977740691288,
            "start_logit": 0.06476710736751556,
            "end_logit": 2.6332385540008545
        },
        {
            "text": "a reversible jump Markov Chain Monte Carlo (RJMCMC)",
            "probability": 0.012211047429625326,
            "start_logit": 1.8383162021636963,
            "end_logit": 0.6771140098571777
        },
        {
            "text": "jump Markov Chain Monte Carlo (RJMCMC) method",
            "probability": 0.008992176199629677,
            "start_logit": 0.06476710736751556,
            "end_logit": 2.144676923751831
        },
        {
            "text": "piecewise constant intensity models",
            "probability": 0.006473693282500318,
            "start_logit": 2.027226448059082,
            "end_logit": -0.14639052748680115
        },
        {
            "text": "jump Markov Chain Monte Carlo (RJMCMC",
            "probability": 0.00292658644003087,
            "start_logit": 0.06476710736751556,
            "end_logit": 1.0221587419509888
        },
        {
            "text": "RJMCMC) method can be used to obtain a posteriori distribution on the intensity of the patterns along the genome",
            "probability": 0.002322491556388979,
            "start_logit": 2.386415958404541,
            "end_logit": -1.5306862592697144
        }
    ],
    "5c72c9207c78d6947100007b_002": [
        {
            "text": "Markov models",
            "probability": 0.1800586984824866,
            "start_logit": 0.7313168048858643,
            "end_logit": -0.30873847007751465
        },
        {
            "text": "",
            "probability": 0.1624804945173915,
            "start_logit": 0.3549700677394867,
            "end_logit": -0.03511667251586914
        },
        {
            "text": "higher-order Markov-model-based segmentation",
            "probability": 0.1375620796571314,
            "start_logit": 1.6019158363342285,
            "end_logit": -1.4485450983047485
        },
        {
            "text": "higher-order Markov-model-based",
            "probability": 0.12013543066314958,
            "start_logit": 1.6019158363342285,
            "end_logit": -1.5840007066726685
        },
        {
            "text": "higher-order Markov-model-based segmentation procedures in detecting compositional inhomogeneity in chimeric DNA sequences",
            "probability": 0.11116634465176053,
            "start_logit": 1.6019158363342285,
            "end_logit": -1.661592721939087
        },
        {
            "text": "higher-order Markov-model-based segmentation procedures",
            "probability": 0.08142516419952237,
            "start_logit": 1.6019158363342285,
            "end_logit": -1.9729360342025757
        },
        {
            "text": "higher-order Markov-model",
            "probability": 0.05821147160235732,
            "start_logit": 1.6019158363342285,
            "end_logit": -2.3085379600524902
        },
        {
            "text": "Markov",
            "probability": 0.042302458700735,
            "start_logit": 0.7313168048858643,
            "end_logit": -1.757176160812378
        },
        {
            "text": "Markov models for segmentation of symbolic sequences, extending a segmentation procedure based on the Jensen-Shannon divergence",
            "probability": 0.035023495124218415,
            "start_logit": 0.7313168048858643,
            "end_logit": -1.9460022449493408
        },
        {
            "text": "higher-order Markov-model-based segmentation procedures in detecting compositional inhomogeneity in chimeric DNA",
            "probability": 0.02808796725059631,
            "start_logit": 1.6019158363342285,
            "end_logit": -3.0372791290283203
        },
        {
            "text": "higher-order Markov-model-based segmentation procedures in detecting compositional inhomogeneity",
            "probability": 0.015227675795728916,
            "start_logit": 1.6019158363342285,
            "end_logit": -3.649505853652954
        },
        {
            "text": "Markov models for segmentation of symbolic sequences",
            "probability": 0.012290719106566065,
            "start_logit": 0.7313168048858643,
            "end_logit": -2.9931769371032715
        },
        {
            "text": "higher-order",
            "probability": 0.00839673717909654,
            "start_logit": 1.6019158363342285,
            "end_logit": -4.244777202606201
        },
        {
            "text": "E. coli K12 genome",
            "probability": 0.0025132297774593288,
            "start_logit": -1.7997980117797852,
            "end_logit": -2.049337863922119
        },
        {
            "text": "Jensen-Shannon divergence",
            "probability": 0.0016497083066043157,
            "start_logit": -2.324103832244873,
            "end_logit": -1.9460022449493408
        },
        {
            "text": "compositional inhomogeneity in chimeric DNA sequences",
            "probability": 0.0008036168804035663,
            "start_logit": -3.327744483947754,
            "end_logit": -1.661592721939087
        },
        {
            "text": "E. coli K12",
            "probability": 0.0007863533785470704,
            "start_logit": -1.7997980117797852,
            "end_logit": -3.2112555503845215
        },
        {
            "text": "chimeric DNA sequences",
            "probability": 0.0007287717121061964,
            "start_logit": -3.425506591796875,
            "end_logit": -1.661592721939087
        },
        {
            "text": "compositional inhomogeneity in chimeric DNA sequences constructed from genomes of diverse species",
            "probability": 0.0005822164879299563,
            "start_logit": -3.327744483947754,
            "end_logit": -1.9838730096817017
        },
        {
            "text": "detecting compositional inhomogeneity in chimeric DNA sequences",
            "probability": 0.000567366526208538,
            "start_logit": -3.6758615970611572,
            "end_logit": -1.661592721939087
        }
    ],
    "5c72c9207c78d6947100007b_003": [
        {
            "text": "combinatorial genome segmentation solely using information on combinations of epigenetic marks",
            "probability": 0.41227536094117423,
            "start_logit": 1.0202903747558594,
            "end_logit": 1.6531513929367065
        },
        {
            "text": "information on combinations of epigenetic marks",
            "probability": 0.1571530716589682,
            "start_logit": 0.055819205939769745,
            "end_logit": 1.6531513929367065
        },
        {
            "text": "combinatorial genome segmentation solely using information on combinations of epigenetic marks.",
            "probability": 0.10339378913389459,
            "start_logit": 1.0202903747558594,
            "end_logit": 0.2700048089027405
        },
        {
            "text": "epigenetic marks",
            "probability": 0.09445480431639551,
            "start_logit": -0.45327964425086975,
            "end_logit": 1.6531513929367065
        },
        {
            "text": "combinations of epigenetic marks",
            "probability": 0.08626145291875593,
            "start_logit": -0.5440182685852051,
            "end_logit": 1.6531513929367065
        },
        {
            "text": "information on combinations of epigenetic marks.",
            "probability": 0.03941213347253521,
            "start_logit": 0.055819205939769745,
            "end_logit": 0.2700048089027405
        },
        {
            "text": "epigenetic marks.",
            "probability": 0.023688148857302558,
            "start_logit": -0.45327964425086975,
            "end_logit": 0.2700048089027405
        },
        {
            "text": "combinations of epigenetic marks.",
            "probability": 0.021633353138311433,
            "start_logit": -0.5440182685852051,
            "end_logit": 0.2700048089027405
        },
        {
            "text": "solely using information on combinations of epigenetic marks",
            "probability": 0.017007915918714683,
            "start_logit": -2.167722225189209,
            "end_logit": 1.6531513929367065
        },
        {
            "text": "combinatorial",
            "probability": 0.01034665503570401,
            "start_logit": 1.0202903747558594,
            "end_logit": -2.031876802444458
        },
        {
            "text": "using information on combinations of epigenetic marks",
            "probability": 0.009575578847925084,
            "start_logit": -2.742185115814209,
            "end_logit": 1.6531513929367065
        },
        {
            "text": "combinatorial genome segmentation",
            "probability": 0.004849451299723573,
            "start_logit": 1.0202903747558594,
            "end_logit": -2.7896745204925537
        },
        {
            "text": "solely using information on combinations of epigenetic marks.",
            "probability": 0.004265384349169268,
            "start_logit": -2.167722225189209,
            "end_logit": 0.2700048089027405
        },
        {
            "text": "a combinatorial genome segmentation solely using information on combinations of epigenetic marks",
            "probability": 0.0039545936273197415,
            "start_logit": -3.62652325630188,
            "end_logit": 1.6531513929367065
        },
        {
            "text": "Our method is based on a combinatorial genome segmentation solely using information on combinations of epigenetic marks",
            "probability": 0.003889075155630739,
            "start_logit": -3.6432297229766846,
            "end_logit": 1.6531513929367065
        },
        {
            "text": "using information on combinations of epigenetic marks.",
            "probability": 0.002401442031309298,
            "start_logit": -2.742185115814209,
            "end_logit": 0.2700048089027405
        },
        {
            "text": "information on combinations of epigenetic marks. It does not require prior knowledge about the data (e.g. gene positions",
            "probability": 0.001801427462943674,
            "start_logit": 0.055819205939769745,
            "end_logit": -2.8154895305633545
        },
        {
            "text": "",
            "probability": 0.0015618719949172478,
            "start_logit": -2.027825117111206,
            "end_logit": -0.8745394945144653
        },
        {
            "text": "epigenetic marks. It does not require prior knowledge about the data (e.g. gene positions",
            "probability": 0.0010827244845189477,
            "start_logit": -0.45327964425086975,
            "end_logit": -2.8154895305633545
        },
        {
            "text": "a combinatorial genome segmentation solely using information on combinations of epigenetic marks.",
            "probability": 0.0009917653547859779,
            "start_logit": -3.62652325630188,
            "end_logit": 0.2700048089027405
        }
    ],
    "5e2deb35fbd6abf43b00001c_002": [
        {
            "text": "CAGE",
            "probability": 0.6210656215235795,
            "start_logit": 5.548121929168701,
            "end_logit": 6.189537525177002
        },
        {
            "text": "CAGE)",
            "probability": 0.21648623559350882,
            "start_logit": 5.548121929168701,
            "end_logit": 5.135627746582031
        },
        {
            "text": "Cap analysis of gene expression (CAGE",
            "probability": 0.06990892380879224,
            "start_logit": 3.3638784885406494,
            "end_logit": 6.189537525177002
        },
        {
            "text": "(CAGE",
            "probability": 0.042978928940730285,
            "start_logit": 2.8773951530456543,
            "end_logit": 6.189537525177002
        },
        {
            "text": "Cap analysis of gene expression (CAGE)",
            "probability": 0.024368310248169586,
            "start_logit": 3.3638784885406494,
            "end_logit": 5.135627746582031
        },
        {
            "text": "(CAGE)",
            "probability": 0.014981261582945885,
            "start_logit": 2.8773951530456543,
            "end_logit": 5.135627746582031
        },
        {
            "text": "Cap analysis of gene expression",
            "probability": 0.00707772172027346,
            "start_logit": 3.3638784885406494,
            "end_logit": 3.899296283721924
        },
        {
            "text": "analysis of gene expression (CAGE",
            "probability": 0.0012997823258867466,
            "start_logit": -0.6211180090904236,
            "end_logit": 6.189537525177002
        },
        {
            "text": "analysis of gene expression (CAGE)",
            "probability": 0.0004530680383369343,
            "start_logit": -0.6211180090904236,
            "end_logit": 5.135627746582031
        },
        {
            "text": "",
            "probability": 0.00022673587617245912,
            "start_logit": 1.6601440906524658,
            "end_logit": 2.162109136581421
        },
        {
            "text": "Cap",
            "probability": 0.00019356679925178622,
            "start_logit": 3.3638784885406494,
            "end_logit": 0.3002116084098816
        },
        {
            "text": "CAGE) is a methodology for genome-wide quantitative mapping of mRNA 5' ends",
            "probability": 0.00018866052191105157,
            "start_logit": 5.548121929168701,
            "end_logit": -1.9097052812576294
        },
        {
            "text": "gene expression (CAGE",
            "probability": 0.00017495711384160048,
            "start_logit": -2.6265292167663574,
            "end_logit": 6.189537525177002
        },
        {
            "text": "analysis of gene expression",
            "probability": 0.0001315926079010701,
            "start_logit": -0.6211180090904236,
            "end_logit": 3.899296283721924
        },
        {
            "text": "expression (CAGE",
            "probability": 0.00010886373555319412,
            "start_logit": -3.100973129272461,
            "end_logit": 6.189537525177002
        },
        {
            "text": "CAGE) is a methodology for genome-wide quantitative mapping of mRNA 5' ends to precisely capture transcription start sites at a single nucleotide resolution",
            "probability": 0.00010697507376145593,
            "start_logit": 5.548121929168701,
            "end_logit": -2.4770586490631104
        },
        {
            "text": "Cap analysis",
            "probability": 8.089511846498576e-05,
            "start_logit": 3.3638784885406494,
            "end_logit": -0.5722575783729553
        },
        {
            "text": "gene expression (CAGE)",
            "probability": 6.0985193276287424e-05,
            "start_logit": -2.6265292167663574,
            "end_logit": 5.135627746582031
        },
        {
            "text": "CAGE) is a methodology for genome-wide quantitative mapping",
            "probability": 5.8062705157497986e-05,
            "start_logit": 5.548121929168701,
            "end_logit": -3.0881309509277344
        },
        {
            "text": ")",
            "probability": 4.8851472485225536e-05,
            "start_logit": -2.8483757972717285,
            "end_logit": 5.135627746582031
        }
    ],
    "5e2a046caa19d74431000008_002": [
        {
            "text": "",
            "probability": 0.5051261413542562,
            "start_logit": 1.6680126190185547,
            "end_logit": 2.163412570953369
        },
        {
            "text": "miR-181b-1",
            "probability": 0.47610516813378784,
            "start_logit": 1.1789668798446655,
            "end_logit": 2.5932888984680176
        },
        {
            "text": "miR-181b-1,",
            "probability": 0.006765310103557272,
            "start_logit": 1.1789668798446655,
            "end_logit": -1.6605417728424072
        },
        {
            "text": "LB100 profoundly upregulates miR-181b-1",
            "probability": 0.005174966619699778,
            "start_logit": -3.342839002609253,
            "end_logit": 2.5932888984680176
        },
        {
            "text": "181b-1",
            "probability": 0.002783442640927525,
            "start_logit": -3.9629833698272705,
            "end_logit": 2.5932888984680176
        },
        {
            "text": "1",
            "probability": 0.0019340771070858187,
            "start_logit": -4.3270416259765625,
            "end_logit": 2.5932888984680176
        },
        {
            "text": "LB100 profoundly upregulates miR-181b-1,",
            "probability": 0.00042926728951184505,
            "start_logit": -5.832347393035889,
            "end_logit": 2.5932888984680176
        },
        {
            "text": "profoundly upregulates miR-181b-1",
            "probability": 0.00036366147311915257,
            "start_logit": -5.998203754425049,
            "end_logit": 2.5932888984680176
        },
        {
            "text": "miR-181b",
            "probability": 0.00027586363127377343,
            "start_logit": 1.1789668798446655,
            "end_logit": -4.860198497772217
        },
        {
            "text": "miR-181",
            "probability": 0.00024157834078976438,
            "start_logit": 1.1789668798446655,
            "end_logit": -4.992911338806152
        },
        {
            "text": "upregulates miR-181b-1",
            "probability": 0.00021344360949943279,
            "start_logit": -6.531054496765137,
            "end_logit": 2.5932888984680176
        },
        {
            "text": "-181b-1",
            "probability": 0.00018599872648316325,
            "start_logit": -6.668687343597412,
            "end_logit": 2.5932888984680176
        },
        {
            "text": "miR-181b-1, which we show directly binds to the 3' untranslated region of Bcl-2",
            "probability": 0.00016055918428341915,
            "start_logit": 1.1789668798446655,
            "end_logit": -5.401442527770996
        },
        {
            "text": "miR-181b-1, which we show directly binds to the 3' untranslated region of Bcl-2 mRNA",
            "probability": 8.768980605719044e-05,
            "start_logit": 1.1789668798446655,
            "end_logit": -6.0062994956970215
        },
        {
            "text": "miR",
            "probability": 7.073543483782595e-05,
            "start_logit": 1.1789668798446655,
            "end_logit": -6.221158504486084
        },
        {
            "text": "181b-1,",
            "probability": 3.955187610155822e-05,
            "start_logit": -3.9629833698272705,
            "end_logit": -1.6605417728424072
        },
        {
            "text": "1,",
            "probability": 2.7482649358575468e-05,
            "start_logit": -4.3270416259765625,
            "end_logit": -1.6605417728424072
        },
        {
            "text": "LB100",
            "probability": 6.861531100810678e-06,
            "start_logit": -3.342839002609253,
            "end_logit": -4.0323686599731445
        },
        {
            "text": "profoundly upregulates miR-181b-1,",
            "probability": 5.1675192857309476e-06,
            "start_logit": -5.998203754425049,
            "end_logit": -1.6605417728424072
        },
        {
            "text": "upregulates miR-181b-1,",
            "probability": 3.0329689836100897e-06,
            "start_logit": -6.531054496765137,
            "end_logit": -1.6605417728424072
        }
    ],
    "5e48136dd14c9f295d000008_001": [
        {
            "text": "hemopoietic stem cells",
            "probability": 0.9967370513102456,
            "start_logit": 9.38754940032959,
            "end_logit": 9.167747497558594
        },
        {
            "text": "hemopoietic stem",
            "probability": 0.0020940886321892814,
            "start_logit": 9.38754940032959,
            "end_logit": 3.0023789405822754
        },
        {
            "text": "hemopoietic stem cells, the possible target cells",
            "probability": 0.0004342548826739864,
            "start_logit": 9.38754940032959,
            "end_logit": 1.429136872291565
        },
        {
            "text": "hemopoietic stem cells,",
            "probability": 0.0003099421995496948,
            "start_logit": 9.38754940032959,
            "end_logit": 1.0918910503387451
        },
        {
            "text": "stem cells",
            "probability": 0.0001612038542760667,
            "start_logit": 0.6579768657684326,
            "end_logit": 9.167747497558594
        },
        {
            "text": "hemopoietic",
            "probability": 0.00012250147330024374,
            "start_logit": 9.38754940032959,
            "end_logit": 0.16362828016281128
        },
        {
            "text": "hem",
            "probability": 8.00143121728117e-05,
            "start_logit": 9.38754940032959,
            "end_logit": -0.26228925585746765
        },
        {
            "text": "Number of hemopoietic stem cells",
            "probability": 2.3852620326040116e-05,
            "start_logit": -1.2527987957000732,
            "end_logit": 9.167747497558594
        },
        {
            "text": "hemopoietic stem cells, the possible target cells for radiation-induced leukemias",
            "probability": 1.9368482506443866e-05,
            "start_logit": 9.38754940032959,
            "end_logit": -1.6808476448059082
        },
        {
            "text": "cells",
            "probability": 1.3218917539397089e-05,
            "start_logit": -1.8430439233779907,
            "end_logit": 9.167747497558594
        },
        {
            "text": "hemopoietic stem cells, the possible target",
            "probability": 3.422393797839508e-06,
            "start_logit": 9.38754940032959,
            "end_logit": -3.414154529571533
        },
        {
            "text": "stem",
            "probability": 3.386802549989032e-07,
            "start_logit": 0.6579768657684326,
            "end_logit": 3.0023789405822754
        },
        {
            "text": "spleen",
            "probability": 2.8211278897582916e-07,
            "start_logit": 1.821008563041687,
            "end_logit": 1.6565977334976196
        },
        {
            "text": "the spleen",
            "probability": 1.3253633342614612e-07,
            "start_logit": 1.0655584335327148,
            "end_logit": 1.6565977334976196
        },
        {
            "text": "spleen, as compared with that in the control, when the evaluation was made at the time of radiation exposure.",
            "probability": 8.83650433429377e-08,
            "start_logit": 1.821008563041687,
            "end_logit": 0.4957672357559204
        },
        {
            "text": "stem cells, the possible target cells",
            "probability": 7.023272660851287e-08,
            "start_logit": 0.6579768657684326,
            "end_logit": 1.429136872291565
        },
        {
            "text": "stem cells,",
            "probability": 5.0127440436304975e-08,
            "start_logit": 0.6579768657684326,
            "end_logit": 1.0918910503387451
        },
        {
            "text": "Number of hemopoietic stem",
            "probability": 5.0113017276750415e-08,
            "start_logit": -1.2527987957000732,
            "end_logit": 3.0023789405822754
        },
        {
            "text": "the spleen, as compared with that in the control, when the evaluation was made at the time of radiation exposure.",
            "probability": 4.1513817541674316e-08,
            "start_logit": 1.0655584335327148,
            "end_logit": 0.4957672357559204
        },
        {
            "text": "",
            "probability": 2.7240000099518594e-08,
            "start_logit": 1.0224857330322266,
            "end_logit": 0.11750009655952454
        }
    ],
    "5e48136dd14c9f295d000008_002": [
        {
            "text": "stem cells",
            "probability": 0.32756946543560783,
            "start_logit": 3.225313425064087,
            "end_logit": 1.7092375755310059
        },
        {
            "text": "stem cells to a premalignant state, inactivation of stem cells at high radiation doses, and proliferation of stem cells",
            "probability": 0.2568071860996896,
            "start_logit": 3.225313425064087,
            "end_logit": 1.4658629894256592
        },
        {
            "text": "stem cells to a premalignant state, inactivation of stem cells",
            "probability": 0.23520306203435357,
            "start_logit": 3.225313425064087,
            "end_logit": 1.3779866695404053
        },
        {
            "text": "stem cells at high radiation doses, and proliferation of stem cells",
            "probability": 0.06843110492072377,
            "start_logit": 1.902815341949463,
            "end_logit": 1.4658629894256592
        },
        {
            "text": "hematopoietic stem cells",
            "probability": 0.048358464016297995,
            "start_logit": 1.763361930847168,
            "end_logit": 1.2581301927566528
        },
        {
            "text": "",
            "probability": 0.014225128324317597,
            "start_logit": 1.3452895879745483,
            "end_logit": 0.4525712728500366
        },
        {
            "text": "stem",
            "probability": 0.010705206133915861,
            "start_logit": 3.225313425064087,
            "end_logit": -1.7117323875427246
        },
        {
            "text": "stem cells to a premalignant state, inactivation of stem",
            "probability": 0.007404570052737654,
            "start_logit": 3.225313425064087,
            "end_logit": -2.0803651809692383
        },
        {
            "text": "stem cells to a premalignant state, inactivation of stem cells at high radiation doses, and proliferation of stem",
            "probability": 0.007055517907625036,
            "start_logit": 3.225313425064087,
            "end_logit": -2.128652572631836
        },
        {
            "text": "hematopoietic stem cells (HSCs)",
            "probability": 0.006961318574803026,
            "start_logit": 1.763361930847168,
            "end_logit": -0.6801421642303467
        },
        {
            "text": "stem cells to a premalignant state",
            "probability": 0.004719876453153279,
            "start_logit": 3.225313425064087,
            "end_logit": -2.530679941177368
        },
        {
            "text": "stem cells at high radiation doses, and proliferation of stem",
            "probability": 0.001880075450923364,
            "start_logit": 1.902815341949463,
            "end_logit": -2.128652572631836
        },
        {
            "text": "initiation of stem cells",
            "probability": 0.0018784349183292722,
            "start_logit": -1.9359477758407593,
            "end_logit": 1.7092375755310059
        },
        {
            "text": "long-range migration through the blood stream of hematopoietic stem cells",
            "probability": 0.0015919560052863855,
            "start_logit": -1.6503158807754517,
            "end_logit": 1.2581301927566528
        },
        {
            "text": "proliferation of stem cells",
            "probability": 0.0015668378850911696,
            "start_logit": -1.8739526271820068,
            "end_logit": 1.4658629894256592
        },
        {
            "text": "stem cells to a premalignant state, inactivation of stem cells at high radiation doses",
            "probability": 0.0015073662590351499,
            "start_logit": 3.225313425064087,
            "end_logit": -3.6720986366271973
        },
        {
            "text": "initiation of stem cells to a premalignant state, inactivation of stem cells at high radiation doses, and proliferation of stem cells",
            "probability": 0.0014726512588895987,
            "start_logit": -1.9359477758407593,
            "end_logit": 1.4658629894256592
        },
        {
            "text": "initiation of stem cells to a premalignant state, inactivation of stem cells",
            "probability": 0.0013487632128219398,
            "start_logit": -1.9359477758407593,
            "end_logit": 1.3779866695404053
        },
        {
            "text": "hematopoietic",
            "probability": 0.0007786142089389061,
            "start_logit": 1.763361930847168,
            "end_logit": -2.870750665664673
        },
        {
            "text": "hematopoietic stem",
            "probability": 0.000534400847458934,
            "start_logit": 1.763361930847168,
            "end_logit": -3.2471201419830322
        }
    ],
    "5e48136dd14c9f295d000008_003": [
        {
            "text": "stem cells",
            "probability": 0.32756946543560783,
            "start_logit": 3.225313425064087,
            "end_logit": 1.7092375755310059
        },
        {
            "text": "stem cells to a premalignant state, inactivation of stem cells at high radiation doses, and proliferation of stem cells",
            "probability": 0.2568071860996896,
            "start_logit": 3.225313425064087,
            "end_logit": 1.4658629894256592
        },
        {
            "text": "stem cells to a premalignant state, inactivation of stem cells",
            "probability": 0.23520306203435357,
            "start_logit": 3.225313425064087,
            "end_logit": 1.3779866695404053
        },
        {
            "text": "stem cells at high radiation doses, and proliferation of stem cells",
            "probability": 0.06843110492072377,
            "start_logit": 1.902815341949463,
            "end_logit": 1.4658629894256592
        },
        {
            "text": "hematopoietic stem cells",
            "probability": 0.048358464016297995,
            "start_logit": 1.763361930847168,
            "end_logit": 1.2581301927566528
        },
        {
            "text": "",
            "probability": 0.014225128324317597,
            "start_logit": 1.3452895879745483,
            "end_logit": 0.4525712728500366
        },
        {
            "text": "stem",
            "probability": 0.010705206133915861,
            "start_logit": 3.225313425064087,
            "end_logit": -1.7117323875427246
        },
        {
            "text": "stem cells to a premalignant state, inactivation of stem",
            "probability": 0.007404570052737654,
            "start_logit": 3.225313425064087,
            "end_logit": -2.0803651809692383
        },
        {
            "text": "stem cells to a premalignant state, inactivation of stem cells at high radiation doses, and proliferation of stem",
            "probability": 0.007055517907625036,
            "start_logit": 3.225313425064087,
            "end_logit": -2.128652572631836
        },
        {
            "text": "hematopoietic stem cells (HSCs)",
            "probability": 0.006961318574803026,
            "start_logit": 1.763361930847168,
            "end_logit": -0.6801421642303467
        },
        {
            "text": "stem cells to a premalignant state",
            "probability": 0.004719876453153279,
            "start_logit": 3.225313425064087,
            "end_logit": -2.530679941177368
        },
        {
            "text": "stem cells at high radiation doses, and proliferation of stem",
            "probability": 0.001880075450923364,
            "start_logit": 1.902815341949463,
            "end_logit": -2.128652572631836
        },
        {
            "text": "initiation of stem cells",
            "probability": 0.0018784349183292722,
            "start_logit": -1.9359477758407593,
            "end_logit": 1.7092375755310059
        },
        {
            "text": "long-range migration through the blood stream of hematopoietic stem cells",
            "probability": 0.0015919560052863855,
            "start_logit": -1.6503158807754517,
            "end_logit": 1.2581301927566528
        },
        {
            "text": "proliferation of stem cells",
            "probability": 0.0015668378850911696,
            "start_logit": -1.8739526271820068,
            "end_logit": 1.4658629894256592
        },
        {
            "text": "stem cells to a premalignant state, inactivation of stem cells at high radiation doses",
            "probability": 0.0015073662590351499,
            "start_logit": 3.225313425064087,
            "end_logit": -3.6720986366271973
        },
        {
            "text": "initiation of stem cells to a premalignant state, inactivation of stem cells at high radiation doses, and proliferation of stem cells",
            "probability": 0.0014726512588895987,
            "start_logit": -1.9359477758407593,
            "end_logit": 1.4658629894256592
        },
        {
            "text": "initiation of stem cells to a premalignant state, inactivation of stem cells",
            "probability": 0.0013487632128219398,
            "start_logit": -1.9359477758407593,
            "end_logit": 1.3779866695404053
        },
        {
            "text": "hematopoietic",
            "probability": 0.0007786142089389061,
            "start_logit": 1.763361930847168,
            "end_logit": -2.870750665664673
        },
        {
            "text": "hematopoietic stem",
            "probability": 0.000534400847458934,
            "start_logit": 1.763361930847168,
            "end_logit": -3.2471201419830322
        }
    ],
    "5e2ad60e76af173751000003_001": [
        {
            "text": "a heterogeneous clinical condition defined by the presence of the vermiform appendix within an inguinal hernia sac",
            "probability": 0.7042154299539998,
            "start_logit": 3.2625818252563477,
            "end_logit": 2.1008310317993164
        },
        {
            "text": "a heterogeneous clinical condition",
            "probability": 0.10652785944193009,
            "start_logit": 3.2625818252563477,
            "end_logit": 0.21215325593948364
        },
        {
            "text": "a heterogeneous clinical condition defined by the presence of the vermiform appendix",
            "probability": 0.07660452366886346,
            "start_logit": 3.2625818252563477,
            "end_logit": -0.11759715527296066
        },
        {
            "text": "presence of the vermiform appendix within an inguinal hernia sac",
            "probability": 0.031775804581578956,
            "start_logit": 0.16420264542102814,
            "end_logit": 2.1008310317993164
        },
        {
            "text": "a heterogeneous clinical condition defined by the presence of the vermiform appendix within an inguinal hernia sac,",
            "probability": 0.01963558176706825,
            "start_logit": 3.2625818252563477,
            "end_logit": -1.478909969329834
        },
        {
            "text": "the presence of the vermiform appendix within an inguinal hernia sac",
            "probability": 0.01391798882959751,
            "start_logit": -0.6613203287124634,
            "end_logit": 2.1008310317993164
        },
        {
            "text": "inguinal hernia sac",
            "probability": 0.008929002667343708,
            "start_logit": -1.105197787284851,
            "end_logit": 2.1008310317993164
        },
        {
            "text": "vermiform appendix within an inguinal hernia sac",
            "probability": 0.006720629868635243,
            "start_logit": -1.3893206119537354,
            "end_logit": 2.1008310317993164
        },
        {
            "text": "the vermiform appendix within an inguinal hernia sac",
            "probability": 0.005743146174149788,
            "start_logit": -1.5464953184127808,
            "end_logit": 2.1008310317993164
        },
        {
            "text": "heterogeneous clinical condition defined by the presence of the vermiform appendix within an inguinal hernia sac",
            "probability": 0.004168515460034488,
            "start_logit": -1.8669425249099731,
            "end_logit": 2.1008310317993164
        },
        {
            "text": "presence of the vermiform appendix",
            "probability": 0.003456570632548833,
            "start_logit": 0.16420264542102814,
            "end_logit": -0.11759715527296066
        },
        {
            "text": "a heterogeneous clinical condition defined by the presence of the vermiform appendix within an inguinal",
            "probability": 0.003238257038883015,
            "start_logit": 3.2625818252563477,
            "end_logit": -3.2812180519104004
        },
        {
            "text": "clinical condition defined by the presence of the vermiform appendix within an inguinal hernia sac",
            "probability": 0.0028621471080657484,
            "start_logit": -2.2429304122924805,
            "end_logit": 2.1008310317993164
        },
        {
            "text": "",
            "probability": 0.002860286374434714,
            "start_logit": -0.14105954766273499,
            "end_logit": -0.0016901623457670212
        },
        {
            "text": "an inguinal hernia sac",
            "probability": 0.00200705864504048,
            "start_logit": -2.597832202911377,
            "end_logit": 2.1008310317993164
        },
        {
            "text": "is a heterogeneous clinical condition defined by the presence of the vermiform appendix within an inguinal hernia sac",
            "probability": 0.0019568749861572066,
            "start_logit": -2.6231536865234375,
            "end_logit": 2.1008310317993164
        },
        {
            "text": "defined by the presence of the vermiform appendix within an inguinal hernia sac",
            "probability": 0.0018974787895423132,
            "start_logit": -2.6539764404296875,
            "end_logit": 2.1008310317993164
        },
        {
            "text": "the presence of the vermiform appendix",
            "probability": 0.0015139982161275906,
            "start_logit": -0.6613203287124634,
            "end_logit": -0.11759715527296066
        },
        {
            "text": "hernia is a heterogeneous clinical condition defined by the presence of the vermiform appendix within an inguinal hernia sac",
            "probability": 0.0010828436118137873,
            "start_logit": -3.214911937713623,
            "end_logit": 2.1008310317993164
        },
        {
            "text": "presence of the vermiform appendix within an inguinal hernia sac,",
            "probability": 0.000886002184184933,
            "start_logit": 0.16420264542102814,
            "end_logit": -1.478909969329834
        }
    ],
    "5e2ad60e76af173751000003_002": [
        {
            "text": "a rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.3995156194596045,
            "start_logit": 7.488330841064453,
            "end_logit": 4.987138271331787
        },
        {
            "text": "a rare disease",
            "probability": 0.38186250921371556,
            "start_logit": 7.488330841064453,
            "end_logit": 4.941946029663086
        },
        {
            "text": "a rare disease where the appendix is found within an inguinal hernia sac.",
            "probability": 0.12480003508558278,
            "start_logit": 7.488330841064453,
            "end_logit": 3.8235981464385986
        },
        {
            "text": "rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.03660222352662553,
            "start_logit": 5.09818696975708,
            "end_logit": 4.987138271331787
        },
        {
            "text": "rare disease",
            "probability": 0.03498490731747661,
            "start_logit": 5.09818696975708,
            "end_logit": 4.941946029663086
        },
        {
            "text": "rare disease where the appendix is found within an inguinal hernia sac.",
            "probability": 0.011433742656950316,
            "start_logit": 5.09818696975708,
            "end_logit": 3.8235981464385986
        },
        {
            "text": "the appendix is found within an inguinal hernia sac",
            "probability": 0.0035351029065635365,
            "start_logit": 2.7608203887939453,
            "end_logit": 4.987138271331787
        },
        {
            "text": "a rare disease where the appendix",
            "probability": 0.0013106880488822634,
            "start_logit": 7.488330841064453,
            "end_logit": -0.7325623631477356
        },
        {
            "text": "the appendix is found within an inguinal hernia sac.",
            "probability": 0.0011042896579789,
            "start_logit": 2.7608203887939453,
            "end_logit": 3.8235981464385986
        },
        {
            "text": "appendix is found within an inguinal hernia sac",
            "probability": 0.0007799841024619772,
            "start_logit": 1.2495962381362915,
            "end_logit": 4.987138271331787
        },
        {
            "text": "a rare",
            "probability": 0.0007154279513130993,
            "start_logit": 7.488330841064453,
            "end_logit": -1.3379889726638794
        },
        {
            "text": "a rare disease where the appendix is found within an inguinal",
            "probability": 0.0005104794607563018,
            "start_logit": 7.488330841064453,
            "end_logit": -1.6755194664001465
        },
        {
            "text": "a",
            "probability": 0.0004415811756183402,
            "start_logit": 7.488330841064453,
            "end_logit": -1.8205080032348633
        },
        {
            "text": "An Amyand hernia is a rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.00043521683592504917,
            "start_logit": 0.6661670804023743,
            "end_logit": 4.987138271331787
        },
        {
            "text": "An Amyand hernia is a rare disease",
            "probability": 0.0004159862216230503,
            "start_logit": 0.6661670804023743,
            "end_logit": 4.941946029663086
        },
        {
            "text": "Amyand hernia is a rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.0003743644175243198,
            "start_logit": 0.5155524015426636,
            "end_logit": 4.987138271331787
        },
        {
            "text": "Amyand hernia is a rare disease",
            "probability": 0.0003578226454062887,
            "start_logit": 0.5155524015426636,
            "end_logit": 4.941946029663086
        },
        {
            "text": "is a rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.00029281936750510614,
            "start_logit": 0.269878625869751,
            "end_logit": 4.987138271331787
        },
        {
            "text": "is a rare disease",
            "probability": 0.00027988076804886695,
            "start_logit": 0.269878625869751,
            "end_logit": 4.941946029663086
        },
        {
            "text": "appendix is found within an inguinal hernia sac.",
            "probability": 0.00024365015687025953,
            "start_logit": 1.2495962381362915,
            "end_logit": 3.8235981464385986
        },
        {
            "text": "",
            "probability": 3.6690235673475368e-06,
            "start_logit": 0.7941693663597107,
            "end_logit": 0.08321717381477356
        }
    ],
    "5e2ad60e76af173751000003_003": [
        {
            "text": "a rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.3995156194596045,
            "start_logit": 7.488330841064453,
            "end_logit": 4.987138271331787
        },
        {
            "text": "a rare disease",
            "probability": 0.38186250921371556,
            "start_logit": 7.488330841064453,
            "end_logit": 4.941946029663086
        },
        {
            "text": "a rare disease where the appendix is found within an inguinal hernia sac.",
            "probability": 0.12480003508558278,
            "start_logit": 7.488330841064453,
            "end_logit": 3.8235981464385986
        },
        {
            "text": "rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.03660222352662553,
            "start_logit": 5.09818696975708,
            "end_logit": 4.987138271331787
        },
        {
            "text": "rare disease",
            "probability": 0.03498490731747661,
            "start_logit": 5.09818696975708,
            "end_logit": 4.941946029663086
        },
        {
            "text": "rare disease where the appendix is found within an inguinal hernia sac.",
            "probability": 0.011433742656950316,
            "start_logit": 5.09818696975708,
            "end_logit": 3.8235981464385986
        },
        {
            "text": "the appendix is found within an inguinal hernia sac",
            "probability": 0.0035351029065635365,
            "start_logit": 2.7608203887939453,
            "end_logit": 4.987138271331787
        },
        {
            "text": "a rare disease where the appendix",
            "probability": 0.0013106880488822634,
            "start_logit": 7.488330841064453,
            "end_logit": -0.7325623631477356
        },
        {
            "text": "the appendix is found within an inguinal hernia sac.",
            "probability": 0.0011042896579789,
            "start_logit": 2.7608203887939453,
            "end_logit": 3.8235981464385986
        },
        {
            "text": "appendix is found within an inguinal hernia sac",
            "probability": 0.0007799841024619772,
            "start_logit": 1.2495962381362915,
            "end_logit": 4.987138271331787
        },
        {
            "text": "a rare",
            "probability": 0.0007154279513130993,
            "start_logit": 7.488330841064453,
            "end_logit": -1.3379889726638794
        },
        {
            "text": "a rare disease where the appendix is found within an inguinal",
            "probability": 0.0005104794607563018,
            "start_logit": 7.488330841064453,
            "end_logit": -1.6755194664001465
        },
        {
            "text": "a",
            "probability": 0.0004415811756183402,
            "start_logit": 7.488330841064453,
            "end_logit": -1.8205080032348633
        },
        {
            "text": "An Amyand hernia is a rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.00043521683592504917,
            "start_logit": 0.6661670804023743,
            "end_logit": 4.987138271331787
        },
        {
            "text": "An Amyand hernia is a rare disease",
            "probability": 0.0004159862216230503,
            "start_logit": 0.6661670804023743,
            "end_logit": 4.941946029663086
        },
        {
            "text": "Amyand hernia is a rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.0003743644175243198,
            "start_logit": 0.5155524015426636,
            "end_logit": 4.987138271331787
        },
        {
            "text": "Amyand hernia is a rare disease",
            "probability": 0.0003578226454062887,
            "start_logit": 0.5155524015426636,
            "end_logit": 4.941946029663086
        },
        {
            "text": "is a rare disease where the appendix is found within an inguinal hernia sac",
            "probability": 0.00029281936750510614,
            "start_logit": 0.269878625869751,
            "end_logit": 4.987138271331787
        },
        {
            "text": "is a rare disease",
            "probability": 0.00027988076804886695,
            "start_logit": 0.269878625869751,
            "end_logit": 4.941946029663086
        },
        {
            "text": "appendix is found within an inguinal hernia sac.",
            "probability": 0.00024365015687025953,
            "start_logit": 1.2495962381362915,
            "end_logit": 3.8235981464385986
        },
        {
            "text": "",
            "probability": 3.6690235673475368e-06,
            "start_logit": 0.7941693663597107,
            "end_logit": 0.08321717381477356
        }
    ],
    "5e2ad60e76af173751000003_004": [
        {
            "text": "the incarceration of the vermiform appendix in the hernia sac",
            "probability": 0.7237080652691659,
            "start_logit": 7.374334335327148,
            "end_logit": 7.436746597290039
        },
        {
            "text": "incarceration of the vermiform appendix in the hernia sac",
            "probability": 0.14871824875149636,
            "start_logit": 5.791999816894531,
            "end_logit": 7.436746597290039
        },
        {
            "text": "the incarceration of the vermiform appendix",
            "probability": 0.06987708620201437,
            "start_logit": 7.374334335327148,
            "end_logit": 5.099096298217773
        },
        {
            "text": "the incarceration of the vermiform appendix in the hernia sac.",
            "probability": 0.03210568353092482,
            "start_logit": 7.374334335327148,
            "end_logit": 4.321391582489014
        },
        {
            "text": "incarceration of the vermiform appendix",
            "probability": 0.014359378299806389,
            "start_logit": 5.791999816894531,
            "end_logit": 5.099096298217773
        },
        {
            "text": "incarceration of the vermiform appendix in the hernia sac.",
            "probability": 0.0065975512210342206,
            "start_logit": 5.791999816894531,
            "end_logit": 4.321391582489014
        },
        {
            "text": "the vermiform appendix in the hernia sac",
            "probability": 0.0017763932233128097,
            "start_logit": 1.3645312786102295,
            "end_logit": 7.436746597290039
        },
        {
            "text": "as the incarceration of the vermiform appendix in the hernia sac",
            "probability": 0.0006198365161658968,
            "start_logit": 0.3116467297077179,
            "end_logit": 7.436746597290039
        },
        {
            "text": "vermiform appendix in the hernia sac",
            "probability": 0.000561765242869554,
            "start_logit": 0.2132750153541565,
            "end_logit": 7.436746597290039
        },
        {
            "text": "defined as the incarceration of the vermiform appendix in the hernia sac",
            "probability": 0.0003793978660353285,
            "start_logit": -0.17922359704971313,
            "end_logit": 7.436746597290039
        },
        {
            "text": "hernia sac",
            "probability": 0.00036539389830642424,
            "start_logit": -0.21683308482170105,
            "end_logit": 7.436746597290039
        },
        {
            "text": "the vermiform appendix",
            "probability": 0.00017151830738259977,
            "start_logit": 1.3645312786102295,
            "end_logit": 5.099096298217773
        },
        {
            "text": "the hernia sac",
            "probability": 0.00015426421545641425,
            "start_logit": -1.0791422128677368,
            "end_logit": 7.436746597290039
        },
        {
            "text": "in the hernia sac",
            "probability": 0.00012796588410986977,
            "start_logit": -1.266045331954956,
            "end_logit": 7.436746597290039
        },
        {
            "text": "appendix in the hernia sac",
            "probability": 0.00012590642295439764,
            "start_logit": -1.282270073890686,
            "end_logit": 7.436746597290039
        },
        {
            "text": "the incarceration",
            "probability": 8.02795905910919e-05,
            "start_logit": 7.374334335327148,
            "end_logit": -1.6698813438415527
        },
        {
            "text": "the vermiform appendix in the hernia sac.",
            "probability": 7.880569720188035e-05,
            "start_logit": 1.3645312786102295,
            "end_logit": 4.321391582489014
        },
        {
            "text": "hernia is defined as the incarceration of the vermiform appendix in the hernia sac",
            "probability": 7.829250755327331e-05,
            "start_logit": -1.757357120513916,
            "end_logit": 7.436746597290039
        },
        {
            "text": "as the incarceration of the vermiform appendix",
            "probability": 5.984784714976424e-05,
            "start_logit": 0.3116467297077179,
            "end_logit": 5.099096298217773
        },
        {
            "text": "vermiform appendix",
            "probability": 5.424081917159729e-05,
            "start_logit": 0.2132750153541565,
            "end_logit": 5.099096298217773
        },
        {
            "text": "",
            "probability": 7.868729686658512e-08,
            "start_logit": -0.6881769895553589,
            "end_logit": -0.5351589918136597
        }
    ],
    "5e2ad60e76af173751000003_006": [
        {
            "text": "",
            "probability": 0.7837445582925078,
            "start_logit": 3.0699634552001953,
            "end_logit": 3.578073024749756
        },
        {
            "text": "the appendix",
            "probability": 0.09475218530827903,
            "start_logit": 2.1359341144561768,
            "end_logit": 2.3992841243743896
        },
        {
            "text": "appendix",
            "probability": 0.020216353689055153,
            "start_logit": 0.5911610722541809,
            "end_logit": 2.3992841243743896
        },
        {
            "text": "an inguinal hernia containing the appendix",
            "probability": 0.019683565271566172,
            "start_logit": 0.5644532442092896,
            "end_logit": 2.3992841243743896
        },
        {
            "text": "inguinal hernia containing the appendix",
            "probability": 0.018388548005310763,
            "start_logit": 0.4963972866535187,
            "end_logit": 2.3992841243743896
        },
        {
            "text": "femoral hernia defect, a De Garengeot hernia, is distinctly different than an inguinal hernia containing the appendix",
            "probability": 0.012970186252726803,
            "start_logit": 0.14732256531715393,
            "end_logit": 2.3992841243743896
        },
        {
            "text": "containing the appendix",
            "probability": 0.007739417023419648,
            "start_logit": -0.36900442838668823,
            "end_logit": 2.3992841243743896
        },
        {
            "text": "an inguinal hernia",
            "probability": 0.0064203034708657835,
            "start_logit": 0.5644532442092896,
            "end_logit": 1.2789654731750488
        },
        {
            "text": "inguinal hernia",
            "probability": 0.005997900123979168,
            "start_logit": 0.4963972866535187,
            "end_logit": 1.2789654731750488
        },
        {
            "text": "femoral hernia defect, a De Garengeot hernia, is distinctly different than an inguinal hernia",
            "probability": 0.004230561418486956,
            "start_logit": 0.14732256531715393,
            "end_logit": 1.2789654731750488
        },
        {
            "text": "an incarcerated vermiform appendix within a femoral hernia defect",
            "probability": 0.004209809442932538,
            "start_logit": 0.4998895823955536,
            "end_logit": 0.9214811325073242
        },
        {
            "text": "a De Garengeot hernia, is distinctly different than an inguinal hernia containing the appendix",
            "probability": 0.003289338922140607,
            "start_logit": -1.2246441841125488,
            "end_logit": 2.3992841243743896
        },
        {
            "text": "an incarcerated vermiform appendix",
            "probability": 0.0032878933962872327,
            "start_logit": 0.4998895823955536,
            "end_logit": 0.6743108034133911
        },
        {
            "text": "a femoral hernia defect, a De Garengeot hernia, is distinctly different than an inguinal hernia containing the appendix",
            "probability": 0.0029672586790604996,
            "start_logit": -1.3276922702789307,
            "end_logit": 2.3992841243743896
        },
        {
            "text": "femoral hernia defect",
            "probability": 0.0029589970209158867,
            "start_logit": 0.14732256531715393,
            "end_logit": 0.9214811325073242
        },
        {
            "text": "an incarcerated vermiform appendix within a femoral hernia defect, a De Garengeot hernia",
            "probability": 0.0022711457093886143,
            "start_logit": 0.4998895823955536,
            "end_logit": 0.3043481707572937
        },
        {
            "text": "incarcerated vermiform appendix within a femoral hernia defect",
            "probability": 0.002006195998811528,
            "start_logit": -0.24128741025924683,
            "end_logit": 0.9214811325073242
        },
        {
            "text": "De Garengeot hernia, is distinctly different than an inguinal hernia containing the appendix",
            "probability": 0.0017025813247321102,
            "start_logit": -1.8831852674484253,
            "end_logit": 2.3992841243743896
        },
        {
            "text": "femoral hernia defect, a De Garengeot hernia",
            "probability": 0.0015963462192876505,
            "start_logit": 0.14732256531715393,
            "end_logit": 0.3043481707572937
        },
        {
            "text": "incarcerated vermiform appendix",
            "probability": 0.0015668544302459993,
            "start_logit": -0.24128741025924683,
            "end_logit": 0.6743108034133911
        }
    ],
    "5c74266a7c78d694710000a2_001": [
        {
            "text": "localization",
            "probability": 0.7417077970564248,
            "start_logit": -0.11397586762905121,
            "end_logit": 1.9776012897491455
        },
        {
            "text": "export",
            "probability": 0.05494769064017584,
            "start_logit": -1.72104012966156,
            "end_logit": 0.9820918440818787
        },
        {
            "text": "mRNA nuclear export",
            "probability": 0.038853250081463314,
            "start_logit": -2.0676300525665283,
            "end_logit": 0.9820918440818787
        },
        {
            "text": "ALREX-promoting elements enhance nuclear speckle localization",
            "probability": 0.0365473374769153,
            "start_logit": -3.1243228912353516,
            "end_logit": 1.9776012897491455
        },
        {
            "text": "alternative mRNA nuclear export",
            "probability": 0.036152847068557314,
            "start_logit": -2.1396660804748535,
            "end_logit": 0.9820918440818787
        },
        {
            "text": "nuclear speckle localization",
            "probability": 0.03236811674895278,
            "start_logit": -3.2457573413848877,
            "end_logit": 1.9776012897491455
        },
        {
            "text": "nuclear export",
            "probability": 0.02224338905385789,
            "start_logit": -2.6253769397735596,
            "end_logit": 0.9820918440818787
        },
        {
            "text": "an alternative mRNA nuclear export",
            "probability": 0.006582745375581975,
            "start_logit": -3.8429698944091797,
            "end_logit": 0.9820918440818787
        },
        {
            "text": "export (ALREX) pathway",
            "probability": 0.005339899023474263,
            "start_logit": -1.72104012966156,
            "end_logit": -1.3490830659866333
        },
        {
            "text": "ALREX-promoting elements are trafficked through nuclear speckles. Although ALREX-promoting elements enhance nuclear speckle localization",
            "probability": 0.004273152694081493,
            "start_logit": -5.2705793380737305,
            "end_logit": 1.9776012897491455
        },
        {
            "text": "mRNA nuclear export (ALREX) pathway",
            "probability": 0.0037758171408410496,
            "start_logit": -2.0676300525665283,
            "end_logit": -1.3490830659866333
        },
        {
            "text": "alternative mRNA nuclear export (ALREX) pathway",
            "probability": 0.0035133879241878506,
            "start_logit": -2.1396660804748535,
            "end_logit": -1.3490830659866333
        },
        {
            "text": "localization, additional features within the mRNA largely drive this process",
            "probability": 0.0023986842215491548,
            "start_logit": -0.11397586762905121,
            "end_logit": -3.7564337253570557
        },
        {
            "text": "nuclear export (ALREX) pathway",
            "probability": 0.002161645923670683,
            "start_logit": -2.6253769397735596,
            "end_logit": -1.3490830659866333
        },
        {
            "text": "ALREX) pathway",
            "probability": 0.001981875007982249,
            "start_logit": -2.7122035026550293,
            "end_logit": -1.3490830659866333
        },
        {
            "text": "activate an alternative mRNA nuclear export",
            "probability": 0.0019010493235717438,
            "start_logit": -5.085015773773193,
            "end_logit": 0.9820918440818787
        },
        {
            "text": "localization, additional features within the mRNA largely drive this process. Depletion",
            "probability": 0.0015581048101693598,
            "start_logit": -0.11397586762905121,
            "end_logit": -4.1878838539123535
        },
        {
            "text": "localization, additional features within the mRNA",
            "probability": 0.0015286555519413306,
            "start_logit": -0.11397586762905121,
            "end_logit": -4.206965446472168
        },
        {
            "text": "localization, additional features within the mRNA largely drive this process. Depletion of two TREX-associated RNA helicases",
            "probability": 0.0013672802009256435,
            "start_logit": -0.11397586762905121,
            "end_logit": -4.318530559539795
        },
        {
            "text": "mRNA",
            "probability": 0.0007368369787884371,
            "start_logit": -2.0676300525665283,
            "end_logit": -2.983088493347168
        },
        {
            "text": "",
            "probability": 6.043769688793613e-05,
            "start_logit": -3.97165846824646,
            "end_logit": -3.5798137187957764
        }
    ],
    "5c74266a7c78d694710000a2_002": [
        {
            "text": "localization",
            "probability": 0.7417077970564248,
            "start_logit": -0.11397586762905121,
            "end_logit": 1.9776012897491455
        },
        {
            "text": "export",
            "probability": 0.05494769064017584,
            "start_logit": -1.72104012966156,
            "end_logit": 0.9820918440818787
        },
        {
            "text": "mRNA nuclear export",
            "probability": 0.038853250081463314,
            "start_logit": -2.0676300525665283,
            "end_logit": 0.9820918440818787
        },
        {
            "text": "ALREX-promoting elements enhance nuclear speckle localization",
            "probability": 0.0365473374769153,
            "start_logit": -3.1243228912353516,
            "end_logit": 1.9776012897491455
        },
        {
            "text": "alternative mRNA nuclear export",
            "probability": 0.036152847068557314,
            "start_logit": -2.1396660804748535,
            "end_logit": 0.9820918440818787
        },
        {
            "text": "nuclear speckle localization",
            "probability": 0.03236811674895278,
            "start_logit": -3.2457573413848877,
            "end_logit": 1.9776012897491455
        },
        {
            "text": "nuclear export",
            "probability": 0.02224338905385789,
            "start_logit": -2.6253769397735596,
            "end_logit": 0.9820918440818787
        },
        {
            "text": "an alternative mRNA nuclear export",
            "probability": 0.006582745375581975,
            "start_logit": -3.8429698944091797,
            "end_logit": 0.9820918440818787
        },
        {
            "text": "export (ALREX) pathway",
            "probability": 0.005339899023474263,
            "start_logit": -1.72104012966156,
            "end_logit": -1.3490830659866333
        },
        {
            "text": "ALREX-promoting elements are trafficked through nuclear speckles. Although ALREX-promoting elements enhance nuclear speckle localization",
            "probability": 0.004273152694081493,
            "start_logit": -5.2705793380737305,
            "end_logit": 1.9776012897491455
        },
        {
            "text": "mRNA nuclear export (ALREX) pathway",
            "probability": 0.0037758171408410496,
            "start_logit": -2.0676300525665283,
            "end_logit": -1.3490830659866333
        },
        {
            "text": "alternative mRNA nuclear export (ALREX) pathway",
            "probability": 0.0035133879241878506,
            "start_logit": -2.1396660804748535,
            "end_logit": -1.3490830659866333
        },
        {
            "text": "localization, additional features within the mRNA largely drive this process",
            "probability": 0.0023986842215491548,
            "start_logit": -0.11397586762905121,
            "end_logit": -3.7564337253570557
        },
        {
            "text": "nuclear export (ALREX) pathway",
            "probability": 0.002161645923670683,
            "start_logit": -2.6253769397735596,
            "end_logit": -1.3490830659866333
        },
        {
            "text": "ALREX) pathway",
            "probability": 0.001981875007982249,
            "start_logit": -2.7122035026550293,
            "end_logit": -1.3490830659866333
        },
        {
            "text": "activate an alternative mRNA nuclear export",
            "probability": 0.0019010493235717438,
            "start_logit": -5.085015773773193,
            "end_logit": 0.9820918440818787
        },
        {
            "text": "localization, additional features within the mRNA largely drive this process. Depletion",
            "probability": 0.0015581048101693598,
            "start_logit": -0.11397586762905121,
            "end_logit": -4.1878838539123535
        },
        {
            "text": "localization, additional features within the mRNA",
            "probability": 0.0015286555519413306,
            "start_logit": -0.11397586762905121,
            "end_logit": -4.206965446472168
        },
        {
            "text": "localization, additional features within the mRNA largely drive this process. Depletion of two TREX-associated RNA helicases",
            "probability": 0.0013672802009256435,
            "start_logit": -0.11397586762905121,
            "end_logit": -4.318530559539795
        },
        {
            "text": "mRNA",
            "probability": 0.0007368369787884371,
            "start_logit": -2.0676300525665283,
            "end_logit": -2.983088493347168
        },
        {
            "text": "",
            "probability": 6.043769688793613e-05,
            "start_logit": -3.97165846824646,
            "end_logit": -3.5798137187957764
        }
    ],
    "5c74266a7c78d694710000a2_003": [
        {
            "text": "pre-spliceosomal assembly on microinjected splicing-competent precursor mRNA",
            "probability": 0.5880989164067838,
            "start_logit": 5.330780029296875,
            "end_logit": 6.095150470733643
        },
        {
            "text": "the pre-spliceosomal assembly on microinjected splicing-competent precursor mRNA",
            "probability": 0.21229061059755788,
            "start_logit": 4.311841011047363,
            "end_logit": 6.095150470733643
        },
        {
            "text": "pre-spliceosomal assembly",
            "probability": 0.12917974831070797,
            "start_logit": 5.330780029296875,
            "end_logit": 4.579460144042969
        },
        {
            "text": "the pre-spliceosomal assembly",
            "probability": 0.04663101202987136,
            "start_logit": 4.311841011047363,
            "end_logit": 4.579460144042969
        },
        {
            "text": "assembly on microinjected splicing-competent precursor mRNA",
            "probability": 0.009664203059541994,
            "start_logit": 1.2223135232925415,
            "end_logit": 6.095150470733643
        },
        {
            "text": "microinjected splicing-competent precursor mRNA",
            "probability": 0.008855876630170763,
            "start_logit": 1.1349661350250244,
            "end_logit": 6.095150470733643
        },
        {
            "text": "assembly",
            "probability": 0.0021228049976403734,
            "start_logit": 1.2223135232925415,
            "end_logit": 4.579460144042969
        },
        {
            "text": "on microinjected splicing-competent precursor mRNA",
            "probability": 0.0013821754547360665,
            "start_logit": -0.7224564552307129,
            "end_logit": 6.095150470733643
        },
        {
            "text": "mRNA",
            "probability": 0.0005941732263887865,
            "start_logit": -1.566699504852295,
            "end_logit": 6.095150470733643
        },
        {
            "text": "pre-spliceosomal",
            "probability": 0.00031519818408615055,
            "start_logit": 5.330780029296875,
            "end_logit": -1.4362983703613281
        },
        {
            "text": "precursor mRNA",
            "probability": 0.00018513255290101175,
            "start_logit": -2.7327983379364014,
            "end_logit": 6.095150470733643
        },
        {
            "text": "pre-spliceosomal assembly on microinjected splicing-competent precursor mRNA takes place in the speckles",
            "probability": 0.00014018961495823265,
            "start_logit": 5.330780029296875,
            "end_logit": -2.246504068374634
        },
        {
            "text": "the pre-spliceosomal",
            "probability": 0.00011377952431493123,
            "start_logit": 4.311841011047363,
            "end_logit": -1.4362983703613281
        },
        {
            "text": "competent precursor mRNA",
            "probability": 0.0001038478208719425,
            "start_logit": -3.310943841934204,
            "end_logit": 6.095150470733643
        },
        {
            "text": "pre-spliceosomal assembly on microinjected splicing-competent precursor",
            "probability": 8.465245929582082e-05,
            "start_logit": 5.330780029296875,
            "end_logit": -2.750945806503296
        },
        {
            "text": "pre-spliceosomal assembly on microinjected splicing",
            "probability": 5.547563291569721e-05,
            "start_logit": 5.330780029296875,
            "end_logit": -3.173556089401245
        },
        {
            "text": "the pre-spliceosomal assembly on microinjected splicing-competent precursor mRNA takes place in the speckles",
            "probability": 5.060532867626357e-05,
            "start_logit": 4.311841011047363,
            "end_logit": -2.246504068374634
        },
        {
            "text": "splicing-competent precursor mRNA",
            "probability": 4.518783187205291e-05,
            "start_logit": -4.14304256439209,
            "end_logit": 6.095150470733643
        },
        {
            "text": "pre-spliceosomal assembly on microinjected splicing-competent precursor mRNA takes place",
            "probability": 4.411310333339429e-05,
            "start_logit": 5.330780029296875,
            "end_logit": -3.402743101119995
        },
        {
            "text": "pre-spliceosomal assembly on microinjected splicing-competent",
            "probability": 4.229181184967069e-05,
            "start_logit": 5.330780029296875,
            "end_logit": -3.44490647315979
        },
        {
            "text": "",
            "probability": 5.421525598730643e-09,
            "start_logit": -3.5903053283691406,
            "end_logit": -3.485792636871338
        }
    ],
    "5c74266a7c78d694710000a2_004": [
        {
            "text": "regulation of pre-mRNA splicing",
            "probability": 0.41084642216560036,
            "start_logit": 0.5087275505065918,
            "end_logit": 2.0482254028320312
        },
        {
            "text": "pre-mRNA splicing",
            "probability": 0.21040891808965717,
            "start_logit": -0.16043905913829803,
            "end_logit": 2.0482254028320312
        },
        {
            "text": "accumulate a family of proteins",
            "probability": 0.0859220162854036,
            "start_logit": 0.1036762222647667,
            "end_logit": 0.8884973526000977
        },
        {
            "text": "accumulate a family of proteins, namely, serine- and arginine-rich (SR) proteins",
            "probability": 0.07320503754835625,
            "start_logit": 0.1036762222647667,
            "end_logit": 0.7283214926719666
        },
        {
            "text": "regulation of pre-mRNA splicing. Currently, little is known about the link between inflammatory stimulation and the pre-mRNA splicing",
            "probability": 0.05274573097601869,
            "start_logit": 0.5087275505065918,
            "end_logit": -0.004511233419179916
        },
        {
            "text": "pre-mRNA splicing process",
            "probability": 0.03710892743362746,
            "start_logit": 1.1176434755325317,
            "end_logit": -0.9650524258613586
        },
        {
            "text": "pre-mRNA splicing. Currently, little is known about the link between inflammatory stimulation and the pre-mRNA splicing",
            "probability": 0.027012945932479982,
            "start_logit": -0.16043905913829803,
            "end_logit": -0.004511233419179916
        },
        {
            "text": "regulation of pre-mRNA splicing. Currently, little is known about the link between inflammatory stimulation and the pre-mRNA splicing process",
            "probability": 0.020185038209626745,
            "start_logit": 0.5087275505065918,
            "end_logit": -0.9650524258613586
        },
        {
            "text": "pre-mRNA splicing. Currently, little is known about the link between inflammatory stimulation and the pre-mRNA splicing process",
            "probability": 0.010337468752676798,
            "start_logit": -0.16043905913829803,
            "end_logit": -0.9650524258613586
        },
        {
            "text": "serine- and arginine-rich (SR) proteins. They play important roles in regulation of pre-mRNA splicing",
            "probability": 0.009006530193716963,
            "start_logit": -3.31154203414917,
            "end_logit": 2.0482254028320312
        },
        {
            "text": "Nuclear speckles, a unique nuclear subcompartment, accumulate a family of proteins",
            "probability": 0.008339801336755567,
            "start_logit": -2.228724479675293,
            "end_logit": 0.8884973526000977
        },
        {
            "text": "regulation",
            "probability": 0.007085463204556976,
            "start_logit": 0.5087275505065918,
            "end_logit": -2.011948823928833
        },
        {
            "text": "important roles in regulation of pre-mRNA splicing",
            "probability": 0.006605415659627558,
            "start_logit": -3.6216020584106445,
            "end_logit": 2.0482254028320312
        },
        {
            "text": "rapid aggregation",
            "probability": 0.006272804901256818,
            "start_logit": -0.9161784052848816,
            "end_logit": -0.7088645100593567
        },
        {
            "text": "regulation of pre-mRNA splicing.",
            "probability": 0.005959374465564128,
            "start_logit": 0.5087275505065918,
            "end_logit": -2.185028553009033
        },
        {
            "text": "proteins",
            "probability": 0.005351532406439139,
            "start_logit": -2.6723809242248535,
            "end_logit": 0.8884973526000977
        },
        {
            "text": "They play important roles in regulation of pre-mRNA splicing",
            "probability": 0.005180425594147372,
            "start_logit": -3.8646047115325928,
            "end_logit": 2.0482254028320312
        },
        {
            "text": "accumulate a family of proteins, namely, serine- and arginine-rich (SR) proteins. They play important roles in regulation",
            "probability": 0.004725597088815227,
            "start_logit": 0.1036762222647667,
            "end_logit": -2.011948823928833
        },
        {
            "text": "nuclear subcompartment, accumulate a family of proteins",
            "probability": 0.004694672931077797,
            "start_logit": -2.803335428237915,
            "end_logit": 0.8884973526000977
        },
        {
            "text": "proteins, namely, serine- and arginine-rich (SR) proteins",
            "probability": 0.004559473202459918,
            "start_logit": -2.6723809242248535,
            "end_logit": 0.7283214926719666
        },
        {
            "text": "",
            "probability": 0.004446403622135516,
            "start_logit": -1.1219511032104492,
            "end_logit": -0.8472198247909546
        }
    ],
    "5c74266a7c78d694710000a2_005": [
        {
            "text": "",
            "probability": 0.9999266063887711,
            "start_logit": 3.3041293621063232,
            "end_logit": 4.6380815505981445
        },
        {
            "text": "cellular RNA splicing",
            "probability": 2.158536390193707e-05,
            "start_logit": -2.957368850708008,
            "end_logit": 0.15615808963775635
        },
        {
            "text": "RNA splicing",
            "probability": 1.54286554310575e-05,
            "start_logit": -3.2931578159332275,
            "end_logit": 0.15615808963775635
        },
        {
            "text": "in regulating cellular RNA splicing",
            "probability": 8.323867571074353e-06,
            "start_logit": -3.910257339477539,
            "end_logit": 0.15615808963775635
        },
        {
            "text": "cellular RNA splicing activity",
            "probability": 7.901689892328984e-06,
            "start_logit": -2.957368850708008,
            "end_logit": -0.8487807512283325
        },
        {
            "text": "RNA splicing activity",
            "probability": 5.647921954230909e-06,
            "start_logit": -3.2931578159332275,
            "end_logit": -0.8487807512283325
        },
        {
            "text": "regulating cellular RNA splicing",
            "probability": 3.2242789231958997e-06,
            "start_logit": -4.858675003051758,
            "end_logit": 0.15615808963775635
        },
        {
            "text": "in regulating cellular RNA splicing activity",
            "probability": 3.0470934171066154e-06,
            "start_logit": -3.910257339477539,
            "end_logit": -0.8487807512283325
        },
        {
            "text": "C3G in regulating cellular RNA splicing",
            "probability": 1.922653524976109e-06,
            "start_logit": -5.375678062438965,
            "end_logit": 0.15615808963775635
        },
        {
            "text": "C3G and Rap1 as novel components of nuclear speckles and a role for C3G in regulating cellular RNA splicing",
            "probability": 1.5476789181318851e-06,
            "start_logit": -5.592628002166748,
            "end_logit": 0.15615808963775635
        },
        {
            "text": "regulating cellular RNA splicing activity",
            "probability": 1.1803021849995355e-06,
            "start_logit": -4.858675003051758,
            "end_logit": -0.8487807512283325
        },
        {
            "text": "C3G in regulating cellular RNA splicing activity",
            "probability": 7.038200511130167e-07,
            "start_logit": -5.375678062438965,
            "end_logit": -0.8487807512283325
        },
        {
            "text": "Rap1",
            "probability": 6.620979654495182e-07,
            "start_logit": -3.3831818103790283,
            "end_logit": -2.90238618850708
        },
        {
            "text": "C3G and Rap1 as novel components of nuclear speckles and a role for C3G in regulating cellular RNA splicing activity",
            "probability": 5.665542132868984e-07,
            "start_logit": -5.592628002166748,
            "end_logit": -0.8487807512283325
        },
        {
            "text": "inactivation of Rap signaling",
            "probability": 4.233256348257165e-07,
            "start_logit": -3.2752459049224854,
            "end_logit": -3.4575939178466797
        },
        {
            "text": "Rap1, a substrate of C3G",
            "probability": 4.156006501575659e-07,
            "start_logit": -3.3831818103790283,
            "end_logit": -3.368074893951416
        },
        {
            "text": "Rap1, a substrate of C3G, is also present in nuclear speckles, and inactivation of Rap signaling",
            "probability": 3.800131280833968e-07,
            "start_logit": -3.3831818103790283,
            "end_logit": -3.4575939178466797
        },
        {
            "text": "cellular RNA splicing activity.",
            "probability": 1.8339796522830165e-07,
            "start_logit": -2.957368850708008,
            "end_logit": -4.611954212188721
        },
        {
            "text": "RNA splicing activity.",
            "probability": 1.3108808473739023e-07,
            "start_logit": -3.2931578159332275,
            "end_logit": -4.611954212188721
        },
        {
            "text": "cellular actin cytoskeleton and is lost on expression of the kinase Clk1. Rap1",
            "probability": 1.182078168817682e-07,
            "start_logit": -5.106151103973389,
            "end_logit": -2.90238618850708
        }
    ],
    "5c74266a7c78d694710000a2_006": [
        {
            "text": "",
            "probability": 0.9999266063887711,
            "start_logit": 3.3041293621063232,
            "end_logit": 4.6380815505981445
        },
        {
            "text": "cellular RNA splicing",
            "probability": 2.158536390193707e-05,
            "start_logit": -2.957368850708008,
            "end_logit": 0.15615808963775635
        },
        {
            "text": "RNA splicing",
            "probability": 1.54286554310575e-05,
            "start_logit": -3.2931578159332275,
            "end_logit": 0.15615808963775635
        },
        {
            "text": "in regulating cellular RNA splicing",
            "probability": 8.323867571074353e-06,
            "start_logit": -3.910257339477539,
            "end_logit": 0.15615808963775635
        },
        {
            "text": "cellular RNA splicing activity",
            "probability": 7.901689892328984e-06,
            "start_logit": -2.957368850708008,
            "end_logit": -0.8487807512283325
        },
        {
            "text": "RNA splicing activity",
            "probability": 5.647921954230909e-06,
            "start_logit": -3.2931578159332275,
            "end_logit": -0.8487807512283325
        },
        {
            "text": "regulating cellular RNA splicing",
            "probability": 3.2242789231958997e-06,
            "start_logit": -4.858675003051758,
            "end_logit": 0.15615808963775635
        },
        {
            "text": "in regulating cellular RNA splicing activity",
            "probability": 3.0470934171066154e-06,
            "start_logit": -3.910257339477539,
            "end_logit": -0.8487807512283325
        },
        {
            "text": "C3G in regulating cellular RNA splicing",
            "probability": 1.922653524976109e-06,
            "start_logit": -5.375678062438965,
            "end_logit": 0.15615808963775635
        },
        {
            "text": "C3G and Rap1 as novel components of nuclear speckles and a role for C3G in regulating cellular RNA splicing",
            "probability": 1.5476789181318851e-06,
            "start_logit": -5.592628002166748,
            "end_logit": 0.15615808963775635
        },
        {
            "text": "regulating cellular RNA splicing activity",
            "probability": 1.1803021849995355e-06,
            "start_logit": -4.858675003051758,
            "end_logit": -0.8487807512283325
        },
        {
            "text": "C3G in regulating cellular RNA splicing activity",
            "probability": 7.038200511130167e-07,
            "start_logit": -5.375678062438965,
            "end_logit": -0.8487807512283325
        },
        {
            "text": "Rap1",
            "probability": 6.620979654495182e-07,
            "start_logit": -3.3831818103790283,
            "end_logit": -2.90238618850708
        },
        {
            "text": "C3G and Rap1 as novel components of nuclear speckles and a role for C3G in regulating cellular RNA splicing activity",
            "probability": 5.665542132868984e-07,
            "start_logit": -5.592628002166748,
            "end_logit": -0.8487807512283325
        },
        {
            "text": "inactivation of Rap signaling",
            "probability": 4.233256348257165e-07,
            "start_logit": -3.2752459049224854,
            "end_logit": -3.4575939178466797
        },
        {
            "text": "Rap1, a substrate of C3G",
            "probability": 4.156006501575659e-07,
            "start_logit": -3.3831818103790283,
            "end_logit": -3.368074893951416
        },
        {
            "text": "Rap1, a substrate of C3G, is also present in nuclear speckles, and inactivation of Rap signaling",
            "probability": 3.800131280833968e-07,
            "start_logit": -3.3831818103790283,
            "end_logit": -3.4575939178466797
        },
        {
            "text": "cellular RNA splicing activity.",
            "probability": 1.8339796522830165e-07,
            "start_logit": -2.957368850708008,
            "end_logit": -4.611954212188721
        },
        {
            "text": "RNA splicing activity.",
            "probability": 1.3108808473739023e-07,
            "start_logit": -3.2931578159332275,
            "end_logit": -4.611954212188721
        },
        {
            "text": "cellular actin cytoskeleton and is lost on expression of the kinase Clk1. Rap1",
            "probability": 1.182078168817682e-07,
            "start_logit": -5.106151103973389,
            "end_logit": -2.90238618850708
        }
    ],
    "5c74266a7c78d694710000a2_008": [
        {
            "text": "exosome inactivation",
            "probability": 0.5889218230964485,
            "start_logit": -0.12054306268692017,
            "end_logit": 0.33297494053840637
        },
        {
            "text": "upon exosome inactivation",
            "probability": 0.11453243637670837,
            "start_logit": -1.7579784393310547,
            "end_logit": 0.33297494053840637
        },
        {
            "text": "exosome inactivation, polyA RNAs are apparently accumulated in nuclear foci",
            "probability": 0.07726321269307843,
            "start_logit": -0.12054306268692017,
            "end_logit": -1.6981005668640137
        },
        {
            "text": "exosome inactivation, polyA RNAs",
            "probability": 0.06546156288290665,
            "start_logit": -0.12054306268692017,
            "end_logit": -1.8638553619384766
        },
        {
            "text": "accumulating exosome target mRNAs",
            "probability": 0.0429969311881643,
            "start_logit": -1.2060465812683105,
            "end_logit": -1.1986862421035767
        },
        {
            "text": "upon exosome inactivation, polyA RNAs are apparently accumulated in nuclear foci",
            "probability": 0.01502600794363984,
            "start_logit": -1.7579784393310547,
            "end_logit": -1.6981005668640137
        },
        {
            "text": "upon exosome inactivation, polyA RNAs",
            "probability": 0.012730844726700727,
            "start_logit": -1.7579784393310547,
            "end_logit": -1.8638553619384766
        },
        {
            "text": "exosome",
            "probability": 0.01170217956458705,
            "start_logit": -0.12054306268692017,
            "end_logit": -3.585543394088745
        },
        {
            "text": "polyA RNAs are apparently accumulated in nuclear foci",
            "probability": 0.010482758756268978,
            "start_logit": -2.1180291175842285,
            "end_logit": -1.6981005668640137
        },
        {
            "text": "inactivation",
            "probability": 0.00906542102825853,
            "start_logit": -4.294369220733643,
            "end_logit": 0.33297494053840637
        },
        {
            "text": "polyA RNAs mainly correspond to accumulating exosome target mRNAs",
            "probability": 0.009029256723317034,
            "start_logit": -2.766705274581909,
            "end_logit": -1.1986862421035767
        },
        {
            "text": "polyA RNAs",
            "probability": 0.008881558863411285,
            "start_logit": -2.1180291175842285,
            "end_logit": -1.8638553619384766
        },
        {
            "text": "accumulating exosome target mRNAs. These results suggest that exosomal mRNA degradation",
            "probability": 0.008456540026160241,
            "start_logit": -1.2060465812683105,
            "end_logit": -2.8248748779296875
        },
        {
            "text": "accumulating exosome target mRNAs. These results suggest that exosomal mRNA degradation mostly occurs outside of NSs",
            "probability": 0.005605371201108109,
            "start_logit": -1.2060465812683105,
            "end_logit": -3.2360897064208984
        },
        {
            "text": "exosome target mRNAs are sorted away from properly exported ones in the cells. We show that upon exosome inactivation",
            "probability": 0.0050818297244801655,
            "start_logit": -4.873165130615234,
            "end_logit": 0.33297494053840637
        },
        {
            "text": "exosome target mRNAs",
            "probability": 0.004439814464425152,
            "start_logit": -3.476562738418579,
            "end_logit": -1.1986862421035767
        },
        {
            "text": "exosome inactivation, polyA RNAs are apparently accumulated",
            "probability": 0.0029371498947541393,
            "start_logit": -0.12054306268692017,
            "end_logit": -4.967878818511963
        },
        {
            "text": "accumulating",
            "probability": 0.0027654748413949654,
            "start_logit": -1.2060465812683105,
            "end_logit": -3.9426026344299316
        },
        {
            "text": "nuclear foci",
            "probability": 0.0023266743853156144,
            "start_logit": -3.623321056365967,
            "end_logit": -1.6981005668640137
        },
        {
            "text": "upon exosome",
            "probability": 0.0022758184259549573,
            "start_logit": -1.7579784393310547,
            "end_logit": -3.585543394088745
        },
        {
            "text": "",
            "probability": 1.7333192917279717e-05,
            "start_logit": -5.4485249519348145,
            "end_logit": -4.772468566894531
        }
    ],
    "5c74266a7c78d694710000a2_009": [
        {
            "text": "splicing",
            "probability": 0.361255974127124,
            "start_logit": 2.184647560119629,
            "end_logit": 1.6122838258743286
        },
        {
            "text": "splicing factor storage sites",
            "probability": 0.3073098759447271,
            "start_logit": 2.184647560119629,
            "end_logit": 1.4505536556243896
        },
        {
            "text": "splicing factor",
            "probability": 0.16611764802695358,
            "start_logit": 2.184647560119629,
            "end_logit": 0.8353933095932007
        },
        {
            "text": "splicing factor storage sites.",
            "probability": 0.07852309968207025,
            "start_logit": 2.184647560119629,
            "end_logit": 0.08608989417552948
        },
        {
            "text": "serve as splicing",
            "probability": 0.020808493825485636,
            "start_logit": -0.669577956199646,
            "end_logit": 1.6122838258743286
        },
        {
            "text": "serve as splicing factor storage sites",
            "probability": 0.017701176213230908,
            "start_logit": -0.669577956199646,
            "end_logit": 1.4505536556243896
        },
        {
            "text": "splicing factor storage",
            "probability": 0.012892771705460332,
            "start_logit": 2.184647560119629,
            "end_logit": -1.7206361293792725
        },
        {
            "text": "serve as splicing factor",
            "probability": 0.009568445370696291,
            "start_logit": -0.669577956199646,
            "end_logit": 0.8353933095932007
        },
        {
            "text": "storage sites",
            "probability": 0.005652676707785338,
            "start_logit": -1.8110798597335815,
            "end_logit": 1.4505536556243896
        },
        {
            "text": "serve as splicing factor storage sites.",
            "probability": 0.0045229630841132455,
            "start_logit": -0.669577956199646,
            "end_logit": 0.08608989417552948
        },
        {
            "text": "sp",
            "probability": 0.003833238150342691,
            "start_logit": 2.184647560119629,
            "end_logit": -2.9335930347442627
        },
        {
            "text": "as splicing",
            "probability": 0.002507725046131871,
            "start_logit": -2.7855632305145264,
            "end_logit": 1.6122838258743286
        },
        {
            "text": "as splicing factor storage sites",
            "probability": 0.002133248245077002,
            "start_logit": -2.7855632305145264,
            "end_logit": 1.4505536556243896
        },
        {
            "text": "factor storage sites",
            "probability": 0.001742248406779251,
            "start_logit": -2.988032579421997,
            "end_logit": 1.4505536556243896
        },
        {
            "text": "storage sites.",
            "probability": 0.0014443587119724677,
            "start_logit": -1.8110798597335815,
            "end_logit": 0.08608989417552948
        },
        {
            "text": "as splicing factor",
            "probability": 0.001153136325477399,
            "start_logit": -2.7855632305145264,
            "end_logit": 0.8353933095932007
        },
        {
            "text": "factor",
            "probability": 0.0009417797157450653,
            "start_logit": -2.988032579421997,
            "end_logit": 0.8353933095932007
        },
        {
            "text": "serve as splicing factor storage",
            "probability": 0.0007426289934019504,
            "start_logit": -0.669577956199646,
            "end_logit": -1.7206361293792725
        },
        {
            "text": "Nuclear speckles (NSs) serve as splicing",
            "probability": 0.0006033673009141629,
            "start_logit": -4.210168361663818,
            "end_logit": 1.6122838258743286
        },
        {
            "text": "as splicing factor storage sites.",
            "probability": 0.0005450825948233151,
            "start_logit": -2.7855632305145264,
            "end_logit": 0.08608989417552948
        },
        {
            "text": "",
            "probability": 6.182168813655137e-08,
            "start_logit": -5.7993903160095215,
            "end_logit": -5.984521389007568
        }
    ],
    "5c74266a7c78d694710000a2_010": [
        {
            "text": "active transcription sites",
            "probability": 0.9885052760151023,
            "start_logit": 4.798571586608887,
            "end_logit": 4.579882621765137
        },
        {
            "text": "active transcription sites.",
            "probability": 0.005570871962032899,
            "start_logit": 4.798571586608887,
            "end_logit": -0.5987597703933716
        },
        {
            "text": "protein and RNA-protein components can cycle continuously between speckles and other nuclear locations, including active transcription sites",
            "probability": 0.0012147946742875379,
            "start_logit": -1.9030473232269287,
            "end_logit": 4.579882621765137
        },
        {
            "text": "active transcription",
            "probability": 0.0011231880560993734,
            "start_logit": 4.798571586608887,
            "end_logit": -2.2001402378082275
        },
        {
            "text": "cycle continuously between speckles and other nuclear locations, including active transcription sites",
            "probability": 0.001108456704527361,
            "start_logit": -1.9946537017822266,
            "end_logit": 4.579882621765137
        },
        {
            "text": "active",
            "probability": 0.0008283978469260844,
            "start_logit": 4.798571586608887,
            "end_logit": -2.504573106765747
        },
        {
            "text": "dynamic structures, and both their protein and RNA-protein components can cycle continuously between speckles and other nuclear locations, including active transcription sites",
            "probability": 0.0007037692329291458,
            "start_logit": -2.448927164077759,
            "end_logit": 4.579882621765137
        },
        {
            "text": "both their protein and RNA-protein components can cycle continuously between speckles and other nuclear locations, including active transcription sites",
            "probability": 0.00022481039472110352,
            "start_logit": -3.590120315551758,
            "end_logit": 4.579882621765137
        },
        {
            "text": "transcription sites",
            "probability": 0.00016443962726722368,
            "start_logit": -3.902834177017212,
            "end_logit": 4.579882621765137
        },
        {
            "text": "components can cycle continuously between speckles and other nuclear locations, including active transcription sites",
            "probability": 0.00016367709027745357,
            "start_logit": -3.907482147216797,
            "end_logit": 4.579882621765137
        },
        {
            "text": "sites",
            "probability": 6.392770871561504e-05,
            "start_logit": -4.847624778747559,
            "end_logit": 4.579882621765137
        },
        {
            "text": "",
            "probability": 6.017967616881743e-05,
            "start_logit": -0.25907132029533386,
            "end_logit": -0.06908904016017914
        },
        {
            "text": "can cycle continuously between speckles and other nuclear locations, including active transcription sites",
            "probability": 5.3341595025482685e-05,
            "start_logit": -5.028661251068115,
            "end_logit": 4.579882621765137
        },
        {
            "text": "protein components can cycle continuously between speckles and other nuclear locations, including active transcription sites",
            "probability": 5.2923837587868334e-05,
            "start_logit": -5.036523818969727,
            "end_logit": 4.579882621765137
        },
        {
            "text": "continuously between speckles and other nuclear locations, including active transcription sites",
            "probability": 4.998493246360496e-05,
            "start_logit": -5.093656063079834,
            "end_logit": 4.579882621765137
        },
        {
            "text": "including active transcription sites",
            "probability": 3.6751123433158064e-05,
            "start_logit": -5.401208877563477,
            "end_logit": 4.579882621765137
        },
        {
            "text": "active transcription sites. Studies on the composition, structure and behaviour of speckles have provided a model for understanding the functional compartmentalization",
            "probability": 2.6787277472373057e-05,
            "start_logit": 4.798571586608887,
            "end_logit": -5.9361395835876465
        },
        {
            "text": "structures, and both their protein and RNA-protein components can cycle continuously between speckles and other nuclear locations, including active transcription sites",
            "probability": 1.918736800175904e-05,
            "start_logit": -6.051125526428223,
            "end_logit": 4.579882621765137
        },
        {
            "text": "their protein and RNA-protein components can cycle continuously between speckles and other nuclear locations, including active transcription sites",
            "probability": 1.7526719039347416e-05,
            "start_logit": -6.141651153564453,
            "end_logit": 4.579882621765137
        },
        {
            "text": "protein and RNA-protein components",
            "probability": 1.1708157921406472e-05,
            "start_logit": -1.9030473232269287,
            "end_logit": -0.062161870300769806
        }
    ],
    "5e2e11a1fbd6abf43b000021_001": [
        {
            "text": "",
            "probability": 0.9997834968987385,
            "start_logit": 5.006190776824951,
            "end_logit": 5.16631555557251
        },
        {
            "text": "missense mutations",
            "probability": 4.5947404058329403e-05,
            "start_logit": 0.41143158078193665,
            "end_logit": -0.22672192752361298
        },
        {
            "text": "missense mutations in a CpG doublet of the transmembrane domain",
            "probability": 2.9953952232045134e-05,
            "start_logit": 0.41143158078193665,
            "end_logit": -0.654558002948761
        },
        {
            "text": "recurrent missense mutations",
            "probability": 2.0965898637840935e-05,
            "start_logit": -0.3731685280799866,
            "end_logit": -0.22672192752361298
        },
        {
            "text": "missense",
            "probability": 2.0594680053422232e-05,
            "start_logit": 0.41143158078193665,
            "end_logit": -1.029186487197876
        },
        {
            "text": "missense mutations in a CpG doublet",
            "probability": 1.8366438383982212e-05,
            "start_logit": 0.41143158078193665,
            "end_logit": -1.143694281578064
        },
        {
            "text": "missense mutations in a CpG doublet of the transmembrane domain of the FGFR3 protein",
            "probability": 1.3884969953593685e-05,
            "start_logit": 0.41143158078193665,
            "end_logit": -1.4234123229980469
        },
        {
            "text": "recurrent missense mutations in a CpG doublet of the transmembrane domain",
            "probability": 1.3668052399707681e-05,
            "start_logit": -0.3731685280799866,
            "end_logit": -0.654558002948761
        },
        {
            "text": "recurrent missense",
            "probability": 9.397396508639978e-06,
            "start_logit": -0.3731685280799866,
            "end_logit": -1.029186487197876
        },
        {
            "text": "missense mutations in a CpG doublet of the transmembrane domain of the FGFR3",
            "probability": 8.552093730015801e-06,
            "start_logit": 0.41143158078193665,
            "end_logit": -1.9080431461334229
        },
        {
            "text": "recurrent missense mutations in a CpG doublet",
            "probability": 8.38064507426544e-06,
            "start_logit": -0.3731685280799866,
            "end_logit": -1.143694281578064
        },
        {
            "text": "recurrent missense mutations in a CpG doublet of the transmembrane domain of the FGFR3 protein",
            "probability": 6.3357414548807194e-06,
            "start_logit": -0.3731685280799866,
            "end_logit": -1.4234123229980469
        },
        {
            "text": "paternal origin",
            "probability": 3.940696991086331e-06,
            "start_logit": -2.077796697616577,
            "end_logit": -0.19363339245319366
        },
        {
            "text": "recurrent missense mutations in a CpG doublet of the transmembrane domain of the FGFR3",
            "probability": 3.902338640442128e-06,
            "start_logit": -0.3731685280799866,
            "end_logit": -1.9080431461334229
        },
        {
            "text": "missense mutations in a CpG doublet of the transmembrane domain of the FGFR3 protein (glycine",
            "probability": 3.571770136210677e-06,
            "start_logit": 0.41143158078193665,
            "end_logit": -2.781157970428467
        },
        {
            "text": "CpG doublet of the transmembrane domain",
            "probability": 2.3151994556680796e-06,
            "start_logit": -2.1487338542938232,
            "end_logit": -0.654558002948761
        },
        {
            "text": "a CpG doublet of the transmembrane domain",
            "probability": 2.279035546946509e-06,
            "start_logit": -2.1644773483276367,
            "end_logit": -0.654558002948761
        },
        {
            "text": "recurrent missense mutations in a CpG doublet of the transmembrane domain of the FGFR3 protein (glycine",
            "probability": 1.629806344192911e-06,
            "start_logit": -0.3731685280799866,
            "end_logit": -2.781157970428467
        },
        {
            "text": "CpG doublet",
            "probability": 1.419577884739576e-06,
            "start_logit": -2.1487338542938232,
            "end_logit": -1.143694281578064
        },
        {
            "text": "a CpG doublet",
            "probability": 1.3974037757567852e-06,
            "start_logit": -2.1644773483276367,
            "end_logit": -1.143694281578064
        }
    ],
    "5e2a04feaa19d74431000009_002": [
        {
            "text": "",
            "probability": 0.9999999971551319,
            "start_logit": 7.660648345947266,
            "end_logit": 8.129392623901367
        },
        {
            "text": "LB100 profoundly upregulates miR-181b-1",
            "probability": 7.299412301310098e-10,
            "start_logit": -2.7021656036376953,
            "end_logit": -2.5458505153656006
        },
        {
            "text": "miR-181b-1",
            "probability": 3.43799505780316e-10,
            "start_logit": -3.455070972442627,
            "end_logit": -2.5458505153656006
        },
        {
            "text": "profoundly upregulates miR-181b-1",
            "probability": 3.327600882268331e-10,
            "start_logit": -3.4877078533172607,
            "end_logit": -2.5458505153656006
        },
        {
            "text": "upregulates miR-181b-1",
            "probability": 2.819292775460853e-10,
            "start_logit": -3.653473377227783,
            "end_logit": -2.5458505153656006
        },
        {
            "text": "LB100",
            "probability": 2.556921678085354e-10,
            "start_logit": -2.7021656036376953,
            "end_logit": -3.5948402881622314
        },
        {
            "text": "LB100 profoundly upregulates",
            "probability": 1.8220767687277187e-10,
            "start_logit": -2.7021656036376953,
            "end_logit": -3.9336674213409424
        },
        {
            "text": "181b-1",
            "probability": 1.4384461283315075e-10,
            "start_logit": -4.3263959884643555,
            "end_logit": -2.5458505153656006
        },
        {
            "text": "profoundly upregulates",
            "probability": 8.306345789086024e-11,
            "start_logit": -3.4877078533172607,
            "end_logit": -3.9336674213409424
        },
        {
            "text": "LB100 profoundly upregulates miR-181b-1,",
            "probability": 8.301677348562027e-11,
            "start_logit": -2.7021656036376953,
            "end_logit": -4.719771862030029
        },
        {
            "text": "upregulates",
            "probability": 7.037508854633584e-11,
            "start_logit": -3.653473377227783,
            "end_logit": -3.9336674213409424
        },
        {
            "text": "LB100 profoundly",
            "probability": 6.090759771439574e-11,
            "start_logit": -2.7021656036376953,
            "end_logit": -5.029456615447998
        },
        {
            "text": "miR-181b-1, which we show directly binds to the 3' untranslated region of Bcl-2 mRNA",
            "probability": 5.150894001285364e-11,
            "start_logit": -3.455070972442627,
            "end_logit": -4.444153785705566
        },
        {
            "text": "miR-181b-1,",
            "probability": 3.9100580317555333e-11,
            "start_logit": -3.455070972442627,
            "end_logit": -4.719771862030029
        },
        {
            "text": "profoundly upregulates miR-181b-1,",
            "probability": 3.784505892950306e-11,
            "start_logit": -3.4877078533172607,
            "end_logit": -4.719771862030029
        },
        {
            "text": "LB100 profoundly upregulates miR-181",
            "probability": 3.719022813134973e-11,
            "start_logit": -2.7021656036376953,
            "end_logit": -5.522768497467041
        },
        {
            "text": "upregulates miR-181b-1,",
            "probability": 3.206403201639566e-11,
            "start_logit": -3.653473377227783,
            "end_logit": -4.719771862030029
        },
        {
            "text": "LB100 profoundly upregulates miR-181b-1, which we show directly binds to the 3' untranslated region",
            "probability": 3.030475297770142e-11,
            "start_logit": -2.7021656036376953,
            "end_logit": -5.72750997543335
        },
        {
            "text": "profoundly",
            "probability": 2.7766095066981147e-11,
            "start_logit": -3.4877078533172607,
            "end_logit": -5.029456615447998
        },
        {
            "text": "181b-1, which we show directly binds to the 3' untranslated region of Bcl-2 mRNA",
            "probability": 2.1551175638772927e-11,
            "start_logit": -4.3263959884643555,
            "end_logit": -4.444153785705566
        }
    ],
    "5e482160d14c9f295d00000c_001": [
        {
            "text": "",
            "probability": 0.9983607129121168,
            "start_logit": 5.782288074493408,
            "end_logit": 5.356045722961426
        },
        {
            "text": "thioredoxin 1 (Trx1)",
            "probability": 0.0004373051080862065,
            "start_logit": 3.50362491607666,
            "end_logit": -0.09852990508079529
        },
        {
            "text": "thioredoxin 1 (Trx1), peroxiredoxin 1 (Prx1)",
            "probability": 0.00034528139702845044,
            "start_logit": 3.50362491607666,
            "end_logit": -0.3348013162612915
        },
        {
            "text": "thioredoxin 1",
            "probability": 0.0002779156635755024,
            "start_logit": 3.50362491607666,
            "end_logit": -0.5518433451652527
        },
        {
            "text": "tensin homolog (PTEN)",
            "probability": 0.00020758853227475217,
            "start_logit": -1.2219171524047852,
            "end_logit": 3.881938934326172
        },
        {
            "text": "thioredoxin 1 (Trx1),",
            "probability": 6.979491909078253e-05,
            "start_logit": 3.50362491607666,
            "end_logit": -1.933599829673767
        },
        {
            "text": "thioredoxin 1 (Trx1), peroxiredoxin 1",
            "probability": 6.362395659144009e-05,
            "start_logit": 3.50362491607666,
            "end_logit": -2.0261709690093994
        },
        {
            "text": "thioredoxin 1 (Trx1), peroxiredoxin 1 (Prx1), GSH reductase",
            "probability": 4.8450457163539425e-05,
            "start_logit": 3.50362491607666,
            "end_logit": -2.298619270324707
        },
        {
            "text": "thioredoxin 1 (Trx1",
            "probability": 4.245091414362833e-05,
            "start_logit": 3.50362491607666,
            "end_logit": -2.4308125972747803
        },
        {
            "text": "thioredoxin 1 (Trx1), peroxiredoxin 1 (Prx1),",
            "probability": 3.7870525848930156e-05,
            "start_logit": 3.50362491607666,
            "end_logit": -2.544987916946411
        },
        {
            "text": "tensin homolog",
            "probability": 3.150415957837003e-05,
            "start_logit": -1.2219171524047852,
            "end_logit": 1.9965006113052368
        },
        {
            "text": "tensin homolog (PTEN",
            "probability": 3.0804882287774326e-05,
            "start_logit": -1.2219171524047852,
            "end_logit": 1.974054217338562
        },
        {
            "text": "tensin homolog (PTEN).",
            "probability": 1.6945352005094345e-05,
            "start_logit": -1.2219171524047852,
            "end_logit": 1.37637460231781
        },
        {
            "text": "thioredoxin 1 (Trx1), peroxiredoxin 1 (Prx1",
            "probability": 9.684201672511857e-06,
            "start_logit": 3.50362491607666,
            "end_logit": -3.908665180206299
        },
        {
            "text": "Prx1), GSH reductase (GSR), and phosphatase and tensin homolog (PTEN)",
            "probability": 5.58644742791398e-06,
            "start_logit": -3.2889795303344727,
            "end_logit": 2.333786964416504
        },
        {
            "text": "including thioredoxin 1 (Trx1)",
            "probability": 3.6095131965041836e-06,
            "start_logit": -1.2934333086013794,
            "end_logit": -0.09852990508079529
        },
        {
            "text": "GSH reductase (GSR), and phosphatase and tensin homolog (PTEN)",
            "probability": 3.3515224093400506e-06,
            "start_logit": -3.799908399581909,
            "end_logit": 2.333786964416504
        },
        {
            "text": "including thioredoxin 1 (Trx1), peroxiredoxin 1 (Prx1)",
            "probability": 2.8499501515905183e-06,
            "start_logit": -1.2934333086013794,
            "end_logit": -0.3348013162612915
        },
        {
            "text": "phosphatase and tensin homolog (PTEN)",
            "probability": 2.3756714753419446e-06,
            "start_logit": -4.14404296875,
            "end_logit": 2.333786964416504
        },
        {
            "text": "including thioredoxin 1",
            "probability": 2.293913875328533e-06,
            "start_logit": -1.2934333086013794,
            "end_logit": -0.5518433451652527
        }
    ],
    "5e482160d14c9f295d00000c_002": [
        {
            "text": "",
            "probability": 0.39099969459244416,
            "start_logit": 3.9290664196014404,
            "end_logit": 3.1386759281158447
        },
        {
            "text": "Vitamin C, vitamin E, and alpha-lipoic acid (ALA)",
            "probability": 0.2927982552394763,
            "start_logit": 4.31785774230957,
            "end_logit": 2.4606616497039795
        },
        {
            "text": "Vitamin C, vitamin E, and alpha-lipoic acid",
            "probability": 0.2614865420209596,
            "start_logit": 4.31785774230957,
            "end_logit": 2.3475606441497803
        },
        {
            "text": "Vitamin C, vitamin E",
            "probability": 0.023230164655975556,
            "start_logit": 4.31785774230957,
            "end_logit": -0.0733705386519432
        },
        {
            "text": "Vitamin C",
            "probability": 0.018739914978701994,
            "start_logit": 4.31785774230957,
            "end_logit": -0.28816643357276917
        },
        {
            "text": "Vitamin C, vitamin E, and alpha-lipoic acid (ALA",
            "probability": 0.0051344839751702965,
            "start_logit": 4.31785774230957,
            "end_logit": -1.5828428268432617
        },
        {
            "text": "Vitamin C,",
            "probability": 0.0016289610025872878,
            "start_logit": 4.31785774230957,
            "end_logit": -2.730879783630371
        },
        {
            "text": "Vitamin C, vitamin E, and alpha-lipoic acid (ALA) are potent nutritional antioxidants",
            "probability": 0.0013567459758838313,
            "start_logit": 4.31785774230957,
            "end_logit": -2.9137330055236816
        },
        {
            "text": "alpha-lipoic acid (ALA)",
            "probability": 0.0009253807525986612,
            "start_logit": -1.439176082611084,
            "end_logit": 2.4606616497039795
        },
        {
            "text": "alpha-lipoic acid",
            "probability": 0.0008264209527200526,
            "start_logit": -1.439176082611084,
            "end_logit": 2.3475606441497803
        },
        {
            "text": "Vitamin C, vitamin E,",
            "probability": 0.0006719067145935926,
            "start_logit": 4.31785774230957,
            "end_logit": -3.616457939147949
        },
        {
            "text": "Vitamin C, vitamin E, and alpha-lipoic acid (ALA) are potent nutritional antioxidants,",
            "probability": 0.0005644560213514186,
            "start_logit": 4.31785774230957,
            "end_logit": -3.790714979171753
        },
        {
            "text": "Vitamin",
            "probability": 0.0004762451441989075,
            "start_logit": 4.31785774230957,
            "end_logit": -3.9606447219848633
        },
        {
            "text": "Vitamin C, vitamin E, and alpha-lipoic acid (ALA) are potent nutritional antioxidants, which are important for enhancing immunity",
            "probability": 0.0003187947322729953,
            "start_logit": 4.31785774230957,
            "end_logit": -4.362030029296875
        },
        {
            "text": "vitamin E, and alpha-lipoic acid (ALA)",
            "probability": 0.0002342882845214733,
            "start_logit": -2.81282901763916,
            "end_logit": 2.4606616497039795
        },
        {
            "text": "Vitamin C, vitamin E, and alpha-lipoic acid (ALA) are potent nutritional antioxidants, which are important for enhancing immunity.",
            "probability": 0.0002304708953184593,
            "start_logit": 4.31785774230957,
            "end_logit": -4.686452865600586
        },
        {
            "text": "vitamin E, and alpha-lipoic acid",
            "probability": 0.00020923360115461173,
            "start_logit": -2.81282901763916,
            "end_logit": 2.3475606441497803
        },
        {
            "text": "ALA)",
            "probability": 0.00013322499280252466,
            "start_logit": -3.3773419857025146,
            "end_logit": 2.4606616497039795
        },
        {
            "text": "vitamin E",
            "probability": 1.8588073285984824e-05,
            "start_logit": -2.81282901763916,
            "end_logit": -0.0733705386519432
        },
        {
            "text": "alpha-lipoic acid (ALA",
            "probability": 1.6227393982463386e-05,
            "start_logit": -1.439176082611084,
            "end_logit": -1.5828428268432617
        }
    ],
    "5e482160d14c9f295d00000c_003": [
        {
            "text": "",
            "probability": 0.9955378137208424,
            "start_logit": 3.4473206996917725,
            "end_logit": 3.8201417922973633
        },
        {
            "text": "GCLC, GCLM, GS, GR, GST, GPx, CAT, SOD, NQO1",
            "probability": 0.000763924796127157,
            "start_logit": 2.840542793273926,
            "end_logit": -2.7456493377685547
        },
        {
            "text": "GCLC, GCLM, GS, GR, GST, GPx",
            "probability": 0.000671456114243378,
            "start_logit": 2.840542793273926,
            "end_logit": -2.8746700286865234
        },
        {
            "text": "GCLC, GCLM, GS, GR, GST, GPx, CAT",
            "probability": 0.0004226232096738214,
            "start_logit": 2.840542793273926,
            "end_logit": -3.3376376628875732
        },
        {
            "text": "1",
            "probability": 0.0004129517752531837,
            "start_logit": -3.795572519302368,
            "end_logit": 3.275327444076538
        },
        {
            "text": "GCLC, GCLM, GS, GR, GST",
            "probability": 0.00038064166560684886,
            "start_logit": 2.840542793273926,
            "end_logit": -3.442260265350342
        },
        {
            "text": "GCLC, GCLM",
            "probability": 0.00031702031639328386,
            "start_logit": 2.840542793273926,
            "end_logit": -3.625152826309204
        },
        {
            "text": "GCLC, GCLM, GS, GR, GST, GPx,",
            "probability": 0.00019797030855174492,
            "start_logit": 2.840542793273926,
            "end_logit": -4.096001625061035
        },
        {
            "text": "SOD, NQO1, HO-1",
            "probability": 0.0001743636734297095,
            "start_logit": -4.657760143280029,
            "end_logit": 3.275327444076538
        },
        {
            "text": "GCLC",
            "probability": 0.0001700385341202938,
            "start_logit": 2.840542793273926,
            "end_logit": -4.248093605041504
        },
        {
            "text": "GCLM, GS, GR, GST, GPx, CAT, SOD, NQO1, HO-1",
            "probability": 0.00016806517836274687,
            "start_logit": -4.694551467895508,
            "end_logit": 3.275327444076538
        },
        {
            "text": "GCLC, GCLM, GS, GR",
            "probability": 0.00011945560666229981,
            "start_logit": 2.840542793273926,
            "end_logit": -4.6011738777160645
        },
        {
            "text": "GCLC, GCLM, GS, GR, GST, GPx, CAT, SOD",
            "probability": 0.00010447933820374704,
            "start_logit": 2.840542793273926,
            "end_logit": -4.735129356384277
        },
        {
            "text": "(GCLC, GCLM, GS, GR, GST, GPx, CAT, SOD, NQO1",
            "probability": 0.00010065976869830098,
            "start_logit": 0.8138196468353271,
            "end_logit": -2.7456493377685547
        },
        {
            "text": "GCLC, GCLM, GS, GR, GST,",
            "probability": 9.130583049554711e-05,
            "start_logit": 2.840542793273926,
            "end_logit": -4.869904041290283
        },
        {
            "text": "(GCLC, GCLM, GS, GR, GST, GPx",
            "probability": 8.847548540569708e-05,
            "start_logit": 0.8138196468353271,
            "end_logit": -2.8746700286865234
        },
        {
            "text": "HO-1",
            "probability": 8.06021100929105e-05,
            "start_logit": -5.429378509521484,
            "end_logit": 3.275327444076538
        },
        {
            "text": "GCLC, GCLM, GS, GR, GST, GPx, CAT,",
            "probability": 8.037990283946458e-05,
            "start_logit": 2.840542793273926,
            "end_logit": -4.997354507446289
        },
        {
            "text": "GS, GR, GST, GPx, CAT, SOD, NQO1, HO-1",
            "probability": 6.208504398027233e-05,
            "start_logit": -5.690398216247559,
            "end_logit": 3.275327444076538
        },
        {
            "text": "(GCLC, GCLM, GS, GR, GST, GPx, CAT",
            "probability": 5.568762101710775e-05,
            "start_logit": 0.8138196468353271,
            "end_logit": -3.3376376628875732
        }
    ],
    "5e2b07537d50947c2f000001_002": [
        {
            "text": "Scalp arteriovenous malformations",
            "probability": 0.9766266328468186,
            "start_logit": 9.69178295135498,
            "end_logit": 9.442523956298828
        },
        {
            "text": "Scalp arteriovenous malformations,",
            "probability": 0.014019433147707,
            "start_logit": 9.69178295135498,
            "end_logit": 5.198863983154297
        },
        {
            "text": "arteriovenous malformations",
            "probability": 0.008646513369218461,
            "start_logit": 4.964834690093994,
            "end_logit": 9.442523956298828
        },
        {
            "text": "malformations",
            "probability": 0.0002558078648742753,
            "start_logit": 1.4443498849868774,
            "end_logit": 9.442523956298828
        },
        {
            "text": "arteriovenous malformations,",
            "probability": 0.00012412032609346828,
            "start_logit": 4.964834690093994,
            "end_logit": 5.198863983154297
        },
        {
            "text": "Scalp arteriovenous",
            "probability": 9.370849100780372e-05,
            "start_logit": 9.69178295135498,
            "end_logit": 0.1908530592918396
        },
        {
            "text": "Scalp arteriovenous malformations, also known as cirsoid aneurysms,",
            "probability": 8.011981572705491e-05,
            "start_logit": 9.69178295135498,
            "end_logit": 0.03418746590614319
        },
        {
            "text": "Scalp",
            "probability": 7.580508879833904e-05,
            "start_logit": 9.69178295135498,
            "end_logit": -0.021170319989323616
        },
        {
            "text": "Scalp arteriovenous malformations, also known as cirsoid aneurysms, are rare lesions",
            "probability": 1.5037970915190455e-05,
            "start_logit": 9.69178295135498,
            "end_logit": -1.638757348060608
        },
        {
            "text": "Scalp arteriovenous malformations, also known as cirsoid aneurysms, are rare lesions that are congenital",
            "probability": 1.1041545773475944e-05,
            "start_logit": 9.69178295135498,
            "end_logit": -1.9476706981658936
        },
        {
            "text": "rare lesions that are congenital, traumatic, or postinfectious in nature",
            "probability": 1.0454638279923727e-05,
            "start_logit": 4.035311222076416,
            "end_logit": 3.654181718826294
        },
        {
            "text": "Scalp arteriovenous malformations, also known as cirsoid aneurysms, are rare",
            "probability": 9.903726764466108e-06,
            "start_logit": 9.69178295135498,
            "end_logit": -2.056424617767334
        },
        {
            "text": "are rare lesions that are congenital, traumatic, or postinfectious in nature",
            "probability": 7.712941891371333e-06,
            "start_logit": 3.7311651706695557,
            "end_logit": 3.654181718826294
        },
        {
            "text": "malformations,",
            "probability": 7.617714620668734e-06,
            "start_logit": -2.0696003437042236,
            "end_logit": 9.442523956298828
        },
        {
            "text": "rare lesions that are congenital, traumatic, or postinfectious in nature.",
            "probability": 3.7777229188659063e-06,
            "start_logit": 4.035311222076416,
            "end_logit": 2.6362574100494385
        },
        {
            "text": "Scalp arteriovenous malformations, also known as cirsoid aneurysms, are rare lesions that are congenital, traumatic",
            "probability": 2.8918623031603975e-06,
            "start_logit": 9.69178295135498,
            "end_logit": -3.2874350547790527
        },
        {
            "text": "are rare lesions that are congenital, traumatic, or postinfectious in nature.",
            "probability": 2.787026827209082e-06,
            "start_logit": 3.7311651706695557,
            "end_logit": 2.6362574100494385
        },
        {
            "text": "Scalp arteriovenous malformations, also known as cirsoid aneurysms",
            "probability": 2.446223461814385e-06,
            "start_logit": 9.69178295135498,
            "end_logit": -3.4547903537750244
        },
        {
            "text": "rare lesions that are congenital, traumatic, or postinfectious",
            "probability": 2.211423435106369e-06,
            "start_logit": 4.035311222076416,
            "end_logit": 2.1007723808288574
        },
        {
            "text": "Scalp arte",
            "probability": 1.9743759782940636e-06,
            "start_logit": 9.69178295135498,
            "end_logit": -3.6690833568573
        },
        {
            "text": "",
            "probability": 1.8765857306570546e-09,
            "start_logit": -0.6150285601615906,
            "end_logit": -0.3208254873752594
        }
    ],
    "5e2b07537d50947c2f000001_003": [
        {
            "text": "rare congenital extracranial vascular anomalies",
            "probability": 0.6393330537711804,
            "start_logit": 7.1146674156188965,
            "end_logit": 6.4886155128479
        },
        {
            "text": "rare congenital extracranial vascular anomalies that often present as an enlarging pulsatile scalp mass",
            "probability": 0.20039105049707975,
            "start_logit": 7.1146674156188965,
            "end_logit": 5.328460693359375
        },
        {
            "text": "congenital extracranial vascular anomalies",
            "probability": 0.06783697827818888,
            "start_logit": 4.871349334716797,
            "end_logit": 6.4886155128479
        },
        {
            "text": "congenital extracranial vascular anomalies that often present as an enlarging pulsatile scalp mass",
            "probability": 0.02126266311358143,
            "start_logit": 4.871349334716797,
            "end_logit": 5.328460693359375
        },
        {
            "text": "scalp arteriovenous malformations (AVM), are rare congenital extracranial vascular anomalies",
            "probability": 0.020467955007031833,
            "start_logit": 3.673102378845215,
            "end_logit": 6.4886155128479
        },
        {
            "text": "are rare congenital extracranial vascular anomalies",
            "probability": 0.019772676391698198,
            "start_logit": 3.638542890548706,
            "end_logit": 6.4886155128479
        },
        {
            "text": "rare congenital extracranial vascular anomalies that often present as an enlarging pulsatile scalp mass.",
            "probability": 0.01748679555470259,
            "start_logit": 7.1146674156188965,
            "end_logit": 2.8896360397338867
        },
        {
            "text": "are rare congenital extracranial vascular anomalies that often present as an enlarging pulsatile scalp mass",
            "probability": 0.006197501239611053,
            "start_logit": 3.638542890548706,
            "end_logit": 5.328460693359375
        },
        {
            "text": "congenital extracranial vascular anomalies that often present as an enlarging pulsatile scalp mass.",
            "probability": 0.0018554513382379463,
            "start_logit": 4.871349334716797,
            "end_logit": 2.8896360397338867
        },
        {
            "text": "extracranial vascular anomalies",
            "probability": 0.0010865934667943053,
            "start_logit": 0.7372894287109375,
            "end_logit": 6.4886155128479
        },
        {
            "text": "vascular anomalies",
            "probability": 0.0010336636777728149,
            "start_logit": 0.6873513460159302,
            "end_logit": 6.4886155128479
        },
        {
            "text": "an enlarging pulsatile scalp mass",
            "probability": 0.0006155320144304078,
            "start_logit": 1.329128384590149,
            "end_logit": 5.328460693359375
        },
        {
            "text": "are rare congenital extracranial vascular anomalies that often present as an enlarging pulsatile scalp mass.",
            "probability": 0.0005408147562391948,
            "start_logit": 3.638542890548706,
            "end_logit": 2.8896360397338867
        },
        {
            "text": "scalp arteriovenous malformations",
            "probability": 0.0004943296205350757,
            "start_logit": 3.673102378845215,
            "end_logit": 2.765202283859253
        },
        {
            "text": "arteriovenous malformations (AVM), are rare congenital extracranial vascular anomalies",
            "probability": 0.00040720139383777,
            "start_logit": -0.244205504655838,
            "end_logit": 6.4886155128479
        },
        {
            "text": "extracranial vascular anomalies that often present as an enlarging pulsatile scalp mass",
            "probability": 0.0003405793036818425,
            "start_logit": 0.7372894287109375,
            "end_logit": 5.328460693359375
        },
        {
            "text": "vascular anomalies that often present as an enlarging pulsatile scalp mass",
            "probability": 0.0003239891149499434,
            "start_logit": 0.6873513460159302,
            "end_logit": 5.328460693359375
        },
        {
            "text": "rare congenital extracranial vascular anomalies that often present as an enlarging pulsatile scalp",
            "probability": 0.00020439204219057405,
            "start_logit": 7.1146674156188965,
            "end_logit": -1.5595253705978394
        },
        {
            "text": "rare",
            "probability": 0.00020245236258695625,
            "start_logit": 7.1146674156188965,
            "end_logit": -1.5690606832504272
        },
        {
            "text": "rare congenital extracranial vascular",
            "probability": 0.00014628006565963833,
            "start_logit": 7.1146674156188965,
            "end_logit": -1.8940422534942627
        },
        {
            "text": "",
            "probability": 4.699000951187847e-08,
            "start_logit": -1.3554621934890747,
            "end_logit": -1.46725594997406
        }
    ],
    "5e2b07537d50947c2f000001_004": [
        {
            "text": "right temporal pre-auricular arteriovenous fistula",
            "probability": 0.9634366067543222,
            "start_logit": 7.546392440795898,
            "end_logit": 7.363298416137695
        },
        {
            "text": "a right temporal pre-auricular arteriovenous fistula",
            "probability": 0.030545839239913594,
            "start_logit": 4.095114231109619,
            "end_logit": 7.363298416137695
        },
        {
            "text": "pre-auricular arteriovenous fistula",
            "probability": 0.0028824438696504963,
            "start_logit": 1.7345242500305176,
            "end_logit": 7.363298416137695
        },
        {
            "text": "right temporal pre-auricular arteriovenous fistula (cirsoid aneurysm) causing intractable tinnitus",
            "probability": 0.001148140874500069,
            "start_logit": 7.546392440795898,
            "end_logit": 0.6309357285499573
        },
        {
            "text": "temporal pre-auricular arteriovenous fistula",
            "probability": 0.0005412589596817916,
            "start_logit": 0.06202830374240875,
            "end_logit": 7.363298416137695
        },
        {
            "text": "arteriovenous fistula",
            "probability": 0.0004718573065085247,
            "start_logit": -0.0751929059624672,
            "end_logit": 7.363298416137695
        },
        {
            "text": "fistula",
            "probability": 0.00035346745803669234,
            "start_logit": -0.3640781044960022,
            "end_logit": 7.363298416137695
        },
        {
            "text": "auricular arteriovenous fistula",
            "probability": 0.00020744661807685821,
            "start_logit": -0.896995484828949,
            "end_logit": 7.363298416137695
        },
        {
            "text": "right temporal pre-auricular arteriovenous",
            "probability": 6.895369717685103e-05,
            "start_logit": 7.546392440795898,
            "end_logit": -2.181528329849243
        },
        {
            "text": "right temporal pre-auricular arteriovenous fistula (",
            "probability": 6.117454770429065e-05,
            "start_logit": 7.546392440795898,
            "end_logit": -2.30123233795166
        },
        {
            "text": "right",
            "probability": 6.0049824201108086e-05,
            "start_logit": 7.546392440795898,
            "end_logit": -2.319788932800293
        },
        {
            "text": "right temporal pre-auricular",
            "probability": 4.940719244289824e-05,
            "start_logit": 7.546392440795898,
            "end_logit": -2.5148675441741943
        },
        {
            "text": "a right temporal pre-auricular arteriovenous fistula (cirsoid aneurysm) causing intractable tinnitus",
            "probability": 3.640190369701827e-05,
            "start_logit": 4.095114231109619,
            "end_logit": 0.6309357285499573
        },
        {
            "text": "right temporal pre-auricular arteriovenous fist",
            "probability": 3.5653246593887094e-05,
            "start_logit": 7.546392440795898,
            "end_logit": -2.841123342514038
        },
        {
            "text": "right temporal",
            "probability": 3.17653401293296e-05,
            "start_logit": 7.546392440795898,
            "end_logit": -2.956587791442871
        },
        {
            "text": "right temporal pre-auricular arteriovenous fistula (cirsoid aneurysm",
            "probability": 2.3184671245619926e-05,
            "start_logit": 7.546392440795898,
            "end_logit": -3.271472215652466
        },
        {
            "text": "case of a right temporal pre-auricular arteriovenous fistula",
            "probability": 1.6150088181430538e-05,
            "start_logit": -3.449944019317627,
            "end_logit": 7.363298416137695
        },
        {
            "text": "right temporal pre",
            "probability": 1.4271767764688396e-05,
            "start_logit": 7.546392440795898,
            "end_logit": -3.7566802501678467
        },
        {
            "text": "right temporal pre-auricular arteriovenous fistula (cirsoid",
            "probability": 1.0808055873990997e-05,
            "start_logit": 7.546392440795898,
            "end_logit": -4.034671783447266
        },
        {
            "text": "",
            "probability": 5.118584298717398e-06,
            "start_logit": 1.1717785596847534,
            "end_logit": 1.592528223991394
        }
    ],
    "5e2b07537d50947c2f000001_005": [
        {
            "text": "rare arteriovenous malformations of the scalp",
            "probability": 0.9096642931548141,
            "start_logit": 9.102679252624512,
            "end_logit": 7.849955081939697
        },
        {
            "text": "rare arteriovenous malformations",
            "probability": 0.06068987420995625,
            "start_logit": 9.102679252624512,
            "end_logit": 5.142656326293945
        },
        {
            "text": "rare arteriovenous malformations of the scalp,",
            "probability": 0.011526135550782747,
            "start_logit": 9.102679252624512,
            "end_logit": 3.481496572494507
        },
        {
            "text": "rare arteriovenous malformations of the scalp, which are usually of congenital etiology.",
            "probability": 0.006423995449031672,
            "start_logit": 9.102679252624512,
            "end_logit": 2.8969197273254395
        },
        {
            "text": "arteriovenous malformations of the scalp",
            "probability": 0.005172341095821869,
            "start_logit": 3.932929039001465,
            "end_logit": 7.849955081939697
        },
        {
            "text": "rare arteriovenous malformations of the scalp, which are usually of congenital etiology",
            "probability": 0.004814442749120503,
            "start_logit": 9.102679252624512,
            "end_logit": 2.608499765396118
        },
        {
            "text": "rare",
            "probability": 0.0004348288206199841,
            "start_logit": 9.102679252624512,
            "end_logit": 0.2040766179561615
        },
        {
            "text": "arteriovenous malformations",
            "probability": 0.0003450819525824709,
            "start_logit": 3.932929039001465,
            "end_logit": 5.142656326293945
        },
        {
            "text": "malformations of the scalp",
            "probability": 0.00028466934385572247,
            "start_logit": 1.0331766605377197,
            "end_logit": 7.849955081939697
        },
        {
            "text": "rare arteriovenous",
            "probability": 0.00018773859506893676,
            "start_logit": 9.102679252624512,
            "end_logit": -0.6358252763748169
        },
        {
            "text": "Cirsoid aneurysms are rare arteriovenous malformations of the scalp",
            "probability": 0.00012716151434606732,
            "start_logit": 0.22730639576911926,
            "end_logit": 7.849955081939697
        },
        {
            "text": "are rare arteriovenous malformations of the scalp",
            "probability": 7.67360509206015e-05,
            "start_logit": -0.27778002619743347,
            "end_logit": 7.849955081939697
        },
        {
            "text": "arteriovenous malformations of the scalp,",
            "probability": 6.553747908315548e-05,
            "start_logit": 3.932929039001465,
            "end_logit": 3.481496572494507
        },
        {
            "text": "rare arteriovenous malformations of the scalp, which are usually of congenital",
            "probability": 5.596398588671412e-05,
            "start_logit": 9.102679252624512,
            "end_logit": -1.8461674451828003
        },
        {
            "text": "arteriovenous malformations of the scalp, which are usually of congenital etiology.",
            "probability": 3.652676697374152e-05,
            "start_logit": 3.932929039001465,
            "end_logit": 2.8969197273254395
        },
        {
            "text": "arteriovenous malformations of the scalp, which are usually of congenital etiology",
            "probability": 2.737486814877055e-05,
            "start_logit": 3.932929039001465,
            "end_logit": 2.608499765396118
        },
        {
            "text": "scalp",
            "probability": 2.3884029391643616e-05,
            "start_logit": -1.4449416399002075,
            "end_logit": 7.849955081939697
        },
        {
            "text": "malformations",
            "probability": 1.8992222515536637e-05,
            "start_logit": 1.0331766605377197,
            "end_logit": 5.142656326293945
        },
        {
            "text": "rare arteriovenous malformations of",
            "probability": 1.5935680192744572e-05,
            "start_logit": 9.102679252624512,
            "end_logit": -3.1023151874542236
        },
        {
            "text": "Cirsoid aneurysms are rare arteriovenous malformations",
            "probability": 8.483807013294474e-06,
            "start_logit": 0.22730639576911926,
            "end_logit": 5.142656326293945
        },
        {
            "text": "",
            "probability": 2.6738735919507608e-09,
            "start_logit": -0.7100504040718079,
            "end_logit": -1.9823732376098633
        }
    ],
    "5e2b07537d50947c2f000001_006": [
        {
            "text": "arteriovenous fistulas",
            "probability": 0.9560233439516146,
            "start_logit": 9.198568344116211,
            "end_logit": 8.422954559326172
        },
        {
            "text": "arteriovenous fistulas) of the scalp are rare lesions",
            "probability": 0.03687526263979502,
            "start_logit": 9.198568344116211,
            "end_logit": 5.167713165283203
        },
        {
            "text": "arteriovenous fistulas) of the scalp are rare lesions.",
            "probability": 0.0025023838318728267,
            "start_logit": 9.198568344116211,
            "end_logit": 2.4774160385131836
        },
        {
            "text": "(arteriovenous fistulas",
            "probability": 0.002206611283078402,
            "start_logit": 3.127243995666504,
            "end_logit": 8.422954559326172
        },
        {
            "text": "rare lesions",
            "probability": 0.0008992114360632825,
            "start_logit": 5.484790325164795,
            "end_logit": 5.167713165283203
        },
        {
            "text": "arteriovenous fistulas)",
            "probability": 0.0006766834355655899,
            "start_logit": 9.198568344116211,
            "end_logit": 1.1696205139160156
        },
        {
            "text": "arteriovenous fistulas) of the scalp are rare",
            "probability": 0.00046275291829390785,
            "start_logit": 9.198568344116211,
            "end_logit": 0.7896102070808411
        },
        {
            "text": "(arteriovenous fistulas) of the scalp are rare lesions",
            "probability": 8.5112326097729e-05,
            "start_logit": 3.127243995666504,
            "end_logit": 5.167713165283203
        },
        {
            "text": "rare lesions.",
            "probability": 6.1021183252849965e-05,
            "start_logit": 5.484790325164795,
            "end_logit": 2.4774160385131836
        },
        {
            "text": "arte",
            "probability": 5.503012062118231e-05,
            "start_logit": 9.198568344116211,
            "end_logit": -1.3397023677825928
        },
        {
            "text": "Cirsoid aneurysms (arteriovenous fistulas",
            "probability": 3.900102249030553e-05,
            "start_logit": -0.9083814024925232,
            "end_logit": 8.422954559326172
        },
        {
            "text": "arteriovenous",
            "probability": 2.088977711089451e-05,
            "start_logit": 9.198568344116211,
            "end_logit": -2.3083231449127197
        },
        {
            "text": "fistulas",
            "probability": 2.0243636747021787e-05,
            "start_logit": -1.5641287565231323,
            "end_logit": 8.422954559326172
        },
        {
            "text": "arteriovenous fistulas) of the scalp",
            "probability": 1.7858701503058975e-05,
            "start_logit": 9.198568344116211,
            "end_logit": -2.465092182159424
        },
        {
            "text": "arteriovenous fistulas) of the scalp are rare lesions. They are infrequently encountered in neurosurgical practice",
            "probability": 1.403884729654085e-05,
            "start_logit": 9.198568344116211,
            "end_logit": -2.7057547569274902
        },
        {
            "text": "aneurysms (arteriovenous fistulas",
            "probability": 1.181116084831405e-05,
            "start_logit": -2.102924346923828,
            "end_logit": 8.422954559326172
        },
        {
            "text": "rare",
            "probability": 1.1284332270829156e-05,
            "start_logit": 5.484790325164795,
            "end_logit": 0.7896102070808411
        },
        {
            "text": "fistulas)",
            "probability": 6.536543440015771e-06,
            "start_logit": -2.6945607662200928,
            "end_logit": 8.422954559326172
        },
        {
            "text": "(arteriovenous fistulas) of the scalp are rare lesions.",
            "probability": 5.775788251341078e-06,
            "start_logit": 3.127243995666504,
            "end_logit": 2.4774160385131836
        },
        {
            "text": "lesions",
            "probability": 5.053230220371859e-06,
            "start_logit": 0.30329981446266174,
            "end_logit": 5.167713165283203
        },
        {
            "text": "",
            "probability": 9.383356620470939e-08,
            "start_logit": 0.8650398850440979,
            "end_logit": 0.619712769985199
        }
    ],
    "5c74285c7c78d694710000a3_001": [
        {
            "text": "the cytoplasm",
            "probability": 0.6336100810735733,
            "start_logit": 0.21674412488937378,
            "end_logit": 1.0536656379699707
        },
        {
            "text": "cytoplasm",
            "probability": 0.19267755085786098,
            "start_logit": -0.973671555519104,
            "end_logit": 1.0536656379699707
        },
        {
            "text": "of\u00a0TIA-1",
            "probability": 0.11491337645488209,
            "start_logit": -0.6147799491882324,
            "end_logit": 0.17793455719947815
        },
        {
            "text": "TIA-1, acting as a stress-inducible second messenger to promote multimerization of\u00a0TIA-1",
            "probability": 0.017568893752794575,
            "start_logit": -2.492828607559204,
            "end_logit": 0.17793455719947815
        },
        {
            "text": "of\u00a0TIA-1 and subsequent localization into stress granules.",
            "probability": 0.01672106228512838,
            "start_logit": -0.6147799491882324,
            "end_logit": -1.749574899673462
        },
        {
            "text": "in the cytoplasm",
            "probability": 0.013125172427938082,
            "start_logit": -3.6601576805114746,
            "end_logit": 1.0536656379699707
        },
        {
            "text": "TIA-1, acting as a stress-inducible second messenger to promote multimerization of\u00a0TIA-1 and subsequent localization into stress granules.",
            "probability": 0.002556452310289767,
            "start_logit": -2.492828607559204,
            "end_logit": -1.749574899673462
        },
        {
            "text": "TIA-1",
            "probability": 0.0022950101498983304,
            "start_logit": -2.492828607559204,
            "end_logit": -1.8574581146240234
        },
        {
            "text": "non-membranous structures that transiently form in the cytoplasm",
            "probability": 0.0011773583568476468,
            "start_logit": -6.07141637802124,
            "end_logit": 1.0536656379699707
        },
        {
            "text": "Stress granules are non-membranous structures that transiently form in the cytoplasm",
            "probability": 0.0009787750219046125,
            "start_logit": -6.256143093109131,
            "end_logit": 1.0536656379699707
        },
        {
            "text": "the cy",
            "probability": 0.000685883530558047,
            "start_logit": 0.21674412488937378,
            "end_logit": -5.774815559387207
        },
        {
            "text": "",
            "probability": 0.0005402626578135055,
            "start_logit": -3.0945327281951904,
            "end_logit": -2.702191114425659
        },
        {
            "text": "transiently form in the cytoplasm",
            "probability": 0.0005046515483645285,
            "start_logit": -6.918576717376709,
            "end_logit": 1.0536656379699707
        },
        {
            "text": "the cytoplasm during cellular stress",
            "probability": 0.00046906286754901165,
            "start_logit": 0.21674412488937378,
            "end_logit": -6.154786586761475
        },
        {
            "text": "the",
            "probability": 0.0004662682359466267,
            "start_logit": 0.21674412488937378,
            "end_logit": -6.160762310028076
        },
        {
            "text": "stress granules",
            "probability": 0.0004513403783711821,
            "start_logit": -4.226982593536377,
            "end_logit": -1.749574899673462
        },
        {
            "text": "the cytoplasm during cellular stress, where they promote translational repression of non-essential RNAs",
            "probability": 0.0004054798415774054,
            "start_logit": 0.21674412488937378,
            "end_logit": -6.30045223236084
        },
        {
            "text": "second messenger to promote multimerization of\u00a0TIA-1",
            "probability": 0.0003441092786297272,
            "start_logit": -6.425754547119141,
            "end_logit": 0.17793455719947815
        },
        {
            "text": "stress-inducible second messenger to promote multimerization of\u00a0TIA-1",
            "probability": 0.00030063533339957243,
            "start_logit": -6.560815811157227,
            "end_logit": 0.17793455719947815
        },
        {
            "text": "cy",
            "probability": 0.00020857363667217585,
            "start_logit": -0.973671555519104,
            "end_logit": -5.774815559387207
        }
    ],
    "5c74285c7c78d694710000a3_002": [
        {
            "text": "",
            "probability": 0.999999250894732,
            "start_logit": 5.405616283416748,
            "end_logit": 6.039952754974365
        },
        {
            "text": "cytoplasmic",
            "probability": 6.213188089000195e-07,
            "start_logit": -2.5490028858184814,
            "end_logit": -0.2968488335609436
        },
        {
            "text": "Rbfox2 is a novel constituent of cytoplasmic",
            "probability": 5.2427937711063e-08,
            "start_logit": -5.021407604217529,
            "end_logit": -0.2968488335609436
        },
        {
            "text": "cytoplasmic stress granules",
            "probability": 3.4135250001510744e-08,
            "start_logit": -2.5490028858184814,
            "end_logit": -3.1983625888824463
        },
        {
            "text": "cytoplasmic stress granules, the translational silencing machinery",
            "probability": 1.2426713897650097e-08,
            "start_logit": -2.5490028858184814,
            "end_logit": -4.2088446617126465
        },
        {
            "text": "Rbfox2 in cytoplasmic",
            "probability": 4.038231406266315e-09,
            "start_logit": -6.498260021209717,
            "end_logit": -1.3836292028427124
        },
        {
            "text": "Rbfox2 is a novel constituent of cytoplasmic stress granules",
            "probability": 2.880390445605762e-09,
            "start_logit": -5.021407604217529,
            "end_logit": -3.1983625888824463
        },
        {
            "text": "translational silencing machinery",
            "probability": 2.619436468660336e-09,
            "start_logit": -4.105892181396484,
            "end_logit": -4.2088446617126465
        },
        {
            "text": "cytoplasmic stress granules, the translational silencing machinery assembled in response to cellular stress",
            "probability": 2.611848916036294e-09,
            "start_logit": -2.5490028858184814,
            "end_logit": -5.768634796142578
        },
        {
            "text": "cytoplasmic stress granules, and Rbfox2 regulates the retinoblastoma 1",
            "probability": 2.557743577204285e-09,
            "start_logit": -3.2918524742126465,
            "end_logit": -5.046718120574951
        },
        {
            "text": "cy",
            "probability": 2.2886935449698826e-09,
            "start_logit": -2.086017370223999,
            "end_logit": -6.363697528839111
        },
        {
            "text": "cytoplasmic stress granules.",
            "probability": 2.0351150863503552e-09,
            "start_logit": -2.086017370223999,
            "end_logit": -6.481126308441162
        },
        {
            "text": "translational silencing machinery assembled in response to cellular stress. We also show that the RNA binding activity of the Rbfox family protein",
            "probability": 1.7978939571169585e-09,
            "start_logit": -4.105892181396484,
            "end_logit": -4.585187911987305
        },
        {
            "text": "cytoplasmic stress",
            "probability": 1.413945080399894e-09,
            "start_logit": -2.5490028858184814,
            "end_logit": -6.382309436798096
        },
        {
            "text": "cytoplasmic stress granules, the translational silencing machinery assembled",
            "probability": 1.2741687304892526e-09,
            "start_logit": -2.5490028858184814,
            "end_logit": -6.486399173736572
        },
        {
            "text": "cytoplasmic stress granules,",
            "probability": 1.114104539228046e-09,
            "start_logit": -5.971282482147217,
            "end_logit": -3.1983625888824463
        },
        {
            "text": "stress granules",
            "probability": 1.1057149682077138e-09,
            "start_logit": -5.978841304779053,
            "end_logit": -3.1983625888824463
        },
        {
            "text": "retinoblastoma 1",
            "probability": 1.0936313599419095e-09,
            "start_logit": -4.14147424697876,
            "end_logit": -5.046718120574951
        },
        {
            "text": "Rbfox2 is a novel constituent of cytoplasmic stress granules, the translational silencing machinery",
            "probability": 1.048587251579629e-09,
            "start_logit": -5.021407604217529,
            "end_logit": -4.2088446617126465
        },
        {
            "text": "RNA binding activity of the Rbfox family protein",
            "probability": 9.170522306976707e-10,
            "start_logit": -4.779098987579346,
            "end_logit": -4.585187911987305
        }
    ],
    "5c74285c7c78d694710000a3_003": [
        {
            "text": "cytoplasmic",
            "probability": 0.9119704471995678,
            "start_logit": 3.7235870361328125,
            "end_logit": 5.19924259185791
        },
        {
            "text": "cytoplasmic granules",
            "probability": 0.02544497560280847,
            "start_logit": 3.7235870361328125,
            "end_logit": 1.6201533079147339
        },
        {
            "text": "both nucleus and cytoplasm, or exclusively in the cytoplasm. Stress prompted the formation of cytoplasmic",
            "probability": 0.019991282123633415,
            "start_logit": -0.0967242643237114,
            "end_logit": 5.19924259185791
        },
        {
            "text": "nucleus and cytoplasm, or exclusively in the cytoplasm. Stress prompted the formation of cytoplasmic",
            "probability": 0.013258700931375763,
            "start_logit": -0.5073665380477905,
            "end_logit": 5.19924259185791
        },
        {
            "text": "the cytoplasm. Stress prompted the formation of cytoplasmic",
            "probability": 0.008509543017662768,
            "start_logit": -0.9508323073387146,
            "end_logit": 5.19924259185791
        },
        {
            "text": "in both nucleus and cytoplasm, or exclusively in the cytoplasm. Stress prompted the formation of cytoplasmic",
            "probability": 0.007149817482056817,
            "start_logit": -1.1249337196350098,
            "end_logit": 5.19924259185791
        },
        {
            "text": "",
            "probability": 0.004028213758711045,
            "start_logit": 0.9443836808204651,
            "end_logit": 2.556161403656006
        },
        {
            "text": "FUS P525L fibroblasts",
            "probability": 0.001946784387023244,
            "start_logit": 0.8054149150848389,
            "end_logit": 1.9679861068725586
        },
        {
            "text": "P525L fibroblasts",
            "probability": 0.0017146152654489303,
            "start_logit": 0.6784246563911438,
            "end_logit": 1.9679861068725586
        },
        {
            "text": "cytoplasm. Stress prompted the formation of cytoplasmic",
            "probability": 0.0011104522446304225,
            "start_logit": -2.987253189086914,
            "end_logit": 5.19924259185791
        },
        {
            "text": "exclusively in the cytoplasm. Stress prompted the formation of cytoplasmic",
            "probability": 0.0009081134907236161,
            "start_logit": -3.188406467437744,
            "end_logit": 5.19924259185791
        },
        {
            "text": "in the cytoplasm. Stress prompted the formation of cytoplasmic",
            "probability": 0.0008239075612578383,
            "start_logit": -3.285717487335205,
            "end_logit": 5.19924259185791
        },
        {
            "text": "cytoplasm, or exclusively in the cytoplasm. Stress prompted the formation of cytoplasmic",
            "probability": 0.0006948616742238094,
            "start_logit": -3.4560630321502686,
            "end_logit": 5.19924259185791
        },
        {
            "text": "both nucleus and cytoplasm, or exclusively in the cytoplasm. Stress prompted the formation of cytoplasmic granules",
            "probability": 0.0005577786949859338,
            "start_logit": -0.0967242643237114,
            "end_logit": 1.6201533079147339
        },
        {
            "text": "subcellular",
            "probability": 0.0004689886461538971,
            "start_logit": -0.428813099861145,
            "end_logit": 1.7788584232330322
        },
        {
            "text": "nucleus and cytoplasm, or exclusively in the cytoplasm. Stress prompted the formation of cytoplasmic granules",
            "probability": 0.0003699322963367514,
            "start_logit": -0.5073665380477905,
            "end_logit": 1.6201533079147339
        },
        {
            "text": "the FUS P525L fibroblasts",
            "probability": 0.00028761367523250125,
            "start_logit": -1.1069011688232422,
            "end_logit": 1.9679861068725586
        },
        {
            "text": "cytoplasmic granules in all subjects and in sporadic ALS FUS mislocalization to the cytoplasm",
            "probability": 0.00027590209657668075,
            "start_logit": 3.7235870361328125,
            "end_logit": -2.904074192047119
        },
        {
            "text": "cytoplasmic gran",
            "probability": 0.00025064426928103194,
            "start_logit": 3.7235870361328125,
            "end_logit": -3.0000855922698975
        },
        {
            "text": "the cytoplasm. Stress prompted the formation of cytoplasmic granules",
            "probability": 0.00023742558230957215,
            "start_logit": -0.9508323073387146,
            "end_logit": 1.6201533079147339
        }
    ],
    "5c74285c7c78d694710000a3_004": [
        {
            "text": "",
            "probability": 0.9999382396369163,
            "start_logit": 8.315878868103027,
            "end_logit": 9.110689163208008
        },
        {
            "text": "cytoplasm",
            "probability": 3.478292688945091e-05,
            "start_logit": 2.937230110168457,
            "end_logit": 4.223015785217285
        },
        {
            "text": "the cytoplasm",
            "probability": 2.483858585624321e-05,
            "start_logit": 2.600501775741577,
            "end_logit": 4.223015785217285
        },
        {
            "text": "in the cytoplasm",
            "probability": 1.6868337780654371e-06,
            "start_logit": -0.0890432819724083,
            "end_logit": 4.223015785217285
        },
        {
            "text": "cytoplasm,",
            "probability": 1.2426667164217698e-07,
            "start_logit": 2.937230110168457,
            "end_logit": -1.4114363193511963
        },
        {
            "text": "the cytoplasm,",
            "probability": 8.87391794964188e-08,
            "start_logit": 2.600501775741577,
            "end_logit": -1.4114363193511963
        },
        {
            "text": "Sam68 re-localization in the cytoplasm",
            "probability": 6.971687529287313e-08,
            "start_logit": -3.275209426879883,
            "end_logit": 4.223015785217285
        },
        {
            "text": "cytoplasm, and observed the obvious recruitments of Sam68 to the EV71",
            "probability": 4.0482256903787576e-08,
            "start_logit": 2.937230110168457,
            "end_logit": -2.5330023765563965
        },
        {
            "text": "cy",
            "probability": 3.292376326703069e-08,
            "start_logit": 2.937230110168457,
            "end_logit": -2.739671468734741
        },
        {
            "text": "the cytoplasm, and observed the obvious recruitments of Sam68 to the EV71",
            "probability": 2.890849343860653e-08,
            "start_logit": 2.600501775741577,
            "end_logit": -2.5330023765563965
        },
        {
            "text": "the cy",
            "probability": 2.3510951887915663e-08,
            "start_logit": 2.600501775741577,
            "end_logit": -2.739671468734741
        },
        {
            "text": "in the cytoplasm,",
            "probability": 6.026439922091892e-09,
            "start_logit": -0.0890432819724083,
            "end_logit": -1.4114363193511963
        },
        {
            "text": "cytop",
            "probability": 5.638144763677937e-09,
            "start_logit": 2.937230110168457,
            "end_logit": -4.5043110847473145
        },
        {
            "text": "cytoplasm, and observed the obvious recruitments of Sam68",
            "probability": 5.622742049102173e-09,
            "start_logit": 2.937230110168457,
            "end_logit": -4.507046699523926
        },
        {
            "text": "punctate pattern of Sam68 re-localization in the cytoplasm",
            "probability": 5.367312696179933e-09,
            "start_logit": -5.839324474334717,
            "end_logit": 4.223015785217285
        },
        {
            "text": "the",
            "probability": 4.516011057920753e-09,
            "start_logit": 2.600501775741577,
            "end_logit": -4.3895087242126465
        },
        {
            "text": "cytoplas",
            "probability": 4.416420678468706e-09,
            "start_logit": 2.937230110168457,
            "end_logit": -4.748536586761475
        },
        {
            "text": "the cytop",
            "probability": 4.026215022894335e-09,
            "start_logit": 2.600501775741577,
            "end_logit": -4.5043110847473145
        },
        {
            "text": "the cytoplasm, and observed the obvious recruitments of Sam68",
            "probability": 4.015215901123321e-09,
            "start_logit": 2.600501775741577,
            "end_logit": -4.507046699523926
        },
        {
            "text": "cytoplasm, and observed the obvious recruitments of Sam68 to the EV71-induced stress granules",
            "probability": 3.839865982055365e-09,
            "start_logit": 2.937230110168457,
            "end_logit": -4.888428688049316
        }
    ],
    "5c74285c7c78d694710000a3_005": [
        {
            "text": "cytoplasmic",
            "probability": 0.9647998341695915,
            "start_logit": 2.8423216342926025,
            "end_logit": 4.562932968139648
        },
        {
            "text": "cytoplasmic granules that are formed in cells",
            "probability": 0.026833934981768708,
            "start_logit": 2.8423216342926025,
            "end_logit": 0.9806796312332153
        },
        {
            "text": "cytoplasmic granules",
            "probability": 0.004370840519685523,
            "start_logit": 2.8423216342926025,
            "end_logit": -0.8340323567390442
        },
        {
            "text": "Stress granules (SGs) are cytoplasmic",
            "probability": 0.000895827028791184,
            "start_logit": -4.139606952667236,
            "end_logit": 4.562932968139648
        },
        {
            "text": "cells",
            "probability": 0.000753570239582839,
            "start_logit": -0.730278730392456,
            "end_logit": 0.9806796312332153
        },
        {
            "text": "cytoplasmic granules that are formed in cells when stress occurs",
            "probability": 0.0005013786786306193,
            "start_logit": 2.8423216342926025,
            "end_logit": -2.9993813037872314
        },
        {
            "text": "SGs) are cytoplasmic",
            "probability": 0.0004605488099520008,
            "start_logit": -4.804935455322266,
            "end_logit": 4.562932968139648
        },
        {
            "text": "cytoplasmic granules that are formed in cells when stress occurs.",
            "probability": 0.00044780193094919133,
            "start_logit": 2.8423216342926025,
            "end_logit": -3.112391948699951
        },
        {
            "text": "granules (SGs) are cytoplasmic",
            "probability": 0.00041839852379766415,
            "start_logit": -4.9009199142456055,
            "end_logit": 4.562932968139648
        },
        {
            "text": "cy",
            "probability": 0.00014566832264383442,
            "start_logit": 2.8423216342926025,
            "end_logit": -4.235410690307617
        },
        {
            "text": "in cells",
            "probability": 0.00011783342119701364,
            "start_logit": -2.585829019546509,
            "end_logit": 0.9806796312332153
        },
        {
            "text": "cytoplasmic gran",
            "probability": 5.9838228930597866e-05,
            "start_logit": 2.8423216342926025,
            "end_logit": -5.12509822845459
        },
        {
            "text": "granules that are formed in cells",
            "probability": 4.9951441577519155e-05,
            "start_logit": -3.444049596786499,
            "end_logit": 0.9806796312332153
        },
        {
            "text": "cytop",
            "probability": 3.02884392637506e-05,
            "start_logit": 2.8423216342926025,
            "end_logit": -5.805976867675781
        },
        {
            "text": "formed in cells",
            "probability": 2.71137907596053e-05,
            "start_logit": -4.055058479309082,
            "end_logit": 0.9806796312332153
        },
        {
            "text": "Stress granules (SGs) are cytoplasmic granules that are formed in cells",
            "probability": 2.4915597405946697e-05,
            "start_logit": -4.139606952667236,
            "end_logit": 0.9806796312332153
        },
        {
            "text": "",
            "probability": 2.2791065938966543e-05,
            "start_logit": -2.0809402465820312,
            "end_logit": -1.1671124696731567
        },
        {
            "text": "cells when stress occurs",
            "probability": 1.408008371616392e-05,
            "start_logit": -0.730278730392456,
            "end_logit": -2.9993813037872314
        },
        {
            "text": "SGs) are cytoplasmic granules that are formed in cells",
            "probability": 1.2809223617684212e-05,
            "start_logit": -4.804935455322266,
            "end_logit": 0.9806796312332153
        },
        {
            "text": "cells when stress occurs.",
            "probability": 1.257550219974475e-05,
            "start_logit": -0.730278730392456,
            "end_logit": -3.112391948699951
        }
    ],
    "5c74285c7c78d694710000a3_007": [
        {
            "text": "",
            "probability": 0.6688507559062887,
            "start_logit": 2.747164249420166,
            "end_logit": 4.32146692276001
        },
        {
            "text": "cytoplasmic",
            "probability": 0.29830341278658123,
            "start_logit": 2.07584285736084,
            "end_logit": 4.185338497161865
        },
        {
            "text": "cytoplasmic stress granules in HeLa",
            "probability": 0.011596376388521023,
            "start_logit": 2.07584285736084,
            "end_logit": 0.9379200339317322
        },
        {
            "text": "HeLa",
            "probability": 0.006865148420463809,
            "start_logit": 1.5516078472137451,
            "end_logit": 0.9379200339317322
        },
        {
            "text": "cytoplasmic stress granules in HeLa cells",
            "probability": 0.006817036910383261,
            "start_logit": 2.07584285736084,
            "end_logit": 0.4066522717475891
        },
        {
            "text": "HeLa cells",
            "probability": 0.00403574087366527,
            "start_logit": 1.5516078472137451,
            "end_logit": 0.4066522717475891
        },
        {
            "text": "cytoplasmic stress granules",
            "probability": 0.0026276472045854596,
            "start_logit": 2.07584285736084,
            "end_logit": -0.5466837882995605
        },
        {
            "text": "in HeLa",
            "probability": 0.00022450415507083193,
            "start_logit": -1.8687108755111694,
            "end_logit": 0.9379200339317322
        },
        {
            "text": "in HeLa cells",
            "probability": 0.00013197684003834402,
            "start_logit": -1.8687108755111694,
            "end_logit": 0.4066522717475891
        },
        {
            "text": "cytoplasmic stress",
            "probability": 0.00010834275427140633,
            "start_logit": 2.07584285736084,
            "end_logit": -3.7352280616760254
        },
        {
            "text": "stress granules in HeLa",
            "probability": 9.212534772940606e-05,
            "start_logit": -2.7594549655914307,
            "end_logit": 0.9379200339317322
        },
        {
            "text": "cy",
            "probability": 6.477374321099967e-05,
            "start_logit": 2.07584285736084,
            "end_logit": -4.249627590179443
        },
        {
            "text": "ADAR1(p150) localized to cytoplasmic",
            "probability": 5.8429311140992046e-05,
            "start_logit": -6.46220588684082,
            "end_logit": 4.185338497161865
        },
        {
            "text": "stress granules in HeLa cells",
            "probability": 5.415673610550601e-05,
            "start_logit": -2.7594549655914307,
            "end_logit": 0.4066522717475891
        },
        {
            "text": "cytoplasmic stress granules in He",
            "probability": 5.247939348786874e-05,
            "start_logit": 2.07584285736084,
            "end_logit": -4.460107326507568
        },
        {
            "text": "p150) in various stress pathways. We have previously shown that ADAR1(p150) localized to cytoplasmic",
            "probability": 4.124445721407334e-05,
            "start_logit": -6.810506820678711,
            "end_logit": 4.185338497161865
        },
        {
            "text": "He",
            "probability": 3.1068224524582725e-05,
            "start_logit": 1.5516078472137451,
            "end_logit": -4.460107326507568
        },
        {
            "text": "stress granules",
            "probability": 2.0874875419899223e-05,
            "start_logit": -2.7594549655914307,
            "end_logit": -0.5466837882995605
        },
        {
            "text": "cytoplasmic stress granules in HeLa cells following either oxidative or interferon-induced stress",
            "probability": 1.3402654234260504e-05,
            "start_logit": 2.07584285736084,
            "end_logit": -5.825075149536133
        },
        {
            "text": "granules in HeLa",
            "probability": 1.0503017063101392e-05,
            "start_logit": -4.930942535400391,
            "end_logit": 0.9379200339317322
        }
    ],
    "5c74285c7c78d694710000a3_008": [
        {
            "text": "",
            "probability": 0.5700439613745529,
            "start_logit": 5.547191143035889,
            "end_logit": 6.785803318023682
        },
        {
            "text": "cytoplasmic",
            "probability": 0.4290769680597321,
            "start_logit": 5.65749979019165,
            "end_logit": 6.391417503356934
        },
        {
            "text": "cytoplasmic stress",
            "probability": 0.0006268621237872794,
            "start_logit": 5.65749979019165,
            "end_logit": -0.1372474730014801
        },
        {
            "text": "cytoplasmic stress granules",
            "probability": 0.0001313010366285764,
            "start_logit": 5.65749979019165,
            "end_logit": -1.7004814147949219
        },
        {
            "text": "cy",
            "probability": 6.662089387034289e-05,
            "start_logit": 5.65749979019165,
            "end_logit": -2.378955841064453
        },
        {
            "text": "cytoplasmic stress granules where it is able to bind and sequester wild-type FUS. While FUS",
            "probability": 2.861153172348473e-05,
            "start_logit": 5.65749979019165,
            "end_logit": -3.2241642475128174
        },
        {
            "text": "cytoplasmic stress granules where it is able to bind and sequester wild-type FUS",
            "probability": 6.480357096324431e-06,
            "start_logit": 5.65749979019165,
            "end_logit": -4.709198474884033
        },
        {
            "text": "cytop",
            "probability": 6.163167744401529e-06,
            "start_logit": 5.65749979019165,
            "end_logit": -4.759383201599121
        },
        {
            "text": "to cytoplasmic",
            "probability": 4.302096243265326e-06,
            "start_logit": -5.852789402008057,
            "end_logit": 6.391417503356934
        },
        {
            "text": "mutant FUS to cytoplasmic",
            "probability": 2.5389728412146413e-06,
            "start_logit": -6.38013219833374,
            "end_logit": 6.391417503356934
        },
        {
            "text": "mutant proteins. We also show that oxidative stress recruits mutant FUS to cytoplasmic",
            "probability": 2.4998171162152353e-06,
            "start_logit": -6.395674228668213,
            "end_logit": 6.391417503356934
        },
        {
            "text": "cytoplas",
            "probability": 2.0116183995377917e-06,
            "start_logit": 5.65749979019165,
            "end_logit": -5.879034519195557
        },
        {
            "text": "cytoplasmic stress gran",
            "probability": 1.5726174466451742e-06,
            "start_logit": 5.65749979019165,
            "end_logit": -6.125232696533203
        },
        {
            "text": "stress",
            "probability": 7.038199562285731e-08,
            "start_logit": -3.437044620513916,
            "end_logit": -0.1372474730014801
        },
        {
            "text": "stress granules",
            "probability": 1.4742043959263083e-08,
            "start_logit": -3.437044620513916,
            "end_logit": -1.7004814147949219
        },
        {
            "text": "to cytoplasmic stress",
            "probability": 6.2851688357580465e-09,
            "start_logit": -5.852789402008057,
            "end_logit": -0.1372474730014801
        },
        {
            "text": "FUS",
            "probability": 4.349756503718093e-09,
            "start_logit": -3.6605277061462402,
            "end_logit": -2.6975820064544678
        },
        {
            "text": "mutant FUS to cytoplasmic stress",
            "probability": 3.709324960225941e-09,
            "start_logit": -6.38013219833374,
            "end_logit": -0.1372474730014801
        },
        {
            "text": "mutant proteins. We also show that oxidative stress recruits mutant FUS to cytoplasmic stress",
            "probability": 3.6521202096597412e-09,
            "start_logit": -6.395674228668213,
            "end_logit": -0.1372474730014801
        },
        {
            "text": "stress granules where it is able to bind and sequester wild-type FUS. While FUS",
            "probability": 3.2124076796333767e-09,
            "start_logit": -3.437044620513916,
            "end_logit": -3.2241642475128174
        }
    ],
    "5e2e136bfbd6abf43b000023_002": [
        {
            "text": "OncoPPi Portal",
            "probability": 0.5141221500487684,
            "start_logit": 7.221836566925049,
            "end_logit": 6.193628311157227
        },
        {
            "text": "OncoPPi",
            "probability": 0.43417031699929987,
            "start_logit": 7.221836566925049,
            "end_logit": 6.024604320526123
        },
        {
            "text": "the OncoPPi Portal",
            "probability": 0.02683403648312974,
            "start_logit": 4.269046783447266,
            "end_logit": 6.193628311157227
        },
        {
            "text": "the OncoPPi",
            "probability": 0.022661039064638774,
            "start_logit": 4.269046783447266,
            "end_logit": 6.024604320526123
        },
        {
            "text": "OncoPPi Portal,",
            "probability": 0.001004011653391338,
            "start_logit": 7.221836566925049,
            "end_logit": -0.04482894390821457
        },
        {
            "text": "On",
            "probability": 0.000597913282096024,
            "start_logit": 7.221836566925049,
            "end_logit": -0.5631421208381653
        },
        {
            "text": "",
            "probability": 0.0004229646965403691,
            "start_logit": 3.705719470977783,
            "end_logit": 2.6068179607391357
        },
        {
            "text": "the OncoPPi Portal,",
            "probability": 5.2403276797226e-05,
            "start_logit": 4.269046783447266,
            "end_logit": -0.04482894390821457
        },
        {
            "text": "The OncoPPi Portal",
            "probability": 3.818279213131339e-05,
            "start_logit": 1.20818030834198,
            "end_logit": 2.699453353881836
        },
        {
            "text": "the On",
            "probability": 3.120742186266555e-05,
            "start_logit": 4.269046783447266,
            "end_logit": -0.5631421208381653
        },
        {
            "text": "The OncoPPi",
            "probability": 3.072391610566599e-05,
            "start_logit": 1.20818030834198,
            "end_logit": 2.482109785079956
        },
        {
            "text": "Portal",
            "probability": 1.639580096484988e-05,
            "start_logit": -3.131354331970215,
            "end_logit": 6.193628311157227
        },
        {
            "text": "OncoPPi Portal, an interactive web",
            "probability": 1.3581349265565985e-05,
            "start_logit": 7.221836566925049,
            "end_logit": -4.347890377044678
        },
        {
            "text": "the",
            "probability": 1.5073196054970728e-06,
            "start_logit": 4.269046783447266,
            "end_logit": -3.5934650897979736
        },
        {
            "text": "OncoPPi Portal serves as a resource for the cancer research community to facilitate discovery of cancer targets and therapeutic development.Availability and implementation: The On",
            "probability": 1.4837003107634322e-06,
            "start_logit": 2.3917787075042725,
            "end_logit": -1.7319908142089844
        },
        {
            "text": "the OncoPPi Portal, an interactive web",
            "probability": 7.088634902187249e-07,
            "start_logit": 4.269046783447266,
            "end_logit": -4.347890377044678
        },
        {
            "text": "The On",
            "probability": 4.54271963504752e-07,
            "start_logit": 1.20818030834198,
            "end_logit": -1.7319908142089844
        },
        {
            "text": "OncoPPi Portal is available at http://oncoppi.emory.edu",
            "probability": 4.3544159026267496e-07,
            "start_logit": 2.898864507675171,
            "end_logit": -3.465010404586792
        },
        {
            "text": "Portal serves as a resource for the cancer research community to facilitate discovery of cancer targets and therapeutic development.Availability and implementation: The OncoPPi Portal",
            "probability": 2.679838853177659e-07,
            "start_logit": -3.751033067703247,
            "end_logit": 2.699453353881836
        },
        {
            "text": "Portal serves as a resource for the cancer research community to facilitate discovery of cancer targets and therapeutic development.Availability and implementation: The OncoPPi",
            "probability": 2.156341626840123e-07,
            "start_logit": -3.751033067703247,
            "end_logit": 2.482109785079956
        }
    ],
    "5e2a080caa19d7443100000a_001": [
        {
            "text": "AMPK/Sirt1",
            "probability": 0.885034390356762,
            "start_logit": 4.484415054321289,
            "end_logit": 5.279901504516602
        },
        {
            "text": "AMPK/Sirt1 pathway",
            "probability": 0.05987656829611979,
            "start_logit": 4.484415054321289,
            "end_logit": 2.5865602493286133
        },
        {
            "text": "the AMPK/Sirt1",
            "probability": 0.0328450404481858,
            "start_logit": 1.1905893087387085,
            "end_logit": 5.279901504516602
        },
        {
            "text": "",
            "probability": 0.010371969117112138,
            "start_logit": 2.422926902770996,
            "end_logit": 2.8948700428009033
        },
        {
            "text": "Sirt1",
            "probability": 0.006339321535799793,
            "start_logit": -0.4544396996498108,
            "end_logit": 5.279901504516602
        },
        {
            "text": "the AMPK/Sirt1 pathway",
            "probability": 0.002222115127969036,
            "start_logit": 1.1905893087387085,
            "end_logit": 2.5865602493286133
        },
        {
            "text": "AMPK",
            "probability": 0.0011460269477412918,
            "start_logit": 4.484415054321289,
            "end_logit": -1.3694238662719727
        },
        {
            "text": "inhibition of AMPK",
            "probability": 0.00046087963648363384,
            "start_logit": 0.11784618347883224,
            "end_logit": 2.0862255096435547
        },
        {
            "text": "Pharmacological inhibition of AMPK",
            "probability": 0.0004418501392092643,
            "start_logit": 0.07568003982305527,
            "end_logit": 2.0862255096435547
        },
        {
            "text": "Sirt1 pathway",
            "probability": 0.0004288836942668068,
            "start_logit": -0.4544396996498108,
            "end_logit": 2.5865602493286133
        },
        {
            "text": "via the AMPK/Sirt1",
            "probability": 0.0003090155990013573,
            "start_logit": -3.4755749702453613,
            "end_logit": 5.279901504516602
        },
        {
            "text": "AMP",
            "probability": 0.00020193073519315607,
            "start_logit": 4.484415054321289,
            "end_logit": -3.105555534362793
        },
        {
            "text": "qPCR. Pharmacological inhibition of AMPK",
            "probability": 7.158094865867378e-05,
            "start_logit": -1.7444617748260498,
            "end_logit": 2.0862255096435547
        },
        {
            "text": "AMPK/Sirt1 pathway.",
            "probability": 7.14205184368505e-05,
            "start_logit": -2.247040271759033,
            "end_logit": 2.5865602493286133
        },
        {
            "text": "the AMPK",
            "probability": 4.253089130028069e-05,
            "start_logit": 1.1905893087387085,
            "end_logit": -1.3694238662719727
        },
        {
            "text": "inhibition",
            "probability": 4.120765516138293e-05,
            "start_logit": 0.11784618347883224,
            "end_logit": -0.32828736305236816
        },
        {
            "text": "Pharmacological inhibition",
            "probability": 3.9506211010889335e-05,
            "start_logit": 0.07568003982305527,
            "end_logit": -0.32828736305236816
        },
        {
            "text": "via the AMPK/Sirt1 pathway",
            "probability": 2.0906299031738827e-05,
            "start_logit": -3.4755749702453613,
            "end_logit": 2.5865602493286133
        },
        {
            "text": "inhibition of AMPK was performed to further examine the exact mechanism of LB100 in NAFLD",
            "probability": 1.779530096285031e-05,
            "start_logit": 0.11784618347883224,
            "end_logit": -1.167976975440979
        },
        {
            "text": "Pharmacological inhibition of AMPK was performed to further examine the exact mechanism of LB100 in NAFLD",
            "probability": 1.7060541593239565e-05,
            "start_logit": 0.07568003982305527,
            "end_logit": -1.167976975440979
        }
    ],
    "5e482f08d14c9f295d00000d_001": [
        {
            "text": "chemical decomposition of the water molecule into free radicals",
            "probability": 0.4501780681744836,
            "start_logit": 5.9519476890563965,
            "end_logit": 6.533967971801758
        },
        {
            "text": "chemical decomposition of the water molecule into free radicals after exposure to ionizing radiation",
            "probability": 0.27300227629831914,
            "start_logit": 5.9519476890563965,
            "end_logit": 6.033804893493652
        },
        {
            "text": "involves chemical decomposition of the water molecule into free radicals",
            "probability": 0.1370659070802176,
            "start_logit": 4.762766361236572,
            "end_logit": 6.533967971801758
        },
        {
            "text": "involves chemical decomposition of the water molecule into free radicals after exposure to ionizing radiation",
            "probability": 0.08312111868872749,
            "start_logit": 4.762766361236572,
            "end_logit": 6.033804893493652
        },
        {
            "text": "chemical decomposition of the water molecule into free radicals after exposure to ionizing radiation.",
            "probability": 0.027570759212357267,
            "start_logit": 5.9519476890563965,
            "end_logit": 3.7410805225372314
        },
        {
            "text": "free radicals",
            "probability": 0.009599981574537857,
            "start_logit": 2.1040656566619873,
            "end_logit": 6.533967971801758
        },
        {
            "text": "involves chemical decomposition of the water molecule into free radicals after exposure to ionizing radiation.",
            "probability": 0.008394480734382013,
            "start_logit": 4.762766361236572,
            "end_logit": 3.7410805225372314
        },
        {
            "text": "free radicals after exposure to ionizing radiation",
            "probability": 0.005821733681737156,
            "start_logit": 2.1040656566619873,
            "end_logit": 6.033804893493652
        },
        {
            "text": "chemical decomposition of the water molecule",
            "probability": 0.0014915147063216914,
            "start_logit": 5.9519476890563965,
            "end_logit": 0.8241169452667236
        },
        {
            "text": "Water radiolysis involves chemical decomposition of the water molecule into free radicals",
            "probability": 0.0005991612581873481,
            "start_logit": -0.669920027256012,
            "end_logit": 6.533967971801758
        },
        {
            "text": "free radicals after exposure to ionizing radiation.",
            "probability": 0.0005879424146714836,
            "start_logit": 2.1040656566619873,
            "end_logit": 3.7410805225372314
        },
        {
            "text": "chemical decomposition",
            "probability": 0.0005466721752141194,
            "start_logit": 5.9519476890563965,
            "end_logit": -0.17958121001720428
        },
        {
            "text": "involves chemical decomposition of the water molecule",
            "probability": 0.0004541221143323894,
            "start_logit": 4.762766361236572,
            "end_logit": 0.8241169452667236
        },
        {
            "text": "Water radiolysis involves chemical decomposition of the water molecule into free radicals after exposure to ionizing radiation",
            "probability": 0.00036335041380006157,
            "start_logit": -0.669920027256012,
            "end_logit": 6.033804893493652
        },
        {
            "text": "decomposition of the water molecule into free radicals",
            "probability": 0.0003573861525323507,
            "start_logit": -1.1866339445114136,
            "end_logit": 6.533967971801758
        },
        {
            "text": "decomposition of the water molecule into free radicals after exposure to ionizing radiation",
            "probability": 0.00021673031197293722,
            "start_logit": -1.1866339445114136,
            "end_logit": 6.033804893493652
        },
        {
            "text": "exposure to ionizing radiation",
            "probability": 0.00021328917171012956,
            "start_logit": -1.202638864517212,
            "end_logit": 6.033804893493652
        },
        {
            "text": "involves chemical decomposition",
            "probability": 0.00016644550871855647,
            "start_logit": 4.762766361236572,
            "end_logit": -0.17958121001720428
        },
        {
            "text": "water molecule into free radicals",
            "probability": 0.00015497832440510126,
            "start_logit": -2.022165536880493,
            "end_logit": 6.533967971801758
        },
        {
            "text": "water molecule into free radicals after exposure to ionizing radiation",
            "probability": 9.398377737738517e-05,
            "start_logit": -2.022165536880493,
            "end_logit": 6.033804893493652
        },
        {
            "text": "",
            "probability": 9.822599479551712e-08,
            "start_logit": -1.521654486656189,
            "end_logit": -1.330312728881836
        }
    ],
    "5e482f08d14c9f295d00000d_003": [
        {
            "text": "the PCT processes that generate the DNA-damaging species against cancerous cells",
            "probability": 0.6469391215273924,
            "start_logit": 4.796966552734375,
            "end_logit": 6.396073341369629
        },
        {
            "text": "PCT processes that generate the DNA-damaging species against cancerous cells",
            "probability": 0.24013562324249296,
            "start_logit": 3.8059182167053223,
            "end_logit": 6.396073341369629
        },
        {
            "text": "the PCT processes that generate the DNA-damaging species",
            "probability": 0.03653345881982352,
            "start_logit": 4.796966552734375,
            "end_logit": 3.52204966545105
        },
        {
            "text": "the PCT processes that generate the DNA-damaging species against cancerous cells.",
            "probability": 0.0224761386503403,
            "start_logit": 4.796966552734375,
            "end_logit": 3.0362753868103027
        },
        {
            "text": "PCT processes that generate the DNA-damaging species",
            "probability": 0.013560758054312241,
            "start_logit": 3.8059182167053223,
            "end_logit": 3.52204966545105
        },
        {
            "text": "cancerous cells",
            "probability": 0.011130442804749896,
            "start_logit": 0.7343983054161072,
            "end_logit": 6.396073341369629
        },
        {
            "text": "DNA-damaging species against cancerous cells",
            "probability": 0.010544094832214329,
            "start_logit": 0.680280327796936,
            "end_logit": 6.396073341369629
        },
        {
            "text": "PCT processes that generate the DNA-damaging species against cancerous cells.",
            "probability": 0.008342858521434496,
            "start_logit": 3.8059182167053223,
            "end_logit": 3.0362753868103027
        },
        {
            "text": "generate the DNA-damaging species against cancerous cells",
            "probability": 0.005338891374648285,
            "start_logit": -0.00026762019842863083,
            "end_logit": 6.396073341369629
        },
        {
            "text": "processes that generate the DNA-damaging species against cancerous cells",
            "probability": 0.0012115204244083724,
            "start_logit": -1.4834095239639282,
            "end_logit": 6.396073341369629
        },
        {
            "text": "the DNA-damaging species against cancerous cells",
            "probability": 0.0005967643892993427,
            "start_logit": -2.191518545150757,
            "end_logit": 6.396073341369629
        },
        {
            "text": "DNA-damaging species",
            "probability": 0.0005954381819351849,
            "start_logit": 0.680280327796936,
            "end_logit": 3.52204966545105
        },
        {
            "text": "the PCT processes that generate the DNA",
            "probability": 0.00045349904287827504,
            "start_logit": 4.796966552734375,
            "end_logit": -0.866940975189209
        },
        {
            "text": "cancerous cells.",
            "probability": 0.0003866969354529114,
            "start_logit": 0.7343983054161072,
            "end_logit": 3.0362753868103027
        },
        {
            "text": "DNA-damaging species against cancerous cells.",
            "probability": 0.0003663258713303078,
            "start_logit": 0.680280327796936,
            "end_logit": 3.0362753868103027
        },
        {
            "text": "the PCT processes",
            "probability": 0.0003362223564579542,
            "start_logit": 4.796966552734375,
            "end_logit": -1.1661614179611206
        },
        {
            "text": "generate the DNA-damaging species",
            "probability": 0.00030149385264988256,
            "start_logit": -0.00026762019842863083,
            "end_logit": 3.52204966545105
        },
        {
            "text": "against cancerous cells",
            "probability": 0.00026162673702619175,
            "start_logit": -3.0161221027374268,
            "end_logit": 6.396073341369629
        },
        {
            "text": "water radiolysis reactions-i.e. the PCT processes that generate the DNA-damaging species against cancerous cells",
            "probability": 0.00023861436600460987,
            "start_logit": -3.108192205429077,
            "end_logit": 6.396073341369629
        },
        {
            "text": "reactions-i.e. the PCT processes that generate the DNA-damaging species against cancerous cells",
            "probability": 0.00022700694474059075,
            "start_logit": -3.158060312271118,
            "end_logit": 6.396073341369629
        },
        {
            "text": "",
            "probability": 2.3403070407884275e-05,
            "start_logit": 0.2859623432159424,
            "end_logit": 0.6799373030662537
        }
    ],
    "5e2b0d71fbd6abf43b000001_001": [
        {
            "text": "determine expected disposition prior to surgery",
            "probability": 0.2587450947185834,
            "start_logit": 0.2339843511581421,
            "end_logit": 0.5486166477203369
        },
        {
            "text": "",
            "probability": 0.22784344704628515,
            "start_logit": 0.08775216341018677,
            "end_logit": 0.5676642060279846
        },
        {
            "text": "determine expected disposition prior to surgery in a heterogeneous neurosurgical cohort",
            "probability": 0.16582402051691417,
            "start_logit": 0.2339843511581421,
            "end_logit": 0.10370036959648132
        },
        {
            "text": "to determine expected disposition prior to surgery",
            "probability": 0.09896275069614252,
            "start_logit": -0.7271155118942261,
            "end_logit": 0.5486166477203369
        },
        {
            "text": "to determine expected disposition prior to surgery in a heterogeneous neurosurgical cohort",
            "probability": 0.06342304274288058,
            "start_logit": -0.7271155118942261,
            "end_logit": 0.10370036959648132
        },
        {
            "text": "To assess the capability of the Risk Assessment and Prediction Tool (RAPT) and other preoperative variables to determine expected disposition prior to surgery",
            "probability": 0.0615994576905318,
            "start_logit": -1.2012059688568115,
            "end_logit": 0.5486166477203369
        },
        {
            "text": "determine expected disposition prior to surgery in a heterogeneous neurosurgical cohort, through observational study",
            "probability": 0.023354109461788584,
            "start_logit": 0.2339843511581421,
            "end_logit": -1.856453776359558
        },
        {
            "text": "assess the capability of the Risk Assessment and Prediction Tool (RAPT) and other preoperative variables to determine expected disposition prior to surgery",
            "probability": 0.019975985568269797,
            "start_logit": -2.3273282051086426,
            "end_logit": 0.5486166477203369
        },
        {
            "text": "determine expected disposition prior to surgery in a heterogeneous neurosurgical cohort,",
            "probability": 0.015834548870050355,
            "start_logit": 0.2339843511581421,
            "end_logit": -2.245032548904419
        },
        {
            "text": "Risk Assessment and Prediction Tool (RAPT) and other preoperative variables to determine expected disposition prior to surgery",
            "probability": 0.012806540251854006,
            "start_logit": -2.7719030380249023,
            "end_logit": 0.5486166477203369
        },
        {
            "text": "determine expected disposition prior to surgery in a heterogeneous neurosurgical cohort, through observational study.",
            "probability": 0.009469641176738366,
            "start_logit": 0.2339843511581421,
            "end_logit": -2.7591357231140137
        },
        {
            "text": "to determine expected disposition prior to surgery in a heterogeneous neurosurgical cohort, through observational study",
            "probability": 0.008932292667851742,
            "start_logit": -0.7271155118942261,
            "end_logit": -1.856453776359558
        },
        {
            "text": "to determine expected disposition prior to surgery in a heterogeneous neurosurgical cohort,",
            "probability": 0.006056271381364789,
            "start_logit": -0.7271155118942261,
            "end_logit": -2.245032548904419
        },
        {
            "text": "expected disposition prior to surgery",
            "probability": 0.004855910065704294,
            "start_logit": -3.7416625022888184,
            "end_logit": 0.5486166477203369
        },
        {
            "text": "OBJECTIVE: To assess the capability of the Risk Assessment and Prediction Tool (RAPT) and other preoperative variables to determine expected disposition prior to surgery",
            "probability": 0.0046695457283874855,
            "start_logit": -3.780797243118286,
            "end_logit": 0.5486166477203369
        },
        {
            "text": "To assess",
            "probability": 0.004126170469332588,
            "start_logit": -1.2012059688568115,
            "end_logit": -2.154686689376831
        },
        {
            "text": "to determine expected disposition prior to surgery in a heterogeneous neurosurgical cohort, through observational study.",
            "probability": 0.003621872484093813,
            "start_logit": -0.7271155118942261,
            "end_logit": -2.7591357231140137
        },
        {
            "text": "determine",
            "probability": 0.00348552319081748,
            "start_logit": 0.2339843511581421,
            "end_logit": -3.75860857963562
        },
        {
            "text": "To assess the capability of the Risk Assessment and Prediction Tool",
            "probability": 0.003301729684687595,
            "start_logit": -1.2012059688568115,
            "end_logit": -2.3775899410247803
        },
        {
            "text": "expected disposition prior to surgery in a heterogeneous neurosurgical cohort",
            "probability": 0.0031120455877218464,
            "start_logit": -3.7416625022888184,
            "end_logit": 0.10370036959648132
        }
    ],
    "5e2b0d71fbd6abf43b000001_002": [
        {
            "text": "",
            "probability": 0.9957646730618284,
            "start_logit": 2.5869288444519043,
            "end_logit": 2.785351514816284
        },
        {
            "text": "high risk patients need an accurate discharge plan",
            "probability": 0.0005193596187795936,
            "start_logit": -1.5038719177246094,
            "end_logit": -0.682517409324646
        },
        {
            "text": "accurate discharge plan",
            "probability": 0.00048095916750208955,
            "start_logit": -1.580686092376709,
            "end_logit": -0.682517409324646
        },
        {
            "text": "high risk patients need an accurate discharge plan and could benefit from targeted pre- and postoperative therapeutic exercise programs.",
            "probability": 0.0003932297616148903,
            "start_logit": -1.5038719177246094,
            "end_logit": -0.960719883441925
        },
        {
            "text": "Those high risk patients need an accurate discharge plan",
            "probability": 0.0003896962573564355,
            "start_logit": -1.7911008596420288,
            "end_logit": -0.682517409324646
        },
        {
            "text": "accurate discharge plan and could benefit from targeted pre- and postoperative therapeutic exercise programs.",
            "probability": 0.0003641551093782763,
            "start_logit": -1.580686092376709,
            "end_logit": -0.960719883441925
        },
        {
            "text": "Those high risk patients need an accurate discharge plan and could benefit from targeted pre- and postoperative therapeutic exercise programs.",
            "probability": 0.0002950559898025462,
            "start_logit": -1.7911008596420288,
            "end_logit": -0.960719883441925
        },
        {
            "text": "an accurate discharge plan",
            "probability": 0.00025815912659985467,
            "start_logit": -2.202892303466797,
            "end_logit": -0.682517409324646
        },
        {
            "text": "an accurate discharge plan and could benefit from targeted pre- and postoperative therapeutic exercise programs.",
            "probability": 0.00019546350571134904,
            "start_logit": -2.202892303466797,
            "end_logit": -0.960719883441925
        },
        {
            "text": "need an accurate discharge plan",
            "probability": 0.00015908146930174123,
            "start_logit": -2.687052011489868,
            "end_logit": -0.682517409324646
        },
        {
            "text": "high risk patients need an accurate discharge plan and could benefit from targeted pre- and postoperative therapeutic exercise programs",
            "probability": 0.00014930041993715907,
            "start_logit": -1.5038719177246094,
            "end_logit": -1.9291534423828125
        },
        {
            "text": "RAPT scores",
            "probability": 0.00014769111351044202,
            "start_logit": -3.2978339195251465,
            "end_logit": -0.14602893590927124
        },
        {
            "text": "accurate discharge plan and could benefit from targeted pre- and postoperative therapeutic exercise programs",
            "probability": 0.00013826143405107916,
            "start_logit": -1.580686092376709,
            "end_logit": -1.9291534423828125
        },
        {
            "text": "conventional factors and RAPT scores",
            "probability": 0.00012695789466124908,
            "start_logit": -3.449101448059082,
            "end_logit": -0.14602893590927124
        },
        {
            "text": "need an accurate discharge plan and could benefit from targeted pre- and postoperative therapeutic exercise programs.",
            "probability": 0.00012044750109349104,
            "start_logit": -2.687052011489868,
            "end_logit": -0.960719883441925
        },
        {
            "text": "scores",
            "probability": 0.00011293042757097665,
            "start_logit": -3.5661849975585938,
            "end_logit": -0.14602893590927124
        },
        {
            "text": "Those high risk patients need an accurate discharge plan and could benefit from targeted pre- and postoperative therapeutic exercise programs",
            "probability": 0.00011202606588469924,
            "start_logit": -1.7911008596420288,
            "end_logit": -1.9291534423828125
        },
        {
            "text": "could benefit from targeted pre- and postoperative therapeutic exercise programs.",
            "probability": 0.00010772954090950893,
            "start_logit": -2.798642158508301,
            "end_logit": -0.960719883441925
        },
        {
            "text": "discharge plan",
            "probability": 8.671454415792587e-05,
            "start_logit": -3.293846845626831,
            "end_logit": -0.682517409324646
        },
        {
            "text": "high risk patients need an accurate",
            "probability": 7.810799034873081e-05,
            "start_logit": -1.5038719177246094,
            "end_logit": -2.577021598815918
        }
    ],
    "5e2b0d71fbd6abf43b000001_003": [
        {
            "text": "The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.3980489842310289,
            "start_logit": 1.405704140663147,
            "end_logit": 1.2499828338623047
        },
        {
            "text": "accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.12663288221206584,
            "start_logit": 0.2604212760925293,
            "end_logit": 1.2499828338623047
        },
        {
            "text": "The RAPT accurately predicted discharge disposition for high- and low-risk patients",
            "probability": 0.07959812707318584,
            "start_logit": 1.405704140663147,
            "end_logit": -0.3596016764640808
        },
        {
            "text": "RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.0783102242812159,
            "start_logit": -0.22019276022911072,
            "end_logit": 1.2499828338623047
        },
        {
            "text": "The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort.",
            "probability": 0.052569678223192744,
            "start_logit": 1.405704140663147,
            "end_logit": -0.7744527459144592
        },
        {
            "text": "discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.048773008568612206,
            "start_logit": -0.6936938762664795,
            "end_logit": 1.2499828338623047
        },
        {
            "text": "predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.043775284211171446,
            "start_logit": -0.8018015623092651,
            "end_logit": 1.2499828338623047
        },
        {
            "text": "accurately predicted discharge disposition for high- and low-risk patients",
            "probability": 0.02532286389182061,
            "start_logit": 0.2604212760925293,
            "end_logit": -0.3596016764640808
        },
        {
            "text": "The RAPT accurately predicted discharge disposition",
            "probability": 0.023975327126646757,
            "start_logit": 1.405704140663147,
            "end_logit": -1.5595669746398926
        },
        {
            "text": "The RAPT",
            "probability": 0.017744063607360513,
            "start_logit": 1.405704140663147,
            "end_logit": -1.8605412244796753
        },
        {
            "text": "accurately predicted discharge disposition for high- and low-risk patients in our cohort.",
            "probability": 0.016724197609056066,
            "start_logit": 0.2604212760925293,
            "end_logit": -0.7744527459144592
        },
        {
            "text": "RAPT accurately predicted discharge disposition for high- and low-risk patients",
            "probability": 0.015659749001766202,
            "start_logit": -0.22019276022911072,
            "end_logit": -0.3596016764640808
        },
        {
            "text": "CONCLUSIONS: The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.01402417047206659,
            "start_logit": -1.9400886297225952,
            "end_logit": 1.2499828338623047
        },
        {
            "text": "RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort.",
            "probability": 0.010342303221807002,
            "start_logit": -0.22019276022911072,
            "end_logit": -0.7744527459144592
        },
        {
            "text": "discharge disposition for high- and low-risk patients",
            "probability": 0.009753171814483796,
            "start_logit": -0.6936938762664795,
            "end_logit": -0.3596016764640808
        },
        {
            "text": "predicted discharge disposition for high- and low-risk patients",
            "probability": 0.008753773463426992,
            "start_logit": -0.8018015623092651,
            "end_logit": -0.3596016764640808
        },
        {
            "text": "predict discharge disposition after total joint arthroplasty",
            "probability": 0.008736696320123543,
            "start_logit": -0.30703070759773254,
            "end_logit": -0.8563252687454224
        },
        {
            "text": "accurately predicted discharge disposition",
            "probability": 0.00762736471213368,
            "start_logit": 0.2604212760925293,
            "end_logit": -1.5595669746398926
        },
        {
            "text": "discharge disposition for high- and low-risk patients in our cohort.",
            "probability": 0.006441371459299651,
            "start_logit": -0.6936938762664795,
            "end_logit": -0.7744527459144592
        },
        {
            "text": "predicted discharge disposition for high- and low-risk patients in our cohort.",
            "probability": 0.005781330178635597,
            "start_logit": -0.8018015623092651,
            "end_logit": -0.7744527459144592
        },
        {
            "text": "",
            "probability": 0.0014054283209002701,
            "start_logit": -1.4459967613220215,
            "end_logit": -1.5445492267608643
        }
    ],
    "5e2b0d71fbd6abf43b000001_004": [
        {
            "text": "The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.3980489842310289,
            "start_logit": 1.405704140663147,
            "end_logit": 1.2499828338623047
        },
        {
            "text": "accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.12663288221206584,
            "start_logit": 0.2604212760925293,
            "end_logit": 1.2499828338623047
        },
        {
            "text": "The RAPT accurately predicted discharge disposition for high- and low-risk patients",
            "probability": 0.07959812707318584,
            "start_logit": 1.405704140663147,
            "end_logit": -0.3596016764640808
        },
        {
            "text": "RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.0783102242812159,
            "start_logit": -0.22019276022911072,
            "end_logit": 1.2499828338623047
        },
        {
            "text": "The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort.",
            "probability": 0.052569678223192744,
            "start_logit": 1.405704140663147,
            "end_logit": -0.7744527459144592
        },
        {
            "text": "discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.048773008568612206,
            "start_logit": -0.6936938762664795,
            "end_logit": 1.2499828338623047
        },
        {
            "text": "predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.043775284211171446,
            "start_logit": -0.8018015623092651,
            "end_logit": 1.2499828338623047
        },
        {
            "text": "accurately predicted discharge disposition for high- and low-risk patients",
            "probability": 0.02532286389182061,
            "start_logit": 0.2604212760925293,
            "end_logit": -0.3596016764640808
        },
        {
            "text": "The RAPT accurately predicted discharge disposition",
            "probability": 0.023975327126646757,
            "start_logit": 1.405704140663147,
            "end_logit": -1.5595669746398926
        },
        {
            "text": "The RAPT",
            "probability": 0.017744063607360513,
            "start_logit": 1.405704140663147,
            "end_logit": -1.8605412244796753
        },
        {
            "text": "accurately predicted discharge disposition for high- and low-risk patients in our cohort.",
            "probability": 0.016724197609056066,
            "start_logit": 0.2604212760925293,
            "end_logit": -0.7744527459144592
        },
        {
            "text": "RAPT accurately predicted discharge disposition for high- and low-risk patients",
            "probability": 0.015659749001766202,
            "start_logit": -0.22019276022911072,
            "end_logit": -0.3596016764640808
        },
        {
            "text": "CONCLUSIONS: The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.01402417047206659,
            "start_logit": -1.9400886297225952,
            "end_logit": 1.2499828338623047
        },
        {
            "text": "RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort.",
            "probability": 0.010342303221807002,
            "start_logit": -0.22019276022911072,
            "end_logit": -0.7744527459144592
        },
        {
            "text": "discharge disposition for high- and low-risk patients",
            "probability": 0.009753171814483796,
            "start_logit": -0.6936938762664795,
            "end_logit": -0.3596016764640808
        },
        {
            "text": "predicted discharge disposition for high- and low-risk patients",
            "probability": 0.008753773463426992,
            "start_logit": -0.8018015623092651,
            "end_logit": -0.3596016764640808
        },
        {
            "text": "predict discharge disposition after total joint arthroplasty",
            "probability": 0.008736696320123543,
            "start_logit": -0.30703070759773254,
            "end_logit": -0.8563252687454224
        },
        {
            "text": "accurately predicted discharge disposition",
            "probability": 0.00762736471213368,
            "start_logit": 0.2604212760925293,
            "end_logit": -1.5595669746398926
        },
        {
            "text": "discharge disposition for high- and low-risk patients in our cohort.",
            "probability": 0.006441371459299651,
            "start_logit": -0.6936938762664795,
            "end_logit": -0.7744527459144592
        },
        {
            "text": "predicted discharge disposition for high- and low-risk patients in our cohort.",
            "probability": 0.005781330178635597,
            "start_logit": -0.8018015623092651,
            "end_logit": -0.7744527459144592
        },
        {
            "text": "",
            "probability": 0.0014054283209002701,
            "start_logit": -1.4459967613220215,
            "end_logit": -1.5445492267608643
        }
    ],
    "5e2b0d71fbd6abf43b000001_005": [
        {
            "text": "The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.3980489842310289,
            "start_logit": 1.405704140663147,
            "end_logit": 1.2499828338623047
        },
        {
            "text": "accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.12663288221206584,
            "start_logit": 0.2604212760925293,
            "end_logit": 1.2499828338623047
        },
        {
            "text": "The RAPT accurately predicted discharge disposition for high- and low-risk patients",
            "probability": 0.07959812707318584,
            "start_logit": 1.405704140663147,
            "end_logit": -0.3596016764640808
        },
        {
            "text": "RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.0783102242812159,
            "start_logit": -0.22019276022911072,
            "end_logit": 1.2499828338623047
        },
        {
            "text": "The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort.",
            "probability": 0.052569678223192744,
            "start_logit": 1.405704140663147,
            "end_logit": -0.7744527459144592
        },
        {
            "text": "discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.048773008568612206,
            "start_logit": -0.6936938762664795,
            "end_logit": 1.2499828338623047
        },
        {
            "text": "predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.043775284211171446,
            "start_logit": -0.8018015623092651,
            "end_logit": 1.2499828338623047
        },
        {
            "text": "accurately predicted discharge disposition for high- and low-risk patients",
            "probability": 0.02532286389182061,
            "start_logit": 0.2604212760925293,
            "end_logit": -0.3596016764640808
        },
        {
            "text": "The RAPT accurately predicted discharge disposition",
            "probability": 0.023975327126646757,
            "start_logit": 1.405704140663147,
            "end_logit": -1.5595669746398926
        },
        {
            "text": "The RAPT",
            "probability": 0.017744063607360513,
            "start_logit": 1.405704140663147,
            "end_logit": -1.8605412244796753
        },
        {
            "text": "accurately predicted discharge disposition for high- and low-risk patients in our cohort.",
            "probability": 0.016724197609056066,
            "start_logit": 0.2604212760925293,
            "end_logit": -0.7744527459144592
        },
        {
            "text": "RAPT accurately predicted discharge disposition for high- and low-risk patients",
            "probability": 0.015659749001766202,
            "start_logit": -0.22019276022911072,
            "end_logit": -0.3596016764640808
        },
        {
            "text": "CONCLUSIONS: The RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort",
            "probability": 0.01402417047206659,
            "start_logit": -1.9400886297225952,
            "end_logit": 1.2499828338623047
        },
        {
            "text": "RAPT accurately predicted discharge disposition for high- and low-risk patients in our cohort.",
            "probability": 0.010342303221807002,
            "start_logit": -0.22019276022911072,
            "end_logit": -0.7744527459144592
        },
        {
            "text": "discharge disposition for high- and low-risk patients",
            "probability": 0.009753171814483796,
            "start_logit": -0.6936938762664795,
            "end_logit": -0.3596016764640808
        },
        {
            "text": "predicted discharge disposition for high- and low-risk patients",
            "probability": 0.008753773463426992,
            "start_logit": -0.8018015623092651,
            "end_logit": -0.3596016764640808
        },
        {
            "text": "predict discharge disposition after total joint arthroplasty",
            "probability": 0.008736696320123543,
            "start_logit": -0.30703070759773254,
            "end_logit": -0.8563252687454224
        },
        {
            "text": "accurately predicted discharge disposition",
            "probability": 0.00762736471213368,
            "start_logit": 0.2604212760925293,
            "end_logit": -1.5595669746398926
        },
        {
            "text": "discharge disposition for high- and low-risk patients in our cohort.",
            "probability": 0.006441371459299651,
            "start_logit": -0.6936938762664795,
            "end_logit": -0.7744527459144592
        },
        {
            "text": "predicted discharge disposition for high- and low-risk patients in our cohort.",
            "probability": 0.005781330178635597,
            "start_logit": -0.8018015623092651,
            "end_logit": -0.7744527459144592
        },
        {
            "text": "",
            "probability": 0.0014054283209002701,
            "start_logit": -1.4459967613220215,
            "end_logit": -1.5445492267608643
        }
    ],
    "5e2b0d71fbd6abf43b000001_006": [
        {
            "text": "",
            "probability": 0.6436554599090275,
            "start_logit": 2.501803159713745,
            "end_logit": 2.1895105838775635
        },
        {
            "text": "The difference between the postoperative orientation predicted by the RAPT and the real one is assessed",
            "probability": 0.12081070248529023,
            "start_logit": 1.8894267082214355,
            "end_logit": 1.1289483308792114
        },
        {
            "text": "The difference between the postoperative orientation",
            "probability": 0.09683554241013886,
            "start_logit": 1.8894267082214355,
            "end_logit": 0.9077375531196594
        },
        {
            "text": "The difference between the postoperative orientation predicted by the RAPT and the real one is assessed.",
            "probability": 0.04008345304236236,
            "start_logit": 1.8894267082214355,
            "end_logit": 0.02568705938756466
        },
        {
            "text": "The difference between the postoperative orientation predicted",
            "probability": 0.026447882492517928,
            "start_logit": 1.8894267082214355,
            "end_logit": -0.3901004493236542
        },
        {
            "text": "difference between the postoperative orientation predicted by the RAPT and the real one is assessed",
            "probability": 0.016910106426329695,
            "start_logit": -0.07688671350479126,
            "end_logit": 1.1289483308792114
        },
        {
            "text": "difference between the postoperative orientation",
            "probability": 0.013554257150405952,
            "start_logit": -0.07688671350479126,
            "end_logit": 0.9077375531196594
        },
        {
            "text": "difference between the postoperative orientation predicted by the RAPT and the real one is assessed.",
            "probability": 0.00561055802952281,
            "start_logit": -0.07688671350479126,
            "end_logit": 0.02568705938756466
        },
        {
            "text": "The difference between the postoperative orientation predicted by the RAPT",
            "probability": 0.0054544479771953085,
            "start_logit": 1.8894267082214355,
            "end_logit": -1.9688451290130615
        },
        {
            "text": "postoperative orientation predicted by the RAPT and the real one is assessed",
            "probability": 0.005296873082543815,
            "start_logit": -1.23768150806427,
            "end_logit": 1.1289483308792114
        },
        {
            "text": "The difference",
            "probability": 0.004752447801634237,
            "start_logit": 1.8894267082214355,
            "end_logit": -2.106616735458374
        },
        {
            "text": "postoperative orientation",
            "probability": 0.004245696510938242,
            "start_logit": -1.23768150806427,
            "end_logit": 0.9077375531196594
        },
        {
            "text": "difference between the postoperative orientation predicted",
            "probability": 0.0037019609893750526,
            "start_logit": -0.07688671350479126,
            "end_logit": -0.3901004493236542
        },
        {
            "text": "The difference between the postoperative orientation predicted by the RAPT and the real one",
            "probability": 0.0027869336500094587,
            "start_logit": 1.8894267082214355,
            "end_logit": -2.6403346061706543
        },
        {
            "text": "the postoperative orientation predicted by the RAPT and the real one is assessed",
            "probability": 0.0027812062780277055,
            "start_logit": -1.881913423538208,
            "end_logit": 1.1289483308792114
        },
        {
            "text": "the postoperative orientation",
            "probability": 0.002229269534461058,
            "start_logit": -1.881913423538208,
            "end_logit": 0.9077375531196594
        },
        {
            "text": "postoperative orientation predicted by the RAPT and the real one is assessed.",
            "probability": 0.0017574350542440534,
            "start_logit": -1.23768150806427,
            "end_logit": 0.02568705938756466
        },
        {
            "text": "postoperative orientation predicted",
            "probability": 0.0011595916088804913,
            "start_logit": -1.23768150806427,
            "end_logit": -0.3901004493236542
        },
        {
            "text": "predicted by the RAPT and the real one is assessed",
            "probability": 0.0010034067316107998,
            "start_logit": -2.901397228240967,
            "end_logit": 1.1289483308792114
        },
        {
            "text": "the postoperative orientation predicted by the RAPT and the real one is assessed.",
            "probability": 0.0009227688354847589,
            "start_logit": -1.881913423538208,
            "end_logit": 0.02568705938756466
        }
    ],
    "5e2b0d71fbd6abf43b000001_007": [
        {
            "text": "",
            "probability": 0.6436554599090275,
            "start_logit": 2.501803159713745,
            "end_logit": 2.1895105838775635
        },
        {
            "text": "The difference between the postoperative orientation predicted by the RAPT and the real one is assessed",
            "probability": 0.12081070248529023,
            "start_logit": 1.8894267082214355,
            "end_logit": 1.1289483308792114
        },
        {
            "text": "The difference between the postoperative orientation",
            "probability": 0.09683554241013886,
            "start_logit": 1.8894267082214355,
            "end_logit": 0.9077375531196594
        },
        {
            "text": "The difference between the postoperative orientation predicted by the RAPT and the real one is assessed.",
            "probability": 0.04008345304236236,
            "start_logit": 1.8894267082214355,
            "end_logit": 0.02568705938756466
        },
        {
            "text": "The difference between the postoperative orientation predicted",
            "probability": 0.026447882492517928,
            "start_logit": 1.8894267082214355,
            "end_logit": -0.3901004493236542
        },
        {
            "text": "difference between the postoperative orientation predicted by the RAPT and the real one is assessed",
            "probability": 0.016910106426329695,
            "start_logit": -0.07688671350479126,
            "end_logit": 1.1289483308792114
        },
        {
            "text": "difference between the postoperative orientation",
            "probability": 0.013554257150405952,
            "start_logit": -0.07688671350479126,
            "end_logit": 0.9077375531196594
        },
        {
            "text": "difference between the postoperative orientation predicted by the RAPT and the real one is assessed.",
            "probability": 0.00561055802952281,
            "start_logit": -0.07688671350479126,
            "end_logit": 0.02568705938756466
        },
        {
            "text": "The difference between the postoperative orientation predicted by the RAPT",
            "probability": 0.0054544479771953085,
            "start_logit": 1.8894267082214355,
            "end_logit": -1.9688451290130615
        },
        {
            "text": "postoperative orientation predicted by the RAPT and the real one is assessed",
            "probability": 0.005296873082543815,
            "start_logit": -1.23768150806427,
            "end_logit": 1.1289483308792114
        },
        {
            "text": "The difference",
            "probability": 0.004752447801634237,
            "start_logit": 1.8894267082214355,
            "end_logit": -2.106616735458374
        },
        {
            "text": "postoperative orientation",
            "probability": 0.004245696510938242,
            "start_logit": -1.23768150806427,
            "end_logit": 0.9077375531196594
        },
        {
            "text": "difference between the postoperative orientation predicted",
            "probability": 0.0037019609893750526,
            "start_logit": -0.07688671350479126,
            "end_logit": -0.3901004493236542
        },
        {
            "text": "The difference between the postoperative orientation predicted by the RAPT and the real one",
            "probability": 0.0027869336500094587,
            "start_logit": 1.8894267082214355,
            "end_logit": -2.6403346061706543
        },
        {
            "text": "the postoperative orientation predicted by the RAPT and the real one is assessed",
            "probability": 0.0027812062780277055,
            "start_logit": -1.881913423538208,
            "end_logit": 1.1289483308792114
        },
        {
            "text": "the postoperative orientation",
            "probability": 0.002229269534461058,
            "start_logit": -1.881913423538208,
            "end_logit": 0.9077375531196594
        },
        {
            "text": "postoperative orientation predicted by the RAPT and the real one is assessed.",
            "probability": 0.0017574350542440534,
            "start_logit": -1.23768150806427,
            "end_logit": 0.02568705938756466
        },
        {
            "text": "postoperative orientation predicted",
            "probability": 0.0011595916088804913,
            "start_logit": -1.23768150806427,
            "end_logit": -0.3901004493236542
        },
        {
            "text": "predicted by the RAPT and the real one is assessed",
            "probability": 0.0010034067316107998,
            "start_logit": -2.901397228240967,
            "end_logit": 1.1289483308792114
        },
        {
            "text": "the postoperative orientation predicted by the RAPT and the real one is assessed.",
            "probability": 0.0009227688354847589,
            "start_logit": -1.881913423538208,
            "end_logit": 0.02568705938756466
        }
    ],
    "5c74305d7c78d694710000a4_001": [
        {
            "text": "FUS variants with disease-associated amino acid substitutions or short deletions affecting nuclear localization signal (NLS)",
            "probability": 0.34105606982967196,
            "start_logit": 3.7040960788726807,
            "end_logit": 3.2218823432922363
        },
        {
            "text": "FUS variants with disease-associated amino acid substitutions or short deletions affecting nuclear localization signal (NLS",
            "probability": 0.13996896218149033,
            "start_logit": 3.7040960788726807,
            "end_logit": 2.331256151199341
        },
        {
            "text": "FUS variants",
            "probability": 0.13605777945001635,
            "start_logit": 3.7040960788726807,
            "end_logit": 2.302915096282959
        },
        {
            "text": "FUS variants with disease-associated amino acid substitutions or short deletions",
            "probability": 0.12845750086742744,
            "start_logit": 3.7040960788726807,
            "end_logit": 2.2454335689544678
        },
        {
            "text": "FUS",
            "probability": 0.04192575966116166,
            "start_logit": 3.7040960788726807,
            "end_logit": 1.125735878944397
        },
        {
            "text": "",
            "probability": 0.03910462385425275,
            "start_logit": 1.9859699010849,
            "end_logit": 2.774202346801758
        },
        {
            "text": "disease-associated amino acid substitutions or short deletions affecting nuclear localization signal (NLS)",
            "probability": 0.0322586126907416,
            "start_logit": 1.3458342552185059,
            "end_logit": 3.2218823432922363
        },
        {
            "text": "FUS variants with disease-associated amino acid substitutions or short deletions affecting nuclear localization signal",
            "probability": 0.022023809750073283,
            "start_logit": 3.7040960788726807,
            "end_logit": 0.48195958137512207
        },
        {
            "text": "amino acid substitutions or short deletions affecting nuclear localization signal (NLS)",
            "probability": 0.018844670617282126,
            "start_logit": 0.8082793354988098,
            "end_logit": 3.2218823432922363
        },
        {
            "text": "FUS variants with disease-associated amino acid substitutions",
            "probability": 0.018765233529564673,
            "start_logit": 3.7040960788726807,
            "end_logit": 0.3218413293361664
        },
        {
            "text": "NLS)",
            "probability": 0.013359018784933435,
            "start_logit": 0.4642409086227417,
            "end_logit": 3.2218823432922363
        },
        {
            "text": "disease-associated amino acid substitutions or short deletions affecting nuclear localization signal (NLS",
            "probability": 0.013238892191517686,
            "start_logit": 1.3458342552185059,
            "end_logit": 2.331256151199341
        },
        {
            "text": "nuclear localization signal (NLS)",
            "probability": 0.012847005047306641,
            "start_logit": 0.42515990138053894,
            "end_logit": 3.2218823432922363
        },
        {
            "text": "disease-associated amino acid substitutions or short deletions",
            "probability": 0.012150086552549691,
            "start_logit": 1.3458342552185059,
            "end_logit": 2.2454335689544678
        },
        {
            "text": "amino acid substitutions or short deletions affecting nuclear localization signal (NLS",
            "probability": 0.0077338280191591125,
            "start_logit": 0.8082793354988098,
            "end_logit": 2.331256151199341
        },
        {
            "text": "amino acid substitutions or short deletions",
            "probability": 0.007097775135258122,
            "start_logit": 0.8082793354988098,
            "end_logit": 2.2454335689544678
        },
        {
            "text": "NLS",
            "probability": 0.005482523727034074,
            "start_logit": 0.4642409086227417,
            "end_logit": 2.331256151199341
        },
        {
            "text": "nuclear localization signal (NLS",
            "probability": 0.005272393962992406,
            "start_logit": 0.42515990138053894,
            "end_logit": 2.331256151199341
        },
        {
            "text": "variants with disease-associated amino acid substitutions or short deletions affecting nuclear localization signal (NLS)",
            "probability": 0.0022723434465699594,
            "start_logit": -1.3071391582489014,
            "end_logit": 3.2218823432922363
        },
        {
            "text": "disease-associated amino acid substitutions or short deletions affecting nuclear localization signal",
            "probability": 0.0020831107009970672,
            "start_logit": 1.3458342552185059,
            "end_logit": 0.48195958137512207
        }
    ],
    "5c74305d7c78d694710000a4_002": [
        {
            "text": "endoplasmic-reticulum-bound transcripts",
            "probability": 0.7056841219798572,
            "start_logit": 6.771547317504883,
            "end_logit": 4.173964023590088
        },
        {
            "text": "endoplasmic-reticulum-bound transcripts resume translation faster than those at the cytosol",
            "probability": 0.2854575581545761,
            "start_logit": 6.771547317504883,
            "end_logit": 3.2688896656036377
        },
        {
            "text": "endoplasmic-reticulum",
            "probability": 0.0037035552825203186,
            "start_logit": 6.771547317504883,
            "end_logit": -1.0759104490280151
        },
        {
            "text": "endoplasmic-reticulum-bound",
            "probability": 0.0019229118705303694,
            "start_logit": 6.771547317504883,
            "end_logit": -1.73136305809021
        },
        {
            "text": "endoplasmic-reticulum-bound transcripts resume translation faster than those at the cytosol,",
            "probability": 0.0006552253035091559,
            "start_logit": 6.771547317504883,
            "end_logit": -2.8079798221588135
        },
        {
            "text": "endoplasmic-reticulum-bound transcript",
            "probability": 0.000532679413672168,
            "start_logit": 6.771547317504883,
            "end_logit": -3.0150392055511475
        },
        {
            "text": "endoplasmic-reticulum-bound transcripts resume translation",
            "probability": 0.00044229090414099967,
            "start_logit": 6.771547317504883,
            "end_logit": -3.200991153717041
        },
        {
            "text": "",
            "probability": 0.0003997863175548876,
            "start_logit": 2.790045738220215,
            "end_logit": 0.679472804069519
        },
        {
            "text": "end",
            "probability": 0.00027107590421294385,
            "start_logit": 6.771547317504883,
            "end_logit": -3.6905601024627686
        },
        {
            "text": "endoplasmic-reticulum-bound transcripts resume translation faster",
            "probability": 0.00021880219339953538,
            "start_logit": 6.771547317504883,
            "end_logit": -3.9047908782958984
        },
        {
            "text": "transcripts",
            "probability": 0.0001836796005442407,
            "start_logit": -1.4821827411651611,
            "end_logit": 4.173964023590088
        },
        {
            "text": "endoplasmic-reticulum-bound transcripts resume translation faster than those at the cytosol, which have been sequestered",
            "probability": 0.00012461392342371405,
            "start_logit": 6.771547317504883,
            "end_logit": -4.467738628387451
        },
        {
            "text": "endoplasmic",
            "probability": 0.0001151292994813872,
            "start_logit": 6.771547317504883,
            "end_logit": -4.546903133392334
        },
        {
            "text": "endoplasmic-re",
            "probability": 0.00010217039793086752,
            "start_logit": 6.771547317504883,
            "end_logit": -4.666316986083984
        },
        {
            "text": "transcripts resume translation faster than those at the cytosol",
            "probability": 7.430056681318318e-05,
            "start_logit": -1.4821827411651611,
            "end_logit": 3.2688896656036377
        },
        {
            "text": "bound transcripts",
            "probability": 4.2503182327552195e-05,
            "start_logit": -2.9457967281341553,
            "end_logit": 4.173964023590088
        },
        {
            "text": "those at the cytosol",
            "probability": 2.8883893160222158e-05,
            "start_logit": -2.4270172119140625,
            "end_logit": 3.2688896656036377
        },
        {
            "text": "bound transcripts resume translation faster than those at the cytosol",
            "probability": 1.719303901437093e-05,
            "start_logit": -2.9457967281341553,
            "end_logit": 3.2688896656036377
        },
        {
            "text": "reticulum-bound transcripts",
            "probability": 1.6165168699265646e-05,
            "start_logit": -3.9125168323516846,
            "end_logit": 4.173964023590088
        },
        {
            "text": "the cytosol",
            "probability": 7.353604631469997e-06,
            "start_logit": -3.7951107025146484,
            "end_logit": 3.2688896656036377
        }
    ],
    "5c74305d7c78d694710000a4_003": [
        {
            "text": "mRNAs",
            "probability": 0.44939474099564763,
            "start_logit": -1.103334665298462,
            "end_logit": 3.477879047393799
        },
        {
            "text": "nontranslating mRNAs",
            "probability": 0.41488307913077876,
            "start_logit": -1.1832395792007446,
            "end_logit": 3.477879047393799
        },
        {
            "text": "proteins",
            "probability": 0.07657493943680932,
            "start_logit": 0.5194534063339233,
            "end_logit": 0.08545918017625809
        },
        {
            "text": "mRNAs and proteins",
            "probability": 0.015111889078125032,
            "start_logit": -1.103334665298462,
            "end_logit": 0.08545918017625809
        },
        {
            "text": "nontranslating mRNAs and proteins",
            "probability": 0.01395135834995457,
            "start_logit": -1.1832395792007446,
            "end_logit": 0.08545918017625809
        },
        {
            "text": "higher order assemblies of nontranslating mRNAs",
            "probability": 0.009979677582674144,
            "start_logit": -4.9106855392456055,
            "end_logit": 3.477879047393799
        },
        {
            "text": "",
            "probability": 0.006941971490395951,
            "start_logit": -1.6165554523468018,
            "end_logit": -0.17921601235866547
        },
        {
            "text": "proteins that form when translation initiation is inhibited.",
            "probability": 0.0021913707621245095,
            "start_logit": 0.5194534063339233,
            "end_logit": -3.4682834148406982
        },
        {
            "text": "proteins that form when translation initiation is inhibited",
            "probability": 0.002136738087952114,
            "start_logit": 0.5194534063339233,
            "end_logit": -3.4935302734375
        },
        {
            "text": "nontranslating",
            "probability": 0.002131944058049915,
            "start_logit": -1.1832395792007446,
            "end_logit": -1.7930834293365479
        },
        {
            "text": "Stress granules are higher order assemblies of nontranslating mRNAs",
            "probability": 0.0019159846806474081,
            "start_logit": -6.561004638671875,
            "end_logit": 3.477879047393799
        },
        {
            "text": "assemblies of nontranslating mRNAs",
            "probability": 0.0013260858768595362,
            "start_logit": -6.929004669189453,
            "end_logit": 3.477879047393799
        },
        {
            "text": "proteins that form when translation initiation is inhibited. Stress granules are thought to form by protein-protein interactions of RNA-binding proteins",
            "probability": 0.0007394393684779648,
            "start_logit": 0.5194534063339233,
            "end_logit": -4.554673671722412
        },
        {
            "text": "granules are higher order assemblies of nontranslating mRNAs",
            "probability": 0.0005965756247896896,
            "start_logit": -7.727785587310791,
            "end_logit": 3.477879047393799
        },
        {
            "text": "mRNAs and proteins that form when translation initiation is inhibited.",
            "probability": 0.0004324620055834256,
            "start_logit": -1.103334665298462,
            "end_logit": -3.4682834148406982
        },
        {
            "text": "mRNAs and proteins that form when translation initiation is inhibited",
            "probability": 0.00042168037234666816,
            "start_logit": -1.103334665298462,
            "end_logit": -3.4935302734375
        },
        {
            "text": "nontranslating mRNAs and proteins that form when translation initiation is inhibited.",
            "probability": 0.00039925070793220816,
            "start_logit": -1.1832395792007446,
            "end_logit": -3.4682834148406982
        },
        {
            "text": "nontranslating mRNAs and proteins that form when translation initiation is inhibited",
            "probability": 0.00038929705964203386,
            "start_logit": -1.1832395792007446,
            "end_logit": -3.4935302734375
        },
        {
            "text": "higher order assemblies of nontranslating mRNAs and proteins",
            "probability": 0.00033558866383414846,
            "start_logit": -4.9106855392456055,
            "end_logit": 0.08545918017625809
        },
        {
            "text": "mRNAs and proteins that form when translation initiation is inhibited. Stress granules are thought to form by protein-protein interactions of RNA-binding proteins",
            "probability": 0.00014592666737476211,
            "start_logit": -1.103334665298462,
            "end_logit": -4.554673671722412
        }
    ],
    "5c74305d7c78d694710000a4_004": [
        {
            "text": "cytoplasmic",
            "probability": 0.9267245197019109,
            "start_logit": 7.162293434143066,
            "end_logit": 7.457131385803223
        },
        {
            "text": "cytoplasmic mRNA",
            "probability": 0.07253221483444648,
            "start_logit": 7.162293434143066,
            "end_logit": 4.909505844116211
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein",
            "probability": 0.0005273113421135565,
            "start_logit": 7.162293434143066,
            "end_logit": -0.014489084482192993
        },
        {
            "text": "cy",
            "probability": 7.597258912675045e-05,
            "start_logit": 7.162293434143066,
            "end_logit": -1.9519076347351074
        },
        {
            "text": "mRNA",
            "probability": 3.4764023160569485e-05,
            "start_logit": -0.4809096157550812,
            "end_logit": 4.909505844116211
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein (RNP) granules",
            "probability": 3.38796017719726e-05,
            "start_logit": 7.162293434143066,
            "end_logit": -2.759467124938965
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein (RNP)",
            "probability": 2.4721583376683677e-05,
            "start_logit": 7.162293434143066,
            "end_logit": -3.07460355758667
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein (RNP",
            "probability": 1.602772699267876e-05,
            "start_logit": 7.162293434143066,
            "end_logit": -3.507960081100464
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein (RNP) granules,",
            "probability": 8.097978953944444e-06,
            "start_logit": 7.162293434143066,
            "end_logit": -4.1906657218933105
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble",
            "probability": 6.786733268480923e-06,
            "start_logit": 7.162293434143066,
            "end_logit": -4.367310523986816
        },
        {
            "text": "cytop",
            "probability": 5.362950036334693e-06,
            "start_logit": 7.162293434143066,
            "end_logit": -4.602766036987305
        },
        {
            "text": ", cytoplasmic",
            "probability": 3.884265347005188e-06,
            "start_logit": -5.220184326171875,
            "end_logit": 7.457131385803223
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble rib",
            "probability": 2.1177386403159827e-06,
            "start_logit": 7.162293434143066,
            "end_logit": -5.531931400299072
        },
        {
            "text": "Upon stress, cytoplasmic",
            "probability": 1.3848427444613067e-06,
            "start_logit": -6.251531600952148,
            "end_logit": 7.457131385803223
        },
        {
            "text": "cytoplas",
            "probability": 1.235235382143811e-06,
            "start_logit": 7.162293434143066,
            "end_logit": -6.071018695831299
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleop",
            "probability": 1.034100963521448e-06,
            "start_logit": 7.162293434143066,
            "end_logit": -6.248747825622559
        },
        {
            "text": ", cytoplasmic mRNA",
            "probability": 3.0401091439082504e-07,
            "start_logit": -5.220184326171875,
            "end_logit": 4.909505844116211
        },
        {
            "text": "mRNA is sequestered to insoluble ribonucleoprotein",
            "probability": 2.527354741876821e-07,
            "start_logit": -0.4809096157550812,
            "end_logit": -0.014489084482192993
        },
        {
            "text": "Upon stress, cytoplasmic mRNA",
            "probability": 1.0838788584713526e-07,
            "start_logit": -6.251531600952148,
            "end_logit": 4.909505844116211
        },
        {
            "text": "insoluble ribonucleoprotein",
            "probability": 1.87168835881473e-08,
            "start_logit": -3.083827018737793,
            "end_logit": -0.014489084482192993
        },
        {
            "text": "",
            "probability": 9.006061197689813e-10,
            "start_logit": -3.0032856464385986,
            "end_logit": -3.129143714904785
        }
    ],
    "5c74305d7c78d694710000a4_005": [
        {
            "text": "cytoplasmic",
            "probability": 0.9267245197019109,
            "start_logit": 7.162293434143066,
            "end_logit": 7.457131385803223
        },
        {
            "text": "cytoplasmic mRNA",
            "probability": 0.07253221483444648,
            "start_logit": 7.162293434143066,
            "end_logit": 4.909505844116211
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein",
            "probability": 0.0005273113421135565,
            "start_logit": 7.162293434143066,
            "end_logit": -0.014489084482192993
        },
        {
            "text": "cy",
            "probability": 7.597258912675045e-05,
            "start_logit": 7.162293434143066,
            "end_logit": -1.9519076347351074
        },
        {
            "text": "mRNA",
            "probability": 3.4764023160569485e-05,
            "start_logit": -0.4809096157550812,
            "end_logit": 4.909505844116211
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein (RNP) granules",
            "probability": 3.38796017719726e-05,
            "start_logit": 7.162293434143066,
            "end_logit": -2.759467124938965
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein (RNP)",
            "probability": 2.4721583376683677e-05,
            "start_logit": 7.162293434143066,
            "end_logit": -3.07460355758667
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein (RNP",
            "probability": 1.602772699267876e-05,
            "start_logit": 7.162293434143066,
            "end_logit": -3.507960081100464
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleoprotein (RNP) granules,",
            "probability": 8.097978953944444e-06,
            "start_logit": 7.162293434143066,
            "end_logit": -4.1906657218933105
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble",
            "probability": 6.786733268480923e-06,
            "start_logit": 7.162293434143066,
            "end_logit": -4.367310523986816
        },
        {
            "text": "cytop",
            "probability": 5.362950036334693e-06,
            "start_logit": 7.162293434143066,
            "end_logit": -4.602766036987305
        },
        {
            "text": ", cytoplasmic",
            "probability": 3.884265347005188e-06,
            "start_logit": -5.220184326171875,
            "end_logit": 7.457131385803223
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble rib",
            "probability": 2.1177386403159827e-06,
            "start_logit": 7.162293434143066,
            "end_logit": -5.531931400299072
        },
        {
            "text": "Upon stress, cytoplasmic",
            "probability": 1.3848427444613067e-06,
            "start_logit": -6.251531600952148,
            "end_logit": 7.457131385803223
        },
        {
            "text": "cytoplas",
            "probability": 1.235235382143811e-06,
            "start_logit": 7.162293434143066,
            "end_logit": -6.071018695831299
        },
        {
            "text": "cytoplasmic mRNA is sequestered to insoluble ribonucleop",
            "probability": 1.034100963521448e-06,
            "start_logit": 7.162293434143066,
            "end_logit": -6.248747825622559
        },
        {
            "text": ", cytoplasmic mRNA",
            "probability": 3.0401091439082504e-07,
            "start_logit": -5.220184326171875,
            "end_logit": 4.909505844116211
        },
        {
            "text": "mRNA is sequestered to insoluble ribonucleoprotein",
            "probability": 2.527354741876821e-07,
            "start_logit": -0.4809096157550812,
            "end_logit": -0.014489084482192993
        },
        {
            "text": "Upon stress, cytoplasmic mRNA",
            "probability": 1.0838788584713526e-07,
            "start_logit": -6.251531600952148,
            "end_logit": 4.909505844116211
        },
        {
            "text": "insoluble ribonucleoprotein",
            "probability": 1.87168835881473e-08,
            "start_logit": -3.083827018737793,
            "end_logit": -0.014489084482192993
        },
        {
            "text": "",
            "probability": 9.006061197689813e-10,
            "start_logit": -3.0032856464385986,
            "end_logit": -3.129143714904785
        }
    ],
    "5c74305d7c78d694710000a4_006": [
        {
            "text": "noncoding RNAs (ncRNAs",
            "probability": 0.6299073631599601,
            "start_logit": 3.788625955581665,
            "end_logit": 2.976731777191162
        },
        {
            "text": "noncoding RNAs",
            "probability": 0.20022569081035801,
            "start_logit": 3.788625955581665,
            "end_logit": 1.8306041955947876
        },
        {
            "text": "ncRNAs",
            "probability": 0.10527504769782108,
            "start_logit": 1.9996296167373657,
            "end_logit": 2.976731777191162
        },
        {
            "text": "noncoding RNAs (ncRNAs)",
            "probability": 0.026552983884332207,
            "start_logit": 3.788625955581665,
            "end_logit": -0.18969886004924774
        },
        {
            "text": "nontranslating mRNAs",
            "probability": 0.022659528932745115,
            "start_logit": 1.1126874685287476,
            "end_logit": 2.3276779651641846
        },
        {
            "text": "ncRNAs)",
            "probability": 0.004437742449809537,
            "start_logit": 1.9996296167373657,
            "end_logit": -0.18969886004924774
        },
        {
            "text": "mRNAs",
            "probability": 0.0022313044043573427,
            "start_logit": -1.2053066492080688,
            "end_logit": 2.3276779651641846
        },
        {
            "text": "(ncRNAs",
            "probability": 0.002029768799496059,
            "start_logit": -1.9490249156951904,
            "end_logit": 2.976731777191162
        },
        {
            "text": "some noncoding RNAs (ncRNAs",
            "probability": 0.0016346972411787767,
            "start_logit": -2.1654891967773438,
            "end_logit": 2.976731777191162
        },
        {
            "text": "nontranslating",
            "probability": 0.0014962292110859811,
            "start_logit": 1.1126874685287476,
            "end_logit": -0.38995441794395447
        },
        {
            "text": "noncoding RNA",
            "probability": 0.0006551361463410303,
            "start_logit": 3.788625955581665,
            "end_logit": -3.8917531967163086
        },
        {
            "text": "noncoding RNAs (ncRNA",
            "probability": 0.000544636836214648,
            "start_logit": 3.788625955581665,
            "end_logit": -4.07647705078125
        },
        {
            "text": "some noncoding RNAs",
            "probability": 0.0005196135233899299,
            "start_logit": -2.1654891967773438,
            "end_logit": 1.8306041955947876
        },
        {
            "text": "nontranslating mRNAs.",
            "probability": 0.00039324684954549145,
            "start_logit": 1.1126874685287476,
            "end_logit": -1.7262202501296997
        },
        {
            "text": "nontranslating mRNA",
            "probability": 0.00034920226660563276,
            "start_logit": 1.1126874685287476,
            "end_logit": -1.8450064659118652
        },
        {
            "text": "",
            "probability": 0.0003063930638319898,
            "start_logit": -0.5261533856391907,
            "end_logit": -0.33694812655448914
        },
        {
            "text": "mRNA-protein assemblies formed from nontranslating mRNAs",
            "probability": 0.0002822879648906185,
            "start_logit": -3.2727205753326416,
            "end_logit": 2.3276779651641846
        },
        {
            "text": "RNAs (ncRNAs",
            "probability": 0.00023187258736133138,
            "start_logit": -4.118514060974121,
            "end_logit": 2.976731777191162
        },
        {
            "text": "Stress granules are mRNA-protein assemblies formed from nontranslating mRNAs",
            "probability": 0.00014353857455775992,
            "start_logit": -3.9490444660186768,
            "end_logit": 2.3276779651641846
        },
        {
            "text": "noncoding RNAs (ncRNAs), can be targeted to stress granules",
            "probability": 0.00012371559611737428,
            "start_logit": 3.788625955581665,
            "end_logit": -5.558610916137695
        }
    ],
    "5c74305d7c78d694710000a4_007": [
        {
            "text": "noncoding RNAs (ncRNAs",
            "probability": 0.6299073631599601,
            "start_logit": 3.788625955581665,
            "end_logit": 2.976731777191162
        },
        {
            "text": "noncoding RNAs",
            "probability": 0.20022569081035801,
            "start_logit": 3.788625955581665,
            "end_logit": 1.8306041955947876
        },
        {
            "text": "ncRNAs",
            "probability": 0.10527504769782108,
            "start_logit": 1.9996296167373657,
            "end_logit": 2.976731777191162
        },
        {
            "text": "noncoding RNAs (ncRNAs)",
            "probability": 0.026552983884332207,
            "start_logit": 3.788625955581665,
            "end_logit": -0.18969886004924774
        },
        {
            "text": "nontranslating mRNAs",
            "probability": 0.022659528932745115,
            "start_logit": 1.1126874685287476,
            "end_logit": 2.3276779651641846
        },
        {
            "text": "ncRNAs)",
            "probability": 0.004437742449809537,
            "start_logit": 1.9996296167373657,
            "end_logit": -0.18969886004924774
        },
        {
            "text": "mRNAs",
            "probability": 0.0022313044043573427,
            "start_logit": -1.2053066492080688,
            "end_logit": 2.3276779651641846
        },
        {
            "text": "(ncRNAs",
            "probability": 0.002029768799496059,
            "start_logit": -1.9490249156951904,
            "end_logit": 2.976731777191162
        },
        {
            "text": "some noncoding RNAs (ncRNAs",
            "probability": 0.0016346972411787767,
            "start_logit": -2.1654891967773438,
            "end_logit": 2.976731777191162
        },
        {
            "text": "nontranslating",
            "probability": 0.0014962292110859811,
            "start_logit": 1.1126874685287476,
            "end_logit": -0.38995441794395447
        },
        {
            "text": "noncoding RNA",
            "probability": 0.0006551361463410303,
            "start_logit": 3.788625955581665,
            "end_logit": -3.8917531967163086
        },
        {
            "text": "noncoding RNAs (ncRNA",
            "probability": 0.000544636836214648,
            "start_logit": 3.788625955581665,
            "end_logit": -4.07647705078125
        },
        {
            "text": "some noncoding RNAs",
            "probability": 0.0005196135233899299,
            "start_logit": -2.1654891967773438,
            "end_logit": 1.8306041955947876
        },
        {
            "text": "nontranslating mRNAs.",
            "probability": 0.00039324684954549145,
            "start_logit": 1.1126874685287476,
            "end_logit": -1.7262202501296997
        },
        {
            "text": "nontranslating mRNA",
            "probability": 0.00034920226660563276,
            "start_logit": 1.1126874685287476,
            "end_logit": -1.8450064659118652
        },
        {
            "text": "",
            "probability": 0.0003063930638319898,
            "start_logit": -0.5261533856391907,
            "end_logit": -0.33694812655448914
        },
        {
            "text": "mRNA-protein assemblies formed from nontranslating mRNAs",
            "probability": 0.0002822879648906185,
            "start_logit": -3.2727205753326416,
            "end_logit": 2.3276779651641846
        },
        {
            "text": "RNAs (ncRNAs",
            "probability": 0.00023187258736133138,
            "start_logit": -4.118514060974121,
            "end_logit": 2.976731777191162
        },
        {
            "text": "Stress granules are mRNA-protein assemblies formed from nontranslating mRNAs",
            "probability": 0.00014353857455775992,
            "start_logit": -3.9490444660186768,
            "end_logit": 2.3276779651641846
        },
        {
            "text": "noncoding RNAs (ncRNAs), can be targeted to stress granules",
            "probability": 0.00012371559611737428,
            "start_logit": 3.788625955581665,
            "end_logit": -5.558610916137695
        }
    ],
    "5e2e1792fbd6abf43b000024_001": [
        {
            "text": "TBC1D24",
            "probability": 0.858864241143237,
            "start_logit": 2.5196986198425293,
            "end_logit": 2.3925297260284424
        },
        {
            "text": "",
            "probability": 0.0754721633038826,
            "start_logit": 1.2706104516983032,
            "end_logit": 1.209770917892456
        },
        {
            "text": "TBC1D24 mutations were identified in half of these families. The seizure types in individuals with TBC1D24",
            "probability": 0.03883965004705146,
            "start_logit": -0.5764706134796143,
            "end_logit": 2.3925297260284424
        },
        {
            "text": "TBC1D24 mutations",
            "probability": 0.020186329967248503,
            "start_logit": 2.5196986198425293,
            "end_logit": -1.358075499534607
        },
        {
            "text": "TBC1D24 by Sanger sequencing in subsequent families. We identified TBC1D24",
            "probability": 0.003090484453476232,
            "start_logit": -1.1787171363830566,
            "end_logit": 0.4636624753475189
        },
        {
            "text": "TBC1D24 mutations. More information is needed to understand the cellular roles of TBC1D24",
            "probability": 0.0017624136983310562,
            "start_logit": 0.7108163833618164,
            "end_logit": -1.987514615058899
        },
        {
            "text": "TBC1D24 mutations were identified in half of these families. The seizure types in individuals with TBC1D24 mutations",
            "probability": 0.000912868360450791,
            "start_logit": -0.5764706134796143,
            "end_logit": -1.358075499534607
        },
        {
            "text": "TBC1D24 by Sanger sequencing in subsequent families. We identified TBC1D24 mutations",
            "probability": 0.0002921307442992561,
            "start_logit": -1.1787171363830566,
            "end_logit": -1.8952192068099976
        },
        {
            "text": "TBC1D24 and identify the genes responsible for DOORS phenotypes in individuals who do not have a mutation in TBC1D24",
            "probability": 0.00026850418139277534,
            "start_logit": -1.4706830978393555,
            "end_logit": -1.6875882148742676
        },
        {
            "text": "Sanger sequencing in subsequent families. We identified TBC1D24",
            "probability": 6.516358371227082e-05,
            "start_logit": -5.037899494171143,
            "end_logit": 0.4636624753475189
        },
        {
            "text": "TBC1D24 and identify the genes responsible for DOORS phenotypes",
            "probability": 5.4388550301066944e-05,
            "start_logit": -1.4706830978393555,
            "end_logit": -3.2843010425567627
        },
        {
            "text": "DOORS phenotypes in individuals who do not have a mutation in TBC1D24",
            "probability": 2.982297994176623e-05,
            "start_logit": -3.6682703495025635,
            "end_logit": -1.6875882148742676
        },
        {
            "text": "DOORS syndrome from 17 families without TBC1D24",
            "probability": 2.9374567664108692e-05,
            "start_logit": -5.220157623291016,
            "end_logit": -0.15085092186927795
        },
        {
            "text": "mutations in TBC1D24",
            "probability": 2.4033247409098435e-05,
            "start_logit": -4.048194885253906,
            "end_logit": -1.5235047340393066
        },
        {
            "text": "TBC1",
            "probability": 2.2261858258911673e-05,
            "start_logit": -1.1787171363830566,
            "end_logit": -4.469545841217041
        },
        {
            "text": "TBC1D24 by Sanger sequencing",
            "probability": 2.0731226138257092e-05,
            "start_logit": -1.1787171363830566,
            "end_logit": -4.5407795906066895
        },
        {
            "text": "TBC1D24 mRNA stability. We also detected Tbc1d24",
            "probability": 1.8981857552216246e-05,
            "start_logit": -1.0578587055206299,
            "end_logit": -4.749795436859131
        },
        {
            "text": "TBC1D24.",
            "probability": 1.760943736485686e-05,
            "start_logit": -1.3129591941833496,
            "end_logit": -4.569743633270264
        },
        {
            "text": "phenotypes in individuals who do not have a mutation in TBC1D24",
            "probability": 1.638653920973373e-05,
            "start_logit": -4.267089366912842,
            "end_logit": -1.6875882148742676
        },
        {
            "text": "without TBC1D24",
            "probability": 1.246025307805212e-05,
            "start_logit": -6.077743053436279,
            "end_logit": -0.15085092186927795
        }
    ],
    "5e2a0a02aa19d7443100000b_002": [
        {
            "text": "first-in-class humanized antibody",
            "probability": 0.7124482143646567,
            "start_logit": 8.55726146697998,
            "end_logit": 9.287198066711426
        },
        {
            "text": "a first-in-class humanized antibody",
            "probability": 0.19819834177434162,
            "start_logit": 7.277822494506836,
            "end_logit": 9.287198066711426
        },
        {
            "text": "humanized antibody",
            "probability": 0.08788231942503956,
            "start_logit": 6.464552879333496,
            "end_logit": 9.287198066711426
        },
        {
            "text": "we generated a first-in-class humanized antibody",
            "probability": 0.0005450395074037607,
            "start_logit": 1.3816572427749634,
            "end_logit": 9.287198066711426
        },
        {
            "text": "antibody",
            "probability": 0.00048711027434224187,
            "start_logit": 1.269289493560791,
            "end_logit": 9.287198066711426
        },
        {
            "text": "first-in-class humanized antibody (PRL3-zumab) against PRL-3",
            "probability": 0.00018530983956701445,
            "start_logit": 8.55726146697998,
            "end_logit": 1.0327647924423218
        },
        {
            "text": "cancer therapy. Herein, we generated a first-in-class humanized antibody",
            "probability": 5.236852796868814e-05,
            "start_logit": -0.9608952403068542,
            "end_logit": 9.287198066711426
        },
        {
            "text": "a first-in-class humanized antibody (PRL3-zumab) against PRL-3",
            "probability": 5.155196149856974e-05,
            "start_logit": 7.277822494506836,
            "end_logit": 1.0327647924423218
        },
        {
            "text": "class humanized antibody",
            "probability": 2.4086017113841122e-05,
            "start_logit": -1.7375695705413818,
            "end_logit": 9.287198066711426
        },
        {
            "text": "humanized antibody (PRL3-zumab) against PRL-3",
            "probability": 2.285844526672603e-05,
            "start_logit": 6.464552879333496,
            "end_logit": 1.0327647924423218
        },
        {
            "text": "first-in-class humanized",
            "probability": 1.8098977596086576e-05,
            "start_logit": 8.55726146697998,
            "end_logit": -1.293408989906311
        },
        {
            "text": "first-in-class humanized antibody (PRL3-zumab) against PRL-3,",
            "probability": 1.6394111744045555e-05,
            "start_logit": 8.55726146697998,
            "end_logit": -1.392342209815979
        },
        {
            "text": "in-class humanized antibody",
            "probability": 1.4336196747175538e-05,
            "start_logit": -2.256413459777832,
            "end_logit": 9.287198066711426
        },
        {
            "text": "first-in-class",
            "probability": 1.2497645369725545e-05,
            "start_logit": 8.55726146697998,
            "end_logit": -1.6637241840362549
        },
        {
            "text": "generated a first-in-class humanized antibody",
            "probability": 7.978513294010176e-06,
            "start_logit": -2.8424489498138428,
            "end_logit": 9.287198066711426
        },
        {
            "text": "first",
            "probability": 7.5632556883971215e-06,
            "start_logit": 8.55726146697998,
            "end_logit": -2.1659626960754395
        },
        {
            "text": "first-in-class humanized antibody (",
            "probability": 6.6711705750730145e-06,
            "start_logit": 8.55726146697998,
            "end_logit": -2.291469097137451
        },
        {
            "text": "first-in-class humanized antibody (PRL3-zumab",
            "probability": 6.551175745146185e-06,
            "start_logit": 8.55726146697998,
            "end_logit": -2.309619903564453
        },
        {
            "text": "first-in-class humanized antibody (PRL3-zumab)",
            "probability": 6.366800144110727e-06,
            "start_logit": 8.55726146697998,
            "end_logit": -2.338167428970337
        },
        {
            "text": "humanized antibody (PRL3-zumab) against PRL-3, an intracellular tumor-associated phosphatase",
            "probability": 6.303015172881546e-06,
            "start_logit": 6.464552879333496,
            "end_logit": -0.2555277347564697
        },
        {
            "text": "",
            "probability": 3.900072462095134e-08,
            "start_logit": 0.3962761163711548,
            "end_logit": 0.7275458574295044
        }
    ],
    "5e2a0a02aa19d7443100000b_003": [
        {
            "text": "first-in-class humanized antibody",
            "probability": 0.7124482143646567,
            "start_logit": 8.55726146697998,
            "end_logit": 9.287198066711426
        },
        {
            "text": "a first-in-class humanized antibody",
            "probability": 0.19819834177434162,
            "start_logit": 7.277822494506836,
            "end_logit": 9.287198066711426
        },
        {
            "text": "humanized antibody",
            "probability": 0.08788231942503956,
            "start_logit": 6.464552879333496,
            "end_logit": 9.287198066711426
        },
        {
            "text": "we generated a first-in-class humanized antibody",
            "probability": 0.0005450395074037607,
            "start_logit": 1.3816572427749634,
            "end_logit": 9.287198066711426
        },
        {
            "text": "antibody",
            "probability": 0.00048711027434224187,
            "start_logit": 1.269289493560791,
            "end_logit": 9.287198066711426
        },
        {
            "text": "first-in-class humanized antibody (PRL3-zumab) against PRL-3",
            "probability": 0.00018530983956701445,
            "start_logit": 8.55726146697998,
            "end_logit": 1.0327647924423218
        },
        {
            "text": "cancer therapy. Herein, we generated a first-in-class humanized antibody",
            "probability": 5.236852796868814e-05,
            "start_logit": -0.9608952403068542,
            "end_logit": 9.287198066711426
        },
        {
            "text": "a first-in-class humanized antibody (PRL3-zumab) against PRL-3",
            "probability": 5.155196149856974e-05,
            "start_logit": 7.277822494506836,
            "end_logit": 1.0327647924423218
        },
        {
            "text": "class humanized antibody",
            "probability": 2.4086017113841122e-05,
            "start_logit": -1.7375695705413818,
            "end_logit": 9.287198066711426
        },
        {
            "text": "humanized antibody (PRL3-zumab) against PRL-3",
            "probability": 2.285844526672603e-05,
            "start_logit": 6.464552879333496,
            "end_logit": 1.0327647924423218
        },
        {
            "text": "first-in-class humanized",
            "probability": 1.8098977596086576e-05,
            "start_logit": 8.55726146697998,
            "end_logit": -1.293408989906311
        },
        {
            "text": "first-in-class humanized antibody (PRL3-zumab) against PRL-3,",
            "probability": 1.6394111744045555e-05,
            "start_logit": 8.55726146697998,
            "end_logit": -1.392342209815979
        },
        {
            "text": "in-class humanized antibody",
            "probability": 1.4336196747175538e-05,
            "start_logit": -2.256413459777832,
            "end_logit": 9.287198066711426
        },
        {
            "text": "first-in-class",
            "probability": 1.2497645369725545e-05,
            "start_logit": 8.55726146697998,
            "end_logit": -1.6637241840362549
        },
        {
            "text": "generated a first-in-class humanized antibody",
            "probability": 7.978513294010176e-06,
            "start_logit": -2.8424489498138428,
            "end_logit": 9.287198066711426
        },
        {
            "text": "first",
            "probability": 7.5632556883971215e-06,
            "start_logit": 8.55726146697998,
            "end_logit": -2.1659626960754395
        },
        {
            "text": "first-in-class humanized antibody (",
            "probability": 6.6711705750730145e-06,
            "start_logit": 8.55726146697998,
            "end_logit": -2.291469097137451
        },
        {
            "text": "first-in-class humanized antibody (PRL3-zumab",
            "probability": 6.551175745146185e-06,
            "start_logit": 8.55726146697998,
            "end_logit": -2.309619903564453
        },
        {
            "text": "first-in-class humanized antibody (PRL3-zumab)",
            "probability": 6.366800144110727e-06,
            "start_logit": 8.55726146697998,
            "end_logit": -2.338167428970337
        },
        {
            "text": "humanized antibody (PRL3-zumab) against PRL-3, an intracellular tumor-associated phosphatase",
            "probability": 6.303015172881546e-06,
            "start_logit": 6.464552879333496,
            "end_logit": -0.2555277347564697
        },
        {
            "text": "",
            "probability": 3.900072462095134e-08,
            "start_logit": 0.3962761163711548,
            "end_logit": 0.7275458574295044
        }
    ],
    "5e48339fd14c9f295d00000e_001": [
        {
            "text": "systematically review the effects of KI administration",
            "probability": 0.3928778298737848,
            "start_logit": 4.489393711090088,
            "end_logit": 3.5212619304656982
        },
        {
            "text": "to systematically review the effects of KI administration",
            "probability": 0.24105676261050052,
            "start_logit": 4.000927448272705,
            "end_logit": 3.5212619304656982
        },
        {
            "text": "systematically review the effects of KI administration in the case of accidental radioactive iodine release",
            "probability": 0.15149382766271952,
            "start_logit": 4.489393711090088,
            "end_logit": 2.568308115005493
        },
        {
            "text": "to systematically review the effects of KI administration in the case of accidental radioactive iodine release",
            "probability": 0.09295157139200286,
            "start_logit": 4.000927448272705,
            "end_logit": 2.568308115005493
        },
        {
            "text": "systematically review the effects of KI administration in the case of accidental radioactive iodine release on thyroid cancer",
            "probability": 0.023001098405010374,
            "start_logit": 4.489393711090088,
            "end_logit": 0.6833052039146423
        },
        {
            "text": "systematically review",
            "probability": 0.015834787062826077,
            "start_logit": 4.489393711090088,
            "end_logit": 0.30997246503829956
        },
        {
            "text": "to systematically review the effects of KI administration in the case of accidental radioactive iodine release on thyroid cancer",
            "probability": 0.014112708573498757,
            "start_logit": 4.000927448272705,
            "end_logit": 0.6833052039146423
        },
        {
            "text": "aims to systematically review the effects of KI administration",
            "probability": 0.011307699647972687,
            "start_logit": 0.9413788914680481,
            "end_logit": 3.5212619304656982
        },
        {
            "text": "",
            "probability": 0.010036034066147196,
            "start_logit": 2.810565948486328,
            "end_logit": 1.5327730178833008
        },
        {
            "text": "to systematically review",
            "probability": 0.009715698407359254,
            "start_logit": 4.000927448272705,
            "end_logit": 0.30997246503829956
        },
        {
            "text": "systematically review the effects",
            "probability": 0.007689767076777043,
            "start_logit": 4.489393711090088,
            "end_logit": -0.4123462736606598
        },
        {
            "text": "this study aims to systematically review the effects of KI administration",
            "probability": 0.005728429975535536,
            "start_logit": 0.2613365054130554,
            "end_logit": 3.5212619304656982
        },
        {
            "text": "to systematically review the effects",
            "probability": 0.004718185185843124,
            "start_logit": 4.000927448272705,
            "end_logit": -0.4123462736606598
        },
        {
            "text": "systematically review the effects of KI administration in the case",
            "probability": 0.004415551011432414,
            "start_logit": 4.489393711090088,
            "end_logit": -0.9671041369438171
        },
        {
            "text": "aims to systematically review the effects of KI administration in the case of accidental radioactive iodine release",
            "probability": 0.004360252911909279,
            "start_logit": 0.9413788914680481,
            "end_logit": 2.568308115005493
        },
        {
            "text": "review the effects of KI administration",
            "probability": 0.0031072772438604846,
            "start_logit": -0.35035812854766846,
            "end_logit": 3.5212619304656982
        },
        {
            "text": "to systematically review the effects of KI administration in the case",
            "probability": 0.0027092351642732443,
            "start_logit": 4.000927448272705,
            "end_logit": -0.9671041369438171
        },
        {
            "text": "this study aims to systematically review the effects of KI administration in the case of accidental radioactive iodine release",
            "probability": 0.0022088845882969063,
            "start_logit": 0.2613365054130554,
            "end_logit": 2.568308115005493
        },
        {
            "text": "systematically review the effects of KI",
            "probability": 0.0014762319557263025,
            "start_logit": 4.489393711090088,
            "end_logit": -2.062743902206421
        },
        {
            "text": "review the effects of KI administration in the case of accidental radioactive iodine release",
            "probability": 0.0011981671845237927,
            "start_logit": -0.35035812854766846,
            "end_logit": 2.568308115005493
        }
    ],
    "5e48339fd14c9f295d00000e_002": [
        {
            "text": "",
            "probability": 0.9995420453068807,
            "start_logit": 1.3909235000610352,
            "end_logit": 1.6044394969940186
        },
        {
            "text": "countermeasure",
            "probability": 0.000250267370791706,
            "start_logit": -3.0119407176971436,
            "end_logit": -2.2852189540863037
        },
        {
            "text": "countermeasure in Norway and will be implemented according to recommendations from the Crisis Committee for Nuclear and Radiological Emergencies",
            "probability": 5.117103958932313e-05,
            "start_logit": -3.0119407176971436,
            "end_logit": -3.872575044631958
        },
        {
            "text": "relevant countermeasure",
            "probability": 3.767872243278968e-05,
            "start_logit": -4.905375003814697,
            "end_logit": -2.2852189540863037
        },
        {
            "text": "emergency countermeasures",
            "probability": 2.3125664993357404e-05,
            "start_logit": -4.390750885009766,
            "end_logit": -3.2879955768585205
        },
        {
            "text": "a relevant countermeasure",
            "probability": 9.84596454479692e-06,
            "start_logit": -6.247408866882324,
            "end_logit": -2.2852189540863037
        },
        {
            "text": "radionuclides. Iodine prophylaxis can be a relevant countermeasure",
            "probability": 8.585514119819708e-06,
            "start_logit": -6.38439416885376,
            "end_logit": -2.2852189540863037
        },
        {
            "text": "countermeasure in Norway",
            "probability": 8.542892314396274e-06,
            "start_logit": -3.0119407176971436,
            "end_logit": -5.662649154663086
        },
        {
            "text": "Iodine prophylaxis can be a relevant countermeasure",
            "probability": 8.479976676066141e-06,
            "start_logit": -6.396762847900391,
            "end_logit": -2.2852189540863037
        },
        {
            "text": "intake of radioactive iodine",
            "probability": 8.472689256081099e-06,
            "start_logit": -4.972498893737793,
            "end_logit": -3.7103426456451416
        },
        {
            "text": "be a relevant countermeasure",
            "probability": 8.276131531050122e-06,
            "start_logit": -6.42109489440918,
            "end_logit": -2.2852189540863037
        },
        {
            "text": "can be a relevant countermeasure",
            "probability": 8.133699956596141e-06,
            "start_logit": -6.438454627990723,
            "end_logit": -2.2852189540863037
        },
        {
            "text": "relevant countermeasure in Norway and will be implemented according to recommendations from the Crisis Committee for Nuclear and Radiological Emergencies",
            "probability": 7.70399829264237e-06,
            "start_logit": -4.905375003814697,
            "end_logit": -3.872575044631958
        },
        {
            "text": "protect not only from intake of radioactive iodine",
            "probability": 6.973020852670836e-06,
            "start_logit": -5.167298316955566,
            "end_logit": -3.7103426456451416
        },
        {
            "text": "one of several emergency countermeasures",
            "probability": 5.445997588458776e-06,
            "start_logit": -5.836812973022461,
            "end_logit": -3.2879955768585205
        },
        {
            "text": "protect against intake of radioactive iodine isotopes, but not against other radionuclides",
            "probability": 3.7061990847191147e-06,
            "start_logit": -5.219425678253174,
            "end_logit": -4.290256977081299
        },
        {
            "text": "emergency countermeasures; other measures are sheltering and evacuation",
            "probability": 3.6310952315070937e-06,
            "start_logit": -4.390750885009766,
            "end_logit": -5.139404296875
        },
        {
            "text": "countermeasures",
            "probability": 2.981008840476639e-06,
            "start_logit": -6.439432144165039,
            "end_logit": -3.2879955768585205
        },
        {
            "text": "reduce the risk for thyroid cancer",
            "probability": 2.6372276175440163e-06,
            "start_logit": -4.795921325683594,
            "end_logit": -5.05403995513916
        },
        {
            "text": "emergency countermeasures; other measures are sheltering and evacuation. The latter two countermeasures will protect not only from intake",
            "probability": 2.2964794053647227e-06,
            "start_logit": -4.390750885009766,
            "end_logit": -5.597561359405518
        }
    ],
    "5e48339fd14c9f295d00000e_003": [
        {
            "text": "",
            "probability": 0.9541019811149501,
            "start_logit": 0.6680951118469238,
            "end_logit": 1.8021520376205444
        },
        {
            "text": "an avertable thyroid dose by protective action exceeds 100 mGy",
            "probability": 0.019102579730275775,
            "start_logit": -1.500922441482544,
            "end_logit": 0.06022241711616516
        },
        {
            "text": "avertable thyroid dose by protective action exceeds 100 mGy",
            "probability": 0.014214086308824299,
            "start_logit": -1.7965123653411865,
            "end_logit": 0.06022241711616516
        },
        {
            "text": "when an avertable thyroid dose by protective action exceeds 100 mGy",
            "probability": 0.006076340362094962,
            "start_logit": -2.646343231201172,
            "end_logit": 0.06022241711616516
        },
        {
            "text": "an avertable thyroid dose by protective action exceeds 100 mGy.",
            "probability": 0.0009958059579761374,
            "start_logit": -1.500922441482544,
            "end_logit": -2.893803834915161
        },
        {
            "text": "potassium iodide prophylaxis in cases when an avertable thyroid dose by protective action exceeds 100 mGy",
            "probability": 0.0007425165125302094,
            "start_logit": -4.748456001281738,
            "end_logit": 0.06022241711616516
        },
        {
            "text": "avertable thyroid dose by protective action exceeds 100 mGy.",
            "probability": 0.0007409717448309238,
            "start_logit": -1.7965123653411865,
            "end_logit": -2.893803834915161
        },
        {
            "text": "in cases when an avertable thyroid dose by protective action exceeds 100 mGy",
            "probability": 0.0006809875254588632,
            "start_logit": -4.834957122802734,
            "end_logit": 0.06022241711616516
        },
        {
            "text": "cases when an avertable thyroid dose by protective action exceeds 100 mGy",
            "probability": 0.0006751714382417204,
            "start_logit": -4.843534469604492,
            "end_logit": 0.06022241711616516
        },
        {
            "text": "an avertable thyroid dose by protective action",
            "probability": 0.0005373361304152037,
            "start_logit": -1.500922441482544,
            "end_logit": -3.510732412338257
        },
        {
            "text": "thyroid dose by protective action exceeds 100 mGy",
            "probability": 0.0005092795571299122,
            "start_logit": -5.125504016876221,
            "end_logit": 0.06022241711616516
        },
        {
            "text": "avertable thyroid dose by protective action",
            "probability": 0.00039982778464556164,
            "start_logit": -1.7965123653411865,
            "end_logit": -3.510732412338257
        },
        {
            "text": "when an avertable thyroid dose by protective action exceeds 100 mGy.",
            "probability": 0.00031675595760896164,
            "start_logit": -2.646343231201172,
            "end_logit": -2.893803834915161
        },
        {
            "text": "protective action exceeds 100 mGy",
            "probability": 0.00029566294463360796,
            "start_logit": -5.669281005859375,
            "end_logit": 0.06022241711616516
        },
        {
            "text": "International Atomic Energy Agency recommends potassium iodide prophylaxis in cases when an avertable thyroid dose by protective action exceeds 100 mGy",
            "probability": 0.0001871541845421398,
            "start_logit": -6.12656831741333,
            "end_logit": 0.06022241711616516
        },
        {
            "text": "when an avertable thyroid dose by protective action",
            "probability": 0.00017092127154318587,
            "start_logit": -2.646343231201172,
            "end_logit": -3.510732412338257
        },
        {
            "text": "an avertable thyroid dose by protective action exceeds 100 mGy. This paper reviews experiences and practices with potassium iodide in the thyroid protection",
            "probability": 0.00010229679188621571,
            "start_logit": -1.500922441482544,
            "end_logit": -5.169477939605713
        },
        {
            "text": "avertable thyroid dose by protective action exceeds 100 mGy. This paper reviews experiences and practices with potassium iodide in the thyroid protection",
            "probability": 7.611827562127472e-05,
            "start_logit": -1.7965123653411865,
            "end_logit": -5.169477939605713
        },
        {
            "text": "potassium iodide prophylaxis in cases when an avertable thyroid dose by protective action exceeds 100 mGy.",
            "probability": 3.8706937885534025e-05,
            "start_logit": -4.748456001281738,
            "end_logit": -2.893803834915161
        },
        {
            "text": "in cases when an avertable thyroid dose by protective action exceeds 100 mGy.",
            "probability": 3.549946890600271e-05,
            "start_logit": -4.834957122802734,
            "end_logit": -2.893803834915161
        }
    ],
    "5e2b109cfbd6abf43b000002_001": [
        {
            "text": "Length of stay, Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months",
            "probability": 0.7626257328765718,
            "start_logit": 4.734106540679932,
            "end_logit": 4.974130630493164
        },
        {
            "text": "Length of stay, Acuity of admission, Comorbidity, and Emergency visits",
            "probability": 0.13193928633894633,
            "start_logit": 4.734106540679932,
            "end_logit": 3.219705104827881
        },
        {
            "text": "Length of stay, Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months.",
            "probability": 0.08618889171009436,
            "start_logit": 4.734106540679932,
            "end_logit": 2.7939045429229736
        },
        {
            "text": "Length of stay, Acuity of admission",
            "probability": 0.006240024190580544,
            "start_logit": 4.734106540679932,
            "end_logit": 0.1683472990989685
        },
        {
            "text": "Length of stay, Acuity of admission, Comorbidity",
            "probability": 0.003191968651572062,
            "start_logit": 4.734106540679932,
            "end_logit": -0.5019989013671875
        },
        {
            "text": "Length of stay",
            "probability": 0.002418781903683375,
            "start_logit": 4.734106540679932,
            "end_logit": -0.7793726921081543
        },
        {
            "text": "Length of stay, Acuity of admission,",
            "probability": 0.0012177731105932562,
            "start_logit": 4.734106540679932,
            "end_logit": -1.4656128883361816
        },
        {
            "text": "4 parameters: Length of stay, Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months",
            "probability": 0.0011864348894253347,
            "start_logit": -1.7317079305648804,
            "end_logit": 4.974130630493164
        },
        {
            "text": "a simple tool with 4 parameters: Length of stay, Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months",
            "probability": 0.0011643748927373555,
            "start_logit": -1.7504764795303345,
            "end_logit": 4.974130630493164
        },
        {
            "text": "Comorbidity, and Emergency visits in the previous 6 months",
            "probability": 0.0008347742379810159,
            "start_logit": -2.083254814147949,
            "end_logit": 4.974130630493164
        },
        {
            "text": "Emergency visits in the previous 6 months",
            "probability": 0.0005513287894260401,
            "start_logit": -2.498084783554077,
            "end_logit": 4.974130630493164
        },
        {
            "text": "simple tool with 4 parameters: Length of stay, Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months",
            "probability": 0.0005382654929617471,
            "start_logit": -2.522064208984375,
            "end_logit": 4.974130630493164
        },
        {
            "text": ": Length of stay, Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months",
            "probability": 0.0004067090368490345,
            "start_logit": -2.8023180961608887,
            "end_logit": 4.974130630493164
        },
        {
            "text": "Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months",
            "probability": 0.0002731652845415777,
            "start_logit": -3.2003390789031982,
            "end_logit": 4.974130630493164
        },
        {
            "text": "Length of stay,",
            "probability": 0.00026495795532511027,
            "start_logit": 4.734106540679932,
            "end_logit": -2.99082088470459
        },
        {
            "text": "4 parameters: Length of stay, Acuity of admission, Comorbidity, and Emergency visits",
            "probability": 0.00020526106824111107,
            "start_logit": -1.7317079305648804,
            "end_logit": 3.219705104827881
        },
        {
            "text": "a simple tool with 4 parameters: Length of stay, Acuity of admission, Comorbidity, and Emergency visits",
            "probability": 0.00020144454318278006,
            "start_logit": -1.7504764795303345,
            "end_logit": 3.219705104827881
        },
        {
            "text": "parameters: Length of stay, Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months",
            "probability": 0.00020089012644643797,
            "start_logit": -3.507658004760742,
            "end_logit": 4.974130630493164
        },
        {
            "text": "Length of stay, Acuity of admission, Comorbidity, and Emergency",
            "probability": 0.00018741901764784272,
            "start_logit": 4.734106540679932,
            "end_logit": -3.337045192718506
        },
        {
            "text": "with 4 parameters: Length of stay, Acuity of admission, Comorbidity, and Emergency visits in the previous 6 months",
            "probability": 0.00016049766631749153,
            "start_logit": -3.7321367263793945,
            "end_logit": 4.974130630493164
        },
        {
            "text": "",
            "probability": 2.0182168753412568e-06,
            "start_logit": -1.3909938335418701,
            "end_logit": -1.743077278137207
        }
    ],
    "5e2b109cfbd6abf43b000002_002": [
        {
            "text": "length of stay, acuity of admission, co-morbidities, and emergency department visits",
            "probability": 0.3697161279346482,
            "start_logit": 3.7969744205474854,
            "end_logit": 1.2562941312789917
        },
        {
            "text": "length of stay, acuity of admission, co-morbidities",
            "probability": 0.2364461818422432,
            "start_logit": 3.7969744205474854,
            "end_logit": 0.8092792630195618
        },
        {
            "text": "length of stay, acuity of admission, co-morbidities, and emergency department visits within the last 6 months",
            "probability": 0.21050441857946342,
            "start_logit": 3.7969744205474854,
            "end_logit": 0.6930652856826782
        },
        {
            "text": "length of stay, acuity of admission",
            "probability": 0.06789461874486456,
            "start_logit": 3.7969744205474854,
            "end_logit": -0.4384845793247223
        },
        {
            "text": "length of stay, acuity of admission, co-morbidities, and emergency department visits within the last 6 months)",
            "probability": 0.032791511020483555,
            "start_logit": 3.7969744205474854,
            "end_logit": -1.166271686553955
        },
        {
            "text": "(length of stay, acuity of admission, co-morbidities, and emergency department visits",
            "probability": 0.020557697960989146,
            "start_logit": 0.9074743986129761,
            "end_logit": 1.2562941312789917
        },
        {
            "text": "(length of stay, acuity of admission, co-morbidities",
            "probability": 0.01314735501936544,
            "start_logit": 0.9074743986129761,
            "end_logit": 0.8092792630195618
        },
        {
            "text": "(length of stay, acuity of admission, co-morbidities, and emergency department visits within the last 6 months",
            "probability": 0.011704889047672752,
            "start_logit": 0.9074743986129761,
            "end_logit": 0.6930652856826782
        },
        {
            "text": "length of stay",
            "probability": 0.010201149145594007,
            "start_logit": 3.7969744205474854,
            "end_logit": -2.3339409828186035
        },
        {
            "text": "All patients admitted with a principal diagnosis of COPD to Liverpool Hospital",
            "probability": 0.008389280263092864,
            "start_logit": 1.1792261600494385,
            "end_logit": 0.08826163411140442
        },
        {
            "text": "length of stay, acuity of admission, co-morbidities, and emergency department",
            "probability": 0.00406704744652091,
            "start_logit": 3.7969744205474854,
            "end_logit": -3.2535240650177
        },
        {
            "text": "(length of stay, acuity of admission",
            "probability": 0.003775212818360347,
            "start_logit": 0.9074743986129761,
            "end_logit": -0.4384845793247223
        },
        {
            "text": "",
            "probability": 0.0026870447165527884,
            "start_logit": 0.9530918002128601,
            "end_logit": -0.8241167664527893
        },
        {
            "text": "All patients admitted with a principal diagnosis of COPD",
            "probability": 0.002156177630404454,
            "start_logit": 1.1792261600494385,
            "end_logit": -1.2703560590744019
        },
        {
            "text": "(length of stay, acuity of admission, co-morbidities, and emergency department visits within the last 6 months)",
            "probability": 0.0018233393901677627,
            "start_logit": 0.9074743986129761,
            "end_logit": -1.166271686553955
        },
        {
            "text": "patients admitted with a principal diagnosis of COPD to Liverpool Hospital",
            "probability": 0.001345668735543433,
            "start_logit": -0.6508374810218811,
            "end_logit": 0.08826163411140442
        },
        {
            "text": "All patients admitted with a principal diagnosis of COPD to Liverpool Hospital, a tertiary hospital",
            "probability": 0.0009898215216650615,
            "start_logit": 1.1792261600494385,
            "end_logit": -2.0489237308502197
        },
        {
            "text": "All patients admitted with a principal diagnosis of COPD to Liverpool Hospital, a tertiary hospital in Sydney, Australia, between 2006 and 2016",
            "probability": 0.0006266034388036948,
            "start_logit": 1.1792261600494385,
            "end_logit": -2.506134510040283
        },
        {
            "text": "Methods: All patients admitted with a principal diagnosis of COPD to Liverpool Hospital",
            "probability": 0.0006086299807127862,
            "start_logit": -1.4442733526229858,
            "end_logit": 0.08826163411140442
        },
        {
            "text": "(length of stay",
            "probability": 0.0005672247628515499,
            "start_logit": 0.9074743986129761,
            "end_logit": -2.3339409828186035
        }
    ],
    "5e2b109cfbd6abf43b000002_003": [
        {
            "text": "high risk of early readmission",
            "probability": 0.47994481072942785,
            "start_logit": 5.404548645019531,
            "end_logit": 4.177067279815674
        },
        {
            "text": "high risk of early readmission (\u226430 days postdischarge)",
            "probability": 0.41919357799349255,
            "start_logit": 5.404548645019531,
            "end_logit": 4.041728973388672
        },
        {
            "text": "high risk of early readmission (\u226430 days postdischarge),",
            "probability": 0.03971184710724108,
            "start_logit": 5.404548645019531,
            "end_logit": 1.6850457191467285
        },
        {
            "text": "high risk of early readmission (\u226430 days postdischarge",
            "probability": 0.023985362202063334,
            "start_logit": 5.404548645019531,
            "end_logit": 1.1808398962020874
        },
        {
            "text": "Charlson Comorbidity Index, emergency department visits in the past 6 months) index would identify high risk of early readmission",
            "probability": 0.008528535932405872,
            "start_logit": 1.3742952346801758,
            "end_logit": 4.177067279815674
        },
        {
            "text": "emergency department visits in the past 6 months) index would identify high risk of early readmission",
            "probability": 0.0030714582259105433,
            "start_logit": 0.3530299663543701,
            "end_logit": 4.177067279815674
        },
        {
            "text": "early readmission",
            "probability": 0.002971776254653721,
            "start_logit": 0.3200373649597168,
            "end_logit": 4.177067279815674
        },
        {
            "text": "emergency department visits in the past 6 months) index would identify high risk of early readmission (\u226430 days postdischarge)",
            "probability": 0.0026826742046031677,
            "start_logit": 0.3530299663543701,
            "end_logit": 4.041728973388672
        },
        {
            "text": "early readmission (\u226430 days postdischarge)",
            "probability": 0.0025956099395909368,
            "start_logit": 0.3200373649597168,
            "end_logit": 4.041728973388672
        },
        {
            "text": "length of stay, acuity of admission, Charlson Comorbidity Index",
            "probability": 0.0025208035160913804,
            "start_logit": 2.612039804458618,
            "end_logit": 1.7204827070236206
        },
        {
            "text": "\u226430 days postdischarge)",
            "probability": 0.001974194566687162,
            "start_logit": 0.04637633264064789,
            "end_logit": 4.041728973388672
        },
        {
            "text": "identify high risk of early readmission",
            "probability": 0.0018069382164066837,
            "start_logit": -0.17748865485191345,
            "end_logit": 4.177067279815674
        },
        {
            "text": "length of stay, acuity of admission",
            "probability": 0.0016828631522454976,
            "start_logit": 2.612039804458618,
            "end_logit": 1.3164016008377075
        },
        {
            "text": "index would identify high risk of early readmission",
            "probability": 0.0016687637894486984,
            "start_logit": -0.2570393681526184,
            "end_logit": 4.177067279815674
        },
        {
            "text": "identify high risk of early readmission (\u226430 days postdischarge)",
            "probability": 0.0015782166599478435,
            "start_logit": -0.17748865485191345,
            "end_logit": 4.041728973388672
        },
        {
            "text": "index would identify high risk of early readmission (\u226430 days postdischarge)",
            "probability": 0.0014575322997279927,
            "start_logit": -0.2570393681526184,
            "end_logit": 4.041728973388672
        },
        {
            "text": "high risk",
            "probability": 0.0013779283712527235,
            "start_logit": 5.404548645019531,
            "end_logit": -1.6760226488113403
        },
        {
            "text": "high risk of early readmission (",
            "probability": 0.0012907705437227236,
            "start_logit": 5.404548645019531,
            "end_logit": -1.7413644790649414
        },
        {
            "text": "length of stay, acuity of admission, Charlson Comorbidity Index, emergency department visits in the past 6 months",
            "probability": 0.0011296121296533888,
            "start_logit": 2.612039804458618,
            "end_logit": 0.9177793264389038
        },
        {
            "text": "high risk of early readmission (\u226430 days postdischarge), and",
            "probability": 0.0008267208446179048,
            "start_logit": 5.404548645019531,
            "end_logit": -2.186892032623291
        },
        {
            "text": "",
            "probability": 3.32080872840432e-09,
            "start_logit": -4.379769325256348,
            "end_logit": -4.827588081359863
        }
    ],
    "5e2b109cfbd6abf43b000002_004": [
        {
            "text": "number of ED visits within six months",
            "probability": 0.561686126599132,
            "start_logit": 2.589528799057007,
            "end_logit": 3.4895777702331543
        },
        {
            "text": "Charlson Comorbidity Index and number of ED visits within six months",
            "probability": 0.24053558684258028,
            "start_logit": 1.7414536476135254,
            "end_logit": 3.4895777702331543
        },
        {
            "text": "Charlson Comorbidity Index",
            "probability": 0.03504881510830783,
            "start_logit": 1.7414536476135254,
            "end_logit": 1.5634515285491943
        },
        {
            "text": "number of ED visits within six months (LACE) and Patients At Risk of Hospital Readmission (PARR)",
            "probability": 0.031115911699643825,
            "start_logit": 2.589528799057007,
            "end_logit": 0.5963538885116577
        },
        {
            "text": "number of ED visits within six months (LACE) and Patients At Risk of Hospital Readmission (PARR) using New Zealand hospital admissions",
            "probability": 0.027726772349123123,
            "start_logit": 2.589528799057007,
            "end_logit": 0.4810330271720886
        },
        {
            "text": "number of ED visits within six months (LACE) and Patients At Risk of Hospital Readmission (PARR) using New Zealand hospital admissions.",
            "probability": 0.023417090258927995,
            "start_logit": 2.589528799057007,
            "end_logit": 0.31210067868232727
        },
        {
            "text": "Charlson Comorbidity Index and number of ED visits within six months (LACE) and Patients At Risk of Hospital Readmission (PARR)",
            "probability": 0.01332502927592747,
            "start_logit": 1.7414536476135254,
            "end_logit": 0.5963538885116577
        },
        {
            "text": "number of ED visits within six months (LACE) and Patients At Risk of Hospital Readmission",
            "probability": 0.009951890037295305,
            "start_logit": 2.589528799057007,
            "end_logit": -0.5436029434204102
        },
        {
            "text": "Patients At Risk of Hospital Readmission (PARR)",
            "probability": 0.008978986513326324,
            "start_logit": 1.3466964960098267,
            "end_logit": 0.5963538885116577
        },
        {
            "text": "Patients At Risk of Hospital Readmission (PARR) using New Zealand hospital admissions",
            "probability": 0.008000996962068624,
            "start_logit": 1.3466964960098267,
            "end_logit": 0.4810330271720886
        },
        {
            "text": "Patients At Risk of Hospital Readmission (PARR) using New Zealand hospital admissions.",
            "probability": 0.006757370301274718,
            "start_logit": 1.3466964960098267,
            "end_logit": 0.31210067868232727
        },
        {
            "text": "number of ED visits within six months (LACE",
            "probability": 0.0057610731000084705,
            "start_logit": 2.589528799057007,
            "end_logit": -1.0902416706085205
        },
        {
            "text": "(days), Acute (emergent) admission, Charlson Comorbidity Index and number of ED visits within six months",
            "probability": 0.005749875853238566,
            "start_logit": -1.9922361373901367,
            "end_logit": 3.4895777702331543
        },
        {
            "text": "ED visits within six months",
            "probability": 0.004305502243096466,
            "start_logit": -2.2815206050872803,
            "end_logit": 3.4895777702331543
        },
        {
            "text": "Charlson Comorbidity Index and number of ED visits within six months (LACE) and Patients At Risk of Hospital Readmission",
            "probability": 0.004261781797616068,
            "start_logit": 1.7414536476135254,
            "end_logit": -0.5436029434204102
        },
        {
            "text": "number of ED visits",
            "probability": 0.003085739115378033,
            "start_logit": 2.589528799057007,
            "end_logit": -1.7145742177963257
        },
        {
            "text": "Patients At Risk of Hospital Readmission",
            "probability": 0.00287177464988127,
            "start_logit": 1.3466964960098267,
            "end_logit": -0.5436029434204102
        },
        {
            "text": "Length of stay (days), Acute (emergent) admission, Charlson Comorbidity Index and number of ED visits within six months",
            "probability": 0.00281441148800686,
            "start_logit": -2.7066612243652344,
            "end_logit": 3.4895777702331543
        },
        {
            "text": "Charlson Comorbidity Index and number of ED visits within six months (LACE",
            "probability": 0.002467112918283858,
            "start_logit": 1.7414536476135254,
            "end_logit": -1.0902416706085205
        },
        {
            "text": "Readmission - Length of stay (days), Acute (emergent) admission, Charlson Comorbidity Index",
            "probability": 0.0016345330721277628,
            "start_logit": -1.3239309787750244,
            "end_logit": 1.5634515285491943
        },
        {
            "text": "",
            "probability": 0.0005036198147551096,
            "start_logit": -0.7223846316337585,
            "end_logit": -0.21538563072681427
        }
    ],
    "5e2b109cfbd6abf43b000002_005": [
        {
            "text": "Length of stay, Acute/emergent admission, Charlson comorbidity index score, Emergency department visits in previous 6 months",
            "probability": 0.45939484970621164,
            "start_logit": 4.263460159301758,
            "end_logit": 5.675809383392334
        },
        {
            "text": "(Length of stay, Acute/emergent admission, Charlson comorbidity index score, Emergency department visits in previous 6 months",
            "probability": 0.14290151226799674,
            "start_logit": 3.09570574760437,
            "end_logit": 5.675809383392334
        },
        {
            "text": "Length of stay, Acute/emergent admission, Charlson comorbidity index score",
            "probability": 0.10809069150436368,
            "start_logit": 4.263460159301758,
            "end_logit": 4.228869915008545
        },
        {
            "text": "Length of stay, Acute/emergent admission",
            "probability": 0.0690657281543877,
            "start_logit": 4.263460159301758,
            "end_logit": 3.7809579372406006
        },
        {
            "text": "Length of stay, Acute/emergent admission, Charlson comorbidity index score, Emergency department visits in previous 6 months)",
            "probability": 0.041034278134941246,
            "start_logit": 4.263460159301758,
            "end_logit": 3.2603070735931396
        },
        {
            "text": "(Length of stay, Acute/emergent admission, Charlson comorbidity index score",
            "probability": 0.03362319644624919,
            "start_logit": 3.09570574760437,
            "end_logit": 4.228869915008545
        },
        {
            "text": "Charlson comorbidity index score, Emergency department visits in previous 6 months",
            "probability": 0.03206250683934971,
            "start_logit": 1.601237416267395,
            "end_logit": 5.675809383392334
        },
        {
            "text": "Emergency department visits in previous 6 months",
            "probability": 0.02469186985128175,
            "start_logit": 1.3400241136550903,
            "end_logit": 5.675809383392334
        },
        {
            "text": "(Length of stay, Acute/emergent admission",
            "probability": 0.021483908680003893,
            "start_logit": 3.09570574760437,
            "end_logit": 3.7809579372406006
        },
        {
            "text": "Acute/emergent admission, Charlson comorbidity index score, Emergency department visits in previous 6 months",
            "probability": 0.014647038476755973,
            "start_logit": 0.8177882432937622,
            "end_logit": 5.675809383392334
        },
        {
            "text": "(Length of stay, Acute/emergent admission, Charlson comorbidity index score, Emergency department visits in previous 6 months)",
            "probability": 0.01276431462838276,
            "start_logit": 3.09570574760437,
            "end_logit": 3.2603070735931396
        },
        {
            "text": "Length of stay, Acute/emergent admission, Charlson comorbidity index score,",
            "probability": 0.007830856874292521,
            "start_logit": 4.263460159301758,
            "end_logit": 1.603971242904663
        },
        {
            "text": "Charlson comorbidity index score",
            "probability": 0.0075439647132418425,
            "start_logit": 1.601237416267395,
            "end_logit": 4.228869915008545
        },
        {
            "text": "Length of stay",
            "probability": 0.006287496963311587,
            "start_logit": 4.263460159301758,
            "end_logit": 1.3844623565673828
        },
        {
            "text": "Length of stay, Acute/emergent admission,",
            "probability": 0.005299079504653904,
            "start_logit": 4.263460159301758,
            "end_logit": 1.2134324312210083
        },
        {
            "text": "Acute/emergent admission, Charlson comorbidity index score",
            "probability": 0.0034462913949863715,
            "start_logit": 0.8177882432937622,
            "end_logit": 4.228869915008545
        },
        {
            "text": "Charlson comorbidity index score, Emergency department visits in previous 6 months)",
            "probability": 0.002863901987997282,
            "start_logit": 1.601237416267395,
            "end_logit": 3.2603070735931396
        },
        {
            "text": "(Length of stay, Acute/emergent admission, Charlson comorbidity index score,",
            "probability": 0.0024359029937019955,
            "start_logit": 3.09570574760437,
            "end_logit": 1.603971242904663
        },
        {
            "text": "Emergency department visits in previous 6 months)",
            "probability": 0.00220553855968831,
            "start_logit": 1.3400241136550903,
            "end_logit": 3.2603070735931396
        },
        {
            "text": "Acute/emergent admission",
            "probability": 0.0022020455352284,
            "start_logit": 0.8177882432937622,
            "end_logit": 3.7809579372406006
        },
        {
            "text": "",
            "probability": 0.0001250267829732855,
            "start_logit": 0.39581960439682007,
            "end_logit": 1.3343125581741333
        }
    ],
    "5c7a4a31d774d04240000006_001": [
        {
            "text": "",
            "probability": 0.2991830751934999,
            "start_logit": 0.017078524455428123,
            "end_logit": 0.8161620497703552
        },
        {
            "text": "conflicting data on the prognostic role",
            "probability": 0.20722123497188238,
            "start_logit": 1.2241828441619873,
            "end_logit": -0.7582109570503235
        },
        {
            "text": "conflicting data",
            "probability": 0.1228303451029516,
            "start_logit": 1.2241828441619873,
            "end_logit": -1.2811938524246216
        },
        {
            "text": "there are conflicting data on the prognostic role",
            "probability": 0.10124038197899524,
            "start_logit": 0.5078935623168945,
            "end_logit": -0.7582109570503235
        },
        {
            "text": "there are conflicting data",
            "probability": 0.06001021593429829,
            "start_logit": 0.5078935623168945,
            "end_logit": -1.2811938524246216
        },
        {
            "text": "conflicting data on the prognostic role and so far no data on the predictive role of PD-L1 gene and protein expression",
            "probability": 0.04397294976752487,
            "start_logit": 1.2241828441619873,
            "end_logit": -2.3084232807159424
        },
        {
            "text": "evaluated staining patterns",
            "probability": 0.029745975446120634,
            "start_logit": -3.1335325241088867,
            "end_logit": 1.6584112644195557
        },
        {
            "text": "antibodies, tissue sampling strategies, immunohistochemical staining protocols, cut-off definitions, and evaluated staining patterns",
            "probability": 0.026232187074379496,
            "start_logit": -3.2592391967773438,
            "end_logit": 1.6584112644195557
        },
        {
            "text": "there are conflicting data on the prognostic role and so far no data on the predictive role of PD-L1 gene and protein expression",
            "probability": 0.02148350400387997,
            "start_logit": 0.5078935623168945,
            "end_logit": -2.3084232807159424
        },
        {
            "text": "utilized antibodies, tissue sampling strategies, immunohistochemical staining protocols, cut-off definitions, and evaluated staining patterns",
            "probability": 0.021237446183031784,
            "start_logit": -3.4704604148864746,
            "end_logit": 1.6584112644195557
        },
        {
            "text": "considerable variability",
            "probability": 0.01986094375205698,
            "start_logit": 0.21605335175991058,
            "end_logit": -2.0951132774353027
        },
        {
            "text": "melanoma or non-small cell lung cancer",
            "probability": 0.013224072538788057,
            "start_logit": -2.463904619216919,
            "end_logit": 0.17812836170196533
        },
        {
            "text": "staining patterns",
            "probability": 0.010980682160209025,
            "start_logit": -4.130088806152344,
            "end_logit": 1.6584112644195557
        },
        {
            "text": "no data on the predictive role of PD-L1 gene and protein expression in glioblastoma",
            "probability": 0.005508113585982221,
            "start_logit": -3.6179232597351074,
            "end_logit": 0.4563303589820862
        },
        {
            "text": "there is considerable variability",
            "probability": 0.0050307038365600305,
            "start_logit": -1.157141923904419,
            "end_logit": -2.0951132774353027
        },
        {
            "text": "melanoma or non-small cell lung cancer, and is discussed as a potential predictive biomarker for patient selection in these tumor types",
            "probability": 0.00322498277863192,
            "start_logit": -2.463904619216919,
            "end_logit": -1.232982873916626
        },
        {
            "text": "evaluated staining patterns; (d) there are conflicting data on the prognostic role",
            "probability": 0.0026540097835609493,
            "start_logit": -3.1335325241088867,
            "end_logit": -0.7582109570503235
        },
        {
            "text": "tumors, e.g., melanoma or non-small cell lung cancer",
            "probability": 0.0025467365384380563,
            "start_logit": -4.111130714416504,
            "end_logit": 0.17812836170196533
        },
        {
            "text": "vary and range from 61 to 88%",
            "probability": 0.0019099530477212627,
            "start_logit": -3.51910138130188,
            "end_logit": -0.7016350626945496
        },
        {
            "text": "variability",
            "probability": 0.0019024863214871883,
            "start_logit": -2.129540205001831,
            "end_logit": -2.0951132774353027
        }
    ],
    "5c7a4a31d774d04240000006_002": [
        {
            "text": "",
            "probability": 0.2991830751934999,
            "start_logit": 0.017078524455428123,
            "end_logit": 0.8161620497703552
        },
        {
            "text": "conflicting data on the prognostic role",
            "probability": 0.20722123497188238,
            "start_logit": 1.2241828441619873,
            "end_logit": -0.7582109570503235
        },
        {
            "text": "conflicting data",
            "probability": 0.1228303451029516,
            "start_logit": 1.2241828441619873,
            "end_logit": -1.2811938524246216
        },
        {
            "text": "there are conflicting data on the prognostic role",
            "probability": 0.10124038197899524,
            "start_logit": 0.5078935623168945,
            "end_logit": -0.7582109570503235
        },
        {
            "text": "there are conflicting data",
            "probability": 0.06001021593429829,
            "start_logit": 0.5078935623168945,
            "end_logit": -1.2811938524246216
        },
        {
            "text": "conflicting data on the prognostic role and so far no data on the predictive role of PD-L1 gene and protein expression",
            "probability": 0.04397294976752487,
            "start_logit": 1.2241828441619873,
            "end_logit": -2.3084232807159424
        },
        {
            "text": "evaluated staining patterns",
            "probability": 0.029745975446120634,
            "start_logit": -3.1335325241088867,
            "end_logit": 1.6584112644195557
        },
        {
            "text": "antibodies, tissue sampling strategies, immunohistochemical staining protocols, cut-off definitions, and evaluated staining patterns",
            "probability": 0.026232187074379496,
            "start_logit": -3.2592391967773438,
            "end_logit": 1.6584112644195557
        },
        {
            "text": "there are conflicting data on the prognostic role and so far no data on the predictive role of PD-L1 gene and protein expression",
            "probability": 0.02148350400387997,
            "start_logit": 0.5078935623168945,
            "end_logit": -2.3084232807159424
        },
        {
            "text": "utilized antibodies, tissue sampling strategies, immunohistochemical staining protocols, cut-off definitions, and evaluated staining patterns",
            "probability": 0.021237446183031784,
            "start_logit": -3.4704604148864746,
            "end_logit": 1.6584112644195557
        },
        {
            "text": "considerable variability",
            "probability": 0.01986094375205698,
            "start_logit": 0.21605335175991058,
            "end_logit": -2.0951132774353027
        },
        {
            "text": "melanoma or non-small cell lung cancer",
            "probability": 0.013224072538788057,
            "start_logit": -2.463904619216919,
            "end_logit": 0.17812836170196533
        },
        {
            "text": "staining patterns",
            "probability": 0.010980682160209025,
            "start_logit": -4.130088806152344,
            "end_logit": 1.6584112644195557
        },
        {
            "text": "no data on the predictive role of PD-L1 gene and protein expression in glioblastoma",
            "probability": 0.005508113585982221,
            "start_logit": -3.6179232597351074,
            "end_logit": 0.4563303589820862
        },
        {
            "text": "there is considerable variability",
            "probability": 0.0050307038365600305,
            "start_logit": -1.157141923904419,
            "end_logit": -2.0951132774353027
        },
        {
            "text": "melanoma or non-small cell lung cancer, and is discussed as a potential predictive biomarker for patient selection in these tumor types",
            "probability": 0.00322498277863192,
            "start_logit": -2.463904619216919,
            "end_logit": -1.232982873916626
        },
        {
            "text": "evaluated staining patterns; (d) there are conflicting data on the prognostic role",
            "probability": 0.0026540097835609493,
            "start_logit": -3.1335325241088867,
            "end_logit": -0.7582109570503235
        },
        {
            "text": "tumors, e.g., melanoma or non-small cell lung cancer",
            "probability": 0.0025467365384380563,
            "start_logit": -4.111130714416504,
            "end_logit": 0.17812836170196533
        },
        {
            "text": "vary and range from 61 to 88%",
            "probability": 0.0019099530477212627,
            "start_logit": -3.51910138130188,
            "end_logit": -0.7016350626945496
        },
        {
            "text": "variability",
            "probability": 0.0019024863214871883,
            "start_logit": -2.129540205001831,
            "end_logit": -2.0951132774353027
        }
    ],
    "5c7a4a31d774d04240000006_003": [
        {
            "text": "multiple unresolved issues",
            "probability": 0.5907478444300144,
            "start_logit": 5.1930832862854,
            "end_logit": 4.082798957824707
        },
        {
            "text": "variable detection antibodies",
            "probability": 0.09344454747906837,
            "start_logit": 6.1580915451049805,
            "end_logit": 1.2737696170806885
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability, primary versus metastatic biopsies",
            "probability": 0.06842218043691602,
            "start_logit": 6.1580915451049805,
            "end_logit": 0.9620984792709351
        },
        {
            "text": "multiple unresolved",
            "probability": 0.04519946950974075,
            "start_logit": 5.1930832862854,
            "end_logit": 1.5124950408935547
        },
        {
            "text": "multiple unresolved issues: variable detection antibodies",
            "probability": 0.035600508677377636,
            "start_logit": 5.1930832862854,
            "end_logit": 1.2737696170806885
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability",
            "probability": 0.031301819917656876,
            "start_logit": 6.1580915451049805,
            "end_logit": 0.1800776720046997
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs",
            "probability": 0.030165617386990053,
            "start_logit": 6.1580915451049805,
            "end_logit": 0.1431042104959488
        },
        {
            "text": "multiple unresolved issues: variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability, primary versus metastatic biopsies",
            "probability": 0.026067485948446184,
            "start_logit": 5.1930832862854,
            "end_logit": 0.9620984792709351
        },
        {
            "text": "multiple unresolved issues:",
            "probability": 0.012644987378806467,
            "start_logit": 5.1930832862854,
            "end_logit": 0.23867057263851166
        },
        {
            "text": "multiple unresolved issues: variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability",
            "probability": 0.011925369020015567,
            "start_logit": 5.1930832862854,
            "end_logit": 0.1800776720046997
        },
        {
            "text": "multiple unresolved issues: variable detection antibodies, differing IHC cutoffs",
            "probability": 0.011492498519344318,
            "start_logit": 5.1930832862854,
            "end_logit": 0.1431042104959488
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability, primary versus metastatic biopsies,",
            "probability": 0.008801535269093039,
            "start_logit": 6.1580915451049805,
            "end_logit": -1.088672399520874
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation",
            "probability": 0.007182723448488954,
            "start_logit": 6.1580915451049805,
            "end_logit": -1.2919199466705322
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability,",
            "probability": 0.00579602163365952,
            "start_logit": 6.1580915451049805,
            "end_logit": -1.5064268112182617
        },
        {
            "text": "unresolved issues",
            "probability": 0.005144882450705368,
            "start_logit": 0.44969654083251953,
            "end_logit": 4.082798957824707
        },
        {
            "text": "variable detection antibodies,",
            "probability": 0.00488115849230578,
            "start_logit": 6.1580915451049805,
            "end_logit": -1.6782159805297852
        },
        {
            "text": "multiple unresolved issues: variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability, primary versus metastatic biopsies,",
            "probability": 0.0033532093757720877,
            "start_logit": 5.1930832862854,
            "end_logit": -1.088672399520874
        },
        {
            "text": "multiple unresolved issues: variable detection antibodies, differing IHC cutoffs, tissue preparation",
            "probability": 0.0027364743621067205,
            "start_logit": 5.1930832862854,
            "end_logit": -1.2919199466705322
        },
        {
            "text": "oncogenic versus induced PD-L1 expression, and staining of tumor versus immune cells",
            "probability": 0.002636744975122924,
            "start_logit": -0.8847048878669739,
            "end_logit": 4.748743057250977
        },
        {
            "text": "staining of tumor versus immune cells",
            "probability": 0.0024541528180335535,
            "start_logit": -0.9564684629440308,
            "end_logit": 4.748743057250977
        },
        {
            "text": "",
            "probability": 7.684703352478726e-07,
            "start_logit": -1.6322922706604004,
            "end_logit": -2.6443233489990234
        }
    ],
    "5c7a4a31d774d04240000006_004": [
        {
            "text": "multiple unresolved issues",
            "probability": 0.5907478444300144,
            "start_logit": 5.1930832862854,
            "end_logit": 4.082798957824707
        },
        {
            "text": "variable detection antibodies",
            "probability": 0.09344454747906837,
            "start_logit": 6.1580915451049805,
            "end_logit": 1.2737696170806885
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability, primary versus metastatic biopsies",
            "probability": 0.06842218043691602,
            "start_logit": 6.1580915451049805,
            "end_logit": 0.9620984792709351
        },
        {
            "text": "multiple unresolved",
            "probability": 0.04519946950974075,
            "start_logit": 5.1930832862854,
            "end_logit": 1.5124950408935547
        },
        {
            "text": "multiple unresolved issues: variable detection antibodies",
            "probability": 0.035600508677377636,
            "start_logit": 5.1930832862854,
            "end_logit": 1.2737696170806885
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability",
            "probability": 0.031301819917656876,
            "start_logit": 6.1580915451049805,
            "end_logit": 0.1800776720046997
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs",
            "probability": 0.030165617386990053,
            "start_logit": 6.1580915451049805,
            "end_logit": 0.1431042104959488
        },
        {
            "text": "multiple unresolved issues: variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability, primary versus metastatic biopsies",
            "probability": 0.026067485948446184,
            "start_logit": 5.1930832862854,
            "end_logit": 0.9620984792709351
        },
        {
            "text": "multiple unresolved issues:",
            "probability": 0.012644987378806467,
            "start_logit": 5.1930832862854,
            "end_logit": 0.23867057263851166
        },
        {
            "text": "multiple unresolved issues: variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability",
            "probability": 0.011925369020015567,
            "start_logit": 5.1930832862854,
            "end_logit": 0.1800776720046997
        },
        {
            "text": "multiple unresolved issues: variable detection antibodies, differing IHC cutoffs",
            "probability": 0.011492498519344318,
            "start_logit": 5.1930832862854,
            "end_logit": 0.1431042104959488
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability, primary versus metastatic biopsies,",
            "probability": 0.008801535269093039,
            "start_logit": 6.1580915451049805,
            "end_logit": -1.088672399520874
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation",
            "probability": 0.007182723448488954,
            "start_logit": 6.1580915451049805,
            "end_logit": -1.2919199466705322
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability,",
            "probability": 0.00579602163365952,
            "start_logit": 6.1580915451049805,
            "end_logit": -1.5064268112182617
        },
        {
            "text": "unresolved issues",
            "probability": 0.005144882450705368,
            "start_logit": 0.44969654083251953,
            "end_logit": 4.082798957824707
        },
        {
            "text": "variable detection antibodies,",
            "probability": 0.00488115849230578,
            "start_logit": 6.1580915451049805,
            "end_logit": -1.6782159805297852
        },
        {
            "text": "multiple unresolved issues: variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability, primary versus metastatic biopsies,",
            "probability": 0.0033532093757720877,
            "start_logit": 5.1930832862854,
            "end_logit": -1.088672399520874
        },
        {
            "text": "multiple unresolved issues: variable detection antibodies, differing IHC cutoffs, tissue preparation",
            "probability": 0.0027364743621067205,
            "start_logit": 5.1930832862854,
            "end_logit": -1.2919199466705322
        },
        {
            "text": "oncogenic versus induced PD-L1 expression, and staining of tumor versus immune cells",
            "probability": 0.002636744975122924,
            "start_logit": -0.8847048878669739,
            "end_logit": 4.748743057250977
        },
        {
            "text": "staining of tumor versus immune cells",
            "probability": 0.0024541528180335535,
            "start_logit": -0.9564684629440308,
            "end_logit": 4.748743057250977
        },
        {
            "text": "",
            "probability": 7.684703352478726e-07,
            "start_logit": -1.6322922706604004,
            "end_logit": -2.6443233489990234
        }
    ],
    "5c7a4a31d774d04240000006_005": [
        {
            "text": "PD-L1 expression is just one of many variables that may affect response to PD-1 blockade",
            "probability": 0.22571016617670356,
            "start_logit": -0.2136509269475937,
            "end_logit": 1.4847549200057983
        },
        {
            "text": "researchers say that PD-L1 expression is just one of many variables that may affect response to PD-1 blockade",
            "probability": 0.21661702729672794,
            "start_logit": -0.25477170944213867,
            "end_logit": 1.4847549200057983
        },
        {
            "text": "PD-L1 expression is just one of many variables that may affect response to PD-1 blockade.",
            "probability": 0.09760683909491032,
            "start_logit": -0.2136509269475937,
            "end_logit": 0.6464507579803467
        },
        {
            "text": "researchers say that PD-L1 expression is just one of many variables that may affect response to PD-1 blockade.",
            "probability": 0.09367457251356986,
            "start_logit": -0.25477170944213867,
            "end_logit": 0.6464507579803467
        },
        {
            "text": "that PD-L1 expression is just one of many variables that may affect response to PD-1 blockade",
            "probability": 0.0925846323691441,
            "start_logit": -1.1047794818878174,
            "end_logit": 1.4847549200057983
        },
        {
            "text": "Increasingly, researchers say that PD-L1 expression is just one of many variables that may affect response to PD-1 blockade",
            "probability": 0.04047206485179037,
            "start_logit": -1.9322906732559204,
            "end_logit": 1.4847549200057983
        },
        {
            "text": "that PD-L1 expression is just one of many variables that may affect response to PD-1 blockade.",
            "probability": 0.04003759984493427,
            "start_logit": -1.1047794818878174,
            "end_logit": 0.6464507579803467
        },
        {
            "text": "one of many variables that may affect response to PD-1 blockade",
            "probability": 0.027133034070118228,
            "start_logit": -2.33215069770813,
            "end_logit": 1.4847549200057983
        },
        {
            "text": "just one of many variables that may affect response to PD-1 blockade",
            "probability": 0.021053763971268923,
            "start_logit": -2.5858232975006104,
            "end_logit": 1.4847549200057983
        },
        {
            "text": "variables that may affect response to PD-1 blockade",
            "probability": 0.019598054097652834,
            "start_logit": -2.6574723720550537,
            "end_logit": 1.4847549200057983
        },
        {
            "text": "",
            "probability": 0.01832742932084436,
            "start_logit": -0.8182138800621033,
            "end_logit": -0.42153504490852356
        },
        {
            "text": "Increasingly, researchers say that PD-L1 expression is just one of many variables that may affect response to PD-1 blockade.",
            "probability": 0.017501871487413796,
            "start_logit": -1.9322906732559204,
            "end_logit": 0.6464507579803467
        },
        {
            "text": "it is not clear whether expression of the ligand PD-L1 is a biomarker for response",
            "probability": 0.01593825448855229,
            "start_logit": 0.17576701939105988,
            "end_logit": -1.5551925897598267
        },
        {
            "text": "many variables that may affect response to PD-1 blockade",
            "probability": 0.01569578570599052,
            "start_logit": -2.8795104026794434,
            "end_logit": 1.4847549200057983
        },
        {
            "text": "one of many variables that may affect response to PD-1 blockade.",
            "probability": 0.011733497588962824,
            "start_logit": -2.33215069770813,
            "end_logit": 0.6464507579803467
        },
        {
            "text": "may affect response to PD-1 blockade",
            "probability": 0.00992050054497178,
            "start_logit": -3.33829927444458,
            "end_logit": 1.4847549200057983
        },
        {
            "text": "PD-L1 expression is just one of many variables",
            "probability": 0.009601048745923314,
            "start_logit": -0.2136509269475937,
            "end_logit": -1.6726244688034058
        },
        {
            "text": "researchers say that PD-L1 expression is just one of many variables",
            "probability": 0.009214253276676491,
            "start_logit": -0.25477170944213867,
            "end_logit": -1.6726244688034058
        },
        {
            "text": "just one of many variables that may affect response to PD-1 blockade.",
            "probability": 0.009104558235436582,
            "start_logit": -2.5858232975006104,
            "end_logit": 0.6464507579803467
        },
        {
            "text": "variables that may affect response to PD-1 blockade.",
            "probability": 0.008475046318407196,
            "start_logit": -2.6574723720550537,
            "end_logit": 0.6464507579803467
        }
    ],
    "5c7a4a31d774d04240000006_006": [
        {
            "text": "composition\u00a0and\u00a0amount\u00a0of inflammatory cells",
            "probability": 0.37154220079824757,
            "start_logit": 3.1293458938598633,
            "end_logit": 2.910127878189087
        },
        {
            "text": "composition\u00a0and\u00a0amount\u00a0of inflammatory cells in the tumor microenvironment and their functional status.",
            "probability": 0.33660935290870353,
            "start_logit": 3.1293458938598633,
            "end_logit": 2.8113884925842285
        },
        {
            "text": "many patients considered PD-L1-negative experience a benefit from treatment",
            "probability": 0.09141031072260074,
            "start_logit": 2.657768487930298,
            "end_logit": 1.9794011116027832
        },
        {
            "text": "the composition\u00a0and\u00a0amount\u00a0of inflammatory cells",
            "probability": 0.05583432854633877,
            "start_logit": 1.2340723276138306,
            "end_logit": 2.910127878189087
        },
        {
            "text": "the composition\u00a0and\u00a0amount\u00a0of inflammatory cells in the tumor microenvironment and their functional status.",
            "probability": 0.05058471732604242,
            "start_logit": 1.2340723276138306,
            "end_logit": 2.8113884925842285
        },
        {
            "text": "composition\u00a0and\u00a0amount\u00a0of inflammatory cells in the tumor microenvironment",
            "probability": 0.027419584560188046,
            "start_logit": 3.1293458938598633,
            "end_logit": 0.30372294783592224
        },
        {
            "text": "patients considered PD-L1-negative experience a benefit from treatment",
            "probability": 0.02171572425052398,
            "start_logit": 1.2204468250274658,
            "end_logit": 1.9794011116027832
        },
        {
            "text": "many patients considered PD-L1-negative experience a benefit from treatment.",
            "probability": 0.018351343544914033,
            "start_logit": 2.657768487930298,
            "end_logit": 0.3737456202507019
        },
        {
            "text": "patients considered PD-L1-negative experience a benefit from treatment.",
            "probability": 0.0043596035600112675,
            "start_logit": 1.2204468250274658,
            "end_logit": 0.3737456202507019
        },
        {
            "text": "the composition\u00a0and\u00a0amount\u00a0of inflammatory cells in the tumor microenvironment",
            "probability": 0.0041205389041902825,
            "start_logit": 1.2340723276138306,
            "end_logit": 0.30372294783592224
        },
        {
            "text": "histopathologic\u00a0features,\u00a0such as the composition\u00a0and\u00a0amount\u00a0of inflammatory cells",
            "probability": 0.0038642043846410282,
            "start_logit": -1.4365607500076294,
            "end_logit": 2.910127878189087
        },
        {
            "text": "histopathologic\u00a0features,\u00a0such as the composition\u00a0and\u00a0amount\u00a0of inflammatory cells in the tumor microenvironment and their functional status.",
            "probability": 0.0035008872064234337,
            "start_logit": -1.4365607500076294,
            "end_logit": 2.8113884925842285
        },
        {
            "text": "inflammatory cells",
            "probability": 0.002245715473379481,
            "start_logit": -1.979292392730713,
            "end_logit": 2.910127878189087
        },
        {
            "text": "inflammatory cells in the tumor microenvironment and their functional status",
            "probability": 0.002034570583603259,
            "start_logit": -1.979292392730713,
            "end_logit": 2.8113884925842285
        },
        {
            "text": "",
            "probability": 0.0018714654530347995,
            "start_logit": 0.6379240155220032,
            "end_logit": 0.11060909181833267
        },
        {
            "text": "composition\u00a0and\u00a0amount\u00a0of",
            "probability": 0.0013596650894262014,
            "start_logit": 3.1293458938598633,
            "end_logit": -2.70029616355896
        },
        {
            "text": "composition\u00a0and\u00a0amount\u00a0of inflammatory cells in the tumor microenvironment and their functional status. Multi-parameter quantitative or semi-quantitative algorithms",
            "probability": 0.0011340955828375565,
            "start_logit": 3.1293458938598633,
            "end_logit": -2.8816990852355957
        },
        {
            "text": "functional status",
            "probability": 0.0007528521929304635,
            "start_logit": -2.973463535308838,
            "end_logit": 2.8113884925842285
        },
        {
            "text": "other biomarkers or histopathologic\u00a0features,\u00a0such as the composition\u00a0and\u00a0amount\u00a0of inflammatory cells",
            "probability": 0.0006942983239358639,
            "start_logit": -3.153170108795166,
            "end_logit": 2.910127878189087
        },
        {
            "text": "especially since many patients considered PD-L1-negative experience a benefit from treatment",
            "probability": 0.0005945405880272777,
            "start_logit": -2.377556085586548,
            "end_logit": 1.9794011116027832
        }
    ],
    "5c7a4a31d774d04240000006_007": [
        {
            "text": "heterogeneity",
            "probability": 0.45079880190773325,
            "start_logit": 2.5134308338165283,
            "end_logit": 2.1411266326904297
        },
        {
            "text": "heterogeneity in methodologies of PD-L1 assays in terms of primary antibodies and scoring algorithms",
            "probability": 0.20499915928235957,
            "start_logit": 2.5134308338165283,
            "end_logit": 1.3531113862991333
        },
        {
            "text": "heterogeneity in methodologies",
            "probability": 0.08438720558946265,
            "start_logit": 2.5134308338165283,
            "end_logit": 0.46552130579948425
        },
        {
            "text": "higher response rate and overall survival",
            "probability": 0.057812475837777745,
            "start_logit": 2.1545419692993164,
            "end_logit": 0.446198970079422
        },
        {
            "text": "tumor heterogenity for PD-L1 expression are important issues to be considered",
            "probability": 0.051843868196740174,
            "start_logit": 1.4673963785171509,
            "end_logit": 1.024376630783081
        },
        {
            "text": "tumor heterogenity for PD-L1 expression",
            "probability": 0.04691426088332017,
            "start_logit": 1.4673963785171509,
            "end_logit": 0.9244616627693176
        },
        {
            "text": "higher response rate",
            "probability": 0.02197070468061446,
            "start_logit": 2.1545419692993164,
            "end_logit": -0.5212956666946411
        },
        {
            "text": "higher response rate and overall survival in several clinical trials",
            "probability": 0.02178964785818568,
            "start_logit": 2.1545419692993164,
            "end_logit": -0.5295706391334534
        },
        {
            "text": "heterogeneity in methodologies of PD-L1 assays in terms of primary antibodies and scoring algorithms, and tumor heterogenity",
            "probability": 0.01400456738000251,
            "start_logit": 2.5134308338165283,
            "end_logit": -1.3305109739303589
        },
        {
            "text": "higher response rate and overall survival in several clinical trials evaluating anti-PD-1 and anti-PD-L1 monoclonal antibodies",
            "probability": 0.00910256622969678,
            "start_logit": 2.1545419692993164,
            "end_logit": -1.4024492502212524
        },
        {
            "text": "heterogeneity in methodologies of PD-L1 assays",
            "probability": 0.00603659410245728,
            "start_logit": 2.5134308338165283,
            "end_logit": -2.1720545291900635
        },
        {
            "text": "tumor heterogenity for PD-L1 expression are important issues to be considered.",
            "probability": 0.005645079384883789,
            "start_logit": 1.4673963785171509,
            "end_logit": -1.1930757761001587
        },
        {
            "text": "tumor heterogenity",
            "probability": 0.004920199421654894,
            "start_logit": 1.4673963785171509,
            "end_logit": -1.3305109739303589
        },
        {
            "text": "",
            "probability": 0.004039933803750693,
            "start_logit": 0.3606269061565399,
            "end_logit": -0.42086225748062134
        },
        {
            "text": "heterogeneity in methodologies of PD-L1 assays in terms of primary antibodies",
            "probability": 0.003615590814065462,
            "start_logit": 2.5134308338165283,
            "end_logit": -2.6846392154693604
        },
        {
            "text": "higher response rate and overall survival in several clinical trials evaluating anti-PD-1 and anti-PD-L1 monoclonal antibodies.",
            "probability": 0.003542267341698093,
            "start_logit": 2.1545419692993164,
            "end_logit": -2.346238613128662
        },
        {
            "text": "heterogeneity in methodologies of PD-L1 assays in terms of primary antibodies and scoring algorithms,",
            "probability": 0.0031627145366591764,
            "start_logit": 2.5134308338165283,
            "end_logit": -2.8184638023376465
        },
        {
            "text": "tumor heterogenity for PD-L1 expression are important issues to be considered. More studies are required to compare the different assays",
            "probability": 0.0022069750902316823,
            "start_logit": 1.4673963785171509,
            "end_logit": -2.132237195968628
        },
        {
            "text": "tumor heterogenity for PD-L1 expression are important issues",
            "probability": 0.0017303395037569333,
            "start_logit": 1.4673963785171509,
            "end_logit": -2.375542402267456
        },
        {
            "text": "primary antibodies and scoring algorithms",
            "probability": 0.0014770481549489117,
            "start_logit": -2.419529438018799,
            "end_logit": 1.3531113862991333
        }
    ],
    "5c7a4a31d774d04240000006_008": [
        {
            "text": "PD-L1 overexpression could not be currently considered a robust biomarker to tailor the immune checkpoint inhibitors treatment",
            "probability": 0.46516899492533886,
            "start_logit": 3.6720187664031982,
            "end_logit": 1.7276748418807983
        },
        {
            "text": "PD-L1 overexpression could not be currently considered a robust biomarker to tailor the immune checkpoint inhibitors treatment.",
            "probability": 0.2767100622584891,
            "start_logit": 3.6720187664031982,
            "end_logit": 1.2082443237304688
        },
        {
            "text": "",
            "probability": 0.12363733484600345,
            "start_logit": 3.0008339881896973,
            "end_logit": 1.073811411857605
        },
        {
            "text": "PD-L1 overexpression",
            "probability": 0.0648640809836215,
            "start_logit": 3.6720187664031982,
            "end_logit": -0.2424319088459015
        },
        {
            "text": "PD-L1 overexpression could not be currently considered a robust biomarker",
            "probability": 0.02595697370677011,
            "start_logit": 3.6720187664031982,
            "end_logit": -1.1582856178283691
        },
        {
            "text": "could not be currently considered a robust biomarker to tailor the immune checkpoint inhibitors treatment",
            "probability": 0.008150659242384862,
            "start_logit": -0.3722831904888153,
            "end_logit": 1.7276748418807983
        },
        {
            "text": "PD-L1 overexpression could not be currently considered a robust biomarker to tailor the immune checkpoint inhibitors",
            "probability": 0.0077135198909656835,
            "start_logit": 3.6720187664031982,
            "end_logit": -2.371751308441162
        },
        {
            "text": "could not be currently considered a robust biomarker to tailor the immune checkpoint inhibitors treatment.",
            "probability": 0.004848494742797805,
            "start_logit": -0.3722831904888153,
            "end_logit": 1.2082443237304688
        },
        {
            "text": "overexpression could not be currently considered a robust biomarker to tailor the immune checkpoint inhibitors treatment",
            "probability": 0.0040431335004946604,
            "start_logit": -1.0733619928359985,
            "end_logit": 1.7276748418807983
        },
        {
            "text": "to tailor the immune checkpoint inhibitors treatment",
            "probability": 0.003406331122465583,
            "start_logit": -1.244746208190918,
            "end_logit": 1.7276748418807983
        },
        {
            "text": "PD-L1 overexpression could not be currently considered a robust",
            "probability": 0.0030848444371161803,
            "start_logit": 3.6720187664031982,
            "end_logit": -3.288224697113037
        },
        {
            "text": "overexpression could not be currently considered a robust biomarker to tailor the immune checkpoint inhibitors treatment.",
            "probability": 0.0024050952123772294,
            "start_logit": -1.0733619928359985,
            "end_logit": 1.2082443237304688
        },
        {
            "text": "to tailor the immune checkpoint inhibitors treatment.",
            "probability": 0.0020262874509118247,
            "start_logit": -1.244746208190918,
            "end_logit": 1.2082443237304688
        },
        {
            "text": "PD-L1 overexpression could not",
            "probability": 0.0019320541980041676,
            "start_logit": 3.6720187664031982,
            "end_logit": -3.7561421394348145
        },
        {
            "text": "PD-L1 overexpression could not be currently considered",
            "probability": 0.0016981314959919989,
            "start_logit": 3.6720187664031982,
            "end_logit": -3.885197401046753
        },
        {
            "text": "PD-L1 overexpression could not be currently considered a robust biomarker to tailor",
            "probability": 0.0015841981600076954,
            "start_logit": 3.6720187664031982,
            "end_logit": -3.9546475410461426
        },
        {
            "text": "PD-L1",
            "probability": 0.0010100457306021307,
            "start_logit": 3.6720187664031982,
            "end_logit": -4.404730319976807
        },
        {
            "text": "immune checkpoint inhibitors treatment",
            "probability": 0.0006640563452350297,
            "start_logit": -2.879770278930664,
            "end_logit": 1.7276748418807983
        },
        {
            "text": "overexpression",
            "probability": 0.0005637824998327143,
            "start_logit": -1.0733619928359985,
            "end_logit": -0.2424319088459015
        },
        {
            "text": "PD-L1 overexpression could not be currently considered a robust biomarker to tailor the immune",
            "probability": 0.0005319192505888535,
            "start_logit": 3.6720187664031982,
            "end_logit": -5.045989513397217
        }
    ],
    "5c7a4a31d774d04240000006_009": [
        {
            "text": "many patients with NSCLC",
            "probability": 0.4718971288882874,
            "start_logit": 3.3349506855010986,
            "end_logit": 0.04174176603555679
        },
        {
            "text": "many patients with NSCLC fail to respond",
            "probability": 0.29012008606843215,
            "start_logit": 3.3349506855010986,
            "end_logit": -0.44472432136535645
        },
        {
            "text": "many patients with NSCLC fail to respond to anti-PD-1/PD-L1",
            "probability": 0.1414064021929344,
            "start_logit": 3.3349506855010986,
            "end_logit": -1.1633812189102173
        },
        {
            "text": "patients with NSCLC",
            "probability": 0.025817047480819134,
            "start_logit": 0.4292246997356415,
            "end_logit": 0.04174176603555679
        },
        {
            "text": "patients with NSCLC fail to respond",
            "probability": 0.015872196668823495,
            "start_logit": 0.4292246997356415,
            "end_logit": -0.44472432136535645
        },
        {
            "text": "many patients with NSCLC fail",
            "probability": 0.009081318232096671,
            "start_logit": 3.3349506855010986,
            "end_logit": -3.908799886703491
        },
        {
            "text": "impressive treatment outcomes in a subset of patients who receive these immune therapies, many patients with NSCLC",
            "probability": 0.009054387785926226,
            "start_logit": -0.6185608506202698,
            "end_logit": 0.04174176603555679
        },
        {
            "text": "patients with NSCLC fail to respond to anti-PD-1/PD-L1",
            "probability": 0.007736211085045671,
            "start_logit": 0.4292246997356415,
            "end_logit": -1.1633812189102173
        },
        {
            "text": "impressive treatment outcomes",
            "probability": 0.007479642925593871,
            "start_logit": -0.6185608506202698,
            "end_logit": -0.14932265877723694
        },
        {
            "text": "impressive treatment outcomes in a subset of patients who receive these immune therapies, many patients with NSCLC fail to respond",
            "probability": 0.005566594079388298,
            "start_logit": -0.6185608506202698,
            "end_logit": -0.44472432136535645
        },
        {
            "text": "fail to respond",
            "probability": 0.0025035667878600502,
            "start_logit": -1.4176278114318848,
            "end_logit": -0.44472432136535645
        },
        {
            "text": "Various monoclonal antibodies",
            "probability": 0.0023056270779422444,
            "start_logit": 0.13911710679531097,
            "end_logit": -2.0838329792022705
        },
        {
            "text": "fail to respond to anti-PD-1/PD-L1 and the identification of a biomarker to select these patients",
            "probability": 0.002042220879052644,
            "start_logit": -1.4176278114318848,
            "end_logit": -0.6484028697013855
        },
        {
            "text": "immune therapies, many patients with NSCLC",
            "probability": 0.0016023363936251724,
            "start_logit": -2.3503475189208984,
            "end_logit": 0.04174176603555679
        },
        {
            "text": "NSCLC",
            "probability": 0.0012480228283866905,
            "start_logit": -2.600249767303467,
            "end_logit": 0.04174176603555679
        },
        {
            "text": "impressive treatment outcomes in a subset of patients who receive these immune therapies",
            "probability": 0.0012236989240249992,
            "start_logit": -0.6185608506202698,
            "end_logit": -1.9596295356750488
        },
        {
            "text": "fail to respond to anti-PD-1/PD-L1",
            "probability": 0.0012202546087674419,
            "start_logit": -1.4176278114318848,
            "end_logit": -1.1633812189102173
        },
        {
            "text": "treatment outcomes in a subset of patients who receive these immune therapies, many patients with NSCLC",
            "probability": 0.0011906071125508462,
            "start_logit": -2.6473469734191895,
            "end_logit": 0.04174176603555679
        },
        {
            "text": "immune therapies, many patients with NSCLC fail to respond",
            "probability": 0.0009851087111385356,
            "start_logit": -2.3503475189208984,
            "end_logit": -0.44472432136535645
        },
        {
            "text": "treatment outcomes",
            "probability": 0.000983535969201004,
            "start_logit": -2.6473469734191895,
            "end_logit": -0.14932265877723694
        },
        {
            "text": "",
            "probability": 0.000664005300102573,
            "start_logit": -1.3932222127914429,
            "end_logit": -1.7963114976882935
        }
    ],
    "5c7a4a31d774d04240000006_010": [
        {
            "text": "a subpopulation of TNBC more likely to respond to chemotherapy",
            "probability": 0.2568333810896972,
            "start_logit": 1.907086968421936,
            "end_logit": 3.1003541946411133
        },
        {
            "text": "subpopulation of TNBC more likely to respond to chemotherapy",
            "probability": 0.24012260419385334,
            "start_logit": 1.8398090600967407,
            "end_logit": 3.1003541946411133
        },
        {
            "text": "a subpopulation of TNBC",
            "probability": 0.05498349012936879,
            "start_logit": 1.907086968421936,
            "end_logit": 1.5589596033096313
        },
        {
            "text": "associated with a subpopulation of TNBC more likely to respond to chemotherapy",
            "probability": 0.05412228292601782,
            "start_logit": 0.349905401468277,
            "end_logit": 3.1003541946411133
        },
        {
            "text": "could be associated with a subpopulation of TNBC more likely to respond to chemotherapy",
            "probability": 0.05330505590867491,
            "start_logit": 0.3346906006336212,
            "end_logit": 3.1003541946411133
        },
        {
            "text": "subpopulation of TNBC",
            "probability": 0.05140600797884636,
            "start_logit": 1.8398090600967407,
            "end_logit": 1.5589596033096313
        },
        {
            "text": "a subpopulation of TNBC more likely to respond to chemotherapy.",
            "probability": 0.04361840384152363,
            "start_logit": 1.907086968421936,
            "end_logit": 1.3274058103561401
        },
        {
            "text": "subpopulation of TNBC more likely to respond to chemotherapy.",
            "probability": 0.040780387178518444,
            "start_logit": 1.8398090600967407,
            "end_logit": 1.3274058103561401
        },
        {
            "text": "a subpopulation of TNBC more likely to respond to chemotherapy. These data need to be confirmed by larger studies.",
            "probability": 0.03471301953565619,
            "start_logit": 1.907086968421936,
            "end_logit": 1.09904146194458
        },
        {
            "text": "the expression of this biomarker could be associated with a subpopulation of TNBC more likely to respond to chemotherapy",
            "probability": 0.034283224986163395,
            "start_logit": -0.10668441653251648,
            "end_logit": 3.1003541946411133
        },
        {
            "text": "subpopulation of TNBC more likely to respond to chemotherapy. These data need to be confirmed by larger studies.",
            "probability": 0.03245442868434146,
            "start_logit": 1.8398090600967407,
            "end_logit": 1.09904146194458
        },
        {
            "text": "a subpopulation",
            "probability": 0.016276177484016337,
            "start_logit": 1.907086968421936,
            "end_logit": 0.34162917733192444
        },
        {
            "text": "",
            "probability": 0.015987040171867396,
            "start_logit": 0.32010576128959656,
            "end_logit": 1.9106862545013428
        },
        {
            "text": "subpopulation",
            "probability": 0.015217173512264063,
            "start_logit": 1.8398090600967407,
            "end_logit": 0.34162917733192444
        },
        {
            "text": "associated with a subpopulation of TNBC",
            "probability": 0.011586624746423897,
            "start_logit": 0.349905401468277,
            "end_logit": 1.5589596033096313
        },
        {
            "text": "could be associated with a subpopulation of TNBC",
            "probability": 0.01141167087769048,
            "start_logit": 0.3346906006336212,
            "end_logit": 1.5589596033096313
        },
        {
            "text": "associated with a subpopulation of TNBC more likely to respond to chemotherapy.",
            "probability": 0.009191669647754148,
            "start_logit": 0.349905401468277,
            "end_logit": 1.3274058103561401
        },
        {
            "text": "could be associated with a subpopulation of TNBC more likely to respond to chemotherapy.",
            "probability": 0.009052878740118129,
            "start_logit": 0.3346906006336212,
            "end_logit": 1.3274058103561401
        },
        {
            "text": "the expression of this biomarker could be associated with a subpopulation of TNBC",
            "probability": 0.007339432883030564,
            "start_logit": -0.10668441653251648,
            "end_logit": 1.5589596033096313
        },
        {
            "text": "associated with a subpopulation of TNBC more likely to respond to chemotherapy. These data need to be confirmed by larger studies.",
            "probability": 0.007315045484173371,
            "start_logit": 0.349905401468277,
            "end_logit": 1.09904146194458
        }
    ],
    "5c7a4a31d774d04240000006_011": [
        {
            "text": "better progression-free survival (HR: 0.69, 95% CI: 0.57-0.85) and better overall survival",
            "probability": 0.34986610573921895,
            "start_logit": -0.513766884803772,
            "end_logit": -0.4416663944721222
        },
        {
            "text": "better progression-free survival",
            "probability": 0.18294338142003497,
            "start_logit": -0.513766884803772,
            "end_logit": -1.0900402069091797
        },
        {
            "text": "PD-L1 overexpression predicts activity as well as better survival for patients treated with immune checkpoint inhibitors",
            "probability": 0.18117477443871174,
            "start_logit": -0.7597336173057556,
            "end_logit": -0.8537880182266235
        },
        {
            "text": "",
            "probability": 0.0782363669105451,
            "start_logit": -1.3033392429351807,
            "end_logit": -1.1499099731445312
        },
        {
            "text": "non-small-cell lung cancer",
            "probability": 0.05183011126990091,
            "start_logit": -2.087738275527954,
            "end_logit": -0.7772742509841919
        },
        {
            "text": "PD-L1 overexpression predicts activity",
            "probability": 0.03337912254500797,
            "start_logit": -0.7597336173057556,
            "end_logit": -2.5453195571899414
        },
        {
            "text": "better overall survival",
            "probability": 0.023985374386504086,
            "start_logit": -3.193873167037964,
            "end_logit": -0.4416663944721222
        },
        {
            "text": "PD-L1 expression was also related to better progression-free survival",
            "probability": 0.017033155023214334,
            "start_logit": -2.887781858444214,
            "end_logit": -1.0900402069091797
        },
        {
            "text": "PD-L1 overexpression predicts activity as well as better survival for patients treated with immune checkpoint inhibitors.",
            "probability": 0.012288232192244827,
            "start_logit": -0.7597336173057556,
            "end_logit": -3.5446081161499023
        },
        {
            "text": "clinical significance is still debatable",
            "probability": 0.011590016798471747,
            "start_logit": -1.0113708972930908,
            "end_logit": -3.351468801498413
        },
        {
            "text": "PD-L1 overexpression predicts activity as well as better survival",
            "probability": 0.01069065864078995,
            "start_logit": -0.7597336173057556,
            "end_logit": -3.683879852294922
        },
        {
            "text": "better progression-free survival (HR: 0.69, 95% CI: 0.57-0.85)",
            "probability": 0.008439868195593633,
            "start_logit": -0.513766884803772,
            "end_logit": -4.166250228881836
        },
        {
            "text": "to better progression-free survival (HR: 0.69, 95% CI: 0.57-0.85) and better overall survival",
            "probability": 0.006781406947121486,
            "start_logit": -4.457132816314697,
            "end_logit": -0.4416663944721222
        },
        {
            "text": "overexpression predicts activity as well as better survival for patients treated with immune checkpoint inhibitors",
            "probability": 0.006552247512787143,
            "start_logit": -4.079387664794922,
            "end_logit": -0.8537880182266235
        },
        {
            "text": "CONCLUSION: PD-L1 overexpression predicts activity as well as better survival for patients treated with immune checkpoint inhibitors",
            "probability": 0.0059704255181966814,
            "start_logit": -4.172377586364746,
            "end_logit": -0.8537880182266235
        },
        {
            "text": "clinical significance is still debatable.",
            "probability": 0.00539991548009889,
            "start_logit": -1.0113708972930908,
            "end_logit": -4.115229606628418
        },
        {
            "text": "better survival for patients treated with immune checkpoint inhibitors",
            "probability": 0.0046584537879040214,
            "start_logit": -4.4205121994018555,
            "end_logit": -0.8537880182266235
        },
        {
            "text": "to better progression-free survival",
            "probability": 0.0035459665779012093,
            "start_logit": -4.457132816314697,
            "end_logit": -1.0900402069091797
        },
        {
            "text": "survival hazard ratios",
            "probability": 0.00284861653525462,
            "start_logit": -1.6972178220748901,
            "end_logit": -4.06893253326416
        },
        {
            "text": "survival hazard ratios (HR) were included in the analysis",
            "probability": 0.0027858000804979496,
            "start_logit": -1.6972178220748901,
            "end_logit": -4.091230869293213
        }
    ],
    "5c7a4a31d774d04240000006_013": [
        {
            "text": "",
            "probability": 0.23239668197986754,
            "start_logit": 0.6746620535850525,
            "end_logit": 1.0767738819122314
        },
        {
            "text": "strong PD-L1 expression was associated with the presence of distant metastases",
            "probability": 0.1479441304682455,
            "start_logit": 0.3040679693222046,
            "end_logit": 0.9957569241523743
        },
        {
            "text": "strong PD-L1 expression was associated with the presence of distant metastases in a subset of cases",
            "probability": 0.12474123154430844,
            "start_logit": 0.3040679693222046,
            "end_logit": 0.8251636624336243
        },
        {
            "text": "distant metastases",
            "probability": 0.11119808694158698,
            "start_logit": 0.018546441569924355,
            "end_logit": 0.9957569241523743
        },
        {
            "text": "distant metastases in a subset of cases",
            "probability": 0.09375827392788581,
            "start_logit": 0.018546441569924355,
            "end_logit": 0.8251636624336243
        },
        {
            "text": "presence of distant metastases",
            "probability": 0.07671853029545743,
            "start_logit": -0.35262346267700195,
            "end_logit": 0.9957569241523743
        },
        {
            "text": "presence of distant metastases in a subset of cases",
            "probability": 0.06468633747777361,
            "start_logit": -0.35262346267700195,
            "end_logit": 0.8251636624336243
        },
        {
            "text": "strong PD-L1 expression was associated with the presence of distant metastases in a subset of cases.",
            "probability": 0.0407534825450793,
            "start_logit": 0.3040679693222046,
            "end_logit": -0.2935364842414856
        },
        {
            "text": "distant metastases in a subset of cases.",
            "probability": 0.03063122058899697,
            "start_logit": 0.018546441569924355,
            "end_logit": -0.2935364842414856
        },
        {
            "text": "presence of distant metastases in a subset of cases.",
            "probability": 0.021133297247984698,
            "start_logit": -0.35262346267700195,
            "end_logit": -0.2935364842414856
        },
        {
            "text": "our results provide hints on further application of therapies targeting the PD-1/PD-L1 pathway in HNSCC",
            "probability": 0.020978472604578167,
            "start_logit": -0.7718427777290344,
            "end_logit": 0.11832976341247559
        },
        {
            "text": "the presence of distant metastases",
            "probability": 0.009879325158084918,
            "start_logit": -2.40232253074646,
            "end_logit": 0.9957569241523743
        },
        {
            "text": "the presence of distant metastases in a subset of cases",
            "probability": 0.00832989577312561,
            "start_logit": -2.40232253074646,
            "end_logit": 0.8251636624336243
        },
        {
            "text": "distant metastases in a subset of cases.CONCLUSIONS: In summary, while the significance of PD-L2 in HNSCC seems to minor",
            "probability": 0.0031882641901198605,
            "start_logit": 0.018546441569924355,
            "end_logit": -2.556079626083374
        },
        {
            "text": ", strong PD-L1 expression was associated with the presence of distant metastases",
            "probability": 0.002772070463803117,
            "start_logit": -3.6731722354888916,
            "end_logit": 0.9957569241523743
        },
        {
            "text": "the presence of distant metastases in a subset of cases.",
            "probability": 0.002721411820211371,
            "start_logit": -2.40232253074646,
            "end_logit": -0.2935364842414856
        },
        {
            "text": ", strong PD-L1 expression was associated with the presence of distant metastases in a subset of cases",
            "probability": 0.002337311270734213,
            "start_logit": -3.6731722354888916,
            "end_logit": 0.8251636624336243
        },
        {
            "text": "provide hints on further application of therapies targeting the PD-1/PD-L1 pathway in HNSCC",
            "probability": 0.0020735717725484113,
            "start_logit": -3.086066961288452,
            "end_logit": 0.11832976341247559
        },
        {
            "text": "was associated with the presence of distant metastases",
            "probability": 0.0019127791867226648,
            "start_logit": -4.0442094802856445,
            "end_logit": 0.9957569241523743
        },
        {
            "text": "associated with the presence of distant metastases",
            "probability": 0.0018456247428854217,
            "start_logit": -4.079948902130127,
            "end_logit": 0.9957569241523743
        }
    ],
    "5c7a4a31d774d04240000006_014": [
        {
            "text": "not with gender, primary site, or lymph node status",
            "probability": 0.5299247193129821,
            "start_logit": 1.6846821308135986,
            "end_logit": 4.205343246459961
        },
        {
            "text": "gender, primary site, or lymph node status",
            "probability": 0.13659502374487142,
            "start_logit": 0.3289676904678345,
            "end_logit": 4.205343246459961
        },
        {
            "text": "high-grade WHO classification (G3) (P<0.001) but not with gender, primary site, or lymph node status",
            "probability": 0.12847881780767736,
            "start_logit": 0.26771122217178345,
            "end_logit": 4.205343246459961
        },
        {
            "text": "",
            "probability": 0.06554321990305785,
            "start_logit": 1.1973822116851807,
            "end_logit": 2.6026179790496826
        },
        {
            "text": "not with gender, primary site, or lymph node status.",
            "probability": 0.06402018095826745,
            "start_logit": 1.6846821308135986,
            "end_logit": 2.091806650161743
        },
        {
            "text": "(P<0.001) but not with gender, primary site, or lymph node status",
            "probability": 0.017474570311526955,
            "start_logit": -1.7273061275482178,
            "end_logit": 4.205343246459961
        },
        {
            "text": "gender, primary site, or lymph node status.",
            "probability": 0.016502038533855724,
            "start_logit": 0.3289676904678345,
            "end_logit": 2.091806650161743
        },
        {
            "text": "P<0.001) but not with gender, primary site, or lymph node status",
            "probability": 0.007039211782902359,
            "start_logit": -2.636556625366211,
            "end_logit": 4.205343246459961
        },
        {
            "text": "WHO classification (G3) (P<0.001) but not with gender, primary site, or lymph node status",
            "probability": 0.00645174344534631,
            "start_logit": -2.7237024307250977,
            "end_logit": 4.205343246459961
        },
        {
            "text": "G3) (P<0.001) but not with gender, primary site, or lymph node status",
            "probability": 0.005504010873878077,
            "start_logit": -2.882575750350952,
            "end_logit": 4.205343246459961
        },
        {
            "text": "high-grade WHO classification (G3) (P<0.001)",
            "probability": 0.0040560360973805965,
            "start_logit": 0.26771122217178345,
            "end_logit": 0.7497853636741638
        },
        {
            "text": "PD-L1 expression was significantly associated with a high-grade WHO classification (G3) (P<0.001)",
            "probability": 0.003833543076247988,
            "start_logit": 0.2112945169210434,
            "end_logit": 0.7497853636741638
        },
        {
            "text": "high-grade WHO classification (G3)",
            "probability": 0.002609195122644329,
            "start_logit": 0.26771122217178345,
            "end_logit": 0.30862098932266235
        },
        {
            "text": "PD-L1 expression was significantly associated with a high-grade WHO classification (G3)",
            "probability": 0.002466068263902487,
            "start_logit": 0.2112945169210434,
            "end_logit": 0.30862098932266235
        },
        {
            "text": "(P<0.001) but not with gender, primary site, or lymph node status.",
            "probability": 0.002111102035327374,
            "start_logit": -1.7273061275482178,
            "end_logit": 2.091806650161743
        },
        {
            "text": "high-grade WHO classification",
            "probability": 0.0020235408956019115,
            "start_logit": 0.26771122217178345,
            "end_logit": 0.0544280931353569
        },
        {
            "text": "PD-L1 expression was significantly associated with a high-grade WHO classification",
            "probability": 0.0019125399783421735,
            "start_logit": 0.2112945169210434,
            "end_logit": 0.0544280931353569
        },
        {
            "text": "There are no available data describing PD-L1 expression in these tumors",
            "probability": 0.0013406700759020101,
            "start_logit": 0.4971328675746918,
            "end_logit": -0.5866729021072388
        },
        {
            "text": "significantly associated with a high-grade WHO classification (G3) (P<0.001)",
            "probability": 0.001263360928668674,
            "start_logit": -0.8987193703651428,
            "end_logit": 0.7497853636741638
        },
        {
            "text": "P<0.001) but not with gender, primary site, or lymph node status.",
            "probability": 0.0008504068516170036,
            "start_logit": -2.636556625366211,
            "end_logit": 2.091806650161743
        }
    ],
    "5c7a4a31d774d04240000006_016": [
        {
            "text": "fundamental differences in PD-L1 expression between NSCLC and gastroesophageal cancers",
            "probability": 0.73949552574159,
            "start_logit": 6.564330101013184,
            "end_logit": 6.293735504150391
        },
        {
            "text": "differences in PD-L1 expression between NSCLC and gastroesophageal cancers",
            "probability": 0.14488771417105234,
            "start_logit": 4.93432092666626,
            "end_logit": 6.293735504150391
        },
        {
            "text": "there are fundamental differences in PD-L1 expression between NSCLC and gastroesophageal cancers",
            "probability": 0.04363293014688576,
            "start_logit": 3.7341740131378174,
            "end_logit": 6.293735504150391
        },
        {
            "text": "fundamental differences in PD-L1 expression",
            "probability": 0.04230471529307103,
            "start_logit": 6.564330101013184,
            "end_logit": 3.4326658248901367
        },
        {
            "text": "fundamental differences in PD-L1 expression between NSCLC and gastroesophageal cancers.",
            "probability": 0.012247265192118939,
            "start_logit": 6.564330101013184,
            "end_logit": 2.1930699348449707
        },
        {
            "text": "differences in PD-L1 expression",
            "probability": 0.008288668807459557,
            "start_logit": 4.93432092666626,
            "end_logit": 3.4326658248901367
        },
        {
            "text": "there are fundamental differences in PD-L1 expression",
            "probability": 0.0024961323267173948,
            "start_logit": 3.7341740131378174,
            "end_logit": 3.4326658248901367
        },
        {
            "text": "differences in PD-L1 expression between NSCLC and gastroesophageal cancers.",
            "probability": 0.002399579438635958,
            "start_logit": 4.93432092666626,
            "end_logit": 2.1930699348449707
        },
        {
            "text": "NSCLC and gastroesophageal cancers",
            "probability": 0.002005401136149969,
            "start_logit": 0.6542059779167175,
            "end_logit": 6.293735504150391
        },
        {
            "text": "fundamental differences",
            "probability": 0.0008482139532926123,
            "start_logit": 6.564330101013184,
            "end_logit": -0.4768550992012024
        },
        {
            "text": "there are fundamental differences in PD-L1 expression between NSCLC and gastroesophageal cancers.",
            "probability": 0.0007226332655389814,
            "start_logit": 3.7341740131378174,
            "end_logit": 2.1930699348449707
        },
        {
            "text": "PD-L1 expression between NSCLC and gastroesophageal cancers",
            "probability": 0.00019867952699562352,
            "start_logit": -1.6577003002166748,
            "end_logit": 6.293735504150391
        },
        {
            "text": "differences",
            "probability": 0.00016618867395758004,
            "start_logit": 4.93432092666626,
            "end_logit": -0.4768550992012024
        },
        {
            "text": "expression between NSCLC and gastroesophageal cancers",
            "probability": 7.985728104400944e-05,
            "start_logit": -2.569152355194092,
            "end_logit": 6.293735504150391
        },
        {
            "text": "fundamental differences in PD-L1",
            "probability": 5.722225225630365e-05,
            "start_logit": 6.564330101013184,
            "end_logit": -3.1730451583862305
        },
        {
            "text": "there are fundamental differences",
            "probability": 5.0047713455082086e-05,
            "start_logit": 3.7341740131378174,
            "end_logit": -0.4768550992012024
        },
        {
            "text": "gastroesophageal cancers",
            "probability": 3.589667758606179e-05,
            "start_logit": -3.368748664855957,
            "end_logit": 6.293735504150391
        },
        {
            "text": "NSCLC and gastroesophageal cancers.",
            "probability": 3.32127493352648e-05,
            "start_logit": 0.6542059779167175,
            "end_logit": 2.1930699348449707
        },
        {
            "text": "",
            "probability": 2.654851874927129e-05,
            "start_logit": 1.5397064685821533,
            "end_logit": 1.0836095809936523
        },
        {
            "text": "fundamental",
            "probability": 2.3567134107918577e-05,
            "start_logit": 6.564330101013184,
            "end_logit": -4.0601348876953125
        }
    ],
    "5c7a4a31d774d04240000006_017": [
        {
            "text": "complicated by a number of factors",
            "probability": 0.2606165076667565,
            "start_logit": 1.1944419145584106,
            "end_logit": 1.2821111679077148
        },
        {
            "text": "a number of factors",
            "probability": 0.21114848968081754,
            "start_logit": 0.9839535355567932,
            "end_logit": 1.2821111679077148
        },
        {
            "text": "number of factors",
            "probability": 0.13790623085500386,
            "start_logit": 0.557965874671936,
            "end_logit": 1.2821111679077148
        },
        {
            "text": "complicated",
            "probability": 0.1049179210211372,
            "start_logit": 1.1944419145584106,
            "end_logit": 0.37223950028419495
        },
        {
            "text": "complicated by a number of factors which has prompted many researchers to establish better predictive biomarkers for immunotherapy of NSCLC.",
            "probability": 0.041511207424043815,
            "start_logit": 1.1944419145584106,
            "end_logit": -0.5549753904342651
        },
        {
            "text": "TMB and T effector cell signatures may be more robust to predict clinical response following treatment with checkpoint inhibitors",
            "probability": 0.0412584856486503,
            "start_logit": 0.29355618357658386,
            "end_logit": 0.33980369567871094
        },
        {
            "text": "a number of factors which has prompted many researchers to establish better predictive biomarkers for immunotherapy of NSCLC.",
            "probability": 0.0336319016430901,
            "start_logit": 0.9839535355567932,
            "end_logit": -0.5549753904342651
        },
        {
            "text": "complicated by a number of factors which has prompted many researchers to establish better predictive biomarkers for immunotherapy of NSCLC",
            "probability": 0.030162570324869038,
            "start_logit": 1.1944419145584106,
            "end_logit": -0.8743370771408081
        },
        {
            "text": "its use has been complicated by a number of factors",
            "probability": 0.025218266732723798,
            "start_logit": -1.141039490699768,
            "end_logit": 1.2821111679077148
        },
        {
            "text": "a number of factors which has prompted many researchers to establish better predictive biomarkers for immunotherapy of NSCLC",
            "probability": 0.024437366711747736,
            "start_logit": 0.9839535355567932,
            "end_logit": -0.8743370771408081
        },
        {
            "text": "number of factors which has prompted many researchers to establish better predictive biomarkers for immunotherapy of NSCLC.",
            "probability": 0.021965815616753266,
            "start_logit": 0.557965874671936,
            "end_logit": -0.5549753904342651
        },
        {
            "text": "number of factors which has prompted many researchers to establish better predictive biomarkers for immunotherapy of NSCLC",
            "probability": 0.015960640496804058,
            "start_logit": 0.557965874671936,
            "end_logit": -0.8743370771408081
        },
        {
            "text": "its use has been complicated",
            "probability": 0.010152266028892782,
            "start_logit": -1.141039490699768,
            "end_logit": 0.37223950028419495
        },
        {
            "text": "by a number of factors",
            "probability": 0.009065921251714064,
            "start_logit": -2.164085626602173,
            "end_logit": 1.2821111679077148
        },
        {
            "text": "suggesting that TMB and T effector cell signatures may be more robust to predict clinical response following treatment with checkpoint inhibitors",
            "probability": 0.0067243305168388215,
            "start_logit": -1.5205682516098022,
            "end_logit": 0.33980369567871094
        },
        {
            "text": "TMB and T effector cell signatures may be more robust to predict clinical response",
            "probability": 0.006281322998936031,
            "start_logit": 0.29355618357658386,
            "end_logit": -1.5424724817276
        },
        {
            "text": "predicting response to immune checkpoint inhibitors in some studies, but not in others, and its use has been complicated by a number of factors",
            "probability": 0.006228911229222908,
            "start_logit": -2.5394065380096436,
            "end_logit": 1.2821111679077148
        },
        {
            "text": "TMB and T effector cell signatures may be more robust to predict clinical response following treatment with checkpoint inhibitors.",
            "probability": 0.004562504945053029,
            "start_logit": 0.29355618357658386,
            "end_logit": -1.862181305885315
        },
        {
            "text": "predicting response to immune checkpoint inhibitors",
            "probability": 0.004258952942149381,
            "start_logit": -2.5394065380096436,
            "end_logit": 0.901932954788208
        },
        {
            "text": "TMB and T effector cell signatures",
            "probability": 0.003979780727143931,
            "start_logit": 0.29355618357658386,
            "end_logit": -1.9988263845443726
        },
        {
            "text": "",
            "probability": 1.0605537651998807e-05,
            "start_logit": -3.789621353149414,
            "end_logit": -3.843254566192627
        }
    ],
    "5c7a4a31d774d04240000006_020": [
        {
            "text": "there are currently no consensus guidelines for the treatment of these neoplasms",
            "probability": 0.47559215826208384,
            "start_logit": 1.0086236000061035,
            "end_logit": 1.740322470664978
        },
        {
            "text": "neoplasms",
            "probability": 0.2178643192286126,
            "start_logit": 0.22793540358543396,
            "end_logit": 1.740322470664978
        },
        {
            "text": "most locoregional recurrences and distant metastases are of epithelial origin",
            "probability": 0.08008091914749829,
            "start_logit": 0.09216295182704926,
            "end_logit": 0.875260055065155
        },
        {
            "text": "can modulate the immune system to allow cancer cells to evade host response",
            "probability": 0.07212112637971639,
            "start_logit": -0.10637974739074707,
            "end_logit": 0.9691121578216553
        },
        {
            "text": "no consensus guidelines for the treatment of these neoplasms",
            "probability": 0.031446077568434656,
            "start_logit": -1.70766282081604,
            "end_logit": 1.740322470664978
        },
        {
            "text": "",
            "probability": 0.016534152228320997,
            "start_logit": -0.5522116422653198,
            "end_logit": -0.05797488987445831
        },
        {
            "text": "there are currently no consensus guidelines",
            "probability": 0.015439921773953773,
            "start_logit": 1.0086236000061035,
            "end_logit": -1.6872817277908325
        },
        {
            "text": "overexpression of PD-L1 by tumor cells has been observed",
            "probability": 0.01167577322450911,
            "start_logit": 0.07704956829547882,
            "end_logit": -1.0351481437683105
        },
        {
            "text": "can modulate the immune system to allow cancer cells to evade host response. As this marker could potentially be a therapeutic target for these tumors",
            "probability": 0.01137464787371891,
            "start_logit": -0.10637974739074707,
            "end_logit": -0.8778478503227234
        },
        {
            "text": "there are currently no consensus guidelines for the treatment of these neoplasms and the search for targetable biomarkers has not been successful so far",
            "probability": 0.009772408455695634,
            "start_logit": 1.0086236000061035,
            "end_logit": -2.1446752548217773
        },
        {
            "text": "these neoplasms",
            "probability": 0.00869756742940853,
            "start_logit": -2.992893695831299,
            "end_logit": 1.740322470664978
        },
        {
            "text": "Positive membranous staining for PD-L1 was detected in 25/29 tumors",
            "probability": 0.008263285332521388,
            "start_logit": -1.9808748960494995,
            "end_logit": 0.6770825386047363
        },
        {
            "text": "tumors",
            "probability": 0.00822777948204075,
            "start_logit": -1.9851809740066528,
            "end_logit": 0.6770825386047363
        },
        {
            "text": "there are currently no consensus guidelines for the treatment",
            "probability": 0.006976779192946194,
            "start_logit": 1.0086236000061035,
            "end_logit": -2.4816508293151855
        },
        {
            "text": "most locoregional recurrences and distant metastases are of epithelial origin.",
            "probability": 0.0064637505606815445,
            "start_logit": 0.09216295182704926,
            "end_logit": -1.6415678262710571
        },
        {
            "text": "neoplasms and the search for targetable biomarkers has not been successful so far",
            "probability": 0.004476648906920811,
            "start_logit": 0.22793540358543396,
            "end_logit": -2.1446752548217773
        },
        {
            "text": "neoplasms and the search for targetable biomarkers has not been successful so far.",
            "probability": 0.004422238550792908,
            "start_logit": 0.22793540358543396,
            "end_logit": -2.1569039821624756
        },
        {
            "text": "locoregional recurrences and distant metastases are of epithelial origin",
            "probability": 0.003907294238286592,
            "start_logit": -2.9280295372009277,
            "end_logit": 0.875260055065155
        },
        {
            "text": "there are currently no consensus guidelines for the treatment of these neoplasms and the search for targetable biomarkers has not been successful",
            "probability": 0.003594929309032969,
            "start_logit": 1.0086236000061035,
            "end_logit": -3.144713878631592
        },
        {
            "text": "can modulate the immune system to allow cancer cells to evade host response. As this marker could potentially be a therapeutic target",
            "probability": 0.003068222854824182,
            "start_logit": -0.10637974739074707,
            "end_logit": -2.188136339187622
        }
    ],
    "5c7a4a31d774d04240000006_021": [
        {
            "text": "",
            "probability": 0.8257282921898575,
            "start_logit": 2.0774471759796143,
            "end_logit": 1.9929662942886353
        },
        {
            "text": "4 drug/test combinations",
            "probability": 0.12528560583232562,
            "start_logit": 0.39499631524086,
            "end_logit": 1.7897473573684692
        },
        {
            "text": "existence of 4 drug/test combinations",
            "probability": 0.024730763728824632,
            "start_logit": -1.2275516986846924,
            "end_logit": 1.7897473573684692
        },
        {
            "text": "the existence of 4 drug/test combinations",
            "probability": 0.00717148779544958,
            "start_logit": -2.465486526489258,
            "end_logit": 1.7897473573684692
        },
        {
            "text": "4 such drugs rapidly approaching regulatory approval",
            "probability": 0.004359182471083103,
            "start_logit": -0.0645599365234375,
            "end_logit": -1.1090078353881836
        },
        {
            "text": "4",
            "probability": 0.002659399319477223,
            "start_logit": -0.0645599365234375,
            "end_logit": -1.6031920909881592
        },
        {
            "text": "drug/test combinations",
            "probability": 0.0020338441165397123,
            "start_logit": -3.7256720066070557,
            "end_logit": 1.7897473573684692
        },
        {
            "text": "there are 4 such drugs rapidly approaching regulatory approval",
            "probability": 0.0015960834088031741,
            "start_logit": -1.0692917108535767,
            "end_logit": -1.1090078353881836
        },
        {
            "text": "4 drug/test combinations adds significantly to the problems faced",
            "probability": 0.0012181716724948516,
            "start_logit": 0.39499631524086,
            "end_logit": -2.8434975147247314
        },
        {
            "text": "there are 4",
            "probability": 0.000973719994369818,
            "start_logit": -1.0692917108535767,
            "end_logit": -1.6031920909881592
        },
        {
            "text": "selection performance of the PD-L1 biomarker test is not perfect, and the existence of 4 drug/test combinations",
            "probability": 0.0008437684302248222,
            "start_logit": -4.6054768562316895,
            "end_logit": 1.7897473573684692
        },
        {
            "text": "4 drug/test combinations adds significantly to the problems faced. This article addresses some of the background to this therapeutic problem",
            "probability": 0.0007928306315331906,
            "start_logit": 0.39499631524086,
            "end_logit": -3.27299427986145
        },
        {
            "text": "the selection performance of the PD-L1 biomarker test is not perfect, and the existence of 4 drug/test combinations",
            "probability": 0.0006111731093985554,
            "start_logit": -4.927974700927734,
            "end_logit": 1.7897473573684692
        },
        {
            "text": "4 drug/test",
            "probability": 0.0005349310721996231,
            "start_logit": 0.39499631524086,
            "end_logit": -3.666465997695923
        },
        {
            "text": "4 such drugs",
            "probability": 0.00035907668832264536,
            "start_logit": -0.0645599365234375,
            "end_logit": -3.6055116653442383
        },
        {
            "text": "existence of 4",
            "probability": 0.00027623315290192,
            "start_logit": -1.2275516986846924,
            "end_logit": -2.704810619354248
        },
        {
            "text": "4 such drugs rapidly approaching regulatory approval, each with its own independent PD-L1 immunohistochemistry biomarker test,",
            "probability": 0.0002526247773707131,
            "start_logit": -0.0645599365234375,
            "end_logit": -3.9571423530578613
        },
        {
            "text": "existence of 4 drug/test combinations adds significantly to the problems faced",
            "probability": 0.00024046110974581137,
            "start_logit": -1.2275516986846924,
            "end_logit": -2.8434975147247314
        },
        {
            "text": "drugs rapidly approaching regulatory approval",
            "probability": 0.0001758496233770106,
            "start_logit": -3.274970531463623,
            "end_logit": -1.1090078353881836
        },
        {
            "text": "existence of 4 drug/test combinations adds significantly to the problems faced. This article addresses some of the background to this therapeutic problem",
            "probability": 0.00015650087570046427,
            "start_logit": -1.2275516986846924,
            "end_logit": -3.27299427986145
        }
    ],
    "5c7a4a31d774d04240000006_022": [
        {
            "text": "",
            "probability": 0.8257282921898575,
            "start_logit": 2.0774471759796143,
            "end_logit": 1.9929662942886353
        },
        {
            "text": "4 drug/test combinations",
            "probability": 0.12528560583232562,
            "start_logit": 0.39499631524086,
            "end_logit": 1.7897473573684692
        },
        {
            "text": "existence of 4 drug/test combinations",
            "probability": 0.024730763728824632,
            "start_logit": -1.2275516986846924,
            "end_logit": 1.7897473573684692
        },
        {
            "text": "the existence of 4 drug/test combinations",
            "probability": 0.00717148779544958,
            "start_logit": -2.465486526489258,
            "end_logit": 1.7897473573684692
        },
        {
            "text": "4 such drugs rapidly approaching regulatory approval",
            "probability": 0.004359182471083103,
            "start_logit": -0.0645599365234375,
            "end_logit": -1.1090078353881836
        },
        {
            "text": "4",
            "probability": 0.002659399319477223,
            "start_logit": -0.0645599365234375,
            "end_logit": -1.6031920909881592
        },
        {
            "text": "drug/test combinations",
            "probability": 0.0020338441165397123,
            "start_logit": -3.7256720066070557,
            "end_logit": 1.7897473573684692
        },
        {
            "text": "there are 4 such drugs rapidly approaching regulatory approval",
            "probability": 0.0015960834088031741,
            "start_logit": -1.0692917108535767,
            "end_logit": -1.1090078353881836
        },
        {
            "text": "4 drug/test combinations adds significantly to the problems faced",
            "probability": 0.0012181716724948516,
            "start_logit": 0.39499631524086,
            "end_logit": -2.8434975147247314
        },
        {
            "text": "there are 4",
            "probability": 0.000973719994369818,
            "start_logit": -1.0692917108535767,
            "end_logit": -1.6031920909881592
        },
        {
            "text": "selection performance of the PD-L1 biomarker test is not perfect, and the existence of 4 drug/test combinations",
            "probability": 0.0008437684302248222,
            "start_logit": -4.6054768562316895,
            "end_logit": 1.7897473573684692
        },
        {
            "text": "4 drug/test combinations adds significantly to the problems faced. This article addresses some of the background to this therapeutic problem",
            "probability": 0.0007928306315331906,
            "start_logit": 0.39499631524086,
            "end_logit": -3.27299427986145
        },
        {
            "text": "the selection performance of the PD-L1 biomarker test is not perfect, and the existence of 4 drug/test combinations",
            "probability": 0.0006111731093985554,
            "start_logit": -4.927974700927734,
            "end_logit": 1.7897473573684692
        },
        {
            "text": "4 drug/test",
            "probability": 0.0005349310721996231,
            "start_logit": 0.39499631524086,
            "end_logit": -3.666465997695923
        },
        {
            "text": "4 such drugs",
            "probability": 0.00035907668832264536,
            "start_logit": -0.0645599365234375,
            "end_logit": -3.6055116653442383
        },
        {
            "text": "existence of 4",
            "probability": 0.00027623315290192,
            "start_logit": -1.2275516986846924,
            "end_logit": -2.704810619354248
        },
        {
            "text": "4 such drugs rapidly approaching regulatory approval, each with its own independent PD-L1 immunohistochemistry biomarker test,",
            "probability": 0.0002526247773707131,
            "start_logit": -0.0645599365234375,
            "end_logit": -3.9571423530578613
        },
        {
            "text": "existence of 4 drug/test combinations adds significantly to the problems faced",
            "probability": 0.00024046110974581137,
            "start_logit": -1.2275516986846924,
            "end_logit": -2.8434975147247314
        },
        {
            "text": "drugs rapidly approaching regulatory approval",
            "probability": 0.0001758496233770106,
            "start_logit": -3.274970531463623,
            "end_logit": -1.1090078353881836
        },
        {
            "text": "existence of 4 drug/test combinations adds significantly to the problems faced. This article addresses some of the background to this therapeutic problem",
            "probability": 0.00015650087570046427,
            "start_logit": -1.2275516986846924,
            "end_logit": -3.27299427986145
        }
    ],
    "5e307a05fbd6abf43b000036_002": [
        {
            "text": "",
            "probability": 0.9999980448224868,
            "start_logit": 7.961263656616211,
            "end_logit": 8.403985023498535
        },
        {
            "text": "genome-wide RNAi",
            "probability": 1.607836163422626e-06,
            "start_logit": 1.4692329168319702,
            "end_logit": 1.5553964376449585
        },
        {
            "text": "genome-wide RNAi and CRISPR/Cas9 screens. HiTSelect",
            "probability": 2.2231467958178555e-07,
            "start_logit": 1.4692329168319702,
            "end_logit": -0.4231542646884918
        },
        {
            "text": "HiTSelect using data from both genome-wide RNAi",
            "probability": 5.606351400576512e-08,
            "start_logit": -1.8869264125823975,
            "end_logit": 1.5553964376449585
        },
        {
            "text": "HiTSelect",
            "probability": 3.225627075395746e-08,
            "start_logit": -0.4611484706401825,
            "end_logit": -0.4231542646884918
        },
        {
            "text": "HiTSelect using data from both genome-wide RNAi and CRISPR/Cas9 screens. HiTSelect",
            "probability": 7.751873254230616e-09,
            "start_logit": -1.8869264125823975,
            "end_logit": -0.4231542646884918
        },
        {
            "text": "genome-wide RNAi and CRISPR/Cas9 screens. HiTS",
            "probability": 7.696471442820766e-09,
            "start_logit": 1.4692329168319702,
            "end_logit": -3.7864861488342285
        },
        {
            "text": "genome",
            "probability": 4.366396241961035e-09,
            "start_logit": 1.4692329168319702,
            "end_logit": -4.3533101081848145
        },
        {
            "text": "genome-wide RNAi and CRISPR/Cas9 screens",
            "probability": 4.222499812658392e-09,
            "start_logit": 1.4692329168319702,
            "end_logit": -4.3868207931518555
        },
        {
            "text": "RNAi",
            "probability": 3.95617079927714e-09,
            "start_logit": -4.538135051727295,
            "end_logit": 1.5553964376449585
        },
        {
            "text": "genome-wide RNAi and CRISPR/Cas9",
            "probability": 1.9728931681955126e-09,
            "start_logit": 1.4692329168319702,
            "end_logit": -5.147747039794922
        },
        {
            "text": "genome-wide RNAi and CRISPR/Cas9 screens.",
            "probability": 1.5394828899571283e-09,
            "start_logit": 1.4692329168319702,
            "end_logit": -5.395801544189453
        },
        {
            "text": "Binary executables",
            "probability": 1.4122300391906095e-09,
            "start_logit": -2.1210930347442627,
            "end_logit": -1.8917521238327026
        },
        {
            "text": "HiTS",
            "probability": 1.1167029868506638e-09,
            "start_logit": -0.4611484706401825,
            "end_logit": -3.7864861488342285
        },
        {
            "text": "both genome-wide RNAi",
            "probability": 7.011283100763877e-10,
            "start_logit": -6.2684760093688965,
            "end_logit": 1.5553964376449585
        },
        {
            "text": "data from both genome-wide RNAi",
            "probability": 6.863876587281779e-10,
            "start_logit": -6.289724349975586,
            "end_logit": 1.5553964376449585
        },
        {
            "text": "RNAi and CRISPR/Cas9 screens. HiTSelect",
            "probability": 5.470177021891812e-10,
            "start_logit": -4.538135051727295,
            "end_logit": -0.4231542646884918
        },
        {
            "text": "HiTSelect is implemented as an open-source package, with a user-friendly interface for data visualization and pathway exploration. Binary",
            "probability": 3.0599237089834385e-10,
            "start_logit": -0.4611484706401825,
            "end_logit": -5.081061840057373
        },
        {
            "text": "HiTSelect using data from both genome-wide RNAi and CRISPR/Cas9 screens. HiTS",
            "probability": 2.68367663537951e-10,
            "start_logit": -1.8869264125823975,
            "end_logit": -3.7864861488342285
        },
        {
            "text": "HiTSelect,",
            "probability": 1.6327099167596748e-10,
            "start_logit": -1.484194278717041,
            "end_logit": -4.686164855957031
        }
    ],
    "5e307a05fbd6abf43b000036_004": [
        {
            "text": "MAGeCK)",
            "probability": 0.328245259822285,
            "start_logit": 0.017257127910852432,
            "end_logit": -0.811385452747345
        },
        {
            "text": "",
            "probability": 0.18649784524666246,
            "start_logit": -0.8162604570388794,
            "end_logit": -0.5432092547416687
        },
        {
            "text": "MAGeCK",
            "probability": 0.16811212445213153,
            "start_logit": 0.017257127910852432,
            "end_logit": -1.4805153608322144
        },
        {
            "text": "MAGeCK) method for prioritizing single-guide RNAs, genes and pathways",
            "probability": 0.07169224729541339,
            "start_logit": 0.017257127910852432,
            "end_logit": -2.332763910293579
        },
        {
            "text": "Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK)",
            "probability": 0.040394548955937915,
            "start_logit": -2.0778090953826904,
            "end_logit": -0.811385452747345
        },
        {
            "text": "Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout",
            "probability": 0.024414938103141888,
            "start_logit": -2.0778090953826904,
            "end_logit": -1.314885139465332
        },
        {
            "text": "(MAGeCK)",
            "probability": 0.024158862245390697,
            "start_logit": -2.5918526649475098,
            "end_logit": -0.811385452747345
        },
        {
            "text": "Genome-wide CRISPR/Cas9 Knockout (MAGeCK)",
            "probability": 0.022534094605756748,
            "start_logit": -2.6614744663238525,
            "end_logit": -0.811385452747345
        },
        {
            "text": "Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK",
            "probability": 0.02068823002941448,
            "start_logit": -2.0778090953826904,
            "end_logit": -1.4805153608322144
        },
        {
            "text": "MAGeCK) method for prioritizing single-guide RNAs, genes and pathways in genome-scale CRISPR/Cas9 knockout screens",
            "probability": 0.015504931359723164,
            "start_logit": 0.017257127910852432,
            "end_logit": -3.8639883995056152
        },
        {
            "text": "Genome-wide CRISPR/Cas9 Knockout",
            "probability": 0.01361987048326779,
            "start_logit": -2.6614744663238525,
            "end_logit": -1.314885139465332
        },
        {
            "text": "MAGeCK) method for prioritizing single-guide RNAs",
            "probability": 0.01289997462544895,
            "start_logit": 0.017257127910852432,
            "end_logit": -4.047921180725098
        },
        {
            "text": "(MAGeCK",
            "probability": 0.012373058056094705,
            "start_logit": -2.5918526649475098,
            "end_logit": -1.4805153608322144
        },
        {
            "text": "Genome-wide CRISPR/Cas9 Knockout (MAGeCK",
            "probability": 0.011540926802202962,
            "start_logit": -2.6614744663238525,
            "end_logit": -1.4805153608322144
        },
        {
            "text": "MAGeCK) method for prioritizing single-guide RNAs, genes and pathways in genome-scale",
            "probability": 0.011522803076225037,
            "start_logit": 0.017257127910852432,
            "end_logit": -4.160818576812744
        },
        {
            "text": "MAGeCK) method",
            "probability": 0.0077019093099513795,
            "start_logit": 0.017257127910852432,
            "end_logit": -4.56367826461792
        },
        {
            "text": "MAGeCK) method for prioritizing single-guide RNAs, genes and pathways in genome-scale CRISPR/Cas9 knockout screens.",
            "probability": 0.007621251916247032,
            "start_logit": 0.017257127910852432,
            "end_logit": -4.5742058753967285
        },
        {
            "text": "Model-based Analysis",
            "probability": 0.007397874819459326,
            "start_logit": -2.0778090953826904,
            "end_logit": -2.508887529373169
        },
        {
            "text": "MAGeCK) method for prioritizing",
            "probability": 0.0066726402161119275,
            "start_logit": 0.017257127910852432,
            "end_logit": -4.7071309089660645
        },
        {
            "text": "Model-based Analysis of Genome-wide CRISPR/Cas9",
            "probability": 0.006406608579133678,
            "start_logit": -2.0778090953826904,
            "end_logit": -2.652750253677368
        }
    ],
    "5e2a0eb1aa19d7443100000c_001": [
        {
            "text": "not in vitro",
            "probability": 0.715245316590914,
            "start_logit": 3.225090265274048,
            "end_logit": 6.040714740753174
        },
        {
            "text": "inhibits PRL3+ cancer cells in vivo, but not in vitro",
            "probability": 0.12073697915613894,
            "start_logit": 1.446079134941101,
            "end_logit": 6.040714740753174
        },
        {
            "text": "specifically inhibits PRL3+ cancer cells in vivo, but not in vitro",
            "probability": 0.0386353959861861,
            "start_logit": 0.30663353204727173,
            "end_logit": 6.040714740753174
        },
        {
            "text": "not",
            "probability": 0.038265769661267685,
            "start_logit": 3.225090265274048,
            "end_logit": 3.112644910812378
        },
        {
            "text": "but not in vitro",
            "probability": 0.026257169482863295,
            "start_logit": -0.07959624379873276,
            "end_logit": 6.040714740753174
        },
        {
            "text": "not in vitro.",
            "probability": 0.013940762050956946,
            "start_logit": 3.225090265274048,
            "end_logit": 2.1029062271118164
        },
        {
            "text": "PRL3-zumab specifically inhibits PRL3+ cancer cells in vivo, but not in vitro",
            "probability": 0.012489972626842972,
            "start_logit": -0.8226091861724854,
            "end_logit": 6.040714740753174
        },
        {
            "text": "inhibits PRL3+ cancer cells in vivo, but not",
            "probability": 0.006459452899330989,
            "start_logit": 1.446079134941101,
            "end_logit": 3.112644910812378
        },
        {
            "text": "in vivo, but not in vitro",
            "probability": 0.006331792590985688,
            "start_logit": -1.5019519329071045,
            "end_logit": 6.040714740753174
        },
        {
            "text": "PRL3+ cancer cells in vivo, but not in vitro",
            "probability": 0.00578369974818659,
            "start_logit": -1.5924917459487915,
            "end_logit": 6.040714740753174
        },
        {
            "text": "in vitro",
            "probability": 0.005484685727269133,
            "start_logit": -1.6455755233764648,
            "end_logit": 6.040714740753174
        },
        {
            "text": "inhibits PRL3+ cancer cells in vivo, but not in vitro.",
            "probability": 0.0023532702111068444,
            "start_logit": 1.446079134941101,
            "end_logit": 2.1029062271118164
        },
        {
            "text": "specifically inhibits PRL3+ cancer cells in vivo, but not",
            "probability": 0.0020670015298049757,
            "start_logit": 0.30663353204727173,
            "end_logit": 3.112644910812378
        },
        {
            "text": "but not",
            "probability": 0.0014047638985978615,
            "start_logit": -0.07959624379873276,
            "end_logit": 3.112644910812378
        },
        {
            "text": "inhibits PRL3+ cancer cells in vivo",
            "probability": 0.0012986276083042643,
            "start_logit": 1.446079134941101,
            "end_logit": 1.5084083080291748
        },
        {
            "text": "specifically inhibits PRL3+ cancer cells in vivo, but not in vitro.",
            "probability": 0.0007530379433382223,
            "start_logit": 0.30663353204727173,
            "end_logit": 2.1029062271118164
        },
        {
            "text": "vitro",
            "probability": 0.0007280321677464866,
            "start_logit": -3.664945363998413,
            "end_logit": 6.040714740753174
        },
        {
            "text": "PRL3-zumab specifically inhibits PRL3+ cancer cells in vivo, but not",
            "probability": 0.0006682160715044143,
            "start_logit": -0.8226091861724854,
            "end_logit": 3.112644910812378
        },
        {
            "text": "zumab specifically inhibits PRL3+ cancer cells in vivo, but not in vitro",
            "probability": 0.0005482750569916945,
            "start_logit": -3.9485135078430176,
            "end_logit": 6.040714740753174
        },
        {
            "text": "but not in vitro.",
            "probability": 0.0005117753914655909,
            "start_logit": -0.07959624379873276,
            "end_logit": 2.1029062271118164
        },
        {
            "text": "",
            "probability": 3.6003600197050155e-05,
            "start_logit": -1.0151875019073486,
            "end_logit": 0.3842305839061737
        }
    ],
    "5e48e0e0f8b2df0d49000001_002": [
        {
            "text": "profoundly impacted",
            "probability": 0.576253969033444,
            "start_logit": 4.301525592803955,
            "end_logit": 5.065650939941406
        },
        {
            "text": "Irradiation profoundly impacted",
            "probability": 0.2858322834231968,
            "start_logit": 3.6003823280334473,
            "end_logit": 5.065650939941406
        },
        {
            "text": "profoundly impacted gut microbiota profiles",
            "probability": 0.037969313304978894,
            "start_logit": 4.301525592803955,
            "end_logit": 2.3458807468414307
        },
        {
            "text": "profoundly impacted gut microbiota profiles in both animals",
            "probability": 0.029253825521161212,
            "start_logit": 4.301525592803955,
            "end_logit": 2.0851128101348877
        },
        {
            "text": "Irradiation profoundly impacted gut microbiota profiles",
            "probability": 0.018833459039208838,
            "start_logit": 3.6003823280334473,
            "end_logit": 2.3458807468414307
        },
        {
            "text": "profoundly impacted gut microbiota profiles in both animals.",
            "probability": 0.01849434307840226,
            "start_logit": 4.301525592803955,
            "end_logit": 1.6265673637390137
        },
        {
            "text": "Irradiation profoundly impacted gut microbiota profiles in both animals",
            "probability": 0.014510421093675821,
            "start_logit": 3.6003823280334473,
            "end_logit": 2.0851128101348877
        },
        {
            "text": "Irradiation profoundly impacted gut microbiota profiles in both animals.",
            "probability": 0.009173525210383261,
            "start_logit": 3.6003823280334473,
            "end_logit": 1.6265673637390137
        },
        {
            "text": "profoundly",
            "probability": 0.004148067765567846,
            "start_logit": 4.301525592803955,
            "end_logit": 0.1317450851202011
        },
        {
            "text": "Irradiation profoundly",
            "probability": 0.002057515860958181,
            "start_logit": 3.6003823280334473,
            "end_logit": 0.1317450851202011
        },
        {
            "text": "impacted",
            "probability": 0.0015760923665693058,
            "start_logit": -1.600074291229248,
            "end_logit": 5.065650939941406
        },
        {
            "text": "Irradiation",
            "probability": 0.000719172363759964,
            "start_logit": 3.6003823280334473,
            "end_logit": -0.9194085001945496
        },
        {
            "text": "gut microbiota profiles were dissimilar between minipigs and rhesus macaques. Irradiation profoundly impacted",
            "probability": 0.00021663180845460004,
            "start_logit": -3.5845789909362793,
            "end_logit": 5.065650939941406
        },
        {
            "text": "profoundly impacted gut",
            "probability": 0.00021265186897884866,
            "start_logit": 4.301525592803955,
            "end_logit": -2.838996410369873
        },
        {
            "text": "Baseline gut microbiota profiles were dissimilar between minipigs and rhesus macaques. Irradiation profoundly impacted",
            "probability": 0.00019259332758222243,
            "start_logit": -3.702197313308716,
            "end_logit": 5.065650939941406
        },
        {
            "text": "profoundly impacted gut microbiota",
            "probability": 0.00017517085044855532,
            "start_logit": 4.301525592803955,
            "end_logit": -3.032891035079956
        },
        {
            "text": "Irradiation profoundly impacted gut",
            "probability": 0.00010547913342165133,
            "start_logit": 3.6003823280334473,
            "end_logit": -2.838996410369873
        },
        {
            "text": "impacted gut microbiota profiles",
            "probability": 0.00010384855997474702,
            "start_logit": -1.600074291229248,
            "end_logit": 2.3458807468414307
        },
        {
            "text": "Irradiation profoundly impacted gut microbiota",
            "probability": 8.68878773310245e-05,
            "start_logit": 3.6003823280334473,
            "end_logit": -3.032891035079956
        },
        {
            "text": "profoundly impacted gut microbiota profiles in both animals. Significant increases of intracellular symbionts",
            "probability": 8.230053260507469e-05,
            "start_logit": 4.301525592803955,
            "end_logit": -3.7882752418518066
        },
        {
            "text": "",
            "probability": 2.447979896878246e-06,
            "start_logit": -1.5819087028503418,
            "end_logit": -1.4199553728103638
        }
    ],
    "5e48e0e0f8b2df0d49000001_003": [
        {
            "text": "decrease in the major gut microbiota community Enterobacteriaceae",
            "probability": 0.173662361505873,
            "start_logit": 1.9486002922058105,
            "end_logit": 1.3142050504684448
        },
        {
            "text": "a shift in the gut bacterial composition and structure",
            "probability": 0.15324644817494815,
            "start_logit": 1.501225233078003,
            "end_logit": 1.6365145444869995
        },
        {
            "text": "decrease",
            "probability": 0.13458844511360218,
            "start_logit": 1.9486002922058105,
            "end_logit": 1.0593136548995972
        },
        {
            "text": "shift in the gut bacterial composition and structure",
            "probability": 0.127616240646377,
            "start_logit": 1.31820547580719,
            "end_logit": 1.6365145444869995
        },
        {
            "text": "a shift in the gut bacterial composition and structure by sterilizing irradiation, characterized by a decrease",
            "probability": 0.0860429429528847,
            "start_logit": 1.501225233078003,
            "end_logit": 1.0593136548995972
        },
        {
            "text": "shift in the gut bacterial composition and structure by sterilizing irradiation, characterized by a decrease",
            "probability": 0.07165240724706629,
            "start_logit": 1.31820547580719,
            "end_logit": 1.0593136548995972
        },
        {
            "text": "a shift in the gut bacterial composition and structure by sterilizing irradiation",
            "probability": 0.03611993927185824,
            "start_logit": 1.501225233078003,
            "end_logit": 0.19131219387054443
        },
        {
            "text": "shift in the gut bacterial composition and structure by sterilizing irradiation",
            "probability": 0.030078940929108712,
            "start_logit": 1.31820547580719,
            "end_logit": 0.19131219387054443
        },
        {
            "text": "decrease in the major gut microbiota community",
            "probability": 0.028659873908258644,
            "start_logit": 1.9486002922058105,
            "end_logit": -0.48740988969802856
        },
        {
            "text": "decrease in the major gut microbiota community Enterobacteriaceae,",
            "probability": 0.020167135315324908,
            "start_logit": 1.9486002922058105,
            "end_logit": -0.8388535976409912
        },
        {
            "text": "a shift in the gut bacterial composition and structure by sterilizing",
            "probability": 0.019725275781161927,
            "start_logit": 1.501225233078003,
            "end_logit": -0.41363200545310974
        },
        {
            "text": "a shift in the gut bacterial composition and structure by sterilizing irradiation, characterized by a decrease in the major gut microbiota community",
            "probability": 0.01832237450728928,
            "start_logit": 1.501225233078003,
            "end_logit": -0.48740988969802856
        },
        {
            "text": "shift in the gut bacterial composition and structure by sterilizing",
            "probability": 0.016426256992469867,
            "start_logit": 1.31820547580719,
            "end_logit": -0.41363200545310974
        },
        {
            "text": "a shift",
            "probability": 0.016310415693891696,
            "start_logit": 1.501225233078003,
            "end_logit": -0.6037289500236511
        },
        {
            "text": "shift in the gut bacterial composition and structure by sterilizing irradiation, characterized by a decrease in the major gut microbiota community",
            "probability": 0.015257988567969389,
            "start_logit": 1.31820547580719,
            "end_logit": -0.48740988969802856
        },
        {
            "text": "shift",
            "probability": 0.0135825264404033,
            "start_logit": 1.31820547580719,
            "end_logit": -0.6037289500236511
        },
        {
            "text": "a shift in the gut bacterial composition",
            "probability": 0.010908716372918754,
            "start_logit": 1.501225233078003,
            "end_logit": -1.0059707164764404
        },
        {
            "text": "a shift in the gut bacterial composition and structure by sterilizing irradiation,",
            "probability": 0.010042981614449664,
            "start_logit": 1.501225233078003,
            "end_logit": -1.0886588096618652
        },
        {
            "text": "shift in the gut bacterial composition",
            "probability": 0.009084252133531994,
            "start_logit": 1.31820547580719,
            "end_logit": -1.0059707164764404
        },
        {
            "text": "sterilizing irradiation, characterized by a decrease in the major gut microbiota community Enterobacteriaceae",
            "probability": 0.008504418962013448,
            "start_logit": -1.0679267644882202,
            "end_logit": 1.3142050504684448
        },
        {
            "text": "",
            "probability": 5.786859878022738e-08,
            "start_logit": -6.331050872802734,
            "end_logit": -5.320592403411865
        }
    ],
    "5e2b1ed9fbd6abf43b000005_001": [
        {
            "text": "",
            "probability": 0.9006336959067732,
            "start_logit": 3.2348358631134033,
            "end_logit": 3.0127241611480713
        },
        {
            "text": "Parkinson's Disease",
            "probability": 0.09417990611461378,
            "start_logit": 1.825731635093689,
            "end_logit": 2.1639366149902344
        },
        {
            "text": "Parkinson",
            "probability": 0.002073035550425953,
            "start_logit": 1.825731635093689,
            "end_logit": -1.6522562503814697
        },
        {
            "text": "Parkinson's Disease (PD)",
            "probability": 0.0007804932900160628,
            "start_logit": 1.825731635093689,
            "end_logit": -2.6290993690490723
        },
        {
            "text": "Patients with Parkinson's Disease",
            "probability": 0.000722858617871512,
            "start_logit": -3.0440168380737305,
            "end_logit": 2.1639366149902344
        },
        {
            "text": "Parkinson's Disease (PD",
            "probability": 0.0005686621410724104,
            "start_logit": 1.825731635093689,
            "end_logit": -2.9457390308380127
        },
        {
            "text": "Parkinson's",
            "probability": 0.0002130296942203643,
            "start_logit": 1.825731635093689,
            "end_logit": -3.927593946456909
        },
        {
            "text": "Disease",
            "probability": 0.00016722110225635391,
            "start_logit": -4.507913589477539,
            "end_logit": 2.1639366149902344
        },
        {
            "text": "Parkinson's Disease (PD) undergo motor injuries, which decrease their quality of life (QL)",
            "probability": 0.00013916643362316686,
            "start_logit": 1.825731635093689,
            "end_logit": -4.3533549308776855
        },
        {
            "text": "Parkinson's Disease (PD) undergo motor injuries",
            "probability": 0.00013437635836606058,
            "start_logit": 1.825731635093689,
            "end_logit": -4.388381004333496
        },
        {
            "text": "with Parkinson's Disease",
            "probability": 0.00011489940726093434,
            "start_logit": -4.88317346572876,
            "end_logit": 2.1639366149902344
        },
        {
            "text": "Parkinson's Disease (PD) undergo motor injuries, which decrease their quality of life (QL). Dance",
            "probability": 8.353398846322374e-05,
            "start_logit": 1.825731635093689,
            "end_logit": -4.863771915435791
        },
        {
            "text": "Parkinson's Disease (PD) undergo motor injuries, which decrease their quality of life (QL",
            "probability": 8.160550165818486e-05,
            "start_logit": 1.825731635093689,
            "end_logit": -4.887128829956055
        },
        {
            "text": "Parkinson's Disease (PD) undergo motor injuries, which decrease their quality of life (QL). Dance, added to drug therapy",
            "probability": 3.9818917472118024e-05,
            "start_logit": 1.825731635093689,
            "end_logit": -5.6046833992004395
        },
        {
            "text": "Patients with Parkinson",
            "probability": 1.5911160613770155e-05,
            "start_logit": -3.0440168380737305,
            "end_logit": -1.6522562503814697
        },
        {
            "text": "walking velocity with GAITRite and QL",
            "probability": 1.4413835425382306e-05,
            "start_logit": -1.9205344915390015,
            "end_logit": -2.874570846557617
        },
        {
            "text": "walking velocity with GAITRite and QL with PD",
            "probability": 1.3722850876171272e-05,
            "start_logit": -1.9205344915390015,
            "end_logit": -2.923696994781494
        },
        {
            "text": "PD)",
            "probability": 9.537305111555785e-06,
            "start_logit": -2.5789835453033447,
            "end_logit": -2.6290993690490723
        },
        {
            "text": "walking velocity with GAITRite and QL with PD Questionnaire",
            "probability": 7.163007773361167e-06,
            "start_logit": -1.9205344915390015,
            "end_logit": -3.573829412460327
        },
        {
            "text": "PD",
            "probability": 6.948816106652934e-06,
            "start_logit": -2.5789835453033447,
            "end_logit": -2.9457390308380127
        }
    ],
    "5e2b1ed9fbd6abf43b000005_002": [
        {
            "text": "Parkinson's disease",
            "probability": 0.7332345957556813,
            "start_logit": 3.607719659805298,
            "end_logit": 3.343736171722412
        },
        {
            "text": "Sleep problems commonly occur in patients with Parkinson's disease",
            "probability": 0.10347068867122176,
            "start_logit": 1.6495423316955566,
            "end_logit": 3.343736171722412
        },
        {
            "text": "Parkinson's Disease",
            "probability": 0.09341517164703068,
            "start_logit": 2.423926830291748,
            "end_logit": 2.4671170711517334
        },
        {
            "text": "Parkinson",
            "probability": 0.02539898220579666,
            "start_logit": 3.607719659805298,
            "end_logit": -0.019020425155758858
        },
        {
            "text": "Parkinson's disease (PD",
            "probability": 0.01363260695073284,
            "start_logit": 3.607719659805298,
            "end_logit": -0.6412650346755981
        },
        {
            "text": "Parkinson's disease (PD)",
            "probability": 0.005725895732348688,
            "start_logit": 3.607719659805298,
            "end_logit": -1.5087305307388306
        },
        {
            "text": "Sleep problems",
            "probability": 0.004025089907365256,
            "start_logit": 1.6495423316955566,
            "end_logit": 0.096995048224926
        },
        {
            "text": "Sleep problems commonly occur in patients with Parkinson",
            "probability": 0.003584187374128719,
            "start_logit": 1.6495423316955566,
            "end_logit": -0.019020425155758858
        },
        {
            "text": "",
            "probability": 0.0031774934072267406,
            "start_logit": 1.1408684253692627,
            "end_logit": 0.36921435594558716
        },
        {
            "text": "Parkinson's Disease Questionnaire",
            "probability": 0.0030800457598901283,
            "start_logit": 2.423926830291748,
            "end_logit": -0.9449922442436218
        },
        {
            "text": "Parkinson's",
            "probability": 0.003063300573814454,
            "start_logit": 3.607719659805298,
            "end_logit": -2.1342365741729736
        },
        {
            "text": "Sleep",
            "probability": 0.002888385757264681,
            "start_logit": 1.6495423316955566,
            "end_logit": -0.23485441505908966
        },
        {
            "text": "Sleep problems commonly occur in patients with Parkinson's disease (PD",
            "probability": 0.0019237706973204856,
            "start_logit": 1.6495423316955566,
            "end_logit": -0.6412650346755981
        },
        {
            "text": "Sleep problems commonly occur in patients with Parkinson's disease (PD)",
            "probability": 0.0008080120306859347,
            "start_logit": 1.6495423316955566,
            "end_logit": -1.5087305307388306
        },
        {
            "text": "problems commonly occur in patients with Parkinson's disease",
            "probability": 0.000613204593297168,
            "start_logit": -3.4788026809692383,
            "end_logit": 3.343736171722412
        },
        {
            "text": "patients with Parkinson's disease",
            "probability": 0.000554054455118024,
            "start_logit": -3.5802383422851562,
            "end_logit": 3.343736171722412
        },
        {
            "text": "39-item Parkinson's Disease",
            "probability": 0.0004335133662434701,
            "start_logit": -2.9489595890045166,
            "end_logit": 2.4671170711517334
        },
        {
            "text": "Sleep problems commonly occur in patients with Parkinson's",
            "probability": 0.00043227886656502517,
            "start_logit": 1.6495423316955566,
            "end_logit": -2.1342365741729736
        },
        {
            "text": "disease",
            "probability": 0.0003141333879789146,
            "start_logit": -4.147683620452881,
            "end_logit": 3.343736171722412
        },
        {
            "text": "Parkinson's disease (PD),",
            "probability": 0.00022458886028916145,
            "start_logit": 3.607719659805298,
            "end_logit": -4.747213363647461
        }
    ],
    "5e2b1ed9fbd6abf43b000005_003": [
        {
            "text": "",
            "probability": 0.9903734190047143,
            "start_logit": 6.464715957641602,
            "end_logit": 6.538839340209961
        },
        {
            "text": "Parkinson's disease",
            "probability": 0.009038248569269715,
            "start_logit": 4.074990749359131,
            "end_logit": 4.231947898864746
        },
        {
            "text": "Parkinson's",
            "probability": 0.000306777029645798,
            "start_logit": 4.074990749359131,
            "end_logit": 0.8488484025001526
        },
        {
            "text": "Parkinson",
            "probability": 0.00017523591368130746,
            "start_logit": 4.074990749359131,
            "end_logit": 0.28886035084724426
        },
        {
            "text": "Parkinson's disease (PD)",
            "probability": 5.962476792533657e-05,
            "start_logit": 4.074990749359131,
            "end_logit": -0.7892017364501953
        },
        {
            "text": "Parkinson's disease (PD",
            "probability": 1.8605568348427348e-05,
            "start_logit": 4.074990749359131,
            "end_logit": -1.9538118839263916
        },
        {
            "text": "Non-motor symptoms (NMSs) are a real burden in Parkinson's disease",
            "probability": 6.6621252998100546e-06,
            "start_logit": -3.137791395187378,
            "end_logit": 4.231947898864746
        },
        {
            "text": "Parkinson's disease (",
            "probability": 5.660685590964138e-06,
            "start_logit": 4.074990749359131,
            "end_logit": -3.1437277793884277
        },
        {
            "text": "NMSs) are a real burden in Parkinson's disease",
            "probability": 5.628454478243541e-06,
            "start_logit": -3.3063950538635254,
            "end_logit": 4.231947898864746
        },
        {
            "text": "disease",
            "probability": 2.7155397138286503e-06,
            "start_logit": -4.035239219665527,
            "end_logit": 4.231947898864746
        },
        {
            "text": "Parkinson's disease (PD). They may appear in early pre-symptomatic stage as well as throughout the disease course",
            "probability": 2.6615546188928527e-06,
            "start_logit": 4.074990749359131,
            "end_logit": -3.898362398147583
        },
        {
            "text": "symptoms (NMSs) are a real burden in Parkinson's disease",
            "probability": 2.1598294397740393e-06,
            "start_logit": -4.264200687408447,
            "end_logit": 4.231947898864746
        },
        {
            "text": "Parkinson's disease (PD). They may appear in early pre-symptomatic stage",
            "probability": 1.5481121563456503e-06,
            "start_logit": 4.074990749359131,
            "end_logit": -4.440236568450928
        },
        {
            "text": "NMSs",
            "probability": 2.3818618383675035e-07,
            "start_logit": -1.7234258651733398,
            "end_logit": -0.5135588049888611
        },
        {
            "text": "Non-motor symptoms (NMSs) are a real burden in Parkinson's",
            "probability": 2.2612644418220363e-07,
            "start_logit": -3.137791395187378,
            "end_logit": 0.8488484025001526
        },
        {
            "text": "NMSs) are a real burden in Parkinson's",
            "probability": 1.9104149804010738e-07,
            "start_logit": -3.3063950538635254,
            "end_logit": 0.8488484025001526
        },
        {
            "text": "Non-motor symptoms (NMSs) are a real burden in Parkinson",
            "probability": 1.291670178159194e-07,
            "start_logit": -3.137791395187378,
            "end_logit": 0.28886035084724426
        },
        {
            "text": "NMSs) are a real burden in Parkinson",
            "probability": 1.091259391185727e-07,
            "start_logit": -3.3063950538635254,
            "end_logit": 0.28886035084724426
        },
        {
            "text": "PD)",
            "probability": 8.588891352691384e-08,
            "start_logit": -2.467780828475952,
            "end_logit": -0.7892017364501953
        },
        {
            "text": "symptoms (NMSs) are a real burden in Parkinson's",
            "probability": 7.330912123043816e-08,
            "start_logit": -4.264200687408447,
            "end_logit": 0.8488484025001526
        }
    ],
    "5e2b1ed9fbd6abf43b000005_004": [
        {
            "text": "",
            "probability": 0.9911161945894718,
            "start_logit": 7.3675856590271,
            "end_logit": 6.185610771179199
        },
        {
            "text": "Parkinson's Disease",
            "probability": 0.008039172863362528,
            "start_logit": 5.094417095184326,
            "end_logit": 3.6442737579345703
        },
        {
            "text": "Parkinson's Disease (PD)",
            "probability": 0.0002851816243257989,
            "start_logit": 5.094417095184326,
            "end_logit": 0.30531853437423706
        },
        {
            "text": "Parkinson's Disease (PD",
            "probability": 0.00026780821703275746,
            "start_logit": 5.094417095184326,
            "end_logit": 0.2424633949995041
        },
        {
            "text": "Parkinson",
            "probability": 0.0002459948011744524,
            "start_logit": 5.094417095184326,
            "end_logit": 0.157502681016922
        },
        {
            "text": "Parkinson's",
            "probability": 3.6020751245975005e-05,
            "start_logit": 5.094417095184326,
            "end_logit": -1.7637125253677368
        },
        {
            "text": "Parkinson's Disease (PD),",
            "probability": 4.197679044729952e-06,
            "start_logit": 5.094417095184326,
            "end_logit": -3.913275957107544
        },
        {
            "text": "motor function is available for Parkinson's Disease",
            "probability": 1.8016686163089653e-06,
            "start_logit": -3.3089511394500732,
            "end_logit": 3.6442737579345703
        },
        {
            "text": "PD)",
            "probability": 8.973639517613563e-07,
            "start_logit": -0.6670029163360596,
            "end_logit": 0.30531853437423706
        },
        {
            "text": "PD",
            "probability": 8.426960906714268e-07,
            "start_logit": -0.6670029163360596,
            "end_logit": 0.2424633949995041
        },
        {
            "text": "for Parkinson's Disease",
            "probability": 5.778008769548449e-07,
            "start_logit": -4.446190357208252,
            "end_logit": 3.6442737579345703
        },
        {
            "text": "Objective measurement of motor function is available for Parkinson's Disease",
            "probability": 4.194034562093533e-07,
            "start_logit": -4.7665863037109375,
            "end_logit": 3.6442737579345703
        },
        {
            "text": "Disease",
            "probability": 3.532150547640744e-07,
            "start_logit": -4.938342571258545,
            "end_logit": 3.6442737579345703
        },
        {
            "text": "measurement of motor function is available for Parkinson's Disease",
            "probability": 1.582074090326909e-07,
            "start_logit": -5.741512775421143,
            "end_logit": 3.6442737579345703
        },
        {
            "text": "(PD)",
            "probability": 9.260093618509878e-08,
            "start_logit": -2.9381651878356934,
            "end_logit": 0.30531853437423706
        },
        {
            "text": "(PD",
            "probability": 8.695964080407967e-08,
            "start_logit": -2.9381651878356934,
            "end_logit": 0.2424633949995041
        },
        {
            "text": "motor function is available for Parkinson's Disease (PD)",
            "probability": 6.391239387790675e-08,
            "start_logit": -3.3089511394500732,
            "end_logit": 0.30531853437423706
        },
        {
            "text": "motor function is available for Parkinson's Disease (PD",
            "probability": 6.001881885343169e-08,
            "start_logit": -3.3089511394500732,
            "end_logit": 0.2424633949995041
        },
        {
            "text": "motor function is available for Parkinson",
            "probability": 5.51301882151341e-08,
            "start_logit": -3.3089511394500732,
            "end_logit": 0.157502681016922
        },
        {
            "text": "for Parkinson's Disease (PD)",
            "probability": 2.049690875261666e-08,
            "start_logit": -4.446190357208252,
            "end_logit": 0.30531853437423706
        }
    ],
    "5e2b1ed9fbd6abf43b000005_005": [
        {
            "text": "Parkinson's disease",
            "probability": 0.8096677588547956,
            "start_logit": 4.331571102142334,
            "end_logit": 3.6137709617614746
        },
        {
            "text": "Parkinson",
            "probability": 0.10953249905983233,
            "start_logit": 4.331571102142334,
            "end_logit": 1.613368272781372
        },
        {
            "text": "Parkinson's disease (PD)",
            "probability": 0.028898878811369138,
            "start_logit": 4.331571102142334,
            "end_logit": 0.28094977140426636
        },
        {
            "text": "Parkinson's disease (PD",
            "probability": 0.01896326240838495,
            "start_logit": 4.331571102142334,
            "end_logit": -0.14034947752952576
        },
        {
            "text": "",
            "probability": 0.018285115115275738,
            "start_logit": 2.4397401809692383,
            "end_logit": 1.7150652408599854
        },
        {
            "text": "poor quality of life in patients with Parkinson's disease",
            "probability": 0.005156839467850002,
            "start_logit": -0.7247290015220642,
            "end_logit": 3.6137709617614746
        },
        {
            "text": "Psychiatric symptoms and motor impairment are major contributions to the poor quality of life in patients with Parkinson's disease",
            "probability": 0.0034966300132927295,
            "start_logit": -1.1132532358169556,
            "end_logit": 3.6137709617614746
        },
        {
            "text": "Parkinson's",
            "probability": 0.0014620915502149814,
            "start_logit": 4.331571102142334,
            "end_logit": -2.7029850482940674
        },
        {
            "text": "the poor quality of life in patients with Parkinson's disease",
            "probability": 0.0011092217294996433,
            "start_logit": -2.2613942623138428,
            "end_logit": 3.6137709617614746
        },
        {
            "text": "poor quality of life in patients with Parkinson",
            "probability": 0.0006976213489875224,
            "start_logit": -0.7247290015220642,
            "end_logit": 1.613368272781372
        },
        {
            "text": "Parkinson's disease (PD). Here, we applied a novel diffusion-weighted imaging approach, diffusion MRI",
            "probability": 0.0005764747495249578,
            "start_logit": 4.331571102142334,
            "end_logit": -3.633676767349243
        },
        {
            "text": "Psychiatric symptoms and motor impairment are major contributions to the poor quality of life in patients with Parkinson",
            "probability": 0.00047302689214805805,
            "start_logit": -1.1132532358169556,
            "end_logit": 1.613368272781372
        },
        {
            "text": "quality of life in patients with Parkinson's disease",
            "probability": 0.00042562337734362653,
            "start_logit": -3.2192533016204834,
            "end_logit": 3.6137709617614746
        },
        {
            "text": "patients with Parkinson's disease",
            "probability": 0.0002684077967106457,
            "start_logit": -3.680300712585449,
            "end_logit": 3.6137709617614746
        },
        {
            "text": "PD)",
            "probability": 0.00020052191807209255,
            "start_logit": -0.6390634179115295,
            "end_logit": 0.28094977140426636
        },
        {
            "text": "symptoms and motor impairment are major contributions to the poor quality of life in patients with Parkinson's disease",
            "probability": 0.0001955273336019278,
            "start_logit": -3.997107982635498,
            "end_logit": 3.6137709617614746
        },
        {
            "text": "poor quality of life in patients with Parkinson's disease (PD)",
            "probability": 0.0001840592974109134,
            "start_logit": -0.7247290015220642,
            "end_logit": 0.28094977140426636
        },
        {
            "text": "the poor quality of life in patients with Parkinson",
            "probability": 0.00015005639870779898,
            "start_logit": -2.2613942623138428,
            "end_logit": 1.613368272781372
        },
        {
            "text": "PD",
            "probability": 0.0001315812207059671,
            "start_logit": -0.6390634179115295,
            "end_logit": -0.14034947752952576
        },
        {
            "text": "Psychiatric symptoms and motor impairment are major contributions to the poor quality of life in patients with Parkinson's disease (PD)",
            "probability": 0.00012480265627134172,
            "start_logit": -1.1132532358169556,
            "end_logit": 0.28094977140426636
        }
    ],
    "5e2b1ed9fbd6abf43b000005_006": [
        {
            "text": "",
            "probability": 0.8819073918890074,
            "start_logit": 1.9064459800720215,
            "end_logit": 1.924245834350586
        },
        {
            "text": "quality of life",
            "probability": 0.0923862678634535,
            "start_logit": 0.9408128261566162,
            "end_logit": 0.6337702870368958
        },
        {
            "text": "scale for quality of life",
            "probability": 0.008900798917391404,
            "start_logit": -1.399024486541748,
            "end_logit": 0.6337702870368958
        },
        {
            "text": "quality of life (QOL)",
            "probability": 0.0038854182213318234,
            "start_logit": 0.9408128261566162,
            "end_logit": -2.534977436065674
        },
        {
            "text": "PDQ39 scale for quality of life",
            "probability": 0.003707389652812354,
            "start_logit": -2.2748374938964844,
            "end_logit": 0.6337702870368958
        },
        {
            "text": "quality of life (QOL",
            "probability": 0.0017600268064371248,
            "start_logit": 0.9408128261566162,
            "end_logit": -3.3268790245056152
        },
        {
            "text": "quality of life (QOL).",
            "probability": 0.0016487864665314495,
            "start_logit": 0.9408128261566162,
            "end_logit": -3.3921685218811035
        },
        {
            "text": "for quality of life",
            "probability": 0.0016026870381208385,
            "start_logit": -3.1134839057922363,
            "end_logit": 0.6337702870368958
        },
        {
            "text": "quality",
            "probability": 0.0011383840857779241,
            "start_logit": 0.9408128261566162,
            "end_logit": -3.7625982761383057
        },
        {
            "text": "dyskinesia and fluctuation scores and PDQ39 scale for quality of life",
            "probability": 0.0009890747687714555,
            "start_logit": -3.5961508750915527,
            "end_logit": 0.6337702870368958
        },
        {
            "text": "Parkinsonian",
            "probability": 0.0005182596381366003,
            "start_logit": -2.0495598316192627,
            "end_logit": -1.5591143369674683
        },
        {
            "text": "scale for quality of life (QOL)",
            "probability": 0.0003743340552424646,
            "start_logit": -1.399024486541748,
            "end_logit": -2.534977436065674
        },
        {
            "text": "Moroccan Parkinsonian",
            "probability": 0.00020151370788025548,
            "start_logit": -2.9941787719726562,
            "end_logit": -1.5591143369674683
        },
        {
            "text": "scale for quality of life (QOL",
            "probability": 0.00016956680960929354,
            "start_logit": -1.399024486541748,
            "end_logit": -3.3268790245056152
        },
        {
            "text": "scale for quality of life (QOL).",
            "probability": 0.00015884954696950284,
            "start_logit": -1.399024486541748,
            "end_logit": -3.3921685218811035
        },
        {
            "text": "PDQ39 scale for quality of life (QOL)",
            "probability": 0.0001559188355990779,
            "start_logit": -2.2748374938964844,
            "end_logit": -2.534977436065674
        },
        {
            "text": "quality of life (Q",
            "probability": 0.00015296066550999428,
            "start_logit": 0.9408128261566162,
            "end_logit": -5.769782543182373
        },
        {
            "text": "STN DBS is an effective treatment in Moroccan Parkinsonian",
            "probability": 0.00011942625840402148,
            "start_logit": -3.5173370838165283,
            "end_logit": -1.5591143369674683
        },
        {
            "text": "quality of life (",
            "probability": 0.00011326908124036249,
            "start_logit": 0.9408128261566162,
            "end_logit": -6.070197105407715
        },
        {
            "text": "scale for quality",
            "probability": 0.0001096756917731928,
            "start_logit": -1.399024486541748,
            "end_logit": -3.7625982761383057
        }
    ],
    "5e2b1ed9fbd6abf43b000005_007": [
        {
            "text": "",
            "probability": 0.999619758886484,
            "start_logit": 6.880980968475342,
            "end_logit": 6.574009418487549
        },
        {
            "text": "autonomic dysfunction",
            "probability": 0.00023188932829256337,
            "start_logit": 2.301258087158203,
            "end_logit": 2.7848622798919678
        },
        {
            "text": "Parkinson's Disease Quality of Life 39",
            "probability": 6.92166223061936e-05,
            "start_logit": 2.8527557849884033,
            "end_logit": 1.0243453979492188
        },
        {
            "text": "Parkinson's Disease",
            "probability": 3.443712708976281e-05,
            "start_logit": 2.8527557849884033,
            "end_logit": 0.32623961567878723
        },
        {
            "text": "Parkinson's Disease Quality of Life",
            "probability": 1.4065859639645461e-05,
            "start_logit": 2.8527557849884033,
            "end_logit": -0.5691450834274292
        },
        {
            "text": "Parkinson's disease",
            "probability": 6.188327570301453e-06,
            "start_logit": 0.5843431949615479,
            "end_logit": 0.8781818151473999
        },
        {
            "text": "Parkinson's Disease Quality of Life 39 (K-PDQ39)].CONCLUSION: The K-SCOPA-AUT",
            "probability": 5.577850771206573e-06,
            "start_logit": 2.8527557849884033,
            "end_logit": -1.4940921068191528
        },
        {
            "text": "Parkinson",
            "probability": 3.842793297026598e-06,
            "start_logit": 2.8527557849884033,
            "end_logit": -1.8666961193084717
        },
        {
            "text": "Korean PD",
            "probability": 3.212363232968039e-06,
            "start_logit": -0.23748408257961273,
            "end_logit": 1.0443511009216309
        },
        {
            "text": "Autonomic symptoms are commonly observed in patients with Parkinson's disease",
            "probability": 2.89867471882388e-06,
            "start_logit": -0.17406803369522095,
            "end_logit": 0.8781818151473999
        },
        {
            "text": "autonomic dysfunction in Korean PD",
            "probability": 2.5589738024625647e-06,
            "start_logit": 2.301258087158203,
            "end_logit": -1.7217916250228882
        },
        {
            "text": "Autonomic",
            "probability": 1.8908413338317454e-06,
            "start_logit": -0.17406803369522095,
            "end_logit": 0.4509500563144684
        },
        {
            "text": "Autonomic symptoms",
            "probability": 1.1112637129060522e-06,
            "start_logit": -0.17406803369522095,
            "end_logit": -0.08057397603988647
        },
        {
            "text": "Parkinson's",
            "probability": 9.589714757646264e-07,
            "start_logit": 2.8527557849884033,
            "end_logit": -3.2547895908355713
        },
        {
            "text": "auto",
            "probability": 4.5004356863730076e-07,
            "start_logit": 2.301258087158203,
            "end_logit": -3.459808826446533
        },
        {
            "text": "autonomic",
            "probability": 4.392084826128058e-07,
            "start_logit": 2.301258087158203,
            "end_logit": -3.4841790199279785
        },
        {
            "text": "SCOPA-AUT, which was written in English, into Korean and to evaluate its reliability and validity for Korean PD",
            "probability": 3.959759338085027e-07,
            "start_logit": -2.33089280128479,
            "end_logit": 1.0443511009216309
        },
        {
            "text": "autonomic dysfunction in Korean PD patients",
            "probability": 3.920648875252485e-07,
            "start_logit": 2.301258087158203,
            "end_logit": -3.5977258682250977
        },
        {
            "text": "K-SCOPA-AUT had good reliability and validity for the assessment of autonomic dysfunction",
            "probability": 3.913858155462666e-07,
            "start_logit": -4.08306360244751,
            "end_logit": 2.7848622798919678
        },
        {
            "text": "Parkinson's disease (PD)",
            "probability": 3.2343758464622564e-07,
            "start_logit": 0.5843431949615479,
            "end_logit": -2.0732321739196777
        }
    ],
    "5e2b1ed9fbd6abf43b000005_008": [
        {
            "text": "Parkinson's disease",
            "probability": 0.9349586327223371,
            "start_logit": 4.426948547363281,
            "end_logit": 3.104661464691162
        },
        {
            "text": "Parkinson's",
            "probability": 0.021096394533018033,
            "start_logit": 4.426948547363281,
            "end_logit": -0.6867386698722839
        },
        {
            "text": "Parkinson",
            "probability": 0.020839867941734494,
            "start_logit": 4.426948547363281,
            "end_logit": -0.6989729404449463
        },
        {
            "text": "patient-perceived quality of life (the 39-item Parkinson's disease",
            "probability": 0.015411978407130548,
            "start_logit": 0.3215912878513336,
            "end_logit": 3.104661464691162
        },
        {
            "text": "",
            "probability": 0.0034377937908360175,
            "start_logit": 1.453445553779602,
            "end_logit": 0.4724920988082886
        },
        {
            "text": "Parkinson's disease Questionnaire",
            "probability": 0.002594927833779121,
            "start_logit": 4.426948547363281,
            "end_logit": -2.7822821140289307
        },
        {
            "text": "patient-perceived quality of life (the 39-item Parkinson's",
            "probability": 0.0003477556820503092,
            "start_logit": 0.3215912878513336,
            "end_logit": -0.6867386698722839
        },
        {
            "text": "patient-perceived quality of life (the 39-item Parkinson",
            "probability": 0.0003435270647111602,
            "start_logit": 0.3215912878513336,
            "end_logit": -0.6989729404449463
        },
        {
            "text": "patient-perceived quality of life",
            "probability": 0.00030653945131348765,
            "start_logit": 0.3215912878513336,
            "end_logit": -0.8128923773765564
        },
        {
            "text": "quality of life (the 39-item Parkinson's disease",
            "probability": 0.0001696539639300705,
            "start_logit": -4.1875481605529785,
            "end_logit": 3.104661464691162
        },
        {
            "text": "39-item Parkinson's disease",
            "probability": 0.00013389393058637592,
            "start_logit": -4.424261093139648,
            "end_logit": 3.104661464691162
        },
        {
            "text": "perceived quality of life (the 39-item Parkinson's disease",
            "probability": 0.00010779713150566303,
            "start_logit": -4.641057968139648,
            "end_logit": 3.104661464691162
        },
        {
            "text": "life (the 39-item Parkinson's disease",
            "probability": 6.316943399653111e-05,
            "start_logit": -5.175488471984863,
            "end_logit": 3.104661464691162
        },
        {
            "text": "the 39-item Parkinson's disease",
            "probability": 6.125158243277665e-05,
            "start_logit": -5.206319332122803,
            "end_logit": 3.104661464691162
        },
        {
            "text": "patient-perceived quality of life (the 39-item Parkinson's disease Questionnaire",
            "probability": 4.277512431305924e-05,
            "start_logit": 0.3215912878513336,
            "end_logit": -2.7822821140289307
        },
        {
            "text": "disease",
            "probability": 3.78470468846164e-05,
            "start_logit": -5.687756061553955,
            "end_logit": 3.104661464691162
        },
        {
            "text": "patient",
            "probability": 1.3833285153740333e-05,
            "start_logit": 0.3215912878513336,
            "end_logit": -3.911161184310913
        },
        {
            "text": "randomized controlled trial was conducted",
            "probability": 1.2383444362937678e-05,
            "start_logit": -1.9782167673110962,
            "end_logit": -1.722070336341858
        },
        {
            "text": "randomized controlled trial",
            "probability": 1.0632369687904252e-05,
            "start_logit": -1.9782167673110962,
            "end_logit": -1.8745276927947998
        },
        {
            "text": "A randomized controlled trial was conducted",
            "probability": 9.345260235769745e-06,
            "start_logit": -2.2597079277038574,
            "end_logit": -1.722070336341858
        }
    ],
    "5e2b1ed9fbd6abf43b000005_009": [
        {
            "text": "",
            "probability": 0.9999999228052849,
            "start_logit": 8.920380592346191,
            "end_logit": 8.43775749206543
        },
        {
            "text": "Parkinson disease",
            "probability": 5.2639567323915674e-08,
            "start_logit": 0.8822028636932373,
            "end_logit": -0.28386247158050537
        },
        {
            "text": "Parkinson",
            "probability": 1.6706439136813273e-08,
            "start_logit": 0.8822028636932373,
            "end_logit": -1.431536316871643
        },
        {
            "text": "Parkinson disease (PD)",
            "probability": 5.110409716726179e-09,
            "start_logit": 0.8822028636932373,
            "end_logit": -2.616050958633423
        },
        {
            "text": "Parkinson disease (PD",
            "probability": 1.5657371575489772e-09,
            "start_logit": 0.8822028636932373,
            "end_logit": -3.798973798751831
        },
        {
            "text": "nonmotor symptoms (NMS) for Parkinson disease",
            "probability": 2.690724978028768e-10,
            "start_logit": -4.394039630889893,
            "end_logit": -0.28386247158050537
        },
        {
            "text": "yoga",
            "probability": 1.7486914630387824e-10,
            "start_logit": -2.713935136795044,
            "end_logit": -2.3949098587036133
        },
        {
            "text": "yoga in PDQ39; and acupuncture in depression",
            "probability": 1.1394203958398488e-10,
            "start_logit": -2.713935136795044,
            "end_logit": -2.8232579231262207
        },
        {
            "text": "nonmotor symptoms (NMS) for Parkinson",
            "probability": 8.539666141768923e-11,
            "start_logit": -4.394039630889893,
            "end_logit": -1.431536316871643
        },
        {
            "text": "disease",
            "probability": 8.100357084231993e-11,
            "start_logit": -5.594527244567871,
            "end_logit": -0.28386247158050537
        },
        {
            "text": "NMS) for Parkinson disease",
            "probability": 7.513929833808122e-11,
            "start_logit": -5.669676780700684,
            "end_logit": -0.28386247158050537
        },
        {
            "text": "for Parkinson disease",
            "probability": 7.223736476912135e-11,
            "start_logit": -5.7090630531311035,
            "end_logit": -0.28386247158050537
        },
        {
            "text": "symptoms (NMS) for Parkinson disease",
            "probability": 6.882220981774044e-11,
            "start_logit": -5.75749397277832,
            "end_logit": -0.28386247158050537
        },
        {
            "text": "CAM) therapy in nonmotor symptoms (NMS) for Parkinson disease",
            "probability": 5.6325702191213624e-11,
            "start_logit": -5.957869529724121,
            "end_logit": -0.28386247158050537
        },
        {
            "text": "PD)",
            "probability": 4.596038297957033e-11,
            "start_logit": -3.829052209854126,
            "end_logit": -2.616050958633423
        },
        {
            "text": "acupuncture in depression",
            "probability": 3.113050143060583e-11,
            "start_logit": -4.011436939239502,
            "end_logit": -2.8232579231262207
        },
        {
            "text": "nonmotor symptoms (NMS) for Parkinson disease (PD)",
            "probability": 2.6122378605700863e-11,
            "start_logit": -4.394039630889893,
            "end_logit": -2.616050958633423
        },
        {
            "text": "depression",
            "probability": 2.5766456782910467e-11,
            "start_logit": -4.200551509857178,
            "end_logit": -2.8232579231262207
        },
        {
            "text": "NMS) for Parkinson",
            "probability": 2.384727265601374e-11,
            "start_logit": -5.669676780700684,
            "end_logit": -1.431536316871643
        },
        {
            "text": "for Parkinson",
            "probability": 2.292627388999848e-11,
            "start_logit": -5.7090630531311035,
            "end_logit": -1.431536316871643
        }
    ],
    "5c7a4c35d774d04240000007_001": [
        {
            "text": "",
            "probability": 0.730851533627868,
            "start_logit": 3.3042285442352295,
            "end_logit": 3.0510196685791016
        },
        {
            "text": "might improve the efficiency",
            "probability": 0.05792283344383793,
            "start_logit": 1.7843140363693237,
            "end_logit": 2.0358355045318604
        },
        {
            "text": "improve the efficiency",
            "probability": 0.0576362715286497,
            "start_logit": 1.779354453086853,
            "end_logit": 2.0358355045318604
        },
        {
            "text": "might improve the efficiency of CIK therapy for NSCLC patients",
            "probability": 0.016732383758305675,
            "start_logit": 1.7843140363693237,
            "end_logit": 0.7940698266029358
        },
        {
            "text": "improve the efficiency of CIK therapy for NSCLC patients",
            "probability": 0.01664960355488048,
            "start_logit": 1.779354453086853,
            "end_logit": 0.7940698266029358
        },
        {
            "text": "might improve",
            "probability": 0.01612090293693215,
            "start_logit": 1.7843140363693237,
            "end_logit": 0.7568405866622925
        },
        {
            "text": "improve",
            "probability": 0.01604114791554408,
            "start_logit": 1.779354453086853,
            "end_logit": 0.7568405866622925
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1 might improve the efficiency",
            "probability": 0.01475092552465878,
            "start_logit": 0.41650819778442383,
            "end_logit": 2.0358355045318604
        },
        {
            "text": "might improve the efficiency of CIK therapy for NSCLC patients.",
            "probability": 0.012629117894291532,
            "start_logit": 1.7843140363693237,
            "end_logit": 0.5127289295196533
        },
        {
            "text": "improve the efficiency of CIK therapy for NSCLC patients.",
            "probability": 0.012566637798002126,
            "start_logit": 1.779354453086853,
            "end_logit": 0.5127289295196533
        },
        {
            "text": "might improve the efficiency of CIK therapy",
            "probability": 0.011838365675233949,
            "start_logit": 1.7843140363693237,
            "end_logit": 0.44806942343711853
        },
        {
            "text": "improve the efficiency of CIK therapy",
            "probability": 0.011779797671238029,
            "start_logit": 1.779354453086853,
            "end_logit": 0.44806942343711853
        },
        {
            "text": "implementing combined treatment on CIK cells before transfusion via antibodies",
            "probability": 0.005302534049894831,
            "start_logit": 0.416843056678772,
            "end_logit": 1.0123796463012695
        },
        {
            "text": "antibodies",
            "probability": 0.005300758746460302,
            "start_logit": 0.41650819778442383,
            "end_logit": 1.0123796463012695
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1 might improve",
            "probability": 0.004105431735198325,
            "start_logit": 0.41650819778442383,
            "end_logit": 0.7568405866622925
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1 might improve the efficiency of CIK therapy",
            "probability": 0.0030148188551302703,
            "start_logit": 0.41650819778442383,
            "end_logit": 0.44806942343711853
        },
        {
            "text": "efficiency",
            "probability": 0.0022159697794167706,
            "start_logit": -1.4791074991226196,
            "end_logit": 2.0358355045318604
        },
        {
            "text": "TIM- 3, CEACAM-1, LAG-3, TIGIT and BTLA) on CIK cells from NSCLC patients",
            "probability": 0.0015283413810956107,
            "start_logit": -1.2762633562088013,
            "end_logit": 1.4614843130111694
        },
        {
            "text": "might improve the efficiency of CIK therapy for NSCLC",
            "probability": 0.0015100473940835972,
            "start_logit": 1.7843140363693237,
            "end_logit": -1.6111351251602173
        },
        {
            "text": "improve the efficiency of CIK therapy for NSCLC",
            "probability": 0.0015025767292775815,
            "start_logit": 1.779354453086853,
            "end_logit": -1.6111351251602173
        }
    ],
    "5c7a4c35d774d04240000007_002": [
        {
            "text": "",
            "probability": 0.730851533627868,
            "start_logit": 3.3042285442352295,
            "end_logit": 3.0510196685791016
        },
        {
            "text": "might improve the efficiency",
            "probability": 0.05792283344383793,
            "start_logit": 1.7843140363693237,
            "end_logit": 2.0358355045318604
        },
        {
            "text": "improve the efficiency",
            "probability": 0.0576362715286497,
            "start_logit": 1.779354453086853,
            "end_logit": 2.0358355045318604
        },
        {
            "text": "might improve the efficiency of CIK therapy for NSCLC patients",
            "probability": 0.016732383758305675,
            "start_logit": 1.7843140363693237,
            "end_logit": 0.7940698266029358
        },
        {
            "text": "improve the efficiency of CIK therapy for NSCLC patients",
            "probability": 0.01664960355488048,
            "start_logit": 1.779354453086853,
            "end_logit": 0.7940698266029358
        },
        {
            "text": "might improve",
            "probability": 0.01612090293693215,
            "start_logit": 1.7843140363693237,
            "end_logit": 0.7568405866622925
        },
        {
            "text": "improve",
            "probability": 0.01604114791554408,
            "start_logit": 1.779354453086853,
            "end_logit": 0.7568405866622925
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1 might improve the efficiency",
            "probability": 0.01475092552465878,
            "start_logit": 0.41650819778442383,
            "end_logit": 2.0358355045318604
        },
        {
            "text": "might improve the efficiency of CIK therapy for NSCLC patients.",
            "probability": 0.012629117894291532,
            "start_logit": 1.7843140363693237,
            "end_logit": 0.5127289295196533
        },
        {
            "text": "improve the efficiency of CIK therapy for NSCLC patients.",
            "probability": 0.012566637798002126,
            "start_logit": 1.779354453086853,
            "end_logit": 0.5127289295196533
        },
        {
            "text": "might improve the efficiency of CIK therapy",
            "probability": 0.011838365675233949,
            "start_logit": 1.7843140363693237,
            "end_logit": 0.44806942343711853
        },
        {
            "text": "improve the efficiency of CIK therapy",
            "probability": 0.011779797671238029,
            "start_logit": 1.779354453086853,
            "end_logit": 0.44806942343711853
        },
        {
            "text": "implementing combined treatment on CIK cells before transfusion via antibodies",
            "probability": 0.005302534049894831,
            "start_logit": 0.416843056678772,
            "end_logit": 1.0123796463012695
        },
        {
            "text": "antibodies",
            "probability": 0.005300758746460302,
            "start_logit": 0.41650819778442383,
            "end_logit": 1.0123796463012695
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1 might improve",
            "probability": 0.004105431735198325,
            "start_logit": 0.41650819778442383,
            "end_logit": 0.7568405866622925
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1 might improve the efficiency of CIK therapy",
            "probability": 0.0030148188551302703,
            "start_logit": 0.41650819778442383,
            "end_logit": 0.44806942343711853
        },
        {
            "text": "efficiency",
            "probability": 0.0022159697794167706,
            "start_logit": -1.4791074991226196,
            "end_logit": 2.0358355045318604
        },
        {
            "text": "TIM- 3, CEACAM-1, LAG-3, TIGIT and BTLA) on CIK cells from NSCLC patients",
            "probability": 0.0015283413810956107,
            "start_logit": -1.2762633562088013,
            "end_logit": 1.4614843130111694
        },
        {
            "text": "might improve the efficiency of CIK therapy for NSCLC",
            "probability": 0.0015100473940835972,
            "start_logit": 1.7843140363693237,
            "end_logit": -1.6111351251602173
        },
        {
            "text": "improve the efficiency of CIK therapy for NSCLC",
            "probability": 0.0015025767292775815,
            "start_logit": 1.779354453086853,
            "end_logit": -1.6111351251602173
        }
    ],
    "5c7a4c35d774d04240000007_003": [
        {
            "text": "",
            "probability": 0.730851533627868,
            "start_logit": 3.3042285442352295,
            "end_logit": 3.0510196685791016
        },
        {
            "text": "might improve the efficiency",
            "probability": 0.05792283344383793,
            "start_logit": 1.7843140363693237,
            "end_logit": 2.0358355045318604
        },
        {
            "text": "improve the efficiency",
            "probability": 0.0576362715286497,
            "start_logit": 1.779354453086853,
            "end_logit": 2.0358355045318604
        },
        {
            "text": "might improve the efficiency of CIK therapy for NSCLC patients",
            "probability": 0.016732383758305675,
            "start_logit": 1.7843140363693237,
            "end_logit": 0.7940698266029358
        },
        {
            "text": "improve the efficiency of CIK therapy for NSCLC patients",
            "probability": 0.01664960355488048,
            "start_logit": 1.779354453086853,
            "end_logit": 0.7940698266029358
        },
        {
            "text": "might improve",
            "probability": 0.01612090293693215,
            "start_logit": 1.7843140363693237,
            "end_logit": 0.7568405866622925
        },
        {
            "text": "improve",
            "probability": 0.01604114791554408,
            "start_logit": 1.779354453086853,
            "end_logit": 0.7568405866622925
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1 might improve the efficiency",
            "probability": 0.01475092552465878,
            "start_logit": 0.41650819778442383,
            "end_logit": 2.0358355045318604
        },
        {
            "text": "might improve the efficiency of CIK therapy for NSCLC patients.",
            "probability": 0.012629117894291532,
            "start_logit": 1.7843140363693237,
            "end_logit": 0.5127289295196533
        },
        {
            "text": "improve the efficiency of CIK therapy for NSCLC patients.",
            "probability": 0.012566637798002126,
            "start_logit": 1.779354453086853,
            "end_logit": 0.5127289295196533
        },
        {
            "text": "might improve the efficiency of CIK therapy",
            "probability": 0.011838365675233949,
            "start_logit": 1.7843140363693237,
            "end_logit": 0.44806942343711853
        },
        {
            "text": "improve the efficiency of CIK therapy",
            "probability": 0.011779797671238029,
            "start_logit": 1.779354453086853,
            "end_logit": 0.44806942343711853
        },
        {
            "text": "implementing combined treatment on CIK cells before transfusion via antibodies",
            "probability": 0.005302534049894831,
            "start_logit": 0.416843056678772,
            "end_logit": 1.0123796463012695
        },
        {
            "text": "antibodies",
            "probability": 0.005300758746460302,
            "start_logit": 0.41650819778442383,
            "end_logit": 1.0123796463012695
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1 might improve",
            "probability": 0.004105431735198325,
            "start_logit": 0.41650819778442383,
            "end_logit": 0.7568405866622925
        },
        {
            "text": "antibodies targeting PD-L1, LAG-3, TIM-3, and CEACAM-1 might improve the efficiency of CIK therapy",
            "probability": 0.0030148188551302703,
            "start_logit": 0.41650819778442383,
            "end_logit": 0.44806942343711853
        },
        {
            "text": "efficiency",
            "probability": 0.0022159697794167706,
            "start_logit": -1.4791074991226196,
            "end_logit": 2.0358355045318604
        },
        {
            "text": "TIM- 3, CEACAM-1, LAG-3, TIGIT and BTLA) on CIK cells from NSCLC patients",
            "probability": 0.0015283413810956107,
            "start_logit": -1.2762633562088013,
            "end_logit": 1.4614843130111694
        },
        {
            "text": "might improve the efficiency of CIK therapy for NSCLC",
            "probability": 0.0015100473940835972,
            "start_logit": 1.7843140363693237,
            "end_logit": -1.6111351251602173
        },
        {
            "text": "improve the efficiency of CIK therapy for NSCLC",
            "probability": 0.0015025767292775815,
            "start_logit": 1.779354453086853,
            "end_logit": -1.6111351251602173
        }
    ],
    "5c7a4c35d774d04240000007_004": [
        {
            "text": "non-small cell lung cancer",
            "probability": 0.3952921648304358,
            "start_logit": -0.475738525390625,
            "end_logit": -0.1240445002913475
        },
        {
            "text": "",
            "probability": 0.19311648778694737,
            "start_logit": -0.6916835308074951,
            "end_logit": -0.6244310736656189
        },
        {
            "text": "inhibitory",
            "probability": 0.10312553115508791,
            "start_logit": -3.4646453857421875,
            "end_logit": 1.5211842060089111
        },
        {
            "text": "highly challenging",
            "probability": 0.05610213579069321,
            "start_logit": -1.3255845308303833,
            "end_logit": -1.2266497611999512
        },
        {
            "text": "lung cancer",
            "probability": 0.03596733791981999,
            "start_logit": -2.8727524280548096,
            "end_logit": -0.1240445002913475
        },
        {
            "text": "challenging",
            "probability": 0.024221769924482873,
            "start_logit": -2.165506601333618,
            "end_logit": -1.2266497611999512
        },
        {
            "text": "highly challenging for several reasons",
            "probability": 0.02362454956040753,
            "start_logit": -1.3255845308303833,
            "end_logit": -2.0915372371673584
        },
        {
            "text": "melanoma, non-small cell lung cancer",
            "probability": 0.021066163818676636,
            "start_logit": -3.4076955318450928,
            "end_logit": -0.1240445002913475
        },
        {
            "text": "successful approaches to treat patients with cancer including melanoma, non-small cell lung cancer",
            "probability": 0.01888931937101217,
            "start_logit": -3.5167670249938965,
            "end_logit": -0.1240445002913475
        },
        {
            "text": "highly challenging for several reasons: (i) multiplicity of immunotherapy agents with different mechanisms of action",
            "probability": 0.018285105268111928,
            "start_logit": -1.3255845308303833,
            "end_logit": -2.3477368354797363
        },
        {
            "text": "cancer",
            "probability": 0.015845030702885742,
            "start_logit": -3.692507743835449,
            "end_logit": -0.1240445002913475
        },
        {
            "text": "highly successful approaches to treat patients with cancer including melanoma, non-small cell lung cancer",
            "probability": 0.014597829326530292,
            "start_logit": -3.7744908332824707,
            "end_logit": -0.1240445002913475
        },
        {
            "text": "Recent clinical trial results have highlighted the potential for combination therapies",
            "probability": 0.012774016117867291,
            "start_logit": -1.190694808959961,
            "end_logit": -2.8413002490997314
        },
        {
            "text": "news",
            "probability": 0.011743275785229268,
            "start_logit": -1.699816107749939,
            "end_logit": -2.416311264038086
        },
        {
            "text": "news in immunotherapy",
            "probability": 0.011369597411831519,
            "start_logit": -1.699816107749939,
            "end_logit": -2.4486491680145264
        },
        {
            "text": "challenging for several reasons",
            "probability": 0.010199761487808835,
            "start_logit": -2.165506601333618,
            "end_logit": -2.0915372371673584
        },
        {
            "text": "non-small cell lung cancer (NSCLC",
            "probability": 0.009738557560773561,
            "start_logit": -0.475738525390625,
            "end_logit": -3.8275766372680664
        },
        {
            "text": "Tim-3",
            "probability": 0.008995807487402571,
            "start_logit": -1.4889253377914429,
            "end_logit": -2.893724203109741
        },
        {
            "text": "challenging for several reasons: (i) multiplicity of immunotherapy agents with different mechanisms of action",
            "probability": 0.007894487555723846,
            "start_logit": -2.165506601333618,
            "end_logit": -2.3477368354797363
        },
        {
            "text": "Agents targeting other immune inhibitory",
            "probability": 0.007151071138271451,
            "start_logit": -2.8783445358276367,
            "end_logit": -1.7338014841079712
        }
    ],
    "5c7a4c35d774d04240000007_005": [
        {
            "text": "",
            "probability": 0.9999964478443863,
            "start_logit": 5.144330978393555,
            "end_logit": 5.157284259796143
        },
        {
            "text": "B7-H3 as a prognostic marker",
            "probability": 3.4840202296363307e-07,
            "start_logit": -2.858412504196167,
            "end_logit": -1.7098774909973145
        },
        {
            "text": "METHODS",
            "probability": 3.128063980767253e-07,
            "start_logit": -2.5628511905670166,
            "end_logit": -2.1132113933563232
        },
        {
            "text": "using EMT as a predictive biomarker for immune checkpoint blockade agents and other immunotherapies",
            "probability": 2.876513678317505e-07,
            "start_logit": -3.270159959793091,
            "end_logit": -1.489737868309021
        },
        {
            "text": "B7-H3 as a prognostic marker for NSCLC",
            "probability": 2.869272037354652e-07,
            "start_logit": -2.858412504196167,
            "end_logit": -1.904006004333496
        },
        {
            "text": "we identify B7-H3 as a prognostic marker",
            "probability": 2.1336797323933386e-07,
            "start_logit": -3.3487513065338135,
            "end_logit": -1.7098774909973145
        },
        {
            "text": "We conducted an integrated analysis",
            "probability": 2.0661967453394936e-07,
            "start_logit": -1.180287480354309,
            "end_logit": -3.910479784011841
        },
        {
            "text": "We conducted an integrated analysis of three independent large datasets",
            "probability": 1.9944913907119114e-07,
            "start_logit": -1.180287480354309,
            "end_logit": -3.945800304412842
        },
        {
            "text": "identify B7-H3 as a prognostic marker",
            "probability": 1.8024113973187763e-07,
            "start_logit": -3.5174739360809326,
            "end_logit": -1.7098774909973145
        },
        {
            "text": "using EMT as a predictive biomarker",
            "probability": 1.7852386309668846e-07,
            "start_logit": -3.270159959793091,
            "end_logit": -1.9667648077011108
        },
        {
            "text": "we identify B7-H3 as a prognostic marker for NSCLC",
            "probability": 1.7571963390883068e-07,
            "start_logit": -3.3487513065338135,
            "end_logit": -1.904006004333496
        },
        {
            "text": "identification of biomarkers that predict clinical benefit to immune checkpoint blockade is critical to successful clinical translation of these agents.METHODS",
            "probability": 1.7152947192520235e-07,
            "start_logit": -3.1636805534362793,
            "end_logit": -2.1132113933563232
        },
        {
            "text": "identify B7-H3 as a prognostic marker for NSCLC",
            "probability": 1.4843796193100503e-07,
            "start_logit": -3.5174739360809326,
            "end_logit": -1.904006004333496
        },
        {
            "text": "a prognostic marker",
            "probability": 1.2703687388164514e-07,
            "start_logit": -3.8672921657562256,
            "end_logit": -1.7098774909973145
        },
        {
            "text": "strong association between EMT status and an inflammatory tumor microenvironment with elevation of multiple targetable immune checkpoint molecules warrants further investigation",
            "probability": 1.2627695954358818e-07,
            "start_logit": -2.9373488426208496,
            "end_logit": -2.6458206176757812
        },
        {
            "text": "investigation of using EMT as a predictive biomarker for immune checkpoint blockade agents and other immunotherapies",
            "probability": 1.256632089512957e-07,
            "start_logit": -4.09830379486084,
            "end_logit": -1.489737868309021
        },
        {
            "text": "a predictive biomarker for immune checkpoint blockade agents and other immunotherapies",
            "probability": 1.2081006334072332e-07,
            "start_logit": -4.137689590454102,
            "end_logit": -1.489737868309021
        },
        {
            "text": "using EMT as a predictive biomarker for immune checkpoint blockade agents and other immunotherapies in NSCLC",
            "probability": 1.1681438668778742e-07,
            "start_logit": -3.270159959793091,
            "end_logit": -2.3909008502960205
        },
        {
            "text": "elevation of multiple targetable immune checkpoint molecules warrants further investigation of using EMT as a predictive biomarker",
            "probability": 1.1672912498850038e-07,
            "start_logit": -3.695026159286499,
            "end_logit": -1.9667648077011108
        },
        {
            "text": "EMT as a predictive biomarker for immune checkpoint blockade agents and other immunotherapies",
            "probability": 1.0914914633780642e-07,
            "start_logit": -4.239193916320801,
            "end_logit": -1.489737868309021
        }
    ],
    "5c7a4c35d774d04240000007_006": [
        {
            "text": "",
            "probability": 0.9631661871469273,
            "start_logit": 1.7460952997207642,
            "end_logit": 1.8909080028533936
        },
        {
            "text": "resistance",
            "probability": 0.006253411247487668,
            "start_logit": -1.1426564455032349,
            "end_logit": -0.25743910670280457
        },
        {
            "text": "resistance to immunotherapy in lung cancer",
            "probability": 0.005552131307868323,
            "start_logit": -1.1426564455032349,
            "end_logit": -0.37638434767723083
        },
        {
            "text": "\"hot\" cluster with abundant CD8+ T cells expressing high levels of PD-1 and TIM-3",
            "probability": 0.0036289139438761835,
            "start_logit": -0.06618206202983856,
            "end_logit": -1.8781071901321411
        },
        {
            "text": "\"hot\" cluster",
            "probability": 0.003410249038062845,
            "start_logit": -0.06618206202983856,
            "end_logit": -1.9402552843093872
        },
        {
            "text": "\"hot",
            "probability": 0.002931178098896289,
            "start_logit": -0.06618206202983856,
            "end_logit": -2.0916361808776855
        },
        {
            "text": "support the use of immune-based metrics to study response and resistance",
            "probability": 0.0021561348469281323,
            "start_logit": -2.2074663639068604,
            "end_logit": -0.25743910670280457
        },
        {
            "text": "support the use of immune-based metrics to study response and resistance to immunotherapy in lung cancer",
            "probability": 0.001914338161019717,
            "start_logit": -2.2074663639068604,
            "end_logit": -0.37638434767723083
        },
        {
            "text": "\"hot\"",
            "probability": 0.001035434649792701,
            "start_logit": -0.06618206202983856,
            "end_logit": -3.1322193145751953
        },
        {
            "text": "Our results support the use of immune-based metrics to study response and resistance",
            "probability": 0.0010132923546646122,
            "start_logit": -2.962578773498535,
            "end_logit": -0.25743910670280457
        },
        {
            "text": "lung cancer",
            "probability": 0.0009993722952141367,
            "start_logit": -2.857466220855713,
            "end_logit": -0.37638434767723083
        },
        {
            "text": "\"hot\" cluster with abundant CD8+ T cells expressing high levels of PD-1",
            "probability": 0.0009991313599221378,
            "start_logit": -0.06618206202983856,
            "end_logit": -3.167909622192383
        },
        {
            "text": "immune-based metrics to study response and resistance",
            "probability": 0.0009284683231137219,
            "start_logit": -3.0500025749206543,
            "end_logit": -0.25743910670280457
        },
        {
            "text": "resistance to immunotherapy",
            "probability": 0.0009241644686291113,
            "start_logit": -1.1426564455032349,
            "end_logit": -2.169431447982788
        },
        {
            "text": "\"hot\" cluster with abundant CD8+ T cells",
            "probability": 0.0009025502261212148,
            "start_logit": -0.06618206202983856,
            "end_logit": -3.269571542739868
        },
        {
            "text": "Our results support the use of immune-based metrics to study response and resistance to immunotherapy in lung cancer",
            "probability": 0.000899658119976876,
            "start_logit": -2.962578773498535,
            "end_logit": -0.37638434767723083
        },
        {
            "text": "resistance to immunotherapy in lung cancer.",
            "probability": 0.0008315757196801009,
            "start_logit": -1.1426564455032349,
            "end_logit": -2.2749991416931152
        },
        {
            "text": "immune-based metrics to study response and resistance to immunotherapy in lung cancer",
            "probability": 0.0008243465591991459,
            "start_logit": -3.0500025749206543,
            "end_logit": -0.37638434767723083
        },
        {
            "text": "study response and resistance",
            "probability": 0.0008224863508543913,
            "start_logit": -3.1712069511413574,
            "end_logit": -0.25743910670280457
        },
        {
            "text": "immunologically \"hot\" cluster with abundant CD8+ T cells expressing high levels of PD-1 and TIM-3",
            "probability": 0.0008069757817650106,
            "start_logit": -1.5695770978927612,
            "end_logit": -1.8781071901321411
        }
    ],
    "5c7a4c35d774d04240000007_007": [
        {
            "text": "",
            "probability": 0.5502862639012124,
            "start_logit": 1.9372738599777222,
            "end_logit": 2.4562325477600098
        },
        {
            "text": "activated but not completely exhausted PD-1-positive",
            "probability": 0.05626978959128347,
            "start_logit": 0.5588374137878418,
            "end_logit": 1.554388165473938
        },
        {
            "text": "activated but not completely exhausted",
            "probability": 0.05540884647435686,
            "start_logit": 0.5588374137878418,
            "end_logit": 1.53896963596344
        },
        {
            "text": "display an activated but not completely exhausted PD-1-positive",
            "probability": 0.052766534053194585,
            "start_logit": 0.4945567846298218,
            "end_logit": 1.554388165473938
        },
        {
            "text": "display an activated but not completely exhausted",
            "probability": 0.051959191700803625,
            "start_logit": 0.4945567846298218,
            "end_logit": 1.53896963596344
        },
        {
            "text": "activated but not completely exhausted PD-1-positive Tim-3-negative phenotype",
            "probability": 0.041988509247047875,
            "start_logit": 0.5588374137878418,
            "end_logit": 1.2616263628005981
        },
        {
            "text": "display an activated but not completely exhausted PD-1-positive Tim-3-negative phenotype",
            "probability": 0.03937438044677592,
            "start_logit": 0.4945567846298218,
            "end_logit": 1.2616263628005981
        },
        {
            "text": "an activated but not completely exhausted PD-1-positive",
            "probability": 0.0282017951376244,
            "start_logit": -0.1319347470998764,
            "end_logit": 1.554388165473938
        },
        {
            "text": "an activated but not completely exhausted",
            "probability": 0.027770299985695256,
            "start_logit": -0.1319347470998764,
            "end_logit": 1.53896963596344
        },
        {
            "text": "an activated but not completely exhausted PD-1-positive Tim-3-negative phenotype",
            "probability": 0.02104417564950206,
            "start_logit": -0.1319347470998764,
            "end_logit": 1.2616263628005981
        },
        {
            "text": "Tim-3-negative phenotype",
            "probability": 0.0185186718421508,
            "start_logit": -0.25977906584739685,
            "end_logit": 1.2616263628005981
        },
        {
            "text": "PD-1-positive",
            "probability": 0.012276634361320855,
            "start_logit": -0.9636225700378418,
            "end_logit": 1.554388165473938
        },
        {
            "text": "highly express OX40 co-stimulatory receptor, less frequently 4-1BB, and display an activated but not completely exhausted",
            "probability": 0.012015157410617757,
            "start_logit": -0.9697328805923462,
            "end_logit": 1.53896963596344
        },
        {
            "text": "PD-1-positive Tim-3-negative phenotype",
            "probability": 0.0091608228704448,
            "start_logit": -0.9636225700378418,
            "end_logit": 1.2616263628005981
        },
        {
            "text": "negative phenotype",
            "probability": 0.006918863600332381,
            "start_logit": -1.244307041168213,
            "end_logit": 1.2616263628005981
        },
        {
            "text": "activated but not completely exhausted PD-1-positive Tim-3-negative phenotype.",
            "probability": 0.0037897432338992376,
            "start_logit": 0.5588374137878418,
            "end_logit": -1.143471360206604
        },
        {
            "text": "display an activated but not completely exhausted PD-1-positive Tim-3-negative phenotype.",
            "probability": 0.0035538006602993362,
            "start_logit": 0.4945567846298218,
            "end_logit": -1.143471360206604
        },
        {
            "text": "favorable outcome in NSCLC, independently of the size of T and B cell infiltrates",
            "probability": 0.0035040005523502664,
            "start_logit": -0.4624972641468048,
            "end_logit": -0.20052962005138397
        },
        {
            "text": "favorable outcome in NSCLC",
            "probability": 0.002802315924611788,
            "start_logit": -0.4624972641468048,
            "end_logit": -0.4239887595176697
        },
        {
            "text": "highly express OX40 co-stimulatory receptor",
            "probability": 0.0023902033564762743,
            "start_logit": -0.9697328805923462,
            "end_logit": -0.07582088559865952
        }
    ],
    "5c7a4c35d774d04240000007_008": [
        {
            "text": "",
            "probability": 0.524402473496537,
            "start_logit": 0.7135099768638611,
            "end_logit": 0.7061262130737305
        },
        {
            "text": "overexpression of targetable immune checkpoints",
            "probability": 0.06615314808183452,
            "start_logit": 0.3157438635826111,
            "end_logit": -0.9663946628570557
        },
        {
            "text": "overexpression of targetable immune checkpoints, such as CTLA-4 and TIM-3 were associated with EMT",
            "probability": 0.06567445720979755,
            "start_logit": 0.3157438635826111,
            "end_logit": -0.9736570715904236
        },
        {
            "text": "overexpression",
            "probability": 0.03964004933491174,
            "start_logit": 0.3157438635826111,
            "end_logit": -1.4785271883010864
        },
        {
            "text": "An association may exist between immune exclusion and EMT in NSCLC",
            "probability": 0.037963968936231066,
            "start_logit": -0.9250208735466003,
            "end_logit": -0.2809648811817169
        },
        {
            "text": "associated with EMT in both NSCLCs. An association may exist between immune exclusion and EMT in NSCLC",
            "probability": 0.03152403424792594,
            "start_logit": -1.1109081506729126,
            "end_logit": -0.2809648811817169
        },
        {
            "text": "associated with EMT in both NSCLCs",
            "probability": 0.03017351148720694,
            "start_logit": -1.1109081506729126,
            "end_logit": -0.324750691652298
        },
        {
            "text": "overexpression of targetable immune checkpoints, such as CTLA-4 and TIM-3",
            "probability": 0.022604780834345948,
            "start_logit": 0.3157438635826111,
            "end_logit": -2.040205717086792
        },
        {
            "text": "An association may exist between immune exclusion and EMT in NSCLC. Further investigation is merited as its mechanism is not completely understood",
            "probability": 0.022029607930185387,
            "start_logit": -0.9250208735466003,
            "end_logit": -0.8252150416374207
        },
        {
            "text": "not completely understood",
            "probability": 0.017258657696238335,
            "start_logit": -1.1690943241119385,
            "end_logit": -0.8252150416374207
        },
        {
            "text": "associated with EMT in both NSCLCs.",
            "probability": 0.017126288158001175,
            "start_logit": -1.1109081506729126,
            "end_logit": -0.8911005258560181
        },
        {
            "text": "not completely understood and a better understanding of this association could lead to the development of biomarkers that could accurately predict response to immunotherapy",
            "probability": 0.015958894104977674,
            "start_logit": -1.1690943241119385,
            "end_logit": -0.9035126566886902
        },
        {
            "text": "associated with EMT",
            "probability": 0.01576919031826066,
            "start_logit": -1.1109081506729126,
            "end_logit": -0.9736570715904236
        },
        {
            "text": "were associated with EMT in both NSCLCs. An association may exist between immune exclusion and EMT in NSCLC",
            "probability": 0.015521693963647247,
            "start_logit": -1.8194197416305542,
            "end_logit": -0.2809648811817169
        },
        {
            "text": "its mechanism is not completely understood",
            "probability": 0.014870541438713976,
            "start_logit": -1.318026065826416,
            "end_logit": -0.8252150416374207
        },
        {
            "text": "were associated with EMT in both NSCLCs",
            "probability": 0.014856728280068865,
            "start_logit": -1.8194197416305542,
            "end_logit": -0.324750691652298
        },
        {
            "text": "TIM-3 were associated with EMT in both NSCLCs. An association may exist between immune exclusion and EMT in NSCLC",
            "probability": 0.013757589417478667,
            "start_logit": -1.9400677680969238,
            "end_logit": -0.2809648811817169
        },
        {
            "text": "TIM-3 were associated with EMT in both NSCLCs",
            "probability": 0.013168199826831515,
            "start_logit": -1.9400677680969238,
            "end_logit": -0.324750691652298
        },
        {
            "text": "overexpression of targetable immune checkpoints, such as CTLA-4 and TIM-3 were associated",
            "probability": 0.013113603244568499,
            "start_logit": 0.3157438635826111,
            "end_logit": -2.584717035293579
        },
        {
            "text": "were associated with EMT in both NSCLCs.",
            "probability": 0.008432581992237233,
            "start_logit": -1.8194197416305542,
            "end_logit": -0.8911005258560181
        }
    ],
    "5e30b56efbd6abf43b000037_002": [
        {
            "text": "The adaptation of the CRISPR-Cas9 system",
            "probability": 0.1581645695635648,
            "start_logit": 1.2036700248718262,
            "end_logit": 1.4196687936782837
        },
        {
            "text": "CRISPR-Cas9 system",
            "probability": 0.15545635680703188,
            "start_logit": 1.186398983001709,
            "end_logit": 1.4196687936782837
        },
        {
            "text": "The adaptation of the CRISPR-Cas9",
            "probability": 0.1262843699657923,
            "start_logit": 1.2036700248718262,
            "end_logit": 1.1945689916610718
        },
        {
            "text": "CRISPR-Cas9",
            "probability": 0.12412203397211301,
            "start_logit": 1.186398983001709,
            "end_logit": 1.1945689916610718
        },
        {
            "text": "The adaptation of the CRISPR-Cas9 system to pooled library gene knockout screens in mammalian cells",
            "probability": 0.06911013888413024,
            "start_logit": 1.2036700248718262,
            "end_logit": 0.5917341709136963
        },
        {
            "text": "CRISPR-Cas9 system to pooled library gene knockout screens in mammalian cells",
            "probability": 0.06792678309055256,
            "start_logit": 1.186398983001709,
            "end_logit": 0.5917341709136963
        },
        {
            "text": "adaptation of the CRISPR-Cas9 system",
            "probability": 0.06458935472344648,
            "start_logit": 0.30808356404304504,
            "end_logit": 1.4196687936782837
        },
        {
            "text": "adaptation of the CRISPR-Cas9",
            "probability": 0.05157050020908406,
            "start_logit": 0.30808356404304504,
            "end_logit": 1.1945689916610718
        },
        {
            "text": "adaptation of the CRISPR-Cas9 system to pooled library gene knockout screens in mammalian cells",
            "probability": 0.028222371721372087,
            "start_logit": 0.30808356404304504,
            "end_logit": 0.5917341709136963
        },
        {
            "text": "the CRISPR-Cas9 system",
            "probability": 0.02732466756715208,
            "start_logit": -0.5521761775016785,
            "end_logit": 1.4196687936782837
        },
        {
            "text": "The adaptation of the CRISPR-Cas9 system to pooled library gene knockout screens",
            "probability": 0.02613458040685364,
            "start_logit": 1.2036700248718262,
            "end_logit": -0.38070791959762573
        },
        {
            "text": "CRISPR-Cas9 system to pooled library gene knockout screens",
            "probability": 0.02568708445855257,
            "start_logit": 1.186398983001709,
            "end_logit": -0.38070791959762573
        },
        {
            "text": "the CRISPR-Cas9",
            "probability": 0.021817012734041706,
            "start_logit": -0.5521761775016785,
            "end_logit": 1.1945689916610718
        },
        {
            "text": "the CRISPR-Cas9 system to pooled library gene knockout screens in mammalian cells",
            "probability": 0.011939535989250962,
            "start_logit": -0.5521761775016785,
            "end_logit": 0.5917341709136963
        },
        {
            "text": "adaptation of the CRISPR-Cas9 system to pooled library gene knockout screens",
            "probability": 0.010672527286639292,
            "start_logit": 0.30808356404304504,
            "end_logit": -0.38070791959762573
        },
        {
            "text": "The adaptation of the CRISPR-Cas9 system to pooled library gene knockout screens in mammalian cells represents a major technological leap over RNA interference",
            "probability": 0.00768015271845673,
            "start_logit": 1.2036700248718262,
            "end_logit": -1.605327844619751
        },
        {
            "text": "CRISPR-Cas9 system to pooled library gene knockout screens in mammalian cells represents a major technological leap over RNA interference",
            "probability": 0.007548647365382781,
            "start_logit": 1.186398983001709,
            "end_logit": -1.605327844619751
        },
        {
            "text": "The adaptation",
            "probability": 0.005484076719460313,
            "start_logit": 1.2036700248718262,
            "end_logit": -1.942118525505066
        },
        {
            "text": "the CRISPR-Cas9 system to pooled library gene knockout screens",
            "probability": 0.0045150359754703735,
            "start_logit": -0.5521761775016785,
            "end_logit": -0.38070791959762573
        },
        {
            "text": "The adaptation of the CRISPR",
            "probability": 0.004137233720989845,
            "start_logit": 1.2036700248718262,
            "end_logit": -2.223939895629883
        },
        {
            "text": "",
            "probability": 0.0016129661206624637,
            "start_logit": -1.2256896495819092,
            "end_logit": -0.7365328073501587
        }
    ],
    "5e2a1096aa19d7443100000e_001": [
        {
            "text": "a modified mRNA encoding vascular endothelial growth factor A",
            "probability": 0.38974741510224287,
            "start_logit": 5.683853626251221,
            "end_logit": 4.298601150512695
        },
        {
            "text": "a modified mRNA encoding vascular endothelial growth factor A (VEGF-A)",
            "probability": 0.31109844177465557,
            "start_logit": 5.683853626251221,
            "end_logit": 4.073211669921875
        },
        {
            "text": "a modified mRNA encoding vascular endothelial growth factor A (VEGF-A",
            "probability": 0.09835101742258795,
            "start_logit": 5.683853626251221,
            "end_logit": 2.921645164489746
        },
        {
            "text": "a modified mRNA",
            "probability": 0.029556582460407096,
            "start_logit": 5.683853626251221,
            "end_logit": 1.7194087505340576
        },
        {
            "text": "mRNA encoding vascular endothelial growth factor A",
            "probability": 0.027685464944815597,
            "start_logit": 3.039262294769287,
            "end_logit": 4.298601150512695
        },
        {
            "text": "modified mRNA encoding vascular endothelial growth factor A",
            "probability": 0.025595305156071637,
            "start_logit": 2.960763692855835,
            "end_logit": 4.298601150512695
        },
        {
            "text": "mRNA encoding vascular endothelial growth factor A (VEGF-A)",
            "probability": 0.0220986840974418,
            "start_logit": 3.039262294769287,
            "end_logit": 4.073211669921875
        },
        {
            "text": "modified mRNA encoding vascular endothelial growth factor A (VEGF-A)",
            "probability": 0.020430307533179766,
            "start_logit": 2.960763692855835,
            "end_logit": 4.073211669921875
        },
        {
            "text": "a modified mRNA encoding vascular endothelial growth factor",
            "probability": 0.019409033569529076,
            "start_logit": 5.683853626251221,
            "end_logit": 1.298840880393982
        },
        {
            "text": "vascular endothelial growth factor A",
            "probability": 0.013324320545197848,
            "start_logit": 2.307945728302002,
            "end_logit": 4.298601150512695
        },
        {
            "text": "vascular endothelial growth factor A (VEGF-A)",
            "probability": 0.010635542914966276,
            "start_logit": 2.307945728302002,
            "end_logit": 4.073211669921875
        },
        {
            "text": "mRNA encoding vascular endothelial growth factor A (VEGF-A",
            "probability": 0.006986303281641283,
            "start_logit": 3.039262294769287,
            "end_logit": 2.921645164489746
        },
        {
            "text": "modified mRNA encoding vascular endothelial growth factor A (VEGF-A",
            "probability": 0.00645886080522403,
            "start_logit": 2.960763692855835,
            "end_logit": 2.921645164489746
        },
        {
            "text": "VEGF-A)",
            "probability": 0.004877632724454239,
            "start_logit": 1.5284042358398438,
            "end_logit": 4.073211669921875
        },
        {
            "text": "vascular endothelial growth factor A (VEGF-A",
            "probability": 0.003362332709098598,
            "start_logit": 2.307945728302002,
            "end_logit": 2.921645164489746
        },
        {
            "text": "a modified mRNA encoding vascular",
            "probability": 0.0024661447206358713,
            "start_logit": 5.683853626251221,
            "end_logit": -0.764241635799408
        },
        {
            "text": "a modified mRNA encoding vascular endothelial growth factor A (VEGF-A),",
            "probability": 0.0023308158549327287,
            "start_logit": 5.683853626251221,
            "end_logit": -0.8206793665885925
        },
        {
            "text": "mRNA",
            "probability": 0.0020995334308541594,
            "start_logit": 3.039262294769287,
            "end_logit": 1.7194087505340576
        },
        {
            "text": "modified mRNA",
            "probability": 0.0019410256954398484,
            "start_logit": 2.960763692855835,
            "end_logit": 1.7194087505340576
        },
        {
            "text": "VEGF-A",
            "probability": 0.0015420203917680488,
            "start_logit": 1.5284042358398438,
            "end_logit": 2.921645164489746
        },
        {
            "text": "",
            "probability": 3.214864855710252e-06,
            "start_logit": -0.6128255724906921,
            "end_logit": -1.1101884841918945
        }
    ],
    "5e48edb1f8b2df0d49000002_001": [
        {
            "text": "",
            "probability": 0.9999775246104113,
            "start_logit": 5.600196838378906,
            "end_logit": 5.696179389953613
        },
        {
            "text": "proton beams",
            "probability": 2.0361500783331477e-05,
            "start_logit": 0.511870801448822,
            "end_logit": -0.017336754128336906
        },
        {
            "text": "protons",
            "probability": 8.438456869146334e-07,
            "start_logit": -1.0614137649536133,
            "end_logit": -1.6274837255477905
        },
        {
            "text": "hadron beams, especially proton beams",
            "probability": 3.132087867583385e-07,
            "start_logit": -3.6626603603363037,
            "end_logit": -0.017336754128336906
        },
        {
            "text": "proton",
            "probability": 1.9518229199779867e-07,
            "start_logit": 0.511870801448822,
            "end_logit": -4.664803981781006
        },
        {
            "text": "protons themselves to develop images of tumors",
            "probability": 1.5403330819210474e-07,
            "start_logit": -1.0614137649536133,
            "end_logit": -3.328284502029419
        },
        {
            "text": "protons themselves to develop images of tumors and surrounding tissue",
            "probability": 1.5154230848280415e-07,
            "start_logit": -1.0614137649536133,
            "end_logit": -3.3445885181427
        },
        {
            "text": "beams, especially proton beams",
            "probability": 1.274140941510303e-07,
            "start_logit": -4.5620880126953125,
            "end_logit": -0.017336754128336906
        },
        {
            "text": "beams",
            "probability": 7.24056601952527e-08,
            "start_logit": -5.127245903015137,
            "end_logit": -0.017336754128336906
        },
        {
            "text": "proton beams,",
            "probability": 4.9485895383728133e-08,
            "start_logit": 0.511870801448822,
            "end_logit": -6.037050247192383
        },
        {
            "text": "especially proton beams",
            "probability": 4.556994578172169e-08,
            "start_logit": -5.590281963348389,
            "end_logit": -0.017336754128336906
        },
        {
            "text": "proton beams, in cancer radiotherapy",
            "probability": 3.7451470934571996e-08,
            "start_logit": 0.511870801448822,
            "end_logit": -6.315691947937012
        },
        {
            "text": "protons themselves to develop images",
            "probability": 2.111728434100231e-08,
            "start_logit": -1.0614137649536133,
            "end_logit": -5.315361499786377
        },
        {
            "text": "tumors",
            "probability": 1.95915855463685e-08,
            "start_logit": -3.1234824657440186,
            "end_logit": -3.328284502029419
        },
        {
            "text": "tumors and surrounding tissue",
            "probability": 1.927475385279819e-08,
            "start_logit": -3.1234824657440186,
            "end_logit": -3.3445885181427
        },
        {
            "text": "protons themselves",
            "probability": 1.8786857735559972e-08,
            "start_logit": -1.0614137649536133,
            "end_logit": -5.432295799255371
        },
        {
            "text": "phantoms in hospital proton beams",
            "probability": 1.5269390904333037e-08,
            "start_logit": -3.26859712600708,
            "end_logit": -3.432419776916504
        },
        {
            "text": "hadron beams, especially proton beams,",
            "probability": 1.4097234830042263e-08,
            "start_logit": -6.763551712036133,
            "end_logit": -0.017336754128336906
        },
        {
            "text": "hadron beams",
            "probability": 7.823972753922156e-09,
            "start_logit": -3.6626603603363037,
            "end_logit": -3.707014322280884
        },
        {
            "text": "Bragg peak throughout the tumor being treated. A half century ago, suggestions had already been made to use protons",
            "probability": 7.788277364486806e-09,
            "start_logit": -5.746763706207275,
            "end_logit": -1.6274837255477905
        }
    ],
    "5e2b2c85fbd6abf43b000007_001": [
        {
            "text": "Grade IV vestibular schwannoma",
            "probability": 0.7850642037380253,
            "start_logit": 7.508752822875977,
            "end_logit": 9.425843238830566
        },
        {
            "text": "vestibular schwannoma",
            "probability": 0.21373119582089178,
            "start_logit": 6.207706451416016,
            "end_logit": 9.425843238830566
        },
        {
            "text": "schwannoma",
            "probability": 0.0007756129991039934,
            "start_logit": 0.5888857245445251,
            "end_logit": 9.425843238830566
        },
        {
            "text": "IV vestibular schwannoma",
            "probability": 0.00012908723508413936,
            "start_logit": -1.2042795419692993,
            "end_logit": 9.425843238830566
        },
        {
            "text": "Grade IV vestibular schwannoma (Koos classification",
            "probability": 5.974027081661648e-05,
            "start_logit": 7.508752822875977,
            "end_logit": -0.0576711967587471
        },
        {
            "text": "Grade IV",
            "probability": 5.9513530874611636e-05,
            "start_logit": 7.508752822875977,
            "end_logit": -0.061473846435546875
        },
        {
            "text": "Grade IV vestibular schwannoma (",
            "probability": 5.646499331106576e-05,
            "start_logit": 7.508752822875977,
            "end_logit": -0.11405668407678604
        },
        {
            "text": "Grade IV vestibular schwannoma (Koos",
            "probability": 4.8155982650324956e-05,
            "start_logit": 7.508752822875977,
            "end_logit": -0.2732321619987488
        },
        {
            "text": "Grade IV vestibular",
            "probability": 1.738639869435802e-05,
            "start_logit": 7.508752822875977,
            "end_logit": -1.2919893264770508
        },
        {
            "text": "vestibular schwannoma (Koos classification",
            "probability": 1.626409592935681e-05,
            "start_logit": 6.207706451416016,
            "end_logit": -0.0576711967587471
        },
        {
            "text": "vestibular schwannoma (",
            "probability": 1.5372412198811607e-05,
            "start_logit": 6.207706451416016,
            "end_logit": -0.11405668407678604
        },
        {
            "text": "vestibular schwannoma (Koos",
            "probability": 1.311031086219114e-05,
            "start_logit": 6.207706451416016,
            "end_logit": -0.2732321619987488
        },
        {
            "text": "vestibular",
            "probability": 4.733390933213355e-06,
            "start_logit": 6.207706451416016,
            "end_logit": -1.2919893264770508
        },
        {
            "text": "Grade IV vestibular sc",
            "probability": 3.595012023699053e-06,
            "start_logit": 7.508752822875977,
            "end_logit": -2.8681302070617676
        },
        {
            "text": "Grade IV vestibular schwannoma (Koos classification)",
            "probability": 3.452702718726759e-06,
            "start_logit": 7.508752822875977,
            "end_logit": -2.908520221710205
        },
        {
            "text": "vestibular sc",
            "probability": 9.787304212281794e-07,
            "start_logit": 6.207706451416016,
            "end_logit": -2.8681302070617676
        },
        {
            "text": "vestibular schwannoma (Koos classification)",
            "probability": 9.399871722259384e-07,
            "start_logit": 6.207706451416016,
            "end_logit": -2.908520221710205
        },
        {
            "text": "",
            "probability": 7.758199229389089e-08,
            "start_logit": -0.2867985665798187,
            "end_logit": 1.0914539098739624
        },
        {
            "text": "schwannoma (Koos classification",
            "probability": 5.902107164578187e-08,
            "start_logit": 0.5888857245445251,
            "end_logit": -0.0576711967587471
        },
        {
            "text": "schwannoma (",
            "probability": 5.5785224441333664e-08,
            "start_logit": 0.5888857245445251,
            "end_logit": -0.11405668407678604
        }
    ],
    "5e2b2c85fbd6abf43b000007_002": [
        {
            "text": "",
            "probability": 0.9999217005521103,
            "start_logit": 6.867321491241455,
            "end_logit": 7.055568695068359
        },
        {
            "text": "vestibular schwannoma",
            "probability": 3.974296464150058e-05,
            "start_logit": 1.433751106262207,
            "end_logit": 2.356139659881592
        },
        {
            "text": "unilateral vestibular schwannoma",
            "probability": 1.7870714970109318e-05,
            "start_logit": 0.6344816088676453,
            "end_logit": 2.356139659881592
        },
        {
            "text": "QOL) in small unilateral vestibular schwannoma",
            "probability": 9.15163108687036e-06,
            "start_logit": -0.034749604761600494,
            "end_logit": 2.356139659881592
        },
        {
            "text": "small unilateral vestibular schwannoma",
            "probability": 4.059841660825333e-06,
            "start_logit": -0.8475377559661865,
            "end_logit": 2.356139659881592
        },
        {
            "text": "vestibular schwannoma (VS)",
            "probability": 1.6930436518968912e-06,
            "start_logit": 1.433751106262207,
            "end_logit": -0.7997652888298035
        },
        {
            "text": "quality of life (QOL) in small unilateral vestibular schwannoma",
            "probability": 1.1609988728378692e-06,
            "start_logit": -2.0994009971618652,
            "end_logit": 2.356139659881592
        },
        {
            "text": "QOL)",
            "probability": 9.631755976521976e-07,
            "start_logit": -0.034749604761600494,
            "end_logit": 0.10468799620866776
        },
        {
            "text": "QOL",
            "probability": 9.002336285752961e-07,
            "start_logit": -0.034749604761600494,
            "end_logit": 0.03710657358169556
        },
        {
            "text": "unilateral vestibular schwannoma (VS)",
            "probability": 7.612894711787146e-07,
            "start_logit": 0.6344816088676453,
            "end_logit": -0.7997652888298035
        },
        {
            "text": "(QOL) in small unilateral vestibular schwannoma",
            "probability": 4.6670258783281807e-07,
            "start_logit": -3.01074481010437,
            "end_logit": 2.356139659881592
        },
        {
            "text": "QOL) in small unilateral vestibular schwannoma (VS)",
            "probability": 3.8985795488313366e-07,
            "start_logit": -0.034749604761600494,
            "end_logit": -0.7997652888298035
        },
        {
            "text": "schwannoma",
            "probability": 3.4010219024578343e-07,
            "start_logit": -3.32719087600708,
            "end_logit": 2.356139659881592
        },
        {
            "text": "small unilateral vestibular schwannoma (VS)",
            "probability": 1.7294857627177102e-07,
            "start_logit": -0.8475377559661865,
            "end_logit": -0.7997652888298035
        },
        {
            "text": "vestibular",
            "probability": 1.3848293707234042e-07,
            "start_logit": 1.433751106262207,
            "end_logit": -3.3033013343811035
        },
        {
            "text": "quality of life (QOL)",
            "probability": 1.221908720537768e-07,
            "start_logit": -2.0994009971618652,
            "end_logit": 0.10468799620866776
        },
        {
            "text": "quality of life (QOL",
            "probability": 1.1420589599226154e-07,
            "start_logit": -2.0994009971618652,
            "end_logit": 0.03710657358169556
        },
        {
            "text": "vestibular schwannoma (VS) patients",
            "probability": 1.0312285962346438e-07,
            "start_logit": 1.433751106262207,
            "end_logit": -3.5981273651123047
        },
        {
            "text": "unilateral",
            "probability": 8.567056816762007e-08,
            "start_logit": 0.6344816088676453,
            "end_logit": -2.984269618988037
        },
        {
            "text": "unilateral vestibular",
            "probability": 6.22698663516195e-08,
            "start_logit": 0.6344816088676453,
            "end_logit": -3.3033013343811035
        }
    ],
    "5e2b2c85fbd6abf43b000007_004": [
        {
            "text": "vestibular schwannoma",
            "probability": 0.9461940517233386,
            "start_logit": 4.214707374572754,
            "end_logit": 4.104953289031982
        },
        {
            "text": "vestibular schwannomas",
            "probability": 0.03327926325158568,
            "start_logit": 2.747084617614746,
            "end_logit": 2.225062847137451
        },
        {
            "text": "",
            "probability": 0.016760802382835813,
            "start_logit": 2.817861318588257,
            "end_logit": 1.4683946371078491
        },
        {
            "text": "vestibular",
            "probability": 0.001419232427428952,
            "start_logit": 4.214707374572754,
            "end_logit": -2.3973782062530518
        },
        {
            "text": "schwannoma",
            "probability": 0.0007950569128061408,
            "start_logit": -2.867081880569458,
            "end_logit": 4.104953289031982
        },
        {
            "text": "vestibular schwannomas is designed to stratify tumors",
            "probability": 0.0006124421886706474,
            "start_logit": 3.908182144165039,
            "end_logit": -2.931269884109497
        },
        {
            "text": "vestibular schwannoma is a reliable method for tumor",
            "probability": 0.00023196471031168003,
            "start_logit": 4.214707374572754,
            "end_logit": -4.208664417266846
        },
        {
            "text": "vest",
            "probability": 0.00018256698589616364,
            "start_logit": 4.214707374572754,
            "end_logit": -4.448132514953613
        },
        {
            "text": "Koos classification system for vestibular schwannoma",
            "probability": 0.00015643715085707102,
            "start_logit": -4.4928412437438965,
            "end_logit": 4.104953289031982
        },
        {
            "text": "vestibular sc",
            "probability": 0.00014516631310485537,
            "start_logit": 4.214707374572754,
            "end_logit": -4.677369594573975
        },
        {
            "text": "vestibular schwannomas is designed to stratify tumors based on extrameatal extension and compression of the brainstem.",
            "probability": 0.00011289984056798405,
            "start_logit": 3.908182144165039,
            "end_logit": -4.622223377227783
        },
        {
            "text": "vestibular schwannomas is designed to stratify tumors based on extrameatal extension and compression of the brainstem",
            "probability": 8.249757605729741e-05,
            "start_logit": 3.908182144165039,
            "end_logit": -4.93595552444458
        },
        {
            "text": "schwannomas",
            "probability": 2.3308944255417934e-05,
            "start_logit": -4.516767978668213,
            "end_logit": 2.225062847137451
        },
        {
            "text": "Koos classification of vestibular schwannomas",
            "probability": 1.9241849399541172e-06,
            "start_logit": -4.8357648849487305,
            "end_logit": 0.049725063145160675
        },
        {
            "text": "The Koos classification of vestibular schwannomas",
            "probability": 9.433813463896258e-07,
            "start_logit": -5.5485520362854,
            "end_logit": 0.049725063145160675
        },
        {
            "text": "tumors",
            "probability": 4.803191839143157e-07,
            "start_logit": -3.242576837539673,
            "end_logit": -2.931269884109497
        },
        {
            "text": "schwannomas is designed to stratify tumors",
            "probability": 4.101695222532261e-07,
            "start_logit": -3.4004571437835693,
            "end_logit": -2.931269884109497
        },
        {
            "text": "Koos classification system for vestibular",
            "probability": 2.3464602947627447e-07,
            "start_logit": -4.4928412437438965,
            "end_logit": -2.3973782062530518
        },
        {
            "text": "schwannoma is a reliable method for tumor",
            "probability": 1.9491260394680637e-07,
            "start_logit": -2.867081880569458,
            "end_logit": -4.208664417266846
        },
        {
            "text": "sc",
            "probability": 1.219786581097032e-07,
            "start_logit": -2.867081880569458,
            "end_logit": -4.677369594573975
        }
    ],
    "5e2b2c85fbd6abf43b000007_006": [
        {
            "text": "vestibular schwannoma",
            "probability": 0.7585060488870744,
            "start_logit": 5.303017616271973,
            "end_logit": 5.778717994689941
        },
        {
            "text": "",
            "probability": 0.23193035631527645,
            "start_logit": 5.114443302154541,
            "end_logit": 4.782378673553467
        },
        {
            "text": "middle fossa craniotomy for vestibular schwannoma",
            "probability": 0.002571408015754697,
            "start_logit": -0.38387954235076904,
            "end_logit": 5.778717994689941
        },
        {
            "text": "vestibular schwannoma (stage I or II of Koos classification",
            "probability": 0.0015459116008763208,
            "start_logit": 5.303017616271973,
            "end_logit": -0.4170190095901489
        },
        {
            "text": "vestibular schwannoma (stage I or II of Koos classification)",
            "probability": 0.001470608269259843,
            "start_logit": 5.303017616271973,
            "end_logit": -0.4669566750526428
        },
        {
            "text": "schwannoma",
            "probability": 0.0013223357114335562,
            "start_logit": -1.048933506011963,
            "end_logit": 5.778717994689941
        },
        {
            "text": "vestibular schwannoma (stage I or II",
            "probability": 0.0012618474344630202,
            "start_logit": 5.303017616271973,
            "end_logit": -0.6200559139251709
        },
        {
            "text": "vestibular schwannoma (stage I or II of Koos",
            "probability": 0.0004978253665370353,
            "start_logit": 5.303017616271973,
            "end_logit": -1.5501387119293213
        },
        {
            "text": "vestibular",
            "probability": 0.00019394931887253605,
            "start_logit": 5.303017616271973,
            "end_logit": -2.492791175842285
        },
        {
            "text": "vestibular schwannoma (",
            "probability": 0.00018347037693953834,
            "start_logit": 5.303017616271973,
            "end_logit": -2.548334836959839
        },
        {
            "text": "vestibular sc",
            "probability": 0.00016562218241942357,
            "start_logit": 5.303017616271973,
            "end_logit": -2.650678873062134
        },
        {
            "text": "craniotomy for vestibular schwannoma",
            "probability": 0.00016269676181923908,
            "start_logit": -3.144200325012207,
            "end_logit": 5.778717994689941
        },
        {
            "text": "PATIENTS: Eighteen patients who underwent a middle fossa craniotomy for vestibular schwannoma",
            "probability": 0.00015189390960946179,
            "start_logit": -3.2129061222076416,
            "end_logit": 5.778717994689941
        },
        {
            "text": "middle fossa craniotomy",
            "probability": 9.148361646818447e-06,
            "start_logit": -0.38387954235076904,
            "end_logit": 0.140083909034729
        },
        {
            "text": "middle fossa craniotomy for vestibular schwannoma (stage I or II of Koos classification",
            "probability": 5.240788109698208e-06,
            "start_logit": -0.38387954235076904,
            "end_logit": -0.4170190095901489
        },
        {
            "text": "middle fossa craniotomy for vestibular schwannoma (stage I or II of Koos classification)",
            "probability": 4.985502616832648e-06,
            "start_logit": -0.38387954235076904,
            "end_logit": -0.4669566750526428
        },
        {
            "text": "stage I or II of Koos classification",
            "probability": 4.47091207186114e-06,
            "start_logit": -0.5427590012550354,
            "end_logit": -0.4170190095901489
        },
        {
            "text": "middle fossa craniotomy for vestibular schwannoma (stage I or II",
            "probability": 4.277783430202784e-06,
            "start_logit": -0.38387954235076904,
            "end_logit": -0.6200559139251709
        },
        {
            "text": "stage I or II of Koos classification)",
            "probability": 4.253128225627873e-06,
            "start_logit": -0.5427590012550354,
            "end_logit": -0.4669566750526428
        },
        {
            "text": "stage I or II",
            "probability": 3.6493735633976126e-06,
            "start_logit": -0.5427590012550354,
            "end_logit": -0.6200559139251709
        }
    ],
    "5c7a4ed5d774d04240000008_002": [
        {
            "text": "",
            "probability": 0.999999600545186,
            "start_logit": 6.948394775390625,
            "end_logit": 7.379852294921875
        },
        {
            "text": "they may provide real-time information on patient's disease status",
            "probability": 1.817845521796704e-07,
            "start_logit": -0.7420362234115601,
            "end_logit": -0.4501599371433258
        },
        {
            "text": "mutation analysis of circulating tumor cells (CTCs) may be desirable since they may provide real-time information on patient's disease status",
            "probability": 6.204270102527538e-08,
            "start_logit": -1.8170355558395386,
            "end_logit": -0.4501599371433258
        },
        {
            "text": "provide real-time information on patient's disease status",
            "probability": 4.9898736076407035e-08,
            "start_logit": -2.034862756729126,
            "end_logit": -0.4501599371433258
        },
        {
            "text": "may be desirable since they may provide real-time information on patient's disease status",
            "probability": 2.3860159358197324e-08,
            "start_logit": -2.772648334503174,
            "end_logit": -0.4501599371433258
        },
        {
            "text": "may provide real-time information on patient's disease status",
            "probability": 1.7227574056775388e-08,
            "start_logit": -3.0983471870422363,
            "end_logit": -0.4501599371433258
        },
        {
            "text": "real-time information on patient's disease status",
            "probability": 1.3031631470272875e-08,
            "start_logit": -3.377478837966919,
            "end_logit": -0.4501599371433258
        },
        {
            "text": "mutation analysis of circulating tumor cells (CTCs) may be desirable",
            "probability": 1.2205792025974449e-08,
            "start_logit": -1.8170355558395386,
            "end_logit": -2.0760722160339355
        },
        {
            "text": "mutation analysis of circulating tumor cells",
            "probability": 8.181450780699703e-09,
            "start_logit": -1.8170355558395386,
            "end_logit": -2.4761133193969727
        },
        {
            "text": "circulating tumor cells (CTCs) may be desirable since they may provide real-time information on patient's disease status",
            "probability": 7.249645845130208e-09,
            "start_logit": -3.9639058113098145,
            "end_logit": -0.4501599371433258
        },
        {
            "text": "may be desirable",
            "probability": 4.6940597043658755e-09,
            "start_logit": -2.772648334503174,
            "end_logit": -2.0760722160339355
        },
        {
            "text": "they may provide real-time information on patient's disease status.",
            "probability": 3.736917431354151e-09,
            "start_logit": -0.7420362234115601,
            "end_logit": -4.334721088409424
        },
        {
            "text": "they may provide real-time information",
            "probability": 2.9016551047214094e-09,
            "start_logit": -0.7420362234115601,
            "end_logit": -4.587700843811035
        },
        {
            "text": "desirable since they may provide real-time information on patient's disease status",
            "probability": 2.5605049864535534e-09,
            "start_logit": -5.0046539306640625,
            "end_logit": -0.4501599371433258
        },
        {
            "text": ", mutation analysis of circulating tumor cells (CTCs) may be desirable since they may provide real-time information on patient's disease status",
            "probability": 2.2740787920014254e-09,
            "start_logit": -5.123283386230469,
            "end_logit": -0.4501599371433258
        },
        {
            "text": "mutation analysis of circulating tumor cells (CTCs)",
            "probability": 2.020904615792432e-09,
            "start_logit": -1.8170355558395386,
            "end_logit": -3.8744375705718994
        },
        {
            "text": "CTCs) may be desirable since they may provide real-time information on patient's disease status",
            "probability": 1.642532964984005e-09,
            "start_logit": -5.4486188888549805,
            "end_logit": -0.4501599371433258
        },
        {
            "text": "mutation",
            "probability": 1.4402772761707954e-09,
            "start_logit": -1.8170355558395386,
            "end_logit": -4.213147163391113
        },
        {
            "text": "circulating tumor cells (CTCs) may be desirable",
            "probability": 1.4262381873345644e-09,
            "start_logit": -3.9639058113098145,
            "end_logit": -2.0760722160339355
        },
        {
            "text": "mutation analysis of circulating tumor cells (CTCs) may be desirable since they may provide real-time information on patient's disease status.",
            "probability": 1.2754023824889892e-09,
            "start_logit": -1.8170355558395386,
            "end_logit": -4.334721088409424
        }
    ],
    "5c7a4ed5d774d04240000008_003": [
        {
            "text": "",
            "probability": 0.999999600545186,
            "start_logit": 6.948394775390625,
            "end_logit": 7.379852294921875
        },
        {
            "text": "they may provide real-time information on patient's disease status",
            "probability": 1.817845521796704e-07,
            "start_logit": -0.7420362234115601,
            "end_logit": -0.4501599371433258
        },
        {
            "text": "mutation analysis of circulating tumor cells (CTCs) may be desirable since they may provide real-time information on patient's disease status",
            "probability": 6.204270102527538e-08,
            "start_logit": -1.8170355558395386,
            "end_logit": -0.4501599371433258
        },
        {
            "text": "provide real-time information on patient's disease status",
            "probability": 4.9898736076407035e-08,
            "start_logit": -2.034862756729126,
            "end_logit": -0.4501599371433258
        },
        {
            "text": "may be desirable since they may provide real-time information on patient's disease status",
            "probability": 2.3860159358197324e-08,
            "start_logit": -2.772648334503174,
            "end_logit": -0.4501599371433258
        },
        {
            "text": "may provide real-time information on patient's disease status",
            "probability": 1.7227574056775388e-08,
            "start_logit": -3.0983471870422363,
            "end_logit": -0.4501599371433258
        },
        {
            "text": "real-time information on patient's disease status",
            "probability": 1.3031631470272875e-08,
            "start_logit": -3.377478837966919,
            "end_logit": -0.4501599371433258
        },
        {
            "text": "mutation analysis of circulating tumor cells (CTCs) may be desirable",
            "probability": 1.2205792025974449e-08,
            "start_logit": -1.8170355558395386,
            "end_logit": -2.0760722160339355
        },
        {
            "text": "mutation analysis of circulating tumor cells",
            "probability": 8.181450780699703e-09,
            "start_logit": -1.8170355558395386,
            "end_logit": -2.4761133193969727
        },
        {
            "text": "circulating tumor cells (CTCs) may be desirable since they may provide real-time information on patient's disease status",
            "probability": 7.249645845130208e-09,
            "start_logit": -3.9639058113098145,
            "end_logit": -0.4501599371433258
        },
        {
            "text": "may be desirable",
            "probability": 4.6940597043658755e-09,
            "start_logit": -2.772648334503174,
            "end_logit": -2.0760722160339355
        },
        {
            "text": "they may provide real-time information on patient's disease status.",
            "probability": 3.736917431354151e-09,
            "start_logit": -0.7420362234115601,
            "end_logit": -4.334721088409424
        },
        {
            "text": "they may provide real-time information",
            "probability": 2.9016551047214094e-09,
            "start_logit": -0.7420362234115601,
            "end_logit": -4.587700843811035
        },
        {
            "text": "desirable since they may provide real-time information on patient's disease status",
            "probability": 2.5605049864535534e-09,
            "start_logit": -5.0046539306640625,
            "end_logit": -0.4501599371433258
        },
        {
            "text": ", mutation analysis of circulating tumor cells (CTCs) may be desirable since they may provide real-time information on patient's disease status",
            "probability": 2.2740787920014254e-09,
            "start_logit": -5.123283386230469,
            "end_logit": -0.4501599371433258
        },
        {
            "text": "mutation analysis of circulating tumor cells (CTCs)",
            "probability": 2.020904615792432e-09,
            "start_logit": -1.8170355558395386,
            "end_logit": -3.8744375705718994
        },
        {
            "text": "CTCs) may be desirable since they may provide real-time information on patient's disease status",
            "probability": 1.642532964984005e-09,
            "start_logit": -5.4486188888549805,
            "end_logit": -0.4501599371433258
        },
        {
            "text": "mutation",
            "probability": 1.4402772761707954e-09,
            "start_logit": -1.8170355558395386,
            "end_logit": -4.213147163391113
        },
        {
            "text": "circulating tumor cells (CTCs) may be desirable",
            "probability": 1.4262381873345644e-09,
            "start_logit": -3.9639058113098145,
            "end_logit": -2.0760722160339355
        },
        {
            "text": "mutation analysis of circulating tumor cells (CTCs) may be desirable since they may provide real-time information on patient's disease status.",
            "probability": 1.2754023824889892e-09,
            "start_logit": -1.8170355558395386,
            "end_logit": -4.334721088409424
        }
    ],
    "5c7a4ed5d774d04240000008_005": [
        {
            "text": "",
            "probability": 0.9999999957101788,
            "start_logit": 6.992912769317627,
            "end_logit": 7.357039928436279
        },
        {
            "text": "different mutations and treatments",
            "probability": 1.1922920147475234e-09,
            "start_logit": -2.7853827476501465,
            "end_logit": -3.412052869796753
        },
        {
            "text": "different mutations and treatments (and 6 healthy donors as controls",
            "probability": 7.471395893967264e-10,
            "start_logit": -2.7853827476501465,
            "end_logit": -3.8794336318969727
        },
        {
            "text": "Control values were used as baseline and results are shown in logarithmic scale.",
            "probability": 4.973082264529954e-10,
            "start_logit": -3.0374412536621094,
            "end_logit": -4.034417152404785
        },
        {
            "text": "different mutations and treatments (and 6 healthy donors as controls), were used as exosome sources",
            "probability": 2.911069963782602e-10,
            "start_logit": -2.7853827476501465,
            "end_logit": -4.821994781494141
        },
        {
            "text": "mutations and treatments",
            "probability": 2.850444011114128e-10,
            "start_logit": -4.216370582580566,
            "end_logit": -3.412052869796753
        },
        {
            "text": "different mutations",
            "probability": 1.8362864956115884e-10,
            "start_logit": -2.7853827476501465,
            "end_logit": -5.282770156860352
        },
        {
            "text": "mutations and treatments (and 6 healthy donors as controls",
            "probability": 1.7862063502229718e-10,
            "start_logit": -4.216370582580566,
            "end_logit": -3.8794336318969727
        },
        {
            "text": "One ml of plasma from 12 NSCLC patients, with different mutations and treatments",
            "probability": 1.3863836891206696e-10,
            "start_logit": -4.9371466636657715,
            "end_logit": -3.412052869796753
        },
        {
            "text": "Control values were used as baseline and results are shown in logarithmic scale",
            "probability": 1.3679779000634785e-10,
            "start_logit": -3.0374412536621094,
            "end_logit": -5.325123310089111
        },
        {
            "text": "different mutations and treatments (and 6 healthy donors",
            "probability": 1.24578851767002e-10,
            "start_logit": -2.7853827476501465,
            "end_logit": -5.670746803283691
        },
        {
            "text": "One ml of plasma from 12 NSCLC patients, with different mutations and treatments (and 6 healthy donors as controls",
            "probability": 8.687654764300999e-11,
            "start_logit": -4.9371466636657715,
            "end_logit": -3.8794336318969727
        },
        {
            "text": "plasma-isolated exosomes can be used as a non-invasive and repeatable way for the detection and follow-up of these biomarkers",
            "probability": 7.08873020683232e-11,
            "start_logit": -4.169044017791748,
            "end_logit": -4.850933074951172
        },
        {
            "text": "mutations and treatments (and 6 healthy donors as controls), were used as exosome sources",
            "probability": 6.959571851158853e-11,
            "start_logit": -4.216370582580566,
            "end_logit": -4.821994781494141
        },
        {
            "text": "plasma from 12 NSCLC patients, with different mutations and treatments",
            "probability": 6.952743900758516e-11,
            "start_logit": -5.627294063568115,
            "end_logit": -3.412052869796753
        },
        {
            "text": "plasma-isolated exosomes",
            "probability": 5.5282558425381706e-11,
            "start_logit": -4.169044017791748,
            "end_logit": -5.09956693649292
        },
        {
            "text": "mutations",
            "probability": 4.390058626044048e-11,
            "start_logit": -4.216370582580566,
            "end_logit": -5.282770156860352
        },
        {
            "text": "plasma from 12 NSCLC patients, with different mutations and treatments (and 6 healthy donors as controls",
            "probability": 4.356877475434003e-11,
            "start_logit": -5.627294063568115,
            "end_logit": -3.8794336318969727
        },
        {
            "text": "One ml of plasma from 12 NSCLC patients",
            "probability": 3.78616196382798e-11,
            "start_logit": -4.9371466636657715,
            "end_logit": -4.709983825683594
        },
        {
            "text": "6 healthy donors as controls",
            "probability": 3.716484211217498e-11,
            "start_logit": -5.786271572113037,
            "end_logit": -3.8794336318969727
        }
    ],
    "5c7a4ed5d774d04240000008_006": [
        {
            "text": "",
            "probability": 0.9998973105378083,
            "start_logit": 5.178196907043457,
            "end_logit": 5.894504547119141
        },
        {
            "text": "to detect both epithelial cell adhesion molecule (EpCAM)-positive CTCs and EpCAM-low/negative CTCs",
            "probability": 6.420588557393744e-05,
            "start_logit": -0.41022151708602905,
            "end_logit": 1.829609990119934
        },
        {
            "text": "epithelial cell adhesion molecule (EpCAM)-positive CTCs and EpCAM-low/negative CTCs",
            "probability": 1.6711859030850234e-05,
            "start_logit": -1.7561978101730347,
            "end_logit": 1.829609990119934
        },
        {
            "text": "detect both epithelial cell adhesion molecule (EpCAM)-positive CTCs and EpCAM-low/negative CTCs",
            "probability": 4.406412330309508e-06,
            "start_logit": -3.0892555713653564,
            "end_logit": 1.829609990119934
        },
        {
            "text": "both epithelial cell adhesion molecule (EpCAM)-positive CTCs and EpCAM-low/negative CTCs",
            "probability": 3.888480208212185e-06,
            "start_logit": -3.2142980098724365,
            "end_logit": 1.829609990119934
        },
        {
            "text": "to detect both epithelial cell adhesion molecule (EpCAM)-positive CTCs",
            "probability": 2.238432161785489e-06,
            "start_logit": -0.41022151708602905,
            "end_logit": -1.5267091989517212
        },
        {
            "text": "positive CTCs and EpCAM-low/negative CTCs",
            "probability": 1.9285870279538486e-06,
            "start_logit": -3.9155287742614746,
            "end_logit": 1.829609990119934
        },
        {
            "text": "EpCAM-low/negative CTCs",
            "probability": 1.422024454194675e-06,
            "start_logit": -4.2202348709106445,
            "end_logit": 1.829609990119934
        },
        {
            "text": "\"druggable\" mutations and, in particular, to monitor tyrosine kinase inhibitor (TKI) treatments",
            "probability": 9.771453988966643e-07,
            "start_logit": -2.0110156536102295,
            "end_logit": -0.7548105716705322
        },
        {
            "text": "whether circulating tumor cells (CTCs) are better tools than cell-free DNA (cfDNA)",
            "probability": 9.722886767259417e-07,
            "start_logit": -0.979108452796936,
            "end_logit": -1.7917004823684692
        },
        {
            "text": "to detect \"druggable\" mutations and, in particular, to monitor tyrosine kinase inhibitor (TKI) treatments",
            "probability": 9.26641560737309e-07,
            "start_logit": -2.06408429145813,
            "end_logit": -0.7548105716705322
        },
        {
            "text": "to monitor tyrosine kinase inhibitor (TKI) treatments",
            "probability": 7.843807830872357e-07,
            "start_logit": -2.2307565212249756,
            "end_logit": -0.7548105716705322
        },
        {
            "text": "druggable\" mutations and, in particular, to monitor tyrosine kinase inhibitor (TKI) treatments",
            "probability": 6.345315896326319e-07,
            "start_logit": -2.4427640438079834,
            "end_logit": -0.7548105716705322
        },
        {
            "text": "whether circulating tumor cells (CTCs) are better tools than cell-free DNA",
            "probability": 5.949358693329449e-07,
            "start_logit": -0.979108452796936,
            "end_logit": -2.2828996181488037
        },
        {
            "text": "epithelial cell adhesion molecule (EpCAM)-positive CTCs",
            "probability": 5.82631364764873e-07,
            "start_logit": -1.7561978101730347,
            "end_logit": -1.5267091989517212
        },
        {
            "text": "\"druggable\" mutations",
            "probability": 5.58233392256014e-07,
            "start_logit": -2.0110156536102295,
            "end_logit": -1.314668893814087
        },
        {
            "text": "to detect both epithelial cell adhesion molecule",
            "probability": 5.535149620868723e-07,
            "start_logit": -0.41022151708602905,
            "end_logit": -2.9239513874053955
        },
        {
            "text": "to detect \"druggable\" mutations",
            "probability": 5.293810546924546e-07,
            "start_logit": -2.06408429145813,
            "end_logit": -1.314668893814087
        },
        {
            "text": "to detect both epithelial cell adhesion molecule (EpCAM)-positive CTCs and EpCAM-low/negative CTCs,",
            "probability": 4.11595202263295e-07,
            "start_logit": -0.41022151708602905,
            "end_logit": -3.2201998233795166
        },
        {
            "text": "druggable\" mutations",
            "probability": 3.625015501011273e-07,
            "start_logit": -2.4427640438079834,
            "end_logit": -1.314668893814087
        }
    ],
    "5c7a4ed5d774d04240000008_007": [
        {
            "text": "",
            "probability": 0.9990461462639656,
            "start_logit": 4.194599628448486,
            "end_logit": 5.362757682800293
        },
        {
            "text": "improve patient care",
            "probability": 0.0003498873504925674,
            "start_logit": -0.11705774068832397,
            "end_logit": 1.7174700498580933
        },
        {
            "text": "significant potential to improve patient care",
            "probability": 0.0002512092487973898,
            "start_logit": -0.44838273525238037,
            "end_logit": 1.7174700498580933
        },
        {
            "text": "to improve patient care",
            "probability": 7.234915723483184e-05,
            "start_logit": -1.6931651830673218,
            "end_logit": 1.7174700498580933
        },
        {
            "text": "identifying unmet needs. In summary, the panel concluded that liquid biopsy approaches have significant potential to improve patient care",
            "probability": 5.85225831365604e-05,
            "start_logit": -1.9052562713623047,
            "end_logit": 1.7174700498580933
        },
        {
            "text": "identifying unmet needs",
            "probability": 5.4107130013543594e-05,
            "start_logit": -1.9052562713623047,
            "end_logit": 1.6390233039855957
        },
        {
            "text": "liquid biopsy approaches have significant potential to improve patient care",
            "probability": 5.092659892002322e-05,
            "start_logit": -2.044283628463745,
            "end_logit": 1.7174700498580933
        },
        {
            "text": "unmet needs. In summary, the panel concluded that liquid biopsy approaches have significant potential to improve patient care",
            "probability": 2.6777070083900612e-05,
            "start_logit": -2.6871230602264404,
            "end_logit": 1.7174700498580933
        },
        {
            "text": "unmet needs",
            "probability": 2.475677481683582e-05,
            "start_logit": -2.6871230602264404,
            "end_logit": 1.6390233039855957
        },
        {
            "text": "potential to improve patient care",
            "probability": 1.8303487685012536e-05,
            "start_logit": -3.067577362060547,
            "end_logit": 1.7174700498580933
        },
        {
            "text": "improve patient care, and immediate implementation in the clinic is justified in a number of therapeutic settings",
            "probability": 1.3460704547791393e-05,
            "start_logit": -0.11705774068832397,
            "end_logit": -1.540366530418396
        },
        {
            "text": "significant potential to improve patient care, and immediate implementation in the clinic is justified in a number of therapeutic settings",
            "probability": 9.664406195233734e-06,
            "start_logit": -0.44838273525238037,
            "end_logit": -1.540366530418396
        },
        {
            "text": "improve patient care,",
            "probability": 4.213758131865636e-06,
            "start_logit": -0.11705774068832397,
            "end_logit": -2.7017862796783447
        },
        {
            "text": "improve patient care, and immediate implementation in the clinic is justified in a number of therapeutic settings relevant to NSCLC.",
            "probability": 3.3041237335571265e-06,
            "start_logit": -0.11705774068832397,
            "end_logit": -2.944969892501831
        },
        {
            "text": "significant potential to improve patient care,",
            "probability": 3.025359486216538e-06,
            "start_logit": -0.44838273525238037,
            "end_logit": -2.7017862796783447
        },
        {
            "text": "have significant potential to improve patient care",
            "probability": 2.9588755407169574e-06,
            "start_logit": -4.889859676361084,
            "end_logit": 1.7174700498580933
        },
        {
            "text": "to improve patient care, and immediate implementation in the clinic is justified in a number of therapeutic settings",
            "probability": 2.7833833616698963e-06,
            "start_logit": -1.6931651830673218,
            "end_logit": -1.540366530418396
        },
        {
            "text": "immediate implementation in the clinic is justified in a number of therapeutic settings",
            "probability": 2.5840134952574024e-06,
            "start_logit": -1.7674885988235474,
            "end_logit": -1.540366530418396
        },
        {
            "text": "improve patient care, and immediate implementation in the clinic is justified in a number of therapeutic settings relevant to NSCLC",
            "probability": 2.5816933140638103e-06,
            "start_logit": -0.11705774068832397,
            "end_logit": -3.1916956901550293
        },
        {
            "text": "increasing number of innovative platforms have been recently developed that improve not only the fidelity of the molecular analysis but also the number of tests performed on a single specimen",
            "probability": 2.438017047447226e-06,
            "start_logit": -3.003810405731201,
            "end_logit": -0.3622035086154938
        }
    ],
    "5c7a4ed5d774d04240000008_008": [
        {
            "text": "",
            "probability": 0.9990461462639656,
            "start_logit": 4.194599628448486,
            "end_logit": 5.362757682800293
        },
        {
            "text": "improve patient care",
            "probability": 0.0003498873504925674,
            "start_logit": -0.11705774068832397,
            "end_logit": 1.7174700498580933
        },
        {
            "text": "significant potential to improve patient care",
            "probability": 0.0002512092487973898,
            "start_logit": -0.44838273525238037,
            "end_logit": 1.7174700498580933
        },
        {
            "text": "to improve patient care",
            "probability": 7.234915723483184e-05,
            "start_logit": -1.6931651830673218,
            "end_logit": 1.7174700498580933
        },
        {
            "text": "identifying unmet needs. In summary, the panel concluded that liquid biopsy approaches have significant potential to improve patient care",
            "probability": 5.85225831365604e-05,
            "start_logit": -1.9052562713623047,
            "end_logit": 1.7174700498580933
        },
        {
            "text": "identifying unmet needs",
            "probability": 5.4107130013543594e-05,
            "start_logit": -1.9052562713623047,
            "end_logit": 1.6390233039855957
        },
        {
            "text": "liquid biopsy approaches have significant potential to improve patient care",
            "probability": 5.092659892002322e-05,
            "start_logit": -2.044283628463745,
            "end_logit": 1.7174700498580933
        },
        {
            "text": "unmet needs. In summary, the panel concluded that liquid biopsy approaches have significant potential to improve patient care",
            "probability": 2.6777070083900612e-05,
            "start_logit": -2.6871230602264404,
            "end_logit": 1.7174700498580933
        },
        {
            "text": "unmet needs",
            "probability": 2.475677481683582e-05,
            "start_logit": -2.6871230602264404,
            "end_logit": 1.6390233039855957
        },
        {
            "text": "potential to improve patient care",
            "probability": 1.8303487685012536e-05,
            "start_logit": -3.067577362060547,
            "end_logit": 1.7174700498580933
        },
        {
            "text": "improve patient care, and immediate implementation in the clinic is justified in a number of therapeutic settings",
            "probability": 1.3460704547791393e-05,
            "start_logit": -0.11705774068832397,
            "end_logit": -1.540366530418396
        },
        {
            "text": "significant potential to improve patient care, and immediate implementation in the clinic is justified in a number of therapeutic settings",
            "probability": 9.664406195233734e-06,
            "start_logit": -0.44838273525238037,
            "end_logit": -1.540366530418396
        },
        {
            "text": "improve patient care,",
            "probability": 4.213758131865636e-06,
            "start_logit": -0.11705774068832397,
            "end_logit": -2.7017862796783447
        },
        {
            "text": "improve patient care, and immediate implementation in the clinic is justified in a number of therapeutic settings relevant to NSCLC.",
            "probability": 3.3041237335571265e-06,
            "start_logit": -0.11705774068832397,
            "end_logit": -2.944969892501831
        },
        {
            "text": "significant potential to improve patient care,",
            "probability": 3.025359486216538e-06,
            "start_logit": -0.44838273525238037,
            "end_logit": -2.7017862796783447
        },
        {
            "text": "have significant potential to improve patient care",
            "probability": 2.9588755407169574e-06,
            "start_logit": -4.889859676361084,
            "end_logit": 1.7174700498580933
        },
        {
            "text": "to improve patient care, and immediate implementation in the clinic is justified in a number of therapeutic settings",
            "probability": 2.7833833616698963e-06,
            "start_logit": -1.6931651830673218,
            "end_logit": -1.540366530418396
        },
        {
            "text": "immediate implementation in the clinic is justified in a number of therapeutic settings",
            "probability": 2.5840134952574024e-06,
            "start_logit": -1.7674885988235474,
            "end_logit": -1.540366530418396
        },
        {
            "text": "improve patient care, and immediate implementation in the clinic is justified in a number of therapeutic settings relevant to NSCLC",
            "probability": 2.5816933140638103e-06,
            "start_logit": -0.11705774068832397,
            "end_logit": -3.1916956901550293
        },
        {
            "text": "increasing number of innovative platforms have been recently developed that improve not only the fidelity of the molecular analysis but also the number of tests performed on a single specimen",
            "probability": 2.438017047447226e-06,
            "start_logit": -3.003810405731201,
            "end_logit": -0.3622035086154938
        }
    ],
    "5e355e20fbd6abf43b000065_002": [
        {
            "text": "lamin B1 (LMNB1)",
            "probability": 0.624619440650841,
            "start_logit": 8.781357765197754,
            "end_logit": 8.201545715332031
        },
        {
            "text": "lamin B1",
            "probability": 0.28229567753739215,
            "start_logit": 8.781357765197754,
            "end_logit": 7.407358169555664
        },
        {
            "text": "lamin B1 (LMNB1",
            "probability": 0.03523673560557215,
            "start_logit": 8.781357765197754,
            "end_logit": 5.3264923095703125
        },
        {
            "text": "lamin B1 (LMNB1) gene",
            "probability": 0.031033370165704177,
            "start_logit": 8.781357765197754,
            "end_logit": 5.199466228485107
        },
        {
            "text": "LMNB1)",
            "probability": 0.011993601387228915,
            "start_logit": 4.828588485717773,
            "end_logit": 8.201545715332031
        },
        {
            "text": "the lamin B1 (LMNB1)",
            "probability": 0.00830167401207653,
            "start_logit": 4.460672378540039,
            "end_logit": 8.201545715332031
        },
        {
            "text": "the lamin B1",
            "probability": 0.0037519272334716265,
            "start_logit": 4.460672378540039,
            "end_logit": 7.407358169555664
        },
        {
            "text": "LMNB1",
            "probability": 0.0006765965538953637,
            "start_logit": 4.828588485717773,
            "end_logit": 5.3264923095703125
        },
        {
            "text": "LMNB1) gene",
            "probability": 0.0005958858262271682,
            "start_logit": 4.828588485717773,
            "end_logit": 5.199466228485107
        },
        {
            "text": "the lamin B1 (LMNB1",
            "probability": 0.0004683233873450785,
            "start_logit": 4.460672378540039,
            "end_logit": 5.3264923095703125
        },
        {
            "text": "the lamin B1 (LMNB1) gene",
            "probability": 0.00041245741942218977,
            "start_logit": 4.460672378540039,
            "end_logit": 5.199466228485107
        },
        {
            "text": "B1 (LMNB1)",
            "probability": 0.00018327173947158457,
            "start_logit": 0.647429883480072,
            "end_logit": 8.201545715332031
        },
        {
            "text": "(LMNB1)",
            "probability": 0.00012507630390715834,
            "start_logit": 0.26538389921188354,
            "end_logit": 8.201545715332031
        },
        {
            "text": "B1",
            "probability": 8.282934615944494e-05,
            "start_logit": 0.647429883480072,
            "end_logit": 7.407358169555664
        },
        {
            "text": "Duplication or over expression of the lamin B1 (LMNB1)",
            "probability": 7.563572990422132e-05,
            "start_logit": -0.2376112937927246,
            "end_logit": 8.201545715332031
        },
        {
            "text": "lamin",
            "probability": 3.65367353075944e-05,
            "start_logit": 8.781357765197754,
            "end_logit": -1.5450339317321777
        },
        {
            "text": "Duplication or over expression of the lamin B1",
            "probability": 3.418343751372735e-05,
            "start_logit": -0.2376112937927246,
            "end_logit": 7.407358169555664
        },
        {
            "text": "lamin B1 (LMNB1) gene causes ADLD.",
            "probability": 3.234097207015733e-05,
            "start_logit": 8.781357765197754,
            "end_logit": -1.6670172214508057
        },
        {
            "text": "lamin B1 (LMNB1) gene causes ADLD",
            "probability": 2.4673671362631052e-05,
            "start_logit": 8.781357765197754,
            "end_logit": -1.9376153945922852
        },
        {
            "text": "lam",
            "probability": 1.976050712713176e-05,
            "start_logit": 8.781357765197754,
            "end_logit": -2.1596667766571045
        },
        {
            "text": "",
            "probability": 1.7779998443177928e-09,
            "start_logit": -1.3271857500076294,
            "end_logit": -1.3670748472213745
        }
    ],
    "5e355e20fbd6abf43b000065_003": [
        {
            "text": "lamin B1",
            "probability": 0.7806209549152736,
            "start_logit": 8.755078315734863,
            "end_logit": 8.6817626953125
        },
        {
            "text": "lamin B1 (LMNB1)",
            "probability": 0.18482248866739193,
            "start_logit": 8.755078315734863,
            "end_logit": 7.2410688400268555
        },
        {
            "text": "lamin B1 (LMNB1",
            "probability": 0.022460804991190016,
            "start_logit": 8.755078315734863,
            "end_logit": 5.133444786071777
        },
        {
            "text": "the lamin B1",
            "probability": 0.006360799832355795,
            "start_logit": 3.9451427459716797,
            "end_logit": 8.6817626953125
        },
        {
            "text": "lamin B1 (LMNB1) gene",
            "probability": 0.002222661401191968,
            "start_logit": 8.755078315734863,
            "end_logit": 2.820378303527832
        },
        {
            "text": "the lamin B1 (LMNB1)",
            "probability": 0.0015060047357538919,
            "start_logit": 3.9451427459716797,
            "end_logit": 7.2410688400268555
        },
        {
            "text": "LMNB1)",
            "probability": 0.0009420457158825633,
            "start_logit": 3.4759809970855713,
            "end_logit": 7.2410688400268555
        },
        {
            "text": "lamin",
            "probability": 0.00036940975380444634,
            "start_logit": 8.755078315734863,
            "end_logit": 1.0258241891860962
        },
        {
            "text": "B1",
            "probability": 0.00023516087618870874,
            "start_logit": 0.6475031971931458,
            "end_logit": 8.6817626953125
        },
        {
            "text": "the lamin B1 (LMNB1",
            "probability": 0.00018301927936080606,
            "start_logit": 3.9451427459716797,
            "end_logit": 5.133444786071777
        },
        {
            "text": "LMNB1",
            "probability": 0.00011448339035896409,
            "start_logit": 3.4759809970855713,
            "end_logit": 5.133444786071777
        },
        {
            "text": "B1 (LMNB1)",
            "probability": 5.567749379610099e-05,
            "start_logit": 0.6475031971931458,
            "end_logit": 7.2410688400268555
        },
        {
            "text": "lam",
            "probability": 2.7890627262974003e-05,
            "start_logit": 8.755078315734863,
            "end_logit": -1.5577915906906128
        },
        {
            "text": "the lamin B1 (LMNB1) gene",
            "probability": 1.8111100117239426e-05,
            "start_logit": 3.9451427459716797,
            "end_logit": 2.820378303527832
        },
        {
            "text": "duplication of the lamin B1",
            "probability": 1.3316630755017106e-05,
            "start_logit": -2.223752975463867,
            "end_logit": 8.6817626953125
        },
        {
            "text": "(LMNB1)",
            "probability": 1.2677045866028851e-05,
            "start_logit": -0.8322798609733582,
            "end_logit": 7.2410688400268555
        },
        {
            "text": "LMNB1) gene",
            "probability": 1.1328971197972213e-05,
            "start_logit": 3.4759809970855713,
            "end_logit": 2.820378303527832
        },
        {
            "text": "lamin B1 (LMNB",
            "probability": 1.0229798235214752e-05,
            "start_logit": 8.755078315734863,
            "end_logit": -2.560777425765991
        },
        {
            "text": "B1 (LMNB1",
            "probability": 6.766283365023489e-06,
            "start_logit": 0.6475031971931458,
            "end_logit": 5.133444786071777
        },
        {
            "text": "lamin B1 (LM",
            "probability": 6.1647775797912625e-06,
            "start_logit": 8.755078315734863,
            "end_logit": -3.067230224609375
        },
        {
            "text": "",
            "probability": 3.7130719855903062e-09,
            "start_logit": -0.7528941631317139,
            "end_logit": -0.9740055203437805
        }
    ],
    "5e355e20fbd6abf43b000065_004": [
        {
            "text": "lamin B1 (LMNB1)",
            "probability": 0.5546555487626447,
            "start_logit": 8.437973976135254,
            "end_logit": 7.84796667098999
        },
        {
            "text": "lamin B1",
            "probability": 0.375733833281475,
            "start_logit": 8.437973976135254,
            "end_logit": 7.458500385284424
        },
        {
            "text": "lamin B1 (LMNB1) gene",
            "probability": 0.02007567115936621,
            "start_logit": 8.437973976135254,
            "end_logit": 4.529128074645996
        },
        {
            "text": "lamin B1 (LMNB1",
            "probability": 0.016415792579172292,
            "start_logit": 8.437973976135254,
            "end_logit": 4.3278632164001465
        },
        {
            "text": "the lamin B1 (LMNB1)",
            "probability": 0.014023145777912695,
            "start_logit": 4.760335922241211,
            "end_logit": 7.84796667098999
        },
        {
            "text": "the lamin B1",
            "probability": 0.00949953593641021,
            "start_logit": 4.760335922241211,
            "end_logit": 7.458500385284424
        },
        {
            "text": "lamin B1 (LMNB1) gene.",
            "probability": 0.0037941988359080146,
            "start_logit": 8.437973976135254,
            "end_logit": 2.8630926609039307
        },
        {
            "text": "LMNB1)",
            "probability": 0.0027277963811056126,
            "start_logit": 3.1231207847595215,
            "end_logit": 7.84796667098999
        },
        {
            "text": "B1 (LMNB1)",
            "probability": 0.0009327797201591487,
            "start_logit": 2.0500404834747314,
            "end_logit": 7.84796667098999
        },
        {
            "text": "B1",
            "probability": 0.0006318820764427241,
            "start_logit": 2.0500404834747314,
            "end_logit": 7.458500385284424
        },
        {
            "text": "the lamin B1 (LMNB1) gene",
            "probability": 0.0005075655763027503,
            "start_logit": 4.760335922241211,
            "end_logit": 4.529128074645996
        },
        {
            "text": "the lamin B1 (LMNB1",
            "probability": 0.0004150342548835134,
            "start_logit": 4.760335922241211,
            "end_logit": 4.3278632164001465
        },
        {
            "text": "(LMNB1)",
            "probability": 0.00012465758943655032,
            "start_logit": 0.037442103028297424,
            "end_logit": 7.84796667098999
        },
        {
            "text": "lamin",
            "probability": 0.00010322839008967966,
            "start_logit": 8.437973976135254,
            "end_logit": -0.7411919832229614
        },
        {
            "text": "LMNB1) gene",
            "probability": 9.873216496067197e-05,
            "start_logit": 3.1231207847595215,
            "end_logit": 4.529128074645996
        },
        {
            "text": "the lamin B1 (LMNB1) gene.",
            "probability": 9.592728947726364e-05,
            "start_logit": 4.760335922241211,
            "end_logit": 2.8630926609039307
        },
        {
            "text": "LMNB1",
            "probability": 8.073287951475796e-05,
            "start_logit": 3.1231207847595215,
            "end_logit": 4.3278632164001465
        },
        {
            "text": "B1 (LMNB1) gene",
            "probability": 3.376181662261573e-05,
            "start_logit": 2.0500404834747314,
            "end_logit": 4.529128074645996
        },
        {
            "text": "B1 (LMNB1",
            "probability": 2.760689664486455e-05,
            "start_logit": 2.0500404834747314,
            "end_logit": 4.3278632164001465
        },
        {
            "text": "duplications of the lamin B1 (LMNB1)",
            "probability": 2.25589633420259e-05,
            "start_logit": -1.6719961166381836,
            "end_logit": 7.84796667098999
        },
        {
            "text": "",
            "probability": 9.668128651025477e-09,
            "start_logit": -0.721314013004303,
            "end_logit": -0.8577684164047241
        }
    ],
    "5e355e20fbd6abf43b000065_005": [
        {
            "text": "LMNB1",
            "probability": 0.9073970713351759,
            "start_logit": 3.8667726516723633,
            "end_logit": 4.6918463706970215
        },
        {
            "text": "the LMNB1",
            "probability": 0.054638329711417646,
            "start_logit": 1.0569281578063965,
            "end_logit": 4.6918463706970215
        },
        {
            "text": "LMNB1 gene",
            "probability": 0.034893616897250596,
            "start_logit": 3.8667726516723633,
            "end_logit": 1.433570146560669
        },
        {
            "text": "the LMNB1 gene",
            "probability": 0.0021010966478550988,
            "start_logit": 1.0569281578063965,
            "end_logit": 1.433570146560669
        },
        {
            "text": "L",
            "probability": 0.0005392400982238618,
            "start_logit": 3.8667726516723633,
            "end_logit": -2.736328125
        },
        {
            "text": "LM",
            "probability": 0.00013700076572091514,
            "start_logit": 3.8667726516723633,
            "end_logit": -4.106502532958984
        },
        {
            "text": "Duplication of the LMNB1",
            "probability": 0.00013374823206077638,
            "start_logit": -4.95560359954834,
            "end_logit": 4.6918463706970215
        },
        {
            "text": "Lamin B1",
            "probability": 4.000339303073788e-05,
            "start_logit": -1.0093985795974731,
            "end_logit": -0.4613535404205322
        },
        {
            "text": "the L",
            "probability": 3.2469994902032744e-05,
            "start_logit": 1.0569281578063965,
            "end_logit": -2.736328125
        },
        {
            "text": "LMNB1 gene. Lamin B1",
            "probability": 2.7347627515535632e-05,
            "start_logit": -1.389733076095581,
            "end_logit": -0.4613535404205322
        },
        {
            "text": "Lamin B1 levels were dramatically increased in ADLD nuclei, both in skin fibroblasts and skeletal muscle fibres. Since lamin B1",
            "probability": 9.864000542684242e-06,
            "start_logit": -1.0093985795974731,
            "end_logit": -1.8614259958267212
        },
        {
            "text": "the LM",
            "probability": 8.249412792529325e-06,
            "start_logit": 1.0569281578063965,
            "end_logit": -4.106502532958984
        },
        {
            "text": "",
            "probability": 7.0711390403967495e-06,
            "start_logit": -1.8468807935714722,
            "end_logit": -1.3568140268325806
        },
        {
            "text": "B1",
            "probability": 7.01078023133701e-06,
            "start_logit": -2.7509138584136963,
            "end_logit": -0.4613535404205322
        },
        {
            "text": "gene",
            "probability": 6.37216464115255e-06,
            "start_logit": -4.741347312927246,
            "end_logit": 1.433570146560669
        },
        {
            "text": "Lamin",
            "probability": 6.162391321781429e-06,
            "start_logit": -1.0093985795974731,
            "end_logit": -2.331852912902832
        },
        {
            "text": "Duplication of the LMNB1 gene",
            "probability": 5.143238519985712e-06,
            "start_logit": -4.95560359954834,
            "end_logit": 1.433570146560669
        },
        {
            "text": "lamin B1",
            "probability": 4.260645689572442e-06,
            "start_logit": -1.8488696813583374,
            "end_logit": -1.8614259958267212
        },
        {
            "text": "LMNB1 gene. Lamin",
            "probability": 4.212812206793431e-06,
            "start_logit": -1.389733076095581,
            "end_logit": -2.331852912902832
        },
        {
            "text": "B1 levels were dramatically increased in ADLD nuclei, both in skin fibroblasts and skeletal muscle fibres. Since lamin B1",
            "probability": 1.7287118608516854e-06,
            "start_logit": -2.7509138584136963,
            "end_logit": -1.8614259958267212
        }
    ],
    "5e355e20fbd6abf43b000065_006": [
        {
            "text": "LMNB1",
            "probability": 0.9848705720586556,
            "start_logit": 9.58948802947998,
            "end_logit": 10.149174690246582
        },
        {
            "text": "LMNB1 gene",
            "probability": 0.013505786714720096,
            "start_logit": 9.58948802947998,
            "end_logit": 5.859782695770264
        },
        {
            "text": "the LMNB1",
            "probability": 0.0010970005263521486,
            "start_logit": 2.789557456970215,
            "end_logit": 10.149174690246582
        },
        {
            "text": "LMNB1 gene,",
            "probability": 0.00027716738223767016,
            "start_logit": 9.58948802947998,
            "end_logit": 1.9735307693481445
        },
        {
            "text": "ADLD is caused by duplication of the LMNB1",
            "probability": 0.00011477316167118053,
            "start_logit": 0.5321801900863647,
            "end_logit": 10.149174690246582
        },
        {
            "text": "L",
            "probability": 4.391264196488374e-05,
            "start_logit": 9.58948802947998,
            "end_logit": 0.13111142814159393
        },
        {
            "text": "LMNB1 gene, which results in increased lamin B1",
            "probability": 2.8647760189332292e-05,
            "start_logit": 9.58948802947998,
            "end_logit": -0.29601556062698364
        },
        {
            "text": "LMNB1 gene, which results in increased lamin",
            "probability": 1.57813919706273e-05,
            "start_logit": 9.58948802947998,
            "end_logit": -0.8922592997550964
        },
        {
            "text": "the LMNB1 gene",
            "probability": 1.5043453987947379e-05,
            "start_logit": 2.789557456970215,
            "end_logit": 5.859782695770264
        },
        {
            "text": "LMNB",
            "probability": 1.173436683575231e-05,
            "start_logit": 9.58948802947998,
            "end_logit": -1.1885689496994019
        },
        {
            "text": "LMNB1 gene, which results in increased lamin B1 transcripts and protein expression. How duplication of LMNB1",
            "probability": 8.149742262379261e-06,
            "start_logit": 9.58948802947998,
            "end_logit": -1.5531045198440552
        },
        {
            "text": "LM",
            "probability": 5.280647659151e-06,
            "start_logit": 9.58948802947998,
            "end_logit": -1.9870420694351196
        },
        {
            "text": "duplication of the LMNB1",
            "probability": 4.029986505009633e-06,
            "start_logit": -2.817014455795288,
            "end_logit": 10.149174690246582
        },
        {
            "text": "ADLD is caused by duplication of the LMNB1 gene",
            "probability": 1.5739142645565135e-06,
            "start_logit": 0.5321801900863647,
            "end_logit": 5.859782695770264
        },
        {
            "text": "the LMNB1 gene,",
            "probability": 3.087235752884928e-07,
            "start_logit": 2.789557456970215,
            "end_logit": 1.9735307693481445
        },
        {
            "text": "gene",
            "probability": 6.512296585534184e-08,
            "start_logit": -2.6528635025024414,
            "end_logit": 5.859782695770264
        },
        {
            "text": "duplication of the LMNB1 gene",
            "probability": 5.526425475998365e-08,
            "start_logit": -2.817014455795288,
            "end_logit": 5.859782695770264
        },
        {
            "text": "the L",
            "probability": 4.891220503045139e-08,
            "start_logit": 2.789557456970215,
            "end_logit": 0.13111142814159393
        },
        {
            "text": "ADLD is caused by duplication of the LMNB1 gene,",
            "probability": 3.230005817418965e-08,
            "start_logit": 0.5321801900863647,
            "end_logit": 1.9735307693481445
        },
        {
            "text": "the LMNB1 gene, which results in increased lamin B1",
            "probability": 3.190937865146811e-08,
            "start_logit": 2.789557456970215,
            "end_logit": -0.29601556062698364
        },
        {
            "text": "",
            "probability": 4.0182860871947265e-09,
            "start_logit": -0.012308608740568161,
            "end_logit": 0.43380600214004517
        }
    ],
    "5e355e20fbd6abf43b000065_008": [
        {
            "text": "lamin B1",
            "probability": 0.48854901445920507,
            "start_logit": 6.637756824493408,
            "end_logit": 6.059924125671387
        },
        {
            "text": "lamin B1 (LMNB1)",
            "probability": 0.29854791464636754,
            "start_logit": 6.637756824493408,
            "end_logit": 5.5674147605896
        },
        {
            "text": "lamin B1 (LMNB1) gene",
            "probability": 0.1115317596281796,
            "start_logit": 6.637756824493408,
            "end_logit": 4.582793712615967
        },
        {
            "text": "the lamin B1",
            "probability": 0.039099073426381616,
            "start_logit": 4.112415790557861,
            "end_logit": 6.059924125671387
        },
        {
            "text": "the lamin B1 (LMNB1)",
            "probability": 0.02389309258759369,
            "start_logit": 4.112415790557861,
            "end_logit": 5.5674147605896
        },
        {
            "text": "lamin B1 (LMNB1",
            "probability": 0.020730551242629482,
            "start_logit": 6.637756824493408,
            "end_logit": 2.900092840194702
        },
        {
            "text": "the lamin B1 (LMNB1) gene",
            "probability": 0.00892599990996374,
            "start_logit": 4.112415790557861,
            "end_logit": 4.582793712615967
        },
        {
            "text": "LMNB1)",
            "probability": 0.0030397951135786258,
            "start_logit": 2.050616502761841,
            "end_logit": 5.5674147605896
        },
        {
            "text": "the lamin B1 (LMNB1",
            "probability": 0.0016590870541457596,
            "start_logit": 4.112415790557861,
            "end_logit": 2.900092840194702
        },
        {
            "text": "LMNB1) gene",
            "probability": 0.0011356089970621782,
            "start_logit": 2.050616502761841,
            "end_logit": 4.582793712615967
        },
        {
            "text": "B1",
            "probability": 0.000525385665144255,
            "start_logit": -0.19730566442012787,
            "end_logit": 6.059924125671387
        },
        {
            "text": "ADLD is associated with duplications of the lamin B1",
            "probability": 0.0005164067531221409,
            "start_logit": -0.21454352140426636,
            "end_logit": 6.059924125671387
        },
        {
            "text": "lamin",
            "probability": 0.0004121827465563517,
            "start_logit": 6.637756824493408,
            "end_logit": -1.0178041458129883
        },
        {
            "text": "B1 (LMNB1)",
            "probability": 0.00032105846101754775,
            "start_logit": -0.19730566442012787,
            "end_logit": 5.5674147605896
        },
        {
            "text": "ADLD is associated with duplications of the lamin B1 (LMNB1)",
            "probability": 0.0003155715285283631,
            "start_logit": -0.21454352140426636,
            "end_logit": 5.5674147605896
        },
        {
            "text": "LMNB1",
            "probability": 0.00021107710112053577,
            "start_logit": 2.050616502761841,
            "end_logit": 2.900092840194702
        },
        {
            "text": "duplications of the lamin B1",
            "probability": 0.00017896647165050386,
            "start_logit": -1.2742397785186768,
            "end_logit": 6.059924125671387
        },
        {
            "text": "(LMNB1)",
            "probability": 0.00016824830842495793,
            "start_logit": -0.8434879779815674,
            "end_logit": 5.5674147605896
        },
        {
            "text": "B1 (LMNB1) gene",
            "probability": 0.00011994126685901502,
            "start_logit": -0.19730566442012787,
            "end_logit": 4.582793712615967
        },
        {
            "text": "ADLD is associated with duplications of the lamin B1 (LMNB1) gene",
            "probability": 0.00011789145439857743,
            "start_logit": -0.21454352140426636,
            "end_logit": 4.582793712615967
        },
        {
            "text": "",
            "probability": 1.3731780707272173e-06,
            "start_logit": 0.2605164647102356,
            "end_logit": -0.34490278363227844
        }
    ],
    "5e2a120c76af173751000001_002": [
        {
            "text": "",
            "probability": 0.7458782749957117,
            "start_logit": 0.0992240458726883,
            "end_logit": 0.25895464420318604
        },
        {
            "text": "a modified mRNA encoding vascular endothelial growth factor A (VEGF-A)",
            "probability": 0.06262015777271593,
            "start_logit": -0.7760607600212097,
            "end_logit": -1.343235731124878
        },
        {
            "text": "modified mRNA encoding vascular endothelial growth factor A (VEGF-A)",
            "probability": 0.02865721263389031,
            "start_logit": -1.5577428340911865,
            "end_logit": -1.343235731124878
        },
        {
            "text": "a modified mRNA encoding vascular endothelial growth factor A",
            "probability": 0.026168466210552153,
            "start_logit": -0.7760607600212097,
            "end_logit": -2.2157678604125977
        },
        {
            "text": "accelerated re-epithelialization during the early phase of diabetic wound healing",
            "probability": 0.023691625338274912,
            "start_logit": -1.1684166193008423,
            "end_logit": -1.922845482826233
        },
        {
            "text": "improves vascularization and tissue oxygenation of the wound bed",
            "probability": 0.019268536126624134,
            "start_logit": -2.156024217605591,
            "end_logit": -1.1418859958648682
        },
        {
            "text": "a modified mRNA encoding vascular endothelial growth factor A (VEGF-A",
            "probability": 0.01869277700255568,
            "start_logit": -0.7760607600212097,
            "end_logit": -2.5521857738494873
        },
        {
            "text": "accelerated re-epithelialization during the early phase of diabetic wound healing.",
            "probability": 0.014420121958483488,
            "start_logit": -1.1684166193008423,
            "end_logit": -2.419342517852783
        },
        {
            "text": "modified mRNA encoding vascular endothelial growth factor A",
            "probability": 0.011975621384098628,
            "start_logit": -1.5577428340911865,
            "end_logit": -2.2157678604125977
        },
        {
            "text": "modified mRNA encoding vascular endothelial growth factor A (VEGF-A",
            "probability": 0.00855447996832633,
            "start_logit": -1.5577428340911865,
            "end_logit": -2.5521857738494873
        },
        {
            "text": "a modified mRNA encoding vascular endothelial growth factor A (VEGF-A),",
            "probability": 0.0057226956910347675,
            "start_logit": -0.7760607600212097,
            "end_logit": -3.7358829975128174
        },
        {
            "text": "pronounced, sustained and dose-dependent vasodilation, blood flow upregulation, and neovessel formation",
            "probability": 0.005661263259184545,
            "start_logit": -2.899186849594116,
            "end_logit": -1.6235498189926147
        },
        {
            "text": "accelerated re-epithelialization",
            "probability": 0.005530550079330209,
            "start_logit": -1.1684166193008423,
            "end_logit": -3.3776798248291016
        },
        {
            "text": "vascular endothelial growth factor A (VEGF-A)",
            "probability": 0.0051895119420054215,
            "start_logit": -3.2665083408355713,
            "end_logit": -1.343235731124878
        },
        {
            "text": "mRNA encoding vascular endothelial growth factor A (VEGF-A)",
            "probability": 0.004678761464402561,
            "start_logit": -3.37011456489563,
            "end_logit": -1.343235731124878
        },
        {
            "text": "sequential dosing of AZD8601 improves vascularization and tissue oxygenation of the wound bed",
            "probability": 0.004276342669490742,
            "start_logit": -3.6613996028900146,
            "end_logit": -1.1418859958648682
        },
        {
            "text": "modified mRNA encoding vascular endothelial growth factor A (VEGF-A),",
            "probability": 0.002618909199371032,
            "start_logit": -1.5577428340911865,
            "end_logit": -3.7358829975128174
        },
        {
            "text": "vascular endothelial growth factor A",
            "probability": 0.002168655792860291,
            "start_logit": -3.2665083408355713,
            "end_logit": -2.2157678604125977
        },
        {
            "text": "VEGF-A)",
            "probability": 0.0021660906856330138,
            "start_logit": -4.140223979949951,
            "end_logit": -1.343235731124878
        },
        {
            "text": "improves vascularization and tissue oxygenation of the wound bed, leading to accelerated re-epithelialization",
            "probability": 0.002059945825454132,
            "start_logit": -2.156024217605591,
            "end_logit": -3.3776798248291016
        }
    ],
    "5e48efd9f8b2df0d49000004_001": [
        {
            "text": "to enable the creation of the large radiotherapy cohorts required to exploit advances in genomics",
            "probability": 0.6059494643039844,
            "start_logit": 4.347301483154297,
            "end_logit": 4.448914051055908
        },
        {
            "text": "enable the creation of the large radiotherapy cohorts required to exploit advances in genomics",
            "probability": 0.15064119532995351,
            "start_logit": 2.9554057121276855,
            "end_logit": 4.448914051055908
        },
        {
            "text": "to exploit advances in genomics",
            "probability": 0.045605347662981105,
            "start_logit": 1.76052987575531,
            "end_logit": 4.448914051055908
        },
        {
            "text": "to enable the creation of the large radiotherapy cohorts required to exploit advances in genomics.",
            "probability": 0.03523957309650126,
            "start_logit": 4.347301483154297,
            "end_logit": 1.6042871475219727
        },
        {
            "text": "the creation of the large radiotherapy cohorts required to exploit advances in genomics",
            "probability": 0.03345201231798588,
            "start_logit": 1.4506168365478516,
            "end_logit": 4.448914051055908
        },
        {
            "text": "to enable the creation of the large radiotherapy cohorts",
            "probability": 0.026528037481515127,
            "start_logit": 4.347301483154297,
            "end_logit": 1.320319652557373
        },
        {
            "text": "creation of the large radiotherapy cohorts required to exploit advances in genomics",
            "probability": 0.02642082521480522,
            "start_logit": 1.2146574258804321,
            "end_logit": 4.448914051055908
        },
        {
            "text": "exploit advances in genomics",
            "probability": 0.022029218622618443,
            "start_logit": 1.032874584197998,
            "end_logit": 4.448914051055908
        },
        {
            "text": "to enable the creation of the large radiotherapy cohorts required",
            "probability": 0.010755680749215872,
            "start_logit": 4.347301483154297,
            "end_logit": 0.41755151748657227
        },
        {
            "text": "enable the creation of the large radiotherapy cohorts required to exploit advances in genomics.",
            "probability": 0.008760683401662535,
            "start_logit": 2.9554057121276855,
            "end_logit": 1.6042871475219727
        },
        {
            "text": "to advance radiobiology in the genomic era was establishment of the Radiogenomics Consortium to enable the creation of the large radiotherapy cohorts",
            "probability": 0.007781793169303241,
            "start_logit": 3.1208860874176025,
            "end_logit": 1.320319652557373
        },
        {
            "text": "enable the creation of the large radiotherapy cohorts",
            "probability": 0.0065949646156770615,
            "start_logit": 2.9554057121276855,
            "end_logit": 1.320319652557373
        },
        {
            "text": "large radiotherapy cohorts required to exploit advances in genomics",
            "probability": 0.004837425764461112,
            "start_logit": -0.4831123948097229,
            "end_logit": 4.448914051055908
        },
        {
            "text": "to advance radiobiology in the genomic era was establishment of the Radiogenomics Consortium to enable the creation of the large radiotherapy cohorts required",
            "probability": 0.0031550951721843724,
            "start_logit": 3.1208860874176025,
            "end_logit": 0.41755151748657227
        },
        {
            "text": "enable the creation of the large radiotherapy cohorts required",
            "probability": 0.002673900547977751,
            "start_logit": 2.9554057121276855,
            "end_logit": 0.41755151748657227
        },
        {
            "text": "to exploit advances in genomics.",
            "probability": 0.0026522227961814668,
            "start_logit": 1.76052987575531,
            "end_logit": 1.6042871475219727
        },
        {
            "text": "to enable the creation of the large radiotherapy",
            "probability": 0.001956947809153881,
            "start_logit": 4.347301483154297,
            "end_logit": -1.2864965200424194
        },
        {
            "text": "the creation of the large radiotherapy cohorts required to exploit advances in genomics.",
            "probability": 0.0019454339062066441,
            "start_logit": 1.4506168365478516,
            "end_logit": 1.6042871475219727
        },
        {
            "text": "creation of the large radiotherapy cohorts required to exploit advances in genomics.",
            "probability": 0.001536528466934879,
            "start_logit": 1.2146574258804321,
            "end_logit": 1.6042871475219727
        },
        {
            "text": "the creation of the large radiotherapy cohorts",
            "probability": 0.0014645053570976475,
            "start_logit": 1.4506168365478516,
            "end_logit": 1.320319652557373
        },
        {
            "text": "",
            "probability": 1.9144213598610372e-05,
            "start_logit": -1.1509166955947876,
            "end_logit": -0.4154191315174103
        }
    ],
    "5e48efd9f8b2df0d49000004_002": [
        {
            "text": "identification of genomic markers that are predictive for the development of adverse effects resulting from cancer treatment with radiation",
            "probability": 0.7470354457624399,
            "start_logit": 5.236628532409668,
            "end_logit": 4.525117874145508
        },
        {
            "text": "the identification of genomic markers that are predictive for the development of adverse effects resulting from cancer treatment with radiation",
            "probability": 0.10431128592681156,
            "start_logit": 3.267895460128784,
            "end_logit": 4.525117874145508
        },
        {
            "text": "identification of genomic markers",
            "probability": 0.05709822484147988,
            "start_logit": 5.236628532409668,
            "end_logit": 1.9537782669067383
        },
        {
            "text": "identification of genomic markers that are predictive for the development of adverse effects resulting from cancer treatment with radiation.",
            "probability": 0.04894789154580072,
            "start_logit": 5.236628532409668,
            "end_logit": 1.7997615337371826
        },
        {
            "text": "The overall goal of radiogenomics is the identification of genomic markers that are predictive for the development of adverse effects resulting from cancer treatment with radiation",
            "probability": 0.010664378463693853,
            "start_logit": 0.9874249696731567,
            "end_logit": 4.525117874145508
        },
        {
            "text": "the identification of genomic markers",
            "probability": 0.007972833539744791,
            "start_logit": 3.267895460128784,
            "end_logit": 1.9537782669067383
        },
        {
            "text": "the identification of genomic markers that are predictive for the development of adverse effects resulting from cancer treatment with radiation.",
            "probability": 0.006834772753436723,
            "start_logit": 3.267895460128784,
            "end_logit": 1.7997615337371826
        },
        {
            "text": "identification of genomic markers that are predictive",
            "probability": 0.0031465398874886597,
            "start_logit": 5.236628532409668,
            "end_logit": -0.9446913599967957
        },
        {
            "text": "identification of genomic markers that are predictive for the development of adverse effects resulting from cancer treatment",
            "probability": 0.0029890831303218002,
            "start_logit": 5.236628532409668,
            "end_logit": -0.9960280656814575
        },
        {
            "text": "identification of genomic markers that are predictive for the development of adverse effects",
            "probability": 0.002955889573310526,
            "start_logit": 5.236628532409668,
            "end_logit": -1.0071951150894165
        },
        {
            "text": "overall goal of radiogenomics is the identification of genomic markers that are predictive for the development of adverse effects resulting from cancer treatment with radiation",
            "probability": 0.0013016701847101942,
            "start_logit": -1.1158359050750732,
            "end_logit": 4.525117874145508
        },
        {
            "text": "predictive for the development of adverse effects resulting from cancer treatment with radiation",
            "probability": 0.0010807903225865684,
            "start_logit": -1.3017915487289429,
            "end_logit": 4.525117874145508
        },
        {
            "text": "identification of genomic markers that are predictive for the development of adverse effects resulting from cancer",
            "probability": 0.0010798034705912334,
            "start_logit": 5.236628532409668,
            "end_logit": -2.0142157077789307
        },
        {
            "text": "genomic markers that are predictive for the development of adverse effects resulting from cancer treatment with radiation",
            "probability": 0.0009527611286370438,
            "start_logit": -1.4278751611709595,
            "end_logit": 4.525117874145508
        },
        {
            "text": "The overall goal of radiogenomics is the identification of genomic markers",
            "probability": 0.0008151113615407552,
            "start_logit": 0.9874249696731567,
            "end_logit": 1.9537782669067383
        },
        {
            "text": "development of adverse effects resulting from cancer treatment with radiation",
            "probability": 0.0007885481753776992,
            "start_logit": -1.6170458793640137,
            "end_logit": 4.525117874145508
        },
        {
            "text": "goal of radiogenomics is the identification of genomic markers that are predictive for the development of adverse effects resulting from cancer treatment with radiation",
            "probability": 0.00059117084953722,
            "start_logit": -1.9051343202590942,
            "end_logit": 4.525117874145508
        },
        {
            "text": "the identification of genomic markers that are predictive",
            "probability": 0.00043936284917372195,
            "start_logit": 3.267895460128784,
            "end_logit": -0.9446913599967957
        },
        {
            "text": "the identification of genomic markers that are predictive for the development of adverse effects resulting from cancer treatment",
            "probability": 0.00041737658746270295,
            "start_logit": 3.267895460128784,
            "end_logit": -0.9960280656814575
        },
        {
            "text": "the identification of genomic markers that are predictive for the development of adverse effects",
            "probability": 0.0004127416499427074,
            "start_logit": 3.267895460128784,
            "end_logit": -1.0071951150894165
        },
        {
            "text": "",
            "probability": 0.0001643179959116645,
            "start_logit": 1.1277141571044922,
            "end_logit": 0.21196788549423218
        }
    ],
    "5e48efd9f8b2df0d49000004_004": [
        {
            "text": "",
            "probability": 0.9999583920465078,
            "start_logit": 6.017167568206787,
            "end_logit": 5.90133810043335
        },
        {
            "text": "to meta-analyze individual level data",
            "probability": 1.3794649402752507e-05,
            "start_logit": 1.5295560359954834,
            "end_logit": -0.8022385239601135
        },
        {
            "text": "to identify enough variants for a future test involving polygenic risk profiling",
            "probability": 9.840647740433463e-06,
            "start_logit": -0.5305412411689758,
            "end_logit": 0.9200994968414307
        },
        {
            "text": "to meta-analyze",
            "probability": 3.3978456308609218e-06,
            "start_logit": 1.5295560359954834,
            "end_logit": -2.2033777236938477
        },
        {
            "text": "We aimed to meta-analyze individual level data",
            "probability": 3.38388655098326e-06,
            "start_logit": 0.12430015951395035,
            "end_logit": -0.8022385239601135
        },
        {
            "text": "to meta-analyze individual level data from four genome-wide association studies",
            "probability": 2.974264368436825e-06,
            "start_logit": 1.5295560359954834,
            "end_logit": -2.3365225791931152
        },
        {
            "text": "identify enough variants for a future test involving polygenic risk profiling",
            "probability": 1.2948472485428593e-06,
            "start_logit": -2.5586700439453125,
            "end_logit": 0.9200994968414307
        },
        {
            "text": "meta-analyze individual level data",
            "probability": 9.433693349135038e-07,
            "start_logit": -1.1530221700668335,
            "end_logit": -0.8022385239601135
        },
        {
            "text": "to meta-analyze individual level data from four genome-wide association studies from prostate cancer radiotherapy cohorts including 1564 men to identify genetic markers",
            "probability": 8.807381417402536e-07,
            "start_logit": 1.5295560359954834,
            "end_logit": -3.553514242172241
        },
        {
            "text": "We aimed to meta-analyze",
            "probability": 8.335060788346874e-07,
            "start_logit": 0.12430015951395035,
            "end_logit": -2.2033777236938477
        },
        {
            "text": "We aimed to meta-analyze individual level data from four genome-wide association studies",
            "probability": 7.295997818845519e-07,
            "start_logit": 0.12430015951395035,
            "end_logit": -2.3365225791931152
        },
        {
            "text": "to identify genetic markers of toxicity",
            "probability": 7.24594237443736e-07,
            "start_logit": -0.5644544959068298,
            "end_logit": -1.6546522378921509
        },
        {
            "text": "a future test involving polygenic risk profiling",
            "probability": 5.200246812185354e-07,
            "start_logit": -3.4709417819976807,
            "end_logit": 0.9200994968414307
        },
        {
            "text": "to meta-analyze individual level data from four genome-wide association studies from prostate cancer",
            "probability": 4.569968650665317e-07,
            "start_logit": 1.5295560359954834,
            "end_logit": -4.209598064422607
        },
        {
            "text": "to identify enough variants for a future test",
            "probability": 4.179331450004031e-07,
            "start_logit": -0.5305412411689758,
            "end_logit": -2.2388558387756348
        },
        {
            "text": "to identify genetic markers of toxicity.",
            "probability": 3.4502227524606084e-07,
            "start_logit": -0.5644544959068298,
            "end_logit": -2.3966550827026367
        },
        {
            "text": "larger collaborative efforts to identify enough variants for a future test involving polygenic risk profiling",
            "probability": 3.364450309085811e-07,
            "start_logit": -3.9063832759857178,
            "end_logit": 0.9200994968414307
        },
        {
            "text": "to meta-analyze individual level data from four genome-wide association studies from prostate cancer radiotherapy cohorts",
            "probability": 2.7898557721077296e-07,
            "start_logit": 1.5295560359954834,
            "end_logit": -4.7031145095825195
        },
        {
            "text": "meta-analyze",
            "probability": 2.323671504318501e-07,
            "start_logit": -1.1530221700668335,
            "end_logit": -2.2033777236938477
        },
        {
            "text": "future test involving polygenic risk profiling",
            "probability": 2.222302500205763e-07,
            "start_logit": -4.321104049682617,
            "end_logit": 0.9200994968414307
        }
    ],
    "5e2f0afcfbd6abf43b000028_001": [
        {
            "text": "VEGF-R",
            "probability": 0.9990943925806095,
            "start_logit": 6.310927391052246,
            "end_logit": 8.678442001342773
        },
        {
            "text": "R",
            "probability": 0.00080761368316233,
            "start_logit": -0.8095933198928833,
            "end_logit": 8.678442001342773
        },
        {
            "text": "VEGF-R inhibitor",
            "probability": 4.3552902361351485e-05,
            "start_logit": 6.310927391052246,
            "end_logit": -1.3621861934661865
        },
        {
            "text": "VEGF-R inhibitor Tivozanib",
            "probability": 1.4415578608034688e-05,
            "start_logit": 6.310927391052246,
            "end_logit": -2.46785306930542
        },
        {
            "text": "VEGF-R inhibitor Tivozan",
            "probability": 1.0692696907120086e-05,
            "start_logit": 6.310927391052246,
            "end_logit": -2.7666015625
        },
        {
            "text": "VEGF",
            "probability": 1.0134105769530538e-05,
            "start_logit": 6.310927391052246,
            "end_logit": -2.820255994796753
        },
        {
            "text": "VEGF-R inhibitor Tivozanib to these systems abrogated the tension-induced paracrine",
            "probability": 9.738030643519271e-06,
            "start_logit": 6.310927391052246,
            "end_logit": -2.860123634338379
        },
        {
            "text": "VE",
            "probability": 8.68330317600888e-06,
            "start_logit": 6.310927391052246,
            "end_logit": -2.9747605323791504
        },
        {
            "text": "",
            "probability": 5.776586609166969e-07,
            "start_logit": -0.6745820641517639,
            "end_logit": 1.300574779510498
        },
        {
            "text": "VEGF release, and its conditioned medium enhanced the proliferation and tubular formation of VECs with a concurrent increase in BMP-2",
            "probability": 5.151413869654368e-08,
            "start_logit": 0.18133151531219482,
            "end_logit": -1.9724656343460083
        },
        {
            "text": "R inhibitor",
            "probability": 3.520580252443213e-08,
            "start_logit": -0.8095933198928833,
            "end_logit": -1.3621861934661865
        },
        {
            "text": "BMSCs incubated in a shared culture medium. Instead, BMSCs subjected to tension induced robust VEGF",
            "probability": 2.1662807384713552e-08,
            "start_logit": -2.692641258239746,
            "end_logit": 0.03524767607450485
        },
        {
            "text": "VEGF release",
            "probability": 1.4873809749303264e-08,
            "start_logit": 0.18133151531219482,
            "end_logit": -3.2147200107574463
        },
        {
            "text": "VEGF release, and its conditioned medium enhanced the proliferation and tubular formation of VECs",
            "probability": 1.3514541388666074e-08,
            "start_logit": 0.18133151531219482,
            "end_logit": -3.3105556964874268
        },
        {
            "text": "VEGF release, and its conditioned medium enhanced the proliferation and tubular formation of VECs with a concurrent increase in BMP-2 and IGF",
            "probability": 1.2900115145436141e-08,
            "start_logit": 0.18133151531219482,
            "end_logit": -3.357085704803467
        },
        {
            "text": "robust VEGF",
            "probability": 1.258644230169574e-08,
            "start_logit": -3.2356178760528564,
            "end_logit": 0.03524767607450485
        },
        {
            "text": "R inhibitor Tivozanib",
            "probability": 1.165277137076081e-08,
            "start_logit": -0.8095933198928833,
            "end_logit": -2.46785306930542
        },
        {
            "text": "BMSCs subjected to tension induced robust VEGF",
            "probability": 9.034581608545509e-09,
            "start_logit": -3.56717848777771,
            "end_logit": 0.03524767607450485
        },
        {
            "text": "R inhibitor Tivozan",
            "probability": 8.643395855513188e-09,
            "start_logit": -0.8095933198928833,
            "end_logit": -2.7666015625
        },
        {
            "text": "R inhibitor Tivozanib to these systems abrogated the tension-induced paracrine",
            "probability": 7.87169546057251e-09,
            "start_logit": -0.8095933198928833,
            "end_logit": -2.860123634338379
        }
    ],
    "5e2f0afcfbd6abf43b000028_002": [
        {
            "text": "endothelial growth factor receptors 1, 2\u00a0and 3 tyrosine kinases.",
            "probability": 0.3174010682050093,
            "start_logit": 4.839569091796875,
            "end_logit": 4.109536170959473
        },
        {
            "text": "endothelial growth factor",
            "probability": 0.309864470922176,
            "start_logit": 4.839569091796875,
            "end_logit": 4.08550500869751
        },
        {
            "text": "vascular endothelial growth factor receptors 1, 2\u00a0and 3 tyrosine kinases.",
            "probability": 0.1502605922735539,
            "start_logit": 4.091773986816406,
            "end_logit": 4.109536170959473
        },
        {
            "text": "vascular endothelial growth factor",
            "probability": 0.14669269762893244,
            "start_logit": 4.091773986816406,
            "end_logit": 4.08550500869751
        },
        {
            "text": "endothelial growth factor receptors",
            "probability": 0.025695321386909744,
            "start_logit": 4.839569091796875,
            "end_logit": 1.5956789255142212
        },
        {
            "text": "vascular endothelial growth factor receptors",
            "probability": 0.012164402067363427,
            "start_logit": 4.091773986816406,
            "end_logit": 1.5956789255142212
        },
        {
            "text": "endothelial growth factor receptors 1, 2\u00a0and 3",
            "probability": 0.00906104328158395,
            "start_logit": 4.839569091796875,
            "end_logit": 0.5533542633056641
        },
        {
            "text": "endothelial growth",
            "probability": 0.006023649282525772,
            "start_logit": 4.839569091796875,
            "end_logit": 0.14506326615810394
        },
        {
            "text": "sorafenib",
            "probability": 0.005367291299225645,
            "start_logit": 2.9795591831207275,
            "end_logit": 1.8897032737731934
        },
        {
            "text": "vascular endothelial growth factor receptors 1, 2\u00a0and 3",
            "probability": 0.004289581436530348,
            "start_logit": 4.091773986816406,
            "end_logit": 0.5533542633056641
        },
        {
            "text": "1, 2\u00a0and 3 tyrosine kinases.",
            "probability": 0.0031868823645240115,
            "start_logit": 0.23844604194164276,
            "end_logit": 4.109536170959473
        },
        {
            "text": "vascular endothelial growth",
            "probability": 0.002851651111192466,
            "start_logit": 4.091773986816406,
            "end_logit": 0.14506326615810394
        },
        {
            "text": "tumour",
            "probability": 0.0022736034992883623,
            "start_logit": -0.5697677731513977,
            "end_logit": 4.58007287979126
        },
        {
            "text": "endothelial",
            "probability": 0.0010632270048811642,
            "start_logit": 4.839569091796875,
            "end_logit": -1.5893213748931885
        },
        {
            "text": "vascular",
            "probability": 0.0009309447846007538,
            "start_logit": 4.091773986816406,
            "end_logit": -0.9743902087211609
        },
        {
            "text": "3 tyrosine kinases",
            "probability": 0.0005883064338867123,
            "start_logit": -1.4511044025421143,
            "end_logit": 4.109536170959473
        },
        {
            "text": "end",
            "probability": 0.0005708487266978633,
            "start_logit": 4.839569091796875,
            "end_logit": -2.211261034011841
        },
        {
            "text": "tyrosine kinases",
            "probability": 0.0005697072340483852,
            "start_logit": -1.4832297563552856,
            "end_logit": 4.109536170959473
        },
        {
            "text": "endothelial growth factor receptors 1, 2\u00a0and 3 tyrosine",
            "probability": 0.0005518377254360022,
            "start_logit": 4.839569091796875,
            "end_logit": -2.245131254196167
        },
        {
            "text": "endothelial growth factor receptors 1",
            "probability": 0.0005500440806771844,
            "start_logit": 4.839569091796875,
            "end_logit": -2.248386859893799
        },
        {
            "text": "",
            "probability": 4.282925095664469e-05,
            "start_logit": 0.13874420523643494,
            "end_logit": -0.10033909231424332
        }
    ],
    "5e2f0afcfbd6abf43b000028_004": [
        {
            "text": "VEGFR1-3",
            "probability": 0.9873164233165016,
            "start_logit": 6.568904399871826,
            "end_logit": 7.582314968109131
        },
        {
            "text": "VEGFR1-3,",
            "probability": 0.00577254012096445,
            "start_logit": 6.568904399871826,
            "end_logit": 2.440436601638794
        },
        {
            "text": "VEGFR1-3, with activity against PDGFR\u03b1/\u03b2 and cKIT",
            "probability": 0.002340418251113123,
            "start_logit": 6.568904399871826,
            "end_logit": 1.5376540422439575
        },
        {
            "text": "FGF, and activity of tivozanib.Conclusion: Tivozanib was well tolerated and showed antitumor",
            "probability": 0.0011306005894818594,
            "start_logit": 0.9370255470275879,
            "end_logit": 6.441952228546143
        },
        {
            "text": "Tivozanib is a potent small molecule tyrosine kinase inhibitor against VEGFR1-3",
            "probability": 0.0009437089957314745,
            "start_logit": -0.38402360677719116,
            "end_logit": 7.582314968109131
        },
        {
            "text": "VEGFR1-3, with activity against PDGFR\u03b1/\u03b2 and cKIT.",
            "probability": 0.000695917578933174,
            "start_logit": 6.568904399871826,
            "end_logit": 0.3248003423213959
        },
        {
            "text": "small molecule tyrosine kinase inhibitor against VEGFR1-3",
            "probability": 0.0006340672573480742,
            "start_logit": -0.7816864252090454,
            "end_logit": 7.582314968109131
        },
        {
            "text": "tyrosine kinase inhibitor against VEGFR1-3",
            "probability": 0.00038110588334404924,
            "start_logit": -1.2907642126083374,
            "end_logit": 7.582314968109131
        },
        {
            "text": "against VEGFR1-3",
            "probability": 0.00020582210345391577,
            "start_logit": -1.9068292379379272,
            "end_logit": 7.582314968109131
        },
        {
            "text": "3",
            "probability": 0.00011619308740941605,
            "start_logit": -2.478588104248047,
            "end_logit": 7.582314968109131
        },
        {
            "text": "a potent small molecule tyrosine kinase inhibitor against VEGFR1-3",
            "probability": 8.655482575517025e-05,
            "start_logit": -2.7730634212493896,
            "end_logit": 7.582314968109131
        },
        {
            "text": "kinase inhibitor against VEGFR1-3",
            "probability": 6.91330564283931e-05,
            "start_logit": -2.9978084564208984,
            "end_logit": 7.582314968109131
        },
        {
            "text": "potent small molecule tyrosine kinase inhibitor against VEGFR1-3",
            "probability": 6.534854810842391e-05,
            "start_logit": -3.0541062355041504,
            "end_logit": 7.582314968109131
        },
        {
            "text": "Tivozanib was well tolerated and showed antitumor",
            "probability": 5.465278668885302e-05,
            "start_logit": -2.0924785137176514,
            "end_logit": 6.441952228546143
        },
        {
            "text": "inhibitor against VEGFR1-3",
            "probability": 4.364481380309658e-05,
            "start_logit": -3.457756996154785,
            "end_logit": 7.582314968109131
        },
        {
            "text": "antitumor",
            "probability": 3.9016386129175414e-05,
            "start_logit": -2.429497003555298,
            "end_logit": 6.441952228546143
        },
        {
            "text": "VEGFR1-3, with activity against PDGFR\u03b1/\u03b2",
            "probability": 3.574423914187761e-05,
            "start_logit": 6.568904399871826,
            "end_logit": -2.6440417766571045
        },
        {
            "text": "Tivozanib is a potent small molecule tyrosine kinase inhibitor against VEGFR1-3,",
            "probability": 2.9758075455858523e-05,
            "start_logit": -3.840740919113159,
            "end_logit": 7.582314968109131
        },
        {
            "text": "VEGFR1",
            "probability": 1.972627521032596e-05,
            "start_logit": 6.568904399871826,
            "end_logit": -3.2384793758392334
        },
        {
            "text": "PDGFR\u03b1/\u03b2 and cKIT",
            "probability": 1.9308926719584533e-05,
            "start_logit": 1.771386981010437,
            "end_logit": 1.5376540422439575
        },
        {
            "text": "",
            "probability": 3.148822778210435e-07,
            "start_logit": -1.0433564186096191,
            "end_logit": 0.23627349734306335
        }
    ],
    "5e2f0afcfbd6abf43b000028_005": [
        {
            "text": "pan-VEGF",
            "probability": 0.839668864700885,
            "start_logit": 2.1961498260498047,
            "end_logit": 5.3055195808410645
        },
        {
            "text": "oral pan-VEGF",
            "probability": 0.07648155943596852,
            "start_logit": -0.19980812072753906,
            "end_logit": 5.3055195808410645
        },
        {
            "text": "anti-VEGF",
            "probability": 0.028151774484419002,
            "start_logit": 0.3827225863933563,
            "end_logit": 3.7235496044158936
        },
        {
            "text": "VEGF",
            "probability": 0.01817664980438478,
            "start_logit": -0.05475001037120819,
            "end_logit": 3.7235496044158936
        },
        {
            "text": "pan-VEGF receptor",
            "probability": 0.014619263561894712,
            "start_logit": 2.1961498260498047,
            "end_logit": 1.254852056503296
        },
        {
            "text": "pan-VEGF receptor tyrosine kinase",
            "probability": 0.006798072086993922,
            "start_logit": 2.1961498260498047,
            "end_logit": 0.4891510307788849
        },
        {
            "text": "Tivozanib is an oral pan-VEGF",
            "probability": 0.006205677888701249,
            "start_logit": -2.711393117904663,
            "end_logit": 5.3055195808410645
        },
        {
            "text": "an oral pan-VEGF",
            "probability": 0.002561977403411864,
            "start_logit": -3.596078395843506,
            "end_logit": 5.3055195808410645
        },
        {
            "text": "glioblastoma because of its high vascularization. Tivozanib is an oral pan-VEGF",
            "probability": 0.0014574886921399815,
            "start_logit": -4.16014289855957,
            "end_logit": 5.3055195808410645
        },
        {
            "text": "oral pan-VEGF receptor",
            "probability": 0.0013316012085519465,
            "start_logit": -0.19980812072753906,
            "end_logit": 1.254852056503296
        },
        {
            "text": "pan-VEGF receptor tyrosine kinase inhibitor",
            "probability": 0.0010375192290842546,
            "start_logit": 2.1961498260498047,
            "end_logit": -1.390655517578125
        },
        {
            "text": "oral pan-VEGF receptor tyrosine kinase",
            "probability": 0.0006192049940504078,
            "start_logit": -0.19980812072753906,
            "end_logit": 0.4891510307788849
        },
        {
            "text": "PlGF and VEGF increased after treatment, suggesting an anti-angiogenic",
            "probability": 0.0005796219685801047,
            "start_logit": -0.5120420455932617,
            "end_logit": 0.7353246808052063
        },
        {
            "text": "anti-VEGF monotherapy",
            "probability": 0.0004821603794401581,
            "start_logit": 0.3827225863933563,
            "end_logit": -0.3435392677783966
        },
        {
            "text": "pan-VEGF receptor tyrosine kinase inhibitor that hits a central pathway in glioblastoma angiogenesis",
            "probability": 0.0003793447446553131,
            "start_logit": 2.1961498260498047,
            "end_logit": -2.3967978954315186
        },
        {
            "text": "VEGF monotherapy",
            "probability": 0.0003113146693997436,
            "start_logit": -0.05475001037120819,
            "end_logit": -0.3435392677783966
        },
        {
            "text": "anti-tumor activity, highlighting the limitations of anti-VEGF",
            "probability": 0.00031125821385803335,
            "start_logit": -4.122020244598389,
            "end_logit": 3.7235496044158936
        },
        {
            "text": "tivozanib had limited anti-tumor activity, highlighting the limitations of anti-VEGF",
            "probability": 0.00028978319107488893,
            "start_logit": -4.193510055541992,
            "end_logit": 3.7235496044158936
        },
        {
            "text": "tumor vasculature, tivozanib had limited anti-tumor activity, highlighting the limitations of anti-VEGF",
            "probability": 0.0002254351391333702,
            "start_logit": -4.444610595703125,
            "end_logit": 3.7235496044158936
        },
        {
            "text": "pan-VEGF receptor tyrosine kinase inhibitor that hits a central pathway in glioblastoma angiogenesis.",
            "probability": 0.0002225129954298786,
            "start_logit": 2.1961498260498047,
            "end_logit": -2.930257797241211
        },
        {
            "text": "",
            "probability": 8.89152079426182e-05,
            "start_logit": -1.5072667598724365,
            "end_logit": -0.14414352178573608
        }
    ],
    "5e2f0afcfbd6abf43b000028_006": [
        {
            "text": "VEGF",
            "probability": 0.9850529349894669,
            "start_logit": 1.8955645561218262,
            "end_logit": 3.5291199684143066
        },
        {
            "text": "Tivozanib, a pan-inhibitor of VEGF",
            "probability": 0.003860625885220039,
            "start_logit": -3.646301507949829,
            "end_logit": 3.5291199684143066
        },
        {
            "text": "",
            "probability": 0.0034693457397315976,
            "start_logit": -0.2507270574569702,
            "end_logit": 0.026682229712605476
        },
        {
            "text": "VEGF receptors",
            "probability": 0.0021834478295685816,
            "start_logit": 1.8955645561218262,
            "end_logit": -2.582670211791992
        },
        {
            "text": "apatinib synergistically increased cisplatin sensitivity. Tivozanib, a pan-inhibitor of VEGF",
            "probability": 0.002099098487609415,
            "start_logit": -4.255622863769531,
            "end_logit": 3.5291199684143066
        },
        {
            "text": "cisplatin sensitivity. Tivozanib, a pan-inhibitor of VEGF",
            "probability": 0.0018913708350986956,
            "start_logit": -4.359828948974609,
            "end_logit": 3.5291199684143066
        },
        {
            "text": "a pan-inhibitor of VEGF",
            "probability": 0.001207977690853437,
            "start_logit": -4.808183193206787,
            "end_logit": 3.5291199684143066
        },
        {
            "text": "VEGF receptors,",
            "probability": 0.0001968854712187218,
            "start_logit": 1.8955645561218262,
            "end_logit": -4.98870849609375
        },
        {
            "text": "Tivozanib, a pan-inhibitor of VEGF receptors",
            "probability": 8.557382969423988e-06,
            "start_logit": -3.646301507949829,
            "end_logit": -2.582670211791992
        },
        {
            "text": "VEGFR2",
            "probability": 5.077934023258276e-06,
            "start_logit": -2.508538246154785,
            "end_logit": -4.242323398590088
        },
        {
            "text": "VEGFR2-inhibitor apatinib synergistically increased cisplatin",
            "probability": 4.997201189696199e-06,
            "start_logit": -2.8721437454223633,
            "end_logit": -3.894744396209717
        },
        {
            "text": "apatinib synergistically increased cisplatin sensitivity. Tivozanib, a pan-inhibitor of VEGF receptors",
            "probability": 4.652818010100623e-06,
            "start_logit": -4.255622863769531,
            "end_logit": -2.582670211791992
        },
        {
            "text": "cisplatin sensitivity. Tivozanib, a pan-inhibitor of VEGF receptors",
            "probability": 4.192373219871399e-06,
            "start_logit": -4.359828948974609,
            "end_logit": -2.582670211791992
        },
        {
            "text": "a pan-inhibitor of VEGF receptors",
            "probability": 2.6775782027281683e-06,
            "start_logit": -4.808183193206787,
            "end_logit": -2.582670211791992
        },
        {
            "text": "VEGFR",
            "probability": 2.6170317590657325e-06,
            "start_logit": -2.508538246154785,
            "end_logit": -4.905187129974365
        },
        {
            "text": "VEGFR2 correlated with resistance to cisplatin and combination with VEGFR2",
            "probability": 1.9678990963627706e-06,
            "start_logit": -2.508538246154785,
            "end_logit": -5.190261363983154
        },
        {
            "text": "apatinib synergistically increased cisplatin",
            "probability": 1.2528223364285729e-06,
            "start_logit": -4.255622863769531,
            "end_logit": -3.894744396209717
        },
        {
            "text": "cisplatin",
            "probability": 1.1288425210480728e-06,
            "start_logit": -4.359828948974609,
            "end_logit": -3.894744396209717
        },
        {
            "text": "Tivozanib, a pan-inhibitor of VEGF receptors,",
            "probability": 7.716348224665409e-07,
            "start_logit": -3.646301507949829,
            "end_logit": -4.98870849609375
        },
        {
            "text": "apatinib synergistically increased cisplatin sensitivity. Tivozanib, a pan-inhibitor of VEGF receptors,",
            "probability": 4.1955308206041243e-07,
            "start_logit": -4.255622863769531,
            "end_logit": -4.98870849609375
        }
    ],
    "5c7a4fddd774d04240000009_001": [
        {
            "text": "",
            "probability": 0.999230436275578,
            "start_logit": 4.431807994842529,
            "end_logit": 4.4113078117370605
        },
        {
            "text": "Circulating tumor cells are rare",
            "probability": 0.0004952797401412332,
            "start_logit": 1.4051862955093384,
            "end_logit": -0.17168845236301422
        },
        {
            "text": "Circulating tumor cells are rare events",
            "probability": 9.558052708604399e-05,
            "start_logit": 1.4051862955093384,
            "end_logit": -1.8168420791625977
        },
        {
            "text": "rare",
            "probability": 8.800564183632326e-05,
            "start_logit": -0.32253551483154297,
            "end_logit": -0.17168845236301422
        },
        {
            "text": "Circulating tumor cells",
            "probability": 4.421757188420671e-05,
            "start_logit": 1.4051862955093384,
            "end_logit": -2.58768892288208
        },
        {
            "text": "rare events",
            "probability": 1.6983585136881914e-05,
            "start_logit": -0.32253551483154297,
            "end_logit": -1.8168420791625977
        },
        {
            "text": "Circulating tumor cells are rare events which can be detected specifically only by using a combination of surface and intracellular markers",
            "probability": 9.93216927355086e-06,
            "start_logit": 1.4051862955093384,
            "end_logit": -4.0810322761535645
        },
        {
            "text": "Circulating",
            "probability": 5.3896983012469236e-06,
            "start_logit": 1.4051862955093384,
            "end_logit": -4.69232177734375
        },
        {
            "text": "Circulating tumor cells are rare events which can be detected specifically only by using a combination of surface and intracellular markers,",
            "probability": 5.3703808390699835e-06,
            "start_logit": 1.4051862955093384,
            "end_logit": -4.6959123611450195
        },
        {
            "text": "Circulating tumor",
            "probability": 1.9947315476020836e-06,
            "start_logit": 1.4051862955093384,
            "end_logit": -5.6863017082214355
        },
        {
            "text": "rare events which can be detected specifically only by using a combination of surface and intracellular markers",
            "probability": 1.7648348214215245e-06,
            "start_logit": -0.32253551483154297,
            "end_logit": -4.0810322761535645
        },
        {
            "text": "Circulating tumor cells are rare events which can be detected specifically only by using a combination of surface and intracellular",
            "probability": 1.043228189537239e-06,
            "start_logit": 1.4051862955093384,
            "end_logit": -6.33449125289917
        },
        {
            "text": "rare events which can be detected specifically only by using a combination of surface and intracellular markers,",
            "probability": 9.542563007182033e-07,
            "start_logit": -0.32253551483154297,
            "end_logit": -4.6959123611450195
        },
        {
            "text": "Circulating tumor cells are rare events which can be detected",
            "probability": 7.6602471495761e-07,
            "start_logit": 1.4051862955093384,
            "end_logit": -6.643352031707764
        },
        {
            "text": "tumor cells are rare",
            "probability": 7.198078555537169e-07,
            "start_logit": -5.128707408905029,
            "end_logit": -0.17168845236301422
        },
        {
            "text": "events",
            "probability": 6.374038012480382e-07,
            "start_logit": -3.6051347255706787,
            "end_logit": -1.8168420791625977
        },
        {
            "text": "cells are rare",
            "probability": 3.545516201938583e-07,
            "start_logit": -5.8368377685546875,
            "end_logit": -0.17168845236301422
        },
        {
            "text": ". Circulating tumor cells are rare",
            "probability": 2.4529053427231e-07,
            "start_logit": -6.2052483558654785,
            "end_logit": -0.17168845236301422
        },
        {
            "text": "rare events which can be detected specifically only by using a combination of surface and intracellular",
            "probability": 1.8536992120006736e-07,
            "start_logit": -0.32253551483154297,
            "end_logit": -6.33449125289917
        },
        {
            "text": "tumor cells are rare events",
            "probability": 1.3891061688669214e-07,
            "start_logit": -5.128707408905029,
            "end_logit": -1.8168420791625977
        }
    ],
    "5c7a4fddd774d04240000009_002": [
        {
            "text": "",
            "probability": 0.6756417116772588,
            "start_logit": 3.3186709880828857,
            "end_logit": 2.504249334335327
        },
        {
            "text": "extremely low",
            "probability": 0.100909543655547,
            "start_logit": 3.394150495529175,
            "end_logit": 0.5273314118385315
        },
        {
            "text": "extremely low number",
            "probability": 0.07698557371788058,
            "start_logit": 3.394150495529175,
            "end_logit": 0.2567249536514282
        },
        {
            "text": "extremely low number of CTCs (as low as 1 in 10(9) hematologic cells",
            "probability": 0.047948462631831515,
            "start_logit": 3.394150495529175,
            "end_logit": -0.216766357421875
        },
        {
            "text": "low",
            "probability": 0.02707431491031415,
            "start_logit": 2.0785114765167236,
            "end_logit": 0.5273314118385315
        },
        {
            "text": "low number",
            "probability": 0.020655446361980724,
            "start_logit": 2.0785114765167236,
            "end_logit": 0.2567249536514282
        },
        {
            "text": "low number of CTCs (as low as 1 in 10(9) hematologic cells",
            "probability": 0.012864707635493071,
            "start_logit": 2.0785114765167236,
            "end_logit": -0.216766357421875
        },
        {
            "text": "extremely low number of CTCs (as low as 1 in 10",
            "probability": 0.01115493164285388,
            "start_logit": 3.394150495529175,
            "end_logit": -1.675011396408081
        },
        {
            "text": "extremely low number of CTCs (as low as 1 in 10(9)",
            "probability": 0.009044955711297185,
            "start_logit": 3.394150495529175,
            "end_logit": -1.8846858739852905
        },
        {
            "text": "extremely low number of CTCs (as low as 1 in 10(9) hematologic cells)",
            "probability": 0.0033239862390686626,
            "start_logit": 3.394150495529175,
            "end_logit": -2.885728359222412
        },
        {
            "text": "low number of CTCs (as low as 1 in 10",
            "probability": 0.002992899592654657,
            "start_logit": 2.0785114765167236,
            "end_logit": -1.675011396408081
        },
        {
            "text": "low number of CTCs (as low as 1 in 10(9)",
            "probability": 0.0024267871046312387,
            "start_logit": 2.0785114765167236,
            "end_logit": -1.8846858739852905
        },
        {
            "text": "extremely low number of CTCs",
            "probability": 0.0020339593602019222,
            "start_logit": 3.394150495529175,
            "end_logit": -3.376908779144287
        },
        {
            "text": "extremely low number of CTCs (as low as 1 in 10(9) hematologic cells) in the blood of patients",
            "probability": 0.0017187895089389408,
            "start_logit": 3.394150495529175,
            "end_logit": -3.5452728271484375
        },
        {
            "text": "1 in 10(9) hematologic cells",
            "probability": 0.0011324334033765706,
            "start_logit": -0.35160747170448303,
            "end_logit": -0.216766357421875
        },
        {
            "text": "extremely low number of CTCs (as low as 1 in 10(9",
            "probability": 0.0009317612223965048,
            "start_logit": 3.394150495529175,
            "end_logit": -4.157571792602539
        },
        {
            "text": "low number of CTCs (as low as 1 in 10(9) hematologic cells)",
            "probability": 0.0008918348744226905,
            "start_logit": 2.0785114765167236,
            "end_logit": -2.885728359222412
        },
        {
            "text": "extremely low number of CTCs (as low as 1 in 10(9) hematologic cells) in the blood",
            "probability": 0.000827390997186995,
            "start_logit": 3.394150495529175,
            "end_logit": -4.276371002197266
        },
        {
            "text": "extremely",
            "probability": 0.0007337583389708939,
            "start_logit": 3.394150495529175,
            "end_logit": -4.396468639373779
        },
        {
            "text": "as low as 1 in 10(9) hematologic cells",
            "probability": 0.0007067514136944042,
            "start_logit": -0.8230525255203247,
            "end_logit": -0.216766357421875
        }
    ],
    "5c7a4fddd774d04240000009_003": [
        {
            "text": "",
            "probability": 0.9999999960513399,
            "start_logit": 6.07958984375,
            "end_logit": 6.2782368659973145
        },
        {
            "text": "tumor cells",
            "probability": 8.374104594919114e-10,
            "start_logit": -3.8264403343200684,
            "end_logit": -4.716439723968506
        },
        {
            "text": "almost 28 MCF-7 cells were obtained from one target cell",
            "probability": 4.367772231842744e-10,
            "start_logit": -3.428462266921997,
            "end_logit": -5.765308856964111
        },
        {
            "text": "tumor",
            "probability": 4.2370463292589684e-10,
            "start_logit": -3.8264403343200684,
            "end_logit": -5.397717475891113
        },
        {
            "text": "almost 28 MCF-7 cells",
            "probability": 3.4184212449261236e-10,
            "start_logit": -3.428462266921997,
            "end_logit": -6.010383129119873
        },
        {
            "text": "almost 28",
            "probability": 2.1646355228090333e-10,
            "start_logit": -3.428462266921997,
            "end_logit": -6.467309951782227
        },
        {
            "text": "one",
            "probability": 2.1530222637665783e-10,
            "start_logit": -4.195491313934326,
            "end_logit": -5.705660343170166
        },
        {
            "text": "almost",
            "probability": 1.673977342439628e-10,
            "start_logit": -3.428462266921997,
            "end_logit": -6.724359512329102
        },
        {
            "text": "one CTC",
            "probability": 1.5279609528239973e-10,
            "start_logit": -4.195491313934326,
            "end_logit": -6.048598766326904
        },
        {
            "text": "28 MCF-7 cells were obtained from one target cell",
            "probability": 1.471735530790799e-10,
            "start_logit": -4.516273021697998,
            "end_logit": -5.765308856964111
        },
        {
            "text": "tumor cells (CTCs) served as an important biomarker for tumor recurrence",
            "probability": 1.3716762286095785e-10,
            "start_logit": -3.8264403343200684,
            "end_logit": -6.525550365447998
        },
        {
            "text": "7 day proliferation",
            "probability": 1.3258947031002757e-10,
            "start_logit": -4.706364631652832,
            "end_logit": -5.679572105407715
        },
        {
            "text": "tumor cells (CTCs",
            "probability": 1.2844922486835784e-10,
            "start_logit": -3.8264403343200684,
            "end_logit": -6.591220378875732
        },
        {
            "text": "7 day proliferation, almost 28 MCF-7 cells were obtained from one target cell",
            "probability": 1.2169536497608172e-10,
            "start_logit": -4.706364631652832,
            "end_logit": -5.765308856964111
        },
        {
            "text": "28 MCF-7 cells",
            "probability": 1.1518485255915761e-10,
            "start_logit": -4.516273021697998,
            "end_logit": -6.010383129119873
        },
        {
            "text": "7 day proliferation, almost 28 MCF-7 cells",
            "probability": 9.524444017717589e-11,
            "start_logit": -4.706364631652832,
            "end_logit": -6.010383129119873
        },
        {
            "text": "one CTC. Furthermore, it was demonstrated that the designed probe allowed capturing living CTCs with minimal cell damage",
            "probability": 8.316213965176135e-11,
            "start_logit": -4.195491313934326,
            "end_logit": -6.6569108963012695
        },
        {
            "text": "28",
            "probability": 7.293812133573431e-11,
            "start_logit": -4.516273021697998,
            "end_logit": -6.467309951782227
        },
        {
            "text": "extremely scare number of CTCs",
            "probability": 6.305033561452638e-11,
            "start_logit": -5.109395503997803,
            "end_logit": -6.0198655128479
        },
        {
            "text": "7 day proliferation, almost 28",
            "probability": 6.031132028084221e-11,
            "start_logit": -4.706364631652832,
            "end_logit": -6.467309951782227
        }
    ],
    "5c7a4fddd774d04240000009_004": [
        {
            "text": "",
            "probability": 0.9999990146434418,
            "start_logit": 5.690557479858398,
            "end_logit": 6.157118320465088
        },
        {
            "text": "rare number",
            "probability": 2.886677712423639e-07,
            "start_logit": -1.4179160594940186,
            "end_logit": -1.7923965454101562
        },
        {
            "text": "rare",
            "probability": 2.392040644451764e-07,
            "start_logit": -1.4179160594940186,
            "end_logit": -1.980355978012085
        },
        {
            "text": "as low as one",
            "probability": 9.655105867127998e-08,
            "start_logit": -1.8004804849624634,
            "end_logit": -2.5050365924835205
        },
        {
            "text": "one",
            "probability": 7.894867331617011e-08,
            "start_logit": -2.0017545223236084,
            "end_logit": -2.5050365924835205
        },
        {
            "text": "proliferation of the rare number",
            "probability": 4.702064732970404e-08,
            "start_logit": -3.2326056957244873,
            "end_logit": -1.7923965454101562
        },
        {
            "text": "proliferation of the rare",
            "probability": 3.896358054001487e-08,
            "start_logit": -3.2326056957244873,
            "end_logit": -1.980355978012085
        },
        {
            "text": "rare number CTCs",
            "probability": 3.3121118613096146e-08,
            "start_logit": -1.4179160594940186,
            "end_logit": -3.9575018882751465
        },
        {
            "text": "98%) owing to the nontoxic and biocompatible properties of PIL, which realized the proliferation of the rare number",
            "probability": 3.086120160687383e-08,
            "start_logit": -3.6536927223205566,
            "end_logit": -1.7923965454101562
        },
        {
            "text": "98%) owing to the nontoxic and biocompatible properties of PIL, which realized the proliferation of the rare",
            "probability": 2.5573082946721598e-08,
            "start_logit": -3.6536927223205566,
            "end_logit": -1.980355978012085
        },
        {
            "text": "as low as one CTC",
            "probability": 2.0395681764758543e-08,
            "start_logit": -1.8004804849624634,
            "end_logit": -4.05978536605835
        },
        {
            "text": "one CTC",
            "probability": 1.6677310832899892e-08,
            "start_logit": -2.0017545223236084,
            "end_logit": -4.05978536605835
        },
        {
            "text": "the rare number",
            "probability": 1.1909842681200489e-08,
            "start_logit": -4.605827331542969,
            "end_logit": -1.7923965454101562
        },
        {
            "text": "as low as one CTC in the whole blood",
            "probability": 1.0362553672800978e-08,
            "start_logit": -1.8004804849624634,
            "end_logit": -4.736909866333008
        },
        {
            "text": "the rare",
            "probability": 9.869071160887882e-09,
            "start_logit": -4.605827331542969,
            "end_logit": -1.980355978012085
        },
        {
            "text": "one CTC in the whole blood",
            "probability": 8.473339141941461e-09,
            "start_logit": -2.0017545223236084,
            "end_logit": -4.736909866333008
        },
        {
            "text": "proliferation",
            "probability": 7.636834783851248e-09,
            "start_logit": -3.2326056957244873,
            "end_logit": -3.6100001335144043
        },
        {
            "text": "as low as one CTC in the whole blood was captured and identified by the ICC method.",
            "probability": 7.5362405248257e-09,
            "start_logit": -1.8004804849624634,
            "end_logit": -5.055385112762451
        },
        {
            "text": "low as one",
            "probability": 7.422189407210114e-09,
            "start_logit": -4.3660783767700195,
            "end_logit": -2.5050365924835205
        },
        {
            "text": "one CTC in the whole blood was captured and identified by the ICC method.",
            "probability": 6.162295881728411e-09,
            "start_logit": -2.0017545223236084,
            "end_logit": -5.055385112762451
        }
    ],
    "5c7a4fddd774d04240000009_005": [
        {
            "text": "",
            "probability": 0.9925686655298076,
            "start_logit": 4.2978644371032715,
            "end_logit": 3.9799256324768066
        },
        {
            "text": "rare",
            "probability": 0.006421952379292953,
            "start_logit": 2.266012668609619,
            "end_logit": 0.9712033867835999
        },
        {
            "text": "rare cell species",
            "probability": 0.00037313030325605037,
            "start_logit": 2.266012668609619,
            "end_logit": -1.874346375465393
        },
        {
            "text": "rare cell species in blood circulation",
            "probability": 0.00031372249385614077,
            "start_logit": 2.266012668609619,
            "end_logit": -2.0477652549743652
        },
        {
            "text": "a rare",
            "probability": 0.00017681337360898506,
            "start_logit": -1.3263700008392334,
            "end_logit": 0.9712033867835999
        },
        {
            "text": "rare cell",
            "probability": 6.541603576396968e-05,
            "start_logit": 2.266012668609619,
            "end_logit": -3.615506649017334
        },
        {
            "text": "rare cell species in blood",
            "probability": 2.506548251482579e-05,
            "start_logit": 2.266012668609619,
            "end_logit": -4.574782371520996
        },
        {
            "text": "rare cell species in blood circulation.",
            "probability": 1.1409640090269602e-05,
            "start_logit": 2.266012668609619,
            "end_logit": -5.361815452575684
        },
        {
            "text": "a rare cell species",
            "probability": 1.0273266417729125e-05,
            "start_logit": -1.3263700008392334,
            "end_logit": -1.874346375465393
        },
        {
            "text": "a rare cell species in blood circulation",
            "probability": 8.637611934742426e-06,
            "start_logit": -1.3263700008392334,
            "end_logit": -2.0477652549743652
        },
        {
            "text": "cell species",
            "probability": 7.1767613032570995e-06,
            "start_logit": -1.685066819190979,
            "end_logit": -1.874346375465393
        },
        {
            "text": "cell species in blood circulation",
            "probability": 6.0341157880254665e-06,
            "start_logit": -1.685066819190979,
            "end_logit": -2.0477652549743652
        },
        {
            "text": "tumor cells (CTCs), a rare",
            "probability": 2.8816248663667664e-06,
            "start_logit": -5.443110466003418,
            "end_logit": 0.9712033867835999
        },
        {
            "text": "rare cell species in blood circulation. Based on the metabolic features of cancer cells, live CTCs",
            "probability": 1.8571955040275192e-06,
            "start_logit": 2.266012668609619,
            "end_logit": -7.177206516265869
        },
        {
            "text": "a rare cell",
            "probability": 1.8010768826079253e-06,
            "start_logit": -1.3263700008392334,
            "end_logit": -3.615506649017334
        },
        {
            "text": "rare cell species in blood circulation. Based on the metabolic features of cancer cells",
            "probability": 1.3994649364277317e-06,
            "start_logit": 2.266012668609619,
            "end_logit": -7.460184097290039
        },
        {
            "text": "cell",
            "probability": 1.258207307170052e-06,
            "start_logit": -1.685066819190979,
            "end_logit": -3.615506649017334
        },
        {
            "text": "circulating tumor cells (CTCs), a rare",
            "probability": 1.2177701389351893e-06,
            "start_logit": -6.304443359375,
            "end_logit": 0.9712033867835999
        },
        {
            "text": "a rare cell species in blood",
            "probability": 6.901191822713767e-07,
            "start_logit": -1.3263700008392334,
            "end_logit": -4.574782371520996
        },
        {
            "text": "species",
            "probability": 5.975475479691217e-07,
            "start_logit": -4.170836448669434,
            "end_logit": -1.874346375465393
        }
    ],
    "5e35c4ea9be68b5512000002_002": [
        {
            "text": "accurately identifies individual gene targets, gene signatures, and cell states affected by individual perturbations and\u00a0their genetic interactions.",
            "probability": 0.371777282548023,
            "start_logit": -0.1600789576768875,
            "end_logit": 1.9465223550796509
        },
        {
            "text": "identifies individual gene targets, gene signatures, and cell states affected by individual perturbations and\u00a0their genetic interactions.",
            "probability": 0.3544736543025602,
            "start_logit": -0.2077399045228958,
            "end_logit": 1.9465223550796509
        },
        {
            "text": "accurately identifies individual gene targets, gene signatures, and cell states",
            "probability": 0.08590038202138636,
            "start_logit": -0.1600789576768875,
            "end_logit": 0.48141565918922424
        },
        {
            "text": "identifies individual gene targets, gene signatures, and cell states",
            "probability": 0.08190232096059707,
            "start_logit": -0.2077399045228958,
            "end_logit": 0.48141565918922424
        },
        {
            "text": "individual gene targets, gene signatures, and cell states affected by individual perturbations and\u00a0their genetic interactions.",
            "probability": 0.0397880679842391,
            "start_logit": -2.3948068618774414,
            "end_logit": 1.9465223550796509
        },
        {
            "text": "Perturb-seq accurately identifies individual gene targets, gene signatures, and cell states affected by individual perturbations and\u00a0their genetic interactions.",
            "probability": 0.02473605136963067,
            "start_logit": -2.870112180709839,
            "end_logit": 1.9465223550796509
        },
        {
            "text": "individual gene targets, gene signatures, and cell states",
            "probability": 0.009193165909209494,
            "start_logit": -2.3948068618774414,
            "end_logit": 0.48141565918922424
        },
        {
            "text": "Perturb-seq accurately identifies individual gene targets, gene signatures, and cell states",
            "probability": 0.00571534723097946,
            "start_logit": -2.870112180709839,
            "end_logit": 0.48141565918922424
        },
        {
            "text": "individual perturbations and\u00a0their genetic interactions.",
            "probability": 0.005458700782716019,
            "start_logit": -4.381163120269775,
            "end_logit": 1.9465223550796509
        },
        {
            "text": "accurately identifies individual gene targets, gene signatures, and cell states affected by individual perturbations",
            "probability": 0.005065592147072658,
            "start_logit": -0.1600789576768875,
            "end_logit": -2.34930157661438
        },
        {
            "text": "identifies individual gene targets, gene signatures, and cell states affected by individual perturbations",
            "probability": 0.004829824316517387,
            "start_logit": -0.2077399045228958,
            "end_logit": -2.34930157661438
        },
        {
            "text": "accurately identifies individual gene targets, gene signatures, and cell states affected by individual",
            "probability": 0.0019787630690891065,
            "start_logit": -0.1600789576768875,
            "end_logit": -3.2893006801605225
        },
        {
            "text": "identifies individual gene targets, gene signatures, and cell states affected by individual",
            "probability": 0.0018866655092309509,
            "start_logit": -0.2077399045228958,
            "end_logit": -3.2893006801605225
        },
        {
            "text": "accurately identifies individual gene targets, gene signatures",
            "probability": 0.001370528539170569,
            "start_logit": -0.1600789576768875,
            "end_logit": -3.656576156616211
        },
        {
            "text": "identifies individual gene targets, gene signatures",
            "probability": 0.0013067400360671246,
            "start_logit": -0.2077399045228958,
            "end_logit": -3.656576156616211
        },
        {
            "text": "accurately identifies individual gene targets, gene signatures, and cell states affected",
            "probability": 0.001279470496076409,
            "start_logit": -0.1600789576768875,
            "end_logit": -3.7253262996673584
        },
        {
            "text": "identifies individual gene targets, gene signatures, and cell states affected",
            "probability": 0.0012199201070278681,
            "start_logit": -0.2077399045228958,
            "end_logit": -3.7253262996673584
        },
        {
            "text": "single-cell RNA sequencing",
            "probability": 0.0011103976885649377,
            "start_logit": -2.691056966781616,
            "end_logit": -1.3360763788223267
        },
        {
            "text": "individual gene targets, gene signatures, and cell states affected by individual perturbations",
            "probability": 0.0005421259829186042,
            "start_logit": -2.3948068618774414,
            "end_logit": -2.34930157661438
        },
        {
            "text": "transcription factors regulating the response of dendritic cells to lipopolysaccharide",
            "probability": 0.0004614178772919271,
            "start_logit": -3.3868892192840576,
            "end_logit": -1.5184135437011719
        },
        {
            "text": "",
            "probability": 3.581121631222345e-06,
            "start_logit": -4.981029987335205,
            "end_logit": -4.782900810241699
        }
    ],
    "5e2daaa2fbd6abf43b00000e_001": [
        {
            "text": "selective adenosine A2A receptor",
            "probability": 0.4215130080059735,
            "start_logit": 8.010417938232422,
            "end_logit": 6.518697261810303
        },
        {
            "text": "selective adenosine A2A receptor antagonist",
            "probability": 0.28621445101350007,
            "start_logit": 8.010417938232422,
            "end_logit": 6.131587982177734
        },
        {
            "text": "a selective adenosine A2A receptor",
            "probability": 0.09581339183024125,
            "start_logit": 6.528969764709473,
            "end_logit": 6.518697261810303
        },
        {
            "text": "selective adenosine A2A",
            "probability": 0.06912927779250293,
            "start_logit": 8.010417938232422,
            "end_logit": 4.710824966430664
        },
        {
            "text": "a selective adenosine A2A receptor antagonist",
            "probability": 0.06505891116424393,
            "start_logit": 6.528969764709473,
            "end_logit": 6.131587982177734
        },
        {
            "text": "adenosine A2A receptor",
            "probability": 0.020886395254094088,
            "start_logit": 5.005665302276611,
            "end_logit": 6.518697261810303
        },
        {
            "text": "a selective adenosine A2A",
            "probability": 0.01571365640981787,
            "start_logit": 6.528969764709473,
            "end_logit": 4.710824966430664
        },
        {
            "text": "adenosine A2A receptor antagonist",
            "probability": 0.01418221511023165,
            "start_logit": 5.005665302276611,
            "end_logit": 6.131587982177734
        },
        {
            "text": "adenosine A2A",
            "probability": 0.003425425531787676,
            "start_logit": 5.005665302276611,
            "end_logit": 4.710824966430664
        },
        {
            "text": "selective",
            "probability": 0.002985164839885271,
            "start_logit": 8.010417938232422,
            "end_logit": 1.568501591682434
        },
        {
            "text": "selective adenosine A2A receptor antagonist,",
            "probability": 0.0029258178370946317,
            "start_logit": 8.010417938232422,
            "end_logit": 1.5484206676483154
        },
        {
            "text": "a selective",
            "probability": 0.0006785526497387087,
            "start_logit": 6.528969764709473,
            "end_logit": 1.568501591682434
        },
        {
            "text": "a selective adenosine A2A receptor antagonist,",
            "probability": 0.0006650625853176142,
            "start_logit": 6.528969764709473,
            "end_logit": 1.5484206676483154
        },
        {
            "text": "selective adenosine A2",
            "probability": 0.0002341329617400045,
            "start_logit": 8.010417938232422,
            "end_logit": -0.9770194888114929
        },
        {
            "text": "selective adenosine",
            "probability": 0.0002002774626524778,
            "start_logit": 8.010417938232422,
            "end_logit": -1.1332049369812012
        },
        {
            "text": "adenosine A2A receptor antagonist,",
            "probability": 0.0001449772287600935,
            "start_logit": 5.005665302276611,
            "end_logit": 1.5484206676483154
        },
        {
            "text": "Istradefylline, a selective adenosine A2A receptor",
            "probability": 7.77221460021452e-05,
            "start_logit": -0.5880477428436279,
            "end_logit": 6.518697261810303
        },
        {
            "text": "a selective adenosine A2",
            "probability": 5.3220358037567424e-05,
            "start_logit": 6.528969764709473,
            "end_logit": -0.9770194888114929
        },
        {
            "text": "Istradefylline, a selective adenosine A2A receptor antagonist",
            "probability": 5.277464971918455e-05,
            "start_logit": -0.5880477428436279,
            "end_logit": 6.131587982177734
        },
        {
            "text": "a selective adenosine",
            "probability": 4.5524723174418434e-05,
            "start_logit": 6.528969764709473,
            "end_logit": -1.1332049369812012
        },
        {
            "text": "",
            "probability": 4.0445484717384626e-08,
            "start_logit": -0.339479923248291,
            "end_logit": -1.2908110618591309
        }
    ],
    "5e48f2b6f8b2df0d49000005_001": [
        {
            "text": "adverse late reactions after radiotherapy",
            "probability": 0.4630808710694534,
            "start_logit": 6.599086761474609,
            "end_logit": 7.350070953369141
        },
        {
            "text": "predictive assay for adverse late reactions after radiotherapy",
            "probability": 0.22382281621667105,
            "start_logit": 5.872039794921875,
            "end_logit": 7.350070953369141
        },
        {
            "text": "a predictive assay for adverse late reactions after radiotherapy",
            "probability": 0.14672325629303853,
            "start_logit": 5.449733257293701,
            "end_logit": 7.350070953369141
        },
        {
            "text": "as a predictive assay for adverse late reactions after radiotherapy",
            "probability": 0.07146473155860748,
            "start_logit": 4.73038911819458,
            "end_logit": 7.350070953369141
        },
        {
            "text": "adverse late reactions after radiotherapy.",
            "probability": 0.03156266049949501,
            "start_logit": 6.599086761474609,
            "end_logit": 4.664144039154053
        },
        {
            "text": "for adverse late reactions after radiotherapy",
            "probability": 0.01541178717502265,
            "start_logit": 3.196317672729492,
            "end_logit": 7.350070953369141
        },
        {
            "text": "predictive assay for adverse late reactions after radiotherapy.",
            "probability": 0.015255312844110379,
            "start_logit": 5.872039794921875,
            "end_logit": 4.664144039154053
        },
        {
            "text": "a predictive assay for adverse late reactions after radiotherapy.",
            "probability": 0.010000361956352568,
            "start_logit": 5.449733257293701,
            "end_logit": 4.664144039154053
        },
        {
            "text": "adverse late reactions",
            "probability": 0.005765107643873463,
            "start_logit": 6.599086761474609,
            "end_logit": 2.9639930725097656
        },
        {
            "text": "as a predictive assay for adverse late reactions after radiotherapy.",
            "probability": 0.004870892323111257,
            "start_logit": 4.73038911819458,
            "end_logit": 4.664144039154053
        },
        {
            "text": "predictive assay for adverse late reactions",
            "probability": 0.0027864736145632877,
            "start_logit": 5.872039794921875,
            "end_logit": 2.9639930725097656
        },
        {
            "text": "radiotherapy",
            "probability": 0.002768671744888521,
            "start_logit": 1.4795527458190918,
            "end_logit": 7.350070953369141
        },
        {
            "text": "a predictive assay for adverse late reactions",
            "probability": 0.0018266255836383626,
            "start_logit": 5.449733257293701,
            "end_logit": 2.9639930725097656
        },
        {
            "text": "for adverse late reactions after radiotherapy.",
            "probability": 0.0010504364068684557,
            "start_logit": 3.196317672729492,
            "end_logit": 4.664144039154053
        },
        {
            "text": "as a predictive assay for adverse late reactions",
            "probability": 0.0008896974500898798,
            "start_logit": 4.73038911819458,
            "end_logit": 2.9639930725097656
        },
        {
            "text": "assay for adverse late reactions after radiotherapy",
            "probability": 0.0007974181335182106,
            "start_logit": 0.23480895161628723,
            "end_logit": 7.350070953369141
        },
        {
            "text": "suggested as a predictive assay for adverse late reactions after radiotherapy",
            "probability": 0.0006870381936399965,
            "start_logit": 0.08581966161727905,
            "end_logit": 7.350070953369141
        },
        {
            "text": "predictive assay",
            "probability": 0.0005658178914115168,
            "start_logit": 5.872039794921875,
            "end_logit": 1.369733214378357
        },
        {
            "text": "a predictive assay",
            "probability": 0.00037091233548054665,
            "start_logit": 5.449733257293701,
            "end_logit": 1.369733214378357
        },
        {
            "text": "after radiotherapy",
            "probability": 0.0002956971443987857,
            "start_logit": -0.7572344541549683,
            "end_logit": 7.350070953369141
        },
        {
            "text": "",
            "probability": 3.413921766827324e-06,
            "start_logit": 0.7976441383361816,
            "end_logit": 1.3337182998657227
        }
    ],
    "5e48f2b6f8b2df0d49000005_002": [
        {
            "text": "severity of radiation toxicity",
            "probability": 0.4964222924533273,
            "start_logit": 5.172678470611572,
            "end_logit": 6.4889020919799805
        },
        {
            "text": "radiation toxicity",
            "probability": 0.24246908705577946,
            "start_logit": 4.456125736236572,
            "end_logit": 6.4889020919799805
        },
        {
            "text": "the severity of radiation toxicity",
            "probability": 0.2336401280718384,
            "start_logit": 4.419033527374268,
            "end_logit": 6.4889020919799805
        },
        {
            "text": "severity of radiation toxicity.",
            "probability": 0.012856017153375664,
            "start_logit": 5.172678470611572,
            "end_logit": 2.835287094116211
        },
        {
            "text": "radiation toxicity.",
            "probability": 0.006279304515007269,
            "start_logit": 4.456125736236572,
            "end_logit": 2.835287094116211
        },
        {
            "text": "the severity of radiation toxicity.",
            "probability": 0.006050657957692022,
            "start_logit": 4.419033527374268,
            "end_logit": 2.835287094116211
        },
        {
            "text": "correlates with the severity of radiation toxicity",
            "probability": 0.001207430656593087,
            "start_logit": -0.8462538123130798,
            "end_logit": 6.4889020919799805
        },
        {
            "text": "",
            "probability": 0.0005374773028463587,
            "start_logit": 2.04086971282959,
            "end_logit": 2.792415142059326
        },
        {
            "text": "toxicity",
            "probability": 0.00024097975295961214,
            "start_logit": -2.4577908515930176,
            "end_logit": 6.4889020919799805
        },
        {
            "text": "severity",
            "probability": 0.00010436442470636985,
            "start_logit": 5.172678470611572,
            "end_logit": -1.9783912897109985
        },
        {
            "text": "the severity",
            "probability": 4.911890123635513e-05,
            "start_logit": 4.419033527374268,
            "end_logit": -1.9783912897109985
        },
        {
            "text": "correlates with the severity of radiation toxicity.",
            "probability": 3.126924287778995e-05,
            "start_logit": -0.8462538123130798,
            "end_logit": 2.835287094116211
        },
        {
            "text": "severity of radiation",
            "probability": 2.9559341649383717e-05,
            "start_logit": 5.172678470611572,
            "end_logit": -3.239880323410034
        },
        {
            "text": "with the severity of radiation toxicity",
            "probability": 2.3398661182943633e-05,
            "start_logit": -4.789824962615967,
            "end_logit": 6.4889020919799805
        },
        {
            "text": "radiation",
            "probability": 1.4437761342818416e-05,
            "start_logit": 4.456125736236572,
            "end_logit": -3.239880323410034
        },
        {
            "text": "the severity of radiation",
            "probability": 1.3912043181119935e-05,
            "start_logit": 4.419033527374268,
            "end_logit": -3.239880323410034
        },
        {
            "text": "CD8 T-lymphocyte apoptosis (RILA) correlates with the severity of radiation toxicity",
            "probability": 9.11210387852327e-06,
            "start_logit": -5.732900142669678,
            "end_logit": 6.4889020919799805
        },
        {
            "text": "CD4 or CD8 T-lymphocyte apoptosis (RILA) correlates with the severity of radiation toxicity",
            "probability": 8.842752272646607e-06,
            "start_logit": -5.762905597686768,
            "end_logit": 6.4889020919799805
        },
        {
            "text": "RILA) correlates with the severity of radiation toxicity",
            "probability": 6.369113530089159e-06,
            "start_logit": -6.091043472290039,
            "end_logit": 6.4889020919799805
        },
        {
            "text": "toxicity.",
            "probability": 6.2407347227588e-06,
            "start_logit": -2.4577908515930176,
            "end_logit": 2.835287094116211
        }
    ],
    "5e2f906ffbd6abf43b00002c_001": [
        {
            "text": "oral viscous lidocaine/ antacid \u00b1 anticholinergic",
            "probability": 0.9930521667170544,
            "start_logit": 8.204824447631836,
            "end_logit": 8.471458435058594
        },
        {
            "text": "oral viscous lidocaine/ antacid",
            "probability": 0.005083669997782213,
            "start_logit": 8.204824447631836,
            "end_logit": 3.1967086791992188
        },
        {
            "text": "oral viscous lidocaine",
            "probability": 0.000829656926606724,
            "start_logit": 8.204824447631836,
            "end_logit": 1.3839322328567505
        },
        {
            "text": "lidocaine/ antacid \u00b1 anticholinergic",
            "probability": 0.0004799969860641125,
            "start_logit": 0.5700657963752747,
            "end_logit": 8.471458435058594
        },
        {
            "text": "(oral viscous lidocaine/ antacid \u00b1 anticholinergic",
            "probability": 0.00011961243354526918,
            "start_logit": -0.8194572329521179,
            "end_logit": 8.471458435058594
        },
        {
            "text": "antacid \u00b1 anticholinergic",
            "probability": 8.599737516785197e-05,
            "start_logit": -1.1493972539901733,
            "end_logit": 8.471458435058594
        },
        {
            "text": "viscous lidocaine/ antacid \u00b1 anticholinergic",
            "probability": 8.193809770399897e-05,
            "start_logit": -1.1977499723434448,
            "end_logit": 8.471458435058594
        },
        {
            "text": "oral gastrointestinal (GI) cocktail (oral viscous lidocaine/ antacid \u00b1 anticholinergic",
            "probability": 7.807327554923944e-05,
            "start_logit": -1.2460662126541138,
            "end_logit": 8.471458435058594
        },
        {
            "text": "oral",
            "probability": 5.181734083504463e-05,
            "start_logit": 8.204824447631836,
            "end_logit": -1.389355182647705
        },
        {
            "text": "anticholinergic)",
            "probability": 2.10599492227575e-05,
            "start_logit": -2.5563409328460693,
            "end_logit": 8.471458435058594
        },
        {
            "text": "\u00b1 anticholinergic",
            "probability": 1.7960943717489823e-05,
            "start_logit": -2.7155144214630127,
            "end_logit": 8.471458435058594
        },
        {
            "text": "GI) cocktail (oral viscous lidocaine/ antacid \u00b1 anticholinergic",
            "probability": 1.6936461215820223e-05,
            "start_logit": -2.774245262145996,
            "end_logit": 8.471458435058594
        },
        {
            "text": "oral viscous lidocaine/ antacid \u00b1 anticholinergic)",
            "probability": 1.3587019990622846e-05,
            "start_logit": 8.204824447631836,
            "end_logit": -2.7279651165008545
        },
        {
            "text": "gastrointestinal (GI) cocktail (oral viscous lidocaine/ antacid \u00b1 anticholinergic",
            "probability": 1.3342972841225036e-05,
            "start_logit": -3.0127241611480713,
            "end_logit": 8.471458435058594
        },
        {
            "text": "anticholinergic",
            "probability": 1.3058069696378674e-05,
            "start_logit": -3.0343077182769775,
            "end_logit": 8.471458435058594
        },
        {
            "text": "cocktail (oral viscous lidocaine/ antacid \u00b1 anticholinergic",
            "probability": 1.1982184097663932e-05,
            "start_logit": -3.120293140411377,
            "end_logit": 8.471458435058594
        },
        {
            "text": "oral viscous lidocaine/ antacid \u00b1 anticholinergic) to standard diagnostic protocols (serial electrocardiograms (ECGs",
            "probability": 1.082828977826778e-05,
            "start_logit": 8.204824447631836,
            "end_logit": -2.9549179077148438
        },
        {
            "text": "/ antacid \u00b1 anticholinergic",
            "probability": 8.792387922570322e-06,
            "start_logit": -3.4298276901245117,
            "end_logit": 8.471458435058594
        },
        {
            "text": "oral viscous lidocaine/",
            "probability": 4.7598934691053445e-06,
            "start_logit": 8.204824447631836,
            "end_logit": -3.7768547534942627
        },
        {
            "text": "lidocaine/ antacid \u00b1 anticholinergic)",
            "probability": 4.335274774249515e-06,
            "start_logit": -4.136929035186768,
            "end_logit": 8.471458435058594
        },
        {
            "text": "",
            "probability": 4.2740296500727176e-07,
            "start_logit": 0.674458384513855,
            "end_logit": 1.343258023262024
        }
    ],
    "5e2f906ffbd6abf43b00002c_002": [
        {
            "text": "",
            "probability": 0.9999973467941459,
            "start_logit": 5.967016696929932,
            "end_logit": 6.356442928314209
        },
        {
            "text": "IV pantoprazole",
            "probability": 2.1730093834232654e-06,
            "start_logit": -0.3631257712841034,
            "end_logit": -0.35280948877334595
        },
        {
            "text": "gastrointestinal",
            "probability": 2.1296638363392831e-07,
            "start_logit": -0.7296069860458374,
            "end_logit": -2.3090622425079346
        },
        {
            "text": "pantoprazole",
            "probability": 1.192530510376798e-07,
            "start_logit": -3.2657463550567627,
            "end_logit": -0.35280948877334595
        },
        {
            "text": "GI indicates gastrointestinal",
            "probability": 4.0489997566017217e-08,
            "start_logit": -2.389686346054077,
            "end_logit": -2.3090622425079346
        },
        {
            "text": "IV pantoprazole in addition to the conventional GI cocktail",
            "probability": 2.8148869608103066e-08,
            "start_logit": -0.3631257712841034,
            "end_logit": -4.6991705894470215
        },
        {
            "text": "gastrointestinal), an intravenous (IV) proton pump inhibitor",
            "probability": 1.2355249586927356e-08,
            "start_logit": -0.7296069860458374,
            "end_logit": -5.156115531921387
        },
        {
            "text": "gastrointestinal), an intravenous (IV) proton pump inhibitor (PPI",
            "probability": 9.884449210263308e-09,
            "start_logit": -0.7296069860458374,
            "end_logit": -5.3792338371276855
        },
        {
            "text": "gas",
            "probability": 9.340562321673512e-09,
            "start_logit": -0.7296069860458374,
            "end_logit": -5.435830116271973
        },
        {
            "text": "IV pantoprazole in addition to the conventional GI cocktail in the relief of severe dyspeptic pain",
            "probability": 9.193360056736018e-09,
            "start_logit": -0.3631257712841034,
            "end_logit": -5.8181962966918945
        },
        {
            "text": "immediate effect of IV pantoprazole",
            "probability": 7.992216920510326e-09,
            "start_logit": -5.9685258865356445,
            "end_logit": -0.35280948877334595
        },
        {
            "text": "the immediate effect of IV pantoprazole",
            "probability": 4.7675715048726455e-09,
            "start_logit": -6.485157012939453,
            "end_logit": -0.35280948877334595
        },
        {
            "text": "IV pantoprazole in addition to the conventional GI cocktail in the relief of severe dyspeptic pain.",
            "probability": 4.654156467852854e-09,
            "start_logit": -0.3631257712841034,
            "end_logit": -6.498917102813721
        },
        {
            "text": "gastrointestinal), an intravenous (IV) proton pump inhibitor (PPI)",
            "probability": 4.648866921821695e-09,
            "start_logit": -0.7296069860458374,
            "end_logit": -6.133573055267334
        },
        {
            "text": "IV",
            "probability": 3.6008514019127696e-09,
            "start_logit": -0.3631257712841034,
            "end_logit": -6.755507469177246
        },
        {
            "text": "gastrointestinal), an intravenous",
            "probability": 3.263897148365753e-09,
            "start_logit": -0.7296069860458374,
            "end_logit": -6.487274646759033
        },
        {
            "text": "IV pantoprazole in addition to the conventional GI",
            "probability": 2.6918767215761594e-09,
            "start_logit": -0.3631257712841034,
            "end_logit": -7.046439170837402
        },
        {
            "text": "gastrointestinal)",
            "probability": 2.5618891001608286e-09,
            "start_logit": -0.7296069860458374,
            "end_logit": -6.729451656341553
        },
        {
            "text": "GI indicates gastrointestinal), an intravenous (IV) proton pump inhibitor",
            "probability": 2.349028129069124e-09,
            "start_logit": -2.389686346054077,
            "end_logit": -5.156115531921387
        },
        {
            "text": "gastrointestinal), an intravenous (IV)",
            "probability": 2.0341931616626202e-09,
            "start_logit": -0.7296069860458374,
            "end_logit": -6.960097312927246
        }
    ],
    "5e2f906ffbd6abf43b00002c_003": [
        {
            "text": "",
            "probability": 0.9999973467941459,
            "start_logit": 5.967016696929932,
            "end_logit": 6.356442928314209
        },
        {
            "text": "IV pantoprazole",
            "probability": 2.1730093834232654e-06,
            "start_logit": -0.3631257712841034,
            "end_logit": -0.35280948877334595
        },
        {
            "text": "gastrointestinal",
            "probability": 2.1296638363392831e-07,
            "start_logit": -0.7296069860458374,
            "end_logit": -2.3090622425079346
        },
        {
            "text": "pantoprazole",
            "probability": 1.192530510376798e-07,
            "start_logit": -3.2657463550567627,
            "end_logit": -0.35280948877334595
        },
        {
            "text": "GI indicates gastrointestinal",
            "probability": 4.0489997566017217e-08,
            "start_logit": -2.389686346054077,
            "end_logit": -2.3090622425079346
        },
        {
            "text": "IV pantoprazole in addition to the conventional GI cocktail",
            "probability": 2.8148869608103066e-08,
            "start_logit": -0.3631257712841034,
            "end_logit": -4.6991705894470215
        },
        {
            "text": "gastrointestinal), an intravenous (IV) proton pump inhibitor",
            "probability": 1.2355249586927356e-08,
            "start_logit": -0.7296069860458374,
            "end_logit": -5.156115531921387
        },
        {
            "text": "gastrointestinal), an intravenous (IV) proton pump inhibitor (PPI",
            "probability": 9.884449210263308e-09,
            "start_logit": -0.7296069860458374,
            "end_logit": -5.3792338371276855
        },
        {
            "text": "gas",
            "probability": 9.340562321673512e-09,
            "start_logit": -0.7296069860458374,
            "end_logit": -5.435830116271973
        },
        {
            "text": "IV pantoprazole in addition to the conventional GI cocktail in the relief of severe dyspeptic pain",
            "probability": 9.193360056736018e-09,
            "start_logit": -0.3631257712841034,
            "end_logit": -5.8181962966918945
        },
        {
            "text": "immediate effect of IV pantoprazole",
            "probability": 7.992216920510326e-09,
            "start_logit": -5.9685258865356445,
            "end_logit": -0.35280948877334595
        },
        {
            "text": "the immediate effect of IV pantoprazole",
            "probability": 4.7675715048726455e-09,
            "start_logit": -6.485157012939453,
            "end_logit": -0.35280948877334595
        },
        {
            "text": "IV pantoprazole in addition to the conventional GI cocktail in the relief of severe dyspeptic pain.",
            "probability": 4.654156467852854e-09,
            "start_logit": -0.3631257712841034,
            "end_logit": -6.498917102813721
        },
        {
            "text": "gastrointestinal), an intravenous (IV) proton pump inhibitor (PPI)",
            "probability": 4.648866921821695e-09,
            "start_logit": -0.7296069860458374,
            "end_logit": -6.133573055267334
        },
        {
            "text": "IV",
            "probability": 3.6008514019127696e-09,
            "start_logit": -0.3631257712841034,
            "end_logit": -6.755507469177246
        },
        {
            "text": "gastrointestinal), an intravenous",
            "probability": 3.263897148365753e-09,
            "start_logit": -0.7296069860458374,
            "end_logit": -6.487274646759033
        },
        {
            "text": "IV pantoprazole in addition to the conventional GI",
            "probability": 2.6918767215761594e-09,
            "start_logit": -0.3631257712841034,
            "end_logit": -7.046439170837402
        },
        {
            "text": "gastrointestinal)",
            "probability": 2.5618891001608286e-09,
            "start_logit": -0.7296069860458374,
            "end_logit": -6.729451656341553
        },
        {
            "text": "GI indicates gastrointestinal), an intravenous (IV) proton pump inhibitor",
            "probability": 2.349028129069124e-09,
            "start_logit": -2.389686346054077,
            "end_logit": -5.156115531921387
        },
        {
            "text": "gastrointestinal), an intravenous (IV)",
            "probability": 2.0341931616626202e-09,
            "start_logit": -0.7296069860458374,
            "end_logit": -6.960097312927246
        }
    ],
    "5e2f906ffbd6abf43b00002c_004": [
        {
            "text": "Benzocaine and Lidocaine",
            "probability": 0.9995160578772413,
            "start_logit": 7.995631217956543,
            "end_logit": 7.624664783477783
        },
        {
            "text": "Benzocaine and Lidocaine as the topical anesthetic",
            "probability": 0.00018237322253166602,
            "start_logit": 7.995631217956543,
            "end_logit": -0.9843064546585083
        },
        {
            "text": "Benzocaine",
            "probability": 0.00010728109520854982,
            "start_logit": 7.995631217956543,
            "end_logit": -1.514909267425537
        },
        {
            "text": "Lidocaine",
            "probability": 6.710082138816135e-05,
            "start_logit": -1.61319899559021,
            "end_logit": 7.624664783477783
        },
        {
            "text": "viscous Lidocaine in this preparation. This was a prospective randomized, single-blinded comparison between Benzocaine and Lidocaine",
            "probability": 4.3934684679070984e-05,
            "start_logit": -2.036691188812256,
            "end_logit": 7.624664783477783
        },
        {
            "text": "Lidocaine in this preparation. This was a prospective randomized, single-blinded comparison between Benzocaine and Lidocaine",
            "probability": 3.958502142450813e-05,
            "start_logit": -2.140944480895996,
            "end_logit": 7.624664783477783
        },
        {
            "text": "Benzocaine and Lidocaine as the topical anesthetic in a gastrointestinal",
            "probability": 1.722448727679098e-05,
            "start_logit": 7.995631217956543,
            "end_logit": -3.344029664993286
        },
        {
            "text": "Benz",
            "probability": 1.2578036018602753e-05,
            "start_logit": 7.995631217956543,
            "end_logit": -3.658409595489502
        },
        {
            "text": "Benzocaine and Lidocaine as the topical anesthetic in a gastrointestinal (GI) cocktail.",
            "probability": 1.1591585550067031e-05,
            "start_logit": 7.995631217956543,
            "end_logit": -3.740082263946533
        },
        {
            "text": "",
            "probability": 1.414447381265289e-06,
            "start_logit": 1.1013381481170654,
            "end_logit": 1.0506702661514282
        },
        {
            "text": "Benzocaine (Hurricaine) would work as quickly and effectively as viscous Lidocaine",
            "probability": 5.350674746384066e-07,
            "start_logit": 2.0200483798980713,
            "end_logit": -0.8401412963867188
        },
        {
            "text": "Benzocaine (Hurricaine)",
            "probability": 1.1055510381028065e-07,
            "start_logit": 2.0200483798980713,
            "end_logit": -2.417020082473755
        },
        {
            "text": "Benzocaine (Hurricaine",
            "probability": 9.22466234816968e-08,
            "start_logit": 2.0200483798980713,
            "end_logit": -2.5980684757232666
        },
        {
            "text": "Benzocaine or viscous Lidocaine",
            "probability": 6.482467368226139e-08,
            "start_logit": 0.015234237536787987,
            "end_logit": -0.9460337162017822
        },
        {
            "text": "Benzocaine or viscous Lidocaine in addition to 30 cc of Maalox and 10 cc of Donnatal",
            "probability": 1.707563459535339e-08,
            "start_logit": 0.015234237536787987,
            "end_logit": -2.2800674438476562
        },
        {
            "text": "Lidocaine as the topical anesthetic",
            "probability": 1.2243318088426047e-08,
            "start_logit": -1.61319899559021,
            "end_logit": -0.9843064546585083
        },
        {
            "text": "viscous Lidocaine",
            "probability": 9.259529996501123e-09,
            "start_logit": -2.036691188812256,
            "end_logit": -0.8401412963867188
        },
        {
            "text": "Benzocaine (Hurricaine) would work as quickly and effectively as viscous",
            "probability": 8.484517902812056e-09,
            "start_logit": 2.0200483798980713,
            "end_logit": -4.984291076660156
        },
        {
            "text": "viscous Lidocaine in this preparation. This was a prospective randomized, single-blinded comparison between Benzocaine",
            "probability": 4.71564318838779e-09,
            "start_logit": -2.036691188812256,
            "end_logit": -1.514909267425537
        },
        {
            "text": "Lidocaine in this preparation. This was a prospective randomized, single-blinded comparison between Benzocaine",
            "probability": 4.248780616185674e-09,
            "start_logit": -2.140944480895996,
            "end_logit": -1.514909267425537
        }
    ],
    "5e2f906ffbd6abf43b00002c_005": [
        {
            "text": "Benzocaine and Lidocaine",
            "probability": 0.9995160578772413,
            "start_logit": 7.995631217956543,
            "end_logit": 7.624664783477783
        },
        {
            "text": "Benzocaine and Lidocaine as the topical anesthetic",
            "probability": 0.00018237322253166602,
            "start_logit": 7.995631217956543,
            "end_logit": -0.9843064546585083
        },
        {
            "text": "Benzocaine",
            "probability": 0.00010728109520854982,
            "start_logit": 7.995631217956543,
            "end_logit": -1.514909267425537
        },
        {
            "text": "Lidocaine",
            "probability": 6.710082138816135e-05,
            "start_logit": -1.61319899559021,
            "end_logit": 7.624664783477783
        },
        {
            "text": "viscous Lidocaine in this preparation. This was a prospective randomized, single-blinded comparison between Benzocaine and Lidocaine",
            "probability": 4.3934684679070984e-05,
            "start_logit": -2.036691188812256,
            "end_logit": 7.624664783477783
        },
        {
            "text": "Lidocaine in this preparation. This was a prospective randomized, single-blinded comparison between Benzocaine and Lidocaine",
            "probability": 3.958502142450813e-05,
            "start_logit": -2.140944480895996,
            "end_logit": 7.624664783477783
        },
        {
            "text": "Benzocaine and Lidocaine as the topical anesthetic in a gastrointestinal",
            "probability": 1.722448727679098e-05,
            "start_logit": 7.995631217956543,
            "end_logit": -3.344029664993286
        },
        {
            "text": "Benz",
            "probability": 1.2578036018602753e-05,
            "start_logit": 7.995631217956543,
            "end_logit": -3.658409595489502
        },
        {
            "text": "Benzocaine and Lidocaine as the topical anesthetic in a gastrointestinal (GI) cocktail.",
            "probability": 1.1591585550067031e-05,
            "start_logit": 7.995631217956543,
            "end_logit": -3.740082263946533
        },
        {
            "text": "",
            "probability": 1.414447381265289e-06,
            "start_logit": 1.1013381481170654,
            "end_logit": 1.0506702661514282
        },
        {
            "text": "Benzocaine (Hurricaine) would work as quickly and effectively as viscous Lidocaine",
            "probability": 5.350674746384066e-07,
            "start_logit": 2.0200483798980713,
            "end_logit": -0.8401412963867188
        },
        {
            "text": "Benzocaine (Hurricaine)",
            "probability": 1.1055510381028065e-07,
            "start_logit": 2.0200483798980713,
            "end_logit": -2.417020082473755
        },
        {
            "text": "Benzocaine (Hurricaine",
            "probability": 9.22466234816968e-08,
            "start_logit": 2.0200483798980713,
            "end_logit": -2.5980684757232666
        },
        {
            "text": "Benzocaine or viscous Lidocaine",
            "probability": 6.482467368226139e-08,
            "start_logit": 0.015234237536787987,
            "end_logit": -0.9460337162017822
        },
        {
            "text": "Benzocaine or viscous Lidocaine in addition to 30 cc of Maalox and 10 cc of Donnatal",
            "probability": 1.707563459535339e-08,
            "start_logit": 0.015234237536787987,
            "end_logit": -2.2800674438476562
        },
        {
            "text": "Lidocaine as the topical anesthetic",
            "probability": 1.2243318088426047e-08,
            "start_logit": -1.61319899559021,
            "end_logit": -0.9843064546585083
        },
        {
            "text": "viscous Lidocaine",
            "probability": 9.259529996501123e-09,
            "start_logit": -2.036691188812256,
            "end_logit": -0.8401412963867188
        },
        {
            "text": "Benzocaine (Hurricaine) would work as quickly and effectively as viscous",
            "probability": 8.484517902812056e-09,
            "start_logit": 2.0200483798980713,
            "end_logit": -4.984291076660156
        },
        {
            "text": "viscous Lidocaine in this preparation. This was a prospective randomized, single-blinded comparison between Benzocaine",
            "probability": 4.71564318838779e-09,
            "start_logit": -2.036691188812256,
            "end_logit": -1.514909267425537
        },
        {
            "text": "Lidocaine in this preparation. This was a prospective randomized, single-blinded comparison between Benzocaine",
            "probability": 4.248780616185674e-09,
            "start_logit": -2.140944480895996,
            "end_logit": -1.514909267425537
        }
    ],
    "5e2f906ffbd6abf43b00002c_006": [
        {
            "text": "",
            "probability": 0.9637265154529641,
            "start_logit": 2.645566940307617,
            "end_logit": 3.0289454460144043
        },
        {
            "text": "Donnatal or Donnatal + lidocaine",
            "probability": 0.033970484365728554,
            "start_logit": 1.386740803718567,
            "end_logit": 0.942456066608429
        },
        {
            "text": "Donnatal + lidocaine",
            "probability": 0.001042336692582526,
            "start_logit": -2.0972862243652344,
            "end_logit": 0.942456066608429
        },
        {
            "text": "antacid + Donnatal + viscous lidocaine",
            "probability": 0.0003908719784216431,
            "start_logit": -1.445248007774353,
            "end_logit": -0.6904223561286926
        },
        {
            "text": "Donnatal",
            "probability": 0.00017629465001657327,
            "start_logit": 1.386740803718567,
            "end_logit": -4.318634510040283
        },
        {
            "text": "Donnatal or Donnatal + lidocaine to an antacid",
            "probability": 0.00015192462403619084,
            "start_logit": 1.386740803718567,
            "end_logit": -4.467406749725342
        },
        {
            "text": "Donnatal or Donnatal",
            "probability": 9.811100648957907e-05,
            "start_logit": 1.386740803718567,
            "end_logit": -4.904691696166992
        },
        {
            "text": "antacid + Donnatal (group 2); antacid + Donnatal + viscous lidocaine",
            "probability": 9.392209656187072e-05,
            "start_logit": -2.8711624145507812,
            "end_logit": -0.6904223561286926
        },
        {
            "text": "lidocaine",
            "probability": 7.675493227625308e-05,
            "start_logit": -3.0730104446411133,
            "end_logit": -0.6904223561286926
        },
        {
            "text": "Donnatal or Donnatal +",
            "probability": 5.473309304870114e-05,
            "start_logit": 1.386740803718567,
            "end_logit": -5.488322734832764
        },
        {
            "text": "Donnatal or Donnatal + lidocaine to an antacid did not relieve dyspepsia better than plain antacid",
            "probability": 5.4271070169903e-05,
            "start_logit": 1.386740803718567,
            "end_logit": -5.496799945831299
        },
        {
            "text": "antacid + Donnatal",
            "probability": 2.5034588449107802e-05,
            "start_logit": -1.445248007774353,
            "end_logit": -3.4385440349578857
        },
        {
            "text": "Donnatal or",
            "probability": 2.1977174156415438e-05,
            "start_logit": 1.386740803718567,
            "end_logit": -6.400786876678467
        },
        {
            "text": "viscous lidocaine",
            "probability": 2.020303143120801e-05,
            "start_logit": -4.407795429229736,
            "end_logit": -0.6904223561286926
        },
        {
            "text": "Donna",
            "probability": 1.976213866649972e-05,
            "start_logit": 1.386740803718567,
            "end_logit": -6.507023334503174
        },
        {
            "text": "addition of Donnatal or Donnatal + lidocaine",
            "probability": 1.9750554910423e-05,
            "start_logit": -6.063324928283691,
            "end_logit": 0.942456066608429
        },
        {
            "text": "antacid (group 1); antacid + Donnatal (group 2); antacid + Donnatal",
            "probability": 1.86785462617121e-05,
            "start_logit": -1.738130807876587,
            "end_logit": -3.4385440349578857
        },
        {
            "text": "antacid (group 1); antacid + Donnatal",
            "probability": 1.482446154626565e-05,
            "start_logit": -1.738130807876587,
            "end_logit": -3.6696410179138184
        },
        {
            "text": "Donnatal or Donnatal + lidocaine to an antacid did not relieve dyspepsia",
            "probability": 1.435932498854629e-05,
            "start_logit": 1.386740803718567,
            "end_logit": -6.826391696929932
        },
        {
            "text": "Donnatal or Donnatal + lid",
            "probability": 9.190217294105457e-06,
            "start_logit": 1.386740803718567,
            "end_logit": -7.272651672363281
        }
    ],
    "5e2f906ffbd6abf43b00002c_007": [
        {
            "text": "liquid antacid, viscous lidocaine, and an anticholinergic",
            "probability": 0.9601251978428146,
            "start_logit": 3.9264471530914307,
            "end_logit": 4.7526021003723145
        },
        {
            "text": "liquid antacid, viscous lidocaine",
            "probability": 0.011907668283391086,
            "start_logit": 3.9264471530914307,
            "end_logit": 0.3627209961414337
        },
        {
            "text": "a mixture of liquid antacid, viscous lidocaine, and an anticholinergic",
            "probability": 0.011424048051361426,
            "start_logit": -0.5048959255218506,
            "end_logit": 4.7526021003723145
        },
        {
            "text": "morphine or nitroglycerin",
            "probability": 0.008897308936819625,
            "start_logit": 2.143498659133911,
            "end_logit": 1.8542357683181763
        },
        {
            "text": "mixture of liquid antacid, viscous lidocaine, and an anticholinergic",
            "probability": 0.004084845682588853,
            "start_logit": -1.5333325862884521,
            "end_logit": 4.7526021003723145
        },
        {
            "text": "(a mixture of liquid antacid, viscous lidocaine, and an anticholinergic",
            "probability": 0.0011457803310446675,
            "start_logit": -2.804530620574951,
            "end_logit": 4.7526021003723145
        },
        {
            "text": "liquid antacid, viscous lidocaine, and an anticholinergic)",
            "probability": 0.000547116665059505,
            "start_logit": 3.9264471530914307,
            "end_logit": -2.717554807662964
        },
        {
            "text": "antacid, viscous lidocaine, and an anticholinergic",
            "probability": 0.00039310999420877005,
            "start_logit": -3.8742823600769043,
            "end_logit": 4.7526021003723145
        },
        {
            "text": "anticholinergic",
            "probability": 0.00037412258353398476,
            "start_logit": -3.92378830909729,
            "end_logit": 4.7526021003723145
        },
        {
            "text": "lidocaine, and an anticholinergic",
            "probability": 0.00026622043548478567,
            "start_logit": -4.264047145843506,
            "end_logit": 4.7526021003723145
        },
        {
            "text": "liquid antacid",
            "probability": 0.00020793797006683832,
            "start_logit": 3.9264471530914307,
            "end_logit": -3.6849770545959473
        },
        {
            "text": "a mixture of liquid antacid, viscous lidocaine",
            "probability": 0.00014168337103824533,
            "start_logit": -0.5048959255218506,
            "end_logit": 0.3627209961414337
        },
        {
            "text": "liquid antacid, viscous",
            "probability": 0.00010288557755857882,
            "start_logit": 3.9264471530914307,
            "end_logit": -4.388599395751953
        },
        {
            "text": "an anticholinergic",
            "probability": 8.250935869479674e-05,
            "start_logit": -5.435460090637207,
            "end_logit": 4.7526021003723145
        },
        {
            "text": "anticholinergic)",
            "probability": 6.253588742060531e-05,
            "start_logit": -5.7126312255859375,
            "end_logit": 4.7526021003723145
        },
        {
            "text": "liquid antacid,",
            "probability": 5.437305697484409e-05,
            "start_logit": 3.9264471530914307,
            "end_logit": -5.026348114013672
        },
        {
            "text": "viscous lidocaine, and an anticholinergic",
            "probability": 5.19516460236172e-05,
            "start_logit": -5.8980584144592285,
            "end_logit": 4.7526021003723145
        },
        {
            "text": "mixture of liquid antacid, viscous lidocaine",
            "probability": 5.0661088248069796e-05,
            "start_logit": -1.5333325862884521,
            "end_logit": 0.3627209961414337
        },
        {
            "text": "liquid",
            "probability": 3.862929184673795e-05,
            "start_logit": 3.9264471530914307,
            "end_logit": -5.368206024169922
        },
        {
            "text": "morphine",
            "probability": 3.257312878778218e-05,
            "start_logit": 2.143498659133911,
            "end_logit": -3.7557806968688965
        },
        {
            "text": "",
            "probability": 8.84081703268284e-06,
            "start_logit": -2.3321335315704346,
            "end_logit": -0.5842568874359131
        }
    ],
    "5e2f906ffbd6abf43b00002c_008": [
        {
            "text": "",
            "probability": 0.9999996119647168,
            "start_logit": 6.938914775848389,
            "end_logit": 7.56074333190918
        },
        {
            "text": "antacid and viscous lidocaine",
            "probability": 1.6224839915471817e-07,
            "start_logit": -1.3460636138916016,
            "end_logit": 0.21158476173877716
        },
        {
            "text": "2% viscous lidocaine",
            "probability": 6.48442105706041e-08,
            "start_logit": -1.4370428323745728,
            "end_logit": -0.6145768761634827
        },
        {
            "text": "viscous lidocaine",
            "probability": 5.997832652709938e-08,
            "start_logit": -1.5150471925735474,
            "end_logit": -0.6145768761634827
        },
        {
            "text": "lidocaine",
            "probability": 3.556921414272465e-08,
            "start_logit": -2.0375499725341797,
            "end_logit": -0.6145768761634827
        },
        {
            "text": "antacid plus 15 mL of 2% viscous lidocaine",
            "probability": 3.477718677053658e-08,
            "start_logit": -2.0600688457489014,
            "end_logit": -0.6145768761634827
        },
        {
            "text": "antacid",
            "probability": 9.925371842136675e-09,
            "start_logit": -1.3460636138916016,
            "end_logit": -2.582449436187744
        },
        {
            "text": "15 mL of 2% viscous lidocaine",
            "probability": 5.680702086238738e-09,
            "start_logit": -3.871955633163452,
            "end_logit": -0.6145768761634827
        },
        {
            "text": "Mylanta II), or 30 mL of antacid plus 15 mL of 2% viscous lidocaine",
            "probability": 3.5577015793430406e-09,
            "start_logit": -4.339915752410889,
            "end_logit": -0.6145768761634827
        },
        {
            "text": "antacid and viscous",
            "probability": 1.989004513502889e-09,
            "start_logit": -1.3460636138916016,
            "end_logit": -4.1899094581604
        },
        {
            "text": "30 mL of antacid plus 15 mL of 2% viscous lidocaine",
            "probability": 1.6071980019235754e-09,
            "start_logit": -5.134538173675537,
            "end_logit": -0.6145768761634827
        },
        {
            "text": "antacid (Mylanta II), or 30 mL of antacid plus 15 mL of 2% viscous lidocaine",
            "probability": 1.2058584315184776e-09,
            "start_logit": -5.421838760375977,
            "end_logit": -0.6145768761634827
        },
        {
            "text": "2% viscous lidocaine (GI cocktail",
            "probability": 1.1059095428995739e-09,
            "start_logit": -1.4370428323745728,
            "end_logit": -4.685896396636963
        },
        {
            "text": "viscous lidocaine (GI cocktail",
            "probability": 1.0229225260016595e-09,
            "start_logit": -1.5150471925735474,
            "end_logit": -4.685896396636963
        },
        {
            "text": "2% viscous",
            "probability": 8.55870948683692e-10,
            "start_logit": -1.4370428323745728,
            "end_logit": -4.942200183868408
        },
        {
            "text": "viscous",
            "probability": 7.916467294997027e-10,
            "start_logit": -1.5150471925735474,
            "end_logit": -4.942200183868408
        },
        {
            "text": "2% viscous lidocaine (GI cocktail)",
            "probability": 7.709110960223666e-10,
            "start_logit": -1.4370428323745728,
            "end_logit": -5.046746730804443
        },
        {
            "text": "2% viscous lidocaine (GI cocktail).",
            "probability": 7.230207939108646e-10,
            "start_logit": -1.4370428323745728,
            "end_logit": -5.110881805419922
        },
        {
            "text": "viscous lidocaine (GI cocktail)",
            "probability": 7.130622307483943e-10,
            "start_logit": -1.5150471925735474,
            "end_logit": -5.046746730804443
        },
        {
            "text": "viscous lidocaine (GI cocktail).",
            "probability": 6.687655980613855e-10,
            "start_logit": -1.5150471925735474,
            "end_logit": -5.110881805419922
        }
    ],
    "5c7f806d617e120c34000001_001": [
        {
            "text": "unknown how many tumours express tumour specific antigen at all and whether these putative antigens are of unique specificity",
            "probability": 0.2017804105701096,
            "start_logit": 3.890842914581299,
            "end_logit": 2.9166152477264404
        },
        {
            "text": "unknown",
            "probability": 0.14313194757967626,
            "start_logit": 3.890842914581299,
            "end_logit": 2.573202133178711
        },
        {
            "text": "unknown how many tumours express tumour specific antigen at all",
            "probability": 0.10734328069023265,
            "start_logit": 3.890842914581299,
            "end_logit": 2.2854671478271484
        },
        {
            "text": "unknown how many tumours express tumour specific antigen",
            "probability": 0.10214960773634356,
            "start_logit": 3.890842914581299,
            "end_logit": 2.2358736991882324
        },
        {
            "text": "whether these putative antigens are of unique specificity",
            "probability": 0.0759953660949605,
            "start_logit": 2.914335250854492,
            "end_logit": 2.9166152477264404
        },
        {
            "text": "unknown how many tumours express tumour specific antigen at all and whether these putative antigens",
            "probability": 0.06572208639348846,
            "start_logit": 3.890842914581299,
            "end_logit": 1.7948702573776245
        },
        {
            "text": "these putative antigens are of unique specificity",
            "probability": 0.05502255665121589,
            "start_logit": 2.5914061069488525,
            "end_logit": 2.9166152477264404
        },
        {
            "text": "whether these putative antigens are of unique specificity or are shared by certain groups of (histologically related) neoplasias.",
            "probability": 0.03616569529180742,
            "start_logit": 2.914335250854492,
            "end_logit": 2.174053907394409
        },
        {
            "text": "It is thus unknown how many tumours express tumour specific antigen at all and whether these putative antigens are of unique specificity",
            "probability": 0.02644268535818134,
            "start_logit": 1.8586424589157104,
            "end_logit": 2.9166152477264404
        },
        {
            "text": "these putative antigens are of unique specificity or are shared by certain groups of (histologically related) neoplasias.",
            "probability": 0.02618487310841502,
            "start_logit": 2.5914061069488525,
            "end_logit": 2.174053907394409
        },
        {
            "text": "whether these putative antigens",
            "probability": 0.0247525218225403,
            "start_logit": 2.914335250854492,
            "end_logit": 1.7948702573776245
        },
        {
            "text": "unique specificity",
            "probability": 0.018862660188416706,
            "start_logit": 1.520847201347351,
            "end_logit": 2.9166152477264404
        },
        {
            "text": "It is thus unknown",
            "probability": 0.018756989560381732,
            "start_logit": 1.8586424589157104,
            "end_logit": 2.573202133178711
        },
        {
            "text": "these putative antigens",
            "probability": 0.0179214484280443,
            "start_logit": 2.5914061069488525,
            "end_logit": 1.7948702573776245
        },
        {
            "text": "unknown how many tumours express tumour specific antigen at all and",
            "probability": 0.017703152164428602,
            "start_logit": 3.890842914581299,
            "end_logit": 0.48317793011665344
        },
        {
            "text": "It is thus unknown how many tumours express tumour specific antigen at all",
            "probability": 0.014066997824947598,
            "start_logit": 1.8586424589157104,
            "end_logit": 2.2854671478271484
        },
        {
            "text": "It is thus unknown how many tumours express tumour specific antigen",
            "probability": 0.013386383391737951,
            "start_logit": 1.8586424589157104,
            "end_logit": 2.2358736991882324
        },
        {
            "text": "unknown how many tumours express tumour specific antigen at all and whether these putative antigens are of unique",
            "probability": 0.01217996597925834,
            "start_logit": 3.890842914581299,
            "end_logit": 0.10922768712043762
        },
        {
            "text": "unknown how many tumours express tumour specific antigen at all and whether these putative antigens are of unique specificity or are shared",
            "probability": 0.01209544406884897,
            "start_logit": 3.890842914581299,
            "end_logit": 0.10226407647132874
        },
        {
            "text": "whether these putative antigens are of unique specificity or are shared by certain groups of (histologically related) neoplasias",
            "probability": 0.010250858998342788,
            "start_logit": 2.914335250854492,
            "end_logit": 0.9133043885231018
        },
        {
            "text": "",
            "probability": 8.506809862205581e-05,
            "start_logit": -0.5291498303413391,
            "end_logit": -0.4348752200603485
        }
    ],
    "5c7f806d617e120c34000001_002": [
        {
            "text": "unknown how many tumours express tumour specific antigen at all and whether these putative antigens are of unique specificity",
            "probability": 0.2017804105701096,
            "start_logit": 3.890842914581299,
            "end_logit": 2.9166152477264404
        },
        {
            "text": "unknown",
            "probability": 0.14313194757967626,
            "start_logit": 3.890842914581299,
            "end_logit": 2.573202133178711
        },
        {
            "text": "unknown how many tumours express tumour specific antigen at all",
            "probability": 0.10734328069023265,
            "start_logit": 3.890842914581299,
            "end_logit": 2.2854671478271484
        },
        {
            "text": "unknown how many tumours express tumour specific antigen",
            "probability": 0.10214960773634356,
            "start_logit": 3.890842914581299,
            "end_logit": 2.2358736991882324
        },
        {
            "text": "whether these putative antigens are of unique specificity",
            "probability": 0.0759953660949605,
            "start_logit": 2.914335250854492,
            "end_logit": 2.9166152477264404
        },
        {
            "text": "unknown how many tumours express tumour specific antigen at all and whether these putative antigens",
            "probability": 0.06572208639348846,
            "start_logit": 3.890842914581299,
            "end_logit": 1.7948702573776245
        },
        {
            "text": "these putative antigens are of unique specificity",
            "probability": 0.05502255665121589,
            "start_logit": 2.5914061069488525,
            "end_logit": 2.9166152477264404
        },
        {
            "text": "whether these putative antigens are of unique specificity or are shared by certain groups of (histologically related) neoplasias.",
            "probability": 0.03616569529180742,
            "start_logit": 2.914335250854492,
            "end_logit": 2.174053907394409
        },
        {
            "text": "It is thus unknown how many tumours express tumour specific antigen at all and whether these putative antigens are of unique specificity",
            "probability": 0.02644268535818134,
            "start_logit": 1.8586424589157104,
            "end_logit": 2.9166152477264404
        },
        {
            "text": "these putative antigens are of unique specificity or are shared by certain groups of (histologically related) neoplasias.",
            "probability": 0.02618487310841502,
            "start_logit": 2.5914061069488525,
            "end_logit": 2.174053907394409
        },
        {
            "text": "whether these putative antigens",
            "probability": 0.0247525218225403,
            "start_logit": 2.914335250854492,
            "end_logit": 1.7948702573776245
        },
        {
            "text": "unique specificity",
            "probability": 0.018862660188416706,
            "start_logit": 1.520847201347351,
            "end_logit": 2.9166152477264404
        },
        {
            "text": "It is thus unknown",
            "probability": 0.018756989560381732,
            "start_logit": 1.8586424589157104,
            "end_logit": 2.573202133178711
        },
        {
            "text": "these putative antigens",
            "probability": 0.0179214484280443,
            "start_logit": 2.5914061069488525,
            "end_logit": 1.7948702573776245
        },
        {
            "text": "unknown how many tumours express tumour specific antigen at all and",
            "probability": 0.017703152164428602,
            "start_logit": 3.890842914581299,
            "end_logit": 0.48317793011665344
        },
        {
            "text": "It is thus unknown how many tumours express tumour specific antigen at all",
            "probability": 0.014066997824947598,
            "start_logit": 1.8586424589157104,
            "end_logit": 2.2854671478271484
        },
        {
            "text": "It is thus unknown how many tumours express tumour specific antigen",
            "probability": 0.013386383391737951,
            "start_logit": 1.8586424589157104,
            "end_logit": 2.2358736991882324
        },
        {
            "text": "unknown how many tumours express tumour specific antigen at all and whether these putative antigens are of unique",
            "probability": 0.01217996597925834,
            "start_logit": 3.890842914581299,
            "end_logit": 0.10922768712043762
        },
        {
            "text": "unknown how many tumours express tumour specific antigen at all and whether these putative antigens are of unique specificity or are shared",
            "probability": 0.01209544406884897,
            "start_logit": 3.890842914581299,
            "end_logit": 0.10226407647132874
        },
        {
            "text": "whether these putative antigens are of unique specificity or are shared by certain groups of (histologically related) neoplasias",
            "probability": 0.010250858998342788,
            "start_logit": 2.914335250854492,
            "end_logit": 0.9133043885231018
        },
        {
            "text": "",
            "probability": 8.506809862205581e-05,
            "start_logit": -0.5291498303413391,
            "end_logit": -0.4348752200603485
        }
    ],
    "5c7f806d617e120c34000001_003": [
        {
            "text": "tumour-associated antigens",
            "probability": 0.33268212977655925,
            "start_logit": 0.7404786348342896,
            "end_logit": 2.43497371673584
        },
        {
            "text": "tumour-associated antigens in conjunction with class I molecules expressed on tumour cells",
            "probability": 0.16049500759912738,
            "start_logit": 0.7404786348342896,
            "end_logit": 1.7060490846633911
        },
        {
            "text": "derived from tumour-associated antigens",
            "probability": 0.09184202555853352,
            "start_logit": -0.5466388463973999,
            "end_logit": 2.43497371673584
        },
        {
            "text": "in conjunction with class I molecules expressed on tumour cells",
            "probability": 0.08522368902315779,
            "start_logit": 0.10749523341655731,
            "end_logit": 1.7060490846633911
        },
        {
            "text": "short peptides derived from tumour-associated antigens",
            "probability": 0.08475306245292631,
            "start_logit": -0.6269669532775879,
            "end_logit": 2.43497371673584
        },
        {
            "text": "derived from tumour-associated antigens in conjunction with class I molecules expressed on tumour cells",
            "probability": 0.044307118629534153,
            "start_logit": -0.5466388463973999,
            "end_logit": 1.7060490846633911
        },
        {
            "text": "short peptides derived from tumour-associated antigens in conjunction with class I molecules expressed on tumour cells",
            "probability": 0.04088720789291445,
            "start_logit": -0.6269669532775879,
            "end_logit": 1.7060490846633911
        },
        {
            "text": "",
            "probability": 0.026966206247232605,
            "start_logit": -0.048953376710414886,
            "end_logit": 0.7118027210235596
        },
        {
            "text": "tumour-associated antigens in conjunction with class I molecules expressed on tumour cells.",
            "probability": 0.026191584655938436,
            "start_logit": 0.7404786348342896,
            "end_logit": -0.10677558928728104
        },
        {
            "text": "antigens",
            "probability": 0.022627795528806113,
            "start_logit": -1.9475297927856445,
            "end_logit": 2.43497371673584
        },
        {
            "text": "CTLs recognize short peptides derived from tumour-associated antigens",
            "probability": 0.014370426353317456,
            "start_logit": -2.401536464691162,
            "end_logit": 2.43497371673584
        },
        {
            "text": "in conjunction with class I molecules expressed on tumour cells.",
            "probability": 0.013907868532064825,
            "start_logit": 0.10749523341655731,
            "end_logit": -0.10677558928728104
        },
        {
            "text": "antigens in conjunction with class I molecules expressed on tumour cells",
            "probability": 0.010916270789135492,
            "start_logit": -1.9475297927856445,
            "end_logit": 1.7060490846633911
        },
        {
            "text": "from tumour-associated antigens",
            "probability": 0.008093827039671498,
            "start_logit": -2.97560715675354,
            "end_logit": 2.43497371673584
        },
        {
            "text": "short peptides",
            "probability": 0.007605745972575398,
            "start_logit": -0.6269669532775879,
            "end_logit": 0.02413584664463997
        },
        {
            "text": "derived from tumour-associated antigens in conjunction with class I molecules expressed on tumour cells.",
            "probability": 0.007230590320570571,
            "start_logit": -0.5466388463973999,
            "end_logit": -0.10677558928728104
        },
        {
            "text": "CTLs recognize short peptides derived from tumour-associated antigens in conjunction with class I molecules expressed on tumour cells",
            "probability": 0.00693268883521766,
            "start_logit": -2.401536464691162,
            "end_logit": 1.7060490846633911
        },
        {
            "text": "short peptides derived from tumour-associated antigens in conjunction with class I molecules expressed on tumour cells.",
            "probability": 0.006672486471024944,
            "start_logit": -0.6269669532775879,
            "end_logit": -0.10677558928728104
        },
        {
            "text": "class I molecules expressed on tumour cells",
            "probability": 0.004389583591224136,
            "start_logit": -2.8585498332977295,
            "end_logit": 1.7060490846633911
        },
        {
            "text": "from tumour-associated antigens in conjunction with class I molecules expressed on tumour cells",
            "probability": 0.003904684730467985,
            "start_logit": -2.97560715675354,
            "end_logit": 1.7060490846633911
        }
    ],
    "5c7f806d617e120c34000001_004": [
        {
            "text": "melanoma-associated antigens",
            "probability": 0.6203980659907204,
            "start_logit": 1.8215594291687012,
            "end_logit": 2.1666595935821533
        },
        {
            "text": "existence of melanoma-associated antigens",
            "probability": 0.061259543485211634,
            "start_logit": -0.49368223547935486,
            "end_logit": 2.1666595935821533
        },
        {
            "text": "melanoma-associated antigens that were recognised in vivo by effector cells of the immune system.",
            "probability": 0.04477750577491778,
            "start_logit": 1.8215594291687012,
            "end_logit": -0.46199581027030945
        },
        {
            "text": "melanoma-associated antigens that were recognised in vivo by effector cells of the immune system",
            "probability": 0.044098703023341776,
            "start_logit": 1.8215594291687012,
            "end_logit": -0.47727134823799133
        },
        {
            "text": "fundamental evidence of the existence of melanoma-associated antigens",
            "probability": 0.029489142940699584,
            "start_logit": -1.224779725074768,
            "end_logit": 2.1666595935821533
        },
        {
            "text": "recognised by autologous TIL. This provided fundamental evidence of the existence of melanoma-associated antigens",
            "probability": 0.029267142864314206,
            "start_logit": -1.232336401939392,
            "end_logit": 2.1666595935821533
        },
        {
            "text": "recognised by autologous TIL",
            "probability": 0.026063115023439755,
            "start_logit": -1.232336401939392,
            "end_logit": 2.050715208053589
        },
        {
            "text": "This provided fundamental evidence of the existence of melanoma-associated antigens",
            "probability": 0.015665936861404203,
            "start_logit": -1.8573131561279297,
            "end_logit": 2.1666595935821533
        },
        {
            "text": "evidence of the existence of melanoma-associated antigens",
            "probability": 0.014954230624113123,
            "start_logit": -1.9038076400756836,
            "end_logit": 2.1666595935821533
        },
        {
            "text": "provided fundamental evidence of the existence of melanoma-associated antigens",
            "probability": 0.014647668174202443,
            "start_logit": -1.92452073097229,
            "end_logit": 2.1666595935821533
        },
        {
            "text": "recombinant high-dose bolus intravenous interleukin-2",
            "probability": 0.013163836951397716,
            "start_logit": -0.7417200207710266,
            "end_logit": 0.8770511746406555
        },
        {
            "text": "could be recognised by autologous TIL. This provided fundamental evidence of the existence of melanoma-associated antigens",
            "probability": 0.01304420430846323,
            "start_logit": -2.0404579639434814,
            "end_logit": 2.1666595935821533
        },
        {
            "text": "could be recognised by autologous TIL",
            "probability": 0.011616186754439171,
            "start_logit": -2.0404579639434814,
            "end_logit": 2.050715208053589
        },
        {
            "text": "autologous TIL. This provided fundamental evidence of the existence of melanoma-associated antigens",
            "probability": 0.011498070584906263,
            "start_logit": -2.1666226387023926,
            "end_logit": 2.1666595935821533
        },
        {
            "text": "autologous TIL",
            "probability": 0.010239316409919853,
            "start_logit": -2.1666226387023926,
            "end_logit": 2.050715208053589
        },
        {
            "text": "high-dose bolus intravenous interleukin-2",
            "probability": 0.009571845229318207,
            "start_logit": -1.060367465019226,
            "end_logit": 0.8770511746406555
        },
        {
            "text": "melanoma-associated antigen",
            "probability": 0.008749646546163135,
            "start_logit": 1.8215594291687012,
            "end_logit": -2.0946884155273438
        },
        {
            "text": "melanoma-associated",
            "probability": 0.008665802493504467,
            "start_logit": 1.8215594291687012,
            "end_logit": -2.1043171882629395
        },
        {
            "text": "bolus intravenous interleukin-2",
            "probability": 0.006661830891570913,
            "start_logit": -1.4227991104125977,
            "end_logit": 0.8770511746406555
        },
        {
            "text": "recognised by autologous TIL.",
            "probability": 0.005695245793371022,
            "start_logit": -1.232336401939392,
            "end_logit": 0.5298258662223816
        },
        {
            "text": "",
            "probability": 0.00047295927458090116,
            "start_logit": -1.829932689666748,
            "end_logit": -1.3609555959701538
        }
    ],
    "5c7f806d617e120c34000001_005": [
        {
            "text": "",
            "probability": 0.40292620386688943,
            "start_logit": -0.03858058154582977,
            "end_logit": -0.5056143403053284
        },
        {
            "text": "Tumour-derived peptides eluted from MHC molecules of tumour tissue",
            "probability": 0.13127397326571144,
            "start_logit": -0.7304431200027466,
            "end_logit": -0.9352186918258667
        },
        {
            "text": "MHC molecules of tumour tissue",
            "probability": 0.0630617621908485,
            "start_logit": -1.4636150598526,
            "end_logit": -0.9352186918258667
        },
        {
            "text": "Tumour-derived peptides eluted from MHC molecules of tumour tissue are also a promising source of antigen.",
            "probability": 0.05265888529367247,
            "start_logit": -0.7304431200027466,
            "end_logit": -1.848670244216919
        },
        {
            "text": "Tumour-derived peptides eluted from MHC molecules",
            "probability": 0.049038345228985224,
            "start_logit": -0.7304431200027466,
            "end_logit": -1.9199026823043823
        },
        {
            "text": "eluted from MHC molecules of tumour tissue",
            "probability": 0.043498933259809046,
            "start_logit": -1.8349932432174683,
            "end_logit": -0.9352186918258667
        },
        {
            "text": "mostly arise by point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific",
            "probability": 0.0367001792141161,
            "start_logit": -1.9323670864105225,
            "end_logit": -1.0077996253967285
        },
        {
            "text": "Tumour-derived peptides eluted from MHC molecules of tumour tissue are also a promising source of antigen",
            "probability": 0.029458359061942958,
            "start_logit": -0.7304431200027466,
            "end_logit": -2.429527521133423
        },
        {
            "text": "not only tumour-specific, but also individual-specific",
            "probability": 0.02844847531568588,
            "start_logit": -2.18705415725708,
            "end_logit": -1.0077996253967285
        },
        {
            "text": "MHC molecules of tumour tissue are also a promising source of antigen.",
            "probability": 0.025296424104595296,
            "start_logit": -1.4636150598526,
            "end_logit": -1.848670244216919
        },
        {
            "text": "MHC molecules",
            "probability": 0.02355717883851648,
            "start_logit": -1.4636150598526,
            "end_logit": -1.9199026823043823
        },
        {
            "text": "eluted from MHC molecules of tumour tissue are also a promising source of antigen.",
            "probability": 0.017449044010338498,
            "start_logit": -1.8349932432174683,
            "end_logit": -1.848670244216919
        },
        {
            "text": "point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific",
            "probability": 0.016326387259478308,
            "start_logit": -2.742366075515747,
            "end_logit": -1.0077996253967285
        },
        {
            "text": "eluted from MHC molecules",
            "probability": 0.016249342144687488,
            "start_logit": -1.8349932432174683,
            "end_logit": -1.9199026823043823
        },
        {
            "text": "MHC molecules of tumour tissue are also a promising source of antigen",
            "probability": 0.014151289760512645,
            "start_logit": -1.4636150598526,
            "end_logit": -2.429527521133423
        },
        {
            "text": "Tumour-derived peptides",
            "probability": 0.012314059957462804,
            "start_logit": -0.7304431200027466,
            "end_logit": -3.3017635345458984
        },
        {
            "text": "eluted from MHC molecules of tumour tissue are also a promising source of antigen",
            "probability": 0.009761319497698552,
            "start_logit": -1.8349932432174683,
            "end_logit": -2.429527521133423
        },
        {
            "text": "gene products selectively or preferentially transcribed",
            "probability": 0.009484460806101843,
            "start_logit": -3.0445921421051025,
            "end_logit": -1.2487014532089233
        },
        {
            "text": "MHC molecules of tumour tissue are also a promising source of antigen. Tumour antigens are mostly of weak immunogenicity,",
            "probability": 0.009412961170636735,
            "start_logit": -1.4636150598526,
            "end_logit": -2.8372457027435303
        },
        {
            "text": "mostly arise by point mutations",
            "probability": 0.008932415752310241,
            "start_logit": -1.9323670864105225,
            "end_logit": -2.4208943843841553
        }
    ],
    "5c7f806d617e120c34000001_006": [
        {
            "text": "",
            "probability": 0.40292620386688943,
            "start_logit": -0.03858058154582977,
            "end_logit": -0.5056143403053284
        },
        {
            "text": "Tumour-derived peptides eluted from MHC molecules of tumour tissue",
            "probability": 0.13127397326571144,
            "start_logit": -0.7304431200027466,
            "end_logit": -0.9352186918258667
        },
        {
            "text": "MHC molecules of tumour tissue",
            "probability": 0.0630617621908485,
            "start_logit": -1.4636150598526,
            "end_logit": -0.9352186918258667
        },
        {
            "text": "Tumour-derived peptides eluted from MHC molecules of tumour tissue are also a promising source of antigen.",
            "probability": 0.05265888529367247,
            "start_logit": -0.7304431200027466,
            "end_logit": -1.848670244216919
        },
        {
            "text": "Tumour-derived peptides eluted from MHC molecules",
            "probability": 0.049038345228985224,
            "start_logit": -0.7304431200027466,
            "end_logit": -1.9199026823043823
        },
        {
            "text": "eluted from MHC molecules of tumour tissue",
            "probability": 0.043498933259809046,
            "start_logit": -1.8349932432174683,
            "end_logit": -0.9352186918258667
        },
        {
            "text": "mostly arise by point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific",
            "probability": 0.0367001792141161,
            "start_logit": -1.9323670864105225,
            "end_logit": -1.0077996253967285
        },
        {
            "text": "Tumour-derived peptides eluted from MHC molecules of tumour tissue are also a promising source of antigen",
            "probability": 0.029458359061942958,
            "start_logit": -0.7304431200027466,
            "end_logit": -2.429527521133423
        },
        {
            "text": "not only tumour-specific, but also individual-specific",
            "probability": 0.02844847531568588,
            "start_logit": -2.18705415725708,
            "end_logit": -1.0077996253967285
        },
        {
            "text": "MHC molecules of tumour tissue are also a promising source of antigen.",
            "probability": 0.025296424104595296,
            "start_logit": -1.4636150598526,
            "end_logit": -1.848670244216919
        },
        {
            "text": "MHC molecules",
            "probability": 0.02355717883851648,
            "start_logit": -1.4636150598526,
            "end_logit": -1.9199026823043823
        },
        {
            "text": "eluted from MHC molecules of tumour tissue are also a promising source of antigen.",
            "probability": 0.017449044010338498,
            "start_logit": -1.8349932432174683,
            "end_logit": -1.848670244216919
        },
        {
            "text": "point mutations and have the disadvantage of being not only tumour-specific, but also individual-specific",
            "probability": 0.016326387259478308,
            "start_logit": -2.742366075515747,
            "end_logit": -1.0077996253967285
        },
        {
            "text": "eluted from MHC molecules",
            "probability": 0.016249342144687488,
            "start_logit": -1.8349932432174683,
            "end_logit": -1.9199026823043823
        },
        {
            "text": "MHC molecules of tumour tissue are also a promising source of antigen",
            "probability": 0.014151289760512645,
            "start_logit": -1.4636150598526,
            "end_logit": -2.429527521133423
        },
        {
            "text": "Tumour-derived peptides",
            "probability": 0.012314059957462804,
            "start_logit": -0.7304431200027466,
            "end_logit": -3.3017635345458984
        },
        {
            "text": "eluted from MHC molecules of tumour tissue are also a promising source of antigen",
            "probability": 0.009761319497698552,
            "start_logit": -1.8349932432174683,
            "end_logit": -2.429527521133423
        },
        {
            "text": "gene products selectively or preferentially transcribed",
            "probability": 0.009484460806101843,
            "start_logit": -3.0445921421051025,
            "end_logit": -1.2487014532089233
        },
        {
            "text": "MHC molecules of tumour tissue are also a promising source of antigen. Tumour antigens are mostly of weak immunogenicity,",
            "probability": 0.009412961170636735,
            "start_logit": -1.4636150598526,
            "end_logit": -2.8372457027435303
        },
        {
            "text": "mostly arise by point mutations",
            "probability": 0.008932415752310241,
            "start_logit": -1.9323670864105225,
            "end_logit": -2.4208943843841553
        }
    ],
    "5c7f806d617e120c34000001_007": [
        {
            "text": "specificity residing in a population of bound peptides",
            "probability": 0.2310721894962272,
            "start_logit": 2.7904608249664307,
            "end_logit": 2.8887147903442383
        },
        {
            "text": "specificity residing in a population of bound peptides that identify the tissue of origin of the HSP",
            "probability": 0.16033543758780178,
            "start_logit": 2.7904608249664307,
            "end_logit": 2.5232527256011963
        },
        {
            "text": "heat-shock proteins (HSPs) function as ubiquitous tumour-specific antigens, with the specificity residing in a population of bound peptides",
            "probability": 0.11849941783389259,
            "start_logit": 2.122638702392578,
            "end_logit": 2.8887147903442383
        },
        {
            "text": "specificity residing in a population of bound peptides that identify the tissue of origin of the HSP.",
            "probability": 0.09372672064552244,
            "start_logit": 2.7904608249664307,
            "end_logit": 1.98636794090271
        },
        {
            "text": "bound peptides",
            "probability": 0.06264193496082693,
            "start_logit": 1.4851655960083008,
            "end_logit": 2.8887147903442383
        },
        {
            "text": "bound peptides that identify the tissue of origin of the HSP",
            "probability": 0.043465732830885694,
            "start_logit": 1.4851655960083008,
            "end_logit": 2.5232527256011963
        },
        {
            "text": "tumours express unique sets of antigens",
            "probability": 0.03789910937218282,
            "start_logit": 1.9931840896606445,
            "end_logit": 1.878188967704773
        },
        {
            "text": "residing in a population of bound peptides",
            "probability": 0.036762755553721674,
            "start_logit": 0.9522159099578857,
            "end_logit": 2.8887147903442383
        },
        {
            "text": "the specificity residing in a population of bound peptides",
            "probability": 0.02706292653863483,
            "start_logit": 0.6458954215049744,
            "end_logit": 2.8887147903442383
        },
        {
            "text": "residing in a population of bound peptides that identify the tissue of origin of the HSP",
            "probability": 0.025508792345327193,
            "start_logit": 0.9522159099578857,
            "end_logit": 2.5232527256011963
        },
        {
            "text": "bound peptides that identify the tissue of origin of the HSP.",
            "probability": 0.02540860997408895,
            "start_logit": 1.4851655960083008,
            "end_logit": 1.98636794090271
        },
        {
            "text": "with the specificity residing in a population of bound peptides",
            "probability": 0.019265245441079007,
            "start_logit": 0.3060333728790283,
            "end_logit": 2.8887147903442383
        },
        {
            "text": "the specificity residing in a population of bound peptides that identify the tissue of origin of the HSP",
            "probability": 0.01877831416423825,
            "start_logit": 0.6458954215049744,
            "end_logit": 2.5232527256011963
        },
        {
            "text": "a population of bound peptides",
            "probability": 0.01572667027662683,
            "start_logit": 0.10308866947889328,
            "end_logit": 2.8887147903442383
        },
        {
            "text": "specificity residing in a population of bound peptides that identify the tissue of origin",
            "probability": 0.01567189047273444,
            "start_logit": 2.7904608249664307,
            "end_logit": 0.19785331189632416
        },
        {
            "text": "residing in a population of bound peptides that identify the tissue of origin of the HSP.",
            "probability": 0.014911584676006883,
            "start_logit": 0.9522159099578857,
            "end_logit": 1.98636794090271
        },
        {
            "text": "heat-shock proteins (HSPs) function as ubiquitous tumour-specific antigens",
            "probability": 0.014559156884797269,
            "start_logit": 2.122638702392578,
            "end_logit": 0.7920268774032593
        },
        {
            "text": "with the specificity residing in a population of bound peptides that identify the tissue of origin of the HSP",
            "probability": 0.013367690697725611,
            "start_logit": 0.3060333728790283,
            "end_logit": 2.5232527256011963
        },
        {
            "text": "specificity",
            "probability": 0.013229647690263061,
            "start_logit": 2.7904608249664307,
            "end_logit": 0.028444968163967133
        },
        {
            "text": "specificity residing in a population of bound peptides that identify the tissue",
            "probability": 0.012105304652370237,
            "start_logit": 2.7904608249664307,
            "end_logit": -0.06037162244319916
        },
        {
            "text": "",
            "probability": 8.679050466132332e-07,
            "start_logit": -3.333109140396118,
            "end_logit": -3.4798736572265625
        }
    ],
    "5c7f806d617e120c34000001_008": [
        {
            "text": "tumour-specific CD4(+) T cells collaborate with macrophages and dendritic cells.",
            "probability": 0.1831528425726882,
            "start_logit": 1.8196828365325928,
            "end_logit": -0.5379401445388794
        },
        {
            "text": "tumour-specific CD4(+) T cells collaborate with macrophages and dendritic cells",
            "probability": 0.17925198030218642,
            "start_logit": 1.8196828365325928,
            "end_logit": -0.5594686269760132
        },
        {
            "text": "antigenic peptides on their MHC class II molecules",
            "probability": 0.0940091279851926,
            "start_logit": -0.6986606121063232,
            "end_logit": 1.313474178314209
        },
        {
            "text": "directly to CD4(+) T cells",
            "probability": 0.07003755278026032,
            "start_logit": 0.03471284359693527,
            "end_logit": 0.2857404053211212
        },
        {
            "text": "directly to CD4(+) T cells.",
            "probability": 0.06393774515565111,
            "start_logit": 0.03471284359693527,
            "end_logit": 0.19461871683597565
        },
        {
            "text": "antigen-presenting cells endocytose and process TSA to display antigenic peptides on their MHC class II molecules",
            "probability": 0.05732257650241529,
            "start_logit": -1.1933579444885254,
            "end_logit": 1.313474178314209
        },
        {
            "text": "MHC class II molecules",
            "probability": 0.05523585867852479,
            "start_logit": -1.2304401397705078,
            "end_logit": 1.313474178314209
        },
        {
            "text": "antigenic peptides",
            "probability": 0.03902019174935195,
            "start_logit": -0.6986606121063232,
            "end_logit": 0.43416154384613037
        },
        {
            "text": "tumour-specific CD4(+) T cells",
            "probability": 0.03421619427907549,
            "start_logit": 1.8196828365325928,
            "end_logit": -2.215562105178833
        },
        {
            "text": "These professional antigen-presenting cells endocytose and process TSA to display antigenic peptides on their MHC class II molecules",
            "probability": 0.029435386095755627,
            "start_logit": -1.8598549365997314,
            "end_logit": 1.313474178314209
        },
        {
            "text": "cannot present tumour-specific antigens (TSA) directly to CD4(+) T cells",
            "probability": 0.02645019940762792,
            "start_logit": -0.9390550255775452,
            "end_logit": 0.2857404053211212
        },
        {
            "text": "tumour-specific CD4(+) T cells collaborate with macrophages and dendritic cells. These professional antigen-presenting cells",
            "probability": 0.024193574280451317,
            "start_logit": 1.8196828365325928,
            "end_logit": -2.562174081802368
        },
        {
            "text": "cannot present tumour-specific antigens (TSA) directly to CD4(+) T cells.",
            "probability": 0.024146561978643455,
            "start_logit": -0.9390550255775452,
            "end_logit": 0.19461871683597565
        },
        {
            "text": "antigen-presenting cells endocytose and process TSA to display antigenic peptides",
            "probability": 0.023792773900035005,
            "start_logit": -1.1933579444885254,
            "end_logit": 0.43416154384613037
        },
        {
            "text": "antigenic peptides on their MHC class II molecules for indirect cancer cell recognition by CD4(+) T cells",
            "probability": 0.021046604713105422,
            "start_logit": -0.6986606121063232,
            "end_logit": -0.18317845463752747
        },
        {
            "text": "endocytose and process TSA to display antigenic peptides on their MHC class II molecules",
            "probability": 0.020544376218370658,
            "start_logit": -2.2194652557373047,
            "end_logit": 1.313474178314209
        },
        {
            "text": "tumour-specific CD4",
            "probability": 0.014899245519826269,
            "start_logit": 1.8196828365325928,
            "end_logit": -3.046950578689575
        },
        {
            "text": "MHC class II molecules for indirect cancer cell recognition by CD4(+) T cells",
            "probability": 0.012366110701281845,
            "start_logit": -1.2304401397705078,
            "end_logit": -0.18317845463752747
        },
        {
            "text": "These professional antigen-presenting cells endocytose and process TSA to display antigenic peptides",
            "probability": 0.012217690284857287,
            "start_logit": -1.8598549365997314,
            "end_logit": 0.43416154384613037
        },
        {
            "text": "professional antigen-presenting cells endocytose and process TSA to display antigenic peptides on their MHC class II molecules",
            "probability": 0.011884314589646868,
            "start_logit": -2.7668330669403076,
            "end_logit": 1.313474178314209
        },
        {
            "text": "",
            "probability": 0.0028390923050524565,
            "start_logit": -1.4037790298461914,
            "end_logit": -1.4813148975372314
        }
    ],
    "5c7f806d617e120c34000001_009": [
        {
            "text": "",
            "probability": 0.38142686000386167,
            "start_logit": 1.5609112977981567,
            "end_logit": 1.9964256286621094
        },
        {
            "text": "FSPs",
            "probability": 0.3766907471159931,
            "start_logit": 1.3614472150802612,
            "end_logit": 2.1833951473236084
        },
        {
            "text": "frame-shifted peptide (FSP) sequences",
            "probability": 0.14044514701194646,
            "start_logit": 0.7486748695373535,
            "end_logit": 1.809559941291809
        },
        {
            "text": "FSPs as shared and general tumour-specific antigens",
            "probability": 0.02257192687757133,
            "start_logit": 1.3614472150802612,
            "end_logit": -0.63132244348526
        },
        {
            "text": "peptide (FSP) sequences",
            "probability": 0.01641832274133947,
            "start_logit": -1.3977441787719727,
            "end_logit": 1.809559941291809
        },
        {
            "text": "MSI(+) leukaemia and lymphomas (L/L)",
            "probability": 0.01034074574135808,
            "start_logit": -0.9278925061225891,
            "end_logit": 0.8774023056030273
        },
        {
            "text": "FSP) sequences",
            "probability": 0.0076945240932220415,
            "start_logit": -2.1556332111358643,
            "end_logit": 1.809559941291809
        },
        {
            "text": "MSI(+) leukaemia and lymphomas (L/L).",
            "probability": 0.006559090482938815,
            "start_logit": -0.9278925061225891,
            "end_logit": 0.422162264585495
        },
        {
            "text": "FSPs as shared",
            "probability": 0.006073642989300617,
            "start_logit": 1.3614472150802612,
            "end_logit": -1.944070816040039
        },
        {
            "text": "MSI(+) leukaemia and lymphomas",
            "probability": 0.005051697881915707,
            "start_logit": -0.9278925061225891,
            "end_logit": 0.1610347181558609
        },
        {
            "text": "lymphomas (L/L)",
            "probability": 0.00440887898190582,
            "start_logit": -1.7803640365600586,
            "end_logit": 0.8774023056030273
        },
        {
            "text": "frame-shifted peptide (FSP)",
            "probability": 0.003878742961434836,
            "start_logit": 0.7486748695373535,
            "end_logit": -1.7797459363937378
        },
        {
            "text": "peptide (FSP) sequences represent tumour-specific antigens also for MSI(+) leukaemia and lymphomas",
            "probability": 0.003157790986911554,
            "start_logit": -1.3977441787719727,
            "end_logit": 0.1610347181558609
        },
        {
            "text": "lymphomas (L/L).",
            "probability": 0.0027965329478113173,
            "start_logit": -1.7803640365600586,
            "end_logit": 0.422162264585495
        },
        {
            "text": "leukaemia and lymphomas (L/L)",
            "probability": 0.002508136334820481,
            "start_logit": -2.344444513320923,
            "end_logit": 0.8774023056030273
        },
        {
            "text": "expand the importance of FSPs",
            "probability": 0.002179742619999188,
            "start_logit": -3.7907705307006836,
            "end_logit": 2.1833951473236084
        },
        {
            "text": "lymphomas",
            "probability": 0.002153841238493813,
            "start_logit": -1.7803640365600586,
            "end_logit": 0.1610347181558609
        },
        {
            "text": "Data presented here expand the importance of FSPs",
            "probability": 0.00215179556139494,
            "start_logit": -3.8036746978759766,
            "end_logit": 2.1833951473236084
        },
        {
            "text": "frame-shifted peptide",
            "probability": 0.0019009333539267011,
            "start_logit": 0.7486748695373535,
            "end_logit": -2.4929120540618896
        },
        {
            "text": "leukaemia and lymphomas (L/L).",
            "probability": 0.001590900073854199,
            "start_logit": -2.344444513320923,
            "end_logit": 0.422162264585495
        }
    ],
    "5c7f806d617e120c34000001_010": [
        {
            "text": "",
            "probability": 0.38142686000386167,
            "start_logit": 1.5609112977981567,
            "end_logit": 1.9964256286621094
        },
        {
            "text": "FSPs",
            "probability": 0.3766907471159931,
            "start_logit": 1.3614472150802612,
            "end_logit": 2.1833951473236084
        },
        {
            "text": "frame-shifted peptide (FSP) sequences",
            "probability": 0.14044514701194646,
            "start_logit": 0.7486748695373535,
            "end_logit": 1.809559941291809
        },
        {
            "text": "FSPs as shared and general tumour-specific antigens",
            "probability": 0.02257192687757133,
            "start_logit": 1.3614472150802612,
            "end_logit": -0.63132244348526
        },
        {
            "text": "peptide (FSP) sequences",
            "probability": 0.01641832274133947,
            "start_logit": -1.3977441787719727,
            "end_logit": 1.809559941291809
        },
        {
            "text": "MSI(+) leukaemia and lymphomas (L/L)",
            "probability": 0.01034074574135808,
            "start_logit": -0.9278925061225891,
            "end_logit": 0.8774023056030273
        },
        {
            "text": "FSP) sequences",
            "probability": 0.0076945240932220415,
            "start_logit": -2.1556332111358643,
            "end_logit": 1.809559941291809
        },
        {
            "text": "MSI(+) leukaemia and lymphomas (L/L).",
            "probability": 0.006559090482938815,
            "start_logit": -0.9278925061225891,
            "end_logit": 0.422162264585495
        },
        {
            "text": "FSPs as shared",
            "probability": 0.006073642989300617,
            "start_logit": 1.3614472150802612,
            "end_logit": -1.944070816040039
        },
        {
            "text": "MSI(+) leukaemia and lymphomas",
            "probability": 0.005051697881915707,
            "start_logit": -0.9278925061225891,
            "end_logit": 0.1610347181558609
        },
        {
            "text": "lymphomas (L/L)",
            "probability": 0.00440887898190582,
            "start_logit": -1.7803640365600586,
            "end_logit": 0.8774023056030273
        },
        {
            "text": "frame-shifted peptide (FSP)",
            "probability": 0.003878742961434836,
            "start_logit": 0.7486748695373535,
            "end_logit": -1.7797459363937378
        },
        {
            "text": "peptide (FSP) sequences represent tumour-specific antigens also for MSI(+) leukaemia and lymphomas",
            "probability": 0.003157790986911554,
            "start_logit": -1.3977441787719727,
            "end_logit": 0.1610347181558609
        },
        {
            "text": "lymphomas (L/L).",
            "probability": 0.0027965329478113173,
            "start_logit": -1.7803640365600586,
            "end_logit": 0.422162264585495
        },
        {
            "text": "leukaemia and lymphomas (L/L)",
            "probability": 0.002508136334820481,
            "start_logit": -2.344444513320923,
            "end_logit": 0.8774023056030273
        },
        {
            "text": "expand the importance of FSPs",
            "probability": 0.002179742619999188,
            "start_logit": -3.7907705307006836,
            "end_logit": 2.1833951473236084
        },
        {
            "text": "lymphomas",
            "probability": 0.002153841238493813,
            "start_logit": -1.7803640365600586,
            "end_logit": 0.1610347181558609
        },
        {
            "text": "Data presented here expand the importance of FSPs",
            "probability": 0.00215179556139494,
            "start_logit": -3.8036746978759766,
            "end_logit": 2.1833951473236084
        },
        {
            "text": "frame-shifted peptide",
            "probability": 0.0019009333539267011,
            "start_logit": 0.7486748695373535,
            "end_logit": -2.4929120540618896
        },
        {
            "text": "leukaemia and lymphomas (L/L).",
            "probability": 0.001590900073854199,
            "start_logit": -2.344444513320923,
            "end_logit": 0.422162264585495
        }
    ],
    "5e35cb27158f994d3a000002_001": [
        {
            "text": "5376 and 110 regulatory variants",
            "probability": 0.7940489597863241,
            "start_logit": 1.1880829334259033,
            "end_logit": 1.8658515214920044
        },
        {
            "text": "5376 and 110 regulatory variants associated with promoter usage (puQTLs) and enhancer activity (eaQTLs)",
            "probability": 0.04818459656943698,
            "start_logit": 1.1880829334259033,
            "end_logit": -0.9362542033195496
        },
        {
            "text": "genetic variants",
            "probability": 0.0427291853628386,
            "start_logit": 0.26442211866378784,
            "end_logit": -0.13275060057640076
        },
        {
            "text": "110 regulatory variants",
            "probability": 0.03886470030295364,
            "start_logit": -1.828975796699524,
            "end_logit": 1.8658515214920044
        },
        {
            "text": "5376 and 110 regulatory variants associated with promoter usage (puQTLs) and enhancer activity (eaQTLs",
            "probability": 0.01937438714219642,
            "start_logit": 1.1880829334259033,
            "end_logit": -1.8473416566848755
        },
        {
            "text": "5376 and 110 regulatory variants associated with promoter usage (puQTLs) and enhancer activity",
            "probability": 0.015561795808082297,
            "start_logit": 1.1880829334259033,
            "end_logit": -2.066474676132202
        },
        {
            "text": "genetic variants affecting gene expression",
            "probability": 0.013125961355832414,
            "start_logit": 0.26442211866378784,
            "end_logit": -1.3130407333374023
        },
        {
            "text": "regulatory variants",
            "probability": 0.006921525776788349,
            "start_logit": -3.5544259548187256,
            "end_logit": 1.8658515214920044
        },
        {
            "text": "variants",
            "probability": 0.0041721654954185545,
            "start_logit": -4.060626983642578,
            "end_logit": 1.8658515214920044
        },
        {
            "text": "map 5376 and 110 regulatory variants",
            "probability": 0.003066917723764407,
            "start_logit": -4.368389129638672,
            "end_logit": 1.8658515214920044
        },
        {
            "text": "enhancer activity (eaQTLs)",
            "probability": 0.0025588647156491243,
            "start_logit": -1.7473927736282349,
            "end_logit": -0.9362542033195496
        },
        {
            "text": "5376 and 110",
            "probability": 0.0023989422068188405,
            "start_logit": 1.1880829334259033,
            "end_logit": -3.936265707015991
        },
        {
            "text": "110 regulatory variants associated with promoter usage (puQTLs) and enhancer activity (eaQTLs)",
            "probability": 0.002358393499304915,
            "start_logit": -1.828975796699524,
            "end_logit": -0.9362542033195496
        },
        {
            "text": "genetic variants affecting gene expression, namely expression quantitative trait loci (eQTLs",
            "probability": 0.0015395991178061244,
            "start_logit": 0.26442211866378784,
            "end_logit": -3.456110715866089
        },
        {
            "text": "enhancer activity (eaQTLs",
            "probability": 0.001028885560431118,
            "start_logit": -1.7473927736282349,
            "end_logit": -1.8473416566848755
        },
        {
            "text": "110 regulatory variants associated with promoter usage (puQTLs) and enhancer activity (eaQTLs",
            "probability": 0.0009482787434637366,
            "start_logit": -1.828975796699524,
            "end_logit": -1.8473416566848755
        },
        {
            "text": "enhancer activity",
            "probability": 0.0008264161794538301,
            "start_logit": -1.7473927736282349,
            "end_logit": -2.066474676132202
        },
        {
            "text": "5376 and 110 regulatory variants associated with promoter usage (puQTLs",
            "probability": 0.0007833233006114004,
            "start_logit": 1.1880829334259033,
            "end_logit": -5.0555033683776855
        },
        {
            "text": "110 regulatory variants associated with promoter usage (puQTLs) and enhancer activity",
            "probability": 0.0007616715856156147,
            "start_logit": -1.828975796699524,
            "end_logit": -2.066474676132202
        },
        {
            "text": "5376 and 110 regulatory variants associated with promoter usage (puQTLs) and enhancer activity (eaQTLs), respectively.",
            "probability": 0.0007446025366666228,
            "start_logit": 1.1880829334259033,
            "end_logit": -5.106198310852051
        },
        {
            "text": "",
            "probability": 8.272305428793297e-07,
            "start_logit": -5.63042688369751,
            "end_logit": -5.090210914611816
        }
    ],
    "5e48f90bf8b2df0d49000006_001": [
        {
            "text": "wide range of products",
            "probability": 0.8443301726324363,
            "start_logit": 5.382539749145508,
            "end_logit": 5.174570560455322
        },
        {
            "text": "wide range of products as indicated by the pharmacopoeias",
            "probability": 0.09877802008971621,
            "start_logit": 5.382539749145508,
            "end_logit": 3.028902053833008
        },
        {
            "text": "wide range of products as indicated by the pharmacopoeias.",
            "probability": 0.03553315303634357,
            "start_logit": 5.382539749145508,
            "end_logit": 2.006493091583252
        },
        {
            "text": "for wide range of products",
            "probability": 0.00919632977444356,
            "start_logit": 0.8628005981445312,
            "end_logit": 5.174570560455322
        },
        {
            "text": "range of products",
            "probability": 0.002676777259590386,
            "start_logit": -0.37139031291007996,
            "end_logit": 5.174570560455322
        },
        {
            "text": "employed for wide range of products",
            "probability": 0.0011658569986747862,
            "start_logit": -1.2025474309921265,
            "end_logit": 5.174570560455322
        },
        {
            "text": "Gamma (\u03b3)-sterilization has been commonly employed for wide range of products",
            "probability": 0.001155820987604746,
            "start_logit": -1.2111929655075073,
            "end_logit": 5.174570560455322
        },
        {
            "text": "commonly employed for wide range of products",
            "probability": 0.0010921039055936798,
            "start_logit": -1.2678978443145752,
            "end_logit": 5.174570560455322
        },
        {
            "text": "for wide range of products as indicated by the pharmacopoeias",
            "probability": 0.0010758768034777961,
            "start_logit": 0.8628005981445312,
            "end_logit": 3.028902053833008
        },
        {
            "text": "products",
            "probability": 0.0008171800370903018,
            "start_logit": -1.5578997135162354,
            "end_logit": 5.174570560455322
        },
        {
            "text": "pharmacopoeias",
            "probability": 0.0007643183977201799,
            "start_logit": 0.5208938121795654,
            "end_logit": 3.028902053833008
        },
        {
            "text": "wide range of products as indicated",
            "probability": 0.0005567753985767608,
            "start_logit": 5.382539749145508,
            "end_logit": -2.149566411972046
        },
        {
            "text": "wide range",
            "probability": 0.0005338920040025597,
            "start_logit": 5.382539749145508,
            "end_logit": -2.1915347576141357
        },
        {
            "text": "has been commonly employed for wide range of products",
            "probability": 0.0004263734076347371,
            "start_logit": -2.2084436416625977,
            "end_logit": 5.174570560455322
        },
        {
            "text": "industrial manufacturing, research and development studies. Gamma (\u03b3)-sterilization has been commonly employed for wide range of products",
            "probability": 0.00039128032986718005,
            "start_logit": -2.294334888458252,
            "end_logit": 5.174570560455322
        },
        {
            "text": "for wide range of products as indicated by the pharmacopoeias.",
            "probability": 0.0003870222856411425,
            "start_logit": 0.8628005981445312,
            "end_logit": 2.006493091583252
        },
        {
            "text": "range of products as indicated by the pharmacopoeias",
            "probability": 0.0003131556427731967,
            "start_logit": -0.37139031291007996,
            "end_logit": 3.028902053833008
        },
        {
            "text": "pharmacopoeias.",
            "probability": 0.0002749462134391531,
            "start_logit": 0.5208938121795654,
            "end_logit": 2.006493091583252
        },
        {
            "text": "wide",
            "probability": 0.0002592737533535152,
            "start_logit": 5.382539749145508,
            "end_logit": -2.913843870162964
        },
        {
            "text": "wide range of products as indicated by the ph",
            "probability": 0.00023993839804699633,
            "start_logit": 5.382539749145508,
            "end_logit": -2.9913461208343506
        },
        {
            "text": "",
            "probability": 3.173264397309532e-05,
            "start_logit": 0.17117038369178772,
            "end_logit": 0.19698695838451385
        }
    ],
    "5e48f90bf8b2df0d49000006_002": [
        {
            "text": "minimize the risk of infection transmission through bone allografts",
            "probability": 0.4159052262944787,
            "start_logit": 7.911990165710449,
            "end_logit": 7.648636817932129
        },
        {
            "text": "to minimize the risk of infection transmission through bone allografts",
            "probability": 0.3872374899194081,
            "start_logit": 7.84057092666626,
            "end_logit": 7.648636817932129
        },
        {
            "text": "minimize the risk of infection transmission",
            "probability": 0.06147718241235162,
            "start_logit": 7.911990165710449,
            "end_logit": 5.73684549331665
        },
        {
            "text": "to minimize the risk of infection transmission",
            "probability": 0.05723965052514337,
            "start_logit": 7.84057092666626,
            "end_logit": 5.73684549331665
        },
        {
            "text": "minimize the risk of infection transmission through bone allografts.",
            "probability": 0.02640106933621291,
            "start_logit": 7.911990165710449,
            "end_logit": 4.8915839195251465
        },
        {
            "text": "to minimize the risk of infection transmission through bone allografts.",
            "probability": 0.024581282404238604,
            "start_logit": 7.84057092666626,
            "end_logit": 4.8915839195251465
        },
        {
            "text": "minimize the risk of infection",
            "probability": 0.010387463969857614,
            "start_logit": 7.911990165710449,
            "end_logit": 3.9587790966033936
        },
        {
            "text": "to minimize the risk of infection",
            "probability": 0.009671471335317894,
            "start_logit": 7.84057092666626,
            "end_logit": 3.9587790966033936
        },
        {
            "text": "bone allografts",
            "probability": 0.0020805510607924686,
            "start_logit": 2.6141655445098877,
            "end_logit": 7.648636817932129
        },
        {
            "text": "used to minimize the risk of infection transmission through bone allografts",
            "probability": 0.001620013024491543,
            "start_logit": 2.363966941833496,
            "end_logit": 7.648636817932129
        },
        {
            "text": "Gamma sterilization is usually used to minimize the risk of infection transmission through bone allografts",
            "probability": 0.0012769559679952274,
            "start_logit": 2.126011848449707,
            "end_logit": 7.648636817932129
        },
        {
            "text": "risk of infection transmission through bone allografts",
            "probability": 0.00036766085991158786,
            "start_logit": 0.8809384107589722,
            "end_logit": 7.648636817932129
        },
        {
            "text": "usually used to minimize the risk of infection transmission through bone allografts",
            "probability": 0.0003399939063311888,
            "start_logit": 0.8027051687240601,
            "end_logit": 7.648636817932129
        },
        {
            "text": "minimize the risk of infection transmission through bone",
            "probability": 0.0003319969466696755,
            "start_logit": 7.911990165710449,
            "end_logit": 0.515549898147583
        },
        {
            "text": "to minimize the risk of infection transmission through bone",
            "probability": 0.0003091128847663136,
            "start_logit": 7.84057092666626,
            "end_logit": 0.515549898147583
        },
        {
            "text": "used to minimize the risk of infection transmission",
            "probability": 0.00023946281489267785,
            "start_logit": 2.363966941833496,
            "end_logit": 5.73684549331665
        },
        {
            "text": "Gamma sterilization is usually used to minimize the risk of infection transmission",
            "probability": 0.00018875371121544813,
            "start_logit": 2.126011848449707,
            "end_logit": 5.73684549331665
        },
        {
            "text": "bone allografts.",
            "probability": 0.00013207040772943154,
            "start_logit": 2.6141655445098877,
            "end_logit": 4.8915839195251465
        },
        {
            "text": "infection transmission through bone allografts",
            "probability": 0.00010959743815577413,
            "start_logit": -0.32940852642059326,
            "end_logit": 7.648636817932129
        },
        {
            "text": "used to minimize the risk of infection transmission through bone allografts.",
            "probability": 0.00010283611140506844,
            "start_logit": 2.363966941833496,
            "end_logit": 4.8915839195251465
        },
        {
            "text": "",
            "probability": 1.586686347159124e-07,
            "start_logit": 0.7215271592140198,
            "end_logit": 0.05994982272386551
        }
    ],
    "5e48f90bf8b2df0d49000006_003": [
        {
            "text": "to provide safety against disease transmission",
            "probability": 0.28319498161928125,
            "start_logit": 4.938826084136963,
            "end_logit": 7.3824920654296875
        },
        {
            "text": "provide safety against disease transmission",
            "probability": 0.21155618034936896,
            "start_logit": 4.647181034088135,
            "end_logit": 7.3824920654296875
        },
        {
            "text": "safety against disease transmission",
            "probability": 0.19678241077801717,
            "start_logit": 4.574789047241211,
            "end_logit": 7.3824920654296875
        },
        {
            "text": "as a gold standard method to provide safety against disease transmission",
            "probability": 0.07857142019813342,
            "start_logit": 3.65669846534729,
            "end_logit": 7.3824920654296875
        },
        {
            "text": "a gold standard method to provide safety against disease transmission",
            "probability": 0.06395638012368458,
            "start_logit": 3.4508917331695557,
            "end_logit": 7.3824920654296875
        },
        {
            "text": "gold standard method to provide safety against disease transmission",
            "probability": 0.06052647195324413,
            "start_logit": 3.3957712650299072,
            "end_logit": 7.3824920654296875
        },
        {
            "text": "used as a gold standard method to provide safety against disease transmission",
            "probability": 0.02128397884005773,
            "start_logit": 2.350645065307617,
            "end_logit": 7.3824920654296875
        },
        {
            "text": "disease transmission",
            "probability": 0.01716204596649071,
            "start_logit": 2.1353907585144043,
            "end_logit": 7.3824920654296875
        },
        {
            "text": "to provide safety against disease transmission.",
            "probability": 0.014944283440937421,
            "start_logit": 4.938826084136963,
            "end_logit": 4.440685272216797
        },
        {
            "text": "provide safety against disease transmission.",
            "probability": 0.011163882582754747,
            "start_logit": 4.647181034088135,
            "end_logit": 4.440685272216797
        },
        {
            "text": "safety against disease transmission.",
            "probability": 0.010384266366736514,
            "start_logit": 4.574789047241211,
            "end_logit": 4.440685272216797
        },
        {
            "text": "Gamma sterilization of bone allografts is used as a gold standard method to provide safety against disease transmission",
            "probability": 0.008863315980944995,
            "start_logit": 1.4746114015579224,
            "end_logit": 7.3824920654296875
        },
        {
            "text": "as a gold standard method to provide safety against disease transmission.",
            "probability": 0.0041462372217331575,
            "start_logit": 3.65669846534729,
            "end_logit": 4.440685272216797
        },
        {
            "text": "a gold standard method to provide safety against disease transmission.",
            "probability": 0.0033749972084943353,
            "start_logit": 3.4508917331695557,
            "end_logit": 4.440685272216797
        },
        {
            "text": "gold standard method to provide safety against disease transmission.",
            "probability": 0.003193999933816783,
            "start_logit": 3.3957712650299072,
            "end_logit": 4.440685272216797
        },
        {
            "text": "bone allografts is used as a gold standard method to provide safety against disease transmission",
            "probability": 0.003101537817679365,
            "start_logit": 0.42458850145339966,
            "end_logit": 7.3824920654296875
        },
        {
            "text": "is used as a gold standard method to provide safety against disease transmission",
            "probability": 0.002857594726159424,
            "start_logit": 0.3426707088947296,
            "end_logit": 7.3824920654296875
        },
        {
            "text": "as a gold standard method",
            "probability": 0.0019086678370907975,
            "start_logit": 3.65669846534729,
            "end_logit": 3.6648895740509033
        },
        {
            "text": "a gold standard method",
            "probability": 0.0015536372565368233,
            "start_logit": 3.4508917331695557,
            "end_logit": 3.6648895740509033
        },
        {
            "text": "gold standard method",
            "probability": 0.0014703174515417472,
            "start_logit": 3.3957712650299072,
            "end_logit": 3.6648895740509033
        },
        {
            "text": "",
            "probability": 3.3923472959564813e-06,
            "start_logit": 0.08084037899971008,
            "end_logit": 0.9081089496612549
        }
    ],
    "5e48f90bf8b2df0d49000006_004": [
        {
            "text": "",
            "probability": 0.7633972047175214,
            "start_logit": -1.303321123123169,
            "end_logit": -0.7106204032897949
        },
        {
            "text": "the preferred sterilization",
            "probability": 0.04151506671257716,
            "start_logit": -3.0347511768341064,
            "end_logit": -1.890912413597107
        },
        {
            "text": "the preferred sterilization method of choice for this device",
            "probability": 0.02896693785523821,
            "start_logit": -3.0347511768341064,
            "end_logit": -2.2508137226104736
        },
        {
            "text": "sterilization",
            "probability": 0.02826295278029164,
            "start_logit": -3.4192557334899902,
            "end_logit": -1.890912413597107
        },
        {
            "text": "gamma sterilization was the preferred sterilization",
            "probability": 0.027390232272038646,
            "start_logit": -3.4506211280822754,
            "end_logit": -1.890912413597107
        },
        {
            "text": "sterilization method of choice for this device",
            "probability": 0.019720339183369642,
            "start_logit": -3.4192557334899902,
            "end_logit": -2.2508137226104736
        },
        {
            "text": "gamma sterilization was the preferred sterilization method of choice for this device",
            "probability": 0.01911140265190316,
            "start_logit": -3.4506211280822754,
            "end_logit": -2.2508137226104736
        },
        {
            "text": "the preferred sterilization method of choice",
            "probability": 0.01353781428460168,
            "start_logit": -3.0347511768341064,
            "end_logit": -3.011482000350952
        },
        {
            "text": "sterilization method of choice",
            "probability": 0.009216379405651757,
            "start_logit": -3.4192557334899902,
            "end_logit": -3.011482000350952
        },
        {
            "text": "gamma sterilization was the preferred sterilization method of choice",
            "probability": 0.00893179048171025,
            "start_logit": -3.4506211280822754,
            "end_logit": -3.011482000350952
        },
        {
            "text": "preferred sterilization",
            "probability": 0.008021315020205392,
            "start_logit": -4.678705215454102,
            "end_logit": -1.890912413597107
        },
        {
            "text": "preferred sterilization method of choice for this device",
            "probability": 0.005596833923361759,
            "start_logit": -4.678705215454102,
            "end_logit": -2.2508137226104736
        },
        {
            "text": "the preferred sterilization method",
            "probability": 0.00518852658771054,
            "start_logit": -3.0347511768341064,
            "end_logit": -3.9705190658569336
        },
        {
            "text": "method of choice for this device",
            "probability": 0.0048114517859943464,
            "start_logit": -4.829907417297363,
            "end_logit": -2.2508137226104736
        },
        {
            "text": "sterilization method",
            "probability": 0.0035322858316237417,
            "start_logit": -3.4192557334899902,
            "end_logit": -3.9705190658569336
        },
        {
            "text": "gamma sterilization was the preferred sterilization method",
            "probability": 0.0034232137785288803,
            "start_logit": -3.4506211280822754,
            "end_logit": -3.9705190658569336
        },
        {
            "text": "device",
            "probability": 0.0026462821562458867,
            "start_logit": -5.427750587463379,
            "end_logit": -2.2508137226104736
        },
        {
            "text": "preferred sterilization method of choice",
            "probability": 0.0026157027233905047,
            "start_logit": -4.678705215454102,
            "end_logit": -3.011482000350952
        },
        {
            "text": "method of choice",
            "probability": 0.0022486512396866147,
            "start_logit": -4.829907417297363,
            "end_logit": -3.011482000350952
        },
        {
            "text": "the preferred sterilization method of choice for this device.",
            "probability": 0.0018656166083488507,
            "start_logit": -3.0347511768341064,
            "end_logit": -4.993377208709717
        }
    ],
    "5e2f93bbfbd6abf43b00002e_001": [
        {
            "text": "",
            "probability": 0.9078898541660856,
            "start_logit": 4.366187572479248,
            "end_logit": 3.787367343902588
        },
        {
            "text": "shock, acute abdominal pain, and pulsatile abdominal mass",
            "probability": 0.03947894898250966,
            "start_logit": 3.044316530227661,
            "end_logit": 1.9738829135894775
        },
        {
            "text": "Shock, acute abdominal pain, and abdominal swelling",
            "probability": 0.03892593905692905,
            "start_logit": 2.293137788772583,
            "end_logit": 2.7109549045562744
        },
        {
            "text": "shock",
            "probability": 0.007891340340857405,
            "start_logit": 3.044316530227661,
            "end_logit": 0.36388131976127625
        },
        {
            "text": "shock, acute abdominal pain",
            "probability": 0.0012721371355934514,
            "start_logit": 3.044316530227661,
            "end_logit": -1.461186408996582
        },
        {
            "text": "Shock, acute abdominal pain, and abdominal swelling were found in five of 19 (26%) patients. Shock and acute abdominal pain or abdominal swelling",
            "probability": 0.0008418932603684135,
            "start_logit": 2.293137788772583,
            "end_logit": -1.1228079795837402
        },
        {
            "text": "shock, acute abdominal pain, and pulsatile abdominal mass was made in only one of 19 (5.3%) patients. Shock",
            "probability": 0.0006878303555305636,
            "start_logit": 3.044316530227661,
            "end_logit": -2.0760977268218994
        },
        {
            "text": "Shock, acute abdominal pain, and abdominal swelling were found in five of 19 (26%) patients. Shock and acute abdominal pain",
            "probability": 0.000506016848427753,
            "start_logit": 2.293137788772583,
            "end_logit": -1.6318912506103516
        },
        {
            "text": "acute abdominal pain, and pulsatile abdominal mass",
            "probability": 0.00041051457192353816,
            "start_logit": -1.5217949151992798,
            "end_logit": 1.9738829135894775
        },
        {
            "text": "Shock, acute abdominal pain, and abdominal swelling were found in five of 19 (26%) patients",
            "probability": 0.0003788110090276067,
            "start_logit": 2.293137788772583,
            "end_logit": -1.9214237928390503
        },
        {
            "text": "Shock",
            "probability": 0.0003245252969504305,
            "start_logit": 2.293137788772583,
            "end_logit": -2.0760977268218994
        },
        {
            "text": "Shock, acute abdominal pain",
            "probability": 0.0002826632302752917,
            "start_logit": 2.293137788772583,
            "end_logit": -2.214205026626587
        },
        {
            "text": "Shock, acute abdominal pain, and abdominal swelling were found in five of 19 (26%) patients.",
            "probability": 0.0002452007875990821,
            "start_logit": 2.293137788772583,
            "end_logit": -2.356383800506592
        },
        {
            "text": "Shock, acute abdominal pain, and abdominal swelling were found in five of 19 (26%) patients. Shock",
            "probability": 0.00018813365695703562,
            "start_logit": 2.293137788772583,
            "end_logit": -2.6213085651397705
        },
        {
            "text": "abdominal swelling",
            "probability": 0.00014728464930686744,
            "start_logit": -3.2839112281799316,
            "end_logit": 2.7109549045562744
        },
        {
            "text": "acute abdominal pain, and abdominal swelling",
            "probability": 0.00014650952219202155,
            "start_logit": -3.2891879081726074,
            "end_logit": 2.7109549045562744
        },
        {
            "text": "classic triad of shock, acute abdominal pain, and pulsatile abdominal mass",
            "probability": 0.00014198270308314156,
            "start_logit": -2.583501100540161,
            "end_logit": 1.9738829135894775
        },
        {
            "text": "shock, acute abdominal pain, and pulsatile abdominal mass was made in only one of 19 (5.3%) patients",
            "probability": 0.00010334942469063872,
            "start_logit": 3.044316530227661,
            "end_logit": -3.971524238586426
        },
        {
            "text": "shock, acute abdominal pain, and pulsatile abdominal mass was made in only one of 19 (5.3%) patients.",
            "probability": 7.882015513451325e-05,
            "start_logit": 3.044316530227661,
            "end_logit": -4.242471218109131
        },
        {
            "text": "shock, acute abdominal pain, and pulsatile",
            "probability": 5.8244846557660025e-05,
            "start_logit": 3.044316530227661,
            "end_logit": -4.544984340667725
        }
    ],
    "5e2f93bbfbd6abf43b00002e_002": [
        {
            "text": "hypotension, back pain and a pulsatile abdominal mass",
            "probability": 0.9430591947830396,
            "start_logit": 8.023012161254883,
            "end_logit": 7.404171466827393
        },
        {
            "text": "hypotension, back pain and a pulsatile abdominal mass.",
            "probability": 0.04455441710439521,
            "start_logit": 8.023012161254883,
            "end_logit": 4.3517537117004395
        },
        {
            "text": "hypotension, back pain",
            "probability": 0.005220913479915126,
            "start_logit": 8.023012161254883,
            "end_logit": 2.207714796066284
        },
        {
            "text": "the classic triad of hypotension, back pain and a pulsatile abdominal mass",
            "probability": 0.003573690312583343,
            "start_logit": 2.447481870651245,
            "end_logit": 7.404171466827393
        },
        {
            "text": "triad of hypotension, back pain and a pulsatile abdominal mass",
            "probability": 0.001076714358053032,
            "start_logit": 1.2477972507476807,
            "end_logit": 7.404171466827393
        },
        {
            "text": "pulsatile abdominal mass",
            "probability": 0.0010526524635629275,
            "start_logit": 1.2251962423324585,
            "end_logit": 7.404171466827393
        },
        {
            "text": "hypotension",
            "probability": 0.000612482892133463,
            "start_logit": 8.023012161254883,
            "end_logit": 0.06480814516544342
        },
        {
            "text": "classic triad of hypotension, back pain and a pulsatile abdominal mass",
            "probability": 0.00018673473075602655,
            "start_logit": -0.5041831135749817,
            "end_logit": 7.404171466827393
        },
        {
            "text": "the classic triad of hypotension, back pain and a pulsatile abdominal mass.",
            "probability": 0.0001688374278832049,
            "start_logit": 2.447481870651245,
            "end_logit": 4.3517537117004395
        },
        {
            "text": "a pulsatile abdominal mass",
            "probability": 0.00012356206844230222,
            "start_logit": -0.9171285629272461,
            "end_logit": 7.404171466827393
        },
        {
            "text": "of hypotension, back pain and a pulsatile abdominal mass",
            "probability": 6.655053373312658e-05,
            "start_logit": -1.5359106063842773,
            "end_logit": 7.404171466827393
        },
        {
            "text": "triad of hypotension, back pain and a pulsatile abdominal mass.",
            "probability": 5.086889654050025e-05,
            "start_logit": 1.2477972507476807,
            "end_logit": 4.3517537117004395
        },
        {
            "text": "pulsatile abdominal mass.",
            "probability": 4.973210291252368e-05,
            "start_logit": 1.2251962423324585,
            "end_logit": 4.3517537117004395
        },
        {
            "text": "abdominal mass",
            "probability": 3.951691157586211e-05,
            "start_logit": -2.057143449783325,
            "end_logit": 7.404171466827393
        },
        {
            "text": "back pain and a pulsatile abdominal mass",
            "probability": 3.870015985896167e-05,
            "start_logit": -2.078028440475464,
            "end_logit": 7.404171466827393
        },
        {
            "text": "hypotension, back pain and a pulsatile",
            "probability": 3.0330048928754463e-05,
            "start_logit": 8.023012161254883,
            "end_logit": -2.9405739307403564
        },
        {
            "text": "h",
            "probability": 2.876309624954154e-05,
            "start_logit": 8.023012161254883,
            "end_logit": -2.993619680404663
        },
        {
            "text": "hypotension, back pain and a pulsatile abdominal",
            "probability": 2.635703407955326e-05,
            "start_logit": 8.023012161254883,
            "end_logit": -3.08097767829895
        },
        {
            "text": "the classic triad of hypotension, back pain",
            "probability": 1.9784471673913237e-05,
            "start_logit": 2.447481870651245,
            "end_logit": 2.207714796066284
        },
        {
            "text": "mass",
            "probability": 1.8186548127517443e-05,
            "start_logit": -2.8331899642944336,
            "end_logit": 7.404171466827393
        },
        {
            "text": "",
            "probability": 2.0105755557884736e-06,
            "start_logit": 1.9380604028701782,
            "end_logit": 0.4306599199771881
        }
    ],
    "5e2f93bbfbd6abf43b00002e_003": [
        {
            "text": "abdominal pain, pulsatile abdominal mass and shock",
            "probability": 0.9464797424720343,
            "start_logit": 7.2503204345703125,
            "end_logit": 5.1898722648620605
        },
        {
            "text": "abdominal pain, pulsatile abdominal mass and shock.",
            "probability": 0.027280534490512258,
            "start_logit": 7.2503204345703125,
            "end_logit": 1.6432961225509644
        },
        {
            "text": "abdominal pain",
            "probability": 0.017787055944477166,
            "start_logit": 7.2503204345703125,
            "end_logit": 1.215593695640564
        },
        {
            "text": "abdominal pain, pulsatile abdominal mass",
            "probability": 0.005057759231476479,
            "start_logit": 7.2503204345703125,
            "end_logit": -0.04195375740528107
        },
        {
            "text": "abdominal pain, pulsatile abdominal mass and shock. Most symptoms are misleading and will only present as vague abdominal pain",
            "probability": 0.002252655517157661,
            "start_logit": 7.2503204345703125,
            "end_logit": -0.8507675528526306
        },
        {
            "text": "",
            "probability": 0.00017533177619412786,
            "start_logit": 3.1562044620513916,
            "end_logit": 0.6901634335517883
        },
        {
            "text": "abdominal pain, pulsatile abdominal mass and shock. Most symptoms are misleading",
            "probability": 0.00017255091437948776,
            "start_logit": 7.2503204345703125,
            "end_logit": -3.419940233230591
        },
        {
            "text": "shock",
            "probability": 0.0001583606853660069,
            "start_logit": -1.4453091621398926,
            "end_logit": 5.1898722648620605
        },
        {
            "text": "abdominal pain, pulsatile abdominal mass and shock. Most symptoms are misleading and will only present as vague abdominal pain.",
            "probability": 0.0001533816936890642,
            "start_logit": 7.2503204345703125,
            "end_logit": -3.537703037261963
        },
        {
            "text": "abdominal",
            "probability": 0.00011306273361461018,
            "start_logit": 7.2503204345703125,
            "end_logit": -3.8426897525787354
        },
        {
            "text": "abdominal pain,",
            "probability": 0.00010724264887259032,
            "start_logit": 7.2503204345703125,
            "end_logit": -3.895538568496704
        },
        {
            "text": "pain, pulsatile abdominal mass and shock",
            "probability": 7.283710698022698e-05,
            "start_logit": -2.221958875656128,
            "end_logit": 5.1898722648620605
        },
        {
            "text": "pulsatile abdominal mass and shock",
            "probability": 6.763665542988033e-05,
            "start_logit": -2.296034336090088,
            "end_logit": 5.1898722648620605
        },
        {
            "text": "the classic triad of symptoms such as abdominal pain, pulsatile abdominal mass and shock",
            "probability": 4.209979244819044e-05,
            "start_logit": -2.7701416015625,
            "end_logit": 5.1898722648620605
        },
        {
            "text": "classic triad of symptoms such as abdominal pain, pulsatile abdominal mass and shock",
            "probability": 2.987454069567938e-05,
            "start_logit": -3.11317777633667,
            "end_logit": 5.1898722648620605
        },
        {
            "text": "abdominal pain, pulsatile",
            "probability": 1.9378346347971065e-05,
            "start_logit": 7.2503204345703125,
            "end_logit": -5.606476306915283
        },
        {
            "text": "abdominal pain, pulsatile abdominal",
            "probability": 1.4967907704044663e-05,
            "start_logit": 7.2503204345703125,
            "end_logit": -5.864724159240723
        },
        {
            "text": "symptoms such as abdominal pain, pulsatile abdominal mass and shock",
            "probability": 5.760951037478152e-06,
            "start_logit": -4.759081840515137,
            "end_logit": 5.1898722648620605
        },
        {
            "text": "mass and shock",
            "probability": 5.202136639868543e-06,
            "start_logit": -4.861114978790283,
            "end_logit": 5.1898722648620605
        },
        {
            "text": "shock.",
            "probability": 4.5644549430979075e-06,
            "start_logit": -1.4453091621398926,
            "end_logit": 1.6432961225509644
        }
    ],
    "5e2f93bbfbd6abf43b00002e_004": [
        {
            "text": "",
            "probability": 0.9968989682318897,
            "start_logit": 7.30983304977417,
            "end_logit": 6.470428466796875
        },
        {
            "text": "continuous abdominal bruit, abdominal and left flank pain",
            "probability": 0.0028535698925777186,
            "start_logit": 4.563045978546143,
            "end_logit": 3.3611369132995605
        },
        {
            "text": "continuous abdominal bruit, abdominal and left flank pain with an associated pulsatile mass",
            "probability": 0.00011242659787234554,
            "start_logit": 4.563045978546143,
            "end_logit": 0.12711137533187866
        },
        {
            "text": "continuous abdominal bruit",
            "probability": 5.7364765132747235e-05,
            "start_logit": 4.563045978546143,
            "end_logit": -0.5457589030265808
        },
        {
            "text": "abdominal bruit, abdominal and left flank pain",
            "probability": 4.8930774555027905e-05,
            "start_logit": 0.49712643027305603,
            "end_logit": 3.3611369132995605
        },
        {
            "text": "continuous abdominal bruit, abdominal and left flank pain with an associated pulsatile mass (Mansour Triad",
            "probability": 4.316264201115013e-06,
            "start_logit": 4.563045978546143,
            "end_logit": -3.132798910140991
        },
        {
            "text": "continuous abdominal bruit, abdominal and left flank pain with an associated pulsatile mass (Mansour Triad)",
            "probability": 4.144328801518243e-06,
            "start_logit": 4.563045978546143,
            "end_logit": -3.173448324203491
        },
        {
            "text": "continuous abdominal bruit, abdominal and left flank",
            "probability": 3.3912639122843168e-06,
            "start_logit": 4.563045978546143,
            "end_logit": -3.3739864826202393
        },
        {
            "text": "continuous abdominal bruit,",
            "probability": 2.5997321232425085e-06,
            "start_logit": 4.563045978546143,
            "end_logit": -3.6397807598114014
        },
        {
            "text": "abdominal and left flank pain",
            "probability": 2.0629065274174596e-06,
            "start_logit": -2.6691641807556152,
            "end_logit": 3.3611369132995605
        },
        {
            "text": "unique syndrome: continuous abdominal bruit, abdominal and left flank pain",
            "probability": 2.0077858085577723e-06,
            "start_logit": -2.6962475776672363,
            "end_logit": 3.3611369132995605
        },
        {
            "text": "pulsatile mass",
            "probability": 1.967402369646061e-06,
            "start_logit": 0.517459511756897,
            "end_logit": 0.12711137533187866
        },
        {
            "text": "abdominal bruit, abdominal and left flank pain with an associated pulsatile mass",
            "probability": 1.927802970163519e-06,
            "start_logit": 0.49712643027305603,
            "end_logit": 0.12711137533187866
        },
        {
            "text": "continuous abdominal bruit, abdominal and left flank pain with an associated pulsatile mass (Mansour Triad).",
            "probability": 1.8931671014362638e-06,
            "start_logit": 4.563045978546143,
            "end_logit": -3.9569380283355713
        },
        {
            "text": "continuous",
            "probability": 1.1060639719430485e-06,
            "start_logit": 4.563045978546143,
            "end_logit": -4.494381427764893
        },
        {
            "text": "abdominal bruit",
            "probability": 9.836459227487218e-07,
            "start_logit": 0.49712643027305603,
            "end_logit": -0.5457589030265808
        },
        {
            "text": "pain",
            "probability": 8.663278105282835e-07,
            "start_logit": -3.5367720127105713,
            "end_logit": 3.3611369132995605
        },
        {
            "text": "left flank pain",
            "probability": 5.465887065026942e-07,
            "start_logit": -3.9973387718200684,
            "end_logit": 3.3611369132995605
        },
        {
            "text": "continuous abdominal bruit, abdominal and left flank pain with an associated pulsatile mass (Mansour",
            "probability": 4.858927540695649e-07,
            "start_logit": 4.563045978546143,
            "end_logit": -5.316956520080566
        },
        {
            "text": "continuous abdominal",
            "probability": 4.405649913207902e-07,
            "start_logit": 4.563045978546143,
            "end_logit": -5.414886474609375
        }
    ],
    "5e2f93bbfbd6abf43b00002e_005": [
        {
            "text": "pain, hypotension, and a pulsatile mass",
            "probability": 0.8859030660328581,
            "start_logit": 7.000871658325195,
            "end_logit": 5.014476776123047
        },
        {
            "text": "classical triad of pain, hypotension, and a pulsatile mass",
            "probability": 0.05121974357940395,
            "start_logit": 4.150389194488525,
            "end_logit": 5.014476776123047
        },
        {
            "text": "pain, hypotension, and a pulsatile mass.",
            "probability": 0.04557203444597916,
            "start_logit": 7.000871658325195,
            "end_logit": 2.047163486480713
        },
        {
            "text": "pain",
            "probability": 0.006381077654922421,
            "start_logit": 7.000871658325195,
            "end_logit": 0.08120623230934143
        },
        {
            "text": "classical triad of pain, hypotension, and a pulsatile mass.",
            "probability": 0.0026348118752624813,
            "start_logit": 4.150389194488525,
            "end_logit": 2.047163486480713
        },
        {
            "text": "",
            "probability": 0.002425738682725516,
            "start_logit": 3.7631635665893555,
            "end_logit": 2.3517134189605713
        },
        {
            "text": "triad of pain, hypotension, and a pulsatile mass",
            "probability": 0.002169815119427579,
            "start_logit": 0.9889060854911804,
            "end_logit": 5.014476776123047
        },
        {
            "text": "the classical triad of pain, hypotension, and a pulsatile mass",
            "probability": 0.0018045310884755102,
            "start_logit": 0.804564893245697,
            "end_logit": 5.014476776123047
        },
        {
            "text": "pain, hypotension",
            "probability": 0.000787153186745104,
            "start_logit": 7.000871658325195,
            "end_logit": -2.011463165283203
        },
        {
            "text": "classical triad of pain",
            "probability": 0.00036893106455652367,
            "start_logit": 4.150389194488525,
            "end_logit": 0.08120623230934143
        },
        {
            "text": "pulsatile mass",
            "probability": 0.00020060535394571634,
            "start_logit": -1.3921515941619873,
            "end_logit": 5.014476776123047
        },
        {
            "text": "triad of pain, hypotension, and a pulsatile mass.",
            "probability": 0.00011161818166717177,
            "start_logit": 0.9889060854911804,
            "end_logit": 2.047163486480713
        },
        {
            "text": "the classical triad of pain, hypotension, and a pulsatile mass.",
            "probability": 9.282748426541294e-05,
            "start_logit": 0.804564893245697,
            "end_logit": 2.047163486480713
        },
        {
            "text": "pain, hypotension,",
            "probability": 7.530566124918495e-05,
            "start_logit": 7.000871658325195,
            "end_logit": -4.358330726623535
        },
        {
            "text": "pain,",
            "probability": 5.232146449037059e-05,
            "start_logit": 7.000871658325195,
            "end_logit": -4.722479343414307
        },
        {
            "text": "classical triad of pain, hypotension",
            "probability": 4.5510379102017366e-05,
            "start_logit": 4.150389194488525,
            "end_logit": -2.011463165283203
        },
        {
            "text": "classical",
            "probability": 4.4827586521721974e-05,
            "start_logit": 4.150389194488525,
            "end_logit": -2.0265798568725586
        },
        {
            "text": "hypotension, and a pulsatile mass",
            "probability": 4.088472325869338e-05,
            "start_logit": -2.9827346801757812,
            "end_logit": 5.014476776123047
        },
        {
            "text": "a pulsatile mass",
            "probability": 3.86637380039026e-05,
            "start_logit": -3.0385890007019043,
            "end_logit": 5.014476776123047
        },
        {
            "text": "pain, hypotension, and a",
            "probability": 3.053269713960347e-05,
            "start_logit": 7.000871658325195,
            "end_logit": -5.261087894439697
        }
    ],
    "5ca61b14ecadf2e73f00004f_001": [
        {
            "text": "",
            "probability": 0.9964321667306977,
            "start_logit": 3.4406187534332275,
            "end_logit": 3.969557523727417
        },
        {
            "text": "We showed that CTCF acts upstream of the \"pioneer\" factor FOXA1 in determining the genomic response to estrogen",
            "probability": 0.0005125974467716408,
            "start_logit": -0.5532692074775696,
            "end_logit": 0.390999972820282
        },
        {
            "text": "We showed that CTCF acts upstream",
            "probability": 0.00039950077889055606,
            "start_logit": -0.5532692074775696,
            "end_logit": 0.1417248547077179
        },
        {
            "text": "CTCF acts upstream of the \"pioneer\" factor FOXA1 in determining the genomic response to estrogen",
            "probability": 0.00037467137858899417,
            "start_logit": -0.8667107224464417,
            "end_logit": 0.390999972820282
        },
        {
            "text": "CTCF acts upstream",
            "probability": 0.0002920059561689231,
            "start_logit": -0.8667107224464417,
            "end_logit": 0.1417248547077179
        },
        {
            "text": "We showed that CTCF acts upstream of the \"pioneer\" factor FOXA1 in determining the genomic response to estrogen.",
            "probability": 0.00021721226973255096,
            "start_logit": -0.5532692074775696,
            "end_logit": -0.4676157832145691
        },
        {
            "text": "acts upstream of the \"pioneer\" factor FOXA1 in determining the genomic response to estrogen",
            "probability": 0.00020857402817260834,
            "start_logit": -1.4524660110473633,
            "end_logit": 0.390999972820282
        },
        {
            "text": "determining the genomic response to estrogen",
            "probability": 0.00018601551868982087,
            "start_logit": -1.5669299364089966,
            "end_logit": 0.390999972820282
        },
        {
            "text": "acts upstream",
            "probability": 0.00016255540724224255,
            "start_logit": -1.4524660110473633,
            "end_logit": 0.1417248547077179
        },
        {
            "text": "CTCF acts upstream of the \"pioneer\" factor FOXA1 in determining the genomic response to estrogen.",
            "probability": 0.0001587663400582545,
            "start_logit": -0.8667107224464417,
            "end_logit": -0.4676157832145691
        },
        {
            "text": "FOXA1 in determining the genomic response to estrogen",
            "probability": 0.00015741940522642629,
            "start_logit": -1.7338464260101318,
            "end_logit": 0.390999972820282
        },
        {
            "text": "We showed that CTCF acts upstream of the \"pioneer\" factor FOXA1 in determining the genomic response",
            "probability": 0.00015052578122863418,
            "start_logit": -0.5532692074775696,
            "end_logit": -0.8343564867973328
        },
        {
            "text": "We showed that CTCF acts upstream of the \"pioneer\" factor FOXA1",
            "probability": 0.0001272490882368146,
            "start_logit": -0.5532692074775696,
            "end_logit": -1.0023443698883057
        },
        {
            "text": "CTCF acts upstream of the \"pioneer\" factor FOXA1 in determining the genomic response",
            "probability": 0.00011002337666976825,
            "start_logit": -0.8667107224464417,
            "end_logit": -0.8343564867973328
        },
        {
            "text": "We showed that CTCF acts upstream of the \"pioneer\" factor",
            "probability": 9.46281985132071e-05,
            "start_logit": -0.5532692074775696,
            "end_logit": -1.2985353469848633
        },
        {
            "text": "CTCF acts upstream of the \"pioneer\" factor FOXA1",
            "probability": 9.300981035732614e-05,
            "start_logit": -0.8667107224464417,
            "end_logit": -1.0023443698883057
        },
        {
            "text": "acts upstream of the \"pioneer\" factor FOXA1 in determining the genomic response to estrogen.",
            "probability": 8.838287890812755e-05,
            "start_logit": -1.4524660110473633,
            "end_logit": -0.4676157832145691
        },
        {
            "text": "We showed that CTCF",
            "probability": 8.670553861450356e-05,
            "start_logit": -0.5532692074775696,
            "end_logit": -1.3859730958938599
        },
        {
            "text": "determining the genomic response to estrogen.",
            "probability": 7.882375004902021e-05,
            "start_logit": -1.5669299364089966,
            "end_logit": -0.4676157832145691
        },
        {
            "text": "CTCF acts upstream of the \"pioneer\" factor",
            "probability": 6.916631718247922e-05,
            "start_logit": -0.8667107224464417,
            "end_logit": -1.2985353469848633
        }
    ],
    "5ca61b14ecadf2e73f00004f_002": [
        {
            "text": "",
            "probability": 0.4456187181807432,
            "start_logit": 0.29949167370796204,
            "end_logit": 0.7383573055267334
        },
        {
            "text": "FOXA1 is a key determinant that can influence differential interactions between ER and chromatin",
            "probability": 0.1966187067771278,
            "start_logit": -0.6063841581344604,
            "end_logit": 0.8260357975959778
        },
        {
            "text": "influence differential interactions between ER and chromatin",
            "probability": 0.07728534876751776,
            "start_logit": -1.5401461124420166,
            "end_logit": 0.8260357975959778
        },
        {
            "text": "FOXA1 is a key determinant that can influence differential interactions between ER and chromatin.",
            "probability": 0.05882824973550992,
            "start_logit": -0.6063841581344604,
            "end_logit": -0.38060837984085083
        },
        {
            "text": "we show that FOXA1 is a key determinant that can influence differential interactions between ER and chromatin",
            "probability": 0.03810055204111453,
            "start_logit": -2.2474217414855957,
            "end_logit": 0.8260357975959778
        },
        {
            "text": "key determinant that can influence differential interactions between ER and chromatin",
            "probability": 0.03302600112795509,
            "start_logit": -2.390355348587036,
            "end_logit": 0.8260357975959778
        },
        {
            "text": "can influence differential interactions between ER and chromatin",
            "probability": 0.03010014030158022,
            "start_logit": -2.4831206798553467,
            "end_logit": 0.8260357975959778
        },
        {
            "text": "influence differential interactions between ER and chromatin.",
            "probability": 0.0231237498848223,
            "start_logit": -1.5401461124420166,
            "end_logit": -0.38060837984085083
        },
        {
            "text": "FOXA1 is a key determinant",
            "probability": 0.021156109351142264,
            "start_logit": -0.6063841581344604,
            "end_logit": -1.4033018350601196
        },
        {
            "text": "we show that FOXA1 is a key determinant that can influence differential interactions between ER and chromatin.",
            "probability": 0.011399672123142118,
            "start_logit": -2.2474217414855957,
            "end_logit": -0.38060837984085083
        },
        {
            "text": "FOXA1",
            "probability": 0.011266283724120132,
            "start_logit": -0.6063841581344604,
            "end_logit": -2.0334160327911377
        },
        {
            "text": "a key determinant that can influence differential interactions between ER and chromatin",
            "probability": 0.010874804988523029,
            "start_logit": -3.501201868057251,
            "end_logit": 0.8260357975959778
        },
        {
            "text": "key determinant that can influence differential interactions between ER and chromatin.",
            "probability": 0.009881368227708142,
            "start_logit": -2.390355348587036,
            "end_logit": -0.38060837984085083
        },
        {
            "text": "can influence differential interactions between ER and chromatin.",
            "probability": 0.009005951670419765,
            "start_logit": -2.4831206798553467,
            "end_logit": -0.38060837984085083
        },
        {
            "text": "Almost all ER-chromatin interactions and gene expression changes depended on the presence of FOXA1 and FOXA1 influenced genome-wide chromatin accessibility",
            "probability": 0.006541775426748538,
            "start_logit": -1.6912860870361328,
            "end_logit": -1.4921200275421143
        },
        {
            "text": "we show that FOXA1 is a key determinant",
            "probability": 0.004099607095037982,
            "start_logit": -2.2474217414855957,
            "end_logit": -1.4033018350601196
        },
        {
            "text": "key determinant",
            "probability": 0.0035535870556099294,
            "start_logit": -2.390355348587036,
            "end_logit": -1.4033018350601196
        },
        {
            "text": "influence differential interactions between ER and chromatin. Almost all ER-chromatin interactions and gene expression changes",
            "probability": 0.003317988298454211,
            "start_logit": -1.5401461124420166,
            "end_logit": -2.3221099376678467
        },
        {
            "text": "a key determinant that can influence differential interactions between ER and chromatin.",
            "probability": 0.0032537379284819,
            "start_logit": -3.501201868057251,
            "end_logit": -0.38060837984085083
        },
        {
            "text": "expression of the Forkhead protein FOXA1 (also called HNF3\u03b1). Here we show that FOXA1 is a key determinant",
            "probability": 0.0029476472942410203,
            "start_logit": -2.577305555343628,
            "end_logit": -1.4033018350601196
        }
    ],
    "5ca61b14ecadf2e73f00004f_004": [
        {
            "text": "",
            "probability": 0.4456187181807432,
            "start_logit": 0.29949167370796204,
            "end_logit": 0.7383573055267334
        },
        {
            "text": "FOXA1 is a key determinant that can influence differential interactions between ER and chromatin",
            "probability": 0.1966187067771278,
            "start_logit": -0.6063841581344604,
            "end_logit": 0.8260357975959778
        },
        {
            "text": "influence differential interactions between ER and chromatin",
            "probability": 0.07728534876751776,
            "start_logit": -1.5401461124420166,
            "end_logit": 0.8260357975959778
        },
        {
            "text": "FOXA1 is a key determinant that can influence differential interactions between ER and chromatin.",
            "probability": 0.05882824973550992,
            "start_logit": -0.6063841581344604,
            "end_logit": -0.38060837984085083
        },
        {
            "text": "we show that FOXA1 is a key determinant that can influence differential interactions between ER and chromatin",
            "probability": 0.03810055204111453,
            "start_logit": -2.2474217414855957,
            "end_logit": 0.8260357975959778
        },
        {
            "text": "key determinant that can influence differential interactions between ER and chromatin",
            "probability": 0.03302600112795509,
            "start_logit": -2.390355348587036,
            "end_logit": 0.8260357975959778
        },
        {
            "text": "can influence differential interactions between ER and chromatin",
            "probability": 0.03010014030158022,
            "start_logit": -2.4831206798553467,
            "end_logit": 0.8260357975959778
        },
        {
            "text": "influence differential interactions between ER and chromatin.",
            "probability": 0.0231237498848223,
            "start_logit": -1.5401461124420166,
            "end_logit": -0.38060837984085083
        },
        {
            "text": "FOXA1 is a key determinant",
            "probability": 0.021156109351142264,
            "start_logit": -0.6063841581344604,
            "end_logit": -1.4033018350601196
        },
        {
            "text": "we show that FOXA1 is a key determinant that can influence differential interactions between ER and chromatin.",
            "probability": 0.011399672123142118,
            "start_logit": -2.2474217414855957,
            "end_logit": -0.38060837984085083
        },
        {
            "text": "FOXA1",
            "probability": 0.011266283724120132,
            "start_logit": -0.6063841581344604,
            "end_logit": -2.0334160327911377
        },
        {
            "text": "a key determinant that can influence differential interactions between ER and chromatin",
            "probability": 0.010874804988523029,
            "start_logit": -3.501201868057251,
            "end_logit": 0.8260357975959778
        },
        {
            "text": "key determinant that can influence differential interactions between ER and chromatin.",
            "probability": 0.009881368227708142,
            "start_logit": -2.390355348587036,
            "end_logit": -0.38060837984085083
        },
        {
            "text": "can influence differential interactions between ER and chromatin.",
            "probability": 0.009005951670419765,
            "start_logit": -2.4831206798553467,
            "end_logit": -0.38060837984085083
        },
        {
            "text": "Almost all ER-chromatin interactions and gene expression changes depended on the presence of FOXA1 and FOXA1 influenced genome-wide chromatin accessibility",
            "probability": 0.006541775426748538,
            "start_logit": -1.6912860870361328,
            "end_logit": -1.4921200275421143
        },
        {
            "text": "we show that FOXA1 is a key determinant",
            "probability": 0.004099607095037982,
            "start_logit": -2.2474217414855957,
            "end_logit": -1.4033018350601196
        },
        {
            "text": "key determinant",
            "probability": 0.0035535870556099294,
            "start_logit": -2.390355348587036,
            "end_logit": -1.4033018350601196
        },
        {
            "text": "influence differential interactions between ER and chromatin. Almost all ER-chromatin interactions and gene expression changes",
            "probability": 0.003317988298454211,
            "start_logit": -1.5401461124420166,
            "end_logit": -2.3221099376678467
        },
        {
            "text": "a key determinant that can influence differential interactions between ER and chromatin.",
            "probability": 0.0032537379284819,
            "start_logit": -3.501201868057251,
            "end_logit": -0.38060837984085083
        },
        {
            "text": "expression of the Forkhead protein FOXA1 (also called HNF3\u03b1). Here we show that FOXA1 is a key determinant",
            "probability": 0.0029476472942410203,
            "start_logit": -2.577305555343628,
            "end_logit": -1.4033018350601196
        }
    ],
    "5ca61b14ecadf2e73f00004f_006": [
        {
            "text": "knockdown of FoxA1 expression blocks the association of ER with chromatin and estrogen-induced gene expression",
            "probability": 0.4359136522155765,
            "start_logit": 4.8518548011779785,
            "end_logit": 3.943579912185669
        },
        {
            "text": "knockdown",
            "probability": 0.18647729606367447,
            "start_logit": 4.8518548011779785,
            "end_logit": 3.09444522857666
        },
        {
            "text": "knockdown of FoxA1 expression",
            "probability": 0.127368976426261,
            "start_logit": 4.8518548011779785,
            "end_logit": 2.713223934173584
        },
        {
            "text": "blocks the association of ER with chromatin and estrogen-induced gene expression",
            "probability": 0.07538142478457874,
            "start_logit": 3.0969715118408203,
            "end_logit": 3.943579912185669
        },
        {
            "text": "knockdown of FoxA1 expression blocks the association of ER with chromatin and estrogen-induced gene expression demonstrating the necessity of FoxA1",
            "probability": 0.04673512364744039,
            "start_logit": 4.8518548011779785,
            "end_logit": 1.7106317281723022
        },
        {
            "text": "knockdown of FoxA1 expression blocks the association of ER with chromatin and estrogen",
            "probability": 0.029018311363355056,
            "start_logit": 4.8518548011779785,
            "end_logit": 1.2340627908706665
        },
        {
            "text": "knockdown of FoxA1 expression blocks the association of ER",
            "probability": 0.021979216246613836,
            "start_logit": 4.8518548011779785,
            "end_logit": 0.956233024597168
        },
        {
            "text": "knockdown of FoxA1",
            "probability": 0.021303125257919223,
            "start_logit": 4.8518548011779785,
            "end_logit": 0.9249895215034485
        },
        {
            "text": "knockdown of FoxA1 expression blocks the association of ER with chromatin",
            "probability": 0.00829283767217061,
            "start_logit": 4.8518548011779785,
            "end_logit": -0.018472054973244667
        },
        {
            "text": "blocks the association of ER with chromatin and estrogen-induced gene expression demonstrating the necessity of FoxA1",
            "probability": 0.008081784523429591,
            "start_logit": 3.0969715118408203,
            "end_logit": 1.7106317281723022
        },
        {
            "text": "blocks the association of ER with chromatin and estrogen-induced gene expression demonstrating the necessity of FoxA1 in mediating an estrogen response",
            "probability": 0.007805992345171179,
            "start_logit": 3.0969715118408203,
            "end_logit": 1.6759107112884521
        },
        {
            "text": "knockdown of FoxA1 expression blocks",
            "probability": 0.007352759831174529,
            "start_logit": 4.8518548011779785,
            "end_logit": -0.13878853619098663
        },
        {
            "text": "knockdown of FoxA1 expression blocks the association of ER with chromatin and estrogen-induced gene expression demonstrating the necessity",
            "probability": 0.005123506120258301,
            "start_logit": 4.8518548011779785,
            "end_logit": -0.5000252723693848
        },
        {
            "text": "blocks the association of ER with chromatin and estrogen",
            "probability": 0.005018061820946272,
            "start_logit": 3.0969715118408203,
            "end_logit": 1.2340627908706665
        },
        {
            "text": "blocks the association of ER",
            "probability": 0.0038008092380156676,
            "start_logit": 3.0969715118408203,
            "end_logit": 0.956233024597168
        },
        {
            "text": "FoxA1 expression blocks the association of ER with chromatin and estrogen-induced gene expression",
            "probability": 0.0032691308473617466,
            "start_logit": -0.04106522351503372,
            "end_logit": 3.943579912185669
        },
        {
            "text": "knockdown of FoxA1 expression blocks the association",
            "probability": 0.002184900778417598,
            "start_logit": 4.8518548011779785,
            "end_logit": -1.352293848991394
        },
        {
            "text": "knockdown of FoxA1 expression blocks the association of ER with chromatin and estrogen-induced gene expression demonstrating",
            "probability": 0.002074497891909698,
            "start_logit": 4.8518548011779785,
            "end_logit": -1.4041451215744019
        },
        {
            "text": "blocks the association of ER with chromatin",
            "probability": 0.0014340590528839423,
            "start_logit": 3.0969715118408203,
            "end_logit": -0.018472054973244667
        },
        {
            "text": "knockdown of FoxA1 expression blocks the association of ER with chromatin and estrogen-induced",
            "probability": 0.001303540016546557,
            "start_logit": 4.8518548011779785,
            "end_logit": -1.8687806129455566
        },
        {
            "text": "",
            "probability": 8.099385629494724e-05,
            "start_logit": 0.5156408548355103,
            "end_logit": -0.3110322952270508
        }
    ],
    "5ca61b14ecadf2e73f00004f_008": [
        {
            "text": "",
            "probability": 0.9986188757697069,
            "start_logit": 4.467614650726318,
            "end_logit": 4.629447937011719
        },
        {
            "text": "FoxA1 appears to play a critical role in this reprogramming of ER binding.",
            "probability": 0.00036287391211223193,
            "start_logit": 1.086288571357727,
            "end_logit": 0.09070096164941788
        },
        {
            "text": "FoxA1 appears to play a critical role in this reprogramming of ER binding",
            "probability": 0.00017487409812121956,
            "start_logit": 1.086288571357727,
            "end_logit": -0.6392881870269775
        },
        {
            "text": "Given previous findings from cell lines",
            "probability": 0.00013139923176262795,
            "start_logit": 0.021980147808790207,
            "end_logit": 0.13919422030448914
        },
        {
            "text": "Given previous findings from cell lines, FoxA1 appears to play a critical role in this reprogramming of ER binding.",
            "probability": 0.00012517928639171894,
            "start_logit": 0.021980147808790207,
            "end_logit": 0.09070096164941788
        },
        {
            "text": "FoxA1",
            "probability": 7.022306919607356e-05,
            "start_logit": 1.086288571357727,
            "end_logit": -1.5516775846481323
        },
        {
            "text": "FoxA1 appears to play a critical role",
            "probability": 6.321749825417201e-05,
            "start_logit": 1.086288571357727,
            "end_logit": -1.656773328781128
        },
        {
            "text": "Given previous findings from cell lines, FoxA1 appears to play a critical role in this reprogramming of ER binding",
            "probability": 6.0325678095148475e-05,
            "start_logit": 0.021980147808790207,
            "end_logit": -0.6392881870269775
        },
        {
            "text": "previous findings from cell lines",
            "probability": 5.530283145514016e-05,
            "start_logit": -0.8434360027313232,
            "end_logit": 0.13919422030448914
        },
        {
            "text": "appears to play a critical role in this reprogramming of ER binding.",
            "probability": 5.2791912374358074e-05,
            "start_logit": -0.8414088487625122,
            "end_logit": 0.09070096164941788
        },
        {
            "text": "previous findings from cell lines, FoxA1 appears to play a critical role in this reprogramming of ER binding.",
            "probability": 5.268500343671644e-05,
            "start_logit": -0.8434360027313232,
            "end_logit": 0.09070096164941788
        },
        {
            "text": "findings from cell lines",
            "probability": 3.302762412029518e-05,
            "start_logit": -1.3589158058166504,
            "end_logit": 0.13919422030448914
        },
        {
            "text": "findings from cell lines, FoxA1 appears to play a critical role in this reprogramming of ER binding.",
            "probability": 3.146422062848284e-05,
            "start_logit": -1.3589158058166504,
            "end_logit": 0.09070096164941788
        },
        {
            "text": "critical role in this reprogramming of ER binding.",
            "probability": 2.6648192879350678e-05,
            "start_logit": -1.5250455141067505,
            "end_logit": 0.09070096164941788
        },
        {
            "text": "FoxA1 appears to play a critical role in this reprogramming",
            "probability": 2.6014785405618413e-05,
            "start_logit": 1.086288571357727,
            "end_logit": -2.544689416885376
        },
        {
            "text": "appears to play a critical role in this reprogramming of ER binding",
            "probability": 2.5441173246163278e-05,
            "start_logit": -0.8414088487625122,
            "end_logit": -0.6392881870269775
        },
        {
            "text": "previous findings from cell lines, FoxA1 appears to play a critical role in this reprogramming of ER binding",
            "probability": 2.5389652308925453e-05,
            "start_logit": -0.8434360027313232,
            "end_logit": -0.6392881870269775
        },
        {
            "text": "Given previous findings from cell lines, FoxA1",
            "probability": 2.4224595367114784e-05,
            "start_logit": 0.021980147808790207,
            "end_logit": -1.5516775846481323
        },
        {
            "text": "Given previous findings from cell lines, FoxA1 appears to play a critical role",
            "probability": 2.1807909179427172e-05,
            "start_logit": 0.021980147808790207,
            "end_logit": -1.656773328781128
        },
        {
            "text": "Given previous findings",
            "probability": 1.8233555958212698e-05,
            "start_logit": 0.021980147808790207,
            "end_logit": -1.8357824087142944
        }
    ],
    "5ca61b14ecadf2e73f00004f_009": [
        {
            "text": "",
            "probability": 0.999959059389892,
            "start_logit": 3.691880226135254,
            "end_logit": 3.9259564876556396
        },
        {
            "text": "expression and pathologic response were evaluated",
            "probability": 7.562865077487793e-06,
            "start_logit": -2.3185880184173584,
            "end_logit": -1.8557947874069214
        },
        {
            "text": "FOXA1 expression and pathologic response were evaluated",
            "probability": 6.265637751595618e-06,
            "start_logit": -2.5067577362060547,
            "end_logit": -1.8557947874069214
        },
        {
            "text": "expression and pathologic response were evaluated.",
            "probability": 3.7481869680890178e-06,
            "start_logit": -2.3185880184173584,
            "end_logit": -2.557772636413574
        },
        {
            "text": "FOXA1 expression and pathologic response were evaluated.",
            "probability": 3.105275781952515e-06,
            "start_logit": -2.5067577362060547,
            "end_logit": -2.557772636413574
        },
        {
            "text": "estrogen receptor (ER)-positive breast cancer responds poorly to chemotherapy",
            "probability": 2.533611237050557e-06,
            "start_logit": -3.2157633304595947,
            "end_logit": -2.0522239208221436
        },
        {
            "text": "expression and pathologic response",
            "probability": 2.4953906121682454e-06,
            "start_logit": -2.3185880184173584,
            "end_logit": -2.964599609375
        },
        {
            "text": "FOXA1 expression and pathologic response",
            "probability": 2.067366462892435e-06,
            "start_logit": -2.5067577362060547,
            "end_logit": -2.964599609375
        },
        {
            "text": "chemotherapy",
            "probability": 2.043008611922888e-06,
            "start_logit": -3.430985450744629,
            "end_logit": -2.0522239208221436
        },
        {
            "text": "expression",
            "probability": 1.3624571628429756e-06,
            "start_logit": -2.3185880184173584,
            "end_logit": -3.5697550773620605
        },
        {
            "text": "Most estrogen receptor (ER)-positive breast cancer responds poorly to chemotherapy",
            "probability": 1.1812592477336712e-06,
            "start_logit": -3.978827953338623,
            "end_logit": -2.0522239208221436
        },
        {
            "text": "responds poorly to chemotherapy",
            "probability": 1.1348813837772652e-06,
            "start_logit": -4.018880844116211,
            "end_logit": -2.0522239208221436
        },
        {
            "text": "FOXA1 expression",
            "probability": 1.1287604561202205e-06,
            "start_logit": -2.5067577362060547,
            "end_logit": -3.5697550773620605
        },
        {
            "text": "expression and pathologic response were evaluated. We then statistically analyzed FOXA1 expression and its relationship with chemosensitivity",
            "probability": 1.0282723527212592e-06,
            "start_logit": -2.3185880184173584,
            "end_logit": -3.8511648178100586
        },
        {
            "text": "expression and pathologic response were evaluated. We then statistically analyzed FOXA1 expression",
            "probability": 9.111024239140015e-07,
            "start_logit": -2.3185880184173584,
            "end_logit": -3.972144842147827
        },
        {
            "text": "cancer responds poorly to chemotherapy",
            "probability": 9.085499342453138e-07,
            "start_logit": -4.24131441116333,
            "end_logit": -2.0522239208221436
        },
        {
            "text": "expression and pathologic response were evaluated. We then statistically analyzed FOXA1 expression and its relationship with chemosensitivity.",
            "probability": 9.083242492580699e-07,
            "start_logit": -2.3185880184173584,
            "end_logit": -3.975198745727539
        },
        {
            "text": "breast cancer responds poorly to chemotherapy",
            "probability": 8.558996820223892e-07,
            "start_logit": -4.301011085510254,
            "end_logit": -2.0522239208221436
        },
        {
            "text": "FOXA1 expression and pathologic response were evaluated. We then statistically analyzed FOXA1 expression and its relationship with chemosensitivity",
            "probability": 8.518970001607524e-07,
            "start_logit": -2.5067577362060547,
            "end_logit": -3.8511648178100586
        },
        {
            "text": "poor chemoresponse in ER-positive as well as luminal A and luminal B breast cancer patients",
            "probability": 8.478637119828537e-07,
            "start_logit": -3.2928311824798584,
            "end_logit": -3.0698370933532715
        }
    ],
    "5ca61b14ecadf2e73f00004f_010": [
        {
            "text": "",
            "probability": 0.9995345876131835,
            "start_logit": 3.7816097736358643,
            "end_logit": 4.353754043579102
        },
        {
            "text": "FOXA1 expression could be a prognostic marker",
            "probability": 7.100512337392771e-05,
            "start_logit": -0.5464382171630859,
            "end_logit": -0.8704909682273865
        },
        {
            "text": "FOXA1 expression could be a prognostic marker in ER-positive breast cancer",
            "probability": 6.613245781839011e-05,
            "start_logit": -0.5464382171630859,
            "end_logit": -0.9415833353996277
        },
        {
            "text": "FOXA1 expression",
            "probability": 5.293609195725013e-05,
            "start_logit": -0.5464382171630859,
            "end_logit": -1.1641576290130615
        },
        {
            "text": "could be a prognostic marker",
            "probability": 5.243515695035951e-05,
            "start_logit": -0.8496129512786865,
            "end_logit": -0.8704909682273865
        },
        {
            "text": "could be a prognostic marker in ER-positive breast cancer",
            "probability": 4.883683937789769e-05,
            "start_logit": -0.8496129512786865,
            "end_logit": -0.9415833353996277
        },
        {
            "text": "Expression of forkhead box A1",
            "probability": 4.848936114817496e-05,
            "start_logit": -0.6986302733421326,
            "end_logit": -1.0997065305709839
        },
        {
            "text": "Expression",
            "probability": 2.936888671998738e-05,
            "start_logit": -0.6986302733421326,
            "end_logit": -1.601115107536316
        },
        {
            "text": "FOXA1 expression could be a prognostic marker in ER-positive breast cancer.",
            "probability": 1.5984587246372896e-05,
            "start_logit": -0.5464382171630859,
            "end_logit": -2.3616180419921875
        },
        {
            "text": "expression could be a prognostic marker",
            "probability": 1.2692603448993887e-05,
            "start_logit": -2.2681708335876465,
            "end_logit": -0.8704909682273865
        },
        {
            "text": "expression could be a prognostic marker in ER-positive breast cancer",
            "probability": 1.1821584447867561e-05,
            "start_logit": -2.2681708335876465,
            "end_logit": -0.9415833353996277
        },
        {
            "text": "could be a prognostic marker in ER-positive breast cancer.",
            "probability": 1.1804138930037246e-05,
            "start_logit": -0.8496129512786865,
            "end_logit": -2.3616180419921875
        },
        {
            "text": "forkhead box A1",
            "probability": 1.1547207072896151e-05,
            "start_logit": -2.133531093597412,
            "end_logit": -1.0997065305709839
        },
        {
            "text": "expression",
            "probability": 9.462652713304963e-06,
            "start_logit": -2.2681708335876465,
            "end_logit": -1.1641576290130615
        },
        {
            "text": "FOXA1",
            "probability": 7.266421109817213e-06,
            "start_logit": -0.5464382171630859,
            "end_logit": -3.1499791145324707
        },
        {
            "text": "a prognostic marker",
            "probability": 3.7103119574876944e-06,
            "start_logit": -3.4980742931365967,
            "end_logit": -0.8704909682273865
        },
        {
            "text": "a prognostic marker in ER-positive breast cancer",
            "probability": 3.4556949887889547e-06,
            "start_logit": -3.4980742931365967,
            "end_logit": -0.9415833353996277
        },
        {
            "text": "expression could be a prognostic marker in ER-positive breast cancer.",
            "probability": 2.8573434926042783e-06,
            "start_logit": -2.2681708335876465,
            "end_logit": -2.3616180419921875
        },
        {
            "text": "A1",
            "probability": 2.8135820908127015e-06,
            "start_logit": -3.5455162525177,
            "end_logit": -1.0997065305709839
        },
        {
            "text": "expression of FOXA1",
            "probability": 2.792341971495229e-06,
            "start_logit": -2.228633403778076,
            "end_logit": -2.4241671562194824
        }
    ],
    "5ca61b14ecadf2e73f00004f_011": [
        {
            "text": "suppressed its activation",
            "probability": 0.6620193159695305,
            "start_logit": 2.779555082321167,
            "end_logit": 4.334954738616943
        },
        {
            "text": "suppressed its activation.",
            "probability": 0.10447351281948487,
            "start_logit": 2.779555082321167,
            "end_logit": 2.488593578338623
        },
        {
            "text": "the nonphosphorylatable FoxA1 suppressed its activation",
            "probability": 0.08569115570810698,
            "start_logit": 0.7350099682807922,
            "end_logit": 4.334954738616943
        },
        {
            "text": "suppressed its activation. Stimulation with the epidermal growth factor, which activates c-Abl, enhanced the activation of estrogen signaling",
            "probability": 0.030761956684568215,
            "start_logit": 2.779555082321167,
            "end_logit": 1.2659387588500977
        },
        {
            "text": "nonphosphorylatable FoxA1 suppressed its activation",
            "probability": 0.025407540073630604,
            "start_logit": -0.48069366812705994,
            "end_logit": 4.334954738616943
        },
        {
            "text": "FoxA1 suppressed its activation",
            "probability": 0.01496838826911406,
            "start_logit": -1.0097991228103638,
            "end_logit": 4.334954738616943
        },
        {
            "text": "the nonphosphorylatable FoxA1 suppressed its activation.",
            "probability": 0.013522952938731816,
            "start_logit": 0.7350099682807922,
            "end_logit": 2.488593578338623
        },
        {
            "text": "suppressed its activation. Stimulation with the epidermal growth factor, which activates c-Abl, enhanced the activation of estrogen signaling.",
            "probability": 0.011351497174204764,
            "start_logit": 2.779555082321167,
            "end_logit": 0.26900964975357056
        },
        {
            "text": "suppressed",
            "probability": 0.010747431320712002,
            "start_logit": 2.779555082321167,
            "end_logit": 0.21432678401470184
        },
        {
            "text": "enhanced the activation of estrogen signaling. In contrast, the c-Abl inhibitor imatinib reduced its activation",
            "probability": 0.005703117270123586,
            "start_logit": 0.8515649437904358,
            "end_logit": 1.5086630582809448
        },
        {
            "text": "promoted the activation of estrogen signaling, whereas the nonphosphorylatable FoxA1 suppressed its activation",
            "probability": 0.005098037336251836,
            "start_logit": -2.086884021759033,
            "end_logit": 4.334954738616943
        },
        {
            "text": "enhanced the activation of estrogen signaling",
            "probability": 0.004474025736076851,
            "start_logit": 0.8515649437904358,
            "end_logit": 1.2659387588500977
        },
        {
            "text": "nonphosphorylatable FoxA1 suppressed its activation.",
            "probability": 0.004009573285194284,
            "start_logit": -0.48069366812705994,
            "end_logit": 2.488593578338623
        },
        {
            "text": "activation of estrogen signaling, whereas the nonphosphorylatable FoxA1 suppressed its activation",
            "probability": 0.0035488476478210784,
            "start_logit": -2.4491167068481445,
            "end_logit": 4.334954738616943
        },
        {
            "text": "enhanced the activation of estrogen signaling. In contrast, the c-Abl inhibitor imatinib reduced its activation.",
            "probability": 0.0032104051313048584,
            "start_logit": 0.8515649437904358,
            "end_logit": 0.934047281742096
        },
        {
            "text": "suppressed its activation. Stimulation with the epidermal growth factor, which activates c-Abl, enhanced the activation",
            "probability": 0.0031850076795466114,
            "start_logit": 2.779555082321167,
            "end_logit": -1.0018852949142456
        },
        {
            "text": "suppressed its activation. Stimulation with the epidermal growth factor, which activates c-Abl",
            "probability": 0.0031562806261806937,
            "start_logit": 2.779555082321167,
            "end_logit": -1.0109456777572632
        },
        {
            "text": "estrogen signaling, whereas the nonphosphorylatable FoxA1 suppressed its activation",
            "probability": 0.0029127792534004993,
            "start_logit": -2.646631956100464,
            "end_logit": 4.334954738616943
        },
        {
            "text": "FoxA1 suppressed its activation.",
            "probability": 0.0023621668824422774,
            "start_logit": -1.0097991228103638,
            "end_logit": 2.488593578338623
        },
        {
            "text": "the nonphosphorylatable FoxA1",
            "probability": 0.002272248681205031,
            "start_logit": 0.7350099682807922,
            "end_logit": 0.7049750685691833
        },
        {
            "text": "",
            "probability": 0.00112375951236866,
            "start_logit": 0.11211133003234863,
            "end_logit": 0.623783528804779
        }
    ],
    "5ca61b14ecadf2e73f00004f_012": [
        {
            "text": "suppressed its activation",
            "probability": 0.6620193159695305,
            "start_logit": 2.779555082321167,
            "end_logit": 4.334954738616943
        },
        {
            "text": "suppressed its activation.",
            "probability": 0.10447351281948487,
            "start_logit": 2.779555082321167,
            "end_logit": 2.488593578338623
        },
        {
            "text": "the nonphosphorylatable FoxA1 suppressed its activation",
            "probability": 0.08569115570810698,
            "start_logit": 0.7350099682807922,
            "end_logit": 4.334954738616943
        },
        {
            "text": "suppressed its activation. Stimulation with the epidermal growth factor, which activates c-Abl, enhanced the activation of estrogen signaling",
            "probability": 0.030761956684568215,
            "start_logit": 2.779555082321167,
            "end_logit": 1.2659387588500977
        },
        {
            "text": "nonphosphorylatable FoxA1 suppressed its activation",
            "probability": 0.025407540073630604,
            "start_logit": -0.48069366812705994,
            "end_logit": 4.334954738616943
        },
        {
            "text": "FoxA1 suppressed its activation",
            "probability": 0.01496838826911406,
            "start_logit": -1.0097991228103638,
            "end_logit": 4.334954738616943
        },
        {
            "text": "the nonphosphorylatable FoxA1 suppressed its activation.",
            "probability": 0.013522952938731816,
            "start_logit": 0.7350099682807922,
            "end_logit": 2.488593578338623
        },
        {
            "text": "suppressed its activation. Stimulation with the epidermal growth factor, which activates c-Abl, enhanced the activation of estrogen signaling.",
            "probability": 0.011351497174204764,
            "start_logit": 2.779555082321167,
            "end_logit": 0.26900964975357056
        },
        {
            "text": "suppressed",
            "probability": 0.010747431320712002,
            "start_logit": 2.779555082321167,
            "end_logit": 0.21432678401470184
        },
        {
            "text": "enhanced the activation of estrogen signaling. In contrast, the c-Abl inhibitor imatinib reduced its activation",
            "probability": 0.005703117270123586,
            "start_logit": 0.8515649437904358,
            "end_logit": 1.5086630582809448
        },
        {
            "text": "promoted the activation of estrogen signaling, whereas the nonphosphorylatable FoxA1 suppressed its activation",
            "probability": 0.005098037336251836,
            "start_logit": -2.086884021759033,
            "end_logit": 4.334954738616943
        },
        {
            "text": "enhanced the activation of estrogen signaling",
            "probability": 0.004474025736076851,
            "start_logit": 0.8515649437904358,
            "end_logit": 1.2659387588500977
        },
        {
            "text": "nonphosphorylatable FoxA1 suppressed its activation.",
            "probability": 0.004009573285194284,
            "start_logit": -0.48069366812705994,
            "end_logit": 2.488593578338623
        },
        {
            "text": "activation of estrogen signaling, whereas the nonphosphorylatable FoxA1 suppressed its activation",
            "probability": 0.0035488476478210784,
            "start_logit": -2.4491167068481445,
            "end_logit": 4.334954738616943
        },
        {
            "text": "enhanced the activation of estrogen signaling. In contrast, the c-Abl inhibitor imatinib reduced its activation.",
            "probability": 0.0032104051313048584,
            "start_logit": 0.8515649437904358,
            "end_logit": 0.934047281742096
        },
        {
            "text": "suppressed its activation. Stimulation with the epidermal growth factor, which activates c-Abl, enhanced the activation",
            "probability": 0.0031850076795466114,
            "start_logit": 2.779555082321167,
            "end_logit": -1.0018852949142456
        },
        {
            "text": "suppressed its activation. Stimulation with the epidermal growth factor, which activates c-Abl",
            "probability": 0.0031562806261806937,
            "start_logit": 2.779555082321167,
            "end_logit": -1.0109456777572632
        },
        {
            "text": "estrogen signaling, whereas the nonphosphorylatable FoxA1 suppressed its activation",
            "probability": 0.0029127792534004993,
            "start_logit": -2.646631956100464,
            "end_logit": 4.334954738616943
        },
        {
            "text": "FoxA1 suppressed its activation.",
            "probability": 0.0023621668824422774,
            "start_logit": -1.0097991228103638,
            "end_logit": 2.488593578338623
        },
        {
            "text": "the nonphosphorylatable FoxA1",
            "probability": 0.002272248681205031,
            "start_logit": 0.7350099682807922,
            "end_logit": 0.7049750685691833
        },
        {
            "text": "",
            "probability": 0.00112375951236866,
            "start_logit": 0.11211133003234863,
            "end_logit": 0.623783528804779
        }
    ],
    "5e369c30b5b409ea53000001_002": [
        {
            "text": "Our reconstruction method",
            "probability": 0.5416712293677928,
            "start_logit": 1.901610255241394,
            "end_logit": -0.1938602775335312
        },
        {
            "text": "ChromoTrace can assign the 3D positions of the majority of loci with high accuracy and reasonable sensitivity to specific genome sequences",
            "probability": 0.29359112008311816,
            "start_logit": 0.7410311102867126,
            "end_logit": 0.35424768924713135
        },
        {
            "text": "ChromoTrace can assign the 3D positions of the majority of loci",
            "probability": 0.04224559680605951,
            "start_logit": 0.7410311102867126,
            "end_logit": -1.5844402313232422
        },
        {
            "text": "ChromoTrace can assign the 3D positions of the majority of loci with high accuracy",
            "probability": 0.03798646593610977,
            "start_logit": 0.7410311102867126,
            "end_logit": -1.690710425376892
        },
        {
            "text": "Our reconstruction",
            "probability": 0.02172256483742378,
            "start_logit": 1.901610255241394,
            "end_logit": -3.410167932510376
        },
        {
            "text": "can assign the 3D positions of the majority of loci with high accuracy and reasonable sensitivity to specific genome sequences",
            "probability": 0.009320430379336983,
            "start_logit": -2.7089481353759766,
            "end_logit": 0.35424768924713135
        },
        {
            "text": "3D DNA path based on super-resolution microscopy images",
            "probability": 0.007943394354906368,
            "start_logit": -4.091032028198242,
            "end_logit": 1.5764634609222412
        },
        {
            "text": "We find that ChromoTrace can assign the 3D positions of the majority of loci with high accuracy and reasonable sensitivity to specific genome sequences",
            "probability": 0.006809674598613041,
            "start_logit": -3.022812604904175,
            "end_logit": 0.35424768924713135
        },
        {
            "text": "ChromoTrace can assign the 3D positions of the majority of loci with high accuracy and reasonable sensitivity to specific genome sequences.",
            "probability": 0.006298080513248245,
            "start_logit": 0.7410311102867126,
            "end_logit": -3.4876954555511475
        },
        {
            "text": "Our reconstruction method, ChromoTrace",
            "probability": 0.005329737631342946,
            "start_logit": 1.901610255241394,
            "end_logit": -4.8152174949646
        },
        {
            "text": "ChromoTrace",
            "probability": 0.004947847672081105,
            "start_logit": 0.7410311102867126,
            "end_logit": -3.728987693786621
        },
        {
            "text": "Our reconstruction method, ChromoTrace,",
            "probability": 0.00441866781660399,
            "start_logit": 1.901610255241394,
            "end_logit": -5.002681255340576
        },
        {
            "text": "reconstruction method",
            "probability": 0.004190597894358384,
            "start_logit": -2.960205554962158,
            "end_logit": -0.1938602775335312
        },
        {
            "text": "assign the 3D positions of the majority of loci with high accuracy and reasonable sensitivity to specific genome sequences",
            "probability": 0.0038662027578510692,
            "start_logit": -3.588884115219116,
            "end_logit": 0.35424768924713135
        },
        {
            "text": "super-resolution microscopy images",
            "probability": 0.0027939809619723453,
            "start_logit": -5.1359052658081055,
            "end_logit": 1.5764634609222412
        },
        {
            "text": "images",
            "probability": 0.0015958590666504695,
            "start_logit": -5.695960521697998,
            "end_logit": 1.5764634609222412
        },
        {
            "text": "3D positions of the majority of loci with high accuracy and reasonable sensitivity to specific genome sequences",
            "probability": 0.001402786369060954,
            "start_logit": -4.602696418762207,
            "end_logit": 0.35424768924713135
        },
        {
            "text": "can assign the 3D positions of the majority of loci",
            "probability": 0.0013411411889874098,
            "start_logit": -2.7089481353759766,
            "end_logit": -1.5844402313232422
        },
        {
            "text": "can assign the 3D positions of the majority of loci with high accuracy",
            "probability": 0.001205929562904806,
            "start_logit": -2.7089481353759766,
            "end_logit": -1.690710425376892
        },
        {
            "text": "based on super-resolution microscopy images",
            "probability": 0.00118527295835676,
            "start_logit": -5.993399620056152,
            "end_logit": 1.5764634609222412
        },
        {
            "text": "",
            "probability": 0.00013341924322138803,
            "start_logit": -3.0117955207824707,
            "end_logit": -3.5893726348876953
        }
    ],
    "5e2dad57fbd6abf43b000010_001": [
        {
            "text": "Extended-release amantadine (amantadine ER) is the first approved medication for the treatment of dyskinesia",
            "probability": 0.4950223903976518,
            "start_logit": 1.7920221090316772,
            "end_logit": 0.33968624472618103
        },
        {
            "text": "Extended-release",
            "probability": 0.19570407694833966,
            "start_logit": 1.7920221090316772,
            "end_logit": -0.5883130431175232
        },
        {
            "text": "Extended-release amantadine (amantadine ER) is the first approved",
            "probability": 0.07563342819767642,
            "start_logit": 1.7920221090316772,
            "end_logit": -1.5390183925628662
        },
        {
            "text": "Extended-release amantadine (amantadine ER) is the first approved medication for the treatment of dyskinesia.",
            "probability": 0.05400316777993632,
            "start_logit": 1.7920221090316772,
            "end_logit": -1.8758740425109863
        },
        {
            "text": "Extended-release amantadine (amantadine ER) is the first approved medication",
            "probability": 0.04192918518023587,
            "start_logit": 1.7920221090316772,
            "end_logit": -2.128934621810913
        },
        {
            "text": "Extended-release amantadine",
            "probability": 0.027223132824654318,
            "start_logit": 1.7920221090316772,
            "end_logit": -2.560849666595459
        },
        {
            "text": "Extended-release amantadine (amantadine ER) is the first",
            "probability": 0.020662855447700714,
            "start_logit": 1.7920221090316772,
            "end_logit": -2.8365790843963623
        },
        {
            "text": "the first approved medication for the treatment of dyskinesia",
            "probability": 0.012292488912521484,
            "start_logit": -1.9035924673080444,
            "end_logit": 0.33968624472618103
        },
        {
            "text": "dyskinesia",
            "probability": 0.010951050600394667,
            "start_logit": -2.0191454887390137,
            "end_logit": 0.33968624472618103
        },
        {
            "text": "first approved medication for the treatment of dyskinesia",
            "probability": 0.010593078335893085,
            "start_logit": -2.052380084991455,
            "end_logit": 0.33968624472618103
        },
        {
            "text": "amantadine ER) is the first approved medication for the treatment of dyskinesia",
            "probability": 0.010559017587700205,
            "start_logit": -2.055600643157959,
            "end_logit": 0.33968624472618103
        },
        {
            "text": "approved medication for the treatment of dyskinesia",
            "probability": 0.009407531090518137,
            "start_logit": -2.1710703372955322,
            "end_logit": 0.33968624472618103
        },
        {
            "text": "Extended",
            "probability": 0.008548248351845157,
            "start_logit": 1.7920221090316772,
            "end_logit": -3.7191903591156006
        },
        {
            "text": "amantadine (amantadine ER) is the first approved medication for the treatment of dyskinesia",
            "probability": 0.006527191243618632,
            "start_logit": -2.536604166030884,
            "end_logit": 0.33968624472618103
        },
        {
            "text": "Extended-release ama",
            "probability": 0.003730938743536781,
            "start_logit": 1.7920221090316772,
            "end_logit": -4.548256874084473
        },
        {
            "text": "Extended-release amantadine (amantadine ER) is the first approved medication for the treatment",
            "probability": 0.003611714162910048,
            "start_logit": 1.7920221090316772,
            "end_logit": -4.5807342529296875
        },
        {
            "text": "Extended-release amantadine (amantadine ER",
            "probability": 0.0033583348811972616,
            "start_logit": 1.7920221090316772,
            "end_logit": -4.65347146987915
        },
        {
            "text": "Extended-release amantadine (amantadine",
            "probability": 0.00327063811908129,
            "start_logit": 1.7920221090316772,
            "end_logit": -4.679931640625
        },
        {
            "text": "treatment of dyskinesia",
            "probability": 0.003033546953360428,
            "start_logit": -3.3028483390808105,
            "end_logit": 0.33968624472618103
        },
        {
            "text": "Extended-release amantadine (amantadine ER)",
            "probability": 0.0027688540087846053,
            "start_logit": 1.7920221090316772,
            "end_logit": -4.84648323059082
        },
        {
            "text": "",
            "probability": 0.0011691302324429089,
            "start_logit": -1.6956956386566162,
            "end_logit": -2.2209389209747314
        }
    ],
    "5e49032df8b2df0d49000008_001": [
        {
            "text": "single technologist",
            "probability": 0.6296206462087609,
            "start_logit": 5.369121074676514,
            "end_logit": 5.41917610168457
        },
        {
            "text": "A single technologist",
            "probability": 0.29623076435621304,
            "start_logit": 4.615142345428467,
            "end_logit": 5.41917610168457
        },
        {
            "text": "technologist",
            "probability": 0.0535890989223273,
            "start_logit": 2.9053492546081543,
            "end_logit": 5.41917610168457
        },
        {
            "text": "single technologist wore 3 electronic dosimeters for 3 mo, at the front waist, the back waist, and the front collar.",
            "probability": 0.008496140274380202,
            "start_logit": 5.369121074676514,
            "end_logit": 1.1136705875396729
        },
        {
            "text": "A single technologist wore 3 electronic dosimeters for 3 mo, at the front waist, the back waist, and the front collar.",
            "probability": 0.003997356412487721,
            "start_logit": 4.615142345428467,
            "end_logit": 1.1136705875396729
        },
        {
            "text": "single technologist wore 3 electronic dosimeters for 3 mo, at the front waist, the back waist, and the front collar",
            "probability": 0.0033296860287812618,
            "start_logit": 5.369121074676514,
            "end_logit": 0.17693662643432617
        },
        {
            "text": "A single technologist wore 3 electronic dosimeters for 3 mo, at the front waist, the back waist, and the front collar",
            "probability": 0.0015665868699055252,
            "start_logit": 4.615142345428467,
            "end_logit": 0.17693662643432617
        },
        {
            "text": "technologist wore 3 electronic dosimeters for 3 mo, at the front waist, the back waist, and the front collar.",
            "probability": 0.0007231346436355067,
            "start_logit": 2.9053492546081543,
            "end_logit": 1.1136705875396729
        },
        {
            "text": "single technologist wore 3 electronic dosimeters for 3 mo",
            "probability": 0.0006761694891606435,
            "start_logit": 5.369121074676514,
            "end_logit": -1.4172528982162476
        },
        {
            "text": "single technologist wore 3 electronic dosimeters",
            "probability": 0.0003261538396647876,
            "start_logit": 5.369121074676514,
            "end_logit": -2.146327495574951
        },
        {
            "text": "A single technologist wore 3 electronic dosimeters for 3 mo",
            "probability": 0.00031813156988183344,
            "start_logit": 4.615142345428467,
            "end_logit": -1.4172528982162476
        },
        {
            "text": "technologist wore 3 electronic dosimeters for 3 mo, at the front waist, the back waist, and the front collar",
            "probability": 0.0002834006080504025,
            "start_logit": 2.9053492546081543,
            "end_logit": 0.17693662643432617
        },
        {
            "text": "single technologist wore 3 electronic dosimeters for 3 mo,",
            "probability": 0.00019936766371603145,
            "start_logit": 5.369121074676514,
            "end_logit": -2.6385459899902344
        },
        {
            "text": "single",
            "probability": 0.00015873427452220797,
            "start_logit": 5.369121074676514,
            "end_logit": -2.8664650917053223
        },
        {
            "text": "A single technologist wore 3 electronic dosimeters",
            "probability": 0.00015345240313097822,
            "start_logit": 4.615142345428467,
            "end_logit": -2.146327495574951
        },
        {
            "text": "A single technologist wore 3 electronic dosimeters for 3 mo,",
            "probability": 9.380066515628608e-05,
            "start_logit": 4.615142345428467,
            "end_logit": -2.6385459899902344
        },
        {
            "text": "A single",
            "probability": 7.468302660400963e-05,
            "start_logit": 4.615142345428467,
            "end_logit": -2.8664650917053223
        },
        {
            "text": "METHODS: A single technologist",
            "probability": 5.779264732290889e-05,
            "start_logit": -3.9268901348114014,
            "end_logit": 5.41917610168457
        },
        {
            "text": "technologist wore 3 electronic dosimeters for 3 mo",
            "probability": 5.755102514677519e-05,
            "start_logit": 2.9053492546081543,
            "end_logit": -1.4172528982162476
        },
        {
            "text": "",
            "probability": 4.7349071151645065e-05,
            "start_logit": 0.8201779127120972,
            "end_logit": 0.47279369831085205
        }
    ],
    "5e49032df8b2df0d49000008_002": [
        {
            "text": "",
            "probability": 0.9883424054441494,
            "start_logit": 0.3615269064903259,
            "end_logit": 0.4384533166885376
        },
        {
            "text": "collar",
            "probability": 0.004306694421281369,
            "start_logit": -2.6236016750335693,
            "end_logit": -2.0122766494750977
        },
        {
            "text": "collar above the apron",
            "probability": 0.0031938059913861594,
            "start_logit": -2.6236016750335693,
            "end_logit": -2.3112339973449707
        },
        {
            "text": "the collar",
            "probability": 0.0007337479395014576,
            "start_logit": -4.393362045288086,
            "end_logit": -2.0122766494750977
        },
        {
            "text": "the collar above the apron",
            "probability": 0.0005441408969642568,
            "start_logit": -4.393362045288086,
            "end_logit": -2.3112339973449707
        },
        {
            "text": "at the collar",
            "probability": 0.0005419982997522905,
            "start_logit": -4.696264743804932,
            "end_logit": -2.0122766494750977
        },
        {
            "text": "at the collar above the apron",
            "probability": 0.00040194108235683517,
            "start_logit": -4.696264743804932,
            "end_logit": -2.3112339973449707
        },
        {
            "text": "dosimeters are worn at the collar",
            "probability": 0.00030788075137564986,
            "start_logit": -5.261815071105957,
            "end_logit": -2.0122766494750977
        },
        {
            "text": "unshielded tissues such as the brain and lens of the eye become less challenging when dosimeters are worn at the collar",
            "probability": 0.00027623886355390335,
            "start_logit": -5.3702616691589355,
            "end_logit": -2.0122766494750977
        },
        {
            "text": "dosimeters are worn at the collar above the apron",
            "probability": 0.00022832160636172065,
            "start_logit": -5.261815071105957,
            "end_logit": -2.3112339973449707
        },
        {
            "text": "unshielded tissues such as the brain and lens of the eye become less challenging when dosimeters are worn at the collar above the apron",
            "probability": 0.00020485626588980603,
            "start_logit": -5.3702616691589355,
            "end_logit": -2.3112339973449707
        },
        {
            "text": "collar above the apron.",
            "probability": 0.00016897778057087105,
            "start_logit": -2.6236016750335693,
            "end_logit": -5.2504353523254395
        },
        {
            "text": "Estimating doses to unshielded tissues such as the brain and lens of the eye become less challenging when dosimeters are worn at the collar",
            "probability": 0.00011993085317440471,
            "start_logit": -6.2046122550964355,
            "end_logit": -2.0122766494750977
        },
        {
            "text": "the brain and lens of the eye become less challenging when dosimeters are worn at the collar",
            "probability": 0.00011433878434025041,
            "start_logit": -6.25236177444458,
            "end_logit": -2.0122766494750977
        },
        {
            "text": "above the apron",
            "probability": 0.0001085277659464445,
            "start_logit": -6.005564212799072,
            "end_logit": -2.3112339973449707
        },
        {
            "text": "the apron",
            "probability": 0.00010489485253359385,
            "start_logit": -6.03961181640625,
            "end_logit": -2.3112339973449707
        },
        {
            "text": "the brain and lens of the eye become less challenging when dosimeters are worn at the collar above the apron",
            "probability": 8.479261789951913e-05,
            "start_logit": -6.25236177444458,
            "end_logit": -2.3112339973449707
        },
        {
            "text": "worn at the collar",
            "probability": 8.038993901647668e-05,
            "start_logit": -6.604638576507568,
            "end_logit": -2.0122766494750977
        },
        {
            "text": "brain and lens of the eye become less challenging when dosimeters are worn at the collar",
            "probability": 7.649938552914767e-05,
            "start_logit": -6.654244899749756,
            "end_logit": -2.0122766494750977
        },
        {
            "text": "worn at the collar above the apron",
            "probability": 5.961645841629056e-05,
            "start_logit": -6.604638576507568,
            "end_logit": -2.3112339973449707
        }
    ],
    "5e49032df8b2df0d49000008_004": [
        {
            "text": "",
            "probability": 0.9999999606097059,
            "start_logit": 3.652883768081665,
            "end_logit": 3.8166933059692383
        },
        {
            "text": "radiation worker",
            "probability": 1.5065545191858668e-08,
            "start_logit": -5.719132423400879,
            "end_logit": -4.822145938873291
        },
        {
            "text": "worker",
            "probability": 5.4626945108254525e-09,
            "start_logit": -6.733600616455078,
            "end_logit": -4.822145938873291
        },
        {
            "text": "Radiation Safety Professionals is to help maintain radiation worker",
            "probability": 3.2149667871107872e-09,
            "start_logit": -7.263725757598877,
            "end_logit": -4.822145938873291
        },
        {
            "text": "dosimeter return compliance,",
            "probability": 3.0360562127190434e-09,
            "start_logit": -6.593191623687744,
            "end_logit": -5.549937725067139
        },
        {
            "text": "collective dose, dosimeter return compliance,",
            "probability": 1.864894754031473e-09,
            "start_logit": -7.0805463790893555,
            "end_logit": -5.549937725067139
        },
        {
            "text": "Radiation Safety Professionals that could help improve the radiological protection programs effectiveness, enhances quality,",
            "probability": 1.4066993016441212e-09,
            "start_logit": -6.247940540313721,
            "end_logit": -6.664502143859863
        },
        {
            "text": ",",
            "probability": 1.1255182604741145e-09,
            "start_logit": -7.585507392883301,
            "end_logit": -5.549937725067139
        },
        {
            "text": "dosimeter return compliance, and number of workers exceeding ALARA levels were chosen as meaningful parameters in characterizing the health of the program",
            "probability": 8.752401256298534e-10,
            "start_logit": -6.593191623687744,
            "end_logit": -6.7937541007995605
        },
        {
            "text": "dose per participant, collective dose, dosimeter return compliance,",
            "probability": 8.504275944707551e-10,
            "start_logit": -7.865767002105713,
            "end_logit": -5.549937725067139
        },
        {
            "text": "Radiation Safety Professionals that could help improve the radiological protection programs",
            "probability": 8.177671130428548e-10,
            "start_logit": -6.247940540313721,
            "end_logit": -7.206925868988037
        },
        {
            "text": "2,200 institutions",
            "probability": 7.360662159803607e-10,
            "start_logit": -7.138886451721191,
            "end_logit": -6.421237468719482
        },
        {
            "text": "2,200 institutions chosen from different industries were surveyed for more than 2 years after the implementation of this tool. Four indicators: dose per participant",
            "probability": 6.966097560778688e-10,
            "start_logit": -7.138886451721191,
            "end_logit": -6.476332187652588
        },
        {
            "text": "More than 2,200 institutions",
            "probability": 6.897946430912527e-10,
            "start_logit": -7.203812599182129,
            "end_logit": -6.421237468719482
        },
        {
            "text": "Radiation Safety Professionals",
            "probability": 6.549065764583403e-10,
            "start_logit": -6.247940540313721,
            "end_logit": -7.42901086807251
        },
        {
            "text": "More than 2,200 institutions chosen from different industries were surveyed for more than 2 years after the implementation of this tool. Four indicators: dose per participant",
            "probability": 6.528185476188723e-10,
            "start_logit": -7.203812599182129,
            "end_logit": -6.476332187652588
        },
        {
            "text": ".",
            "probability": 5.8790297974643e-10,
            "start_logit": -7.808793544769287,
            "end_logit": -5.976088523864746
        },
        {
            "text": "institutions",
            "probability": 5.666830615709201e-10,
            "start_logit": -7.400406360626221,
            "end_logit": -6.421237468719482
        },
        {
            "text": ", and compared to benchmarks developed based on more than 1 million monitored workers.",
            "probability": 5.480867037728552e-10,
            "start_logit": -7.878921985626221,
            "end_logit": -5.976088523864746
        },
        {
            "text": "collective dose, dosimeter return compliance, and number of workers exceeding ALARA levels were chosen as meaningful parameters in characterizing the health of the program",
            "probability": 5.376154472921176e-10,
            "start_logit": -7.0805463790893555,
            "end_logit": -6.7937541007995605
        }
    ],
    "5e2f9596fbd6abf43b00002f_001": [
        {
            "text": "European Society of Endocrinology",
            "probability": 0.548598690741819,
            "start_logit": -0.6495798826217651,
            "end_logit": -1.545655369758606
        },
        {
            "text": "an autosomal recessive disorder",
            "probability": 0.09555569745153915,
            "start_logit": -2.059753179550171,
            "end_logit": -1.883139967918396
        },
        {
            "text": "",
            "probability": 0.07258885254737439,
            "start_logit": -2.2684288024902344,
            "end_logit": -1.9493622779846191
        },
        {
            "text": "European Society of Endocrinology.",
            "probability": 0.06241197105132691,
            "start_logit": -0.6495798826217651,
            "end_logit": -3.7192654609680176
        },
        {
            "text": "autosomal recessive disorder",
            "probability": 0.056151171682912004,
            "start_logit": -2.5914149284362793,
            "end_logit": -1.883139967918396
        },
        {
            "text": "alacrima, achalasia and adrenal insufficiency",
            "probability": 0.028732462000604697,
            "start_logit": -2.6741180419921875,
            "end_logit": -2.470456838607788
        },
        {
            "text": "an autosomal recessive disorder due to mutations in the AAAS gene",
            "probability": 0.021649291637541916,
            "start_logit": -2.059753179550171,
            "end_logit": -3.3678765296936035
        },
        {
            "text": "\u00a9 2018 European Society of Endocrinology",
            "probability": 0.01927046409845899,
            "start_logit": -3.998373508453369,
            "end_logit": -1.545655369758606
        },
        {
            "text": "autosomal recessive disorder due to mutations in the AAAS gene",
            "probability": 0.01272172276456412,
            "start_logit": -2.5914149284362793,
            "end_logit": -3.3678765296936035
        },
        {
            "text": "an autosomal recessive disorder due to mutations in the AAAS gene,",
            "probability": 0.012249798428900862,
            "start_logit": -2.059753179550171,
            "end_logit": -3.9373397827148438
        },
        {
            "text": "alacrima, achalasia and adrenal insufficiency, the canonic symptoms that are associated with progressive peripheral neuropathy",
            "probability": 0.011486237490368954,
            "start_logit": -2.6741180419921875,
            "end_logit": -3.3873348236083984
        },
        {
            "text": "neuropathy and cognitive disorders",
            "probability": 0.011180154981316595,
            "start_logit": -2.9070119857788086,
            "end_logit": -3.181450128555298
        },
        {
            "text": "alacrima, achalasia and adrenal insufficiency, the canonic symptoms that are associated with progressive peripheral neuropathy.",
            "probability": 0.007241519686681777,
            "start_logit": -2.6741180419921875,
            "end_logit": -3.8486533164978027
        },
        {
            "text": "autosomal recessive disorder due to mutations in the AAAS gene,",
            "probability": 0.007198320487494897,
            "start_logit": -2.5914149284362793,
            "end_logit": -3.9373397827148438
        },
        {
            "text": "an autosomal recessive disorder due to mutations in the AAAS gene, which encodes a nucleoporin named ALADIN",
            "probability": 0.006981239242902872,
            "start_logit": -2.059753179550171,
            "end_logit": -4.499622821807861
        },
        {
            "text": "Triple-A or Allgrove syndrome is an autosomal recessive disorder",
            "probability": 0.006882521660417326,
            "start_logit": -4.69047737121582,
            "end_logit": -1.883139967918396
        },
        {
            "text": "2018 European Society of Endocrinology",
            "probability": 0.005528182607438507,
            "start_logit": -5.2470879554748535,
            "end_logit": -1.545655369758606
        },
        {
            "text": "neuropathy and cognitive disorders.",
            "probability": 0.004950641739672424,
            "start_logit": -2.9070119857788086,
            "end_logit": -3.9960732460021973
        },
        {
            "text": "an autosomal recessive",
            "probability": 0.00451869036075543,
            "start_logit": -2.059753179550171,
            "end_logit": -4.934627056121826
        },
        {
            "text": "autosomal recessive disorder due to mutations in the AAAS gene, which encodes a nucleoporin named ALADIN",
            "probability": 0.004102369337909193,
            "start_logit": -2.5914149284362793,
            "end_logit": -4.499622821807861
        }
    ],
    "5e2f9596fbd6abf43b00002f_002": [
        {
            "text": "adrenal insufficiency and alacrima",
            "probability": 0.46407404140007946,
            "start_logit": -0.39184024930000305,
            "end_logit": -1.9032233953475952
        },
        {
            "text": "",
            "probability": 0.2076099795146235,
            "start_logit": -1.519261121749878,
            "end_logit": -1.5801854133605957
        },
        {
            "text": "OMIM #231550",
            "probability": 0.14526061899031947,
            "start_logit": -2.0809905529022217,
            "end_logit": -1.3755877017974854
        },
        {
            "text": "adrenal insufficiency and alacrima.",
            "probability": 0.08267344200574255,
            "start_logit": -0.39184024930000305,
            "end_logit": -3.628369092941284
        },
        {
            "text": "adrenal insufficiency and alacrima. In all cases, genetic analysis revealed homozygous mutations in the AAAS gene",
            "probability": 0.026658664326572656,
            "start_logit": -0.39184024930000305,
            "end_logit": -4.760153293609619
        },
        {
            "text": "adrenal insufficiency",
            "probability": 0.022904832466039464,
            "start_logit": -0.39184024930000305,
            "end_logit": -4.911919593811035
        },
        {
            "text": "(OMIM #231550",
            "probability": 0.00890459215595484,
            "start_logit": -4.872952938079834,
            "end_logit": -1.3755877017974854
        },
        {
            "text": "ad",
            "probability": 0.007873341357919714,
            "start_logit": -0.39184024930000305,
            "end_logit": -5.979784965515137
        },
        {
            "text": "adrenal insufficiency and alacrima. In all cases, genetic analysis revealed homozygous mutations in the AAAS gene.",
            "probability": 0.005543479778541582,
            "start_logit": -0.39184024930000305,
            "end_logit": -6.3306450843811035
        },
        {
            "text": "231550",
            "probability": 0.004243009190459697,
            "start_logit": -5.6142473220825195,
            "end_logit": -1.3755877017974854
        },
        {
            "text": "adrenal insufficiency and alacrima. In all cases, genetic analysis revealed homozygous mutations in the AAAS",
            "probability": 0.0035334004013263024,
            "start_logit": -0.39184024930000305,
            "end_logit": -6.781006813049316
        },
        {
            "text": "usually adrenal insufficiency and alacrima",
            "probability": 0.0033791891995197726,
            "start_logit": -5.314248561859131,
            "end_logit": -1.9032233953475952
        },
        {
            "text": "adrenal insufficiency and alacrima. In all cases, genetic analysis revealed homozygous mutations",
            "probability": 0.002975167499976844,
            "start_logit": -0.39184024930000305,
            "end_logit": -6.952967166900635
        },
        {
            "text": "OMIM #231550)",
            "probability": 0.002760181032127691,
            "start_logit": -2.0809905529022217,
            "end_logit": -5.338820934295654
        },
        {
            "text": "Triple A syndrome (TAS) or Allgrove syndrome (OMIM #231550",
            "probability": 0.0027455618451732527,
            "start_logit": -6.049534320831299,
            "end_logit": -1.3755877017974854
        },
        {
            "text": "alacrima",
            "probability": 0.002358220861732037,
            "start_logit": -5.673976898193359,
            "end_logit": -1.9032233953475952
        },
        {
            "text": "Allgrove syndrome (OMIM #231550",
            "probability": 0.002159364194928208,
            "start_logit": -6.289706230163574,
            "end_logit": -1.3755877017974854
        },
        {
            "text": "at least two symptoms, usually adrenal insufficiency and alacrima",
            "probability": 0.002152946324295961,
            "start_logit": -5.765047073364258,
            "end_logit": -1.9032233953475952
        },
        {
            "text": "OMIM #231550) is a rare autosomal recessive disorder",
            "probability": 0.0012891287699170555,
            "start_logit": -2.0809905529022217,
            "end_logit": -6.1001505851745605
        },
        {
            "text": "TAS, based on the presence of at least two symptoms, usually adrenal insufficiency and alacrima",
            "probability": 0.0009008386847499059,
            "start_logit": -6.636313438415527,
            "end_logit": -1.9032233953475952
        }
    ],
    "5e2f9596fbd6abf43b00002f_003": [
        {
            "text": "",
            "probability": 0.7847493226516996,
            "start_logit": -1.9642970561981201,
            "end_logit": -1.928066372871399
        },
        {
            "text": "alacrima, achalasia, adrenal insufficiency and autonomic/neurological abnormalities",
            "probability": 0.06020962064005597,
            "start_logit": -3.6655921936035156,
            "end_logit": -2.7943034172058105
        },
        {
            "text": "alacrima, achalasia, adrenal insufficiency and autonomic/neurological abnormalities.",
            "probability": 0.05927273701826077,
            "start_logit": -3.6655921936035156,
            "end_logit": -2.809986114501953
        },
        {
            "text": "rare autosomal recessive disorder",
            "probability": 0.019163887970082352,
            "start_logit": -3.5543060302734375,
            "end_logit": -4.050394058227539
        },
        {
            "text": "autosomal recessive disorder characterized by alacrima, achalasia, adrenal insufficiency and autonomic/neurological abnormalities",
            "probability": 0.015769069419233648,
            "start_logit": -5.005373954772949,
            "end_logit": -2.7943034172058105
        },
        {
            "text": "Triple A syndrome (or Allgrove syndrome) is a rare autosomal recessive disorder",
            "probability": 0.010679317947804624,
            "start_logit": -4.13902473449707,
            "end_logit": -4.050394058227539
        },
        {
            "text": "a rare autosomal recessive disorder",
            "probability": 0.0068180710378845134,
            "start_logit": -4.587757110595703,
            "end_logit": -4.050394058227539
        },
        {
            "text": "characterized by alacrima, achalasia, adrenal insufficiency and autonomic/neurological abnormalities",
            "probability": 0.005228316842114759,
            "start_logit": -6.109334945678711,
            "end_logit": -2.7943034172058105
        },
        {
            "text": "characterized by alacrima, achalasia, adrenal insufficiency and autonomic/neurological abnormalities.",
            "probability": 0.005146962328220436,
            "start_logit": -6.109334945678711,
            "end_logit": -2.809986114501953
        },
        {
            "text": "autosomal recessive disorder",
            "probability": 0.004490480666296667,
            "start_logit": -5.005373954772949,
            "end_logit": -4.050394058227539
        },
        {
            "text": "rare autosomal recessive disorder characterized by alacrima",
            "probability": 0.0038053849134779705,
            "start_logit": -3.5543060302734375,
            "end_logit": -5.667004585266113
        },
        {
            "text": "alacrima",
            "probability": 0.0034046119991398833,
            "start_logit": -3.6655921936035156,
            "end_logit": -5.667004585266113
        },
        {
            "text": "Triple A syndrome",
            "probability": 0.0030992442759806833,
            "start_logit": -4.13902473449707,
            "end_logit": -5.2875447273254395
        },
        {
            "text": "rare autosomal recessive",
            "probability": 0.0030323857185278074,
            "start_logit": -3.5543060302734375,
            "end_logit": -5.89407205581665
        },
        {
            "text": "rare autosomal recessive disorder characterized by alacrima, achalasia",
            "probability": 0.002978733835677348,
            "start_logit": -3.5543060302734375,
            "end_logit": -5.911923408508301
        },
        {
            "text": "rare autosomal recessive disorder characterized by alacrima, achalasia, adrenal insufficiency",
            "probability": 0.0027159547482833576,
            "start_logit": -3.5543060302734375,
            "end_logit": -6.004278182983398
        },
        {
            "text": "alacrima, achalasia",
            "probability": 0.0026650215917112577,
            "start_logit": -3.6655921936035156,
            "end_logit": -5.911923408508301
        },
        {
            "text": "alacrima, achalasia, adrenal insufficiency",
            "probability": 0.002429917691736282,
            "start_logit": -3.6655921936035156,
            "end_logit": -6.004278182983398
        },
        {
            "text": "BACKGROUND: Triple A syndrome (or Allgrove syndrome) is a rare autosomal recessive disorder",
            "probability": 0.002220360030502468,
            "start_logit": -5.709664344787598,
            "end_logit": -4.050394058227539
        },
        {
            "text": "Triple A syndrome (or Allgrove syndrome) is a rare autosomal recessive disorder characterized by alacrima",
            "probability": 0.0021205986733095895,
            "start_logit": -4.13902473449707,
            "end_logit": -5.667004585266113
        }
    ],
    "5e2f9596fbd6abf43b00002f_004": [
        {
            "text": "",
            "probability": 0.7524389156305524,
            "start_logit": -4.098442554473877,
            "end_logit": -3.840311050415039
        },
        {
            "text": "esophageal achalasia, adrenocorticotropic hormone refractoriness, and alacrima",
            "probability": 0.09207739314483572,
            "start_logit": -5.311558723449707,
            "end_logit": -4.7278852462768555
        },
        {
            "text": "esophageal achalasia",
            "probability": 0.04211660122708684,
            "start_logit": -5.311558723449707,
            "end_logit": -5.510072708129883
        },
        {
            "text": "esophageal achalasia, adrenocorticotropic hormone refractoriness, and alacrima.",
            "probability": 0.027716935357363203,
            "start_logit": -5.311558723449707,
            "end_logit": -5.928471088409424
        },
        {
            "text": "adrenocorticotropic hormone refractoriness, and alacrima",
            "probability": 0.014852737706522413,
            "start_logit": -7.1360039710998535,
            "end_logit": -4.7278852462768555
        },
        {
            "text": "per-oral endoscopic myotomy (POEM) was performed for esophageal achalasia",
            "probability": 0.010803530632805352,
            "start_logit": -6.711304664611816,
            "end_logit": -5.470895767211914
        },
        {
            "text": "alacrima",
            "probability": 0.01027128455230334,
            "start_logit": -7.504836082458496,
            "end_logit": -4.7278852462768555
        },
        {
            "text": "Triple A syndrome, is a rare autosomal recessive genetic disease characterized by three signs: esophageal achalasia",
            "probability": 0.0072247666509950535,
            "start_logit": -7.074485778808594,
            "end_logit": -5.510072708129883
        },
        {
            "text": "rare autosomal recessive genetic disease characterized by three signs: esophageal achalasia",
            "probability": 0.004985393125223662,
            "start_logit": -7.445488452911377,
            "end_logit": -5.510072708129883
        },
        {
            "text": "Allgrove syndrome, a per-oral endoscopic myotomy (POEM) was performed for esophageal achalasia",
            "probability": 0.004668743287850815,
            "start_logit": -7.55028772354126,
            "end_logit": -5.470895767211914
        },
        {
            "text": "adrenocorticotropic hormone refractoriness, and alacrima.",
            "probability": 0.004470938596665102,
            "start_logit": -7.1360039710998535,
            "end_logit": -5.928471088409424
        },
        {
            "text": "Triple A syndrome, is a rare autosomal recessive genetic disease",
            "probability": 0.003944810638961307,
            "start_logit": -7.074485778808594,
            "end_logit": -6.11518669128418
        },
        {
            "text": "Allgrove syndrome, also known as Triple A syndrome, is a rare autosomal recessive genetic disease",
            "probability": 0.003537975833962278,
            "start_logit": -7.1833319664001465,
            "end_logit": -6.11518669128418
        },
        {
            "text": "per-oral endoscopic myotomy",
            "probability": 0.0031648722018235067,
            "start_logit": -6.711304664611816,
            "end_logit": -6.69865608215332
        },
        {
            "text": "a per-oral endoscopic myotomy (POEM) was performed for esophageal achalasia",
            "probability": 0.0031604279230109987,
            "start_logit": -7.940470218658447,
            "end_logit": -5.470895767211914
        },
        {
            "text": "alacrima.",
            "probability": 0.003091839595474496,
            "start_logit": -7.504836082458496,
            "end_logit": -5.928471088409424
        },
        {
            "text": "per-oral endoscopic myotomy (POEM) was performed for esophageal achalasia. After the POEM",
            "probability": 0.0030366477868261884,
            "start_logit": -6.711304664611816,
            "end_logit": -6.740014553070068
        },
        {
            "text": "POEM) was performed for esophageal achalasia",
            "probability": 0.0030119749656131465,
            "start_logit": -7.988581657409668,
            "end_logit": -5.470895767211914
        },
        {
            "text": "rare autosomal recessive genetic disease",
            "probability": 0.0027220854028660204,
            "start_logit": -7.445488452911377,
            "end_logit": -6.11518669128418
        },
        {
            "text": "esophageal achalasia. After the POEM",
            "probability": 0.002702125739258063,
            "start_logit": -6.828020095825195,
            "end_logit": -6.740014553070068
        }
    ],
    "5e2f9596fbd6abf43b00002f_005": [
        {
            "text": "",
            "probability": 0.9995177485234195,
            "start_logit": 2.067040205001831,
            "end_logit": 2.215607166290283
        },
        {
            "text": "hypoglycemic seizures at the severe end of the spectrum to insidious hyperpigmentation and delayed development",
            "probability": 0.00012587471585409139,
            "start_logit": -3.1415669918060303,
            "end_logit": -1.5555267333984375
        },
        {
            "text": "insidious hyperpigmentation and delayed development",
            "probability": 0.00010542313514300068,
            "start_logit": -3.3188719749450684,
            "end_logit": -1.5555267333984375
        },
        {
            "text": "hypoglycemic seizures at the severe end of the spectrum to insidious hyperpigmentation and delayed development.",
            "probability": 6.90542458780117e-05,
            "start_logit": -3.1415669918060303,
            "end_logit": -2.155921459197998
        },
        {
            "text": "insidious hyperpigmentation and delayed development.",
            "probability": 5.7834609961179116e-05,
            "start_logit": -3.3188719749450684,
            "end_logit": -2.155921459197998
        },
        {
            "text": "hypoglycemic seizures",
            "probability": 2.3647544132331758e-05,
            "start_logit": -3.1415669918060303,
            "end_logit": -3.2275545597076416
        },
        {
            "text": "from hypoglycemic seizures at the severe end of the spectrum to insidious hyperpigmentation and delayed development",
            "probability": 1.6602248293287414e-05,
            "start_logit": -5.16731595993042,
            "end_logit": -1.5555267333984375
        },
        {
            "text": "Results Our cohort consisted mostly of children and displayed a wide phenotypic variability in the presenting symptoms ranging from hypoglycemic seizures",
            "probability": 1.4911876467329322e-05,
            "start_logit": -3.602668285369873,
            "end_logit": -3.2275545597076416
        },
        {
            "text": "hypoglycemic seizures at the severe end of the spectrum",
            "probability": 1.266977077401492e-05,
            "start_logit": -3.1415669918060303,
            "end_logit": -3.851594924926758
        },
        {
            "text": "from hypoglycemic seizures at the severe end of the spectrum to insidious hyperpigmentation and delayed development.",
            "probability": 9.107911211504874e-06,
            "start_logit": -5.16731595993042,
            "end_logit": -2.155921459197998
        },
        {
            "text": "Results Our cohort consisted mostly of children and displayed a wide phenotypic variability",
            "probability": 7.442032327627243e-06,
            "start_logit": -3.602668285369873,
            "end_logit": -3.9225685596466064
        },
        {
            "text": "children and displayed a wide phenotypic variability in the presenting symptoms ranging from hypoglycemic seizures",
            "probability": 5.8920917372655405e-06,
            "start_logit": -4.531215190887451,
            "end_logit": -3.2275545597076416
        },
        {
            "text": "insidious hyperpigmentation and delayed development. Neurological and autonomic features were present in a few patients",
            "probability": 5.775457792271012e-06,
            "start_logit": -3.3188719749450684,
            "end_logit": -4.459891319274902
        },
        {
            "text": "Our cohort consisted mostly of children and displayed a wide phenotypic variability in the presenting symptoms ranging from hypoglycemic seizures",
            "probability": 5.640005839448371e-06,
            "start_logit": -4.574941158294678,
            "end_logit": -3.2275545597076416
        },
        {
            "text": "Results Our cohort consisted mostly of children",
            "probability": 5.528941913000183e-06,
            "start_logit": -3.602668285369873,
            "end_logit": -4.2197160720825195
        },
        {
            "text": "hypoglycemic seizures at the severe end of the spectrum to insidious hyperpigmentation",
            "probability": 4.1526020647341655e-06,
            "start_logit": -3.1415669918060303,
            "end_logit": -4.967078685760498
        },
        {
            "text": "insidious hyperpigmentation",
            "probability": 3.4779051987932986e-06,
            "start_logit": -3.3188719749450684,
            "end_logit": -4.967078685760498
        },
        {
            "text": "children and displayed a wide phenotypic variability in the presenting symptoms ranging from hypoglycemic seizures at the severe end of the spectrum",
            "probability": 3.1568373981193104e-06,
            "start_logit": -4.531215190887451,
            "end_logit": -3.851594924926758
        },
        {
            "text": "from hypoglycemic seizures",
            "probability": 3.1189933303724936e-06,
            "start_logit": -5.16731595993042,
            "end_logit": -3.2275545597076416
        },
        {
            "text": "children and displayed a wide phenotypic variability",
            "probability": 2.9405512634271966e-06,
            "start_logit": -4.531215190887451,
            "end_logit": -3.9225685596466064
        }
    ],
    "5e2f9596fbd6abf43b00002f_006": [
        {
            "text": "",
            "probability": 0.29289155721650223,
            "start_logit": -3.185961961746216,
            "end_logit": -3.037813901901245
        },
        {
            "text": "rare autosomal recessive disorder characterized by the triad of achalasia, alacrimia and adrenal insufficiency",
            "probability": 0.13026846622993438,
            "start_logit": -4.053250312805176,
            "end_logit": -2.9807305335998535
        },
        {
            "text": "rare autosomal recessive disorder",
            "probability": 0.10225037776051428,
            "start_logit": -4.053250312805176,
            "end_logit": -3.2229034900665283
        },
        {
            "text": "achalasia, alacrimia and adrenal insufficiency",
            "probability": 0.083348759424681,
            "start_logit": -4.499814033508301,
            "end_logit": -2.9807305335998535
        },
        {
            "text": "a rare autosomal recessive disorder characterized by the triad of achalasia, alacrimia and adrenal insufficiency",
            "probability": 0.06055244892279593,
            "start_logit": -4.819337844848633,
            "end_logit": -2.9807305335998535
        },
        {
            "text": "rare autosomal recessive disorder characterized by the triad of achalasia, alacrimia and adrenal insufficiency.",
            "probability": 0.05156716698951101,
            "start_logit": -4.053250312805176,
            "end_logit": -3.907442808151245
        },
        {
            "text": "a rare autosomal recessive disorder",
            "probability": 0.04752885295933102,
            "start_logit": -4.819337844848633,
            "end_logit": -3.2229034900665283
        },
        {
            "text": "autosomal recessive disorder characterized by the triad of achalasia, alacrimia and adrenal insufficiency",
            "probability": 0.033984715016767766,
            "start_logit": -5.396936893463135,
            "end_logit": -2.9807305335998535
        },
        {
            "text": "achalasia, alacrimia and adrenal insufficiency.",
            "probability": 0.03299385891313622,
            "start_logit": -4.499814033508301,
            "end_logit": -3.907442808151245
        },
        {
            "text": "Allgrove syndrome is a rare autosomal recessive disorder",
            "probability": 0.02867109778847611,
            "start_logit": -5.324785232543945,
            "end_logit": -3.2229034900665283
        },
        {
            "text": "autosomal recessive disorder",
            "probability": 0.026675296402234126,
            "start_logit": -5.396936893463135,
            "end_logit": -3.2229034900665283
        },
        {
            "text": "a rare autosomal recessive disorder characterized by the triad of achalasia, alacrimia and adrenal insufficiency.",
            "probability": 0.023969870342329485,
            "start_logit": -4.819337844848633,
            "end_logit": -3.907442808151245
        },
        {
            "text": "triad of achalasia, alacrimia and adrenal insufficiency",
            "probability": 0.018203080445205258,
            "start_logit": -6.021256923675537,
            "end_logit": -2.9807305335998535
        },
        {
            "text": "autosomal recessive disorder characterized by the triad of achalasia, alacrimia and adrenal insufficiency.",
            "probability": 0.013452952391926606,
            "start_logit": -5.396936893463135,
            "end_logit": -3.907442808151245
        },
        {
            "text": "rare autosomal recessive",
            "probability": 0.011229318607864695,
            "start_logit": -4.053250312805176,
            "end_logit": -5.43179988861084
        },
        {
            "text": "the triad of achalasia, alacrimia and adrenal insufficiency",
            "probability": 0.009689643324498818,
            "start_logit": -6.651790142059326,
            "end_logit": -2.9807305335998535
        },
        {
            "text": "rare autosomal recessive disorder characterized by the triad of achalasia",
            "probability": 0.009147472598659813,
            "start_logit": -4.053250312805176,
            "end_logit": -5.636850357055664
        },
        {
            "text": "BACKGROUND: Allgrove syndrome is a rare autosomal recessive disorder",
            "probability": 0.008536228705963189,
            "start_logit": -6.536355495452881,
            "end_logit": -3.2229034900665283
        },
        {
            "text": "characterized by the triad of achalasia, alacrimia and adrenal insufficiency",
            "probability": 0.007833091421426836,
            "start_logit": -6.864490509033203,
            "end_logit": -2.9807305335998535
        },
        {
            "text": "triad of achalasia, alacrimia and adrenal insufficiency.",
            "probability": 0.007205744538241156,
            "start_logit": -6.021256923675537,
            "end_logit": -3.907442808151245
        }
    ],
    "5ca61f17ecadf2e73f000050_001": [
        {
            "text": "",
            "probability": 0.7721517936039826,
            "start_logit": 3.8990962505340576,
            "end_logit": 4.770930767059326
        },
        {
            "text": "Modifications of histones",
            "probability": 0.1668334612581454,
            "start_logit": 3.518953561782837,
            "end_logit": 3.6188883781433105
        },
        {
            "text": "Modifications of histones further lead to repressed, activated or poised gene transcription",
            "probability": 0.0346937267030075,
            "start_logit": 3.518953561782837,
            "end_logit": 2.0484511852264404
        },
        {
            "text": "repressed, activated or poised gene transcription",
            "probability": 0.006089536603437884,
            "start_logit": 1.7789666652679443,
            "end_logit": 2.0484511852264404
        },
        {
            "text": "DNA is wrapped around histones that are subjected to chemical modifications. Modifications of histones",
            "probability": 0.004646246570880668,
            "start_logit": -0.061982810497283936,
            "end_logit": 3.6188883781433105
        },
        {
            "text": "histones",
            "probability": 0.0033398449672897104,
            "start_logit": -0.3921181261539459,
            "end_logit": 3.6188883781433105
        },
        {
            "text": "Modifications of histones further lead to repressed",
            "probability": 0.0020846617065530234,
            "start_logit": 3.518953561782837,
            "end_logit": -0.7635011076927185
        },
        {
            "text": "chemical modifications. Modifications of histones",
            "probability": 0.0016850033030183177,
            "start_logit": -1.0762749910354614,
            "end_logit": 3.6188883781433105
        },
        {
            "text": "Modifications of histones further lead to repressed, activated or poised gene transcription, thus bringing another level of fine tuning regulation of gene transcription",
            "probability": 0.0015057556581975105,
            "start_logit": 3.518953561782837,
            "end_logit": -1.0888128280639648
        },
        {
            "text": "Modifications of histones further lead to repressed, activated or poised gene transcription, thus bringing another level of fine tuning regulation",
            "probability": 0.0011505633172085494,
            "start_logit": 3.518953561782837,
            "end_logit": -1.357856035232544
        },
        {
            "text": "DNA is wrapped around histones that are subjected to chemical modifications. Modifications of histones further lead to repressed, activated or poised gene transcription",
            "probability": 0.0009662067040346172,
            "start_logit": -0.061982810497283936,
            "end_logit": 2.0484511852264404
        },
        {
            "text": "histones that are subjected to chemical modifications. Modifications of histones",
            "probability": 0.0008751901467142631,
            "start_logit": -1.7313566207885742,
            "end_logit": 3.6188883781433105
        },
        {
            "text": "Modifications of histones further lead to repressed, activated or poised gene transcription,",
            "probability": 0.0008214930824120292,
            "start_logit": 3.518953561782837,
            "end_logit": -1.6947394609451294
        },
        {
            "text": "histones further lead to repressed, activated or poised gene transcription",
            "probability": 0.0006945349431207523,
            "start_logit": -0.3921181261539459,
            "end_logit": 2.0484511852264404
        },
        {
            "text": "Modifications",
            "probability": 0.0006377762254317791,
            "start_logit": 3.518953561782837,
            "end_logit": -1.9478754997253418
        },
        {
            "text": "Modifications of histones further lead to repressed, activated or poised gene transcription, thus bringing another level of fine tuning regulation of gene transcription.",
            "probability": 0.0006093979990633743,
            "start_logit": 3.518953561782837,
            "end_logit": -1.9933913946151733
        },
        {
            "text": "repressed",
            "probability": 0.0003659054524903334,
            "start_logit": 1.7789666652679443,
            "end_logit": -0.7635011076927185
        },
        {
            "text": "chemical modifications. Modifications of histones further lead to repressed, activated or poised gene transcription",
            "probability": 0.0003504035919876252,
            "start_logit": -1.0762749910354614,
            "end_logit": 2.0484511852264404
        },
        {
            "text": "repressed, activated or poised gene transcription, thus bringing another level of fine tuning regulation of gene transcription",
            "probability": 0.00026429429951186473,
            "start_logit": 1.7789666652679443,
            "end_logit": -1.0888128280639648
        },
        {
            "text": "Modifications of histones further lead to repressed, activated",
            "probability": 0.00023420386351207713,
            "start_logit": 3.518953561782837,
            "end_logit": -2.9496710300445557
        }
    ],
    "5ca61f17ecadf2e73f000050_002": [
        {
            "text": "preexistence of a structural backbone poised to integrate novel regulatory inputs, and a highly adaptive transcriptional readout",
            "probability": 0.2871492332105031,
            "start_logit": 3.017432928085327,
            "end_logit": 3.4810807704925537
        },
        {
            "text": "preexistence of a structural backbone poised to integrate novel regulatory inputs",
            "probability": 0.17818550174721975,
            "start_logit": 3.017432928085327,
            "end_logit": 3.003903865814209
        },
        {
            "text": "preexistence of a structural backbone",
            "probability": 0.13174958919902408,
            "start_logit": 3.017432928085327,
            "end_logit": 2.701981782913208
        },
        {
            "text": "highly adaptive transcriptional readout",
            "probability": 0.0876294437807697,
            "start_logit": 1.8305479288101196,
            "end_logit": 3.4810807704925537
        },
        {
            "text": "the preexistence of a structural backbone poised to integrate novel regulatory inputs, and a highly adaptive transcriptional readout",
            "probability": 0.04447667850857943,
            "start_logit": 1.1523958444595337,
            "end_logit": 3.4810807704925537
        },
        {
            "text": "structural backbone poised to integrate novel regulatory inputs, and a highly adaptive transcriptional readout",
            "probability": 0.03967045354489703,
            "start_logit": 1.0380375385284424,
            "end_logit": 3.4810807704925537
        },
        {
            "text": "a structural backbone poised to integrate novel regulatory inputs, and a highly adaptive transcriptional readout",
            "probability": 0.036646858978537804,
            "start_logit": 0.9587585926055908,
            "end_logit": 3.4810807704925537
        },
        {
            "text": "the preexistence of a structural backbone poised to integrate novel regulatory inputs",
            "probability": 0.027599235378390465,
            "start_logit": 1.1523958444595337,
            "end_logit": 3.003903865814209
        },
        {
            "text": "structural backbone poised to integrate novel regulatory inputs",
            "probability": 0.024616815411292892,
            "start_logit": 1.0380375385284424,
            "end_logit": 3.003903865814209
        },
        {
            "text": "a structural backbone poised to integrate novel regulatory inputs",
            "probability": 0.022740575976963873,
            "start_logit": 0.9587585926055908,
            "end_logit": 3.003903865814209
        },
        {
            "text": "the preexistence of a structural backbone",
            "probability": 0.020406755250315146,
            "start_logit": 1.1523958444595337,
            "end_logit": 2.701981782913208
        },
        {
            "text": "structural backbone",
            "probability": 0.01820156682796247,
            "start_logit": 1.0380375385284424,
            "end_logit": 2.701981782913208
        },
        {
            "text": "a structural backbone",
            "probability": 0.016814283506435355,
            "start_logit": 0.9587585926055908,
            "end_logit": 2.701981782913208
        },
        {
            "text": "a highly adaptive transcriptional readout",
            "probability": 0.013285428491045286,
            "start_logit": -0.05590129643678665,
            "end_logit": 3.4810807704925537
        },
        {
            "text": "",
            "probability": 0.00961443498995824,
            "start_logit": 0.7830399870872498,
            "end_logit": 2.318737268447876
        },
        {
            "text": "to integrate novel regulatory inputs, and a highly adaptive transcriptional readout",
            "probability": 0.009590568996815776,
            "start_logit": -0.3817889094352722,
            "end_logit": 3.4810807704925537
        },
        {
            "text": "preexistence of a structural backbone poised to integrate novel regulatory inputs, and a highly adaptive transcriptional readout.",
            "probability": 0.009318428233326879,
            "start_logit": 3.017432928085327,
            "end_logit": 0.05307268351316452
        },
        {
            "text": "both the preexistence of a structural backbone poised to integrate novel regulatory inputs, and a highly adaptive transcriptional readout",
            "probability": 0.0084489356856032,
            "start_logit": -0.5085286498069763,
            "end_logit": 3.4810807704925537
        },
        {
            "text": "integrate novel regulatory inputs, and a highly adaptive transcriptional readout",
            "probability": 0.007866931040733344,
            "start_logit": -0.5799010992050171,
            "end_logit": 3.4810807704925537
        },
        {
            "text": "preexistence",
            "probability": 0.005988281241626032,
            "start_logit": 3.017432928085327,
            "end_logit": -0.3891168534755707
        }
    ],
    "5ca61f17ecadf2e73f000050_003": [
        {
            "text": "",
            "probability": 0.39842928448664805,
            "start_logit": 2.949978828430176,
            "end_logit": 4.747416973114014
        },
        {
            "text": "not at active promoters with high levels of H3.3K27M proteins",
            "probability": 0.23111360706962764,
            "start_logit": 1.9437669515609741,
            "end_logit": 5.20900821685791
        },
        {
            "text": "the PRC2 complex is sequestered at poised enhancers, but not at active promoters with high levels of H3.3K27M proteins",
            "probability": 0.12045833292174148,
            "start_logit": 1.292161464691162,
            "end_logit": 5.20900821685791
        },
        {
            "text": "active promoters with high levels of H3.3K27M proteins",
            "probability": 0.09639811104940534,
            "start_logit": 1.069344162940979,
            "end_logit": 5.20900821685791
        },
        {
            "text": "high levels of H3.3K27M proteins",
            "probability": 0.04673761373902028,
            "start_logit": 0.34540683031082153,
            "end_logit": 5.20900821685791
        },
        {
            "text": "PRC2 complex is sequestered at poised enhancers, but not at active promoters with high levels of H3.3K27M proteins",
            "probability": 0.029691323224393076,
            "start_logit": -0.10828758776187897,
            "end_logit": 5.20900821685791
        },
        {
            "text": "not at active promoters",
            "probability": 0.01618901082961105,
            "start_logit": 1.9437669515609741,
            "end_logit": 2.550431489944458
        },
        {
            "text": "H3.3K27M proteins",
            "probability": 0.011143336975425501,
            "start_logit": -1.0883007049560547,
            "end_logit": 5.20900821685791
        },
        {
            "text": "the PRC2 complex is sequestered at poised enhancers, but not at active promoters",
            "probability": 0.008437847000499016,
            "start_logit": 1.292161464691162,
            "end_logit": 2.550431489944458
        },
        {
            "text": "active promoters",
            "probability": 0.0067524802348081225,
            "start_logit": 1.069344162940979,
            "end_logit": 2.550431489944458
        },
        {
            "text": "sequestered at poised enhancers, but not at active promoters with high levels of H3.3K27M proteins",
            "probability": 0.006578172889370225,
            "start_logit": -1.6153854131698608,
            "end_logit": 5.20900821685791
        },
        {
            "text": "not at active promoters with high levels of H3.3K27M proteins, thereby contributing to the global reduction of H3K27me3",
            "probability": 0.005640221193690598,
            "start_logit": 1.9437669515609741,
            "end_logit": 1.49602210521698
        },
        {
            "text": "at active promoters with high levels of H3.3K27M proteins",
            "probability": 0.004477404383548613,
            "start_logit": -2.000098943710327,
            "end_logit": 5.20900821685791
        },
        {
            "text": "promoters with high levels of H3.3K27M proteins",
            "probability": 0.004223294246976262,
            "start_logit": -2.0585269927978516,
            "end_logit": 5.20900821685791
        },
        {
            "text": "not at active promoters with high levels",
            "probability": 0.0037158207221685683,
            "start_logit": 1.9437669515609741,
            "end_logit": 1.0786983966827393
        },
        {
            "text": "active promoters with high levels of H3.3K27M proteins, thereby contributing to the global reduction of H3K27me3",
            "probability": 0.0023525515259202943,
            "start_logit": 1.069344162940979,
            "end_logit": 1.49602210521698
        },
        {
            "text": "but not at active promoters with high levels of H3.3K27M proteins",
            "probability": 0.0020951786843134567,
            "start_logit": -2.7595036029815674,
            "end_logit": 5.20900821685791
        },
        {
            "text": "PRC2 complex is sequestered at poised enhancers, but not at active promoters",
            "probability": 0.0020798132975371245,
            "start_logit": -0.10828758776187897,
            "end_logit": 2.550431489944458
        },
        {
            "text": "the PRC2 complex is sequestered at poised enhancers, but not at active promoters with high levels",
            "probability": 0.0019367166447003625,
            "start_logit": 1.292161464691162,
            "end_logit": 1.0786983966827393
        },
        {
            "text": "active promoters with high levels",
            "probability": 0.0015498788805947405,
            "start_logit": 1.069344162940979,
            "end_logit": 1.0786983966827393
        }
    ],
    "5ca61f17ecadf2e73f000050_004": [
        {
            "text": "future activation is not always observed",
            "probability": 0.271228962410878,
            "start_logit": 3.3725805282592773,
            "end_logit": 2.8483636379241943
        },
        {
            "text": "repression by transcriptional repressors",
            "probability": 0.14514434645405452,
            "start_logit": 2.011143684387207,
            "end_logit": 3.5845658779144287
        },
        {
            "text": "future activation",
            "probability": 0.1408693630281377,
            "start_logit": 3.3725805282592773,
            "end_logit": 2.1932332515716553
        },
        {
            "text": "the poised enhancer state is more generally the result of repression by transcriptional repressors",
            "probability": 0.1281276613109745,
            "start_logit": 1.8864420652389526,
            "end_logit": 3.5845658779144287
        },
        {
            "text": "future activation is not always observed, and alternative reasons for the widespread occurrence of this enhancer signature have not been investigated",
            "probability": 0.043149336883354775,
            "start_logit": 3.3725805282592773,
            "end_logit": 1.010067343711853
        },
        {
            "text": "repression by transcriptional repressors.",
            "probability": 0.04261287307099405,
            "start_logit": 2.011143684387207,
            "end_logit": 2.3589935302734375
        },
        {
            "text": "more generally the result of repression by transcriptional repressors",
            "probability": 0.03778057209133689,
            "start_logit": 0.665209949016571,
            "end_logit": 3.5845658779144287
        },
        {
            "text": "the poised enhancer state is more generally the result of repression by transcriptional repressors.",
            "probability": 0.03761695099888855,
            "start_logit": 1.8864420652389526,
            "end_logit": 2.3589935302734375
        },
        {
            "text": "the result of repression by transcriptional repressors",
            "probability": 0.036272223289696946,
            "start_logit": 0.6244671940803528,
            "end_logit": 3.5845658779144287
        },
        {
            "text": "future activation is not always observed, and alternative reasons for the widespread occurrence",
            "probability": 0.023808885044895766,
            "start_logit": 3.3725805282592773,
            "end_logit": 0.41545912623405457
        },
        {
            "text": "future activation is not always observed, and alternative reasons for the widespread occurrence of this enhancer signature",
            "probability": 0.018947765989723718,
            "start_logit": 3.3725805282592773,
            "end_logit": 0.1870863288640976
        },
        {
            "text": "future activation is not always observed, and alternative reasons for the widespread occurrence of this enhancer signature have not been investigated.",
            "probability": 0.016191972727011675,
            "start_logit": 3.3725805282592773,
            "end_logit": 0.029915902763605118
        },
        {
            "text": "more generally the result of repression by transcriptional repressors.",
            "probability": 0.011091983686648831,
            "start_logit": 0.665209949016571,
            "end_logit": 2.3589935302734375
        },
        {
            "text": "the result of repression by transcriptional repressors.",
            "probability": 0.010649148139820179,
            "start_logit": 0.6244671940803528,
            "end_logit": 2.3589935302734375
        },
        {
            "text": "the enhancers are not induced",
            "probability": 0.007045898794792425,
            "start_logit": 0.16398508846759796,
            "end_logit": 2.4064414501190186
        },
        {
            "text": "poised enhancer state is more generally the result of repression by transcriptional repressors",
            "probability": 0.006733948872034724,
            "start_logit": -1.0594233274459839,
            "end_logit": 3.5845658779144287
        },
        {
            "text": "enhancers are not induced",
            "probability": 0.00587592565733902,
            "start_logit": -0.017597021535038948,
            "end_logit": 2.4064414501190186
        },
        {
            "text": "specifically generated during patterning in the tissue where the enhancers are not induced",
            "probability": 0.005107319949797101,
            "start_logit": -0.1577858328819275,
            "end_logit": 2.4064414501190186
        },
        {
            "text": "repression",
            "probability": 0.005105842661062602,
            "start_logit": 2.011143684387207,
            "end_logit": 0.23722264170646667
        },
        {
            "text": "future activation is not always observed,",
            "probability": 0.005099176820833678,
            "start_logit": 3.3725805282592773,
            "end_logit": -1.1255205869674683
        },
        {
            "text": "",
            "probability": 0.0015398421177244006,
            "start_logit": 0.45375052094459534,
            "end_logit": 0.5959101915359497
        }
    ],
    "5ca61f17ecadf2e73f000050_006": [
        {
            "text": "the amount of actively used enhancers is lower than previously anticipated",
            "probability": 0.44657794684385954,
            "start_logit": 4.2403459548950195,
            "end_logit": 5.333630084991455
        },
        {
            "text": "histone H3K27ac distinguishes active enhancers from inactive/poised enhancer elements containing H3K4me1 alone",
            "probability": 0.1125407566125673,
            "start_logit": 4.366926670074463,
            "end_logit": 3.8287508487701416
        },
        {
            "text": "lower than previously anticipated",
            "probability": 0.06921173419262067,
            "start_logit": 2.3759024143218994,
            "end_logit": 5.333630084991455
        },
        {
            "text": "histone H3K27ac distinguishes active enhancers from inactive/poised enhancer elements containing H3K4me1",
            "probability": 0.06554585318284235,
            "start_logit": 4.366926670074463,
            "end_logit": 3.2881853580474854
        },
        {
            "text": "H3K4me1 alone. This indicates that the amount of actively used enhancers is lower than previously anticipated",
            "probability": 0.0530574698819148,
            "start_logit": 2.110107660293579,
            "end_logit": 5.333630084991455
        },
        {
            "text": "the amount of actively used enhancers is lower",
            "probability": 0.04338044493711019,
            "start_logit": 4.2403459548950195,
            "end_logit": 3.0020248889923096
        },
        {
            "text": "This indicates that the amount of actively used enhancers is lower than previously anticipated",
            "probability": 0.03944589773074612,
            "start_logit": 1.813662052154541,
            "end_logit": 5.333630084991455
        },
        {
            "text": "histone H3K27ac",
            "probability": 0.03924783658586982,
            "start_logit": 4.366926670074463,
            "end_logit": 2.775331735610962
        },
        {
            "text": "indicates that the amount of actively used enhancers is lower than previously anticipated",
            "probability": 0.02711376778521209,
            "start_logit": 1.4387736320495605,
            "end_logit": 5.333630084991455
        },
        {
            "text": "the amount of actively used enhancers is lower than previously anticipated.",
            "probability": 0.022899256183556184,
            "start_logit": 4.2403459548950195,
            "end_logit": 2.3631205558776855
        },
        {
            "text": "actively used enhancers is lower than previously anticipated",
            "probability": 0.01281431464695972,
            "start_logit": 0.6892948746681213,
            "end_logit": 5.333630084991455
        },
        {
            "text": "H3K4me1 alone",
            "probability": 0.011781098524824155,
            "start_logit": 2.110107660293579,
            "end_logit": 3.8287508487701416
        },
        {
            "text": "amount of actively used enhancers is lower than previously anticipated",
            "probability": 0.010057141016076404,
            "start_logit": 0.4470149278640747,
            "end_logit": 5.333630084991455
        },
        {
            "text": "histone H3K27ac distinguishes active enhancers from inactive/poised enhancer elements containing H3K4me1 alone.",
            "probability": 0.008064440152530529,
            "start_logit": 4.366926670074463,
            "end_logit": 1.1928997039794922
        },
        {
            "text": "containing H3K4me1 alone. This indicates that the amount of actively used enhancers is lower than previously anticipated",
            "probability": 0.007325584939220552,
            "start_logit": 0.13010500371456146,
            "end_logit": 5.333630084991455
        },
        {
            "text": "inactive/poised enhancer elements containing H3K4me1 alone. This indicates that the amount of actively used enhancers is lower than previously anticipated",
            "probability": 0.007164049925961108,
            "start_logit": 0.1078074499964714,
            "end_logit": 5.333630084991455
        },
        {
            "text": "H3K4me1",
            "probability": 0.006861533345640346,
            "start_logit": 2.110107660293579,
            "end_logit": 3.2881853580474854
        },
        {
            "text": "lower",
            "probability": 0.0067232066548835925,
            "start_logit": 2.3759024143218994,
            "end_logit": 3.0020248889923096
        },
        {
            "text": "H3K4me1 alone. This indicates that the amount of actively used enhancers is lower",
            "probability": 0.005153986368967595,
            "start_logit": 2.110107660293579,
            "end_logit": 3.0020248889923096
        },
        {
            "text": "the amount of actively used enhancers",
            "probability": 0.005024730674810056,
            "start_logit": 4.2403459548950195,
            "end_logit": 0.8463879823684692
        },
        {
            "text": "",
            "probability": 8.949813826831471e-06,
            "start_logit": -0.934994637966156,
            "end_logit": -0.30876582860946655
        }
    ],
    "5e369ecfb5b409ea53000002_002": [
        {
            "text": "",
            "probability": 0.8849720244965731,
            "start_logit": -1.8706698417663574,
            "end_logit": -1.5614420175552368
        },
        {
            "text": "Transcribed-ultraconserved regions",
            "probability": 0.08170999912600589,
            "start_logit": -2.6883456707000732,
            "end_logit": -3.126145839691162
        },
        {
            "text": "Transcribed-ultraconserved regions (T-UCRs) are long non-coding RNAs",
            "probability": 0.008715724280895886,
            "start_logit": -2.6883456707000732,
            "end_logit": -5.364193439483643
        },
        {
            "text": "long non-coding RNAs (lncRNA) encoded by a subset of long ultraconserved stretches in the human genome",
            "probability": 0.004145975276237148,
            "start_logit": -4.927495002746582,
            "end_logit": -3.868034839630127
        },
        {
            "text": "Transcribed-ultraconserved regions (T-UCRs) are long non-coding RNAs (lncRNA",
            "probability": 0.00411016506998182,
            "start_logit": -2.6883456707000732,
            "end_logit": -6.115859031677246
        },
        {
            "text": "Transcribed-ultraconserved",
            "probability": 0.003417836662044142,
            "start_logit": -2.6883456707000732,
            "end_logit": -6.300314426422119
        },
        {
            "text": "Transcribed-ultraconserved regions (T-UCRs) are long non-coding RNAs (lncRNA)",
            "probability": 0.00314014227973391,
            "start_logit": -2.6883456707000732,
            "end_logit": -6.385054111480713
        },
        {
            "text": "ultraconserved regions",
            "probability": 0.0019938655342693914,
            "start_logit": -6.40144681930542,
            "end_logit": -3.126145839691162
        },
        {
            "text": "non-coding RNAs (lncRNA) encoded by a subset of long ultraconserved stretches in the human genome",
            "probability": 0.0013920095112006257,
            "start_logit": -6.018884658813477,
            "end_logit": -3.868034839630127
        },
        {
            "text": "long non-coding RNAs",
            "probability": 0.0009286526106339475,
            "start_logit": -4.927495002746582,
            "end_logit": -5.364193439483643
        },
        {
            "text": "lncRNA) encoded by a subset of long ultraconserved stretches in the human genome",
            "probability": 0.0008333240647856466,
            "start_logit": -6.531965732574463,
            "end_logit": -3.868034839630127
        },
        {
            "text": "long non-coding RNAs (lncRNA) encoded by a subset of long ultraconserved stretches in the human genome.",
            "probability": 0.0007797437408200273,
            "start_logit": -4.927495002746582,
            "end_logit": -5.5389628410339355
        },
        {
            "text": "long non-coding RNAs (lncRNA) encoded by a subset of long ultraconserved stretches",
            "probability": 0.0006940927642217117,
            "start_logit": -4.927495002746582,
            "end_logit": -5.655322551727295
        },
        {
            "text": "(lncRNA) encoded by a subset of long ultraconserved stretches in the human genome",
            "probability": 0.0006907701988429987,
            "start_logit": -6.719581127166748,
            "end_logit": -3.868034839630127
        },
        {
            "text": "long ultraconserved stretches in the human genome",
            "probability": 0.0005050154831541591,
            "start_logit": -7.032799243927002,
            "end_logit": -3.868034839630127
        },
        {
            "text": "uc.63 is associated with bad outcome in luminal A subtype of breast cancer patients",
            "probability": 0.0004848814308157527,
            "start_logit": -5.301042556762695,
            "end_logit": -5.640476226806641
        },
        {
            "text": "long non-coding RNAs (lncRNA",
            "probability": 0.00043793440445809273,
            "start_logit": -4.927495002746582,
            "end_logit": -6.115859031677246
        },
        {
            "text": "uc.63",
            "probability": 0.0004014689838097502,
            "start_logit": -5.301042556762695,
            "end_logit": -5.829250335693359
        },
        {
            "text": "long non-coding RNAs (lncRNA)",
            "probability": 0.00033457934554317794,
            "start_logit": -4.927495002746582,
            "end_logit": -6.385054111480713
        },
        {
            "text": "non-coding RNAs",
            "probability": 0.0003117947359727103,
            "start_logit": -6.018884658813477,
            "end_logit": -5.364193439483643
        }
    ],
    "5e369ecfb5b409ea53000002_004": [
        {
            "text": "",
            "probability": 0.5819094545364354,
            "start_logit": -0.5340415239334106,
            "end_logit": -0.6090453863143921
        },
        {
            "text": "clinical significance and biological mechanism of T-UCRs in breast cancer remain largely unknown",
            "probability": 0.2080796863544977,
            "start_logit": -2.3057241439819336,
            "end_logit": 0.13424348831176758
        },
        {
            "text": "unknown",
            "probability": 0.06893140154727119,
            "start_logit": -3.4105334281921387,
            "end_logit": 0.13424348831176758
        },
        {
            "text": "the clinical significance and biological mechanism of T-UCRs in breast cancer remain largely unknown",
            "probability": 0.06500455100200007,
            "start_logit": -3.4691879749298096,
            "end_logit": 0.13424348831176758
        },
        {
            "text": "largely unknown",
            "probability": 0.02567902681182177,
            "start_logit": -4.397970676422119,
            "end_logit": 0.13424348831176758
        },
        {
            "text": "remain largely unknown",
            "probability": 0.01345616288297421,
            "start_logit": -5.04420804977417,
            "end_logit": 0.13424348831176758
        },
        {
            "text": "clinical significance and biological mechanism of T-UCRs in breast cancer remain largely unknown.",
            "probability": 0.010986397481054537,
            "start_logit": -2.3057241439819336,
            "end_logit": -2.8070197105407715
        },
        {
            "text": "biological mechanism of T-UCRs in breast cancer remain largely unknown",
            "probability": 0.0043803743947227235,
            "start_logit": -6.166511058807373,
            "end_logit": 0.13424348831176758
        },
        {
            "text": "clinical significance and biological mechanism",
            "probability": 0.003764103647354507,
            "start_logit": -2.3057241439819336,
            "end_logit": -3.8781678676605225
        },
        {
            "text": "unknown.",
            "probability": 0.003639508447904433,
            "start_logit": -3.4105334281921387,
            "end_logit": -2.8070197105407715
        },
        {
            "text": "the clinical significance and biological mechanism of T-UCRs in breast cancer remain largely unknown.",
            "probability": 0.00343217470142067,
            "start_logit": -3.4691879749298096,
            "end_logit": -2.8070197105407715
        },
        {
            "text": "clinical significance and biological mechanism of T-UCRs in breast cancer remain largely unknown. The expression of uc.38",
            "probability": 0.0027004030017983294,
            "start_logit": -2.3057241439819336,
            "end_logit": -4.2102766036987305
        },
        {
            "text": "T-UCRs in breast cancer remain largely unknown",
            "probability": 0.0019385717936800276,
            "start_logit": -6.981693744659424,
            "end_logit": 0.13424348831176758
        },
        {
            "text": "largely unknown.",
            "probability": 0.001355826704778347,
            "start_logit": -4.397970676422119,
            "end_logit": -2.8070197105407715
        },
        {
            "text": "the clinical significance and biological mechanism",
            "probability": 0.0011759142461624616,
            "start_logit": -3.4691879749298096,
            "end_logit": -3.8781678676605225
        },
        {
            "text": "unknown. The expression of uc.38",
            "probability": 0.0008945734536493529,
            "start_logit": -3.4105334281921387,
            "end_logit": -4.2102766036987305
        },
        {
            "text": "the clinical significance and biological mechanism of T-UCRs in breast cancer remain largely unknown. The expression of uc.38",
            "probability": 0.0008436118283900869,
            "start_logit": -3.4691879749298096,
            "end_logit": -4.2102766036987305
        },
        {
            "text": "remain largely unknown.",
            "probability": 0.0007104718225608375,
            "start_logit": -5.04420804977417,
            "end_logit": -2.8070197105407715
        },
        {
            "text": "clinical significance and biological mechanism of T-UCRs in breast cancer",
            "probability": 0.0005808423729799252,
            "start_logit": -2.3057241439819336,
            "end_logit": -5.74695348739624
        },
        {
            "text": "unknown. The expression of uc.38, a T-UCR, was down-regulated in both breast cancer tissues and breast cancer cell lines",
            "probability": 0.0005369429685431654,
            "start_logit": -3.4105334281921387,
            "end_logit": -4.720731735229492
        }
    ],
    "5e2dadcffbd6abf43b000011_001": [
        {
            "text": "hallucination, dizziness, orthostatic hypotension and pedal edema",
            "probability": 0.9203492702804008,
            "start_logit": 7.8080525398254395,
            "end_logit": 6.889261722564697
        },
        {
            "text": "hallucination, dizziness, orthostatic hypotension and pedal edema.",
            "probability": 0.07495223876536881,
            "start_logit": 7.8080525398254395,
            "end_logit": 4.381359577178955
        },
        {
            "text": "The most common side effects are hallucination, dizziness, orthostatic hypotension and pedal edema",
            "probability": 0.002432328659002259,
            "start_logit": 1.8721483945846558,
            "end_logit": 6.889261722564697
        },
        {
            "text": "hallucination, dizziness, orthostatic hypotension",
            "probability": 0.0009031685663914835,
            "start_logit": 7.8080525398254395,
            "end_logit": -0.03733758628368378
        },
        {
            "text": "",
            "probability": 0.00033847503983973907,
            "start_logit": 4.089914798736572,
            "end_logit": 2.699341297149658
        },
        {
            "text": "pedal edema",
            "probability": 0.000291166381245253,
            "start_logit": -0.2505611181259155,
            "end_logit": 6.889261722564697
        },
        {
            "text": "The most common side effects are hallucination, dizziness, orthostatic hypotension and pedal edema.",
            "probability": 0.00019808618781198478,
            "start_logit": 1.8721483945846558,
            "end_logit": 4.381359577178955
        },
        {
            "text": "hallucination, dizziness",
            "probability": 0.00018065527195771587,
            "start_logit": 7.8080525398254395,
            "end_logit": -1.6466561555862427
        },
        {
            "text": "hallucination",
            "probability": 9.843398140979006e-05,
            "start_logit": 7.8080525398254395,
            "end_logit": -2.2538607120513916
        },
        {
            "text": "most common side effects are hallucination, dizziness, orthostatic hypotension and pedal edema",
            "probability": 5.7748368719769625e-05,
            "start_logit": -1.8683608770370483,
            "end_logit": 6.889261722564697
        },
        {
            "text": "hall",
            "probability": 4.178943111846843e-05,
            "start_logit": 7.8080525398254395,
            "end_logit": -3.1106033325195312
        },
        {
            "text": "hallucination, dizziness,",
            "probability": 3.807497418696645e-05,
            "start_logit": 7.8080525398254395,
            "end_logit": -3.2036895751953125
        },
        {
            "text": "hallucination,",
            "probability": 2.912489581079529e-05,
            "start_logit": 7.8080525398254395,
            "end_logit": -3.471653461456299
        },
        {
            "text": "dizziness, orthostatic hypotension and pedal edema",
            "probability": 2.7656533320975823e-05,
            "start_logit": -2.6045939922332764,
            "end_logit": 6.889261722564697
        },
        {
            "text": "pedal edema.",
            "probability": 2.371227188662155e-05,
            "start_logit": -0.2505611181259155,
            "end_logit": 4.381359577178955
        },
        {
            "text": "hallucination, dizziness, orthostatic hypotension and pedal",
            "probability": 1.5461965233414992e-05,
            "start_logit": 7.8080525398254395,
            "end_logit": -4.10486364364624
        },
        {
            "text": "hallucination, dizziness, orthostatic",
            "probability": 8.586110734024581e-06,
            "start_logit": 7.8080525398254395,
            "end_logit": -4.693100929260254
        },
        {
            "text": "edema.",
            "probability": 5.928375363178466e-06,
            "start_logit": -4.144705772399902,
            "end_logit": 6.889261722564697
        },
        {
            "text": "most common side effects are hallucination, dizziness, orthostatic hypotension and pedal edema.",
            "probability": 4.702964038072213e-06,
            "start_logit": -1.8683608770370483,
            "end_logit": 4.381359577178955
        },
        {
            "text": "side effects are hallucination, dizziness, orthostatic hypotension and pedal edema",
            "probability": 3.3909761593533028e-06,
            "start_logit": -4.703338146209717,
            "end_logit": 6.889261722564697
        }
    ],
    "5e490d276d0a277941000001_001": [
        {
            "text": "DNA damage linked to environmental mutagenic and cytotoxic agents",
            "probability": 0.6484566199556023,
            "start_logit": -3.0730772018432617,
            "end_logit": -3.3876028060913086
        },
        {
            "text": "",
            "probability": 0.07465967791344774,
            "start_logit": -4.40735387802124,
            "end_logit": -4.2149810791015625
        },
        {
            "text": "(i) DNA damage linked to environmental mutagenic and cytotoxic agents",
            "probability": 0.0654153906174134,
            "start_logit": -5.366914749145508,
            "end_logit": -3.3876028060913086
        },
        {
            "text": "DNA damage linked to environmental mutagenic and cytotoxic agents,",
            "probability": 0.051939792012794514,
            "start_logit": -3.0730772018432617,
            "end_logit": -5.912112712860107
        },
        {
            "text": "DNA damage",
            "probability": 0.03788984638958589,
            "start_logit": -3.0730772018432617,
            "end_logit": -6.227514743804932
        },
        {
            "text": "i) DNA damage linked to environmental mutagenic and cytotoxic agents",
            "probability": 0.03325850908344308,
            "start_logit": -6.043361663818359,
            "end_logit": -3.3876028060913086
        },
        {
            "text": "DNA damage linked",
            "probability": 0.01612125409195279,
            "start_logit": -3.0730772018432617,
            "end_logit": -7.082059383392334
        },
        {
            "text": "DNA",
            "probability": 0.015998917404273453,
            "start_logit": -3.0730772018432617,
            "end_logit": -7.089676856994629
        },
        {
            "text": "environmental mutagenic and cytotoxic agents",
            "probability": 0.014432274899984993,
            "start_logit": -6.878205299377441,
            "end_logit": -3.3876028060913086
        },
        {
            "text": "DNA damage linked to environmental",
            "probability": 0.011759104381129402,
            "start_logit": -3.0730772018432617,
            "end_logit": -7.3975701332092285
        },
        {
            "text": "(i) DNA damage linked to environmental mutagenic and cytotoxic agents,",
            "probability": 0.005239613072863361,
            "start_logit": -5.366914749145508,
            "end_logit": -5.912112712860107
        },
        {
            "text": "(i) DNA damage",
            "probability": 0.003822274344547908,
            "start_logit": -5.366914749145508,
            "end_logit": -6.227514743804932
        },
        {
            "text": "DNA damage and repair",
            "probability": 0.0036505577059240154,
            "start_logit": -6.382162570953369,
            "end_logit": -5.258232593536377
        },
        {
            "text": "REPAIRtoire is the first comprehensive database resource for systems biology of DNA damage and repair",
            "probability": 0.0031405569553837787,
            "start_logit": -6.532642364501953,
            "end_logit": -5.258232593536377
        },
        {
            "text": "(ii) pathways comprising individual processes and enzymatic reactions involved in the removal of damage",
            "probability": 0.0027539829539669314,
            "start_logit": -6.442025184631348,
            "end_logit": -5.480201721191406
        },
        {
            "text": "i) DNA damage linked to environmental mutagenic and cytotoxic agents,",
            "probability": 0.002663925374943265,
            "start_logit": -6.043361663818359,
            "end_logit": -5.912112712860107
        },
        {
            "text": "pathways comprising individual processes and enzymatic reactions involved in the removal of damage",
            "probability": 0.002572952553536284,
            "start_logit": -6.510019302368164,
            "end_logit": -5.480201721191406
        },
        {
            "text": "systems biology of DNA damage and repair",
            "probability": 0.0022408371380884112,
            "start_logit": -6.870193004608154,
            "end_logit": -5.258232593536377
        },
        {
            "text": "individual processes and enzymatic reactions involved in the removal of damage",
            "probability": 0.002040591483117565,
            "start_logit": -6.741833686828613,
            "end_logit": -5.480201721191406
        },
        {
            "text": "i) DNA damage",
            "probability": 0.0019433216680008357,
            "start_logit": -6.043361663818359,
            "end_logit": -6.227514743804932
        }
    ],
    "5e2f9ceefbd6abf43b000033_001": [
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide (HCT), enalapril (ENA)",
            "probability": 0.34298153601468906,
            "start_logit": 7.915744781494141,
            "end_logit": 0.977629542350769
        },
        {
            "text": "acetylsalicylic acid",
            "probability": 0.2573359592019445,
            "start_logit": 7.915744781494141,
            "end_logit": 0.6903353929519653
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide (HCT)",
            "probability": 0.24963460844868712,
            "start_logit": 7.915744781494141,
            "end_logit": 0.6599512100219727
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide (HCT), enalapril",
            "probability": 0.05763457207665685,
            "start_logit": 7.915744781494141,
            "end_logit": -0.8059244751930237
        },
        {
            "text": "enalapril (ENA), and atorvastatin (ATR)",
            "probability": 0.023332577559463382,
            "start_logit": 0.1321401447057724,
            "end_logit": 6.073408126831055
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide (HCT), enalapril (ENA),",
            "probability": 0.014368661114022293,
            "start_logit": 7.915744781494141,
            "end_logit": -2.194997549057007
        },
        {
            "text": "atorvastatin (ATR)",
            "probability": 0.008647735221502091,
            "start_logit": -0.8604129552841187,
            "end_logit": 6.073408126831055
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide (HCT),",
            "probability": 0.008284104904234726,
            "start_logit": 7.915744781494141,
            "end_logit": -2.745708465576172
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide (HCT), enalapril (ENA",
            "probability": 0.008009047662233901,
            "start_logit": 7.915744781494141,
            "end_logit": -2.779475212097168
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide (HCT",
            "probability": 0.007930500220656073,
            "start_logit": 7.915744781494141,
            "end_logit": -2.7893309593200684
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide",
            "probability": 0.006962510030042046,
            "start_logit": 7.915744781494141,
            "end_logit": -2.9195070266723633
        },
        {
            "text": "acetylsalicylic acid,",
            "probability": 0.0058450194526344056,
            "start_logit": 7.915744781494141,
            "end_logit": -3.0944571495056152
        },
        {
            "text": "ace",
            "probability": 0.003491694548306003,
            "start_logit": 7.915744781494141,
            "end_logit": -3.6096599102020264
        },
        {
            "text": "acetylsalicylic",
            "probability": 0.0018707236589660071,
            "start_logit": 7.915744781494141,
            "end_logit": -4.233721733093262
        },
        {
            "text": "",
            "probability": 0.0012177908544016563,
            "start_logit": 2.2922894954681396,
            "end_logit": 0.9604466557502747
        },
        {
            "text": "ENA), and atorvastatin (ATR)",
            "probability": 0.0008133218632120863,
            "start_logit": -3.2243387699127197,
            "end_logit": 6.073408126831055
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazi",
            "probability": 0.0006564828880074515,
            "start_logit": 7.915744781494141,
            "end_logit": -5.280905723571777
        },
        {
            "text": "enalapril (ENA), and atorvastatin",
            "probability": 0.0003661415921627562,
            "start_logit": 0.1321401447057724,
            "end_logit": 1.9188224077224731
        },
        {
            "text": "HCT), enalapril (ENA), and atorvastatin (ATR)",
            "probability": 0.0003346266972726842,
            "start_logit": -4.112450122833252,
            "end_logit": 6.073408126831055
        },
        {
            "text": "(ENA), and atorvastatin (ATR)",
            "probability": 0.0002823859909048578,
            "start_logit": -4.282190799713135,
            "end_logit": 6.073408126831055
        }
    ],
    "5e2f9ceefbd6abf43b000033_002": [
        {
            "text": "hydrochlorothiazide, aspirin, atorvastatin and either enalapril or valsartan",
            "probability": 0.9406455002279687,
            "start_logit": 7.075828552246094,
            "end_logit": 5.711956024169922
        },
        {
            "text": "hydrochlorothiazide, aspirin, atorvastatin and either enalapril or valsartan.",
            "probability": 0.04686211634889387,
            "start_logit": 7.075828552246094,
            "end_logit": 2.712599277496338
        },
        {
            "text": "",
            "probability": 0.005199824111429873,
            "start_logit": 4.269072532653809,
            "end_logit": 3.320770502090454
        },
        {
            "text": "hydrochlorothiazide, aspirin, atorvastatin",
            "probability": 0.0030810650039615264,
            "start_logit": 7.075828552246094,
            "end_logit": -0.009335000067949295
        },
        {
            "text": "hydrochlorothiazide, aspirin, atorvastatin and either enalapril",
            "probability": 0.001796158090536207,
            "start_logit": 7.075828552246094,
            "end_logit": -0.5489603281021118
        },
        {
            "text": "enalapril or valsartan",
            "probability": 0.0010107138728107196,
            "start_logit": 0.23991909623146057,
            "end_logit": 5.711956024169922
        },
        {
            "text": "comprising hydrochlorothiazide, aspirin, atorvastatin and either enalapril or valsartan",
            "probability": 0.00027197689252350893,
            "start_logit": -1.072775959968567,
            "end_logit": 5.711956024169922
        },
        {
            "text": "hydrochlorothiazide",
            "probability": 0.0002213456974812707,
            "start_logit": 7.075828552246094,
            "end_logit": -2.6426398754119873
        },
        {
            "text": "hydrochlorothiazide, aspirin",
            "probability": 0.00020484762007517797,
            "start_logit": 7.075828552246094,
            "end_logit": -2.7200992107391357
        },
        {
            "text": "aspirin, atorvastatin and either enalapril or valsartan",
            "probability": 0.00017212495645803854,
            "start_logit": -1.530272364616394,
            "end_logit": 5.711956024169922
        },
        {
            "text": "atorvastatin and either enalapril or valsartan",
            "probability": 0.00015598086304169148,
            "start_logit": -1.628759741783142,
            "end_logit": 5.711956024169922
        },
        {
            "text": "hydro",
            "probability": 9.05553031568239e-05,
            "start_logit": 7.075828552246094,
            "end_logit": -3.536404848098755
        },
        {
            "text": "valsartan",
            "probability": 6.28314515263192e-05,
            "start_logit": -2.5380373001098633,
            "end_logit": 5.711956024169922
        },
        {
            "text": "hydrochlorothiazide, aspirin, atorvastatin and either",
            "probability": 5.1100099174037975e-05,
            "start_logit": 7.075828552246094,
            "end_logit": -4.108579158782959
        },
        {
            "text": "enalapril or valsartan.",
            "probability": 5.035285991547101e-05,
            "start_logit": 0.23991909623146057,
            "end_logit": 2.712599277496338
        },
        {
            "text": "hydrochlorothiazide,",
            "probability": 3.651835761662825e-05,
            "start_logit": 7.075828552246094,
            "end_logit": -4.444550514221191
        },
        {
            "text": "hydrochlorothiazide, aspirin,",
            "probability": 3.1408071761132974e-05,
            "start_logit": 7.075828552246094,
            "end_logit": -4.595300674438477
        },
        {
            "text": "hydrochlorothiazi",
            "probability": 2.0224304970961494e-05,
            "start_logit": 7.075828552246094,
            "end_logit": -5.035480499267578
        },
        {
            "text": "either enalapril or valsartan",
            "probability": 1.890427491573817e-05,
            "start_logit": -3.739104986190796,
            "end_logit": 5.711956024169922
        },
        {
            "text": "hydrochlorothiazide, aspirin, atorvastatin and either enalapril or",
            "probability": 1.6451591782099878e-05,
            "start_logit": 7.075828552246094,
            "end_logit": -5.241943359375
        }
    ],
    "5e2f9ceefbd6abf43b000033_003": [
        {
            "text": "aspirin, valsartan, atorvastatin and hydrochlorthiazide",
            "probability": 0.7479286008069874,
            "start_logit": 5.170571804046631,
            "end_logit": 6.167304039001465
        },
        {
            "text": "hydrochlorthiazide",
            "probability": 0.23275842118873155,
            "start_logit": 4.003265380859375,
            "end_logit": 6.167304039001465
        },
        {
            "text": "valsartan, atorvastatin and hydrochlorthiazide",
            "probability": 0.005281976702011271,
            "start_logit": 0.2175646871328354,
            "end_logit": 6.167304039001465
        },
        {
            "text": "aspirin, valsartan, atorvastatin and hydrochlorthiazide (PolyPill)",
            "probability": 0.004816446815187062,
            "start_logit": 5.170571804046631,
            "end_logit": 1.1220329999923706
        },
        {
            "text": "atorvastatin and hydrochlorthiazide",
            "probability": 0.004132235412526577,
            "start_logit": -0.02791719324886799,
            "end_logit": 6.167304039001465
        },
        {
            "text": "aspirin, valsartan, atorvastatin",
            "probability": 0.0019950458632895522,
            "start_logit": 5.170571804046631,
            "end_logit": 0.2406635582447052
        },
        {
            "text": "hydrochlorthiazide (PolyPill)",
            "probability": 0.0014988978295960916,
            "start_logit": 4.003265380859375,
            "end_logit": 1.1220329999923706
        },
        {
            "text": "aspirin, valsartan, atorvastatin and hydrochlorthiazide (PolyPill",
            "probability": 0.0004293335672206408,
            "start_logit": 5.170571804046631,
            "end_logit": -1.2955245971679688
        },
        {
            "text": "",
            "probability": 0.00024059524257488414,
            "start_logit": 1.2074230909347534,
            "end_logit": 2.088505983352661
        },
        {
            "text": "aspirin, valsartan",
            "probability": 0.0002264070379239165,
            "start_logit": 5.170571804046631,
            "end_logit": -1.9354243278503418
        },
        {
            "text": "aspirin, valsartan, atorvastatin and hydrochlorthiazi",
            "probability": 0.00019492385495977678,
            "start_logit": 5.170571804046631,
            "end_logit": -2.0851497650146484
        },
        {
            "text": "hydrochlorthiazide (PolyPill",
            "probability": 0.00013361035152524003,
            "start_logit": 4.003265380859375,
            "end_logit": -1.2955245971679688
        },
        {
            "text": "aspirin",
            "probability": 6.612610532591125e-05,
            "start_logit": 5.170571804046631,
            "end_logit": -3.1661951541900635
        },
        {
            "text": "a fixed-dose combination pill consisting of aspirin, valsartan, atorvastatin and hydrochlorthiazide",
            "probability": 6.414666813451696e-05,
            "start_logit": -4.193318843841553,
            "end_logit": 6.167304039001465
        },
        {
            "text": "hydrochlorthiazi",
            "probability": 6.066109610396796e-05,
            "start_logit": 4.003265380859375,
            "end_logit": -2.0851497650146484
        },
        {
            "text": "consisting of aspirin, valsartan, atorvastatin and hydrochlorthiazide",
            "probability": 4.676711441736807e-05,
            "start_logit": -4.509310722351074,
            "end_logit": 6.167304039001465
        },
        {
            "text": "fixed-dose combination pill consisting of aspirin, valsartan, atorvastatin and hydrochlorthiazide",
            "probability": 3.853115305550999e-05,
            "start_logit": -4.703023910522461,
            "end_logit": 6.167304039001465
        },
        {
            "text": "valsartan, atorvastatin and hydrochlorthiazide (PolyPill)",
            "probability": 3.401442308376126e-05,
            "start_logit": 0.2175646871328354,
            "end_logit": 1.1220329999923706
        },
        {
            "text": "hydrochlorthiazide (PolyPill) in an unselected group of persons aged over 50 years.",
            "probability": 2.664835015981986e-05,
            "start_logit": 4.003265380859375,
            "end_logit": -2.9077250957489014
        },
        {
            "text": "atorvastatin and hydrochlorthiazide (PolyPill)",
            "probability": 2.6610417185266822e-05,
            "start_logit": -0.02791719324886799,
            "end_logit": 1.1220329999923706
        }
    ],
    "5cc011e2a49efeb44c000001_001": [
        {
            "text": "",
            "probability": 0.9856706664666405,
            "start_logit": 0.304217129945755,
            "end_logit": 0.31644436717033386
        },
        {
            "text": "promotes the association of target mRNA with miRISC",
            "probability": 0.00577926087926515,
            "start_logit": -0.8789723515510559,
            "end_logit": -3.6394126415252686
        },
        {
            "text": "promotes the association of target mRNA with miRISC A well-characterized SUMO-interacting motif",
            "probability": 0.002631402930665766,
            "start_logit": -0.8789723515510559,
            "end_logit": -4.42617130279541
        },
        {
            "text": "promotes",
            "probability": 0.0016885774726751626,
            "start_logit": -0.8789723515510559,
            "end_logit": -4.869801998138428
        },
        {
            "text": "promotes the association of target mRNA with miRISC A well-characterized SUMO-interacting motif (SIM)",
            "probability": 0.0015837209610578616,
            "start_logit": -0.8789723515510559,
            "end_logit": -4.933911323547363
        },
        {
            "text": "promotes the association of target mRNA",
            "probability": 0.0010247802478340474,
            "start_logit": -0.8789723515510559,
            "end_logit": -5.369210243225098
        },
        {
            "text": "A well-characterized SUMO-interacting motif (SIM) in Nup358 is sufficient for Nup358 to directly bind to AGO proteins",
            "probability": 0.00039649723950531873,
            "start_logit": -4.248011589050293,
            "end_logit": -2.949735403060913
        },
        {
            "text": "association of target mRNA with miRISC",
            "probability": 0.0002031414593260452,
            "start_logit": -4.227100849151611,
            "end_logit": -3.6394126415252686
        },
        {
            "text": "Nup358 interacts with AGO and GW182 proteins and promotes the association of target mRNA with miRISC",
            "probability": 0.00018232168048984895,
            "start_logit": -4.335230827331543,
            "end_logit": -3.6394126415252686
        },
        {
            "text": "the association of target mRNA with miRISC",
            "probability": 0.0001293866349460455,
            "start_logit": -4.678198337554932,
            "end_logit": -3.6394126415252686
        },
        {
            "text": "well-characterized SUMO-interacting motif (SIM) in Nup358 is sufficient for Nup358 to directly bind to AGO proteins",
            "probability": 0.00010376687428732257,
            "start_logit": -5.588533878326416,
            "end_logit": -2.949735403060913
        },
        {
            "text": "association of target mRNA with miRISC A well-characterized SUMO-interacting motif",
            "probability": 9.249401308878881e-05,
            "start_logit": -4.227100849151611,
            "end_logit": -4.42617130279541
        },
        {
            "text": "A well-characterized SUMO-interacting motif",
            "probability": 9.05799765427303e-05,
            "start_logit": -4.248011589050293,
            "end_logit": -4.42617130279541
        },
        {
            "text": "SUMO-interacting motif (SIM) in Nup358 is sufficient for Nup358 to directly bind to AGO proteins",
            "probability": 8.537983096199204e-05,
            "start_logit": -5.783570766448975,
            "end_logit": -2.949735403060913
        },
        {
            "text": "the association of target mRNA with miRISC A well-characterized SUMO-interacting motif",
            "probability": 5.8912095767737234e-05,
            "start_logit": -4.678198337554932,
            "end_logit": -4.42617130279541
        },
        {
            "text": "SIM) in Nup358 is sufficient for Nup358 to directly bind to AGO proteins",
            "probability": 5.8723301156160787e-05,
            "start_logit": -6.157844066619873,
            "end_logit": -2.949735403060913
        },
        {
            "text": "A well-characterized SUMO-interacting motif (SIM) in Nup358 is sufficient for Nup358 to directly bind to AGO proteins.",
            "probability": 5.693355368179322e-05,
            "start_logit": -4.248011589050293,
            "end_logit": -4.890519618988037
        },
        {
            "text": "association of target mRNA with miRISC A well-characterized SUMO-interacting motif (SIM)",
            "probability": 5.566791219770104e-05,
            "start_logit": -4.227100849151611,
            "end_logit": -4.933911323547363
        },
        {
            "text": "A well-characterized SUMO-interacting motif (SIM)",
            "probability": 5.45159412232457e-05,
            "start_logit": -4.248011589050293,
            "end_logit": -4.933911323547363
        },
        {
            "text": "Nup358 interacts with AGO and GW182 proteins and promotes",
            "probability": 5.327052868646129e-05,
            "start_logit": -4.335230827331543,
            "end_logit": -4.869801998138428
        }
    ],
    "5cc011e2a49efeb44c000001_002": [
        {
            "text": "",
            "probability": 0.9856706664666405,
            "start_logit": 0.304217129945755,
            "end_logit": 0.31644436717033386
        },
        {
            "text": "promotes the association of target mRNA with miRISC",
            "probability": 0.00577926087926515,
            "start_logit": -0.8789723515510559,
            "end_logit": -3.6394126415252686
        },
        {
            "text": "promotes the association of target mRNA with miRISC A well-characterized SUMO-interacting motif",
            "probability": 0.002631402930665766,
            "start_logit": -0.8789723515510559,
            "end_logit": -4.42617130279541
        },
        {
            "text": "promotes",
            "probability": 0.0016885774726751626,
            "start_logit": -0.8789723515510559,
            "end_logit": -4.869801998138428
        },
        {
            "text": "promotes the association of target mRNA with miRISC A well-characterized SUMO-interacting motif (SIM)",
            "probability": 0.0015837209610578616,
            "start_logit": -0.8789723515510559,
            "end_logit": -4.933911323547363
        },
        {
            "text": "promotes the association of target mRNA",
            "probability": 0.0010247802478340474,
            "start_logit": -0.8789723515510559,
            "end_logit": -5.369210243225098
        },
        {
            "text": "A well-characterized SUMO-interacting motif (SIM) in Nup358 is sufficient for Nup358 to directly bind to AGO proteins",
            "probability": 0.00039649723950531873,
            "start_logit": -4.248011589050293,
            "end_logit": -2.949735403060913
        },
        {
            "text": "association of target mRNA with miRISC",
            "probability": 0.0002031414593260452,
            "start_logit": -4.227100849151611,
            "end_logit": -3.6394126415252686
        },
        {
            "text": "Nup358 interacts with AGO and GW182 proteins and promotes the association of target mRNA with miRISC",
            "probability": 0.00018232168048984895,
            "start_logit": -4.335230827331543,
            "end_logit": -3.6394126415252686
        },
        {
            "text": "the association of target mRNA with miRISC",
            "probability": 0.0001293866349460455,
            "start_logit": -4.678198337554932,
            "end_logit": -3.6394126415252686
        },
        {
            "text": "well-characterized SUMO-interacting motif (SIM) in Nup358 is sufficient for Nup358 to directly bind to AGO proteins",
            "probability": 0.00010376687428732257,
            "start_logit": -5.588533878326416,
            "end_logit": -2.949735403060913
        },
        {
            "text": "association of target mRNA with miRISC A well-characterized SUMO-interacting motif",
            "probability": 9.249401308878881e-05,
            "start_logit": -4.227100849151611,
            "end_logit": -4.42617130279541
        },
        {
            "text": "A well-characterized SUMO-interacting motif",
            "probability": 9.05799765427303e-05,
            "start_logit": -4.248011589050293,
            "end_logit": -4.42617130279541
        },
        {
            "text": "SUMO-interacting motif (SIM) in Nup358 is sufficient for Nup358 to directly bind to AGO proteins",
            "probability": 8.537983096199204e-05,
            "start_logit": -5.783570766448975,
            "end_logit": -2.949735403060913
        },
        {
            "text": "the association of target mRNA with miRISC A well-characterized SUMO-interacting motif",
            "probability": 5.8912095767737234e-05,
            "start_logit": -4.678198337554932,
            "end_logit": -4.42617130279541
        },
        {
            "text": "SIM) in Nup358 is sufficient for Nup358 to directly bind to AGO proteins",
            "probability": 5.8723301156160787e-05,
            "start_logit": -6.157844066619873,
            "end_logit": -2.949735403060913
        },
        {
            "text": "A well-characterized SUMO-interacting motif (SIM) in Nup358 is sufficient for Nup358 to directly bind to AGO proteins.",
            "probability": 5.693355368179322e-05,
            "start_logit": -4.248011589050293,
            "end_logit": -4.890519618988037
        },
        {
            "text": "association of target mRNA with miRISC A well-characterized SUMO-interacting motif (SIM)",
            "probability": 5.566791219770104e-05,
            "start_logit": -4.227100849151611,
            "end_logit": -4.933911323547363
        },
        {
            "text": "A well-characterized SUMO-interacting motif (SIM)",
            "probability": 5.45159412232457e-05,
            "start_logit": -4.248011589050293,
            "end_logit": -4.933911323547363
        },
        {
            "text": "Nup358 interacts with AGO and GW182 proteins and promotes",
            "probability": 5.327052868646129e-05,
            "start_logit": -4.335230827331543,
            "end_logit": -4.869801998138428
        }
    ],
    "5cc011e2a49efeb44c000001_003": [
        {
            "text": "",
            "probability": 0.9938217655661713,
            "start_logit": 2.8244338035583496,
            "end_logit": 2.9022531509399414
        },
        {
            "text": "mislocalization of Tpr to the nuclear interior.",
            "probability": 0.0020796443632574275,
            "start_logit": -0.1881074458360672,
            "end_logit": -0.25456658005714417
        },
        {
            "text": "mislocalization of Tpr to the nuclear interior",
            "probability": 0.001132462245619815,
            "start_logit": -0.1881074458360672,
            "end_logit": -0.8623692393302917
        },
        {
            "text": "cellular depletion of Nup153 by RNAi is shown to result in mislocalization of Tpr to the nuclear interior.",
            "probability": 0.0008041861171882552,
            "start_logit": -1.1382288932800293,
            "end_logit": -0.25456658005714417
        },
        {
            "text": "cellular depletion of Nup153 by RNAi is shown to result in mislocalization of Tpr to the nuclear interior",
            "probability": 0.00043791642083495965,
            "start_logit": -1.1382288932800293,
            "end_logit": -0.8623692393302917
        },
        {
            "text": "mislocalization",
            "probability": 0.00040479491775412686,
            "start_logit": -0.1881074458360672,
            "end_logit": -1.8911381959915161
        },
        {
            "text": "mislocalization of Tpr to the nuclear interior. Nup153 deficiency",
            "probability": 0.00019738787472817082,
            "start_logit": -0.1881074458360672,
            "end_logit": -2.6093480587005615
        },
        {
            "text": "to result in mislocalization of Tpr to the nuclear interior.",
            "probability": 0.0001745109923250048,
            "start_logit": -2.666071891784668,
            "end_logit": -0.25456658005714417
        },
        {
            "text": "cellular depletion of Nup153 by RNAi is shown to result in mislocalization",
            "probability": 0.00015653178924128136,
            "start_logit": -1.1382288932800293,
            "end_logit": -1.8911381959915161
        },
        {
            "text": "cellular depletion of Nup153 by RNAi",
            "probability": 0.0001266535091049325,
            "start_logit": -1.1382288932800293,
            "end_logit": -2.1029422283172607
        },
        {
            "text": "mislocalization of Tpr",
            "probability": 9.981037205535322e-05,
            "start_logit": -0.1881074458360672,
            "end_logit": -3.2912466526031494
        },
        {
            "text": "to result in mislocalization of Tpr to the nuclear interior",
            "probability": 9.502928180670577e-05,
            "start_logit": -2.666071891784668,
            "end_logit": -0.8623692393302917
        },
        {
            "text": "studies of cells depleted of Tpr as a result of posttranscriptional tpr gene silencing by RNA interference (RNAi)",
            "probability": 8.4901576150892e-05,
            "start_logit": -1.758836030960083,
            "end_logit": -1.8822975158691406
        },
        {
            "text": "mislocalization of Tpr to the nuclear interior. Nup153 deficiency also causes mislocalization of Nup50",
            "probability": 7.287864177397854e-05,
            "start_logit": -0.1881074458360672,
            "end_logit": -3.6057231426239014
        },
        {
            "text": "nuclear interior.",
            "probability": 5.8519831174186654e-05,
            "start_logit": -3.7586939334869385,
            "end_logit": -0.25456658005714417
        },
        {
            "text": "studies of cells depleted of Tpr as a result of posttranscriptional tpr gene silencing by RNA interference",
            "probability": 5.620352075730721e-05,
            "start_logit": -1.758836030960083,
            "end_logit": -2.2948107719421387
        },
        {
            "text": "studies of cells depleted of Tpr as a result of posttranscriptional tpr gene silencing by RNA interference (RNAi",
            "probability": 5.284184398013433e-05,
            "start_logit": -1.758836030960083,
            "end_logit": -2.3564867973327637
        },
        {
            "text": "posttranscriptional tpr gene silencing by RNA interference (RNAi)",
            "probability": 5.248347894908516e-05,
            "start_logit": -2.239830255508423,
            "end_logit": -1.8822975158691406
        },
        {
            "text": "result in mislocalization of Tpr to the nuclear interior.",
            "probability": 4.7316312322322165e-05,
            "start_logit": -3.9712045192718506,
            "end_logit": -0.25456658005714417
        },
        {
            "text": "Tpr to the nuclear interior.",
            "probability": 4.416134480456246e-05,
            "start_logit": -4.040209770202637,
            "end_logit": -0.25456658005714417
        }
    ],
    "5cc011e2a49efeb44c000001_004": [
        {
            "text": "co-localize in a small number of dense-staining perinuclear foci.",
            "probability": 0.09578098460432129,
            "start_logit": -1.5605733394622803,
            "end_logit": -0.30528828501701355
        },
        {
            "text": "enhances ulp1 mutant defects",
            "probability": 0.08405213222192806,
            "start_logit": -1.3261852264404297,
            "end_logit": -0.6703033447265625
        },
        {
            "text": "organizing macromolecules at the nuclear envelope",
            "probability": 0.0812326406766034,
            "start_logit": -1.3754832744598389,
            "end_logit": -0.6551253795623779
        },
        {
            "text": "both the major conduit for nucleocytoplasmic trafficking and a platform for organizing macromolecules at the nuclear envelope",
            "probability": 0.07252270164274846,
            "start_logit": -1.4889007806777954,
            "end_logit": -0.6551253795623779
        },
        {
            "text": "essential for proper nuclear basket function",
            "probability": 0.06674102053681731,
            "start_logit": -1.6232469081878662,
            "end_logit": -0.6038591265678406
        },
        {
            "text": "enhances ulp1 mutant defects.",
            "probability": 0.06558740087698094,
            "start_logit": -1.3261852264404297,
            "end_logit": -0.9183569550514221
        },
        {
            "text": "organizing macromolecules at the nuclear envelope.",
            "probability": 0.052262589103170304,
            "start_logit": -1.3754832744598389,
            "end_logit": -1.0961617231369019
        },
        {
            "text": "essential for proper nuclear basket function, which includes mRNA surveillance and regulation of SUMO protein dynamics",
            "probability": 0.050916660061011254,
            "start_logit": -1.6232469081878662,
            "end_logit": -0.8744887113571167
        },
        {
            "text": "both the major conduit for nucleocytoplasmic trafficking and a platform for organizing macromolecules at the nuclear envelope.",
            "probability": 0.046658881516558115,
            "start_logit": -1.4889007806777954,
            "end_logit": -1.0961617231369019
        },
        {
            "text": "essential for proper nuclear basket function, which includes mRNA surveillance and regulation of SUMO protein dynamics.",
            "probability": 0.04533826511095456,
            "start_logit": -1.6232469081878662,
            "end_logit": -0.9905275106430054
        },
        {
            "text": "organizing macromolecules",
            "probability": 0.043654874476484466,
            "start_logit": -1.3754832744598389,
            "end_logit": -1.276127576828003
        },
        {
            "text": "these proteins are essential for proper nuclear basket function",
            "probability": 0.04327167606210616,
            "start_logit": -2.0565683841705322,
            "end_logit": -0.6038591265678406
        },
        {
            "text": "Similar to previous findings with Mlp1, both Esc1 and Ulp1 help retain unspliced pre-mRNAs in the nucleus",
            "probability": 0.03951382055639211,
            "start_logit": -1.2641643285751343,
            "end_logit": -1.48711097240448
        },
        {
            "text": "both the major conduit for nucleocytoplasmic trafficking and a platform for organizing macromolecules",
            "probability": 0.0389741046276436,
            "start_logit": -1.4889007806777954,
            "end_logit": -1.276127576828003
        },
        {
            "text": "these proteins are essential for proper nuclear basket function, which includes mRNA surveillance and regulation of SUMO protein dynamics",
            "probability": 0.03301191984484336,
            "start_logit": -2.0565683841705322,
            "end_logit": -0.8744887113571167
        },
        {
            "text": "proteins are essential for proper nuclear basket function",
            "probability": 0.030776962189700628,
            "start_logit": -2.3973002433776855,
            "end_logit": -0.6038591265678406
        },
        {
            "text": "these proteins are essential for proper nuclear basket function, which includes mRNA surveillance and regulation of SUMO protein dynamics.",
            "probability": 0.029395156162121686,
            "start_logit": -2.0565683841705322,
            "end_logit": -0.9905275106430054
        },
        {
            "text": "help retain unspliced pre-mRNAs in the nucleus. Therefore, these proteins are essential for proper nuclear basket function",
            "probability": 0.028988136191326848,
            "start_logit": -2.4571800231933594,
            "end_logit": -0.6038591265678406
        },
        {
            "text": "alters SUMO conjugate accumulation and enhances ulp1 mutant defects",
            "probability": 0.026259285249521258,
            "start_logit": -2.48960280418396,
            "end_logit": -0.6703033447265625
        },
        {
            "text": "both Esc1 and Ulp1 help retain unspliced pre-mRNAs in the nucleus",
            "probability": 0.02373715150930813,
            "start_logit": -1.773773431777954,
            "end_logit": -1.48711097240448
        },
        {
            "text": "",
            "probability": 0.0013236367794582863,
            "start_logit": -3.299647569656372,
            "end_logit": -2.8478951454162598
        }
    ],
    "5e36ad01b5b409ea53000006_002": [
        {
            "text": "",
            "probability": 0.9999376239038636,
            "start_logit": 3.5796725749969482,
            "end_logit": 3.4269163608551025
        },
        {
            "text": "Transcribed ultraconserved regions",
            "probability": 2.3421105104222192e-05,
            "start_logit": -1.933404803276062,
            "end_logit": -1.721816897392273
        },
        {
            "text": "T-UCRs are dysregulated in cancers",
            "probability": 1.2192922973222186e-05,
            "start_logit": -1.1754449605941772,
            "end_logit": -3.132558584213257
        },
        {
            "text": "Transcribed ultraconserved regions (T-UCRs) are a subset of long noncoding RNAs",
            "probability": 9.071403706206773e-06,
            "start_logit": -1.933404803276062,
            "end_logit": -2.6703274250030518
        },
        {
            "text": "T-UCRs are dysregulated",
            "probability": 6.572167901245514e-06,
            "start_logit": -1.1754449605941772,
            "end_logit": -3.75057053565979
        },
        {
            "text": "T-UCRs",
            "probability": 1.6419693660977524e-06,
            "start_logit": -1.1754449605941772,
            "end_logit": -5.137517929077148
        },
        {
            "text": "T-UCRs) are a subset of long noncoding RNAs",
            "probability": 1.2436642447548952e-06,
            "start_logit": -3.9204697608947754,
            "end_logit": -2.6703274250030518
        },
        {
            "text": "ultraconserved regions",
            "probability": 1.014543384852908e-06,
            "start_logit": -5.072603702545166,
            "end_logit": -1.721816897392273
        },
        {
            "text": "T-UCRs are dysregulated in cancers and play an important role in the development and progression of malignancies",
            "probability": 1.0112098791252185e-06,
            "start_logit": -1.1754449605941772,
            "end_logit": -5.62226676940918
        },
        {
            "text": "uc.160 and microRNA miR-155",
            "probability": 9.808915141995029e-07,
            "start_logit": -2.822596549987793,
            "end_logit": -4.005556106567383
        },
        {
            "text": "long noncoding RNAs",
            "probability": 8.154274886243483e-07,
            "start_logit": -4.342574596405029,
            "end_logit": -2.6703274250030518
        },
        {
            "text": "Transcribed ultraconserved regions (T-UCRs) are a subset of long noncoding RNAs.",
            "probability": 7.848596024935094e-07,
            "start_logit": -1.933404803276062,
            "end_logit": -5.11770486831665
        },
        {
            "text": "dysregulated in cancers",
            "probability": 6.21631710935914e-07,
            "start_logit": -4.151708126068115,
            "end_logit": -3.132558584213257
        },
        {
            "text": "Transcribed ultraconserved regions (T-UCRs",
            "probability": 5.753186844092755e-07,
            "start_logit": -1.933404803276062,
            "end_logit": -5.428285598754883
        },
        {
            "text": "long noncoding RNAs. It has been reported that T-UCRs are dysregulated in cancers",
            "probability": 5.136187929979733e-07,
            "start_logit": -4.342574596405029,
            "end_logit": -3.132558584213257
        },
        {
            "text": "T-UCRs are dysregulated in cancers and play an important role in the development and progression of malignancies.",
            "probability": 4.4652874113405747e-07,
            "start_logit": -1.1754449605941772,
            "end_logit": -6.439665794372559
        },
        {
            "text": "ultraconserved regions (T-UCRs) are a subset of long noncoding RNAs",
            "probability": 3.9295040009888866e-07,
            "start_logit": -5.072603702545166,
            "end_logit": -2.6703274250030518
        },
        {
            "text": "Transcribed",
            "probability": 3.7441645910228236e-07,
            "start_logit": -1.933404803276062,
            "end_logit": -5.8578410148620605
        },
        {
            "text": "microRNA miR-155",
            "probability": 3.663973901394905e-07,
            "start_logit": -3.807339906692505,
            "end_logit": -4.005556106567383
        },
        {
            "text": "dysregulated",
            "probability": 3.3506879244474466e-07,
            "start_logit": -4.151708126068115,
            "end_logit": -3.75057053565979
        }
    ],
    "5e36ad01b5b409ea53000006_004": [
        {
            "text": "",
            "probability": 0.9999978058297501,
            "start_logit": 3.665682315826416,
            "end_logit": 3.8971307277679443
        },
        {
            "text": "GC)",
            "probability": 5.705674712505156e-07,
            "start_logit": -3.9232521057128906,
            "end_logit": -2.8905670642852783
        },
        {
            "text": "(GC)",
            "probability": 3.273140670983813e-07,
            "start_logit": -4.478963375091553,
            "end_logit": -2.8905670642852783
        },
        {
            "text": "T-UCR expression in gastric cancer (GC)",
            "probability": 2.3177870078474897e-07,
            "start_logit": -4.824100494384766,
            "end_logit": -2.8905670642852783
        },
        {
            "text": "T-UCR",
            "probability": 1.4907094423855003e-07,
            "start_logit": -4.824100494384766,
            "end_logit": -3.33192777633667
        },
        {
            "text": "Uc.160+",
            "probability": 1.0658213294083892e-07,
            "start_logit": -3.6088972091674805,
            "end_logit": -4.8826375007629395
        },
        {
            "text": "downregulation of T-UCR expression in gastric cancer (GC)",
            "probability": 9.705327597539042e-08,
            "start_logit": -5.6946234703063965,
            "end_logit": -2.8905670642852783
        },
        {
            "text": "the downregulation of T-UCR expression in gastric cancer (GC)",
            "probability": 8.62314094520854e-08,
            "start_logit": -5.812849044799805,
            "end_logit": -2.8905670642852783
        },
        {
            "text": "Uc.160+ could possibly have a tumor suppressive role in GC.",
            "probability": 8.47279585440302e-08,
            "start_logit": -3.6088972091674805,
            "end_logit": -5.112107753753662
        },
        {
            "text": "gastric cancer (GC)",
            "probability": 8.328558170761499e-08,
            "start_logit": -5.8476080894470215,
            "end_logit": -2.8905670642852783
        },
        {
            "text": "GC),",
            "probability": 8.198749704074121e-08,
            "start_logit": -3.9232521057128906,
            "end_logit": -4.830631732940674
        },
        {
            "text": "downregulation of T-UCR",
            "probability": 6.242084989738632e-08,
            "start_logit": -5.6946234703063965,
            "end_logit": -3.33192777633667
        },
        {
            "text": "Uc.160",
            "probability": 6.20333915171792e-08,
            "start_logit": -3.6088972091674805,
            "end_logit": -5.423880577087402
        },
        {
            "text": "the downregulation of T-UCR",
            "probability": 5.54606509852748e-08,
            "start_logit": -5.812849044799805,
            "end_logit": -3.33192777633667
        },
        {
            "text": "(GC),",
            "probability": 4.70332825823485e-08,
            "start_logit": -4.478963375091553,
            "end_logit": -4.830631732940674
        },
        {
            "text": "Uc.160 was observed by bisulfite genomic DNA sequencing analysis. The effect of DNA methylation on Uc.160+",
            "probability": 3.6660153627704034e-08,
            "start_logit": -4.387710094451904,
            "end_logit": -5.171050071716309
        },
        {
            "text": "T-UCR expression in gastric cancer (GC),",
            "probability": 3.3305360894562694e-08,
            "start_logit": -4.824100494384766,
            "end_logit": -4.830631732940674
        },
        {
            "text": "T-UCRs have distinct signatures in human cancers. We previously discovered the downregulation of T-UCR",
            "probability": 3.000992085841722e-08,
            "start_logit": -6.426994800567627,
            "end_logit": -3.33192777633667
        },
        {
            "text": "GC), indicating that T-UCRs could play an important role in GC biology.",
            "probability": 2.4427542251811326e-08,
            "start_logit": -3.9232521057128906,
            "end_logit": -6.041487216949463
        },
        {
            "text": "Uc.160+ expression was further confirmed by reporter gene assay. We also revealed that Uc.160",
            "probability": 2.4220058090988802e-08,
            "start_logit": -4.462217330932617,
            "end_logit": -5.511052131652832
        }
    ],
    "5e36ad01b5b409ea53000006_005": [
        {
            "text": "",
            "probability": 0.820098227067641,
            "start_logit": 0.7654280066490173,
            "end_logit": 1.3727476596832275
        },
        {
            "text": "26",
            "probability": 0.05044622133279533,
            "start_logit": -0.6247460246086121,
            "end_logit": -0.02559458650648594
        },
        {
            "text": "26 T-UCRs",
            "probability": 0.04881073183513605,
            "start_logit": -0.6247460246086121,
            "end_logit": -0.058552227914333344
        },
        {
            "text": "prostate cancer",
            "probability": 0.019181721301284538,
            "start_logit": 0.4259873330593109,
            "end_logit": -2.0432779788970947
        },
        {
            "text": "prostate cancer (PCa",
            "probability": 0.01476299431442687,
            "start_logit": 0.4259873330593109,
            "end_logit": -2.30511212348938
        },
        {
            "text": "prostate cancer (PCa)",
            "probability": 0.011599683534143493,
            "start_logit": 0.4259873330593109,
            "end_logit": -2.546257972717285
        },
        {
            "text": "prostate",
            "probability": 0.01006186035843609,
            "start_logit": 0.4259873330593109,
            "end_logit": -2.688483715057373
        },
        {
            "text": "26 T-UCRs and determined the regions that were differently expressed in prostate cancer",
            "probability": 0.0067074875846667185,
            "start_logit": -0.6247460246086121,
            "end_logit": -2.0432779788970947
        },
        {
            "text": "26 T-UCRs and determined the regions that were differently expressed in prostate cancer (PCa",
            "probability": 0.005162341769082651,
            "start_logit": -0.6247460246086121,
            "end_logit": -2.30511212348938
        },
        {
            "text": "26 T-UCRs and determined the regions that were differently expressed in prostate cancer (PCa)",
            "probability": 0.004056191416258358,
            "start_logit": -0.6247460246086121,
            "end_logit": -2.546257972717285
        },
        {
            "text": "26 T-UCRs and determined the regions that were differently expressed in prostate",
            "probability": 0.0035184435417868745,
            "start_logit": -0.6247460246086121,
            "end_logit": -2.688483715057373
        },
        {
            "text": "prostate cancer (PCa) and gastric cancer (GC)",
            "probability": 0.0012405191143234583,
            "start_logit": 0.4259873330593109,
            "end_logit": -4.781705856323242
        },
        {
            "text": "Uc.416+A",
            "probability": 0.0010238013769183832,
            "start_logit": -2.0097765922546387,
            "end_logit": -2.537949323654175
        },
        {
            "text": "prostate cancer (PCa) and gastric cancer (GC",
            "probability": 0.0008069591000187371,
            "start_logit": 0.4259873330593109,
            "end_logit": -5.2117180824279785
        },
        {
            "text": "prostate cancer (PCa) and gastric cancer (GC).",
            "probability": 0.0007167106051854565,
            "start_logit": 0.4259873330593109,
            "end_logit": -5.330318927764893
        },
        {
            "text": "26 T-UCRs and determined the regions that were differently expressed in prostate cancer (PCa) and gastric cancer (GC)",
            "probability": 0.0004337862294615413,
            "start_logit": -0.6247460246086121,
            "end_logit": -4.781705856323242
        },
        {
            "text": "26 T",
            "probability": 0.0004230979589983902,
            "start_logit": -0.6247460246086121,
            "end_logit": -4.80665397644043
        },
        {
            "text": "T-UCRs",
            "probability": 0.0003818415605273161,
            "start_logit": -5.475445747375488,
            "end_logit": -0.058552227914333344
        },
        {
            "text": "(PCa",
            "probability": 0.0002852015614428038,
            "start_logit": -3.520695447921753,
            "end_logit": -2.30511212348938
        },
        {
            "text": "26 T-UCRs and determined the regions that were differently expressed in prostate cancer (PCa) and gastric cancer (GC",
            "probability": 0.0002821784374662476,
            "start_logit": -0.6247460246086121,
            "end_logit": -5.2117180824279785
        }
    ],
    "5e2dae57fbd6abf43b000012_001": [
        {
            "text": "approximately twice the level",
            "probability": 0.39558988817218615,
            "start_logit": 6.475462913513184,
            "end_logit": 5.656861782073975
        },
        {
            "text": "twice the level",
            "probability": 0.22857570931072052,
            "start_logit": 5.926952362060547,
            "end_logit": 5.656861782073975
        },
        {
            "text": "approximately twice",
            "probability": 0.18563589389477733,
            "start_logit": 6.475462913513184,
            "end_logit": 4.900270938873291
        },
        {
            "text": "twice",
            "probability": 0.10726223644538485,
            "start_logit": 5.926952362060547,
            "end_logit": 4.900270938873291
        },
        {
            "text": "approximately twice the level achieved",
            "probability": 0.028902234412565085,
            "start_logit": 6.475462913513184,
            "end_logit": 3.04040265083313
        },
        {
            "text": "approximately twice the level achieved by amantadine immediate release",
            "probability": 0.022430813404393714,
            "start_logit": 6.475462913513184,
            "end_logit": 2.786919355392456
        },
        {
            "text": "twice the level achieved",
            "probability": 0.016699993930687305,
            "start_logit": 5.926952362060547,
            "end_logit": 3.04040265083313
        },
        {
            "text": "twice the level achieved by amantadine immediate release",
            "probability": 0.012960743531680087,
            "start_logit": 5.926952362060547,
            "end_logit": 2.786919355392456
        },
        {
            "text": "approximately twice the level achieved by amantadine immediate release.",
            "probability": 0.0007455175914536229,
            "start_logit": 6.475462913513184,
            "end_logit": -0.617192804813385
        },
        {
            "text": "twice the level achieved by amantadine immediate release.",
            "probability": 0.0004307673612626812,
            "start_logit": 5.926952362060547,
            "end_logit": -0.617192804813385
        },
        {
            "text": "plasma concentration approximately twice the level",
            "probability": 0.00038283135034042944,
            "start_logit": -0.46507585048675537,
            "end_logit": 5.656861782073975
        },
        {
            "text": "plasma concentration approximately twice",
            "probability": 0.00017964877782835858,
            "start_logit": -0.46507585048675537,
            "end_logit": 4.900270938873291
        },
        {
            "text": "approximately twice the level achieved by amantadine",
            "probability": 3.378334145569189e-05,
            "start_logit": 6.475462913513184,
            "end_logit": -3.7113037109375
        },
        {
            "text": "approximately",
            "probability": 2.8470885113653093e-05,
            "start_logit": 6.475462913513184,
            "end_logit": -3.882389545440674
        },
        {
            "text": "plasma concentration approximately twice the level achieved",
            "probability": 2.7970081538590436e-05,
            "start_logit": -0.46507585048675537,
            "end_logit": 3.04040265083313
        },
        {
            "text": "concentration approximately twice the level",
            "probability": 2.693146148895626e-05,
            "start_logit": -3.119375228881836,
            "end_logit": 5.656861782073975
        },
        {
            "text": "plasma concentration approximately twice the level achieved by amantadine immediate release",
            "probability": 2.170737635513206e-05,
            "start_logit": -0.46507585048675537,
            "end_logit": 2.786919355392456
        },
        {
            "text": "twice the level achieved by amantadine",
            "probability": 1.9520345355136862e-05,
            "start_logit": 5.926952362060547,
            "end_logit": -3.7113037109375
        },
        {
            "text": "approximately twice the level achieved by amantadine immediate",
            "probability": 1.9381370965680083e-05,
            "start_logit": 6.475462913513184,
            "end_logit": -4.266959190368652
        },
        {
            "text": "it reaches plasma concentration approximately twice the level",
            "probability": 1.695816287652022e-05,
            "start_logit": -3.581921100616455,
            "end_logit": 5.656861782073975
        },
        {
            "text": "",
            "probability": 8.998791570453803e-06,
            "start_logit": 0.783807635307312,
            "end_logit": 0.6574740409851074
        }
    ],
    "5e2dae57fbd6abf43b000012_002": [
        {
            "text": "higher",
            "probability": 0.39637879384808644,
            "start_logit": 2.6973366737365723,
            "end_logit": 1.6899187564849854
        },
        {
            "text": "Amantadine plasma concentrations were higher",
            "probability": 0.13712233044214348,
            "start_logit": 1.635839819908142,
            "end_logit": 1.6899187564849854
        },
        {
            "text": "higher in PD patients versus healthy volunteers.",
            "probability": 0.13427539181650766,
            "start_logit": 2.6973366737365723,
            "end_logit": 0.6074413061141968
        },
        {
            "text": "higher in PD patients versus healthy volunteers",
            "probability": 0.08634764407783682,
            "start_logit": 2.6973366737365723,
            "end_logit": 0.16592997312545776
        },
        {
            "text": "",
            "probability": 0.0636504597207029,
            "start_logit": 1.5892517566680908,
            "end_logit": 0.9690399169921875
        },
        {
            "text": "slow initial rise in amantadine plasma concentration, with delayed time to maximum concentration (12-16\u00a0h). Amantadine plasma concentrations were higher",
            "probability": 0.053677210370424916,
            "start_logit": 0.6979548931121826,
            "end_logit": 1.6899187564849854
        },
        {
            "text": "Amantadine plasma concentrations were higher in PD patients versus healthy volunteers.",
            "probability": 0.04645090739634264,
            "start_logit": 1.635839819908142,
            "end_logit": 0.6074413061141968
        },
        {
            "text": "Amantadine plasma concentrations were higher in PD patients versus healthy volunteers",
            "probability": 0.029870897151676404,
            "start_logit": 1.635839819908142,
            "end_logit": 0.16592997312545776
        },
        {
            "text": "higher in PD patients versus healthy volunteers. The steady-state profile of once-daily ADS-5102 was significantly different",
            "probability": 0.018842780726816843,
            "start_logit": 2.6973366737365723,
            "end_logit": -1.3563216924667358
        },
        {
            "text": "slow initial rise in amantadine plasma concentration, with delayed time to maximum concentration (12-16\u00a0h).",
            "probability": 0.01206707007401659,
            "start_logit": 0.6979548931121826,
            "end_logit": 0.1974104940891266
        },
        {
            "text": "Amantadine plasma concentrations were higher in PD patients versus healthy volunteers. The steady-state profile of once-daily ADS-5102 was significantly different",
            "probability": 0.006518426427882185,
            "start_logit": 1.635839819908142,
            "end_logit": -1.3563216924667358
        },
        {
            "text": "1.4- to 2.0-fold higher",
            "probability": 0.004623567256938713,
            "start_logit": -0.574896514415741,
            "end_logit": 0.5109481811523438
        },
        {
            "text": "slow",
            "probability": 0.0029321651213990063,
            "start_logit": 0.6979548931121826,
            "end_logit": -1.217328667640686
        },
        {
            "text": "slow initial rise in amantadine plasma concentration, with delayed time to maximum concentration",
            "probability": 0.0016562329815762783,
            "start_logit": 0.6979548931121826,
            "end_logit": -1.7885240316390991
        },
        {
            "text": "slow initial rise in amantadine plasma concentration",
            "probability": 0.0013633274211225553,
            "start_logit": 0.6979548931121826,
            "end_logit": -1.9831414222717285
        },
        {
            "text": "slow initial rise",
            "probability": 0.0012653311253691334,
            "start_logit": 0.6979548931121826,
            "end_logit": -2.0577359199523926
        },
        {
            "text": "significantly different from that of twice-daily amantadine IR, such that the two formulations are not bioequivalent",
            "probability": 0.0009656580999865218,
            "start_logit": -0.9261904358863831,
            "end_logit": -0.7038698792457581
        },
        {
            "text": "delayed time to maximum concentration (12-16\u00a0h). Amantadine plasma concentrations were higher",
            "probability": 0.0009107441233951316,
            "start_logit": -3.3785269260406494,
            "end_logit": 1.6899187564849854
        },
        {
            "text": "1.4- to 2.0-fold higher amantadine plasma concentrations during the day versus amantadine IR",
            "probability": 0.0005531060425000817,
            "start_logit": -0.574896514415741,
            "end_logit": -1.6124238967895508
        },
        {
            "text": "initial rise in amantadine plasma concentration, with delayed time to maximum concentration (12-16\u00a0h). Amantadine plasma concentrations were higher",
            "probability": 0.0005279557752756268,
            "start_logit": -3.923776388168335,
            "end_logit": 1.6899187564849854
        }
    ],
    "5e4981e96d0a277941000009_001": [
        {
            "text": "The reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states by February 2018",
            "probability": 0.23520486030007104,
            "start_logit": 1.3570679426193237,
            "end_logit": 0.941706120967865
        },
        {
            "text": "reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states by February 2018",
            "probability": 0.20540223083381226,
            "start_logit": 1.221581220626831,
            "end_logit": 0.941706120967865
        },
        {
            "text": "The reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states",
            "probability": 0.10489738119183187,
            "start_logit": 1.3570679426193237,
            "end_logit": 0.1342317909002304
        },
        {
            "text": "The reduction of the dose limit",
            "probability": 0.09756185897380172,
            "start_logit": 1.3570679426193237,
            "end_logit": 0.06173586845397949
        },
        {
            "text": "reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states",
            "probability": 0.09160591357652544,
            "start_logit": 1.221581220626831,
            "end_logit": 0.1342317909002304
        },
        {
            "text": "reduction of the dose limit",
            "probability": 0.08519986981538837,
            "start_logit": 1.221581220626831,
            "end_logit": 0.06173586845397949
        },
        {
            "text": "The reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states by February 2018.",
            "probability": 0.037662259007577956,
            "start_logit": 1.3570679426193237,
            "end_logit": -0.8900922536849976
        },
        {
            "text": "reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states by February 2018.",
            "probability": 0.032890102732264906,
            "start_logit": 1.221581220626831,
            "end_logit": -0.8900922536849976
        },
        {
            "text": "The reduction of the dose limit for eye lens from 150 to 20 mSv yr-1",
            "probability": 0.01771245012396728,
            "start_logit": 1.3570679426193237,
            "end_logit": -1.644482970237732
        },
        {
            "text": "must be implemented by EU member states by February 2018",
            "probability": 0.016686553938061066,
            "start_logit": -1.288785696029663,
            "end_logit": 0.941706120967865
        },
        {
            "text": "reduction of the dose limit for eye lens from 150 to 20 mSv yr-1",
            "probability": 0.015468119002107268,
            "start_logit": 1.221581220626831,
            "end_logit": -1.644482970237732
        },
        {
            "text": "dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states by February 2018",
            "probability": 0.008162508946917633,
            "start_logit": -2.0038373470306396,
            "end_logit": 0.941706120967865
        },
        {
            "text": "The reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented",
            "probability": 0.007908536226663746,
            "start_logit": 1.3570679426193237,
            "end_logit": -2.450808048248291
        },
        {
            "text": "EU member states by February 2018",
            "probability": 0.007610270591002095,
            "start_logit": -2.073890209197998,
            "end_logit": 0.941706120967865
        },
        {
            "text": "must be implemented by EU member states",
            "probability": 0.007441920234920954,
            "start_logit": -1.288785696029663,
            "end_logit": 0.1342317909002304
        },
        {
            "text": "reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented",
            "probability": 0.006906451599317834,
            "start_logit": 1.221581220626831,
            "end_logit": -2.450808048248291
        },
        {
            "text": "The reduction",
            "probability": 0.005913087575020917,
            "start_logit": 1.3570679426193237,
            "end_logit": -2.7415826320648193
        },
        {
            "text": "February 2018",
            "probability": 0.005353844352808112,
            "start_logit": -2.4255740642547607,
            "end_logit": 0.941706120967865
        },
        {
            "text": "reduction",
            "probability": 0.005163844732950984,
            "start_logit": 1.221581220626831,
            "end_logit": -2.7415826320648193
        },
        {
            "text": "by February 2018",
            "probability": 0.0038859321807751483,
            "start_logit": -2.746026039123535,
            "end_logit": 0.941706120967865
        },
        {
            "text": "",
            "probability": 0.0013620040642132807,
            "start_logit": -1.7713212966918945,
            "end_logit": -1.0814043283462524
        }
    ],
    "5e4981e96d0a277941000009_002": [
        {
            "text": "updated lower occupational exposure limit",
            "probability": 0.38417312825317607,
            "start_logit": 3.2137410640716553,
            "end_logit": 5.404751300811768
        },
        {
            "text": "lower occupational exposure limit",
            "probability": 0.3564224280843384,
            "start_logit": 3.1387643814086914,
            "end_logit": 5.404751300811768
        },
        {
            "text": "the updated lower occupational exposure limit",
            "probability": 0.12581160257837085,
            "start_logit": 2.09743332862854,
            "end_logit": 5.404751300811768
        },
        {
            "text": "updated lower occupational exposure limit for the lens of the eye",
            "probability": 0.046673218166725455,
            "start_logit": 3.2137410640716553,
            "end_logit": 3.296828508377075
        },
        {
            "text": "lower occupational exposure limit for the lens of the eye",
            "probability": 0.04330178381068694,
            "start_logit": 3.1387643814086914,
            "end_logit": 3.296828508377075
        },
        {
            "text": "the updated lower occupational exposure limit for the lens of the eye",
            "probability": 0.015284859723910466,
            "start_logit": 2.09743332862854,
            "end_logit": 3.296828508377075
        },
        {
            "text": "Due to the updated lower occupational exposure limit",
            "probability": 0.011557982920356433,
            "start_logit": -0.2899758815765381,
            "end_logit": 5.404751300811768
        },
        {
            "text": "occupational exposure limit",
            "probability": 0.003929810394784801,
            "start_logit": -1.3687610626220703,
            "end_logit": 5.404751300811768
        },
        {
            "text": "Staff at NMD PMU do not require regular routine eye lens dose monitoring. Eye lens doses were well within the new annual limit of 20 mSv",
            "probability": 0.0015401317224808708,
            "start_logit": 1.6449743509292603,
            "end_logit": 1.45429265499115
        },
        {
            "text": "updated lower occupational",
            "probability": 0.0014330821128849028,
            "start_logit": 3.2137410640716553,
            "end_logit": -0.18651455640792847
        },
        {
            "text": "Due to the updated lower occupational exposure limit for the lens of the eye",
            "probability": 0.0014041800915694904,
            "start_logit": -0.2899758815765381,
            "end_logit": 3.296828508377075
        },
        {
            "text": "lower occupational",
            "probability": 0.0013295635971239958,
            "start_logit": 3.1387643814086914,
            "end_logit": -0.18651455640792847
        },
        {
            "text": "updated lower occupational exposure limit for the lens",
            "probability": 0.0011871075831843675,
            "start_logit": 3.2137410640716553,
            "end_logit": -0.3748222589492798
        },
        {
            "text": "updated lower occupational exposure limit for the lens of the eye,",
            "probability": 0.0011084464537779413,
            "start_logit": 3.2137410640716553,
            "end_logit": -0.4433825612068176
        },
        {
            "text": "lower occupational exposure limit for the lens",
            "probability": 0.0011013570082836863,
            "start_logit": 3.1387643814086914,
            "end_logit": -0.3748222589492798
        },
        {
            "text": "lower occupational exposure limit for the lens of the eye,",
            "probability": 0.0010283779561923122,
            "start_logit": 3.1387643814086914,
            "end_logit": -0.4433825612068176
        },
        {
            "text": "updated lower occupational exposure",
            "probability": 0.0007451003495809128,
            "start_logit": 3.2137410640716553,
            "end_logit": -0.8405783772468567
        },
        {
            "text": "lower occupational exposure",
            "probability": 0.0006912781145616806,
            "start_logit": 3.1387643814086914,
            "end_logit": -0.8405783772468567
        },
        {
            "text": "exposure limit",
            "probability": 0.0006348402834777502,
            "start_logit": -3.1917340755462646,
            "end_logit": 5.404751300811768
        },
        {
            "text": "limit",
            "probability": 0.0006333043500813102,
            "start_logit": -3.1941564083099365,
            "end_logit": 5.404751300811768
        },
        {
            "text": "",
            "probability": 8.416444451085089e-06,
            "start_logit": -1.5110282897949219,
            "end_logit": -0.599140465259552
        }
    ],
    "5e4981e96d0a277941000009_003": [
        {
            "text": "updated lower occupational exposure limit",
            "probability": 0.38417312825317607,
            "start_logit": 3.2137410640716553,
            "end_logit": 5.404751300811768
        },
        {
            "text": "lower occupational exposure limit",
            "probability": 0.3564224280843384,
            "start_logit": 3.1387643814086914,
            "end_logit": 5.404751300811768
        },
        {
            "text": "the updated lower occupational exposure limit",
            "probability": 0.12581160257837085,
            "start_logit": 2.09743332862854,
            "end_logit": 5.404751300811768
        },
        {
            "text": "updated lower occupational exposure limit for the lens of the eye",
            "probability": 0.046673218166725455,
            "start_logit": 3.2137410640716553,
            "end_logit": 3.296828508377075
        },
        {
            "text": "lower occupational exposure limit for the lens of the eye",
            "probability": 0.04330178381068694,
            "start_logit": 3.1387643814086914,
            "end_logit": 3.296828508377075
        },
        {
            "text": "the updated lower occupational exposure limit for the lens of the eye",
            "probability": 0.015284859723910466,
            "start_logit": 2.09743332862854,
            "end_logit": 3.296828508377075
        },
        {
            "text": "Due to the updated lower occupational exposure limit",
            "probability": 0.011557982920356433,
            "start_logit": -0.2899758815765381,
            "end_logit": 5.404751300811768
        },
        {
            "text": "occupational exposure limit",
            "probability": 0.003929810394784801,
            "start_logit": -1.3687610626220703,
            "end_logit": 5.404751300811768
        },
        {
            "text": "Staff at NMD PMU do not require regular routine eye lens dose monitoring. Eye lens doses were well within the new annual limit of 20 mSv",
            "probability": 0.0015401317224808708,
            "start_logit": 1.6449743509292603,
            "end_logit": 1.45429265499115
        },
        {
            "text": "updated lower occupational",
            "probability": 0.0014330821128849028,
            "start_logit": 3.2137410640716553,
            "end_logit": -0.18651455640792847
        },
        {
            "text": "Due to the updated lower occupational exposure limit for the lens of the eye",
            "probability": 0.0014041800915694904,
            "start_logit": -0.2899758815765381,
            "end_logit": 3.296828508377075
        },
        {
            "text": "lower occupational",
            "probability": 0.0013295635971239958,
            "start_logit": 3.1387643814086914,
            "end_logit": -0.18651455640792847
        },
        {
            "text": "updated lower occupational exposure limit for the lens",
            "probability": 0.0011871075831843675,
            "start_logit": 3.2137410640716553,
            "end_logit": -0.3748222589492798
        },
        {
            "text": "updated lower occupational exposure limit for the lens of the eye,",
            "probability": 0.0011084464537779413,
            "start_logit": 3.2137410640716553,
            "end_logit": -0.4433825612068176
        },
        {
            "text": "lower occupational exposure limit for the lens",
            "probability": 0.0011013570082836863,
            "start_logit": 3.1387643814086914,
            "end_logit": -0.3748222589492798
        },
        {
            "text": "lower occupational exposure limit for the lens of the eye,",
            "probability": 0.0010283779561923122,
            "start_logit": 3.1387643814086914,
            "end_logit": -0.4433825612068176
        },
        {
            "text": "updated lower occupational exposure",
            "probability": 0.0007451003495809128,
            "start_logit": 3.2137410640716553,
            "end_logit": -0.8405783772468567
        },
        {
            "text": "lower occupational exposure",
            "probability": 0.0006912781145616806,
            "start_logit": 3.1387643814086914,
            "end_logit": -0.8405783772468567
        },
        {
            "text": "exposure limit",
            "probability": 0.0006348402834777502,
            "start_logit": -3.1917340755462646,
            "end_logit": 5.404751300811768
        },
        {
            "text": "limit",
            "probability": 0.0006333043500813102,
            "start_logit": -3.1941564083099365,
            "end_logit": 5.404751300811768
        },
        {
            "text": "",
            "probability": 8.416444451085089e-06,
            "start_logit": -1.5110282897949219,
            "end_logit": -0.599140465259552
        }
    ],
    "5e4981e96d0a277941000009_004": [
        {
            "text": "European directive 2013/59/Euratom",
            "probability": 0.8457196969119011,
            "start_logit": 4.493858337402344,
            "end_logit": 3.9336605072021484
        },
        {
            "text": "European directive 2013/59/Euratom.",
            "probability": 0.09370695683128911,
            "start_logit": 4.493858337402344,
            "end_logit": 1.733644962310791
        },
        {
            "text": "current European directive 2013/59/Euratom",
            "probability": 0.024911874626437146,
            "start_logit": 0.9690149426460266,
            "end_logit": 3.9336605072021484
        },
        {
            "text": "European directive",
            "probability": 0.004773805114204468,
            "start_logit": 4.493858337402344,
            "end_logit": -1.243383765220642
        },
        {
            "text": "reduced to 20 millisieverts (mSv) in the current European directive 2013/59/Euratom",
            "probability": 0.004579500673924304,
            "start_logit": -0.724739670753479,
            "end_logit": 3.9336605072021484
        },
        {
            "text": "2013/59/Euratom",
            "probability": 0.00403250686344754,
            "start_logit": -0.8519414067268372,
            "end_logit": 3.9336605072021484
        },
        {
            "text": "in the current European directive 2013/59/Euratom",
            "probability": 0.0036871369215892478,
            "start_logit": -0.9414793848991394,
            "end_logit": 3.9336605072021484
        },
        {
            "text": "European directive 2013/59",
            "probability": 0.003374460612544994,
            "start_logit": 4.493858337402344,
            "end_logit": -1.590291976928711
        },
        {
            "text": "current European directive 2013/59/Euratom.",
            "probability": 0.0027602714808819323,
            "start_logit": 0.9690149426460266,
            "end_logit": 1.733644962310791
        },
        {
            "text": "20 millisieverts (mSv) in the current European directive 2013/59/Euratom",
            "probability": 0.0023633127961433637,
            "start_logit": -1.3862652778625488,
            "end_logit": 3.9336605072021484
        },
        {
            "text": "the current European directive 2013/59/Euratom",
            "probability": 0.0022809349218630617,
            "start_logit": -1.4217442274093628,
            "end_logit": 3.9336605072021484
        },
        {
            "text": "European directive 2013/59/Euratom. The aim of this study was to evaluate the personal radiation dose for vascular interventions",
            "probability": 0.0020260984577530577,
            "start_logit": 4.493858337402344,
            "end_logit": -2.1004154682159424
        },
        {
            "text": "European directive 2013",
            "probability": 0.0014864621141685473,
            "start_logit": 4.493858337402344,
            "end_logit": -2.410128593444824
        },
        {
            "text": "European",
            "probability": 0.0008578191848675852,
            "start_logit": 4.493858337402344,
            "end_logit": -2.9598894119262695
        },
        {
            "text": "radiation ocular lens dose has been reduced to 20 millisieverts (mSv) in the current European directive 2013/59/Euratom",
            "probability": 0.0008196419083717142,
            "start_logit": -2.4452173709869385,
            "end_logit": 3.9336605072021484
        },
        {
            "text": "European directive 2013/59/Euratom. The aim of this study was to evaluate the personal radiation dose",
            "probability": 0.0005929866512076017,
            "start_logit": 4.493858337402344,
            "end_logit": -3.329110860824585
        },
        {
            "text": "reduced to 20 millisieverts (mSv) in the current European directive 2013/59/Euratom.",
            "probability": 0.0005074152506169983,
            "start_logit": -0.724739670753479,
            "end_logit": 1.733644962310791
        },
        {
            "text": "new Euratom directive",
            "probability": 0.0005011698421994712,
            "start_logit": -0.9656496047973633,
            "end_logit": 1.9621702432632446
        },
        {
            "text": "yearly limit set by the new Euratom directive",
            "probability": 0.00047025204266708313,
            "start_logit": -1.0293258428573608,
            "end_logit": 1.9621702432632446
        },
        {
            "text": "2013/59/Euratom.",
            "probability": 0.00044680755095895437,
            "start_logit": -0.8519414067268372,
            "end_logit": 1.733644962310791
        },
        {
            "text": "",
            "probability": 0.0001008892429626635,
            "start_logit": -0.17152808606624603,
            "end_logit": -0.4348730146884918
        }
    ],
    "5e4981e96d0a277941000009_005": [
        {
            "text": "European directive 2013/59/Euratom",
            "probability": 0.8457196969119011,
            "start_logit": 4.493858337402344,
            "end_logit": 3.9336605072021484
        },
        {
            "text": "European directive 2013/59/Euratom.",
            "probability": 0.09370695683128911,
            "start_logit": 4.493858337402344,
            "end_logit": 1.733644962310791
        },
        {
            "text": "current European directive 2013/59/Euratom",
            "probability": 0.024911874626437146,
            "start_logit": 0.9690149426460266,
            "end_logit": 3.9336605072021484
        },
        {
            "text": "European directive",
            "probability": 0.004773805114204468,
            "start_logit": 4.493858337402344,
            "end_logit": -1.243383765220642
        },
        {
            "text": "reduced to 20 millisieverts (mSv) in the current European directive 2013/59/Euratom",
            "probability": 0.004579500673924304,
            "start_logit": -0.724739670753479,
            "end_logit": 3.9336605072021484
        },
        {
            "text": "2013/59/Euratom",
            "probability": 0.00403250686344754,
            "start_logit": -0.8519414067268372,
            "end_logit": 3.9336605072021484
        },
        {
            "text": "in the current European directive 2013/59/Euratom",
            "probability": 0.0036871369215892478,
            "start_logit": -0.9414793848991394,
            "end_logit": 3.9336605072021484
        },
        {
            "text": "European directive 2013/59",
            "probability": 0.003374460612544994,
            "start_logit": 4.493858337402344,
            "end_logit": -1.590291976928711
        },
        {
            "text": "current European directive 2013/59/Euratom.",
            "probability": 0.0027602714808819323,
            "start_logit": 0.9690149426460266,
            "end_logit": 1.733644962310791
        },
        {
            "text": "20 millisieverts (mSv) in the current European directive 2013/59/Euratom",
            "probability": 0.0023633127961433637,
            "start_logit": -1.3862652778625488,
            "end_logit": 3.9336605072021484
        },
        {
            "text": "the current European directive 2013/59/Euratom",
            "probability": 0.0022809349218630617,
            "start_logit": -1.4217442274093628,
            "end_logit": 3.9336605072021484
        },
        {
            "text": "European directive 2013/59/Euratom. The aim of this study was to evaluate the personal radiation dose for vascular interventions",
            "probability": 0.0020260984577530577,
            "start_logit": 4.493858337402344,
            "end_logit": -2.1004154682159424
        },
        {
            "text": "European directive 2013",
            "probability": 0.0014864621141685473,
            "start_logit": 4.493858337402344,
            "end_logit": -2.410128593444824
        },
        {
            "text": "European",
            "probability": 0.0008578191848675852,
            "start_logit": 4.493858337402344,
            "end_logit": -2.9598894119262695
        },
        {
            "text": "radiation ocular lens dose has been reduced to 20 millisieverts (mSv) in the current European directive 2013/59/Euratom",
            "probability": 0.0008196419083717142,
            "start_logit": -2.4452173709869385,
            "end_logit": 3.9336605072021484
        },
        {
            "text": "European directive 2013/59/Euratom. The aim of this study was to evaluate the personal radiation dose",
            "probability": 0.0005929866512076017,
            "start_logit": 4.493858337402344,
            "end_logit": -3.329110860824585
        },
        {
            "text": "reduced to 20 millisieverts (mSv) in the current European directive 2013/59/Euratom.",
            "probability": 0.0005074152506169983,
            "start_logit": -0.724739670753479,
            "end_logit": 1.733644962310791
        },
        {
            "text": "new Euratom directive",
            "probability": 0.0005011698421994712,
            "start_logit": -0.9656496047973633,
            "end_logit": 1.9621702432632446
        },
        {
            "text": "yearly limit set by the new Euratom directive",
            "probability": 0.00047025204266708313,
            "start_logit": -1.0293258428573608,
            "end_logit": 1.9621702432632446
        },
        {
            "text": "2013/59/Euratom.",
            "probability": 0.00044680755095895437,
            "start_logit": -0.8519414067268372,
            "end_logit": 1.733644962310791
        },
        {
            "text": "",
            "probability": 0.0001008892429626635,
            "start_logit": -0.17152808606624603,
            "end_logit": -0.4348730146884918
        }
    ],
    "5e4981e96d0a277941000009_006": [
        {
            "text": "The reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states by February 2018",
            "probability": 0.23520486030007104,
            "start_logit": 1.3570679426193237,
            "end_logit": 0.941706120967865
        },
        {
            "text": "reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states by February 2018",
            "probability": 0.20540223083381226,
            "start_logit": 1.221581220626831,
            "end_logit": 0.941706120967865
        },
        {
            "text": "The reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states",
            "probability": 0.10489738119183187,
            "start_logit": 1.3570679426193237,
            "end_logit": 0.1342317909002304
        },
        {
            "text": "The reduction of the dose limit",
            "probability": 0.09756185897380172,
            "start_logit": 1.3570679426193237,
            "end_logit": 0.06173586845397949
        },
        {
            "text": "reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states",
            "probability": 0.09160591357652544,
            "start_logit": 1.221581220626831,
            "end_logit": 0.1342317909002304
        },
        {
            "text": "reduction of the dose limit",
            "probability": 0.08519986981538837,
            "start_logit": 1.221581220626831,
            "end_logit": 0.06173586845397949
        },
        {
            "text": "The reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states by February 2018.",
            "probability": 0.037662259007577956,
            "start_logit": 1.3570679426193237,
            "end_logit": -0.8900922536849976
        },
        {
            "text": "reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states by February 2018.",
            "probability": 0.032890102732264906,
            "start_logit": 1.221581220626831,
            "end_logit": -0.8900922536849976
        },
        {
            "text": "The reduction of the dose limit for eye lens from 150 to 20 mSv yr-1",
            "probability": 0.01771245012396728,
            "start_logit": 1.3570679426193237,
            "end_logit": -1.644482970237732
        },
        {
            "text": "must be implemented by EU member states by February 2018",
            "probability": 0.016686553938061066,
            "start_logit": -1.288785696029663,
            "end_logit": 0.941706120967865
        },
        {
            "text": "reduction of the dose limit for eye lens from 150 to 20 mSv yr-1",
            "probability": 0.015468119002107268,
            "start_logit": 1.221581220626831,
            "end_logit": -1.644482970237732
        },
        {
            "text": "dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented by EU member states by February 2018",
            "probability": 0.008162508946917633,
            "start_logit": -2.0038373470306396,
            "end_logit": 0.941706120967865
        },
        {
            "text": "The reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented",
            "probability": 0.007908536226663746,
            "start_logit": 1.3570679426193237,
            "end_logit": -2.450808048248291
        },
        {
            "text": "EU member states by February 2018",
            "probability": 0.007610270591002095,
            "start_logit": -2.073890209197998,
            "end_logit": 0.941706120967865
        },
        {
            "text": "must be implemented by EU member states",
            "probability": 0.007441920234920954,
            "start_logit": -1.288785696029663,
            "end_logit": 0.1342317909002304
        },
        {
            "text": "reduction of the dose limit for eye lens from 150 to 20 mSv yr-1 must be implemented",
            "probability": 0.006906451599317834,
            "start_logit": 1.221581220626831,
            "end_logit": -2.450808048248291
        },
        {
            "text": "The reduction",
            "probability": 0.005913087575020917,
            "start_logit": 1.3570679426193237,
            "end_logit": -2.7415826320648193
        },
        {
            "text": "February 2018",
            "probability": 0.005353844352808112,
            "start_logit": -2.4255740642547607,
            "end_logit": 0.941706120967865
        },
        {
            "text": "reduction",
            "probability": 0.005163844732950984,
            "start_logit": 1.221581220626831,
            "end_logit": -2.7415826320648193
        },
        {
            "text": "by February 2018",
            "probability": 0.0038859321807751483,
            "start_logit": -2.746026039123535,
            "end_logit": 0.941706120967865
        },
        {
            "text": "",
            "probability": 0.0013620040642132807,
            "start_logit": -1.7713212966918945,
            "end_logit": -1.0814043283462524
        }
    ],
    "5e2f972bfbd6abf43b000030_001": [
        {
            "text": "",
            "probability": 0.9999991936977595,
            "start_logit": 3.4436843395233154,
            "end_logit": 3.9281702041625977
        },
        {
            "text": "dark urine, pigmentation of tissues, and ochronotic arthropathies",
            "probability": 3.1457175882134584e-07,
            "start_logit": -4.198892593383789,
            "end_logit": -3.401305675506592
        },
        {
            "text": "dark urine",
            "probability": 9.61895759949871e-08,
            "start_logit": -4.198892593383789,
            "end_logit": -4.5861968994140625
        },
        {
            "text": "dark urine, pigmentation of tissues, and ochronotic arthropathies.",
            "probability": 7.119865591434621e-08,
            "start_logit": -4.198892593383789,
            "end_logit": -4.8870439529418945
        },
        {
            "text": "a triad of dark urine, pigmentation of tissues, and ochronotic arthropathies",
            "probability": 4.567640846800395e-08,
            "start_logit": -6.128522872924805,
            "end_logit": -3.401305675506592
        },
        {
            "text": "dark urine, pigmentation of tissues",
            "probability": 3.829659713796374e-08,
            "start_logit": -4.198892593383789,
            "end_logit": -5.507156848907471
        },
        {
            "text": "pigmentation of tissues, and ochronotic arthropathies",
            "probability": 2.9097723072865273e-08,
            "start_logit": -6.579444885253906,
            "end_logit": -3.401305675506592
        },
        {
            "text": "ochronotic arthropathies",
            "probability": 2.5857045703943095e-08,
            "start_logit": -6.697521686553955,
            "end_logit": -3.401305675506592
        },
        {
            "text": "tyrosine metabolism characterized by a triad of dark urine, pigmentation of tissues, and ochronotic arthropathies",
            "probability": 2.5134474782175172e-08,
            "start_logit": -6.725864410400391,
            "end_logit": -3.401305675506592
        },
        {
            "text": "dark urine, pigmentation of tissues,",
            "probability": 2.484087934089251e-08,
            "start_logit": -4.198892593383789,
            "end_logit": -5.940027236938477
        },
        {
            "text": "a disorder of tyrosine metabolism characterized by a triad of dark urine, pigmentation of tissues, and ochronotic arthropathies",
            "probability": 2.331669302864155e-08,
            "start_logit": -6.8009352684021,
            "end_logit": -3.401305675506592
        },
        {
            "text": "disorder of tyrosine metabolism characterized by a triad of dark urine, pigmentation of tissues, and ochronotic arthropathies",
            "probability": 1.8338398805445426e-08,
            "start_logit": -7.041107654571533,
            "end_logit": -3.401305675506592
        },
        {
            "text": "triad of dark urine, pigmentation of tissues, and ochronotic arthropathies",
            "probability": 1.6661535846910324e-08,
            "start_logit": -7.137001991271973,
            "end_logit": -3.401305675506592
        },
        {
            "text": "a triad of dark urine",
            "probability": 1.396690656520881e-08,
            "start_logit": -6.128522872924805,
            "end_logit": -4.5861968994140625
        },
        {
            "text": "urine, pigmentation of tissues, and ochronotic arthropathies",
            "probability": 1.3611036210848772e-08,
            "start_logit": -7.339223861694336,
            "end_logit": -3.401305675506592
        },
        {
            "text": "Cardiac ochronosis is a rare complication of alkaptonuria, a disorder of tyrosine metabolism characterized by a triad of dark urine",
            "probability": 1.3003258111227046e-08,
            "start_logit": -6.200013637542725,
            "end_logit": -4.5861968994140625
        },
        {
            "text": "dark urine, pigmentation of tissues, and ochronotic arthropathies. When present, cardiac ochronosis",
            "probability": 1.1387743593983257e-08,
            "start_logit": -4.198892593383789,
            "end_logit": -6.719980239868164
        },
        {
            "text": "a triad of dark urine, pigmentation of tissues, and ochronotic arthropathies.",
            "probability": 1.0338178169908447e-08,
            "start_logit": -6.128522872924805,
            "end_logit": -4.8870439529418945
        },
        {
            "text": "tyrosine metabolism characterized by a triad of dark urine",
            "probability": 7.685605603035685e-09,
            "start_logit": -6.725864410400391,
            "end_logit": -4.5861968994140625
        },
        {
            "text": "a disorder of tyrosine metabolism characterized by a triad of dark urine",
            "probability": 7.1297653178843194e-09,
            "start_logit": -6.8009352684021,
            "end_logit": -4.5861968994140625
        }
    ],
    "5e2f972bfbd6abf43b000030_002": [
        {
            "text": "",
            "probability": 0.9999227562614738,
            "start_logit": 1.421466588973999,
            "end_logit": 1.5652638673782349
        },
        {
            "text": "clinical triad of symptoms",
            "probability": 1.9513600864982425e-05,
            "start_logit": -4.054806232452393,
            "end_logit": -3.8027849197387695
        },
        {
            "text": "a clinical triad of symptoms",
            "probability": 1.4115250742087009e-05,
            "start_logit": -4.378662109375,
            "end_logit": -3.8027849197387695
        },
        {
            "text": "clinical triad of symptoms;",
            "probability": 7.975379232919516e-06,
            "start_logit": -4.054806232452393,
            "end_logit": -4.697537422180176
        },
        {
            "text": "a clinical triad of symptoms;",
            "probability": 5.769026353199108e-06,
            "start_logit": -4.378662109375,
            "end_logit": -4.697537422180176
        },
        {
            "text": "clinical triad of symptoms; homogentisic aciduria from birth,",
            "probability": 4.582806648210773e-06,
            "start_logit": -4.054806232452393,
            "end_logit": -5.251585006713867
        },
        {
            "text": "symptoms",
            "probability": 4.069903209216836e-06,
            "start_logit": -5.622298717498779,
            "end_logit": -3.8027849197387695
        },
        {
            "text": "a clinical triad of symptoms; homogentisic aciduria from birth,",
            "probability": 3.3149937517724592e-06,
            "start_logit": -4.378662109375,
            "end_logit": -5.251585006713867
        },
        {
            "text": "homogentisic aciduria from birth,",
            "probability": 1.9658837158202646e-06,
            "start_logit": -4.9011759757995605,
            "end_logit": -5.251585006713867
        },
        {
            "text": "clinical",
            "probability": 1.9098852398470783e-06,
            "start_logit": -4.054806232452393,
            "end_logit": -6.1268534660339355
        },
        {
            "text": "clinical triad of symptoms; homogentisic aciduria from birth, ochronosis",
            "probability": 1.7967969651460956e-06,
            "start_logit": -4.054806232452393,
            "end_logit": -6.187891006469727
        },
        {
            "text": "symptoms;",
            "probability": 1.6634050147571102e-06,
            "start_logit": -5.622298717498779,
            "end_logit": -4.697537422180176
        },
        {
            "text": "clinical triad of symptoms; homogentisic aciduria from birth, ochronosis (darkening) of collagenous tissues",
            "probability": 1.5611259423697858e-06,
            "start_logit": -4.054806232452393,
            "end_logit": -6.328489303588867
        },
        {
            "text": "clinical triad of symptoms; homogentisic aciduria",
            "probability": 1.5345012633374468e-06,
            "start_logit": -4.054806232452393,
            "end_logit": -6.345691204071045
        },
        {
            "text": "a clinical",
            "probability": 1.3815240577883358e-06,
            "start_logit": -4.378662109375,
            "end_logit": -6.1268534660339355
        },
        {
            "text": "homogentisic aciduria from birth, ochronosis (darkening) of collagenous tissues (from \u223c30years of age)",
            "probability": 1.3263262922548722e-06,
            "start_logit": -4.9011759757995605,
            "end_logit": -5.645113945007324
        },
        {
            "text": "a clinical triad of symptoms; homogentisic aciduria from birth, ochronosis",
            "probability": 1.2997211468628116e-06,
            "start_logit": -4.378662109375,
            "end_logit": -6.187891006469727
        },
        {
            "text": "The condition is characterised by a clinical triad of symptoms",
            "probability": 1.2243722567290762e-06,
            "start_logit": -6.823489665985107,
            "end_logit": -3.8027849197387695
        },
        {
            "text": "a clinical triad of symptoms; homogentisic aciduria from birth, ochronosis (darkening) of collagenous tissues",
            "probability": 1.129247455095277e-06,
            "start_logit": -4.378662109375,
            "end_logit": -6.328489303588867
        },
        {
            "text": "a clinical triad of symptoms; homogentisic aciduria",
            "probability": 1.1099883740538348e-06,
            "start_logit": -4.378662109375,
            "end_logit": -6.345691204071045
        }
    ],
    "5e2f972bfbd6abf43b000030_003": [
        {
            "text": "",
            "probability": 0.46773115194716425,
            "start_logit": -0.8954612016677856,
            "end_logit": -0.33671024441719055
        },
        {
            "text": "severe and rapidly progressing",
            "probability": 0.07904937442074463,
            "start_logit": -2.8417909145355225,
            "end_logit": -0.16820155084133148
        },
        {
            "text": "arthropathy in alkaptonuria is much more severe and rapidly progressing",
            "probability": 0.07701014799147787,
            "start_logit": -2.8679263591766357,
            "end_logit": -0.16820155084133148
        },
        {
            "text": "more severe and rapidly progressing",
            "probability": 0.07423199326318657,
            "start_logit": -2.9046683311462402,
            "end_logit": -0.16820155084133148
        },
        {
            "text": "much more severe and rapidly progressing",
            "probability": 0.05380957937240956,
            "start_logit": -3.226412057876587,
            "end_logit": -0.16820155084133148
        },
        {
            "text": "ochronotic osteoarthropathy",
            "probability": 0.03284041466940475,
            "start_logit": -2.197591543197632,
            "end_logit": -1.690813660621643
        },
        {
            "text": "severe and rapidly progressing.",
            "probability": 0.02763688886196524,
            "start_logit": -2.8417909145355225,
            "end_logit": -1.2191227674484253
        },
        {
            "text": "arthropathy in alkaptonuria is much more severe and rapidly progressing.",
            "probability": 0.02692394363497256,
            "start_logit": -2.8679263591766357,
            "end_logit": -1.2191227674484253
        },
        {
            "text": "more severe and rapidly progressing.",
            "probability": 0.025952657599760353,
            "start_logit": -2.9046683311462402,
            "end_logit": -1.2191227674484253
        },
        {
            "text": "clinical features",
            "probability": 0.022405529873398566,
            "start_logit": -2.7643139362335205,
            "end_logit": -1.5064433813095093
        },
        {
            "text": "much more severe and rapidly progressing.",
            "probability": 0.018812664562138755,
            "start_logit": -3.226412057876587,
            "end_logit": -1.2191227674484253
        },
        {
            "text": "clinical features, the most damaging of which is ochronotic osteoarthropathy",
            "probability": 0.01863306179056846,
            "start_logit": -2.7643139362335205,
            "end_logit": -1.690813660621643
        },
        {
            "text": "rapidly progressing",
            "probability": 0.015596365935350808,
            "start_logit": -4.464825630187988,
            "end_logit": -0.16820155084133148
        },
        {
            "text": "arthropathy",
            "probability": 0.014488790488425185,
            "start_logit": -2.8679263591766357,
            "end_logit": -1.8387634754180908
        },
        {
            "text": "ochronotic osteoarthropathy.",
            "probability": 0.010843000975936053,
            "start_logit": -2.197591543197632,
            "end_logit": -2.7989537715911865
        },
        {
            "text": "the arthropathy in alkaptonuria is much more severe and rapidly progressing",
            "probability": 0.010572848878259872,
            "start_logit": -4.853574275970459,
            "end_logit": -0.16820155084133148
        },
        {
            "text": "clinical features, the most damaging of which is ochronotic osteoarthropathy.",
            "probability": 0.006152124119432521,
            "start_logit": -2.7643139362335205,
            "end_logit": -2.7989537715911865
        },
        {
            "text": "severe",
            "probability": 0.005941608870151135,
            "start_logit": -2.8417909145355225,
            "end_logit": -2.7562942504882812
        },
        {
            "text": "arthropathy in alkaptonuria is much more severe",
            "probability": 0.005788333959006508,
            "start_logit": -2.8679263591766357,
            "end_logit": -2.7562942504882812
        },
        {
            "text": "more severe",
            "probability": 0.005579518786246126,
            "start_logit": -2.9046683311462402,
            "end_logit": -2.7562942504882812
        }
    ],
    "5e2f972bfbd6abf43b000030_004": [
        {
            "text": "homogentisic aciduria, ochronosis, and arthritis",
            "probability": 0.6398160438474583,
            "start_logit": -0.5808773636817932,
            "end_logit": -0.7759407758712769
        },
        {
            "text": "homogentisic aciduria, ochronosis, and arthritis.",
            "probability": 0.18695643614130708,
            "start_logit": -0.5808773636817932,
            "end_logit": -2.0062458515167236
        },
        {
            "text": "",
            "probability": 0.07037073360984406,
            "start_logit": -2.1254942417144775,
            "end_logit": -1.4387271404266357
        },
        {
            "text": "homogentisic aciduria",
            "probability": 0.04156403352673607,
            "start_logit": -0.5808773636817932,
            "end_logit": -3.5098862648010254
        },
        {
            "text": "a triad of homogentisic aciduria, ochronosis, and arthritis",
            "probability": 0.01596940623815677,
            "start_logit": -4.271383285522461,
            "end_logit": -0.7759407758712769
        },
        {
            "text": "homogentisic aciduria, ochronosis, and arthritis. The most common clinical manifestations of ochronosis",
            "probability": 0.007015235274665682,
            "start_logit": -0.5808773636817932,
            "end_logit": -5.289037227630615
        },
        {
            "text": "triad of homogentisic aciduria, ochronosis, and arthritis",
            "probability": 0.0057689886944359186,
            "start_logit": -5.2895612716674805,
            "end_logit": -0.7759407758712769
        },
        {
            "text": "a triad of homogentisic aciduria, ochronosis, and arthritis.",
            "probability": 0.004666315117115686,
            "start_logit": -4.271383285522461,
            "end_logit": -2.0062458515167236
        },
        {
            "text": "arthritis",
            "probability": 0.004616903292277617,
            "start_logit": -5.512333869934082,
            "end_logit": -0.7759407758712769
        },
        {
            "text": "rare inherited genetic disorder of tyrosine metabolism characterized by a triad of homogentisic aciduria, ochronosis, and arthritis",
            "probability": 0.003525844532341136,
            "start_logit": -5.781938076019287,
            "end_logit": -0.7759407758712769
        },
        {
            "text": "homogentisic aciduria, ochronosis",
            "probability": 0.002741634721018277,
            "start_logit": -0.5808773636817932,
            "end_logit": -6.228567123413086
        },
        {
            "text": "tyrosine metabolism characterized by a triad of homogentisic aciduria, ochronosis, and arthritis",
            "probability": 0.0025374449896106094,
            "start_logit": -6.110900402069092,
            "end_logit": -0.7759407758712769
        },
        {
            "text": "a rare inherited genetic disorder of tyrosine metabolism characterized by a triad of homogentisic aciduria, ochronosis, and arthritis",
            "probability": 0.002361717017951004,
            "start_logit": -6.182669162750244,
            "end_logit": -0.7759407758712769
        },
        {
            "text": "genetic disorder of tyrosine metabolism characterized by a triad of homogentisic aciduria, ochronosis, and arthritis",
            "probability": 0.002321254678125119,
            "start_logit": -6.199950218200684,
            "end_logit": -0.7759407758712769
        },
        {
            "text": "homogentisic aciduria,",
            "probability": 0.002218148232796965,
            "start_logit": -0.5808773636817932,
            "end_logit": -6.440448760986328
        },
        {
            "text": "triad of homogentisic aciduria, ochronosis, and arthritis.",
            "probability": 0.0016857182260787038,
            "start_logit": -5.2895612716674805,
            "end_logit": -2.0062458515167236
        },
        {
            "text": "homogentisic aciduria, ochronosis,",
            "probability": 0.001658509576979535,
            "start_logit": -0.5808773636817932,
            "end_logit": -6.731202125549316
        },
        {
            "text": "inherited genetic disorder of tyrosine metabolism characterized by a triad of homogentisic aciduria, ochronosis, and arthritis",
            "probability": 0.0014928717276569367,
            "start_logit": -6.641356468200684,
            "end_logit": -0.7759407758712769
        },
        {
            "text": "homo",
            "probability": 0.001363685623933166,
            "start_logit": -0.5808773636817932,
            "end_logit": -6.9269304275512695
        },
        {
            "text": "arthritis.",
            "probability": 0.0013490749315112223,
            "start_logit": -5.512333869934082,
            "end_logit": -2.0062458515167236
        }
    ],
    "5e2f972bfbd6abf43b000030_005": [
        {
            "text": "",
            "probability": 0.7701789914734696,
            "start_logit": -0.9067989587783813,
            "end_logit": -0.30273351073265076
        },
        {
            "text": "chronology of appearance",
            "probability": 0.06046429014967165,
            "start_logit": -2.8330819606781006,
            "end_logit": -0.9210205078125
        },
        {
            "text": "according to chronology of appearance",
            "probability": 0.0281510259172711,
            "start_logit": -3.597551107406616,
            "end_logit": -0.9210205078125
        },
        {
            "text": "HGD mutations were found in 23 families",
            "probability": 0.026776425568514506,
            "start_logit": -1.4438271522521973,
            "end_logit": -3.1248064041137695
        },
        {
            "text": "a triad of signs, according to chronology of appearance",
            "probability": 0.02353003683794204,
            "start_logit": -3.7768571376800537,
            "end_logit": -0.9210205078125
        },
        {
            "text": "triad of signs, according to chronology of appearance",
            "probability": 0.01908296044808241,
            "start_logit": -3.9863390922546387,
            "end_logit": -0.9210205078125
        },
        {
            "text": "HGD mutations",
            "probability": 0.017802726757722355,
            "start_logit": -1.4438271522521973,
            "end_logit": -3.5329766273498535
        },
        {
            "text": "signs, according to chronology of appearance",
            "probability": 0.011427898308669785,
            "start_logit": -4.499077320098877,
            "end_logit": -0.9210205078125
        },
        {
            "text": "HGD mutations were found in 23 families,",
            "probability": 0.008766398952847846,
            "start_logit": -1.4438271522521973,
            "end_logit": -4.2414021492004395
        },
        {
            "text": "homogentisic aciduria (HGA) or alkaptonuria, ochronosis then ochronotic arthropathy.",
            "probability": 0.005722066106762719,
            "start_logit": -2.429272413253784,
            "end_logit": -3.6825530529022217
        },
        {
            "text": "homogentisic aciduria (HGA) or alkaptonuria, ochronosis then ochronotic arthropathy",
            "probability": 0.004030072246172522,
            "start_logit": -2.429272413253784,
            "end_logit": -4.0330986976623535
        },
        {
            "text": "characterized by a triad of signs, according to chronology of appearance",
            "probability": 0.003942429284995265,
            "start_logit": -5.563337802886963,
            "end_logit": -0.9210205078125
        },
        {
            "text": "a triad of signs",
            "probability": 0.003897218632301648,
            "start_logit": -3.7768571376800537,
            "end_logit": -2.7190351486206055
        },
        {
            "text": "homogentisic aciduria",
            "probability": 0.0034637449463600827,
            "start_logit": -2.429272413253784,
            "end_logit": -4.184532642364502
        },
        {
            "text": "triad of signs",
            "probability": 0.0031606609683593975,
            "start_logit": -3.9863390922546387,
            "end_logit": -2.7190351486206055
        },
        {
            "text": "chronology of appearance:",
            "probability": 0.0028555165838292347,
            "start_logit": -2.8330819606781006,
            "end_logit": -3.973820686340332
        },
        {
            "text": "chronology of appearance: homogentisic aciduria",
            "probability": 0.002312989423859648,
            "start_logit": -2.8330819606781006,
            "end_logit": -4.184532642364502
        },
        {
            "text": "signs",
            "probability": 0.0018927729915314332,
            "start_logit": -4.499077320098877,
            "end_logit": -2.7190351486206055
        },
        {
            "text": "according to chronology of appearance:",
            "probability": 0.0013294743254173595,
            "start_logit": -3.597551107406616,
            "end_logit": -3.973820686340332
        },
        {
            "text": "homogentisic aciduria (HGA)",
            "probability": 0.0012123000762192535,
            "start_logit": -2.429272413253784,
            "end_logit": -5.234363555908203
        }
    ],
    "5e2f972bfbd6abf43b000030_006": [
        {
            "text": "",
            "probability": 0.7025271456312531,
            "start_logit": -1.8427793979644775,
            "end_logit": -1.5430792570114136
        },
        {
            "text": "homogentisic aciduria (dark urine), relentlessly progressive arthritis and ochronosis",
            "probability": 0.07435591024851042,
            "start_logit": -1.996347427368164,
            "end_logit": -3.6353321075439453
        },
        {
            "text": "homogentisic aciduria",
            "probability": 0.0705638942906747,
            "start_logit": -1.996347427368164,
            "end_logit": -3.6876766681671143
        },
        {
            "text": "homogentisic aciduria (dark urine)",
            "probability": 0.04869819913685582,
            "start_logit": -1.996347427368164,
            "end_logit": -4.058553218841553
        },
        {
            "text": "homogentisic aciduria (dark urine",
            "probability": 0.03285194886170431,
            "start_logit": -1.996347427368164,
            "end_logit": -4.452184200286865
        },
        {
            "text": "homogentisic aciduria (dark urine), relentlessly progressive arthritis and ochronosis.",
            "probability": 0.026141748380787262,
            "start_logit": -1.996347427368164,
            "end_logit": -4.680661678314209
        },
        {
            "text": "dark urine), relentlessly progressive arthritis and ochronosis",
            "probability": 0.009499211367324055,
            "start_logit": -4.054001808166504,
            "end_logit": -3.6353321075439453
        },
        {
            "text": "homogentisic aciduria (dark urine), relentlessly progressive arthritis",
            "probability": 0.00863709601283429,
            "start_logit": -1.996347427368164,
            "end_logit": -5.788128852844238
        },
        {
            "text": "dark urine)",
            "probability": 0.006221354634257854,
            "start_logit": -4.054001808166504,
            "end_logit": -4.058553218841553
        },
        {
            "text": "homogentisic aciduria (dark urine),",
            "probability": 0.004687234356280139,
            "start_logit": -1.996347427368164,
            "end_logit": -6.399352550506592
        },
        {
            "text": "dark urine",
            "probability": 0.004196944197480279,
            "start_logit": -4.054001808166504,
            "end_logit": -4.452184200286865
        },
        {
            "text": "dark urine), relentlessly progressive arthritis and ochronosis.",
            "probability": 0.003339694081486607,
            "start_logit": -4.054001808166504,
            "end_logit": -4.680661678314209
        },
        {
            "text": "(dark urine), relentlessly progressive arthritis and ochronosis",
            "probability": 0.0015633027141542936,
            "start_logit": -5.858409881591797,
            "end_logit": -3.6353321075439453
        },
        {
            "text": "homogentisic",
            "probability": 0.0012383624956558092,
            "start_logit": -1.996347427368164,
            "end_logit": -7.730405330657959
        },
        {
            "text": "dark urine), relentlessly progressive arthritis",
            "probability": 0.0011034173390060595,
            "start_logit": -4.054001808166504,
            "end_logit": -5.788128852844238
        },
        {
            "text": "homogentisic aciduria (dark urine), relentlessly progressive",
            "probability": 0.0010692423571045959,
            "start_logit": -1.996347427368164,
            "end_logit": -7.87724494934082
        },
        {
            "text": "(dark urine)",
            "probability": 0.0010238597931305415,
            "start_logit": -5.858409881591797,
            "end_logit": -4.058553218841553
        },
        {
            "text": "arthritis and ochronosis",
            "probability": 0.0008891665263571354,
            "start_logit": -6.4226813316345215,
            "end_logit": -3.6353321075439453
        },
        {
            "text": "homogentisic acid",
            "probability": 0.0007015687369588176,
            "start_logit": -1.996347427368164,
            "end_logit": -8.29863166809082
        },
        {
            "text": "(dark urine",
            "probability": 0.0006906988381840065,
            "start_logit": -5.858409881591797,
            "end_logit": -4.452184200286865
        }
    ],
    "5e2f972bfbd6abf43b000030_007": [
        {
            "text": "homogentisic aciduria, arthritis and ochronosis",
            "probability": 0.8514764514742972,
            "start_logit": -0.33175548911094666,
            "end_logit": 0.07275843620300293
        },
        {
            "text": "a triad of homogentisic aciduria, arthritis and ochronosis",
            "probability": 0.045631040608316464,
            "start_logit": -3.258139133453369,
            "end_logit": 0.07275843620300293
        },
        {
            "text": "homogentisic aciduria",
            "probability": 0.029186815063395134,
            "start_logit": -0.33175548911094666,
            "end_logit": -3.3004963397979736
        },
        {
            "text": "a metabolic disorder characterized by a triad of homogentisic aciduria, arthritis and ochronosis",
            "probability": 0.013775379866493454,
            "start_logit": -4.455844402313232,
            "end_logit": 0.07275843620300293
        },
        {
            "text": "",
            "probability": 0.012172189755350126,
            "start_logit": -2.676381826400757,
            "end_logit": -1.8304332494735718
        },
        {
            "text": "homogentisic aciduria,",
            "probability": 0.009513789659543501,
            "start_logit": -0.33175548911094666,
            "end_logit": -4.421471118927002
        },
        {
            "text": "metabolic disorder characterized by a triad of homogentisic aciduria, arthritis and ochronosis",
            "probability": 0.0077812677660250105,
            "start_logit": -5.027008056640625,
            "end_logit": 0.07275843620300293
        },
        {
            "text": "homogentisic aciduria, arthritis",
            "probability": 0.007168039222107373,
            "start_logit": -0.33175548911094666,
            "end_logit": -4.704581260681152
        },
        {
            "text": "triad of homogentisic aciduria, arthritis and ochronosis",
            "probability": 0.006421367811181327,
            "start_logit": -5.2190961837768555,
            "end_logit": 0.07275843620300293
        },
        {
            "text": "arthritis and ochronosis",
            "probability": 0.005033730878874572,
            "start_logit": -5.462565898895264,
            "end_logit": 0.07275843620300293
        },
        {
            "text": "homo",
            "probability": 0.0020048189919443624,
            "start_logit": -0.33175548911094666,
            "end_logit": -5.978659629821777
        },
        {
            "text": "ochronosis",
            "probability": 0.001931494029920397,
            "start_logit": -6.420433521270752,
            "end_logit": 0.07275843620300293
        },
        {
            "text": "a triad of homogentisic aciduria",
            "probability": 0.0015641357327959042,
            "start_logit": -3.258139133453369,
            "end_logit": -3.3004963397979736
        },
        {
            "text": "homogentisic",
            "probability": 0.0013316305004787811,
            "start_logit": -0.33175548911094666,
            "end_logit": -6.3878092765808105
        },
        {
            "text": "Alkaptonuria, a metabolic disorder characterized by a triad of homogentisic aciduria, arthritis and ochronosis",
            "probability": 0.0012941320576686133,
            "start_logit": -6.820887088775635,
            "end_logit": 0.07275843620300293
        },
        {
            "text": "disorder characterized by a triad of homogentisic aciduria, arthritis and ochronosis",
            "probability": 0.001129352103139178,
            "start_logit": -6.957083225250244,
            "end_logit": 0.07275843620300293
        },
        {
            "text": "homogentisic acid",
            "probability": 0.0007710852343699127,
            "start_logit": -0.33175548911094666,
            "end_logit": -6.934169769287109
        },
        {
            "text": "homogentisic aciduria, arthritis and ochronosis is one of the first conditions in the charter of group of inborn errors of metabolism",
            "probability": 0.0007051980850630334,
            "start_logit": -0.33175548911094666,
            "end_logit": -7.023489952087402
        },
        {
            "text": "aciduria, arthritis and ochronosis",
            "probability": 0.0005669764215896209,
            "start_logit": -7.646164894104004,
            "end_logit": 0.07275843620300293
        },
        {
            "text": "homogentisic aciduria, arthritis and ochronosis is one of the first conditions",
            "probability": 0.0005411047374458724,
            "start_logit": -0.33175548911094666,
            "end_logit": -7.288355827331543
        }
    ],
    "5cc0817da49efeb44c000002_001": [
        {
            "text": "",
            "probability": 0.9987341467825087,
            "start_logit": 3.985929012298584,
            "end_logit": 5.003757476806641
        },
        {
            "text": "DNA fragments of tumor origin",
            "probability": 0.0006218054798517572,
            "start_logit": -0.13793063163757324,
            "end_logit": 1.7460005283355713
        },
        {
            "text": "contains DNA fragments of tumor origin",
            "probability": 0.000259178321974266,
            "start_logit": -1.013041615486145,
            "end_logit": 1.7460005283355713
        },
        {
            "text": "fragments of tumor origin",
            "probability": 0.0001122506668345303,
            "start_logit": -1.8498234748840332,
            "end_logit": 1.7460005283355713
        },
        {
            "text": "cfDNA can be easily purified from serum and plasma and contains DNA fragments of tumor origin",
            "probability": 6.013788331536125e-05,
            "start_logit": -2.4739179611206055,
            "end_logit": 1.7460005283355713
        },
        {
            "text": "tumor origin",
            "probability": 5.270258832242663e-05,
            "start_logit": -2.60589337348938,
            "end_logit": 1.7460005283355713
        },
        {
            "text": "blood of cancer patients. cfDNA can be easily purified from serum and plasma and contains DNA fragments of tumor origin",
            "probability": 2.2787958411685627e-05,
            "start_logit": -3.4443256855010986,
            "end_logit": 1.7460005283355713
        },
        {
            "text": "DNA fragments of tumor origin. For this reason, it is the most widely used material for the detection of somatic mutations in blood",
            "probability": 2.113075879488104e-05,
            "start_logit": -0.13793063163757324,
            "end_logit": -1.6358970403671265
        },
        {
            "text": "DNA fragments of tumor origin. For this reason, it is the most widely used material for the detection of somatic mutations",
            "probability": 1.5021124447026547e-05,
            "start_logit": -0.13793063163757324,
            "end_logit": -1.9771692752838135
        },
        {
            "text": "DNA fragments of tumor origin.",
            "probability": 1.4271513130467512e-05,
            "start_logit": -0.13793063163757324,
            "end_logit": -2.0283613204956055
        },
        {
            "text": "DNA fragments of tumor",
            "probability": 1.228467301549222e-05,
            "start_logit": -0.13793063163757324,
            "end_logit": -2.178274393081665
        },
        {
            "text": "DNA fragments",
            "probability": 1.2147461906415539e-05,
            "start_logit": -0.13793063163757324,
            "end_logit": -2.1895065307617188
        },
        {
            "text": "serum and plasma and contains DNA fragments of tumor origin",
            "probability": 1.0222761768273025e-05,
            "start_logit": -4.245941162109375,
            "end_logit": 1.7460005283355713
        },
        {
            "text": "purified from serum and plasma and contains DNA fragments of tumor origin",
            "probability": 9.410399786611725e-06,
            "start_logit": -4.328742504119873,
            "end_logit": 1.7460005283355713
        },
        {
            "text": "cancer patients. cfDNA can be easily purified from serum and plasma and contains DNA fragments of tumor origin",
            "probability": 8.846274071053715e-06,
            "start_logit": -4.390561580657959,
            "end_logit": 1.7460005283355713
        },
        {
            "text": "contains DNA fragments of tumor origin. For this reason, it is the most widely used material for the detection of somatic mutations in blood",
            "probability": 8.807633229295277e-06,
            "start_logit": -1.013041615486145,
            "end_logit": -1.6358970403671265
        },
        {
            "text": "materials that can be derived from the blood of cancer patients. cfDNA can be easily purified from serum and plasma and contains DNA fragments of tumor origin",
            "probability": 7.517640430557855e-06,
            "start_logit": -4.553305625915527,
            "end_logit": 1.7460005283355713
        },
        {
            "text": "contains DNA fragments of tumor origin. For this reason, it is the most widely used material for the detection of somatic mutations",
            "probability": 6.261041361801956e-06,
            "start_logit": -1.013041615486145,
            "end_logit": -1.9771692752838135
        },
        {
            "text": "contains DNA fragments of tumor origin.",
            "probability": 5.948591553213892e-06,
            "start_logit": -1.013041615486145,
            "end_logit": -2.0283613204956055
        },
        {
            "text": "contains DNA fragments of tumor",
            "probability": 5.120445286067419e-06,
            "start_logit": -1.013041615486145,
            "end_logit": -2.178274393081665
        }
    ],
    "5cc0817da49efeb44c000002_002": [
        {
            "text": "",
            "probability": 0.9998653736819111,
            "start_logit": 3.2640419006347656,
            "end_logit": 3.467322826385498
        },
        {
            "text": "cell",
            "probability": 6.099412726359663e-05,
            "start_logit": -0.4959012567996979,
            "end_logit": -2.477332353591919
        },
        {
            "text": "cell-free DNA (cfDNA) is beginning to inform on tumor genetics, tumor burden, and mechanisms of progression and drug resistance",
            "probability": 2.5542105348620503e-05,
            "start_logit": -0.4959012567996979,
            "end_logit": -3.3477816581726074
        },
        {
            "text": "cell-free DNA",
            "probability": 1.1803590736599315e-05,
            "start_logit": -0.4959012567996979,
            "end_logit": -4.119706153869629
        },
        {
            "text": "cell-free DNA (cfDNA) is beginning to inform on tumor genetics",
            "probability": 9.25946237069557e-06,
            "start_logit": -0.4959012567996979,
            "end_logit": -4.36246395111084
        },
        {
            "text": "cell-free DNA (cfDNA) is beginning to inform on tumor genetics, tumor burden, and mechanisms of progression and drug resistance. This substrate",
            "probability": 5.0577348220087145e-06,
            "start_logit": -0.4959012567996979,
            "end_logit": -4.967191219329834
        },
        {
            "text": "present in the blood of cancer patients for decades, cell",
            "probability": 4.050503767161727e-06,
            "start_logit": -3.2078375816345215,
            "end_logit": -2.477332353591919
        },
        {
            "text": "cell-free DNA (cfDNA) is beginning to inform on tumor genetics, tumor burden",
            "probability": 2.7535862027656406e-06,
            "start_logit": -0.4959012567996979,
            "end_logit": -5.5752058029174805
        },
        {
            "text": "substrate is amenable for inexpensive noninvasive testing",
            "probability": 2.112831754118112e-06,
            "start_logit": -3.982144594192505,
            "end_logit": -2.353837490081787
        },
        {
            "text": "inform on tumor genetics, tumor burden, and mechanisms of progression and drug resistance. This substrate is amenable for inexpensive noninvasive testing",
            "probability": 2.050120324933983e-06,
            "start_logit": -4.012275218963623,
            "end_logit": -2.353837490081787
        },
        {
            "text": "blood of cancer patients for decades, cell",
            "probability": 1.7679897585085236e-06,
            "start_logit": -4.036835670471191,
            "end_logit": -2.477332353591919
        },
        {
            "text": "tumor genetics, tumor burden, and mechanisms of progression and drug resistance. This substrate is amenable for inexpensive noninvasive testing",
            "probability": 1.699307989340267e-06,
            "start_logit": -4.199952602386475,
            "end_logit": -2.353837490081787
        },
        {
            "text": "tumor sampling",
            "probability": 1.3079697515627122e-06,
            "start_logit": -4.503382205963135,
            "end_logit": -2.312152862548828
        },
        {
            "text": "tumor sampling are impractical for this application. Known to be present in the blood of cancer patients for decades, cell",
            "probability": 1.1088202763169434e-06,
            "start_logit": -4.503382205963135,
            "end_logit": -2.477332353591919
        },
        {
            "text": "sampling",
            "probability": 9.27203338265606e-07,
            "start_logit": -4.847440719604492,
            "end_logit": -2.312152862548828
        },
        {
            "text": "substrate is amenable for inexpensive noninvasive testing and thus presents a viable approach to serial sampling",
            "probability": 9.134956787155415e-07,
            "start_logit": -3.982144594192505,
            "end_logit": -3.192343235015869
        },
        {
            "text": "present in the blood",
            "probability": 9.008601179223771e-07,
            "start_logit": -3.2078375816345215,
            "end_logit": -3.980578899383545
        },
        {
            "text": "Known to be present in the blood of cancer patients for decades, cell",
            "probability": 8.067258434927851e-07,
            "start_logit": -4.821450233459473,
            "end_logit": -2.477332353591919
        },
        {
            "text": "sampling are impractical for this application. Known to be present in the blood of cancer patients for decades, cell",
            "probability": 7.860287751374408e-07,
            "start_logit": -4.847440719604492,
            "end_logit": -2.477332353591919
        },
        {
            "text": "present in the blood of cancer patients for decades, cell-free DNA",
            "probability": 7.838539690552424e-07,
            "start_logit": -3.2078375816345215,
            "end_logit": -4.119706153869629
        }
    ],
    "5cc0817da49efeb44c000002_003": [
        {
            "text": "",
            "probability": 0.9653881249325929,
            "start_logit": 3.6328089237213135,
            "end_logit": 3.723586082458496
        },
        {
            "text": "to replace conventional screening",
            "probability": 0.011211376336560374,
            "start_logit": 1.105487585067749,
            "end_logit": 1.7953062057495117
        },
        {
            "text": "replace conventional screening",
            "probability": 0.011079612017611153,
            "start_logit": 1.0936652421951294,
            "end_logit": 1.7953062057495117
        },
        {
            "text": "cell-free DNA (cfDNA) to replace conventional screening",
            "probability": 0.008364778672589113,
            "start_logit": 0.8125884532928467,
            "end_logit": 1.7953062057495117
        },
        {
            "text": "conventional screening",
            "probability": 0.0015446208141003117,
            "start_logit": -0.8766629695892334,
            "end_logit": 1.7953062057495117
        },
        {
            "text": "cell",
            "probability": 0.0009488399756510095,
            "start_logit": 0.8125884532928467,
            "end_logit": -0.38123878836631775
        },
        {
            "text": "to replace conventional screening.",
            "probability": 0.0002632082068992101,
            "start_logit": 1.105487585067749,
            "end_logit": -1.9564327001571655
        },
        {
            "text": "replace conventional screening.",
            "probability": 0.0002601147909721375,
            "start_logit": 1.0936652421951294,
            "end_logit": -1.9564327001571655
        },
        {
            "text": "cell-free DNA (cfDNA) to replace conventional screening.",
            "probability": 0.00019637895735791574,
            "start_logit": 0.8125884532928467,
            "end_logit": -1.9564327001571655
        },
        {
            "text": "screening",
            "probability": 0.00018174982248918427,
            "start_logit": -3.0165655612945557,
            "end_logit": 1.7953062057495117
        },
        {
            "text": "cell-free DNA",
            "probability": 0.0001726010326198519,
            "start_logit": 0.8125884532928467,
            "end_logit": -2.085496187210083
        },
        {
            "text": "to replace",
            "probability": 8.041091726335153e-05,
            "start_logit": 1.105487585067749,
            "end_logit": -3.142228126525879
        },
        {
            "text": "replace",
            "probability": 7.946586917726276e-05,
            "start_logit": 1.0936652421951294,
            "end_logit": -3.142228126525879
        },
        {
            "text": "cell-free DNA (cfDNA) to replace",
            "probability": 5.9994375853247744e-05,
            "start_logit": 0.8125884532928467,
            "end_logit": -3.142228126525879
        },
        {
            "text": "cell-free",
            "probability": 5.668980913002282e-05,
            "start_logit": 0.8125884532928467,
            "end_logit": -3.1988844871520996
        },
        {
            "text": "DNA (cfDNA) to replace conventional screening",
            "probability": 3.707566112805179e-05,
            "start_logit": -4.606235980987549,
            "end_logit": 1.7953062057495117
        },
        {
            "text": "conventional screening.",
            "probability": 3.626288714372707e-05,
            "start_logit": -0.8766629695892334,
            "end_logit": -1.9564327001571655
        },
        {
            "text": "free DNA (cfDNA) to replace conventional screening",
            "probability": 1.4310192176348667e-05,
            "start_logit": -5.558224678039551,
            "end_logit": 1.7953062057495117
        },
        {
            "text": "using cell-free DNA (cfDNA) to replace conventional screening",
            "probability": 1.4265009333503402e-05,
            "start_logit": -5.561387062072754,
            "end_logit": 1.7953062057495117
        },
        {
            "text": "Down syndrome by using cell-free DNA (cfDNA) to replace conventional screening",
            "probability": 1.0119719351187159e-05,
            "start_logit": -5.90471076965332,
            "end_logit": 1.7953062057495117
        }
    ],
    "5cc0817da49efeb44c000002_004": [
        {
            "text": "",
            "probability": 0.9999999396207978,
            "start_logit": 7.439119815826416,
            "end_logit": 7.8753862380981445
        },
        {
            "text": "independent predictor of overall survival",
            "probability": 2.0220758679594143e-08,
            "start_logit": -2.344608783721924,
            "end_logit": -0.05744120478630066
        },
        {
            "text": "an independent predictor of overall survival",
            "probability": 1.4185477623608202e-08,
            "start_logit": -2.6990997791290283,
            "end_logit": -0.05744120478630066
        },
        {
            "text": "predictor of overall survival",
            "probability": 1.1469359243302626e-08,
            "start_logit": -2.911639451980591,
            "end_logit": -0.05744120478630066
        },
        {
            "text": "was an independent predictor of overall survival",
            "probability": 3.995590430426333e-09,
            "start_logit": -3.9661271572113037,
            "end_logit": -0.05744120478630066
        },
        {
            "text": "On univariate and multivariate analysis circulating cfDNA was an independent predictor of overall survival",
            "probability": 2.5340185211618466e-09,
            "start_logit": -4.421512126922607,
            "end_logit": -0.05744120478630066
        },
        {
            "text": "cfDNA was an independent predictor of overall survival",
            "probability": 2.0849973733432206e-09,
            "start_logit": -4.616550922393799,
            "end_logit": -0.05744120478630066
        },
        {
            "text": "overall survival",
            "probability": 1.8215108190803627e-09,
            "start_logit": -4.751652240753174,
            "end_logit": -0.05744120478630066
        },
        {
            "text": "univariate and multivariate analysis circulating cfDNA was an independent predictor of overall survival",
            "probability": 1.452328528517688e-09,
            "start_logit": -4.978150367736816,
            "end_logit": -0.05744120478630066
        },
        {
            "text": "circulating cfDNA was an independent predictor of overall survival",
            "probability": 9.807804595003097e-10,
            "start_logit": -5.370725154876709,
            "end_logit": -0.05744120478630066
        },
        {
            "text": "multivariate analysis circulating cfDNA was an independent predictor of overall survival",
            "probability": 5.731301937419573e-10,
            "start_logit": -5.907960891723633,
            "end_logit": -0.05744120478630066
        },
        {
            "text": "independent predictor",
            "probability": 2.2294385957035643e-10,
            "start_logit": -2.344608783721924,
            "end_logit": -4.564986228942871
        },
        {
            "text": "an independent predictor",
            "probability": 1.5640190268665123e-10,
            "start_logit": -2.6990997791290283,
            "end_logit": -4.564986228942871
        },
        {
            "text": "Chemotherapy",
            "probability": 1.5303689257328945e-10,
            "start_logit": -3.611887216567993,
            "end_logit": -3.6739487648010254
        },
        {
            "text": "predictor",
            "probability": 1.2645535496555132e-10,
            "start_logit": -2.911639451980591,
            "end_logit": -4.564986228942871
        },
        {
            "text": "Chemotherapy is an integral part of the treatment of castration resistant prostate cancer",
            "probability": 9.54985810716614e-11,
            "start_logit": -3.611887216567993,
            "end_logit": -4.145516395568848
        },
        {
            "text": "chemotherapy",
            "probability": 8.215106692707722e-11,
            "start_logit": -5.234718322753906,
            "end_logit": -2.673236846923828
        },
        {
            "text": "On univariate and multivariate analysis",
            "probability": 8.191257793387244e-11,
            "start_logit": -4.421512126922607,
            "end_logit": -3.4893503189086914
        },
        {
            "text": "cfDNA was isolated from a serum specimen before chemotherapy",
            "probability": 7.662274180849111e-11,
            "start_logit": -5.304384231567383,
            "end_logit": -2.673236846923828
        },
        {
            "text": "serum specimen before chemotherapy",
            "probability": 6.622708497880239e-11,
            "start_logit": -5.450188636779785,
            "end_logit": -2.673236846923828
        }
    ],
    "5cc0817da49efeb44c000002_005": [
        {
            "text": "",
            "probability": 0.939811794144912,
            "start_logit": 1.68791663646698,
            "end_logit": 1.9403854608535767
        },
        {
            "text": "Cell-free fetal DNA analysis",
            "probability": 0.029347118794155327,
            "start_logit": 0.26517441868782043,
            "end_logit": -0.10335758328437805
        },
        {
            "text": "Cell-free fetal DNA",
            "probability": 0.008023218653122027,
            "start_logit": 0.26517441868782043,
            "end_logit": -1.400212287902832
        },
        {
            "text": "Cell",
            "probability": 0.005558143926824144,
            "start_logit": 0.26517441868782043,
            "end_logit": -1.7672877311706543
        },
        {
            "text": "Cell-free fetal DNA analysis for non-invasive prenatal screening of fetal chromosomal aneuploidy",
            "probability": 0.0033887666765795754,
            "start_logit": 0.26517441868782043,
            "end_logit": -2.2620859146118164
        },
        {
            "text": "Cell-free fetal DNA analysis for non-invasive prenatal screening",
            "probability": 0.0028154035583732263,
            "start_logit": 0.26517441868782043,
            "end_logit": -2.447446346282959
        },
        {
            "text": "analysis",
            "probability": 0.002567886360550821,
            "start_logit": -2.1709368228912354,
            "end_logit": -0.10335758328437805
        },
        {
            "text": "fetal DNA analysis",
            "probability": 0.001996047765818204,
            "start_logit": -2.4228508472442627,
            "end_logit": -0.10335758328437805
        },
        {
            "text": "Cell-free fetal",
            "probability": 0.001526502273407266,
            "start_logit": 0.26517441868782043,
            "end_logit": -3.05957293510437
        },
        {
            "text": "DNA analysis",
            "probability": 0.0011030867977462394,
            "start_logit": -3.0159075260162354,
            "end_logit": -0.10335758328437805
        },
        {
            "text": "Cell-free",
            "probability": 0.000960940354549467,
            "start_logit": 0.26517441868782043,
            "end_logit": -3.522394895553589
        },
        {
            "text": "complex mutations",
            "probability": 0.000651157041086046,
            "start_logit": -2.133540630340576,
            "end_logit": -1.5128413438796997
        },
        {
            "text": "fetal DNA",
            "probability": 0.0005457001683730739,
            "start_logit": -2.4228508472442627,
            "end_logit": -1.400212287902832
        },
        {
            "text": "DNA",
            "probability": 0.0003015732697225756,
            "start_logit": -3.0159075260162354,
            "end_logit": -1.400212287902832
        },
        {
            "text": "analysis for non-invasive prenatal screening of fetal chromosomal aneuploidy",
            "probability": 0.0002965186391520956,
            "start_logit": -2.1709368228912354,
            "end_logit": -2.2620859146118164
        },
        {
            "text": "assessment of complex mutations",
            "probability": 0.00028024650973952435,
            "start_logit": -2.9766218662261963,
            "end_logit": -1.5128413438796997
        },
        {
            "text": "analysis for non-invasive prenatal screening",
            "probability": 0.00024634910321870115,
            "start_logit": -2.1709368228912354,
            "end_logit": -2.447446346282959
        },
        {
            "text": "fetal DNA analysis for non-invasive prenatal screening of fetal chromosomal aneuploidy",
            "probability": 0.00023048736746903294,
            "start_logit": -2.4228508472442627,
            "end_logit": -2.2620859146118164
        },
        {
            "text": "fetal DNA analysis for non-invasive prenatal screening",
            "probability": 0.00019149000697426882,
            "start_logit": -2.4228508472442627,
            "end_logit": -2.447446346282959
        },
        {
            "text": "mutations",
            "probability": 0.00015756858822647092,
            "start_logit": -3.5524306297302246,
            "end_logit": -1.5128413438796997
        }
    ],
    "5e36d807b5b409ea5300000a_002": [
        {
            "text": "facilitates the transfer of parental (H3-H4)2 tetramers to lagging-strand DNA at replication forks",
            "probability": 0.5352538876673166,
            "start_logit": 4.159882068634033,
            "end_logit": 0.8730649948120117
        },
        {
            "text": "facilitates the transfer of parental (H3-H4)2 tetramers to lagging-strand DNA",
            "probability": 0.2769097525294295,
            "start_logit": 4.159882068634033,
            "end_logit": 0.21401545405387878
        },
        {
            "text": "facilitates the transfer of parental (H3-H4)2 tetramers",
            "probability": 0.07741149481338296,
            "start_logit": 4.159882068634033,
            "end_logit": -1.0605409145355225
        },
        {
            "text": "facilitates the transfer of parental (H3-H4)2 tetramers to lagging-strand DNA at replication forks.",
            "probability": 0.0494617763831658,
            "start_logit": 4.159882068634033,
            "end_logit": -1.5084760189056396
        },
        {
            "text": "facilitates",
            "probability": 0.035793448377737284,
            "start_logit": 4.159882068634033,
            "end_logit": -1.831911325454712
        },
        {
            "text": "facilitates the transfer of parental (H3-H4)2 tetramers to lagging-strand",
            "probability": 0.00809648735827642,
            "start_logit": 4.159882068634033,
            "end_logit": -3.3182458877563477
        },
        {
            "text": "facilitates the transfer",
            "probability": 0.004636535266333365,
            "start_logit": 4.159882068634033,
            "end_logit": -3.875708818435669
        },
        {
            "text": "facilitates the transfer of parental",
            "probability": 0.003821935669644187,
            "start_logit": 4.159882068634033,
            "end_logit": -4.0689191818237305
        },
        {
            "text": "the Mcm2-Ctf4-Pol\u03b1 axis",
            "probability": 0.0016100035833911544,
            "start_logit": -0.14488321542739868,
            "end_logit": -0.6286745071411133
        },
        {
            "text": "transfer of parental (H3-H4)2 tetramers to lagging-strand DNA at replication forks",
            "probability": 0.0012370798655620726,
            "start_logit": -1.9101054668426514,
            "end_logit": 0.8730649948120117
        },
        {
            "text": "the Mcm2-Ctf4-Pol\u03b1 axis facilitates the transfer of parental (H3-H4)2 tetramers",
            "probability": 0.0010453690670837734,
            "start_logit": -0.14488321542739868,
            "end_logit": -1.0605409145355225
        },
        {
            "text": "axis facilitates the transfer of parental (H3-H4)2 tetramers to lagging-strand DNA at replication forks",
            "probability": 0.0010094279652448717,
            "start_logit": -2.1134753227233887,
            "end_logit": 0.8730649948120117
        },
        {
            "text": "transfer of parental (H3-H4)2 tetramers to lagging-strand DNA",
            "probability": 0.0006399943789756253,
            "start_logit": -1.9101054668426514,
            "end_logit": 0.21401545405387878
        },
        {
            "text": "Mcm2-Ctf4-Pol\u03b1 axis",
            "probability": 0.0006324456475989148,
            "start_logit": -1.0792806148529053,
            "end_logit": -0.6286745071411133
        },
        {
            "text": "axis facilitates the transfer of parental (H3-H4)2 tetramers to lagging-strand DNA",
            "probability": 0.0005222203042194005,
            "start_logit": -2.1134753227233887,
            "end_logit": 0.21401545405387878
        },
        {
            "text": "the Mcm2-Ctf4-Pol\u03b1 axis facilitates",
            "probability": 0.0004833566878995043,
            "start_logit": -0.14488321542739868,
            "end_logit": -1.831911325454712
        },
        {
            "text": "Mcm2-Ctf4-Pol\u03b1 axis facilitates the transfer of parental (H3-H4)2 tetramers",
            "probability": 0.00041064450006944196,
            "start_logit": -1.0792806148529053,
            "end_logit": -1.0605409145355225
        },
        {
            "text": "parental (H3-H4)2 tetramers to lagging-strand DNA at replication forks",
            "probability": 0.00039268769161523277,
            "start_logit": -3.0575997829437256,
            "end_logit": 0.8730649948120117
        },
        {
            "text": "Mcm2-Ctf4-Pol\u03b1 axis facilitates the transfer of parental (H3-H4)2 tetramers to lagging-strand DNA at replication forks.",
            "probability": 0.0003263092778100808,
            "start_logit": -3.2427687644958496,
            "end_logit": 0.8730649948120117
        },
        {
            "text": "the transfer of parental (H3-H4)2 tetramers to lagging-strand DNA at replication forks",
            "probability": 0.0002835897561887903,
            "start_logit": -3.3830857276916504,
            "end_logit": 0.8730649948120117
        },
        {
            "text": "",
            "probability": 2.1553209055090762e-05,
            "start_logit": -2.1772842407226562,
            "end_logit": -2.909740447998047
        }
    ],
    "5e2dafccfbd6abf43b000013_001": [
        {
            "text": "",
            "probability": 0.9865716915480582,
            "start_logit": 2.6950299739837646,
            "end_logit": 3.638292074203491
        },
        {
            "text": "NMDA",
            "probability": 0.003968399988812072,
            "start_logit": -0.0991666242480278,
            "end_logit": 0.9166156649589539
        },
        {
            "text": "NMDA)",
            "probability": 0.003617651895182773,
            "start_logit": -0.0991666242480278,
            "end_logit": 0.824077844619751
        },
        {
            "text": "N-methyl-D-aspartate (NMDA",
            "probability": 0.0012079735309401365,
            "start_logit": -1.2885854244232178,
            "end_logit": 0.9166156649589539
        },
        {
            "text": "N-methyl-D-aspartate (NMDA)",
            "probability": 0.0011012064675578138,
            "start_logit": -1.2885854244232178,
            "end_logit": 0.824077844619751
        },
        {
            "text": "N-methyl-D-aspartate",
            "probability": 0.0009289989126304299,
            "start_logit": -1.2885854244232178,
            "end_logit": 0.6540237665176392
        },
        {
            "text": "N-methyl-D-aspartic acid or N-methyl-D-aspartate (NMDA",
            "probability": 0.00047776255632088336,
            "start_logit": -2.2161710262298584,
            "end_logit": 0.9166156649589539
        },
        {
            "text": "N-methyl-D-aspartic acid or N-methyl-D-aspartate (NMDA)",
            "probability": 0.00043553538509080454,
            "start_logit": -2.2161710262298584,
            "end_logit": 0.824077844619751
        },
        {
            "text": "N-methyl-D-aspartic acid or N-methyl-D-aspartate",
            "probability": 0.0003674260105452846,
            "start_logit": -2.2161710262298584,
            "end_logit": 0.6540237665176392
        },
        {
            "text": "(NMDA",
            "probability": 0.00032939673231019943,
            "start_logit": -2.588021993637085,
            "end_logit": 0.9166156649589539
        },
        {
            "text": "(NMDA)",
            "probability": 0.000300282914088436,
            "start_logit": -2.588021993637085,
            "end_logit": 0.824077844619751
        },
        {
            "text": "Amantadine is an N-methyl-D-aspartic acid or N-methyl-D-aspartate (NMDA",
            "probability": 0.00014095168573207556,
            "start_logit": -3.4368677139282227,
            "end_logit": 0.9166156649589539
        },
        {
            "text": "NMDA) receptor antagonist that can be effective against postoperative pain",
            "probability": 0.00013288945315227953,
            "start_logit": -0.0991666242480278,
            "end_logit": -2.479984998703003
        },
        {
            "text": "Amantadine is an N-methyl-D-aspartic acid or N-methyl-D-aspartate (NMDA)",
            "probability": 0.00012849363331706159,
            "start_logit": -3.4368677139282227,
            "end_logit": 0.824077844619751
        },
        {
            "text": "Amantadine is an N-methyl-D-aspartic acid or N-methyl-D-aspartate",
            "probability": 0.0001083996953779391,
            "start_logit": -3.4368677139282227,
            "end_logit": 0.6540237665176392
        },
        {
            "text": "NMDA) receptor",
            "probability": 6.333386340678636e-05,
            "start_logit": -0.0991666242480278,
            "end_logit": -3.2210824489593506
        },
        {
            "text": "N-methyl-D-aspartate (NMDA) receptor antagonist that can be effective against postoperative pain",
            "probability": 4.0451300877338265e-05,
            "start_logit": -1.2885854244232178,
            "end_logit": -2.479984998703003
        },
        {
            "text": "aspartate (NMDA",
            "probability": 2.7885886454908292e-05,
            "start_logit": -5.057164192199707,
            "end_logit": 0.9166156649589539
        },
        {
            "text": ")",
            "probability": 2.5847355216792482e-05,
            "start_logit": -5.040538787841797,
            "end_logit": 0.824077844619751
        },
        {
            "text": "aspartate (NMDA)",
            "probability": 2.5421184927643632e-05,
            "start_logit": -5.057164192199707,
            "end_logit": 0.824077844619751
        }
    ],
    "5e499c636d0a27794100000a_001": [
        {
            "text": "tumor-targeted radionuclides",
            "probability": 0.7006060148891103,
            "start_logit": 1.3701183795928955,
            "end_logit": 2.928394317626953
        },
        {
            "text": "with tumor-targeted radionuclides",
            "probability": 0.16659228334037532,
            "start_logit": -0.06627790629863739,
            "end_logit": 2.928394317626953
        },
        {
            "text": "Molecular radiotherapy with tumor-targeted radionuclides",
            "probability": 0.08169854939858613,
            "start_logit": -0.778791069984436,
            "end_logit": 2.928394317626953
        },
        {
            "text": "",
            "probability": 0.04123294665896198,
            "start_logit": -0.08567913621664047,
            "end_logit": 1.5514837503433228
        },
        {
            "text": "external-beam radiotherapy is limited. Molecular radiotherapy with tumor-targeted radionuclides",
            "probability": 0.0020440062069826347,
            "start_logit": -4.466915607452393,
            "end_logit": 2.928394317626953
        },
        {
            "text": "tumor-targeted radionuclides may overcome some of these challenges",
            "probability": 0.0016338958962750917,
            "start_logit": 1.3701183795928955,
            "end_logit": -3.1325840950012207
        },
        {
            "text": "tumor-targeted radionuclides may overcome some of these challenges, but to date there exists no single cancer-selective agent",
            "probability": 0.001331378455503202,
            "start_logit": 1.3701183795928955,
            "end_logit": -3.337336540222168
        },
        {
            "text": "targeted radionuclides",
            "probability": 0.0011478521430971114,
            "start_logit": -5.0439348220825195,
            "end_logit": 2.928394317626953
        },
        {
            "text": "radionuclides",
            "probability": 0.0007470056935134982,
            "start_logit": -5.473509788513184,
            "end_logit": 2.928394317626953
        },
        {
            "text": "tumor-targeted",
            "probability": 0.0004585996267906547,
            "start_logit": 1.3701183795928955,
            "end_logit": -4.4031291007995605
        },
        {
            "text": "radiotherapy with tumor-targeted radionuclides",
            "probability": 0.00041484705408379135,
            "start_logit": -6.061672687530518,
            "end_logit": 2.928394317626953
        },
        {
            "text": "with tumor-targeted radionuclides may overcome some of these challenges",
            "probability": 0.0003885128621740689,
            "start_logit": -0.06627790629863739,
            "end_logit": -3.1325840950012207
        },
        {
            "text": "metastatic disease, the utility of external-beam radiotherapy is limited. Molecular radiotherapy with tumor-targeted radionuclides",
            "probability": 0.0003218311480104856,
            "start_logit": -6.315555572509766,
            "end_logit": 2.928394317626953
        },
        {
            "text": "with tumor-targeted radionuclides may overcome some of these challenges, but to date there exists no single cancer-selective agent",
            "probability": 0.0003165793215857076,
            "start_logit": -0.06627790629863739,
            "end_logit": -3.337336540222168
        },
        {
            "text": "limited. Molecular radiotherapy with tumor-targeted radionuclides",
            "probability": 0.0002971084412756525,
            "start_logit": -6.3954854011535645,
            "end_logit": 2.928394317626953
        },
        {
            "text": "Molecular radiotherapy with tumor-targeted radionuclides may overcome some of these challenges",
            "probability": 0.00019053065739823205,
            "start_logit": -0.778791069984436,
            "end_logit": -3.1325840950012207
        },
        {
            "text": "tumor",
            "probability": 0.00018015412975965506,
            "start_logit": 1.3701183795928955,
            "end_logit": -5.337493896484375
        },
        {
            "text": "Molecular radiotherapy with tumor-targeted radionuclides may overcome some of these challenges, but to date there exists no single cancer-selective agent",
            "probability": 0.00015525371778653325,
            "start_logit": -0.778791069984436,
            "end_logit": -3.337336540222168
        },
        {
            "text": "tumor-targeted radionuclides may overcome some of these challenges,",
            "probability": 0.00013360310914555817,
            "start_logit": 1.3701183795928955,
            "end_logit": -5.636433124542236
        },
        {
            "text": "with tumor-targeted",
            "probability": 0.00010904724958462046,
            "start_logit": -0.06627790629863739,
            "end_logit": -4.4031291007995605
        }
    ],
    "5e499c636d0a27794100000a_002": [
        {
            "text": "Noradrenaline Transporter Molecule (NAT) and Somatostatin Receptor (SSTR2)",
            "probability": 0.39172238472913257,
            "start_logit": 4.522826671600342,
            "end_logit": 3.6971707344055176
        },
        {
            "text": "directed at distinct molecular targets",
            "probability": 0.32654157617181045,
            "start_logit": 3.405254602432251,
            "end_logit": 4.632746696472168
        },
        {
            "text": "directed at distinct molecular targets: Noradrenaline Transporter Molecule (NAT) and Somatostatin Receptor (SSTR2)",
            "probability": 0.12812179276574298,
            "start_logit": 3.405254602432251,
            "end_logit": 3.6971707344055176
        },
        {
            "text": "131I meta-Iodobenzylguanidine and 177Lu Lutetium DOTATATE, directed at distinct molecular targets",
            "probability": 0.04438906593774901,
            "start_logit": 1.409690499305725,
            "end_logit": 4.632746696472168
        },
        {
            "text": "distinct molecular targets",
            "probability": 0.03062524541006591,
            "start_logit": 1.0385220050811768,
            "end_logit": 4.632746696472168
        },
        {
            "text": "distinct molecular targets: Noradrenaline Transporter Molecule (NAT) and Somatostatin Receptor (SSTR2)",
            "probability": 0.012016115656169895,
            "start_logit": 1.0385220050811768,
            "end_logit": 3.6971707344055176
        },
        {
            "text": "Noradrenaline Transporter Molecule (NAT) and Somatostatin Receptor",
            "probability": 0.010680522777379258,
            "start_logit": 4.522826671600342,
            "end_logit": 0.09503912925720215
        },
        {
            "text": "molecular targets",
            "probability": 0.009422762064989607,
            "start_logit": -0.14017441868782043,
            "end_logit": 4.632746696472168
        },
        {
            "text": "Noradrenaline Transporter Molecule (NAT) and Somatostatin Receptor (SSTR2), respectively.",
            "probability": 0.008274324904419152,
            "start_logit": 4.522826671600342,
            "end_logit": -0.16022531688213348
        },
        {
            "text": "Noradrenaline Transporter Molecule (NAT) and Somatostatin Receptor (SSTR2), respectively",
            "probability": 0.0071192813020805636,
            "start_logit": 4.522826671600342,
            "end_logit": -0.3105758726596832
        },
        {
            "text": "Noradrenaline Transporter Molecule (NAT)",
            "probability": 0.006727394825045307,
            "start_logit": 4.522826671600342,
            "end_logit": -0.36719468235969543
        },
        {
            "text": "Noradrenaline Transporter Molecule",
            "probability": 0.004053312759314331,
            "start_logit": 4.522826671600342,
            "end_logit": -0.8738481402397156
        },
        {
            "text": "molecular targets: Noradrenaline Transporter Molecule (NAT) and Somatostatin Receptor (SSTR2)",
            "probability": 0.003697113190683872,
            "start_logit": -0.14017441868782043,
            "end_logit": 3.6971707344055176
        },
        {
            "text": "directed at distinct molecular targets: Noradrenaline Transporter Molecule (NAT) and Somatostatin Receptor",
            "probability": 0.003493310005399377,
            "start_logit": 3.405254602432251,
            "end_logit": 0.09503912925720215
        },
        {
            "text": "131I meta-Iodobenzylguanidine and 177Lu Lutetium DOTATATE",
            "probability": 0.0027936619868246314,
            "start_logit": 1.409690499305725,
            "end_logit": 1.8671067953109741
        },
        {
            "text": "directed at distinct molecular targets: Noradrenaline Transporter Molecule (NAT) and Somatostatin Receptor (SSTR2), respectively.",
            "probability": 0.0027063077883932194,
            "start_logit": 3.405254602432251,
            "end_logit": -0.16022531688213348
        },
        {
            "text": "directed at distinct molecular targets: Noradrenaline Transporter Molecule (NAT) and Somatostatin Receptor (SSTR2), respectively",
            "probability": 0.0023285242793998516,
            "start_logit": 3.405254602432251,
            "end_logit": -0.3105758726596832
        },
        {
            "text": "directed at distinct molecular targets: Noradrenaline Transporter Molecule (NAT)",
            "probability": 0.002200348816480808,
            "start_logit": 3.405254602432251,
            "end_logit": -0.36719468235969543
        },
        {
            "text": "at distinct molecular targets",
            "probability": 0.001756844369660677,
            "start_logit": -1.8197834491729736,
            "end_logit": 4.632746696472168
        },
        {
            "text": "directed at distinct molecular targets: Noradrenaline Transporter Molecule",
            "probability": 0.0013257289284673108,
            "start_logit": 3.405254602432251,
            "end_logit": -0.8738481402397156
        },
        {
            "text": "",
            "probability": 4.381330790937719e-06,
            "start_logit": -1.716301679611206,
            "end_logit": -1.4646570682525635
        }
    ],
    "5e2f992cfbd6abf43b000031_001": [
        {
            "text": "",
            "probability": 0.9955927988995671,
            "start_logit": 7.23176383972168,
            "end_logit": 6.404172420501709
        },
        {
            "text": "simvastatin",
            "probability": 0.0037017973943393482,
            "start_logit": 4.569580078125,
            "end_logit": 3.4718363285064697
        },
        {
            "text": "thiazide, 12.5 mg; simvastatin",
            "probability": 0.00032518788839778486,
            "start_logit": 2.1374094486236572,
            "end_logit": 3.4718363285064697
        },
        {
            "text": "ramipril, 5 mg; thiazide, 12.5 mg; simvastatin",
            "probability": 0.00011602024213959963,
            "start_logit": 1.1067709922790527,
            "end_logit": 3.4718363285064697
        },
        {
            "text": "aspirin, 100 mg; atenolol",
            "probability": 7.277416052276555e-05,
            "start_logit": 3.259915351867676,
            "end_logit": 0.8522882461547852
        },
        {
            "text": "aspirin, 100 mg; atenolol, 50 mg; ramipril",
            "probability": 3.9130152023941605e-05,
            "start_logit": 3.259915351867676,
            "end_logit": 0.23182061314582825
        },
        {
            "text": "aspirin",
            "probability": 2.854334588935628e-05,
            "start_logit": 3.259915351867676,
            "end_logit": -0.08364886790513992
        },
        {
            "text": "thiazide",
            "probability": 2.5448990724861153e-05,
            "start_logit": 2.1374094486236572,
            "end_logit": 0.9241092801094055
        },
        {
            "text": "simvastatin, 20 mg",
            "probability": 2.2159687405208214e-05,
            "start_logit": 4.569580078125,
            "end_logit": -1.6464626789093018
        },
        {
            "text": "simvastatin, 20 mg)",
            "probability": 2.0186686213511042e-05,
            "start_logit": 4.569580078125,
            "end_logit": -1.7397141456604004
        },
        {
            "text": "aspirin, 100 mg; atenolol, 50 mg; ramipril, 5 mg; thiazide",
            "probability": 9.501803101672464e-06,
            "start_logit": 3.259915351867676,
            "end_logit": -1.1835911273956299
        },
        {
            "text": "ramipril, 5 mg; thiazide",
            "probability": 9.07966800563944e-06,
            "start_logit": 1.1067709922790527,
            "end_logit": 0.9241092801094055
        },
        {
            "text": "aspirin, 100 mg",
            "probability": 8.529759551392006e-06,
            "start_logit": 3.259915351867676,
            "end_logit": -1.2915115356445312
        },
        {
            "text": "atenolol, 50 mg; ramipril, 5 mg; thiazide, 12.5 mg; simvastatin",
            "probability": 8.091626390047029e-06,
            "start_logit": 0.3764379918575287,
            "end_logit": 1.5392343997955322
        },
        {
            "text": "simvastatin,",
            "probability": 5.875963332301148e-06,
            "start_logit": 4.569580078125,
            "end_logit": -2.973867416381836
        },
        {
            "text": "atenolol",
            "probability": 4.070979338881457e-06,
            "start_logit": 0.3764379918575287,
            "end_logit": 0.8522882461547852
        },
        {
            "text": "thiazide, 12.5 mg",
            "probability": 3.837103971367029e-06,
            "start_logit": 2.1374094486236572,
            "end_logit": -0.9678488969802856
        },
        {
            "text": "aspirin, 100 mg; atenolol, 50 mg",
            "probability": 2.7476258964566834e-06,
            "start_logit": 3.259915351867676,
            "end_logit": -2.424335479736328
        },
        {
            "text": "atenolol, 50 mg; ramipril",
            "probability": 2.188936832420408e-06,
            "start_logit": 0.3764379918575287,
            "end_logit": 0.23182061314582825
        },
        {
            "text": "simvastatin, 20 mg) taken as two capsules",
            "probability": 2.029086356229756e-06,
            "start_logit": 4.569580078125,
            "end_logit": -4.03715181350708
        }
    ],
    "5e2f992cfbd6abf43b000031_002": [
        {
            "text": "atenolol, ramipril, hydrochlorothiazide, and a statin",
            "probability": 0.6227506478924139,
            "start_logit": 4.843467712402344,
            "end_logit": 4.303382396697998
        },
        {
            "text": "",
            "probability": 0.12560143749799021,
            "start_logit": 3.3889377117156982,
            "end_logit": 4.156879901885986
        },
        {
            "text": "statin",
            "probability": 0.10014340154967583,
            "start_logit": 3.0159246921539307,
            "end_logit": 4.303382396697998
        },
        {
            "text": "atenolol, ramipril, hydrochlorothiazide",
            "probability": 0.06658878608553155,
            "start_logit": 4.843467712402344,
            "end_logit": 2.067772388458252
        },
        {
            "text": "ramipril, hydrochlorothiazide, and a statin",
            "probability": 0.054957301072913925,
            "start_logit": 2.4158780574798584,
            "end_logit": 4.303382396697998
        },
        {
            "text": "atenolol, ramipril",
            "probability": 0.010575458000001503,
            "start_logit": 4.843467712402344,
            "end_logit": 0.22777223587036133
        },
        {
            "text": "ramipril, hydrochlorothiazide",
            "probability": 0.005876412938898522,
            "start_logit": 2.4158780574798584,
            "end_logit": 2.067772388458252
        },
        {
            "text": "hydrochlorothiazide, and a statin",
            "probability": 0.004640259027538929,
            "start_logit": -0.05590829253196716,
            "end_logit": 4.303382396697998
        },
        {
            "text": "atenolol",
            "probability": 0.0025987444989805223,
            "start_logit": 4.843467712402344,
            "end_logit": -1.175735354423523
        },
        {
            "text": "atenolol, ramipril, hydrochlorothiazide, and a statin)",
            "probability": 0.002385982937911743,
            "start_logit": 4.843467712402344,
            "end_logit": -1.2611526250839233
        },
        {
            "text": "ramipril",
            "probability": 0.0009332766352905448,
            "start_logit": 2.4158780574798584,
            "end_logit": 0.22777223587036133
        },
        {
            "text": "a statin",
            "probability": 0.0007235228493505887,
            "start_logit": -1.9143016338348389,
            "end_logit": 4.303382396697998
        },
        {
            "text": "atenolol, ramipril, hydrochlorothiazi",
            "probability": 0.0005320026412921593,
            "start_logit": 4.843467712402344,
            "end_logit": -2.7618706226348877
        },
        {
            "text": "hydrochlorothiazide",
            "probability": 0.000496168437258097,
            "start_logit": -0.05590829253196716,
            "end_logit": 2.067772388458252
        },
        {
            "text": "statin)",
            "probability": 0.00038368558627858735,
            "start_logit": 3.0159246921539307,
            "end_logit": -1.2611526250839233
        },
        {
            "text": "ramipril, hydrochlorothiazide, and a statin)",
            "probability": 0.00021056129466493121,
            "start_logit": 2.4158780574798584,
            "end_logit": -1.2611526250839233
        },
        {
            "text": "atenolol, ramipril, hydrochlorothiazide,",
            "probability": 0.0001774701495058963,
            "start_logit": 4.843467712402344,
            "end_logit": -3.8597166538238525
        },
        {
            "text": "(comprised of atenolol, ramipril, hydrochlorothiazide, and a statin",
            "probability": 0.0001653991122627908,
            "start_logit": -3.3900723457336426,
            "end_logit": 4.303382396697998
        },
        {
            "text": "comprised of atenolol, ramipril, hydrochlorothiazide, and a statin",
            "probability": 0.00014778051807304743,
            "start_logit": -3.5027055740356445,
            "end_logit": 4.303382396697998
        },
        {
            "text": "atenolol, ramipril, hydrochlorothia",
            "probability": 0.00011170127416680149,
            "start_logit": 4.843467712402344,
            "end_logit": -4.322690963745117
        }
    ],
    "5e2f992cfbd6abf43b000031_003": [
        {
            "text": "",
            "probability": 0.9969217029039513,
            "start_logit": 4.882048606872559,
            "end_logit": 5.401496887207031
        },
        {
            "text": "K(+) supplementation",
            "probability": 0.0021819394987863273,
            "start_logit": 2.6992928981781006,
            "end_logit": 1.459794521331787
        },
        {
            "text": "K(+)",
            "probability": 0.00044917817696842744,
            "start_logit": 2.6992928981781006,
            "end_logit": -0.12075527757406235
        },
        {
            "text": "hydrochlorthiazide",
            "probability": 0.00015924043196180042,
            "start_logit": 1.5259464979171753,
            "end_logit": 0.01558669377118349
        },
        {
            "text": "K",
            "probability": 0.00011734307417856931,
            "start_logit": 2.6992928981781006,
            "end_logit": -1.4630730152130127
        },
        {
            "text": "hydrochlorthiazide, 12.5 mg; atenolol",
            "probability": 3.7395207907263376e-05,
            "start_logit": 1.5259464979171753,
            "end_logit": -1.4332859516143799
        },
        {
            "text": "K(+) supplementation) reduces BP and low-density lipoprotein cholesterol",
            "probability": 3.706438686205724e-05,
            "start_logit": 2.6992928981781006,
            "end_logit": -2.61551833152771
        },
        {
            "text": "supplementation",
            "probability": 2.031124495228288e-05,
            "start_logit": -1.9775018692016602,
            "end_logit": 1.459794521331787
        },
        {
            "text": "K(+) supplementation) reduces BP",
            "probability": 1.9121890722014066e-05,
            "start_logit": 2.6992928981781006,
            "end_logit": -3.27734112739563
        },
        {
            "text": "K(+",
            "probability": 1.225251932532078e-05,
            "start_logit": 2.6992928981781006,
            "end_logit": -3.7224433422088623
        },
        {
            "text": "K(+) supplementation)",
            "probability": 1.0370568534541305e-05,
            "start_logit": 2.6992928981781006,
            "end_logit": -3.8892030715942383
        },
        {
            "text": "hydrochlorthiazide, 12.5 mg; atenolol, 50 mg; ramipril",
            "probability": 9.581118576953464e-06,
            "start_logit": 1.5259464979171753,
            "end_logit": -2.795034170150757
        },
        {
            "text": "simvastatin (20 mg), and aspirin",
            "probability": 4.874244776064303e-06,
            "start_logit": -0.8333226442337036,
            "end_logit": -1.1115942001342773
        },
        {
            "text": "K(+) supplement",
            "probability": 3.4292759642224054e-06,
            "start_logit": 2.6992928981781006,
            "end_logit": -4.99582576751709
        },
        {
            "text": "atenolol",
            "probability": 3.245566836229871e-06,
            "start_logit": -0.9183060526847839,
            "end_logit": -1.4332859516143799
        },
        {
            "text": "aspirin",
            "probability": 3.161015833374486e-06,
            "start_logit": -1.2663943767547607,
            "end_logit": -1.1115942001342773
        },
        {
            "text": "full-dose polycap (plus K(+) supplementation",
            "probability": 2.768920145808003e-06,
            "start_logit": -3.970219135284424,
            "end_logit": 1.459794521331787
        },
        {
            "text": "K(+) supplementation) reduces BP and low-density lipoprotein cholesterol to a greater extent compared with the low dose",
            "probability": 2.5017953916823696e-06,
            "start_logit": 2.6992928981781006,
            "end_logit": -5.311166286468506
        },
        {
            "text": "polycap (plus K(+) supplementation",
            "probability": 2.485478590840184e-06,
            "start_logit": -4.078211307525635,
            "end_logit": 1.459794521331787
        },
        {
            "text": "ramipril, 5 mg) at low doses, simvastatin (20 mg), and aspirin",
            "probability": 2.0326797351237167e-06,
            "start_logit": -1.7079328298568726,
            "end_logit": -1.1115942001342773
        }
    ],
    "5e2f992cfbd6abf43b000031_004": [
        {
            "text": "aspirin",
            "probability": 0.2328803428858349,
            "start_logit": 6.763047695159912,
            "end_logit": 1.5082671642303467
        },
        {
            "text": "aspirin [acetylsalicylic acid], ramipril, simvastatin, atenolol",
            "probability": 0.2197746900353338,
            "start_logit": 6.763047695159912,
            "end_logit": 1.4503452777862549
        },
        {
            "text": "aspirin [acetylsalicylic acid]",
            "probability": 0.17511518918227606,
            "start_logit": 6.763047695159912,
            "end_logit": 1.2231863737106323
        },
        {
            "text": "",
            "probability": 0.17031667776353362,
            "start_logit": 4.56699800491333,
            "end_logit": 3.391451597213745
        },
        {
            "text": "aspirin [acetylsalicylic acid",
            "probability": 0.12395015347627975,
            "start_logit": 6.763047695159912,
            "end_logit": 0.8776218891143799
        },
        {
            "text": "aspirin [acetylsalicylic acid], ramipril, simvastatin",
            "probability": 0.03988144361538982,
            "start_logit": 6.763047695159912,
            "end_logit": -0.2563464641571045
        },
        {
            "text": "aspirin [acetylsalicylic acid], ramipril",
            "probability": 0.021623187969146154,
            "start_logit": 6.763047695159912,
            "end_logit": -0.8684913516044617
        },
        {
            "text": "hydrochlorothiazide",
            "probability": 0.0058163425713562535,
            "start_logit": 0.8946946263313293,
            "end_logit": 3.686767101287842
        },
        {
            "text": "ramipril, simvastatin, atenolol, and hydrochlorothiazide",
            "probability": 0.0037544394875222474,
            "start_logit": 0.456961989402771,
            "end_logit": 3.686767101287842
        },
        {
            "text": "as",
            "probability": 0.0025508043045698644,
            "start_logit": 6.763047695159912,
            "end_logit": -3.0058488845825195
        },
        {
            "text": "atenolol, and hydrochlorothiazide",
            "probability": 0.0017051490711195547,
            "start_logit": -0.33232447504997253,
            "end_logit": 3.686767101287842
        },
        {
            "text": "simvastatin",
            "probability": 0.0005349388929810073,
            "start_logit": 1.2310338020324707,
            "end_logit": 0.964153528213501
        },
        {
            "text": "aspirin [acetylsalicylic acid], ramipril, simvastatin,",
            "probability": 0.0004664057102453875,
            "start_logit": 6.763047695159912,
            "end_logit": -4.704957008361816
        },
        {
            "text": "ramipril, simvastatin, atenolol",
            "probability": 0.0004011247429425337,
            "start_logit": 0.456961989402771,
            "end_logit": 1.4503452777862549
        },
        {
            "text": "aspirin [acetylsalicylic acid], ramipril,",
            "probability": 0.0002579206525840593,
            "start_logit": 6.763047695159912,
            "end_logit": -5.297360897064209
        },
        {
            "text": "aspirin [acetylsalicylic acid], ramipril, simvastatin, atenolol,",
            "probability": 0.000246980738754789,
            "start_logit": 6.763047695159912,
            "end_logit": -5.340702533721924
        },
        {
            "text": "aspirin [acetylsalicylic acid],",
            "probability": 0.00023343393104416636,
            "start_logit": 6.763047695159912,
            "end_logit": -5.397113800048828
        },
        {
            "text": "atenolol",
            "probability": 0.00018217832118608054,
            "start_logit": -0.33232447504997253,
            "end_logit": 1.4503452777862549
        },
        {
            "text": "aspirin [acetylsalicylic",
            "probability": 0.00016481131684638846,
            "start_logit": 6.763047695159912,
            "end_logit": -5.745211601257324
        },
        {
            "text": "simvastatin, atenolol, and hydrochlorothiazide",
            "probability": 0.00014378533105326995,
            "start_logit": -2.805410861968994,
            "end_logit": 3.686767101287842
        }
    ],
    "5e2f992cfbd6abf43b000031_005": [
        {
            "text": "ramipril, hydrochlorothiazide, atenolol, aspirin, and simvastatin",
            "probability": 0.7780549810684961,
            "start_logit": 5.86925745010376,
            "end_logit": 5.78909158706665
        },
        {
            "text": "simvastatin",
            "probability": 0.1238646368304987,
            "start_logit": 4.031649589538574,
            "end_logit": 5.78909158706665
        },
        {
            "text": "ramipril, hydrochlorothiazide, atenolol, aspirin, and simvastatin.",
            "probability": 0.0640177657581557,
            "start_logit": 5.86925745010376,
            "end_logit": 3.291455030441284
        },
        {
            "text": "simvastatin.",
            "probability": 0.01019148710473433,
            "start_logit": 4.031649589538574,
            "end_logit": 3.291455030441284
        },
        {
            "text": "atenolol, aspirin, and simvastatin",
            "probability": 0.008558376996861907,
            "start_logit": 1.3593708276748657,
            "end_logit": 5.78909158706665
        },
        {
            "text": "ramipril, hydrochlorothiazide",
            "probability": 0.0067450793842635595,
            "start_logit": 5.86925745010376,
            "end_logit": 1.0411076545715332
        },
        {
            "text": "aspirin, and simvastatin",
            "probability": 0.002583828557913538,
            "start_logit": 0.1617324948310852,
            "end_logit": 5.78909158706665
        },
        {
            "text": "ramipril, hydrochlorothiazide, atenolol, aspirin",
            "probability": 0.0018403642744232378,
            "start_logit": 5.86925745010376,
            "end_logit": -0.2577420771121979
        },
        {
            "text": "ramipril, hydrochlorothiazide, atenolol",
            "probability": 0.0011979901147859636,
            "start_logit": 5.86925745010376,
            "end_logit": -0.6870603561401367
        },
        {
            "text": "ramipril",
            "probability": 0.0007560780009514415,
            "start_logit": 5.86925745010376,
            "end_logit": -1.147316336631775
        },
        {
            "text": "atenolol, aspirin, and simvastatin.",
            "probability": 0.0007041766805511398,
            "start_logit": 1.3593708276748657,
            "end_logit": 3.291455030441284
        },
        {
            "text": "hydrochlorothiazide, atenolol, aspirin, and simvastatin",
            "probability": 0.0003907805890001814,
            "start_logit": -1.7271487712860107,
            "end_logit": 5.78909158706665
        },
        {
            "text": "aspirin, and simvastatin.",
            "probability": 0.00021259542757837594,
            "start_logit": 0.1617324948310852,
            "end_logit": 3.291455030441284
        },
        {
            "text": "it included ramipril, hydrochlorothiazide, atenolol, aspirin, and simvastatin",
            "probability": 0.00020807402123786288,
            "start_logit": -2.357401132583618,
            "end_logit": 5.78909158706665
        },
        {
            "text": "simvastatin. Blood pressure and LDL levels were effectively lowered and antiplatelet function was demonstrated, but the effect of simvastatin",
            "probability": 0.00018335857228971554,
            "start_logit": 4.031649589538574,
            "end_logit": -0.726409375667572
        },
        {
            "text": "ramipril, hydrochlorothiazide, atenolol, aspirin,",
            "probability": 0.00013119169269069415,
            "start_logit": 5.86925745010376,
            "end_logit": -2.898801326751709
        },
        {
            "text": "ram",
            "probability": 0.00010075281169213926,
            "start_logit": 5.86925745010376,
            "end_logit": -3.1627907752990723
        },
        {
            "text": "ramipril, hydrochlorothiazide,",
            "probability": 8.15749965104397e-05,
            "start_logit": 5.86925745010376,
            "end_logit": -3.3739380836486816
        },
        {
            "text": "ramipril,",
            "probability": 6.484209674196292e-05,
            "start_logit": 5.86925745010376,
            "end_logit": -3.603505849838257
        },
        {
            "text": "ramipril, hydrochlorothiazide, atenolol,",
            "probability": 6.441724369120994e-05,
            "start_logit": 5.86925745010376,
            "end_logit": -3.610079526901245
        },
        {
            "text": "",
            "probability": 4.764777693173473e-05,
            "start_logit": 1.1607483625411987,
            "end_logit": 0.7968841791152954
        }
    ],
    "5e2f992cfbd6abf43b000031_006": [
        {
            "text": "folic acid",
            "probability": 0.9650354605838466,
            "start_logit": 6.305000305175781,
            "end_logit": 5.594610214233398
        },
        {
            "text": "",
            "probability": 0.013711079627855038,
            "start_logit": 3.8008768558502197,
            "end_logit": 3.844773054122925
        },
        {
            "text": "statin, aspirin, and folic acid",
            "probability": 0.009739609375511707,
            "start_logit": 1.7090364694595337,
            "end_logit": 5.594610214233398
        },
        {
            "text": "aspirin, and folic acid",
            "probability": 0.004503155025422542,
            "start_logit": 0.9376137256622314,
            "end_logit": 5.594610214233398
        },
        {
            "text": "thiazide",
            "probability": 0.0023269912457788756,
            "start_logit": 4.197908878326416,
            "end_logit": 1.6741129159927368
        },
        {
            "text": "11-dehydrothromboxane B2 were similar with the Polycap (283.1 ng/mmol creatinine",
            "probability": 0.0014258150310146934,
            "start_logit": 2.764747381210327,
            "end_logit": 2.6174418926239014
        },
        {
            "text": "11-dehydrothromboxane B2",
            "probability": 0.0013308314748890272,
            "start_logit": 2.764747381210327,
            "end_logit": 2.548502206802368
        },
        {
            "text": "thiazide (12.5 mg), atenolol",
            "probability": 0.0007018886264573486,
            "start_logit": 4.197908878326416,
            "end_logit": 0.47555625438690186
        },
        {
            "text": "aspirin",
            "probability": 0.00018600283501452093,
            "start_logit": 2.0979034900665283,
            "end_logit": 1.2475488185882568
        },
        {
            "text": "statin, aspirin",
            "probability": 0.00017061801207995773,
            "start_logit": 1.7090364694595337,
            "end_logit": 1.5500811338424683
        },
        {
            "text": "thiazide (12.5 mg), atenolol (50 mg), ramipril",
            "probability": 0.00016956520886768917,
            "start_logit": 4.197908878326416,
            "end_logit": -0.9449809193611145
        },
        {
            "text": "simvastatin (20 mg), and aspirin",
            "probability": 9.938354251164908e-05,
            "start_logit": 1.6890047788619995,
            "end_logit": 1.0296721458435059
        },
        {
            "text": "folic acid (the polypill",
            "probability": 9.682334776406664e-05,
            "start_logit": 6.305000305175781,
            "end_logit": -3.612421751022339
        },
        {
            "text": "thiazide (12.5 mg), atenolol (50 mg)",
            "probability": 8.434525452168821e-05,
            "start_logit": 4.197908878326416,
            "end_logit": -1.64329993724823
        },
        {
            "text": "simvastatin",
            "probability": 8.420322036215633e-05,
            "start_logit": 1.6890047788619995,
            "end_logit": 0.8639187812805176
        },
        {
            "text": "a statin, aspirin, and folic acid",
            "probability": 7.340294282559114e-05,
            "start_logit": -3.1789557933807373,
            "end_logit": 5.594610214233398
        },
        {
            "text": "creatinine",
            "probability": 7.189443783917986e-05,
            "start_logit": -0.2225525975227356,
            "end_logit": 2.6174418926239014
        },
        {
            "text": "aspirin (350.0 ng/mmol creatinine, 294.6-404.0), and aspirin",
            "probability": 6.565161973918808e-05,
            "start_logit": 2.0979034900665283,
            "end_logit": 0.2061491757631302
        },
        {
            "text": "thiazide (12.5 mg), atenolol (50 mg), ramipril (5 mg)",
            "probability": 6.401668237443623e-05,
            "start_logit": 4.197908878326416,
            "end_logit": -1.9190747737884521
        },
        {
            "text": "283.1 ng/mmol creatinine",
            "probability": 5.926190532384876e-05,
            "start_logit": -0.4157848060131073,
            "end_logit": 2.6174418926239014
        }
    ],
    "5cd96eb2a49efeb44c000003_001": [
        {
            "text": "",
            "probability": 0.9874309012957986,
            "start_logit": 7.101455211639404,
            "end_logit": 6.602650165557861
        },
        {
            "text": "gPLINK",
            "probability": 0.007192082042784693,
            "start_logit": 5.065361499786377,
            "end_logit": 3.716618061065674
        },
        {
            "text": "gPLINK software",
            "probability": 0.00534967990973448,
            "start_logit": 5.065361499786377,
            "end_logit": 3.4206740856170654
        },
        {
            "text": "gPLINK software to set quality control standards",
            "probability": 5.150572191137509e-06,
            "start_logit": 5.065361499786377,
            "end_logit": -3.525010108947754
        },
        {
            "text": "gP",
            "probability": 4.734480032462622e-06,
            "start_logit": 5.065361499786377,
            "end_logit": -3.609246015548706
        },
        {
            "text": "genetic differentiation coefficient Fst was applied to detect the selection signatures. Using gPLINK",
            "probability": 4.297985579764502e-06,
            "start_logit": -2.3572280406951904,
            "end_logit": 3.716618061065674
        },
        {
            "text": "Using gPLINK",
            "probability": 3.457643694462296e-06,
            "start_logit": -2.574787139892578,
            "end_logit": 3.716618061065674
        },
        {
            "text": "genetic differentiation coefficient Fst was applied to detect the selection signatures. Using gPLINK software",
            "probability": 3.1969667436513398e-06,
            "start_logit": -2.3572280406951904,
            "end_logit": 3.4206740856170654
        },
        {
            "text": "Using gPLINK software",
            "probability": 2.571895995797499e-06,
            "start_logit": -2.574787139892578,
            "end_logit": 3.4206740856170654
        },
        {
            "text": "gPLINK software to set quality control standards,",
            "probability": 1.9564241013598205e-06,
            "start_logit": 5.065361499786377,
            "end_logit": -4.49299955368042
        },
        {
            "text": "gPLINK software to set quality control standards, a total of 34 304 SNPs were selected for statistical analysis",
            "probability": 5.5295368849587e-07,
            "start_logit": 5.065361499786377,
            "end_logit": -5.756598949432373
        },
        {
            "text": "software",
            "probability": 2.278028131676808e-07,
            "start_logit": -4.9987053871154785,
            "end_logit": 3.4206740856170654
        },
        {
            "text": "coefficient Fst was applied to detect the selection signatures. Using gPLINK",
            "probability": 2.2488493451398702e-07,
            "start_logit": -5.3075408935546875,
            "end_logit": 3.716618061065674
        },
        {
            "text": "differentiation coefficient Fst was applied to detect the selection signatures. Using gPLINK",
            "probability": 1.9434255305672315e-07,
            "start_logit": -5.453507423400879,
            "end_logit": 3.716618061065674
        },
        {
            "text": "coefficient Fst was applied to detect the selection signatures. Using gPLINK software",
            "probability": 1.6727595834065572e-07,
            "start_logit": -5.3075408935546875,
            "end_logit": 3.4206740856170654
        },
        {
            "text": "gPLINK software to set quality control",
            "probability": 1.6129527763983994e-07,
            "start_logit": 5.065361499786377,
            "end_logit": -6.988636493682861
        },
        {
            "text": "differentiation coefficient Fst was applied to detect the selection signatures. Using gPLINK software",
            "probability": 1.4455764624335545e-07,
            "start_logit": -5.453507423400879,
            "end_logit": 3.4206740856170654
        },
        {
            "text": "genetic differentiation coefficient Fst",
            "probability": 1.2366512419502263e-07,
            "start_logit": -2.3572280406951904,
            "end_logit": 0.16829364001750946
        },
        {
            "text": "Fst was applied to detect the selection signatures. Using gPLINK",
            "probability": 8.868592860994691e-08,
            "start_logit": -6.238028526306152,
            "end_logit": 3.716618061065674
        },
        {
            "text": "Tongcheng pigs (n=45), genetic differentiation coefficient Fst was applied to detect the selection signatures. Using gPLINK",
            "probability": 8.531941921112793e-08,
            "start_logit": -6.276727676391602,
            "end_logit": 3.716618061065674
        }
    ],
    "5cd96eb2a49efeb44c000003_003": [
        {
            "text": "SweeD",
            "probability": 0.9543560256729711,
            "start_logit": 6.202507495880127,
            "end_logit": 5.600325107574463
        },
        {
            "text": "SweeD (Sweep Detector)",
            "probability": 0.03849191961586405,
            "start_logit": 6.202507495880127,
            "end_logit": 2.3897366523742676
        },
        {
            "text": "SweeD (Sweep Detector",
            "probability": 0.005346445783327192,
            "start_logit": 6.202507495880127,
            "end_logit": 0.4157203137874603
        },
        {
            "text": "SweeD (Sweep Detector),",
            "probability": 0.0007891745509485586,
            "start_logit": 6.202507495880127,
            "end_logit": -1.4974794387817383
        },
        {
            "text": "SweeD (Sweep Detector), an open-source tool for the rapid detection of selective sweeps in whole genomes",
            "probability": 0.00027785785971426485,
            "start_logit": 6.202507495880127,
            "end_logit": -2.5413572788238525
        },
        {
            "text": "SweeD (Sweep Detector), an open-source tool for the rapid detection of selective sweeps in whole genomes.",
            "probability": 0.00027343726655246133,
            "start_logit": 6.202507495880127,
            "end_logit": -2.5573947429656982
        },
        {
            "text": "Sw",
            "probability": 0.000222728240214067,
            "start_logit": 6.202507495880127,
            "end_logit": -2.762514591217041
        },
        {
            "text": "",
            "probability": 8.594272038135693e-05,
            "start_logit": 1.455749273300171,
            "end_logit": 1.0319722890853882
        },
        {
            "text": "SweeD (Sweep Detector), an open-source tool",
            "probability": 8.381935018620344e-05,
            "start_logit": 6.202507495880127,
            "end_logit": -3.7398030757904053
        },
        {
            "text": "Sweep Detector)",
            "probability": 2.3685685974002666e-05,
            "start_logit": -1.1908252239227295,
            "end_logit": 2.3897366523742676
        },
        {
            "text": "We present SweeD",
            "probability": 2.0314488286764984e-05,
            "start_logit": -4.55495023727417,
            "end_logit": 5.600325107574463
        },
        {
            "text": "SweepFinder",
            "probability": 1.3520023690608782e-05,
            "start_logit": 0.48977917432785034,
            "end_logit": 0.14843317866325378
        },
        {
            "text": "SweepFinder program. The sequential version of SweeD",
            "probability": 4.0599231116261415e-06,
            "start_logit": 0.48977917432785034,
            "end_logit": -1.0545746088027954
        },
        {
            "text": "SweepFinder program",
            "probability": 3.4399909651828006e-06,
            "start_logit": 0.48977917432785034,
            "end_logit": -1.220269799232483
        },
        {
            "text": "Sweep Detector",
            "probability": 3.289891415255049e-06,
            "start_logit": -1.1908252239227295,
            "end_logit": 0.4157203137874603
        },
        {
            "text": "(Sweep Detector)",
            "probability": 1.9196230829337732e-06,
            "start_logit": -3.7035672664642334,
            "end_logit": 2.3897366523742676
        },
        {
            "text": "We present SweeD (Sweep Detector)",
            "probability": 8.193416598592504e-07,
            "start_logit": -4.55495023727417,
            "end_logit": 2.3897366523742676
        },
        {
            "text": "SweepFinder program. The sequential version of SweeD is up to 22 times faster than SweepFinder",
            "probability": 7.447448251659345e-07,
            "start_logit": 0.48977917432785034,
            "end_logit": -2.7504522800445557
        },
        {
            "text": "Sweep Detector),",
            "probability": 4.85612065570727e-07,
            "start_logit": -1.1908252239227295,
            "end_logit": -1.4974794387817383
        },
        {
            "text": "SweepFinder program.",
            "probability": 3.6961476392207234e-07,
            "start_logit": 0.48977917432785034,
            "end_logit": -3.4510326385498047
        }
    ],
    "5cd96eb2a49efeb44c000003_004": [
        {
            "text": "SweeD",
            "probability": 0.9543560256729711,
            "start_logit": 6.202507495880127,
            "end_logit": 5.600325107574463
        },
        {
            "text": "SweeD (Sweep Detector)",
            "probability": 0.03849191961586405,
            "start_logit": 6.202507495880127,
            "end_logit": 2.3897366523742676
        },
        {
            "text": "SweeD (Sweep Detector",
            "probability": 0.005346445783327192,
            "start_logit": 6.202507495880127,
            "end_logit": 0.4157203137874603
        },
        {
            "text": "SweeD (Sweep Detector),",
            "probability": 0.0007891745509485586,
            "start_logit": 6.202507495880127,
            "end_logit": -1.4974794387817383
        },
        {
            "text": "SweeD (Sweep Detector), an open-source tool for the rapid detection of selective sweeps in whole genomes",
            "probability": 0.00027785785971426485,
            "start_logit": 6.202507495880127,
            "end_logit": -2.5413572788238525
        },
        {
            "text": "SweeD (Sweep Detector), an open-source tool for the rapid detection of selective sweeps in whole genomes.",
            "probability": 0.00027343726655246133,
            "start_logit": 6.202507495880127,
            "end_logit": -2.5573947429656982
        },
        {
            "text": "Sw",
            "probability": 0.000222728240214067,
            "start_logit": 6.202507495880127,
            "end_logit": -2.762514591217041
        },
        {
            "text": "",
            "probability": 8.594272038135693e-05,
            "start_logit": 1.455749273300171,
            "end_logit": 1.0319722890853882
        },
        {
            "text": "SweeD (Sweep Detector), an open-source tool",
            "probability": 8.381935018620344e-05,
            "start_logit": 6.202507495880127,
            "end_logit": -3.7398030757904053
        },
        {
            "text": "Sweep Detector)",
            "probability": 2.3685685974002666e-05,
            "start_logit": -1.1908252239227295,
            "end_logit": 2.3897366523742676
        },
        {
            "text": "We present SweeD",
            "probability": 2.0314488286764984e-05,
            "start_logit": -4.55495023727417,
            "end_logit": 5.600325107574463
        },
        {
            "text": "SweepFinder",
            "probability": 1.3520023690608782e-05,
            "start_logit": 0.48977917432785034,
            "end_logit": 0.14843317866325378
        },
        {
            "text": "SweepFinder program. The sequential version of SweeD",
            "probability": 4.0599231116261415e-06,
            "start_logit": 0.48977917432785034,
            "end_logit": -1.0545746088027954
        },
        {
            "text": "SweepFinder program",
            "probability": 3.4399909651828006e-06,
            "start_logit": 0.48977917432785034,
            "end_logit": -1.220269799232483
        },
        {
            "text": "Sweep Detector",
            "probability": 3.289891415255049e-06,
            "start_logit": -1.1908252239227295,
            "end_logit": 0.4157203137874603
        },
        {
            "text": "(Sweep Detector)",
            "probability": 1.9196230829337732e-06,
            "start_logit": -3.7035672664642334,
            "end_logit": 2.3897366523742676
        },
        {
            "text": "We present SweeD (Sweep Detector)",
            "probability": 8.193416598592504e-07,
            "start_logit": -4.55495023727417,
            "end_logit": 2.3897366523742676
        },
        {
            "text": "SweepFinder program. The sequential version of SweeD is up to 22 times faster than SweepFinder",
            "probability": 7.447448251659345e-07,
            "start_logit": 0.48977917432785034,
            "end_logit": -2.7504522800445557
        },
        {
            "text": "Sweep Detector),",
            "probability": 4.85612065570727e-07,
            "start_logit": -1.1908252239227295,
            "end_logit": -1.4974794387817383
        },
        {
            "text": "SweepFinder program.",
            "probability": 3.6961476392207234e-07,
            "start_logit": 0.48977917432785034,
            "end_logit": -3.4510326385498047
        }
    ],
    "5cd96eb2a49efeb44c000003_005": [
        {
            "text": "SweeD",
            "probability": 0.9543560256729711,
            "start_logit": 6.202507495880127,
            "end_logit": 5.600325107574463
        },
        {
            "text": "SweeD (Sweep Detector)",
            "probability": 0.03849191961586405,
            "start_logit": 6.202507495880127,
            "end_logit": 2.3897366523742676
        },
        {
            "text": "SweeD (Sweep Detector",
            "probability": 0.005346445783327192,
            "start_logit": 6.202507495880127,
            "end_logit": 0.4157203137874603
        },
        {
            "text": "SweeD (Sweep Detector),",
            "probability": 0.0007891745509485586,
            "start_logit": 6.202507495880127,
            "end_logit": -1.4974794387817383
        },
        {
            "text": "SweeD (Sweep Detector), an open-source tool for the rapid detection of selective sweeps in whole genomes",
            "probability": 0.00027785785971426485,
            "start_logit": 6.202507495880127,
            "end_logit": -2.5413572788238525
        },
        {
            "text": "SweeD (Sweep Detector), an open-source tool for the rapid detection of selective sweeps in whole genomes.",
            "probability": 0.00027343726655246133,
            "start_logit": 6.202507495880127,
            "end_logit": -2.5573947429656982
        },
        {
            "text": "Sw",
            "probability": 0.000222728240214067,
            "start_logit": 6.202507495880127,
            "end_logit": -2.762514591217041
        },
        {
            "text": "",
            "probability": 8.594272038135693e-05,
            "start_logit": 1.455749273300171,
            "end_logit": 1.0319722890853882
        },
        {
            "text": "SweeD (Sweep Detector), an open-source tool",
            "probability": 8.381935018620344e-05,
            "start_logit": 6.202507495880127,
            "end_logit": -3.7398030757904053
        },
        {
            "text": "Sweep Detector)",
            "probability": 2.3685685974002666e-05,
            "start_logit": -1.1908252239227295,
            "end_logit": 2.3897366523742676
        },
        {
            "text": "We present SweeD",
            "probability": 2.0314488286764984e-05,
            "start_logit": -4.55495023727417,
            "end_logit": 5.600325107574463
        },
        {
            "text": "SweepFinder",
            "probability": 1.3520023690608782e-05,
            "start_logit": 0.48977917432785034,
            "end_logit": 0.14843317866325378
        },
        {
            "text": "SweepFinder program. The sequential version of SweeD",
            "probability": 4.0599231116261415e-06,
            "start_logit": 0.48977917432785034,
            "end_logit": -1.0545746088027954
        },
        {
            "text": "SweepFinder program",
            "probability": 3.4399909651828006e-06,
            "start_logit": 0.48977917432785034,
            "end_logit": -1.220269799232483
        },
        {
            "text": "Sweep Detector",
            "probability": 3.289891415255049e-06,
            "start_logit": -1.1908252239227295,
            "end_logit": 0.4157203137874603
        },
        {
            "text": "(Sweep Detector)",
            "probability": 1.9196230829337732e-06,
            "start_logit": -3.7035672664642334,
            "end_logit": 2.3897366523742676
        },
        {
            "text": "We present SweeD (Sweep Detector)",
            "probability": 8.193416598592504e-07,
            "start_logit": -4.55495023727417,
            "end_logit": 2.3897366523742676
        },
        {
            "text": "SweepFinder program. The sequential version of SweeD is up to 22 times faster than SweepFinder",
            "probability": 7.447448251659345e-07,
            "start_logit": 0.48977917432785034,
            "end_logit": -2.7504522800445557
        },
        {
            "text": "Sweep Detector),",
            "probability": 4.85612065570727e-07,
            "start_logit": -1.1908252239227295,
            "end_logit": -1.4974794387817383
        },
        {
            "text": "SweepFinder program.",
            "probability": 3.6961476392207234e-07,
            "start_logit": 0.48977917432785034,
            "end_logit": -3.4510326385498047
        }
    ],
    "5cd96eb2a49efeb44c000003_006": [
        {
            "text": "SmileFinder",
            "probability": 0.6825914338276847,
            "start_logit": 4.4462690353393555,
            "end_logit": 4.790253162384033
        },
        {
            "text": "",
            "probability": 0.3150222542131931,
            "start_logit": 3.8893964290618896,
            "end_logit": 4.5738725662231445
        },
        {
            "text": "SmileFinder is a simple program that looks for diversity and divergence patterns consistent with selection sweeps by evaluating allele frequencies in windows",
            "probability": 0.0011423757709038023,
            "start_logit": 4.4462690353393555,
            "end_logit": -1.602533221244812
        },
        {
            "text": "Smile",
            "probability": 0.0005411084457733375,
            "start_logit": 4.4462690353393555,
            "end_logit": -2.349778890609741
        },
        {
            "text": "open source program",
            "probability": 0.00017541423256890162,
            "start_logit": 0.6358575820922852,
            "end_logit": 0.3341630697250366
        },
        {
            "text": "publicly available, open source program",
            "probability": 0.00010167454851584173,
            "start_logit": 0.0904843732714653,
            "end_logit": 0.3341630697250366
        },
        {
            "text": "SmileFinder is a simple program that looks for diversity and divergence patterns consistent with selection sweeps",
            "probability": 7.519203539939492e-05,
            "start_logit": 4.4462690353393555,
            "end_logit": -4.323353290557861
        },
        {
            "text": "open source",
            "probability": 5.557314588109796e-05,
            "start_logit": 0.6358575820922852,
            "end_logit": -0.8152870535850525
        },
        {
            "text": "open source program that will serve as a useful tool for preliminary scans of selection using worldwide databases of human genetic variation, as well as population datasets",
            "probability": 5.087456799613622e-05,
            "start_logit": 0.6358575820922852,
            "end_logit": -0.9036239981651306
        },
        {
            "text": "SmileFinder is",
            "probability": 4.5177822851666895e-05,
            "start_logit": 4.4462690353393555,
            "end_logit": -4.832792282104492
        },
        {
            "text": "genotyping and sequencing technologies",
            "probability": 3.9038121482743544e-05,
            "start_logit": -0.3853755593299866,
            "end_logit": -0.1472153663635254
        },
        {
            "text": "publicly available, open source",
            "probability": 3.221160811364729e-05,
            "start_logit": 0.0904843732714653,
            "end_logit": -0.8152870535850525
        },
        {
            "text": "open source program that will serve as a useful tool for preliminary scans of selection using worldwide databases",
            "probability": 2.8233639135220787e-05,
            "start_logit": 0.6358575820922852,
            "end_logit": -1.4924730062484741
        },
        {
            "text": "output from SmileFinder",
            "probability": 2.0710114518254417e-05,
            "start_logit": -2.984511613845825,
            "end_logit": 1.8180042505264282
        },
        {
            "text": "open source program that will serve as a useful tool for preliminary scans of selection using worldwide databases of human genetic variation",
            "probability": 1.7815841831394885e-05,
            "start_logit": 0.6358575820922852,
            "end_logit": -1.9528990983963013
        },
        {
            "text": "publicly available, open source program that will serve as a useful tool for preliminary scans of selection using worldwide databases",
            "probability": 1.636493498841494e-05,
            "start_logit": 0.0904843732714653,
            "end_logit": -1.4924730062484741
        },
        {
            "text": "a publicly available, open source program",
            "probability": 1.3652031576972076e-05,
            "start_logit": -1.917404294013977,
            "end_logit": 0.3341630697250366
        },
        {
            "text": "worldwide databases of human genetic variation, as well as population datasets",
            "probability": 1.1339867352487702e-05,
            "start_logit": -0.8651809692382812,
            "end_logit": -0.9036239981651306
        },
        {
            "text": "publicly available, open source program that will serve as a useful tool for preliminary scans of selection using worldwide databases of human genetic variation",
            "probability": 1.0326514833539565e-05,
            "start_logit": 0.0904843732714653,
            "end_logit": -1.9528990983963013
        },
        {
            "text": "genotyping and sequencing",
            "probability": 9.228715398904313e-06,
            "start_logit": -0.3853755593299866,
            "end_logit": -1.5894341468811035
        }
    ],
    "5cd96eb2a49efeb44c000003_007": [
        {
            "text": "OmegaPlus",
            "probability": 0.9997303365779663,
            "start_logit": 9.620474815368652,
            "end_logit": 9.184063911437988
        },
        {
            "text": "OmegaPlus,",
            "probability": 0.00014628139547124216,
            "start_logit": 9.620474815368652,
            "end_logit": 0.35435518622398376
        },
        {
            "text": "Omega",
            "probability": 4.531841893056617e-05,
            "start_logit": 9.620474815368652,
            "end_logit": -0.8174633979797363
        },
        {
            "text": "software OmegaPlus",
            "probability": 2.6252209113357563e-05,
            "start_logit": -0.9270159006118774,
            "end_logit": 9.184063911437988
        },
        {
            "text": "sweep-detection software OmegaPlus",
            "probability": 1.4342521108114792e-05,
            "start_logit": -1.531537413597107,
            "end_logit": 9.184063911437988
        },
        {
            "text": "open-source sweep-detection software OmegaPlus",
            "probability": 1.3887603158367625e-05,
            "start_logit": -1.5637694597244263,
            "end_logit": 9.184063911437988
        },
        {
            "text": "OmegaPlus, which implements all four parallelization strategies presented here, with a variety of neutrality tests.CONCLUSIONS: The computational demands of selective sweep",
            "probability": 6.14484052790142e-06,
            "start_logit": 9.620474815368652,
            "end_logit": -2.8155641555786133
        },
        {
            "text": "algorithmic implementations",
            "probability": 3.792578747687786e-06,
            "start_logit": 3.738914966583252,
            "end_logit": 2.5834290981292725
        },
        {
            "text": "OmegaPlus, which implements all four parallelization strategies presented here,",
            "probability": 3.2679787509747648e-06,
            "start_logit": 9.620474815368652,
            "end_logit": -3.447005271911621
        },
        {
            "text": "algorithmic",
            "probability": 3.200905659630776e-06,
            "start_logit": 3.738914966583252,
            "end_logit": 2.4138166904449463
        },
        {
            "text": "OmegaPl",
            "probability": 2.399127526857303e-06,
            "start_logit": 9.620474815368652,
            "end_logit": -3.7560718059539795
        },
        {
            "text": "our open-source sweep-detection software OmegaPlus",
            "probability": 2.177345445405551e-06,
            "start_logit": -3.4166595935821533,
            "end_logit": 9.184063911437988
        },
        {
            "text": "detection software OmegaPlus",
            "probability": 1.1387796394243353e-06,
            "start_logit": -4.0648088455200195,
            "end_logit": 9.184063911437988
        },
        {
            "text": "",
            "probability": 1.0143174714566803e-06,
            "start_logit": 2.673334836959839,
            "end_logit": 2.33017897605896
        },
        {
            "text": "algorithmic implementations used in modern population genetics",
            "probability": 2.3442418060034844e-07,
            "start_logit": 3.738914966583252,
            "end_logit": -0.20024016499519348
        },
        {
            "text": "algorithmic implementations used in modern population genetics need to exploit multiple cores of current workstations",
            "probability": 1.683249330877367e-07,
            "start_logit": 3.738914966583252,
            "end_logit": -0.5314761400222778
        },
        {
            "text": "algorithm",
            "probability": 2.361224041569832e-08,
            "start_logit": 3.738914966583252,
            "end_logit": -2.4956071376800537
        },
        {
            "text": "algorithmic implementations used in modern population genetics need to exploit multiple cores",
            "probability": 1.2319244832192188e-08,
            "start_logit": 3.738914966583252,
            "end_logit": -3.146209716796875
        },
        {
            "text": "software OmegaPlus,",
            "probability": 3.8412456267453854e-09,
            "start_logit": -0.9270159006118774,
            "end_logit": 0.35435518622398376
        },
        {
            "text": "parallel algorithms for computing linkage disequilibrium",
            "probability": 2.878638079686368e-09,
            "start_logit": -0.827023446559906,
            "end_logit": -0.03411667048931122
        }
    ],
    "5cd96eb2a49efeb44c000003_008": [
        {
            "text": "LD-based methods",
            "probability": 0.5433902017686154,
            "start_logit": 1.755782127380371,
            "end_logit": 4.650030136108398
        },
        {
            "text": "Tajima's D",
            "probability": 0.20096040965314696,
            "start_logit": 2.633267879486084,
            "end_logit": 2.777824640274048
        },
        {
            "text": "LD-based",
            "probability": 0.11497636697887303,
            "start_logit": 1.755782127380371,
            "end_logit": 3.0969290733337402
        },
        {
            "text": "",
            "probability": 0.04083175486164276,
            "start_logit": 1.5983070135116577,
            "end_logit": 2.219137668609619
        },
        {
            "text": "SweeD, SweepFinder, SweepFinder2, and OmegaPlus",
            "probability": 0.02462662464822728,
            "start_logit": 1.592272162437439,
            "end_logit": 1.7195405960083008
        },
        {
            "text": "Tajima's D,",
            "probability": 0.016227428139100438,
            "start_logit": 2.633267879486084,
            "end_logit": 0.2614196240901947
        },
        {
            "text": "SweepFinder, SweepFinder2, and OmegaPlus",
            "probability": 0.012778236420030105,
            "start_logit": 0.9361874461174011,
            "end_logit": 1.7195405960083008
        },
        {
            "text": "SweepFinder2, and OmegaPlus",
            "probability": 0.011240785814835248,
            "start_logit": 0.8079927563667297,
            "end_logit": 1.7195405960083008
        },
        {
            "text": "methods",
            "probability": 0.009787046120127924,
            "start_logit": -2.260985851287842,
            "end_logit": 4.650030136108398
        },
        {
            "text": "SweeD, SweepFinder",
            "probability": 0.004823836091125653,
            "start_logit": 1.592272162437439,
            "end_logit": 0.08928191661834717
        },
        {
            "text": "based methods",
            "probability": 0.004725208577077201,
            "start_logit": -2.989133834838867,
            "end_logit": 4.650030136108398
        },
        {
            "text": "SweeD, SweepFinder, SweepFinder2",
            "probability": 0.004015729072171711,
            "start_logit": 1.592272162437439,
            "end_logit": -0.09406864643096924
        },
        {
            "text": "SweepFinder",
            "probability": 0.0025029868650032223,
            "start_logit": 0.9361874461174011,
            "end_logit": 0.08928191661834717
        },
        {
            "text": "SweepFinder, SweepFinder2",
            "probability": 0.002083677167130252,
            "start_logit": 0.9361874461174011,
            "end_logit": -0.09406864643096924
        },
        {
            "text": "SweepFinder2",
            "probability": 0.001832973500651403,
            "start_logit": 0.8079927563667297,
            "end_logit": -0.09406864643096924
        },
        {
            "text": "OmegaPlus",
            "probability": 0.0012233776954241006,
            "start_logit": -1.4099403619766235,
            "end_logit": 1.7195405960083008
        },
        {
            "text": "LD",
            "probability": 0.0011287455993818946,
            "start_logit": 1.755782127380371,
            "end_logit": -1.5266906023025513
        },
        {
            "text": "based",
            "probability": 0.000999810658420903,
            "start_logit": -2.989133834838867,
            "end_logit": 3.0969290733337402
        },
        {
            "text": "SweeD",
            "probability": 0.0009363093967583478,
            "start_logit": 1.592272162437439,
            "end_logit": -1.550096869468689
        },
        {
            "text": "LD-based methods are able to detect selective sweeps accurately. Methods and tools that rely on LD",
            "probability": 0.0009084909722561501,
            "start_logit": 1.755782127380371,
            "end_logit": -1.7437678575515747
        }
    ],
    "5cd96eb2a49efeb44c000003_010": [
        {
            "text": "RAiSD",
            "probability": 0.9896182733770927,
            "start_logit": 7.364581108093262,
            "end_logit": 6.976875305175781
        },
        {
            "text": "RAiSD (Raised Accuracy in Sweep Detection)",
            "probability": 0.00833970162286884,
            "start_logit": 7.364581108093262,
            "end_logit": 2.2005834579467773
        },
        {
            "text": "RAiSD (Raised Accuracy in Sweep Detection),",
            "probability": 0.001138207194916346,
            "start_logit": 7.364581108093262,
            "end_logit": 0.20901040732860565
        },
        {
            "text": "RAiSD (Raised Accuracy in Sweep Detection",
            "probability": 0.000504773112609175,
            "start_logit": 7.364581108093262,
            "end_logit": -0.6040902137756348
        },
        {
            "text": "RAiSD (Raised Accuracy in Sweep Detection), an open-source software that implements a novel, to our knowledge, and parameter-free detection mechanism",
            "probability": 0.00011680989098423691,
            "start_logit": 7.364581108093262,
            "end_logit": -2.0676515102386475
        },
        {
            "text": "We present RAiSD",
            "probability": 6.27148982381993e-05,
            "start_logit": -2.301894426345825,
            "end_logit": 6.976875305175781
        },
        {
            "text": "RAiSD (Raised Accuracy in Sweep Detection), an open-source software",
            "probability": 5.397274783072058e-05,
            "start_logit": 7.364581108093262,
            "end_logit": -2.8397200107574463
        },
        {
            "text": "RAi",
            "probability": 4.960496816348521e-05,
            "start_logit": 7.364581108093262,
            "end_logit": -2.9241082668304443
        },
        {
            "text": "RAiSD (Raised Accuracy in Sweep Detection), an open-source",
            "probability": 4.042207229847121e-05,
            "start_logit": 7.364581108093262,
            "end_logit": -3.1288232803344727
        },
        {
            "text": "",
            "probability": 2.7759787569959376e-05,
            "start_logit": 1.9790490865707397,
            "end_logit": 1.8809212446212769
        },
        {
            "text": "present RAiSD",
            "probability": 1.8376516241288156e-05,
            "start_logit": -3.5294198989868164,
            "end_logit": 6.976875305175781
        },
        {
            "text": "RAiSD (Raised Accuracy in Sweep Detection), an open-source software that implements a novel, to our knowledge, and parameter-free detection",
            "probability": 1.2167520049360523e-05,
            "start_logit": 7.364581108093262,
            "end_logit": -4.3294291496276855
        },
        {
            "text": "RAiSD (Raised Accuracy in Sweep",
            "probability": 6.851995449932475e-06,
            "start_logit": 7.364581108093262,
            "end_logit": -4.903659343719482
        },
        {
            "text": "RAiSD (Raised Accuracy in Sweep Detection), an open-source software that implements a novel,",
            "probability": 5.477447027034354e-06,
            "start_logit": 7.364581108093262,
            "end_logit": -5.127560138702393
        },
        {
            "text": "RAiSD (Raised Accuracy in Sweep Detection), an open",
            "probability": 3.5087483813997174e-06,
            "start_logit": 7.364581108093262,
            "end_logit": -5.572939872741699
        },
        {
            "text": "We present RAiSD (Raised Accuracy in Sweep Detection)",
            "probability": 5.285103889910361e-07,
            "start_logit": -2.301894426345825,
            "end_logit": 2.2005834579467773
        },
        {
            "text": "an open-source software that implements a novel, to our knowledge, and parameter-free detection mechanism that relies on multiple signatures of a selective sweep",
            "probability": 2.8272704117553784e-07,
            "start_logit": -1.3295789957046509,
            "end_logit": 0.6026874780654907
        },
        {
            "text": "selective sweep",
            "probability": 2.0083933714999344e-07,
            "start_logit": -1.6715556383132935,
            "end_logit": 0.6026874780654907
        },
        {
            "text": "selective sweep via the enumeration of SNP vectors. RAiSD",
            "probability": 1.9304291618772818e-07,
            "start_logit": -1.6715556383132935,
            "end_logit": 0.5630947351455688
        },
        {
            "text": "software that implements a novel, to our knowledge, and parameter-free detection mechanism that relies on multiple signatures of a selective sweep",
            "probability": 1.7298059544464012e-07,
            "start_logit": -1.8208814859390259,
            "end_logit": 0.6026874780654907
        }
    ],
    "5e36d924b5b409ea5300000b_002": [
        {
            "text": "",
            "probability": 0.9988683433075428,
            "start_logit": 2.7629053592681885,
            "end_logit": 3.2998809814453125
        },
        {
            "text": "fork protection function of AND-1/Ctf4 manifested via the WD40 domain that is essential for proliferation",
            "probability": 0.00031856901034729886,
            "start_logit": -1.3853321075439453,
            "end_logit": -0.6024206876754761
        },
        {
            "text": "fork protection function",
            "probability": 0.00014993813737430785,
            "start_logit": -1.3853321075439453,
            "end_logit": -1.3560370206832886
        },
        {
            "text": "not for proliferation",
            "probability": 0.0001160943580634323,
            "start_logit": -2.3274152278900146,
            "end_logit": -0.6697733998298645
        },
        {
            "text": "fork protection",
            "probability": 0.00010413528976400655,
            "start_logit": -1.3853321075439453,
            "end_logit": -1.7205688953399658
        },
        {
            "text": "proliferation",
            "probability": 9.253778946057036e-05,
            "start_logit": -2.621554136276245,
            "end_logit": -0.6024206876754761
        },
        {
            "text": "AND-1/Ctf4 manifested via the WD40 domain that is essential for proliferation",
            "probability": 5.395860796708577e-05,
            "start_logit": -3.160953998565674,
            "end_logit": -0.6024206876754761
        },
        {
            "text": "essential for proliferation",
            "probability": 3.897771111643445e-05,
            "start_logit": -3.4861812591552734,
            "end_logit": -0.6024206876754761
        },
        {
            "text": "incompatible with proliferation",
            "probability": 3.251974760877361e-05,
            "start_logit": -2.527967929840088,
            "end_logit": -1.741776466369629
        },
        {
            "text": "a fork protection function of AND-1/Ctf4 manifested via the WD40 domain that is essential for proliferation",
            "probability": 3.197443294344363e-05,
            "start_logit": -3.684234619140625,
            "end_logit": -0.6024206876754761
        },
        {
            "text": "fork protection function of AND-1/Ctf4 manifested via the WD40 domain that is essential for proliferation and averts genome instability.",
            "probability": 2.7237540428983313e-05,
            "start_logit": -1.3853321075439453,
            "end_logit": -3.0616636276245117
        },
        {
            "text": "fork protection function of AND-1/Ctf4 manifested via the WD40 domain that is essential",
            "probability": 2.704969816732746e-05,
            "start_logit": -1.3853321075439453,
            "end_logit": -3.0685839653015137
        },
        {
            "text": "important for fast replication but not for proliferation",
            "probability": 2.5000703330592783e-05,
            "start_logit": -3.862914562225342,
            "end_logit": -0.6697733998298645
        },
        {
            "text": "not",
            "probability": 2.477225867286452e-05,
            "start_logit": -2.3274152278900146,
            "end_logit": -2.2144522666931152
        },
        {
            "text": "AND-1 depletion is incompatible with proliferation",
            "probability": 2.1380723539299223e-05,
            "start_logit": -2.9473257064819336,
            "end_logit": -1.741776466369629
        },
        {
            "text": "incompatible",
            "probability": 1.5460433918236e-05,
            "start_logit": -2.527967929840088,
            "end_logit": -2.485339879989624
        },
        {
            "text": "a fork protection function",
            "probability": 1.5049131470487664e-05,
            "start_logit": -3.684234619140625,
            "end_logit": -1.3560370206832886
        },
        {
            "text": "WD40 domain that is essential for proliferation",
            "probability": 1.2497174283352101e-05,
            "start_logit": -4.623668670654297,
            "end_logit": -0.6024206876754761
        },
        {
            "text": "fork",
            "probability": 1.2350854854427467e-05,
            "start_logit": -1.3853321075439453,
            "end_logit": -3.852534532546997
        },
        {
            "text": "not for proliferation,",
            "probability": 1.2153089146134143e-05,
            "start_logit": -2.3274152278900146,
            "end_logit": -2.92659330368042
        }
    ],
    "5e2db15cfbd6abf43b000014_001": [
        {
            "text": "",
            "probability": 0.9939976198909168,
            "start_logit": 1.9932565689086914,
            "end_logit": 2.0529394149780273
        },
        {
            "text": "recent US FDA-approved",
            "probability": 0.0012029318024860064,
            "start_logit": -1.5702459812164307,
            "end_logit": -1.1005311012268066
        },
        {
            "text": "recent US FDA-approved treatment for dyskinesia in PD patients",
            "probability": 0.0010082747308866812,
            "start_logit": -1.5702459812164307,
            "end_logit": -1.2770521640777588
        },
        {
            "text": "recent",
            "probability": 0.0006533068769656084,
            "start_logit": -1.5702459812164307,
            "end_logit": -1.7110011577606201
        },
        {
            "text": "FDA-approved",
            "probability": 0.0004065465445705345,
            "start_logit": -2.655064582824707,
            "end_logit": -1.1005311012268066
        },
        {
            "text": "FDA-approved treatment for dyskinesia in PD patients",
            "probability": 0.00034075963988368694,
            "start_logit": -2.655064582824707,
            "end_logit": -1.2770521640777588
        },
        {
            "text": "approved",
            "probability": 0.0003337013245031407,
            "start_logit": -2.8525166511535645,
            "end_logit": -1.1005311012268066
        },
        {
            "text": "approved treatment for dyskinesia in PD patients",
            "probability": 0.00027970215141422984,
            "start_logit": -2.8525166511535645,
            "end_logit": -1.2770521640777588
        },
        {
            "text": "recent US FDA",
            "probability": 0.000278736871148107,
            "start_logit": -1.5702459812164307,
            "end_logit": -2.5627799034118652
        },
        {
            "text": "recent US FDA-approved treatment for dyskinesia in PD patients. ADS-5102 is a high-dose",
            "probability": 0.00023824422218665168,
            "start_logit": -1.5702459812164307,
            "end_logit": -2.7197518348693848
        },
        {
            "text": "recent US FDA-approved treatment for dyskinesia in PD patients.",
            "probability": 0.00022567364791647044,
            "start_logit": -1.5702459812164307,
            "end_logit": -2.773958206176758
        },
        {
            "text": "US FDA-approved",
            "probability": 0.00017547671283055965,
            "start_logit": -3.4952566623687744,
            "end_logit": -1.1005311012268066
        },
        {
            "text": "recent US FDA-approved treatment for dyskinesia in PD patients. ADS-5102 is a high-dose, ER",
            "probability": 0.0001499526171701737,
            "start_logit": -1.5702459812164307,
            "end_logit": -3.1827287673950195
        },
        {
            "text": "US FDA-approved treatment for dyskinesia in PD patients",
            "probability": 0.000147081268481278,
            "start_logit": -3.4952566623687744,
            "end_logit": -1.2770521640777588
        },
        {
            "text": "recent US FDA-approved treatment for dyskinesia in PD patients. ADS-5102 is a high-dose, ER formulation",
            "probability": 0.00011879084951991262,
            "start_logit": -1.5702459812164307,
            "end_logit": -3.4156837463378906
        },
        {
            "text": "high-dose",
            "probability": 0.00011796373949656814,
            "start_logit": -2.273164987564087,
            "end_logit": -2.7197518348693848
        },
        {
            "text": "FDA",
            "probability": 9.420277323741589e-05,
            "start_logit": -2.655064582824707,
            "end_logit": -2.5627799034118652
        },
        {
            "text": "FDA-approved treatment for dyskinesia in PD patients. ADS-5102 is a high-dose",
            "probability": 8.051775262214389e-05,
            "start_logit": -2.655064582824707,
            "end_logit": -2.7197518348693848
        },
        {
            "text": "FDA-approved treatment for dyskinesia in PD patients.",
            "probability": 7.626936254529339e-05,
            "start_logit": -2.655064582824707,
            "end_logit": -2.773958206176758
        },
        {
            "text": "high-dose, ER",
            "probability": 7.424722121837068e-05,
            "start_logit": -2.273164987564087,
            "end_logit": -3.1827287673950195
        }
    ],
    "5e4adcbe6d0a277941000017_001": [
        {
            "text": "",
            "probability": 0.9999813544317724,
            "start_logit": 7.440921783447266,
            "end_logit": 7.653418064117432
        },
        {
            "text": "significantly reduced radioiodine uptake",
            "probability": 3.491486111146177e-06,
            "start_logit": 1.2705152034759521,
            "end_logit": 1.2586601972579956
        },
        {
            "text": "significantly reduced",
            "probability": 2.5782079308536893e-06,
            "start_logit": 1.2705152034759521,
            "end_logit": 0.9554272890090942
        },
        {
            "text": "significantly reduced radioiodine uptake and decreased the sensitivity to radioactive iodine (RAI) therapy",
            "probability": 2.4680703207185788e-06,
            "start_logit": 1.2705152034759521,
            "end_logit": 0.9117693305015564
        },
        {
            "text": "BRAF mutation significantly reduced radioiodine uptake",
            "probability": 1.9595876710898428e-06,
            "start_logit": 0.6929218173027039,
            "end_logit": 1.2586601972579956
        },
        {
            "text": "BRAF mutation significantly reduced",
            "probability": 1.447012622699052e-06,
            "start_logit": 0.6929218173027039,
            "end_logit": 0.9554272890090942
        },
        {
            "text": "BRAF mutation significantly reduced radioiodine uptake and decreased the sensitivity to radioactive iodine (RAI) therapy",
            "probability": 1.3851981700351657e-06,
            "start_logit": 0.6929218173027039,
            "end_logit": 0.9117693305015564
        },
        {
            "text": "reduced radioiodine uptake",
            "probability": 1.3554010005095812e-06,
            "start_logit": 0.324285089969635,
            "end_logit": 1.2586601972579956
        },
        {
            "text": "reduced",
            "probability": 1.0008648173753321e-06,
            "start_logit": 0.324285089969635,
            "end_logit": 0.9554272890090942
        },
        {
            "text": "reduced radioiodine uptake and decreased the sensitivity to radioactive iodine (RAI) therapy",
            "probability": 9.581092049459138e-07,
            "start_logit": 0.324285089969635,
            "end_logit": 0.9117693305015564
        },
        {
            "text": "significantly reduced radioiodine uptake and decreased the sensitivity to radioactive iodine (RAI) therapy.",
            "probability": 7.017945617960768e-07,
            "start_logit": 1.2705152034759521,
            "end_logit": -0.3457818329334259
        },
        {
            "text": "BRAF mutation significantly reduced radioiodine uptake and decreased the sensitivity to radioactive iodine (RAI) therapy.",
            "probability": 3.9388040712613175e-07,
            "start_logit": 0.6929218173027039,
            "end_logit": -0.3457818329334259
        },
        {
            "text": "reduced radioiodine uptake and decreased the sensitivity to radioactive iodine (RAI) therapy.",
            "probability": 2.724378734241401e-07,
            "start_logit": 0.324285089969635,
            "end_logit": -0.3457818329334259
        },
        {
            "text": "clinical response to RAI therapy was also compared between positive and negative mutation groups",
            "probability": 1.2736306267854752e-07,
            "start_logit": -0.7133063673973083,
            "end_logit": -0.0685592070221901
        },
        {
            "text": "BRAF mutation",
            "probability": 1.1161164452308187e-07,
            "start_logit": 0.6929218173027039,
            "end_logit": -1.6068037748336792
        },
        {
            "text": "radioiodine uptake",
            "probability": 8.655647509882856e-08,
            "start_logit": -2.4267704486846924,
            "end_logit": 1.2586601972579956
        },
        {
            "text": "decreased the sensitivity to radioactive iodine (RAI) therapy",
            "probability": 8.64860140819647e-08,
            "start_logit": -2.0806939601898193,
            "end_logit": 0.9117693305015564
        },
        {
            "text": "The status of BRAF mutation may not",
            "probability": 7.764512240093722e-08,
            "start_logit": -0.5229797959327698,
            "end_logit": -0.7537788152694702
        },
        {
            "text": "may not",
            "probability": 7.582157858624026e-08,
            "start_logit": -0.5467455983161926,
            "end_logit": -0.7537788152694702
        },
        {
            "text": "the clinical response to RAI therapy was also compared between positive and negative mutation groups",
            "probability": 6.803363920795446e-08,
            "start_logit": -1.340345859527588,
            "end_logit": -0.0685592070221901
        }
    ],
    "5e4adcbe6d0a277941000017_002": [
        {
            "text": "",
            "probability": 0.9999813544317724,
            "start_logit": 7.440921783447266,
            "end_logit": 7.653418064117432
        },
        {
            "text": "significantly reduced radioiodine uptake",
            "probability": 3.491486111146177e-06,
            "start_logit": 1.2705152034759521,
            "end_logit": 1.2586601972579956
        },
        {
            "text": "significantly reduced",
            "probability": 2.5782079308536893e-06,
            "start_logit": 1.2705152034759521,
            "end_logit": 0.9554272890090942
        },
        {
            "text": "significantly reduced radioiodine uptake and decreased the sensitivity to radioactive iodine (RAI) therapy",
            "probability": 2.4680703207185788e-06,
            "start_logit": 1.2705152034759521,
            "end_logit": 0.9117693305015564
        },
        {
            "text": "BRAF mutation significantly reduced radioiodine uptake",
            "probability": 1.9595876710898428e-06,
            "start_logit": 0.6929218173027039,
            "end_logit": 1.2586601972579956
        },
        {
            "text": "BRAF mutation significantly reduced",
            "probability": 1.447012622699052e-06,
            "start_logit": 0.6929218173027039,
            "end_logit": 0.9554272890090942
        },
        {
            "text": "BRAF mutation significantly reduced radioiodine uptake and decreased the sensitivity to radioactive iodine (RAI) therapy",
            "probability": 1.3851981700351657e-06,
            "start_logit": 0.6929218173027039,
            "end_logit": 0.9117693305015564
        },
        {
            "text": "reduced radioiodine uptake",
            "probability": 1.3554010005095812e-06,
            "start_logit": 0.324285089969635,
            "end_logit": 1.2586601972579956
        },
        {
            "text": "reduced",
            "probability": 1.0008648173753321e-06,
            "start_logit": 0.324285089969635,
            "end_logit": 0.9554272890090942
        },
        {
            "text": "reduced radioiodine uptake and decreased the sensitivity to radioactive iodine (RAI) therapy",
            "probability": 9.581092049459138e-07,
            "start_logit": 0.324285089969635,
            "end_logit": 0.9117693305015564
        },
        {
            "text": "significantly reduced radioiodine uptake and decreased the sensitivity to radioactive iodine (RAI) therapy.",
            "probability": 7.017945617960768e-07,
            "start_logit": 1.2705152034759521,
            "end_logit": -0.3457818329334259
        },
        {
            "text": "BRAF mutation significantly reduced radioiodine uptake and decreased the sensitivity to radioactive iodine (RAI) therapy.",
            "probability": 3.9388040712613175e-07,
            "start_logit": 0.6929218173027039,
            "end_logit": -0.3457818329334259
        },
        {
            "text": "reduced radioiodine uptake and decreased the sensitivity to radioactive iodine (RAI) therapy.",
            "probability": 2.724378734241401e-07,
            "start_logit": 0.324285089969635,
            "end_logit": -0.3457818329334259
        },
        {
            "text": "clinical response to RAI therapy was also compared between positive and negative mutation groups",
            "probability": 1.2736306267854752e-07,
            "start_logit": -0.7133063673973083,
            "end_logit": -0.0685592070221901
        },
        {
            "text": "BRAF mutation",
            "probability": 1.1161164452308187e-07,
            "start_logit": 0.6929218173027039,
            "end_logit": -1.6068037748336792
        },
        {
            "text": "radioiodine uptake",
            "probability": 8.655647509882856e-08,
            "start_logit": -2.4267704486846924,
            "end_logit": 1.2586601972579956
        },
        {
            "text": "decreased the sensitivity to radioactive iodine (RAI) therapy",
            "probability": 8.64860140819647e-08,
            "start_logit": -2.0806939601898193,
            "end_logit": 0.9117693305015564
        },
        {
            "text": "The status of BRAF mutation may not",
            "probability": 7.764512240093722e-08,
            "start_logit": -0.5229797959327698,
            "end_logit": -0.7537788152694702
        },
        {
            "text": "may not",
            "probability": 7.582157858624026e-08,
            "start_logit": -0.5467455983161926,
            "end_logit": -0.7537788152694702
        },
        {
            "text": "the clinical response to RAI therapy was also compared between positive and negative mutation groups",
            "probability": 6.803363920795446e-08,
            "start_logit": -1.340345859527588,
            "end_logit": -0.0685592070221901
        }
    ],
    "5e4adcbe6d0a277941000017_003": [
        {
            "text": "predicts the absence of radioiodine uptake at pT-WBS in DTC patients with incomplete bio-chemical response to first RAIT.",
            "probability": 0.224982216802232,
            "start_logit": 1.3250762224197388,
            "end_logit": 2.296535015106201
        },
        {
            "text": "absence of radioiodine uptake at pT-WBS in DTC patients with incomplete bio-chemical response to first RAIT.",
            "probability": 0.17477609350259316,
            "start_logit": 1.0725605487823486,
            "end_logit": 2.296535015106201
        },
        {
            "text": "negative prognostic clue",
            "probability": 0.1563763590433391,
            "start_logit": 1.23515784740448,
            "end_logit": 2.022697687149048
        },
        {
            "text": "incomplete bio-chemical response to first RAIT.",
            "probability": 0.0445333062871888,
            "start_logit": -0.2947077751159668,
            "end_logit": 2.296535015106201
        },
        {
            "text": "the combination of BRAFV600E+ve mutation and MIBI-ve scintigraphy may be considered a negative prognostic clue",
            "probability": 0.0395699943313058,
            "start_logit": -0.13903670012950897,
            "end_logit": 2.022697687149048
        },
        {
            "text": "the absence of radioiodine uptake at pT-WBS in DTC patients with incomplete bio-chemical response to first RAIT.",
            "probability": 0.03697149879544728,
            "start_logit": -0.48079782724380493,
            "end_logit": 2.296535015106201
        },
        {
            "text": "negative prognostic clue,",
            "probability": 0.035540756111530604,
            "start_logit": 1.23515784740448,
            "end_logit": 0.5411121249198914
        },
        {
            "text": "a negative prognostic clue",
            "probability": 0.03495806902630173,
            "start_logit": -0.26295849680900574,
            "end_logit": 2.022697687149048
        },
        {
            "text": "",
            "probability": 0.03459461067937421,
            "start_logit": 0.6677678227424622,
            "end_logit": 1.0815199613571167
        },
        {
            "text": "combination of BRAFV600E+ve mutation and MIBI-ve scintigraphy may be considered a negative prognostic clue",
            "probability": 0.03413624119656967,
            "start_logit": -0.2867482006549835,
            "end_logit": 2.022697687149048
        },
        {
            "text": "predicts the absence",
            "probability": 0.030238295706337084,
            "start_logit": 1.3250762224197388,
            "end_logit": 0.28962284326553345
        },
        {
            "text": "predicts the absence of radioiodine uptake at pT-WBS in DTC patients with incomplete bio-chemical response to first RAIT",
            "probability": 0.0293478864304529,
            "start_logit": 1.3250762224197388,
            "end_logit": 0.259734183549881
        },
        {
            "text": "negative prognostic clue, which predicts the absence",
            "probability": 0.027637977292880932,
            "start_logit": 1.23515784740448,
            "end_logit": 0.28962284326553345
        },
        {
            "text": "absence",
            "probability": 0.0234904397016209,
            "start_logit": 1.0725605487823486,
            "end_logit": 0.28962284326553345
        },
        {
            "text": "absence of radioiodine uptake at pT-WBS in DTC patients with incomplete bio-chemical response to first RAIT",
            "probability": 0.022798730565363665,
            "start_logit": 1.0725605487823486,
            "end_logit": 0.259734183549881
        },
        {
            "text": "may be considered a negative prognostic clue",
            "probability": 0.014219135043002314,
            "start_logit": -1.1625192165374756,
            "end_logit": 2.022697687149048
        },
        {
            "text": "considered a negative prognostic clue",
            "probability": 0.010976984090163983,
            "start_logit": -1.42130708694458,
            "end_logit": 2.022697687149048
        },
        {
            "text": "the combination of BRAFV600E+ve mutation and MIBI-ve scintigraphy may be considered a negative prognostic clue,",
            "probability": 0.008993351210292756,
            "start_logit": -0.13903670012950897,
            "end_logit": 0.5411121249198914
        },
        {
            "text": "a negative prognostic clue,",
            "probability": 0.007945166475256695,
            "start_logit": -0.26295849680900574,
            "end_logit": 0.5411121249198914
        },
        {
            "text": "predicts",
            "probability": 0.00791288770874634,
            "start_logit": 1.3250762224197388,
            "end_logit": -1.05099356174469
        }
    ],
    "5e4adcbe6d0a277941000017_004": [
        {
            "text": "",
            "probability": 0.9961222150484,
            "start_logit": 5.918499946594238,
            "end_logit": 6.4247307777404785
        },
        {
            "text": "lower expression of NIS in PTCs without HT, suggesting the radioiodine-refractory effects",
            "probability": 0.000516066668347768,
            "start_logit": 1.1893945932388306,
            "end_logit": 3.588446855545044
        },
        {
            "text": "correlated with a lower expression of NIS in PTCs without HT, suggesting the radioiodine-refractory effects",
            "probability": 0.0003836304521404099,
            "start_logit": 0.8928383588790894,
            "end_logit": 3.588446855545044
        },
        {
            "text": "suggesting the radioiodine-refractory effects",
            "probability": 0.0003686734626488099,
            "start_logit": 0.8530699610710144,
            "end_logit": 3.588446855545044
        },
        {
            "text": "unclear",
            "probability": 0.00031284742474414306,
            "start_logit": 1.2804913520812988,
            "end_logit": 2.9968297481536865
        },
        {
            "text": "BRAF(V600E) mutation is one possible risk factor that can disturb the NIS expression, but the roles are unclear",
            "probability": 0.0002856287131719074,
            "start_logit": 1.189468502998352,
            "end_logit": 2.9968297481536865
        },
        {
            "text": "the radioiodine-refractory effects",
            "probability": 0.00025607181232853335,
            "start_logit": 0.48861655592918396,
            "end_logit": 3.588446855545044
        },
        {
            "text": "unclear in clinical practice",
            "probability": 0.0002288870122290303,
            "start_logit": 1.2804913520812988,
            "end_logit": 2.684342622756958
        },
        {
            "text": "BRAF(V600E) mutation is one possible risk factor that can disturb the NIS expression, but the roles are unclear in clinical practice",
            "probability": 0.00020897312106119389,
            "start_logit": 1.189468502998352,
            "end_logit": 2.684342622756958
        },
        {
            "text": "the roles are unclear",
            "probability": 0.0001617398097644937,
            "start_logit": 0.6207646727561951,
            "end_logit": 2.9968297481536865
        },
        {
            "text": "BRAF(V600E) mutation is one possible risk factor that can disturb the NIS expression",
            "probability": 0.0001584626955569812,
            "start_logit": 1.189468502998352,
            "end_logit": 2.407656192779541
        },
        {
            "text": "roles are unclear",
            "probability": 0.000148403984879569,
            "start_logit": 0.5347139239311218,
            "end_logit": 2.9968297481536865
        },
        {
            "text": "unclear in clinical practice.",
            "probability": 0.0001288524667914309,
            "start_logit": 1.2804913520812988,
            "end_logit": 2.1097822189331055
        },
        {
            "text": "one possible risk factor that can disturb the NIS expression, but the roles are unclear",
            "probability": 0.00012186558743604905,
            "start_logit": 0.3376944363117218,
            "end_logit": 2.9968297481536865
        },
        {
            "text": "the roles are unclear in clinical practice",
            "probability": 0.00011833289612584474,
            "start_logit": 0.6207646727561951,
            "end_logit": 2.684342622756958
        },
        {
            "text": "BRAF(V600E) mutation is one possible risk factor that can disturb the NIS expression, but the roles are unclear in clinical practice.",
            "probability": 0.00011764189623348134,
            "start_logit": 1.189468502998352,
            "end_logit": 2.1097822189331055
        },
        {
            "text": "roles are unclear in clinical practice",
            "probability": 0.00010857607260071481,
            "start_logit": 0.5347139239311218,
            "end_logit": 2.684342622756958
        },
        {
            "text": "can disturb the NIS expression, but the roles are unclear",
            "probability": 9.310643000920985e-05,
            "start_logit": 0.0685189887881279,
            "end_logit": 2.9968297481536865
        },
        {
            "text": "one possible risk factor that can disturb the NIS expression, but the roles are unclear in clinical practice",
            "probability": 8.91599162901376e-05,
            "start_logit": 0.3376944363117218,
            "end_logit": 2.684342622756958
        },
        {
            "text": "radioiodine-refractory effects",
            "probability": 7.08645292402549e-05,
            "start_logit": -0.7960713505744934,
            "end_logit": 3.588446855545044
        }
    ],
    "5e4adcbe6d0a277941000017_005": [
        {
            "text": "",
            "probability": 0.9999986251528307,
            "start_logit": 6.763167381286621,
            "end_logit": 6.91787576675415
        },
        {
            "text": "significant increase in both uPA and uPAR mRNAs",
            "probability": 1.721186812555126e-07,
            "start_logit": -1.3112064599990845,
            "end_logit": -0.5828306078910828
        },
        {
            "text": "worse prognosis",
            "probability": 1.4728916035861545e-07,
            "start_logit": -1.4152799844741821,
            "end_logit": -0.6345435976982117
        },
        {
            "text": "increase in both uPA and uPAR mRNAs",
            "probability": 1.1033964375814839e-07,
            "start_logit": -1.7558274269104004,
            "end_logit": -0.5828306078910828
        },
        {
            "text": "not",
            "probability": 1.062571473625786e-07,
            "start_logit": -2.33711838722229,
            "end_logit": -0.03924085199832916
        },
        {
            "text": "significant increase in both uPA and uPAR mRNAs.",
            "probability": 1.0580315405629131e-07,
            "start_logit": -1.3112064599990845,
            "end_logit": -1.0694345235824585
        },
        {
            "text": "caused a significant increase in both uPA and uPAR mRNAs",
            "probability": 1.0524346824014283e-07,
            "start_logit": -1.8031142950057983,
            "end_logit": -0.5828306078910828
        },
        {
            "text": "BRAF(V600E) was not",
            "probability": 1.034032693919519e-07,
            "start_logit": -2.3643438816070557,
            "end_logit": -0.03924085199832916
        },
        {
            "text": "increase in both uPA and uPAR mRNAs.",
            "probability": 6.782693338051457e-08,
            "start_logit": -1.7558274269104004,
            "end_logit": -1.0694345235824585
        },
        {
            "text": "Higher levels of uPA and uPAR correlated with lymph node metastases, TNM stage and disease recurrences",
            "probability": 6.718688418895546e-08,
            "start_logit": -1.0149539709091187,
            "end_logit": -1.8197892904281616
        },
        {
            "text": "caused a significant increase in both uPA and uPAR mRNAs.",
            "probability": 6.469426097391506e-08,
            "start_logit": -1.8031142950057983,
            "end_logit": -1.0694345235824585
        },
        {
            "text": "worse prognosis.",
            "probability": 5.883920388346883e-08,
            "start_logit": -1.4152799844741821,
            "end_logit": -1.5521329641342163
        },
        {
            "text": "BRAF(V600E) mutation have a worse prognosis",
            "probability": 4.57647457189749e-08,
            "start_logit": -2.5841636657714844,
            "end_logit": -0.6345435976982117
        },
        {
            "text": "Higher levels of uPA and uPAR correlated with lymph node metastases, TNM stage and disease recurrences.",
            "probability": 3.7115822504295666e-08,
            "start_logit": -1.0149539709091187,
            "end_logit": -2.4132239818573
        },
        {
            "text": "a significant increase in both uPA and uPAR mRNAs",
            "probability": 3.6273394773288985e-08,
            "start_logit": -2.8683061599731445,
            "end_logit": -0.5828306078910828
        },
        {
            "text": "not.",
            "probability": 3.557858287699852e-08,
            "start_logit": -2.33711838722229,
            "end_logit": -1.1333590745925903
        },
        {
            "text": "BRAF(V600E) was not.",
            "probability": 3.4623005427207674e-08,
            "start_logit": -2.3643438816070557,
            "end_logit": -1.1333590745925903
        },
        {
            "text": "significant increase",
            "probability": 2.8554897490908467e-08,
            "start_logit": -1.3112064599990845,
            "end_logit": -2.3791863918304443
        },
        {
            "text": "patients with papillary thyroid cancer (PTC) harbouring the BRAF(V600E) mutation have a worse prognosis",
            "probability": 2.5637278130054206e-08,
            "start_logit": -3.163630247116089,
            "end_logit": -0.6345435976982117
        },
        {
            "text": "a significant increase in both uPA and uPAR mRNAs.",
            "probability": 2.2297635255789807e-08,
            "start_logit": -2.8683061599731445,
            "end_logit": -1.0694345235824585
        }
    ]
}
